data_2k8g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k8g _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.42 HG13 ' OE1' ' A' ' 148' ' ' GLN . 73.2 t . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 112.664 0.616 . . . . 1.3600000000000001 112.664 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.406 ' HA2' ' CB ' ' A' ' 151' ' ' ALA . . . 72.24 25.62 74.07 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 119.732 -1.223 . . . . 0.26000000000000001 112.406 172.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.52 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.2 m120 -85.58 123.85 31.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.806 -0.813 . . . . 0.63 108.806 -174.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.497 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.1 pt -135.72 159.93 39.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 110.319 -0.252 . . . . 1.05 110.319 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.05 141.35 52.12 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.815 -0.439 . . . . 0.26000000000000001 109.815 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 7.2 mt -117.95 137.61 51.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.58 -0.737 . . . . 1.01 110.07 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -120.72 151.57 39.37 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.679 -0.237 . . . . 2.0800000000000001 110.522 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 t30 69.77 54.37 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.86 0.725 . . . . 0.53000000000000003 111.307 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.671 HD22 HG23 ' A' ' 110' ' ' ILE . 14.6 mt -91.61 162.88 14.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.426 -0.807 . . . . 1.04 111.169 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.466 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 14.0 t70 -87.38 155.74 19.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.70999999999999996 109.936 177.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -62.24 -31.39 71.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.388 -0.369 . . . . 2.7799999999999998 111.417 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.8 p -72.32 -4.59 30.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.186 -0.461 . . . . 1.8 111.936 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.671 HG23 HD22 ' A' ' 106' ' ' LEU . 45.1 mm -84.57 118.4 31.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.482 . . . . 1.1000000000000001 110.776 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -108.73 -175.27 2.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.297 -1.001 . . . . 1.5900000000000001 108.297 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -67.66 -32.52 73.25 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.478 -0.934 . . . . 0.92000000000000004 108.478 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -48.72 71.14 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.624 -1.171 . . . . 3.04 109.263 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.43 -43.03 99.79 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.274 -1.33 . . . . 1.03 110.84 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.632 HD13 HG21 ' A' ' 130' ' ' VAL . 3.5 tt -65.73 -47.79 74.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.172 -0.677 . . . . 1.05 109.172 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.648 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 55.3 t80 -59.26 -46.3 88.87 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.743 -0.662 . . . . 1.05 110.486 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.84 -39.85 74.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.505 -0.316 . . . . 0.40000000000000002 111.232 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.448 HG23 HD23 ' A' ' 163' ' ' LEU . 91.3 m -77.73 -53.78 7.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.264 0.468 . . . . 1.02 112.264 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.434 ' CD1' HD22 ' A' ' 115' ' ' LEU . 6.5 m-85 -71.76 -28.09 63.42 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.54 0.57 . . . . 0.14999999999999999 112.54 -173.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.5 t -57.71 -28.86 64.22 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.571 0.224 . . . . 0.56000000000000005 111.296 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.33 -22.86 45.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.678 0.275 . . . . 1.04 111.385 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -89.76 -26.22 20.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.038 0.447 . . . . 0.20999999999999999 110.546 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.89 169.77 35.82 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.125 -0.79 . . . . 0.14000000000000001 111.125 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -71.04 143.59 50.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.65 -0.5 . . . . 0.28999999999999998 109.65 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.423 HG23 ' HB3' ' A' ' 128' ' ' CYS . 76.2 mt -114.76 134.93 56.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 116.014 -0.539 . . . . 1.0700000000000001 110.015 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -93.02 -36.45 12.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 1.26 109.508 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.1 m -156.18 97.61 1.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.733 -0.667 . . . . 1.1799999999999999 111.365 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.648 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.7 p -103.84 153.54 20.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.355 -0.609 . . . . 1.49 109.355 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -150.61 132.44 15.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.818 0.342 . . . . 1.6299999999999999 111.255 -175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.632 HG21 HD13 ' A' ' 115' ' ' LEU . 57.5 t -114.28 110.31 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 107.183 -1.414 . . . . 1.0700000000000001 107.183 171.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.302 -1.493 0 N-CA-C 108.432 -0.951 . . . . 1.1399999999999999 108.432 -175.456 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.693 0 CA-C-O 119.911 -0.383 . . . . 0.31 113.877 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -161.18 153.93 20.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.742 0.771 . . . . 1.01 111.285 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.29 174.06 28.09 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.457 -0.792 . . . . 0.13 111.625 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -139.93 142.65 36.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.928 0.364 . . . . 0.31 110.555 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.5 HG13 ' CE2' ' A' ' 145' ' ' PHE . 24.6 t -118.34 133.96 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.105 0.479 . . . . 1.03 111.362 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.531 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.1 OUTLIER -106.45 106.58 17.16 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.851 -0.796 . . . . 0.32000000000000001 108.851 167.396 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.5 ' CE2' HG13 ' A' ' 143' ' ' VAL . 8.7 m-85 -89.28 139.76 30.17 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.284 0.564 . . . . 0.17000000000000001 111.915 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.538 ' HA ' HD23 ' A' ' 126' ' ' LEU . 43.8 tt0 -52.48 -48.74 65.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.112 -1.404 . . . . 0.56999999999999995 110.07 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.2 p -111.77 144.45 41.03 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.137 -1.392 . . . . 1.1100000000000001 111.062 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.42 ' OE1' HG13 ' A' ' 98' ' ' VAL . 54.3 tp60 -61.92 -40.32 95.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.299 -0.864 . . . . 0.46999999999999997 111.026 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.8 pt-20 -67.68 -35.18 78.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.73999999999999999 111.408 -175.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.84 78.43 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.241 0.543 . . . . 1.03 110.489 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.482 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.97 -44.72 91.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.388 -0.824 . . . . 1.05 110.86 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 37.7 mt-10 -62.06 -37.33 84.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.646 -0.707 . . . . 1.4199999999999999 110.356 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 149' ' ' GLU . 88.8 mtt180 -62.54 -47.05 85.57 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.332 -0.394 . . . . 2.0 110.592 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.78 81.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.997 -0.547 . . . . 1.02 111.012 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.0 mt -61.21 -53.77 44.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.239 -0.437 . . . . 1.04 111.131 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 4.2 pt-20 -64.69 -45.01 88.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.186 0.517 . . . . 1.0800000000000001 111.919 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -75.52 -38.92 59.07 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.483 -0.78 . . . . 1.78 112.893 -170.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 83.8 mmm -93.51 -26.23 17.25 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.917 0.71 . . . . 1.03 112.917 -173.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -64.79 123.74 20.15 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.549 -0.46 . . . . 0.60999999999999999 110.15 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.42 11.65 62.27 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.816 -0.706 . . . . 0.28999999999999998 113.184 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.67 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 75.2 mmm -105.39 164.25 12.0 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.568 -0.372 . . . . 1.72 111.508 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 167' ' ' LYS . 19.8 mt -96.33 123.21 39.89 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.928 -0.768 . . . . 1.1799999999999999 108.928 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.517 HD11 HG12 ' A' ' 168' ' ' VAL . 24.9 mt -106.43 100.21 9.75 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.934 -0.706 . . . . 1.1299999999999999 109.659 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 94.5 m-20 77.72 -28.82 0.16 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.871 -1.059 . . . . 1.71 112.725 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 163' ' ' LEU . 35.7 t70 174.44 -23.85 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.772 -0.649 . . . . 0.84999999999999998 112.221 -174.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.466 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.7 mtt180 -115.96 134.93 54.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.935 0.397 . . . . 1.27 111.602 -173.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.5 ttmt -76.92 123.83 26.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.418 -0.81 . . . . 1.6499999999999999 109.171 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.517 HG12 HD11 ' A' ' 163' ' ' LEU . 23.2 m -103.05 146.6 10.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.434 0.635 . . . . 1.04 111.528 -174.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 73.5 t80 -107.51 119.26 38.94 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.016 -0.993 . . . . 0.41999999999999998 109.116 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.425 ' CG1' HD12 ' A' ' 101' ' ' ILE . 43.0 t -114.82 128.04 72.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.467 -0.568 . . . . 1.03 109.467 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.61 -177.44 22.86 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.365 -0.922 . . . . 0.17999999999999999 112.714 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.477 ' HA ' ' HE ' ' A' ' 172' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 120.889 0.376 . . . . 2.3599999999999999 110.795 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 121.701 0.762 . . . . 1.3600000000000001 111.781 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.89 22.71 78.9 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.265 -0.969 . . . . 0.26000000000000001 111.217 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -96.18 128.38 43.04 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.14 -0.689 . . . . 0.63 109.14 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.471 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.8 pt -133.31 162.5 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.162 -0.472 . . . . 1.05 109.864 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.24 144.63 50.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.006 0.431 . . . . 0.26000000000000001 109.908 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 5.7 mt -119.92 135.49 60.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.588 -0.733 . . . . 1.01 110.071 -177.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -116.66 152.37 34.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.732 -0.213 . . . . 2.0800000000000001 110.652 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 t30 71.58 40.65 0.78 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.942 0.777 . . . . 0.53000000000000003 111.79 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.637 HD23 HG22 ' A' ' 110' ' ' ILE . 20.6 mt -78.24 158.55 28.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.389 0.614 . . . . 1.04 111.755 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.473 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 25.1 t70 -81.93 150.76 27.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.359 -0.837 . . . . 0.70999999999999996 110.916 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -55.72 -36.88 67.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.599 -0.728 . . . . 2.7799999999999998 112.131 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.6 m -84.02 -3.87 58.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.89 0.33 . . . . 1.8 111.89 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.637 HG22 HD23 ' A' ' 106' ' ' LEU . 27.9 mm -71.87 117.14 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.091 0.472 . . . . 1.1000000000000001 110.183 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 15.6 t70 -105.64 -171.74 1.96 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.798 -0.815 . . . . 1.5900000000000001 108.798 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.457 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 87.3 m-20 -72.17 -32.61 67.01 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.319 -0.993 . . . . 0.92000000000000004 108.319 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.607 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -68.68 -45.05 72.71 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.039 -1.437 . . . . 3.04 109.661 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.76 -44.25 97.26 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.662 -1.608 . . . . 1.03 110.574 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.572 HD12 HG21 ' A' ' 130' ' ' VAL . 4.1 tt -67.4 -47.19 71.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.165 -0.925 . . . . 1.05 109.378 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.795 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 83.5 t80 -58.98 -45.31 90.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.893 -0.594 . . . . 1.05 111.165 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.85 -40.89 76.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.852 0.358 . . . . 0.40000000000000002 110.877 -175.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 58.8 m -77.41 -53.71 7.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.238 -0.437 . . . . 1.02 112.136 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.409 ' CD1' HD21 ' A' ' 115' ' ' LEU . 14.1 m-85 -71.59 -28.43 63.81 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.657 0.614 . . . . 0.14999999999999999 112.657 -173.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -57.75 -28.42 63.91 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.609 0.243 . . . . 0.56000000000000005 111.078 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.78 -22.68 37.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.804 0.298 . . . . 1.04 111.804 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -91.88 -15.54 27.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.997 0.427 . . . . 0.20999999999999999 111.038 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.19 166.79 22.6 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.531 -0.628 . . . . 0.14000000000000001 111.531 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -67.57 139.44 56.91 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.033 0.444 . . . . 0.28999999999999998 110.201 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.419 HG23 ' HB3' ' A' ' 128' ' ' CYS . 65.9 mt -113.37 133.91 57.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.725 -0.671 . . . . 1.0700000000000001 109.723 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -90.37 -43.7 10.15 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.884 -0.784 . . . . 1.26 108.884 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 55.7 m -145.65 99.75 3.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.231 -0.895 . . . . 1.1799999999999999 110.962 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.795 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.6 p -97.53 145.9 25.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.17 -0.678 . . . . 1.49 109.17 171.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -148.79 134.27 18.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.063 0.459 . . . . 1.6299999999999999 111.8 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.613 HG23 HG23 ' A' ' 110' ' ' ILE . 99.1 t -114.02 115.07 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 106.587 -1.634 . . . . 1.0700000000000001 106.587 170.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.2 t . . . . . 0 C--N 1.301 -1.514 0 N-CA-C 108.709 -0.848 . . . . 1.1399999999999999 108.709 -176.64 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.696 0 N-CA-C 113.35 0.1 . . . . 0.31 113.35 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -123.68 152.84 41.6 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.457 0.646 . . . . 1.01 111.976 -172.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.89 174.36 23.63 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.954 -1.021 . . . . 0.13 111.309 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -138.72 140.99 38.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.01 0.405 . . . . 0.31 110.72 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.494 HG12 ' CE2' ' A' ' 145' ' ' PHE . 43.0 t -115.45 129.17 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 120.946 0.403 . . . . 1.03 110.492 172.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.1 m170 -100.47 105.19 16.62 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.267 -0.642 . . . . 0.32000000000000001 109.267 167.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.559 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 18.8 m-85 -87.25 142.97 27.5 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.078 0.466 . . . . 0.17000000000000001 110.392 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.546 ' HA ' HD23 ' A' ' 126' ' ' LEU . 35.5 tt0 -52.89 -34.45 54.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.426 -1.261 . . . . 0.56999999999999995 110.706 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.6 p -129.94 152.38 49.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.348 -0.842 . . . . 1.1100000000000001 111.277 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -62.18 -36.02 80.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.694 -0.684 . . . . 0.46999999999999997 111.204 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.26 -35.66 76.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.008 0.373 . . . . 0.73999999999999999 112.008 -175.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.88 -34.67 78.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 1.03 110.553 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.559 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -65.3 -41.72 93.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.722 -0.672 . . . . 1.05 110.944 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 32.4 mt-10 -59.33 -40.19 85.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 1.4199999999999999 110.775 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 70.8 mtt180 -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 2.0 111.192 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.68 84.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.438 -0.346 . . . . 1.02 110.451 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.1 mt -62.26 -53.25 49.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.242 -0.435 . . . . 1.04 111.168 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 0.9 OUTLIER -64.27 -41.86 96.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.07 0.462 . . . . 1.0800000000000001 111.899 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.23 -38.69 24.14 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.084 0.772 . . . . 1.78 113.084 -171.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 92.8 mmm -93.81 -20.52 20.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.843 0.683 . . . . 1.03 112.843 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.443 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 58.2 t30 -68.5 123.83 21.89 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.965 -0.694 . . . . 0.60999999999999999 109.495 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.53 17.01 57.78 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.742 -0.742 . . . . 0.28999999999999998 112.721 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.725 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.4 mmt -100.91 163.4 12.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.675 0.274 . . . . 1.72 111.54 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 mt -104.3 105.21 15.27 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.983 -0.553 . . . . 1.1799999999999999 109.826 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 18.8 mt -93.04 105.97 17.99 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.974 -0.691 . . . . 1.1299999999999999 109.881 175.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 93.3 m-20 75.09 -51.23 0.67 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.124 -0.944 . . . . 1.71 111.843 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -178.63 22.09 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.88 -0.6 . . . . 0.84999999999999998 111.729 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.4 mtt180 -138.76 135.48 34.72 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.681 -0.637 . . . . 1.27 109.957 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.2 ttmt -83.08 117.68 23.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.497 -0.557 . . . . 1.6499999999999999 109.497 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.5 m -100.52 148.39 6.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.588 0.709 . . . . 1.04 111.448 -171.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 69.2 t80 -106.46 120.61 42.35 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.647 -1.16 . . . . 0.41999999999999998 109.292 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.466 ' CG1' HD11 ' A' ' 101' ' ' ILE . 43.2 t -115.65 126.24 73.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.448 -0.575 . . . . 1.03 109.448 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.06 -175.9 21.89 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.745 -0.741 . . . . 0.17999999999999999 111.548 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.3 -0.63 . . . . 2.3599999999999999 109.3 -179.848 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.9 t . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 121.552 0.692 . . . . 1.3600000000000001 112.25 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.8 24.05 76.78 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 119.974 -1.107 . . . . 0.26000000000000001 111.605 177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.48 ' N ' HD21 ' A' ' 100' ' ' ASN . 0.9 OUTLIER -88.74 125.96 35.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.273 -0.64 . . . . 0.63 109.273 -174.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.524 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.6 pt -135.46 161.43 39.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.989 -0.374 . . . . 1.05 109.989 175.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.23 137.87 54.11 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.88 -0.415 . . . . 0.26000000000000001 109.88 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 5.1 mt -115.21 135.05 56.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.612 -0.722 . . . . 1.01 110.013 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -117.12 152.95 33.65 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.292 -0.262 . . . . 2.0800000000000001 110.292 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.3 t30 74.89 35.1 0.65 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.818 0.699 . . . . 0.53000000000000003 111.474 171.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.445 HD22 HG23 ' A' ' 110' ' ' ILE . 30.7 mt -79.79 159.54 26.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.12 0.486 . . . . 1.04 111.185 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -92.66 150.71 20.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.596 -0.729 . . . . 0.70999999999999996 110.414 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -52.1 -31.98 33.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.758 -0.656 . . . . 2.7799999999999998 112.213 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.5 m -71.78 -17.32 62.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.096 0.406 . . . . 1.8 112.096 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.543 HG21 HG22 ' A' ' 130' ' ' VAL . 28.5 mm -71.43 123.52 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.251 0.548 . . . . 1.1000000000000001 110.835 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 26.5 t70 -107.87 -177.98 3.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.279 -0.873 . . . . 1.5900000000000001 109.056 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.466 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 4.6 m-20 -69.61 -35.09 74.96 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.344 -0.984 . . . . 0.92000000000000004 108.344 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -45.66 71.68 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.628 -1.169 . . . . 3.04 109.052 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.24 91.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.006 -1.452 . . . . 1.03 110.669 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.553 HD13 HG23 ' A' ' 130' ' ' VAL . 3.8 tt -68.87 -47.02 66.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.199 -0.91 . . . . 1.05 109.231 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.72 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 65.6 t80 -60.64 -45.1 95.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 1.05 111.132 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -56.8 -40.61 76.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.03 0.443 . . . . 0.40000000000000002 110.543 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.559 HG23 HD21 ' A' ' 163' ' ' LEU . 20.4 m -77.52 -53.81 7.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.747 -0.661 . . . . 1.02 111.822 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.404 ' CD1' HD22 ' A' ' 115' ' ' LEU . 11.1 m-85 -72.48 -28.16 62.73 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.743 0.646 . . . . 0.14999999999999999 112.743 -174.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.6 t -57.57 -29.05 64.12 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.58 0.229 . . . . 0.56000000000000005 111.207 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.35 39.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.928 0.394 . . . . 1.04 111.716 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.418 ' HZ ' ' HE3' ' A' ' 157' ' ' LYS . 33.0 m-85 -92.83 -14.83 27.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.414 -0.357 . . . . 0.20999999999999999 111.019 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.5 169.83 26.43 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.624 -0.59 . . . . 0.14000000000000001 111.624 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -73.15 138.65 45.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.108 0.48 . . . . 0.28999999999999998 110.247 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.401 HG23 ' HB3' ' A' ' 128' ' ' CYS . 69.2 mt -111.03 132.09 60.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.718 -0.673 . . . . 1.0700000000000001 110.038 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.551 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -84.57 -43.27 14.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.569 -0.9 . . . . 1.26 108.569 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.3 m -146.5 131.78 18.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.819 -1.082 . . . . 1.1799999999999999 110.255 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.5 p -128.69 134.67 48.56 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.117 -0.698 . . . . 1.49 109.117 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -133.76 133.33 41.6 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.586 -0.446 . . . . 1.6299999999999999 111.776 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.553 HG23 HD13 ' A' ' 115' ' ' LEU . 83.9 t -114.56 110.44 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 107.012 -1.477 . . . . 1.0700000000000001 107.012 170.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 t . . . . . 0 C--N 1.304 -1.379 0 N-CA-C 108.971 -0.752 . . . . 1.1399999999999999 108.971 -175.13 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 120.253 -0.193 . . . . 0.31 113.527 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 29.9 p90 -132.79 150.75 52.12 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.359 0.6 . . . . 1.01 111.854 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.22 167.14 26.18 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.036 -0.984 . . . . 0.13 111.341 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -133.99 136.97 44.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.937 0.368 . . . . 0.31 110.738 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.561 HG12 ' CE2' ' A' ' 145' ' ' PHE . 42.7 t -110.79 136.16 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 1.03 110.644 174.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.454 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 1.2 m170 -105.95 105.37 15.38 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.774 -0.824 . . . . 0.32000000000000001 108.774 166.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.582 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 17.8 m-85 -88.71 140.8 29.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.099 0.476 . . . . 0.17000000000000001 110.732 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.551 ' HA ' HD21 ' A' ' 126' ' ' LEU . 34.7 tt0 -51.7 -41.33 61.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.749 -1.114 . . . . 0.56999999999999995 110.361 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 78.2 p -115.24 150.52 36.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.701 -1.136 . . . . 1.1100000000000001 110.157 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -65.65 -36.12 82.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.132 -0.485 . . . . 0.46999999999999997 110.593 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 12.5 pt-20 -69.04 -35.0 76.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.73999999999999999 111.828 -176.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.29 79.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.067 0.46 . . . . 1.03 110.639 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.582 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -64.02 -46.31 85.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.705 -0.68 . . . . 1.05 110.507 177.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.506 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 42.7 mt-10 -61.74 -34.55 76.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.328 -0.851 . . . . 1.4199999999999999 110.91 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.497 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 95.9 mtt180 -61.82 -47.63 84.21 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.106 0.479 . . . . 2.0 110.543 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.8 -35.8 77.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.86 -0.609 . . . . 1.02 110.587 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.5 mt -60.61 -54.41 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 1.04 111.225 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 0.8 OUTLIER -64.04 -42.44 97.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.53 . . . . 1.0800000000000001 111.768 -177.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.418 ' HE3' ' HZ ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -80.25 -37.97 31.88 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.486 -0.779 . . . . 1.78 112.819 -170.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 91.9 mmm -96.41 -16.93 20.95 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.818 0.673 . . . . 1.03 112.818 -173.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -70.0 124.04 23.05 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.09 -0.644 . . . . 0.60999999999999999 109.882 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.19 15.56 74.13 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.166 -0.47 . . . . 0.28999999999999998 112.088 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 11.7 tpp -99.91 157.6 16.41 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.065 -0.346 . . . . 1.72 110.065 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.0 mt -96.94 110.92 23.34 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 109.349 -0.612 . . . . 1.1799999999999999 109.349 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.559 HD21 HG23 ' A' ' 118' ' ' THR . 20.8 mt -98.02 105.18 17.29 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.981 -0.687 . . . . 1.1299999999999999 109.539 173.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 61.3 m-20 77.11 -29.62 0.17 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.22 -0.9 . . . . 1.71 112.681 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 21.1 t70 168.19 -22.18 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.701 0.625 . . . . 0.84999999999999998 111.864 -170.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 80.5 mtt-85 -113.3 137.78 50.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.867 0.365 . . . . 1.27 111.118 -170.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 161' ' ' MET . 8.0 tttm -81.5 112.96 19.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.669 -0.696 . . . . 1.6499999999999999 109.307 -177.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.15 148.48 6.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.599 0.714 . . . . 1.04 111.245 -172.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 68.3 t80 -106.68 119.49 39.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.726 -1.124 . . . . 0.41999999999999998 109.384 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 40.1 t -114.57 125.46 71.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.983 -0.747 . . . . 1.03 108.983 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -144.41 -171.68 14.52 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.577 -0.821 . . . . 0.17999999999999999 112.095 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 . . . . . 0 C--N 1.321 -0.658 0 N-CA-C 109.879 -0.415 . . . . 2.3599999999999999 109.879 -178.434 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.4 t . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 121.401 0.62 . . . . 1.3600000000000001 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.69 24.18 73.13 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.384 -0.912 . . . . 0.26000000000000001 112.117 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -86.88 124.26 32.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.445 -0.576 . . . . 0.63 109.445 -174.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.478 HG12 ' HB ' ' A' ' 143' ' ' VAL . 20.2 pt -135.67 161.88 37.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.995 -0.548 . . . . 1.05 109.803 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.42 144.11 50.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.864 -0.421 . . . . 0.26000000000000001 109.864 176.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 4.5 mt -118.82 130.99 72.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.613 -0.721 . . . . 1.01 110.166 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -109.65 152.25 25.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.587 -0.278 . . . . 2.0800000000000001 110.702 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.6 t30 72.14 33.65 1.55 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.926 0.766 . . . . 0.53000000000000003 111.861 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.441 HD23 HG23 ' A' ' 110' ' ' ILE . 17.3 mt -72.64 155.39 40.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.063 0.459 . . . . 1.04 111.446 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.472 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 23.3 t70 -75.25 146.91 40.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.732 -0.667 . . . . 0.70999999999999996 109.832 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -60.47 -31.72 70.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.108 -0.496 . . . . 2.7799999999999998 111.796 -176.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t -79.04 -4.29 49.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.575 -0.284 . . . . 1.8 111.499 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.441 HG23 HD23 ' A' ' 106' ' ' LEU . 32.0 mm -73.03 127.14 34.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.419 . . . . 1.1000000000000001 110.393 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.42 ' H ' ' HB2' ' A' ' 114' ' ' ALA . 10.5 t70 -110.89 -177.15 3.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.748 -0.66 . . . . 1.5900000000000001 109.28 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.586 ' OD1' ' HA ' ' A' ' 129' ' ' LYS . 69.1 m-80 -72.06 -32.08 66.73 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.565 -0.902 . . . . 0.92000000000000004 108.565 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -47.95 74.35 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.675 -1.148 . . . . 3.04 108.797 176.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.42 ' HB2' ' H ' ' A' ' 111' ' ' ASP . . . -61.63 -43.57 98.6 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.039 -1.437 . . . . 1.03 111.103 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.496 HD12 HG21 ' A' ' 130' ' ' VAL . 3.2 tt -66.54 -46.58 75.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.478 -0.783 . . . . 1.05 109.27 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.417 ' CE1' ' HB ' ' A' ' 125' ' ' ILE . 62.3 t80 -60.52 -46.35 90.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 1.05 110.658 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -56.55 -39.49 73.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.858 0.361 . . . . 0.40000000000000002 111.044 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 m -78.1 -54.02 6.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.001 -0.545 . . . . 1.02 112.087 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.405 ' CD1' HD21 ' A' ' 115' ' ' LEU . 9.2 m-85 -72.15 -28.39 63.21 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.683 0.623 . . . . 0.14999999999999999 112.683 -173.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.8 t -57.67 -28.46 63.78 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.826 0.346 . . . . 0.56000000000000005 110.809 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.4 36.01 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.227 -0.442 . . . . 1.04 111.637 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -89.74 -31.99 17.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.984 0.421 . . . . 0.20999999999999999 110.723 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.49 165.41 34.08 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.392 -0.683 . . . . 0.14000000000000001 111.392 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -62.19 140.84 58.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.971 0.415 . . . . 0.28999999999999998 109.972 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.746 HD12 ' SG ' ' A' ' 128' ' ' CYS . 94.8 mt -114.34 133.96 58.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.937 -0.574 . . . . 1.0700000000000001 110.637 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -91.05 -37.12 13.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.076 -0.712 . . . . 1.26 109.076 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 70.5 m -159.54 111.11 2.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.529 -0.759 . . . . 1.1799999999999999 111.227 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.794 ' SG ' HG11 ' A' ' 143' ' ' VAL . 54.2 m -109.12 144.9 36.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.527 -0.546 . . . . 1.49 109.527 169.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.586 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 53.1 tptt -135.62 131.96 36.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.157 -0.474 . . . . 1.6299999999999999 111.416 -175.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.496 HG21 HD12 ' A' ' 115' ' ' LEU . 88.5 t -114.19 110.13 31.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 106.539 -1.652 . . . . 1.0700000000000001 106.539 168.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 C--N 1.308 -1.216 0 CA-C-N 115.55 -0.75 . . . . 1.1399999999999999 109.976 -171.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 CA-C-O 120.529 -0.04 . . . . 0.31 113.114 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -132.34 153.44 50.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.835 0.35 . . . . 1.01 110.907 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.7 173.35 24.02 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.87 -0.605 . . . . 0.13 111.898 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -135.59 143.99 45.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.731 0.265 . . . . 0.31 110.722 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.794 HG11 ' SG ' ' A' ' 128' ' ' CYS . 40.1 t -118.58 136.45 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 1.03 111.142 173.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.1 m170 -106.46 106.38 16.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.19 -0.67 . . . . 0.32000000000000001 109.19 166.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.583 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.5 m-85 -89.4 137.61 32.17 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.329 0.585 . . . . 0.17000000000000001 111.354 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.516 ' HA ' HD21 ' A' ' 126' ' ' LEU . 43.7 tt0 -47.86 -40.25 20.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.19 -1.368 . . . . 0.56999999999999995 110.951 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.1 p -120.3 153.0 37.01 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.276 -0.875 . . . . 1.1100000000000001 110.914 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -67.35 -34.95 78.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 0.46999999999999997 110.453 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 12.1 pt-20 -70.04 -34.74 73.64 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.261 -0.427 . . . . 0.73999999999999999 111.737 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.05 -34.84 77.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.998 0.427 . . . . 1.03 110.649 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.583 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.82 -46.5 84.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.681 -0.691 . . . . 1.05 110.717 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.577 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 40.3 mt-10 -59.18 -37.7 78.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.781 -0.645 . . . . 1.4199999999999999 111.003 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 86.6 mtt180 -59.58 -44.89 93.2 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.983 0.42 . . . . 2.0 110.54 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.79 85.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.984 -0.553 . . . . 1.02 110.452 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 151' ' ' ALA . 78.1 mt -62.76 -54.17 37.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.209 -0.45 . . . . 1.04 111.063 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.3 pt-20 -60.59 -44.04 96.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 1.0800000000000001 111.613 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.431 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -82.04 -39.42 23.52 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.211 0.819 . . . . 1.78 113.211 -170.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 95.4 mmm -92.61 -23.33 19.05 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.618 0.599 . . . . 1.03 112.618 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -66.85 123.49 20.31 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.225 -0.59 . . . . 0.60999999999999999 109.695 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.84 8.57 69.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.912 -0.661 . . . . 0.28999999999999998 112.626 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.609 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 29.2 mmt -96.53 170.75 9.0 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 120.886 0.374 . . . . 1.72 111.541 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 33.3 mt -105.22 126.79 52.48 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.571 -0.74 . . . . 1.1799999999999999 109.377 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 11.5 mt -109.92 108.07 18.22 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.916 -0.772 . . . . 1.1299999999999999 108.916 168.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 4.7 m-20 78.83 -33.75 0.16 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.166 0.916 . . . . 1.71 111.817 176.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 163' ' ' LEU . 33.4 t70 168.77 -20.87 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.13 -0.941 . . . . 0.84999999999999998 111.754 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.472 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 97.6 mtt180 -100.9 138.67 37.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.714 -0.221 . . . . 1.27 110.504 -174.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 161' ' ' MET . 3.5 ttmp? -83.96 120.6 26.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.414 -0.587 . . . . 1.6499999999999999 109.414 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.64 148.98 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.579 0.704 . . . . 1.04 111.615 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 58.4 t80 -107.84 122.42 46.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.862 -1.063 . . . . 0.41999999999999998 109.101 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.444 ' CG1' HD11 ' A' ' 101' ' ' ILE . 47.1 t -115.14 125.42 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.205 -0.665 . . . . 1.03 109.205 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -146.83 -171.46 16.12 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.573 -0.822 . . . . 0.17999999999999999 111.984 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 109.741 -0.466 . . . . 2.3599999999999999 109.741 -178.429 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 121.118 0.485 . . . . 1.3600000000000001 112.22 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.23 23.99 77.11 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.809 -1.186 . . . . 0.26000000000000001 111.48 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.48 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.1 m120 -88.27 125.96 34.92 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.982 -0.747 . . . . 0.63 108.982 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.509 HG12 ' HB ' ' A' ' 143' ' ' VAL . 22.8 pt -135.4 162.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.096 -0.335 . . . . 1.05 110.096 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.81 140.55 52.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.93 0.395 . . . . 0.26000000000000001 109.991 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.8 mt -115.19 141.16 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.626 -0.715 . . . . 1.01 110.033 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.568 ' HZ2' ' HB3' ' A' ' 104' ' ' LYS . 3.0 ttpm? -123.02 148.78 45.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.901 -0.136 . . . . 2.0800000000000001 110.709 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.9 t30 72.43 48.36 0.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.664 0.786 . . . . 0.53000000000000003 111.856 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.53 HD22 HG23 ' A' ' 110' ' ' ILE . 32.3 mt -90.01 160.85 16.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.249 -0.432 . . . . 1.04 110.765 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -93.9 155.57 17.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.70999999999999996 109.988 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -59.93 -28.01 67.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.428 -0.351 . . . . 2.7799999999999998 111.82 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -72.64 -8.47 55.46 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.85 0.315 . . . . 1.8 111.85 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.544 HG21 HG23 ' A' ' 130' ' ' VAL . 30.9 mm -83.83 117.66 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.417 . . . . 1.1000000000000001 110.353 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -108.96 -175.62 2.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.397 -0.964 . . . . 1.5900000000000001 108.397 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -67.09 -30.37 70.38 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.947 -0.76 . . . . 0.92000000000000004 108.947 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -49.54 60.32 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.432 -1.258 . . . . 3.04 109.457 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.71 -39.69 92.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.369 -1.287 . . . . 1.03 110.628 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 130' ' ' VAL . 3.6 tt -67.44 -47.5 70.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.322 -0.854 . . . . 1.05 109.113 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.697 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 61.3 t80 -59.52 -46.43 88.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.919 -0.582 . . . . 1.05 110.775 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -56.09 -39.14 71.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.282 -0.417 . . . . 0.40000000000000002 111.137 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.636 HG21 HD22 ' A' ' 163' ' ' LEU . 26.4 m -78.54 -54.25 6.35 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.436 0.532 . . . . 1.02 112.436 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.0 -27.2 61.64 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.093 0.775 . . . . 0.14999999999999999 113.093 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.3 t -56.13 -28.84 59.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.818 0.303 . . . . 0.56000000000000005 111.818 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.02 37.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.887 0.328 . . . . 1.04 111.887 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -92.2 -12.86 31.61 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.538 0.199 . . . . 0.20999999999999999 111.538 -176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.2 172.93 28.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.075 -0.583 . . . . 0.14000000000000001 111.646 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -71.84 138.78 48.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.06 0.457 . . . . 0.28999999999999998 110.408 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.413 HG23 ' HB3' ' A' ' 128' ' ' CYS . 72.7 mt -111.92 129.25 67.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.79 -0.641 . . . . 1.0700000000000001 109.862 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.571 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.89 -39.63 15.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.53 0.681 . . . . 1.26 109.188 -178.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 50.8 m -151.58 105.06 3.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.286 -0.87 . . . . 1.1799999999999999 111.034 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 4.6 p -104.1 142.04 35.17 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.35 -0.611 . . . . 1.49 109.35 174.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -143.59 130.94 20.92 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.432 -0.507 . . . . 1.6299999999999999 112.038 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.608 HG21 HD13 ' A' ' 115' ' ' LEU . 57.8 t -114.26 110.66 32.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 106.808 -1.553 . . . . 1.0700000000000001 106.808 170.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.304 -1.371 0 CA-C-N 115.729 -0.669 . . . . 1.1399999999999999 109.324 -173.513 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.683 0 N-CA-C 113.572 0.189 . . . . 0.31 113.572 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -128.56 151.88 48.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 117.32 0.56 . . . . 1.01 111.582 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.42 172.14 24.0 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.375 -0.83 . . . . 0.13 111.616 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -135.73 138.17 42.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.995 0.398 . . . . 0.31 110.923 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.569 HG13 ' CE2' ' A' ' 145' ' ' PHE . 47.1 t -110.33 133.89 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 120.985 0.421 . . . . 1.03 110.686 172.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.5 OUTLIER -104.22 105.23 15.31 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.964 -0.754 . . . . 0.32000000000000001 108.964 167.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.569 ' CE2' HG13 ' A' ' 143' ' ' VAL . 14.4 m-85 -89.8 139.53 30.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.048 0.452 . . . . 0.17000000000000001 110.693 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.571 ' HA ' HD22 ' A' ' 126' ' ' LEU . 33.2 tt0 -52.3 -44.06 64.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.749 -1.114 . . . . 0.56999999999999995 110.214 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 63.4 p -111.78 150.47 30.26 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.666 -1.152 . . . . 1.1100000000000001 110.837 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -68.42 -35.55 77.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.968 -0.56 . . . . 0.46999999999999997 110.572 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -69.33 -34.34 74.5 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.237 -0.438 . . . . 0.73999999999999999 111.799 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.89 79.45 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.115 0.483 . . . . 1.03 110.59 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.51 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.64 -45.54 92.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.485 -0.779 . . . . 1.05 110.845 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.0 mt-10 -59.06 -37.4 76.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.95 -0.568 . . . . 1.4199999999999999 110.778 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.3 mtt180 -62.4 -45.59 92.43 Favored 'General case' 0 CA--C 1.523 -0.064 0 CA-C-O 120.986 0.422 . . . . 2.0 110.411 176.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.15 80.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.513 . . . . 1.02 110.517 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 151' ' ' ALA . 89.4 mt -61.68 -54.47 34.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.066 -0.515 . . . . 1.04 111.324 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.1 pt-20 -64.35 -43.16 95.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.329 0.585 . . . . 1.0800000000000001 111.98 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -78.98 -38.42 36.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.23 -0.895 . . . . 1.78 112.773 -169.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.0 mmm -93.1 -24.21 18.35 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.47 0.545 . . . . 1.03 112.47 -175.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -64.75 123.74 20.14 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.464 -0.494 . . . . 0.60999999999999999 109.811 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.24 14.75 61.69 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.869 -0.681 . . . . 0.28999999999999998 112.909 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.6 mmt -106.83 162.65 13.61 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.523 -0.398 . . . . 1.72 111.792 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.9 mt -98.78 108.76 21.53 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.863 -0.608 . . . . 1.1799999999999999 109.7 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.636 HD22 HG21 ' A' ' 118' ' ' THR . 17.3 mt -93.98 110.02 21.72 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.824 -0.751 . . . . 1.1299999999999999 109.114 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 91.7 m-20 73.01 -67.62 0.26 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.323 -0.853 . . . . 1.71 110.919 -175.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -161.79 14.54 0.09 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.854 -0.612 . . . . 0.84999999999999998 111.491 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -131.34 133.2 45.09 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.813 -0.554 . . . . 1.27 109.889 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 161' ' ' MET . 17.6 ttmt -78.64 119.47 21.95 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.41 -0.589 . . . . 1.6499999999999999 109.41 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 18.9 m -101.57 141.98 17.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.348 0.594 . . . . 1.04 111.183 -173.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -106.74 121.85 45.2 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.07 -0.968 . . . . 0.41999999999999998 109.406 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 155' ' ' ILE . 37.7 t -116.07 125.98 73.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.549 -0.537 . . . . 1.03 109.549 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -140.05 -165.96 10.48 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.651 -0.785 . . . . 0.17999999999999999 112.02 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 109.834 -0.432 . . . . 2.3599999999999999 109.834 -177.432 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 121.537 0.684 . . . . 1.3600000000000001 112.008 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.36 25.51 65.7 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.057 -1.068 . . . . 0.26000000000000001 112.063 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.548 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.2 m120 -89.03 123.84 33.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.232 -0.655 . . . . 0.63 109.232 -172.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.555 HG12 ' HB ' ' A' ' 143' ' ' VAL . 17.3 pt -136.43 164.44 31.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.445 -0.343 . . . . 1.05 110.301 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.55 147.81 49.81 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.925 -0.398 . . . . 0.26000000000000001 109.925 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 5.3 mt -122.18 137.37 55.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.786 -0.643 . . . . 1.01 110.195 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -116.62 151.15 36.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.745 -0.207 . . . . 2.0800000000000001 110.739 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 t30 73.97 38.4 0.58 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.938 0.774 . . . . 0.53000000000000003 111.543 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.404 HD22 HG23 ' A' ' 110' ' ' ILE . 23.2 mt -77.97 158.16 29.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.118 0.485 . . . . 1.04 111.399 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.457 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 20.5 t70 -84.91 151.11 24.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.491 -0.777 . . . . 0.70999999999999996 110.561 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.1 pttm -58.52 -29.99 66.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.751 -0.658 . . . . 2.7799999999999998 112.681 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.5 m -82.84 -3.92 57.4 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.168 0.433 . . . . 1.8 112.168 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.527 HG21 HG22 ' A' ' 130' ' ' VAL . 31.5 mm -73.97 127.44 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.135 0.493 . . . . 1.1000000000000001 110.905 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.7 -178.06 3.3 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.049 -0.723 . . . . 1.5900000000000001 109.049 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.95 -32.43 69.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.889 -0.782 . . . . 0.92000000000000004 108.889 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -47.59 72.15 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.802 -1.09 . . . . 3.04 109.01 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.72 -44.16 97.45 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 114.029 -1.441 . . . . 1.03 110.904 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.625 HD11 HG23 ' A' ' 130' ' ' VAL . 3.8 tt -65.07 -46.63 80.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.985 -0.746 . . . . 1.05 108.985 177.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.629 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 52.7 t80 -59.81 -49.63 76.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.859 -0.61 . . . . 1.05 110.911 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -57.46 -38.69 74.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.394 . . . . 0.40000000000000002 110.774 -174.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.2 m -76.76 -53.65 7.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.881 -0.6 . . . . 1.02 111.507 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.88 -28.24 63.39 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.241 0.459 . . . . 0.14999999999999999 112.241 -175.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 33.7 t -57.62 -29.09 64.25 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.305 0.242 . . . . 0.56000000000000005 111.314 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.55 -22.21 43.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.798 0.332 . . . . 1.04 111.475 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.406 ' CE2' ' HG2' ' A' ' 158' ' ' MET . 22.4 m-85 -90.3 -20.36 23.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.189 0.518 . . . . 0.20999999999999999 110.437 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 165.87 162.21 16.66 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.855 -0.898 . . . . 0.14000000000000001 110.855 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.06 142.98 58.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.192 0.52 . . . . 0.28999999999999998 110.03 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.444 ' HB ' ' CD2' ' A' ' 116' ' ' TYR . 76.5 mt -113.44 134.42 56.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.791 -0.641 . . . . 1.0700000000000001 110.014 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.78 -48.25 7.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.881 -0.785 . . . . 1.26 108.881 -178.24 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.2 m -143.86 102.43 3.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.062 -0.972 . . . . 1.1799999999999999 110.749 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.5 p -102.12 150.91 22.78 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.729 -0.471 . . . . 1.49 109.729 174.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -149.81 131.95 15.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.132 0.491 . . . . 1.6299999999999999 111.304 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.625 HG23 HD11 ' A' ' 115' ' ' LEU . 59.6 t -114.66 110.19 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.868 -1.53 . . . . 1.0700000000000001 106.868 171.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 109.097 -0.705 . . . . 1.1399999999999999 109.097 -174.734 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.745 0 CA-C-O 120.278 -0.179 . . . . 0.31 113.365 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 25.7 p90 -130.04 148.13 51.86 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.485 0.643 . . . . 1.01 111.868 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.55 174.5 23.41 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.154 -0.93 . . . . 0.13 111.379 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -138.86 143.68 38.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.864 0.332 . . . . 0.31 110.504 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.588 HG12 ' CE2' ' A' ' 145' ' ' PHE . 39.6 t -119.0 135.41 59.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.877 0.37 . . . . 1.03 111.043 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.402 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 0.9 OUTLIER -104.49 106.33 16.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.844 -0.799 . . . . 0.32000000000000001 108.844 166.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.588 ' CE2' HG12 ' A' ' 143' ' ' VAL . 11.4 m-85 -89.77 135.37 33.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.21 0.529 . . . . 0.17000000000000001 111.41 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.516 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.8 tt0 -47.29 -44.29 23.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.348 -1.297 . . . . 0.56999999999999995 110.245 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.7 p -115.05 141.3 48.19 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.422 -1.263 . . . . 1.1100000000000001 111.001 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -60.4 -39.71 88.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.52 -0.764 . . . . 0.46999999999999997 111.048 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.1 -33.06 73.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.384 -0.371 . . . . 0.73999999999999999 111.728 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.34 -34.95 77.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.137 0.494 . . . . 1.03 110.423 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.565 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -61.59 -47.86 83.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.466 -0.788 . . . . 1.05 110.527 177.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.592 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.9 mt-10 -59.13 -39.98 84.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.833 -0.621 . . . . 1.4199999999999999 110.889 177.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.469 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 87.1 mtt180 -58.93 -43.46 91.17 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.95 0.405 . . . . 2.0 110.708 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.72 92.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 1.02 110.663 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.45 HG21 ' O ' ' A' ' 170' ' ' VAL . 87.5 mt -61.3 -51.92 67.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.978 -0.555 . . . . 1.04 111.109 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.5 pt-20 -64.23 -43.58 94.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.085 0.469 . . . . 1.0800000000000001 111.897 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -81.81 -39.47 23.99 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 113.028 0.751 . . . . 1.78 113.028 -169.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.406 ' HG2' ' CE2' ' A' ' 122' ' ' PHE . 93.9 mmm -90.56 -20.73 22.3 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.51 -0.476 . . . . 1.03 112.217 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -64.9 123.99 20.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.102 -0.703 . . . . 0.60999999999999999 109.102 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.95 25.98 43.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.563 -0.827 . . . . 0.28999999999999998 112.95 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.576 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 4.1 mmt -113.56 156.71 23.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.596 0.198 . . . . 1.72 110.791 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 16.7 mt -95.76 110.76 22.86 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 109.552 -0.536 . . . . 1.1799999999999999 109.552 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 21.8 mt -96.86 100.28 11.81 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.706 -0.798 . . . . 1.1299999999999999 109.626 173.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 84.4 m-20 77.49 -25.64 0.2 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.021 -0.99 . . . . 1.71 113.184 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 33.3 t70 170.12 -23.43 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 O-C-N 123.623 0.577 . . . . 0.84999999999999998 111.918 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.457 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 91.2 mtt180 -111.19 135.49 51.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.441 -0.345 . . . . 1.27 110.977 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.1 ttmt -81.81 117.78 22.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.696 -0.684 . . . . 1.6499999999999999 109.23 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.3 m -100.15 147.29 7.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.862 0.839 . . . . 1.04 111.765 -171.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 52.1 t80 -105.84 119.81 40.11 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.415 -1.266 . . . . 0.41999999999999998 108.915 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.45 ' O ' HG21 ' A' ' 155' ' ' ILE . 41.3 t -114.49 125.34 71.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 1.03 108.82 177.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.72 -170.43 14.51 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.846 -0.692 . . . . 0.17999999999999999 111.62 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 . . . . . 0 C--N 1.319 -0.753 0 N-CA-C 108.996 -0.742 . . . . 2.3599999999999999 108.996 -179.499 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 113.088 0.773 . . . . 1.3600000000000001 113.088 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.62 22.61 76.96 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.357 -0.838 . . . . 0.26000000000000001 111.935 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 143' ' ' VAL . 1.2 m120 -85.48 124.69 32.35 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.094 -0.706 . . . . 0.63 109.094 -175.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.567 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.7 pt -135.86 151.96 30.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.71 -0.478 . . . . 1.05 109.71 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -116.61 137.09 52.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.905 -0.406 . . . . 0.26000000000000001 109.905 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.5 mt -116.0 134.66 58.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.503 -0.771 . . . . 1.01 109.983 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -118.94 151.62 37.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.69 -0.232 . . . . 2.0800000000000001 110.534 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.5 t30 76.91 34.7 0.41 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.045 0.841 . . . . 0.53000000000000003 111.282 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.519 HD22 HG23 ' A' ' 110' ' ' ILE . 22.7 mt -77.06 162.09 27.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.217 -0.447 . . . . 1.04 110.925 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -92.57 152.13 19.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.499 . . . . 0.70999999999999996 110.122 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -57.11 -29.13 63.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.902 -0.59 . . . . 2.7799999999999998 112.16 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.0 m -72.43 -14.96 61.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.427 -0.351 . . . . 1.8 111.741 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.519 HG23 HD22 ' A' ' 106' ' ' LEU . 37.6 mm -76.61 123.18 32.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.2 0.524 . . . . 1.1000000000000001 111.137 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 27.3 t70 -109.31 -177.37 3.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.376 -0.829 . . . . 1.5900000000000001 109.043 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.467 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 88.3 m-20 -71.43 -33.22 69.21 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.79 -0.818 . . . . 0.92000000000000004 108.79 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -46.89 75.09 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.547 -1.206 . . . . 3.04 108.949 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.28 -44.19 97.64 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.973 -1.467 . . . . 1.03 110.83 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 130' ' ' VAL . 3.6 tt -64.21 -46.84 82.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.443 -0.799 . . . . 1.05 109.056 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.731 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 41.6 t80 -59.14 -49.25 78.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 1.05 110.573 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -57.0 -37.42 71.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.937 0.399 . . . . 0.40000000000000002 111.22 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.543 HG21 HD21 ' A' ' 163' ' ' LEU . 9.1 m -77.98 -53.58 7.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.138 -0.483 . . . . 1.02 111.832 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.412 ' CD1' HD22 ' A' ' 115' ' ' LEU . 9.9 m-85 -72.97 -27.5 61.85 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.754 0.649 . . . . 0.14999999999999999 112.754 -174.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.0 t -56.89 -28.35 61.8 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.498 0.319 . . . . 0.56000000000000005 111.633 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.95 -22.57 38.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.833 0.349 . . . . 1.04 111.46 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.56 ' HZ ' ' HE2' ' A' ' 157' ' ' LYS . 34.2 m-85 -91.95 -11.72 35.39 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.83 0.348 . . . . 0.20999999999999999 111.086 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.95 169.1 20.47 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.796 -0.522 . . . . 0.14000000000000001 111.796 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -69.17 138.35 54.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.942 0.401 . . . . 0.28999999999999998 110.438 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.407 HG22 ' HB3' ' A' ' 128' ' ' CYS . 76.0 mt -110.17 132.71 57.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.928 -0.578 . . . . 1.0700000000000001 109.988 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.563 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.27 -45.55 11.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.603 -0.888 . . . . 1.26 108.603 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.1 m -144.73 109.27 4.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.103 -0.953 . . . . 1.1799999999999999 110.75 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.731 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.8 p -103.68 138.4 40.37 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.176 -0.676 . . . . 1.49 109.176 172.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.416 ' HZ3' ' HA ' ' A' ' 131' ' ' VAL . 27.4 tptp -136.23 126.9 27.19 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.938 0.399 . . . . 1.6299999999999999 111.078 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.597 HG21 HD11 ' A' ' 115' ' ' LEU . 89.8 t -111.03 109.82 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 105.983 -1.858 . . . . 1.0700000000000001 105.983 168.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.416 ' HA ' ' HZ3' ' A' ' 129' ' ' LYS . 9.0 t . . . . . 0 C--N 1.302 -1.483 0 N-CA-C 108.688 -0.856 . . . . 1.1399999999999999 108.688 -173.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 120.255 -0.192 . . . . 0.31 113.547 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -132.99 158.7 42.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.337 0.568 . . . . 1.01 111.701 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.88 174.77 28.41 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.496 -0.774 . . . . 0.13 112.165 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -138.92 139.02 37.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.666 0.233 . . . . 0.31 110.541 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.567 ' HB ' HG12 ' A' ' 101' ' ' ILE . 47.7 t -111.64 136.52 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.829 0.347 . . . . 1.03 110.651 173.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -106.1 106.05 16.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.119 -0.697 . . . . 0.32000000000000001 109.119 166.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.6 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.5 m-85 -89.02 137.41 32.34 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.125 0.488 . . . . 0.17000000000000001 110.856 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.563 ' HA ' HD21 ' A' ' 126' ' ' LEU . 43.3 tt0 -47.54 -43.95 25.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.348 -1.296 . . . . 0.56999999999999995 110.528 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.9 p -114.57 146.26 40.98 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.642 -1.163 . . . . 1.1100000000000001 111.191 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -62.37 -37.68 86.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.569 -0.741 . . . . 0.46999999999999997 111.191 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.93 -34.32 73.31 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.559 -0.292 . . . . 0.73999999999999999 111.774 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.21 76.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.125 0.488 . . . . 1.03 110.297 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.6 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.53 -44.12 95.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.439 -0.8 . . . . 1.05 110.51 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -59.46 -44.04 93.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.921 -0.582 . . . . 1.4199999999999999 110.214 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -58.55 -39.58 80.63 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.904 0.383 . . . . 2.0 110.641 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.65 84.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 1.02 110.368 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 151' ' ' ALA . 80.4 mt -61.68 -56.24 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.406 -0.361 . . . . 1.04 111.32 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -43.79 77.83 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.23 0.538 . . . . 1.0800000000000001 111.278 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.56 ' HE2' ' HZ ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -83.14 -39.53 20.94 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.517 -0.765 . . . . 1.78 112.541 -169.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 89.6 mmm -91.85 -24.44 19.35 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.527 -0.469 . . . . 1.03 112.028 -172.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -66.78 123.63 20.67 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.424 -0.584 . . . . 0.60999999999999999 109.424 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.6 62.04 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.765 -0.731 . . . . 0.28999999999999998 112.732 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.663 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 29.5 mmt -106.1 166.13 10.72 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 120.74 0.305 . . . . 1.72 111.186 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 20.7 mt -101.25 122.13 43.11 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 109.368 -0.604 . . . . 1.1799999999999999 109.368 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 118' ' ' THR . 21.6 mt -107.04 102.15 11.52 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.874 -0.731 . . . . 1.1299999999999999 109.212 170.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 57.5 m-20 78.61 -26.39 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.976 0.798 . . . . 1.71 112.584 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 20.2 t70 165.38 -23.65 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.289 0.636 . . . . 0.84999999999999998 111.332 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -101.68 134.15 45.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.269 -0.423 . . . . 1.27 110.578 -172.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 161' ' ' MET . 16.7 ttmt -81.96 118.26 22.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.316 -0.624 . . . . 1.6499999999999999 109.316 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.7 m -101.3 146.95 8.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.568 0.699 . . . . 1.04 111.37 -172.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 72.6 t80 -106.57 120.78 42.84 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.781 -1.1 . . . . 0.41999999999999998 109.186 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.17 124.93 72.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.188 -0.671 . . . . 1.03 109.188 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -142.92 -170.89 13.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.497 -0.859 . . . . 0.17999999999999999 112.47 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 121.136 0.494 . . . . 2.3599999999999999 110.954 -175.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.1 t . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 121.394 0.616 . . . . 1.3600000000000001 112.343 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.27 23.08 78.16 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.635 -0.793 . . . . 0.26000000000000001 112.255 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -85.02 123.96 31.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.377 -0.601 . . . . 0.63 109.377 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.475 HG12 ' HB ' ' A' ' 143' ' ' VAL . 19.5 pt -135.67 163.47 35.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.704 -0.48 . . . . 1.05 109.704 176.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.25 145.18 50.51 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.462 -0.495 . . . . 0.26000000000000001 109.858 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 5.5 mt -118.19 131.64 70.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.642 -0.708 . . . . 1.01 109.863 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -109.21 148.72 30.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.538 -0.301 . . . . 2.0800000000000001 110.66 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.7 t30 70.46 39.93 1.15 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.919 0.762 . . . . 0.53000000000000003 112.148 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.647 HD23 HG21 ' A' ' 110' ' ' ILE . 21.7 mt -73.77 157.36 36.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.081 0.467 . . . . 1.04 111.383 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.54 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 24.5 t70 -81.14 148.98 29.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.381 -0.827 . . . . 0.70999999999999996 111.05 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -52.78 -37.57 59.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.048 -0.978 . . . . 2.7799999999999998 112.419 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.2 m -81.8 -4.74 57.16 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.08 0.4 . . . . 1.8 112.08 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.647 HG21 HD23 ' A' ' 106' ' ' LEU . 28.4 mm -74.47 120.44 23.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.242 0.544 . . . . 1.1000000000000001 110.766 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.402 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 8.1 t70 -109.04 -176.15 2.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.33 -0.85 . . . . 1.5900000000000001 108.882 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -69.4 -33.97 73.82 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.799 -0.815 . . . . 0.92000000000000004 108.799 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -45.98 74.34 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.539 -1.209 . . . . 3.04 108.896 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.402 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.56 -43.8 98.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.687 -1.597 . . . . 1.03 110.646 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.571 HD12 HG21 ' A' ' 130' ' ' VAL . 3.7 tt -65.46 -47.38 76.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.536 -0.756 . . . . 1.05 109.386 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.735 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.6 t80 -59.2 -46.6 88.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.549 . . . . 1.05 110.963 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.93 -40.09 75.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.697 0.284 . . . . 0.40000000000000002 111.087 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 50.9 m -78.46 -53.62 7.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.37 0.508 . . . . 1.02 112.37 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.452 ' CD1' HD21 ' A' ' 115' ' ' LEU . 9.4 m-85 -71.9 -28.09 63.27 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.688 0.625 . . . . 0.14999999999999999 112.688 -173.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.8 t -57.67 -28.96 64.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.539 0.209 . . . . 0.56000000000000005 111.366 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.23 -22.26 39.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.751 0.31 . . . . 1.04 111.645 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -89.84 -20.57 23.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.20999999999999999 111.122 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.4 168.97 30.35 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.584 -0.606 . . . . 0.14000000000000001 111.584 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -68.77 132.59 47.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.28999999999999998 110.092 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.414 HG23 ' HB3' ' A' ' 128' ' ' CYS . 73.5 mt -104.96 126.8 59.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.106 -0.497 . . . . 1.0700000000000001 109.993 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.537 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -83.2 -35.25 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.9 -0.778 . . . . 1.26 108.9 -178.162 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.0 m -159.06 119.63 3.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.129 -0.941 . . . . 1.1799999999999999 110.412 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.735 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.9 p -118.97 142.34 47.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.567 -0.531 . . . . 1.49 109.567 176.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -139.94 132.28 28.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.889 0.376 . . . . 1.6299999999999999 111.485 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.571 HG21 HD12 ' A' ' 115' ' ' LEU . 96.1 t -114.3 109.37 28.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 106.556 -1.646 . . . . 1.0700000000000001 106.556 169.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 C--N 1.305 -1.355 0 N-CA-C 109.159 -0.682 . . . . 1.1399999999999999 109.159 -173.825 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 113.747 0.259 . . . . 0.31 113.747 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -125.03 150.58 46.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 117.3 0.55 . . . . 1.01 111.727 -173.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -140.07 170.94 24.12 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.361 -0.836 . . . . 0.13 111.49 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -135.83 141.05 44.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.927 0.363 . . . . 0.31 110.535 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.522 HG13 ' CE2' ' A' ' 145' ' ' PHE . 30.8 t -115.32 135.49 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 1.03 110.714 173.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.4 OUTLIER -103.62 106.17 16.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.906 -0.776 . . . . 0.32000000000000001 108.906 166.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.522 ' CE2' HG13 ' A' ' 143' ' ' VAL . 12.6 m-85 -91.44 137.39 32.4 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.15 0.5 . . . . 0.17000000000000001 111.08 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.537 ' HA ' HD21 ' A' ' 126' ' ' LEU . 41.8 tt0 -45.73 -42.23 11.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.206 -1.361 . . . . 0.56999999999999995 111.273 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.7 p -121.05 155.76 33.68 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.182 -0.917 . . . . 1.1100000000000001 110.565 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -67.2 -32.01 72.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.852 -0.613 . . . . 0.46999999999999997 110.206 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 152' ' ' GLU . 10.3 pt-20 -70.67 -34.78 72.36 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.2 -0.455 . . . . 0.73999999999999999 111.964 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 145' ' ' PHE . . . -62.3 -34.85 77.4 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.047 0.451 . . . . 1.03 110.22 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.478 ' O ' HG13 ' A' ' 155' ' ' ILE . . . -63.43 -41.08 98.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.648 -0.705 . . . . 1.05 110.171 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 13.0 mm-40 -58.56 -43.43 89.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.545 -0.752 . . . . 1.4199999999999999 111.303 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 44.8 mtt180 -64.14 -40.06 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 2.0 110.97 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.79 86.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.522 -0.308 . . . . 1.02 110.46 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 151' ' ' ALA . 81.9 mt -59.54 -51.88 67.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 1.04 111.251 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.1 pt-20 -63.75 -44.65 92.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.006 0.431 . . . . 1.0800000000000001 111.771 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.42 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.06 -39.29 23.66 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.173 0.805 . . . . 1.78 113.173 -168.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 91.5 mmm -91.25 -20.0 22.39 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.224 0.453 . . . . 1.03 112.224 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.02 122.74 19.95 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.049 -0.66 . . . . 0.60999999999999999 109.353 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.71 17.87 61.01 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.599 -0.81 . . . . 0.28999999999999998 112.458 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -103.63 164.91 11.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.233 -0.654 . . . . 1.72 109.233 176.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 25.7 mt -103.04 132.18 49.5 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.859 -0.793 . . . . 1.1799999999999999 108.859 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 19.7 mt -116.56 104.2 11.17 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 120.226 -0.59 . . . . 1.1299999999999999 109.641 171.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 83.2 m-20 76.44 -27.39 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.129 -0.941 . . . . 1.71 113.063 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 20.5 t70 167.86 -24.5 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 O-C-N 123.938 0.774 . . . . 0.84999999999999998 111.712 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.54 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 94.3 mtt180 -107.2 135.92 47.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.787 0.327 . . . . 1.27 110.852 -171.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 161' ' ' MET . 23.5 tttt -84.3 119.76 25.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.703 -0.68 . . . . 1.6499999999999999 109.207 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.3 m -101.45 151.1 5.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.766 0.793 . . . . 1.04 111.409 -172.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 35.8 t80 -109.93 120.82 43.66 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.665 -1.152 . . . . 0.41999999999999998 109.123 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.439 ' CG1' HD11 ' A' ' 101' ' ' ILE . 42.3 t -115.32 125.72 72.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.28 -0.637 . . . . 1.03 109.28 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.49 -176.76 22.19 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.62 -0.8 . . . . 0.17999999999999999 111.64 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 . . . . . 0 C--N 1.324 -0.541 0 N-CA-C 109.024 -0.732 . . . . 2.3599999999999999 109.024 176.443 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 121.525 0.679 . . . . 1.3600000000000001 111.987 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.78 24.18 77.01 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.74 -1.219 . . . . 0.26000000000000001 111.634 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.463 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.1 m-80 -85.12 124.02 31.3 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.29 -0.633 . . . . 0.63 109.29 -173.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.559 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.3 pt -135.66 159.98 39.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.015 -0.365 . . . . 1.05 110.015 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.51 143.22 50.79 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.605 -0.517 . . . . 0.26000000000000001 109.605 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.1 mt -118.56 133.81 64.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.854 -0.612 . . . . 1.01 110.37 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -114.25 150.07 34.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.25 -0.432 . . . . 2.0800000000000001 110.318 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 67.99 54.68 0.6 Allowed 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.844 0.715 . . . . 0.53000000000000003 111.63 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.534 HD21 HG22 ' A' ' 110' ' ' ILE . 12.1 mt -89.78 159.53 16.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.614 -0.721 . . . . 1.04 111.264 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.561 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 14.9 t70 -77.75 151.09 34.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.70999999999999996 109.95 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -63.65 -31.88 73.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.617 -0.72 . . . . 2.7799999999999998 111.663 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.4 p -76.41 -4.68 43.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.796 0.331 . . . . 1.8 111.753 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.534 HG22 HD21 ' A' ' 106' ' ' LEU . 40.4 mm -77.26 121.55 29.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.216 0.532 . . . . 1.1000000000000001 110.734 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 26.9 t70 -108.15 -178.68 3.67 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.751 -0.833 . . . . 1.5900000000000001 108.751 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.466 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 2.8 m-20 -63.48 -38.95 93.09 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.639 -0.875 . . . . 0.92000000000000004 108.639 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.993 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.87 -49.28 78.11 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.006 -0.997 . . . . 3.04 110.359 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.66 98.44 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.296 -1.32 . . . . 1.03 111.412 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.515 HD13 HG22 ' A' ' 130' ' ' VAL . 4.3 tt -64.49 -47.5 78.7 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.198 -0.667 . . . . 1.05 109.198 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.705 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 68.7 t80 -59.84 -46.7 88.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.989 -0.55 . . . . 1.05 110.608 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -57.03 -39.16 74.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.316 -0.402 . . . . 0.40000000000000002 110.989 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.634 HG22 HD22 ' A' ' 163' ' ' LEU . 20.7 m -77.04 -53.39 7.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.047 -0.524 . . . . 1.02 111.681 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -72.52 -29.0 63.21 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.434 0.531 . . . . 0.14999999999999999 112.434 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.3 t -57.97 -28.05 63.99 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.6 0.238 . . . . 0.56000000000000005 111.003 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.49 -22.73 34.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.461 -0.336 . . . . 1.04 111.345 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -93.02 -13.92 28.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.456 -0.338 . . . . 0.20999999999999999 111.099 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.04 169.08 22.88 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.848 -0.692 . . . . 0.14000000000000001 112.137 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -66.23 137.71 57.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.915 0.388 . . . . 0.28999999999999998 110.54 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.482 ' HB ' ' CE1' ' A' ' 116' ' ' TYR . 76.3 mt -113.34 132.34 62.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.739 -0.664 . . . . 1.0700000000000001 109.711 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.546 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -85.89 -42.34 14.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.869 -0.789 . . . . 1.26 108.869 -178.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.8 m -149.34 125.09 10.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.782 -1.099 . . . . 1.1799999999999999 110.279 -177.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.705 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 19.8 p -122.32 151.74 40.83 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.173 -0.677 . . . . 1.49 109.173 174.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -143.14 129.72 20.19 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.627 -0.429 . . . . 1.6299999999999999 111.727 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.515 HG22 HD13 ' A' ' 115' ' ' LEU . 70.8 t -114.87 109.67 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 106.796 -1.557 . . . . 1.0700000000000001 106.796 168.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.6 t . . . . . 0 C--N 1.305 -1.349 0 CA-C-N 115.775 -0.648 . . . . 1.1399999999999999 109.373 -174.072 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.335 0 N-CA-C 113.75 0.26 . . . . 0.31 113.75 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -133.01 156.62 47.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.243 0.521 . . . . 1.01 110.913 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.56 177.22 26.94 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.893 -0.594 . . . . 0.13 112.012 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -140.82 143.75 34.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.867 0.333 . . . . 0.31 111.174 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.575 HG13 ' CE2' ' A' ' 145' ' ' PHE . 38.8 t -119.21 133.04 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.981 0.42 . . . . 1.03 111.154 172.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.7 OUTLIER -103.47 105.82 16.18 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.775 -0.824 . . . . 0.32000000000000001 108.775 165.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.575 ' CE2' HG13 ' A' ' 143' ' ' VAL . 13.7 m-85 -88.19 138.5 31.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.94 0.4 . . . . 0.17000000000000001 111.008 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.546 ' HA ' HD22 ' A' ' 126' ' ' LEU . 26.4 tt0 -48.48 -47.33 38.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.903 -1.044 . . . . 0.56999999999999995 110.433 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 p -109.98 151.65 26.87 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.62 -1.173 . . . . 1.1100000000000001 110.672 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -67.89 -36.14 79.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.959 -0.564 . . . . 0.46999999999999997 110.719 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 14.0 pt-20 -70.04 -35.38 74.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.352 0.501 . . . . 0.73999999999999999 112.352 -176.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.45 -34.89 77.7 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.043 0.449 . . . . 1.03 110.403 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.514 ' O ' HG13 ' A' ' 155' ' ' ILE . . . -63.6 -43.61 96.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.666 -0.697 . . . . 1.05 110.448 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 33.5 mt-10 -58.89 -37.75 77.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 1.4199999999999999 110.722 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 92.2 mtt180 -66.72 -44.31 81.94 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.805 0.336 . . . . 2.0 110.634 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.12 -38.92 90.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 1.02 110.631 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 151' ' ' ALA . 84.4 mt -59.16 -53.99 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 1.04 111.533 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.1 pt-20 -64.91 -44.63 88.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.332 0.587 . . . . 1.0800000000000001 111.967 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.458 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -77.62 -38.27 48.34 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.311 -0.859 . . . . 1.78 112.665 -169.054 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.408 ' O ' ' HB2' ' A' ' 161' ' ' MET . 89.0 mmm -94.09 -17.75 22.5 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.496 -0.482 . . . . 1.03 112.256 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 52.5 t30 -69.66 123.33 21.09 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.919 -0.712 . . . . 0.60999999999999999 109.113 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.61 8.79 79.76 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.687 -0.768 . . . . 0.28999999999999998 112.061 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.7 OUTLIER -91.32 159.63 15.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.725 0.297 . . . . 1.72 110.248 178.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 15.2 mt -104.49 108.23 19.55 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.644 -0.502 . . . . 1.1799999999999999 109.644 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.634 HD22 HG22 ' A' ' 118' ' ' THR . 22.5 mt -93.42 105.75 17.78 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 119.75 -0.78 . . . . 1.1299999999999999 109.395 173.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 73.06 -58.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.165 -0.925 . . . . 1.71 112.474 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -166.97 14.61 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.288 -0.414 . . . . 0.84999999999999998 111.894 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.561 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 92.7 mtt180 -135.54 134.66 39.65 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.713 -0.395 . . . . 1.27 110.423 -175.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.3 tttt -82.18 121.57 26.77 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.707 -0.679 . . . . 1.6499999999999999 109.236 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.04 143.36 14.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.467 0.651 . . . . 1.04 111.3 -173.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 63.2 t80 -106.32 119.88 40.4 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.231 -0.895 . . . . 0.41999999999999998 109.062 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.43 ' CG1' HD12 ' A' ' 101' ' ' ILE . 43.9 t -115.16 126.57 72.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.234 -0.654 . . . . 1.03 109.234 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.63 -178.91 21.51 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.529 -0.843 . . . . 0.17999999999999999 112.199 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 . . . . . 0 C--N 1.324 -0.535 0 N-CA-C 110.226 -0.287 . . . . 2.3599999999999999 110.226 -178.169 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 121.804 0.811 . . . . 1.3600000000000001 112.587 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.1 23.0 78.63 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.84 -1.172 . . . . 0.26000000000000001 110.739 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.499 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.2 m120 -94.23 127.49 40.12 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.931 -0.766 . . . . 0.63 108.931 -174.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.564 HG12 ' HB ' ' A' ' 143' ' ' VAL . 27.4 pt -134.51 161.36 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.277 -0.268 . . . . 1.05 110.277 177.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.96 143.24 50.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.938 -0.393 . . . . 0.26000000000000001 109.938 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.7 mt -116.6 146.73 20.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.756 -0.656 . . . . 1.01 109.953 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 44.8 tttp -129.61 147.91 51.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.288 -0.415 . . . . 2.0800000000000001 110.342 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.8 t30 64.81 47.7 2.64 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.549 0.74 . . . . 0.53000000000000003 111.954 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.663 HD22 HG22 ' A' ' 110' ' ' ILE . 23.0 mt -80.07 151.84 29.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.167 0.508 . . . . 1.04 111.447 176.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.531 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 17.9 t70 -77.97 150.95 33.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.476 -0.784 . . . . 0.70999999999999996 111.313 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -51.7 -38.64 55.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.137 -0.938 . . . . 2.7799999999999998 112.946 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.3 m -85.09 -4.24 59.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.054 0.39 . . . . 1.8 112.054 -173.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.663 HG22 HD22 ' A' ' 106' ' ' LEU . 33.5 mm -71.88 116.21 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.099 0.476 . . . . 1.1000000000000001 110.23 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -103.72 -179.36 3.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.637 -0.875 . . . . 1.5900000000000001 108.637 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -63.96 -37.25 86.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.736 -0.839 . . . . 0.92000000000000004 108.736 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 1.062 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -61.37 -49.66 76.02 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.168 -0.924 . . . . 3.04 110.712 178.2 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.3 99.12 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.194 -1.366 . . . . 1.03 111.068 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.629 HD12 HG21 ' A' ' 130' ' ' VAL . 3.8 tt -63.94 -47.87 78.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.419 -0.81 . . . . 1.05 109.105 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.641 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 51.5 t80 -58.69 -48.45 81.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.869 -0.605 . . . . 1.05 110.914 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.3 -38.82 74.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.938 0.399 . . . . 0.40000000000000002 110.59 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.6 m -77.47 -54.17 6.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.148 -0.478 . . . . 1.02 111.875 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.422 ' CD1' HD22 ' A' ' 115' ' ' LEU . 7.2 m-85 -72.19 -27.87 62.84 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.248 0.462 . . . . 0.14999999999999999 112.248 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 28.7 t -57.41 -28.03 62.91 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 111.629 0.233 . . . . 0.56000000000000005 111.629 -177.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.83 -22.88 39.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.016 0.436 . . . . 1.04 111.345 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -90.19 -22.29 21.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.113 -0.494 . . . . 0.20999999999999999 110.777 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 169.36 169.02 32.16 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.89 -0.595 . . . . 0.14000000000000001 111.784 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -70.65 139.55 51.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.018 0.437 . . . . 0.28999999999999998 109.893 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 74.1 mt -112.88 131.93 63.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.907 -0.588 . . . . 1.0700000000000001 110.024 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.528 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -88.5 -41.06 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.922 -0.77 . . . . 1.26 108.922 -177.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 72.1 m -147.7 119.6 8.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.163 -0.926 . . . . 1.1799999999999999 110.314 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 9.2 p -117.53 144.95 44.59 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.526 -0.546 . . . . 1.49 109.526 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -142.19 129.3 20.89 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.67 -0.412 . . . . 1.6299999999999999 111.503 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.629 HG21 HD12 ' A' ' 115' ' ' LEU . 61.2 t -115.55 110.7 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 106.848 -1.538 . . . . 1.0700000000000001 106.848 170.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.303 -1.416 0 N-CA-C 108.848 -0.797 . . . . 1.1399999999999999 108.848 -175.368 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 N-CA-C 113.324 0.09 . . . . 0.31 113.324 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -126.07 149.37 48.94 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 121.855 -0.791 . . . . 1.01 111.874 -173.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.86 174.81 24.1 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.077 -0.965 . . . . 0.13 111.348 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -141.57 137.44 31.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.019 0.41 . . . . 0.31 110.615 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.564 ' HB ' HG12 ' A' ' 101' ' ' ILE . 43.2 t -112.88 133.68 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.081 0.467 . . . . 1.03 111.147 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.1 m170 -103.12 105.91 16.31 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.626 -0.715 . . . . 0.32000000000000001 109.143 166.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 12.5 m-85 -88.79 142.55 27.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.261 0.553 . . . . 0.17000000000000001 110.751 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.528 ' HA ' HD22 ' A' ' 126' ' ' LEU . 42.8 tt0 -51.67 -38.32 54.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.277 -1.329 . . . . 0.56999999999999995 110.542 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.6 p -125.32 150.38 47.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.307 -0.86 . . . . 1.1100000000000001 111.443 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -60.65 -37.76 82.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.603 -0.726 . . . . 0.46999999999999997 111.24 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.6 pt-20 -67.82 -35.38 78.5 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.56 -0.291 . . . . 0.73999999999999999 111.645 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.53 78.35 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.21 0.529 . . . . 1.03 110.278 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.586 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.56 -46.57 85.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.339 -0.846 . . . . 1.05 110.565 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 42.6 mt-10 -58.96 -40.19 83.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 1.4199999999999999 110.526 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.519 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 88.8 mtt180 -58.96 -44.76 91.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.005 0.431 . . . . 2.0 110.719 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.4 94.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.968 -0.56 . . . . 1.02 110.598 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 151' ' ' ALA . 88.6 mt -58.97 -53.56 46.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.889 -0.596 . . . . 1.04 111.401 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 0.6 OUTLIER -63.64 -41.83 98.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.091 0.472 . . . . 1.0800000000000001 111.808 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.415 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -81.8 -39.98 23.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.681 -0.691 . . . . 1.78 112.82 -169.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 91.3 mmm -91.24 -19.12 23.36 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.262 0.468 . . . . 1.03 112.262 -173.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -66.54 122.78 18.35 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.396 -0.521 . . . . 0.60999999999999999 109.826 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.48 26.81 37.87 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.91 -0.662 . . . . 0.28999999999999998 113.01 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.698 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 74.5 mmm -112.64 157.06 21.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.958 0.379 . . . . 1.72 110.891 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.476 HD21 ' N ' ' A' ' 167' ' ' LYS . 19.6 mt -94.15 102.38 14.42 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.002 -0.74 . . . . 1.1799999999999999 109.002 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 16.7 mt -83.91 101.47 11.7 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 119.278 -0.969 . . . . 1.1299999999999999 108.645 172.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 98.8 m-20 73.94 -70.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.856 -1.065 . . . . 1.71 111.467 -175.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -147.2 -0.57 0.68 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.425 -0.807 . . . . 0.84999999999999998 112.192 -173.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.531 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 91.6 mtt180 -132.1 128.76 38.84 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.955 -0.466 . . . . 1.27 110.473 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.698 ' HA ' ' O ' ' A' ' 161' ' ' MET . 13.3 tttt -76.45 122.04 23.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.849 -0.614 . . . . 1.6499999999999999 109.35 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 16.0 m -101.18 140.06 20.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.391 0.615 . . . . 1.04 111.056 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -106.08 121.7 44.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.18 -0.918 . . . . 0.41999999999999998 108.871 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.436 HG11 HD13 ' A' ' 101' ' ' ILE . 39.6 t -115.88 130.15 71.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.976 -0.557 . . . . 1.03 109.565 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -142.87 -165.37 10.59 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.773 -0.727 . . . . 0.17999999999999999 111.949 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 . . . . . 0 C--N 1.323 -0.566 0 N-CA-C 109.61 -0.515 . . . . 2.3599999999999999 109.61 -178.055 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 121.221 0.534 . . . . 1.3600000000000001 111.923 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.18 23.05 78.36 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.481 -0.866 . . . . 0.26000000000000001 111.856 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' VAL . 1.8 m120 -89.32 126.2 35.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.335 -0.617 . . . . 0.63 109.335 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.497 HG12 ' HB ' ' A' ' 143' ' ' VAL . 22.0 pt -134.65 163.37 36.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.734 -0.666 . . . . 1.05 109.547 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.07 146.45 50.36 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.564 -0.455 . . . . 0.26000000000000001 109.817 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 4.2 mt -118.22 138.37 49.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.688 -0.687 . . . . 1.01 109.714 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -120.85 152.78 37.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.691 -0.231 . . . . 2.0800000000000001 110.4 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.8 t30 70.57 41.07 0.98 Allowed 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.818 0.699 . . . . 0.53000000000000003 111.699 172.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.529 HD22 HG21 ' A' ' 110' ' ' ILE . 20.0 mt -79.4 164.83 23.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.217 0.532 . . . . 1.04 111.907 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.466 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.8 t70 -89.01 155.55 19.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.406 -0.815 . . . . 0.70999999999999996 110.799 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 109' ' ' SER . 20.0 pttp -59.99 -36.68 77.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.228 -0.442 . . . . 2.7799999999999998 111.724 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.431 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 16.7 m -80.85 -3.21 50.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.243 -0.435 . . . . 1.8 111.891 -173.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.529 HG21 HD22 ' A' ' 106' ' ' LEU . 34.5 mm -76.02 118.53 22.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 1.1000000000000001 110.254 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -108.66 -175.52 2.79 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.128 -0.693 . . . . 1.5900000000000001 109.128 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -69.39 -32.76 71.99 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.081 -0.711 . . . . 0.92000000000000004 109.081 -176.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -67.13 -48.47 67.97 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.54 -1.209 . . . . 3.04 109.253 178.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.2 -41.42 96.78 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.198 -1.365 . . . . 1.03 110.83 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.603 HD13 HG23 ' A' ' 130' ' ' VAL . 3.8 tt -66.98 -47.66 70.86 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.039 -0.726 . . . . 1.05 109.039 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.678 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.6 t80 -59.38 -46.45 88.62 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.933 -0.576 . . . . 1.05 110.81 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.3 -41.08 75.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.09 0.471 . . . . 0.40000000000000002 110.978 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.437 HG22 HD22 ' A' ' 163' ' ' LEU . 18.0 m -77.07 -52.76 8.76 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.787 -0.642 . . . . 1.02 111.691 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.425 ' CD1' HD21 ' A' ' 115' ' ' LEU . 10.6 m-85 -72.69 -28.24 62.57 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.638 0.607 . . . . 0.14999999999999999 112.638 -175.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.8 t -57.3 -28.8 63.35 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.563 0.221 . . . . 0.56000000000000005 111.388 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.57 -24.13 45.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.896 0.379 . . . . 1.04 111.226 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -89.17 -18.18 27.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.20999999999999999 111.408 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.44 173.55 32.27 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.033 -0.604 . . . . 0.14000000000000001 112.024 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -69.46 135.37 50.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.914 0.387 . . . . 0.28999999999999998 110.33 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 70.8 mt -110.67 124.29 67.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.217 -0.447 . . . . 1.0700000000000001 110.597 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -79.97 -36.37 36.21 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.777 -0.823 . . . . 1.26 108.777 -176.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.4 m -154.97 141.49 18.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.86 -1.063 . . . . 1.1799999999999999 109.694 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.6 p -143.5 135.42 26.62 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.803 -0.443 . . . . 1.49 109.803 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -140.76 133.25 28.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.112 0.482 . . . . 1.6299999999999999 111.887 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.603 HG23 HD13 ' A' ' 115' ' ' LEU . 78.1 t -114.26 117.46 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 N-CA-C 106.717 -1.586 . . . . 1.0700000000000001 106.717 169.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 C--N 1.303 -1.433 0 N-CA-C 108.811 -0.811 . . . . 1.1399999999999999 108.811 -176.343 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 113.742 0.257 . . . . 0.31 113.742 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -122.6 152.39 40.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 117.421 0.611 . . . . 1.01 112.208 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.67 175.25 24.47 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.01 -0.996 . . . . 0.13 111.438 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -140.52 142.24 35.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.088 0.444 . . . . 0.31 111.113 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.531 HG11 ' CE2' ' A' ' 145' ' ' PHE . 39.2 t -119.53 135.55 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-O 121.009 0.433 . . . . 1.03 110.873 172.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -104.9 106.22 16.61 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.985 -0.746 . . . . 0.32000000000000001 108.985 166.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.546 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.7 m-85 -90.1 137.34 32.42 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.022 0.439 . . . . 0.17000000000000001 110.993 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.525 ' HA ' HD22 ' A' ' 126' ' ' LEU . 38.8 tt0 -45.81 -43.83 13.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.42 -1.264 . . . . 0.56999999999999995 111.021 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.3 p -116.8 153.39 32.54 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.266 -0.879 . . . . 1.1100000000000001 110.33 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -64.61 -36.95 85.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.939 -0.573 . . . . 0.46999999999999997 110.303 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 13.4 pt-20 -70.35 -34.37 72.56 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.035 -0.529 . . . . 0.73999999999999999 112.293 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.72 -35.76 77.14 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.981 0.42 . . . . 1.03 110.52 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.546 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.82 -42.51 97.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.742 -0.663 . . . . 1.05 110.502 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.6 mt-10 -59.85 -40.55 88.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.884 -0.598 . . . . 1.4199999999999999 110.437 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.483 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 61.5 mtt180 -60.1 -42.09 93.93 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.455 0.472 . . . . 2.0 110.861 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.35 -39.41 85.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 1.02 110.693 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 151' ' ' ALA . 88.2 mt -58.94 -53.61 45.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.119 -0.491 . . . . 1.04 111.075 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.5 pt-20 -60.41 -45.36 93.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.926 0.394 . . . . 1.0800000000000001 111.796 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.461 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -80.93 -38.98 26.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.979 0.733 . . . . 1.78 112.979 -169.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.449 ' O ' ' HB2' ' A' ' 161' ' ' MET . 95.1 mmm -95.23 -17.84 21.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.67 0.619 . . . . 1.03 112.67 -171.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -70.12 122.09 18.77 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.683 -0.807 . . . . 0.60999999999999999 109.187 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.79 23.55 55.52 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.602 -0.809 . . . . 0.28999999999999998 112.178 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.612 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.8 OUTLIER -102.92 158.73 16.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.532 0.206 . . . . 1.72 110.536 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.403 HD21 ' HA ' ' A' ' 162' ' ' LEU . 21.7 mt -102.68 98.13 8.21 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.416 -0.356 . . . . 1.1799999999999999 110.128 -178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 18.6 mt -85.83 107.81 17.84 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 120.041 -0.664 . . . . 1.1299999999999999 109.363 175.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 98.2 m-20 74.32 -61.86 0.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.164 -0.926 . . . . 1.71 111.599 -176.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -172.26 25.23 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.552 -0.749 . . . . 0.84999999999999998 110.658 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.466 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.2 mtt180 -137.82 129.55 28.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.396 -0.366 . . . . 1.27 110.053 -178.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.9 tttt -79.89 118.88 22.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.82 -0.627 . . . . 1.6499999999999999 109.377 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.3 m -102.33 150.78 6.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.294 0.569 . . . . 1.04 111.668 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 64.7 t80 -106.59 120.57 42.29 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.277 -0.874 . . . . 0.41999999999999998 109.278 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.474 ' CG1' HD13 ' A' ' 101' ' ' ILE . 45.4 t -115.44 125.78 72.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.27 -0.641 . . . . 1.03 109.27 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.48 -174.29 20.06 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.708 -0.758 . . . . 0.17999999999999999 111.404 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 108.796 -0.816 . . . . 2.3599999999999999 108.796 178.463 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 121.633 0.73 . . . . 1.3600000000000001 112.44 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.02 23.81 77.11 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.963 -1.113 . . . . 0.26000000000000001 111.012 -179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.505 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.2 m120 -89.62 124.97 35.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.009 -0.737 . . . . 0.63 109.009 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.552 HG12 ' HB ' ' A' ' 143' ' ' VAL . 22.9 pt -135.62 163.41 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.545 -0.298 . . . . 1.05 110.242 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.38 146.47 48.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.882 0.372 . . . . 0.26000000000000001 110.054 176.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.8 mt -124.48 144.92 32.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.765 -0.652 . . . . 1.01 109.788 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -129.94 156.42 44.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.46 0.171 . . . . 2.0800000000000001 111.073 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.7 t30 71.54 36.12 1.34 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.044 0.938 . . . . 0.53000000000000003 111.357 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 110' ' ' ILE . 31.7 mt -76.59 143.36 40.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.187 -0.461 . . . . 1.04 110.779 175.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.44 151.28 41.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.706 -0.679 . . . . 0.70999999999999996 110.923 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -52.84 -32.77 46.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.499 -0.773 . . . . 2.7799999999999998 112.321 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -80.45 -7.47 59.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.006 0.372 . . . . 1.8 112.006 -175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.565 HG23 HD21 ' A' ' 106' ' ' LEU . 28.2 mm -76.07 127.38 37.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.078 0.466 . . . . 1.1000000000000001 110.928 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -115.64 -179.25 3.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.536 -0.756 . . . . 1.5900000000000001 109.026 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -65.71 -36.39 83.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.507 -0.553 . . . . 0.92000000000000004 109.507 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.998 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.98 -49.63 76.68 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.862 0.839 . . . . 3.04 109.986 178.057 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.6 98.56 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.771 -1.559 . . . . 1.03 111.315 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.629 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -64.76 -47.18 79.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.973 -0.751 . . . . 1.05 108.973 177.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.732 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 55.6 t80 -58.65 -49.1 78.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 1.05 111.127 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.68 -37.51 73.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.863 0.363 . . . . 0.40000000000000002 110.922 -174.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.672 HG21 HD22 ' A' ' 163' ' ' LEU . 6.7 m -78.29 -53.9 6.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.521 . . . . 1.02 111.823 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CD1' HD21 ' A' ' 115' ' ' LEU . 21.2 m-85 -72.01 -28.29 63.29 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.31 0.485 . . . . 0.14999999999999999 112.31 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.9 t -57.82 -27.53 63.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.529 0.204 . . . . 0.56000000000000005 111.51 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.58 -21.83 29.41 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.762 0.315 . . . . 1.04 111.736 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -93.12 -9.78 38.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.20999999999999999 110.932 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.29 161.46 10.85 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.743 -0.662 . . . . 0.14000000000000001 111.665 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -61.24 132.23 52.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.24 0.543 . . . . 0.28999999999999998 110.363 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.417 ' HB ' ' CD1' ' A' ' 116' ' ' TYR . 76.8 mt -100.84 134.9 39.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.62 -0.718 . . . . 1.0700000000000001 109.715 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 146' ' ' GLU . 19.9 mt -89.66 -39.14 13.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.847 0.832 . . . . 1.26 108.867 -176.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.7 m -155.95 129.42 8.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.496 -1.229 . . . . 1.1799999999999999 109.502 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.732 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 8.5 p -123.84 149.71 45.43 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.192 -0.67 . . . . 1.49 109.192 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -148.51 128.02 13.17 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.308 -0.557 . . . . 1.6299999999999999 111.704 -177.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.629 HG22 HD12 ' A' ' 115' ' ' LEU . 59.7 t -111.31 109.59 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 106.195 -1.78 . . . . 1.0700000000000001 106.195 169.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 t . . . . . 0 C--N 1.299 -1.604 0 N-CA-C 108.714 -0.847 . . . . 1.1399999999999999 108.714 -174.903 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.792 0 CA-C-O 120.315 -0.158 . . . . 0.31 113.361 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -126.04 152.94 45.12 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.424 0.612 . . . . 1.01 111.811 -173.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.65 174.64 26.43 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.352 -0.84 . . . . 0.13 111.619 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -139.97 136.88 34.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.947 0.374 . . . . 0.31 110.862 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.552 ' HB ' HG12 ' A' ' 101' ' ' ILE . 47.5 t -111.23 134.46 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.036 0.446 . . . . 1.03 111.094 174.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -102.51 107.04 17.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.681 -0.69 . . . . 0.32000000000000001 109.159 165.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 21.2 m-85 -87.36 142.07 28.16 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.286 0.565 . . . . 0.17000000000000001 110.697 176.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.498 ' HA ' HD12 ' A' ' 126' ' ' LEU . 39.4 tt0 -51.7 -35.01 41.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.521 -1.218 . . . . 0.56999999999999995 111.001 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.1 p -130.04 150.06 51.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.582 -1.19 . . . . 1.1100000000000001 111.181 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -62.75 -38.43 90.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.665 -0.698 . . . . 0.46999999999999997 111.04 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -65.19 -33.75 76.75 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.113 -0.494 . . . . 0.73999999999999999 112.285 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.67 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 1.03 110.298 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.515 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -64.62 -43.13 94.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.335 -0.848 . . . . 1.05 111.097 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 28.2 mt-10 -58.44 -40.69 83.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.851 -0.613 . . . . 1.4199999999999999 110.865 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 58.8 mtt85 -64.82 -42.33 95.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.74 0.305 . . . . 2.0 110.784 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.45 94.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.4 -0.364 . . . . 1.02 110.605 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.7 mt -58.81 -54.47 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 1.04 111.013 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.5 pt-20 -64.1 -45.52 88.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.188 0.518 . . . . 1.0800000000000001 111.841 -177.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -77.36 -38.58 49.86 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.479 -0.782 . . . . 1.78 112.617 -170.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -25.46 20.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.17 0.433 . . . . 1.03 112.17 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.416 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 59.0 t30 -66.36 123.4 19.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.25 -0.648 . . . . 0.60999999999999999 109.25 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.98 12.67 63.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.613 -0.803 . . . . 0.28999999999999998 112.638 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.604 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.8 mmt -101.6 158.05 16.37 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.634 -0.333 . . . . 1.72 111.137 177.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 30.7 mt -98.34 107.61 20.12 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 109.207 -0.664 . . . . 1.1799999999999999 109.207 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.672 HD22 HG21 ' A' ' 118' ' ' THR . 17.2 mt -90.77 107.64 19.31 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.853 -0.795 . . . . 1.1299999999999999 108.853 171.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 82.5 m-20 72.78 -67.22 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.246 -0.888 . . . . 1.71 111.61 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -157.03 7.71 0.17 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.328 -0.851 . . . . 0.84999999999999998 111.742 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -130.56 134.35 46.94 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.592 -0.692 . . . . 1.27 110.924 -175.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.6 tttt -79.01 118.97 21.5 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.898 -0.779 . . . . 1.6499999999999999 108.898 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 5.7 m -100.19 146.81 8.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.596 0.712 . . . . 1.04 111.046 -172.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 74.1 t80 -106.58 117.84 35.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.699 -1.137 . . . . 0.41999999999999998 109.369 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.61 131.03 69.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.425 -0.583 . . . . 1.03 109.425 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -151.85 -176.92 25.07 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.595 -0.812 . . . . 0.17999999999999999 112.195 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.389 . . . . 2.3599999999999999 110.284 -179.983 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 121.535 0.683 . . . . 1.3600000000000001 111.958 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.25 24.08 76.15 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.167 -1.016 . . . . 0.26000000000000001 111.551 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.517 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.2 m120 -88.13 125.23 34.49 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.005 -0.739 . . . . 0.63 109.005 -173.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.459 HG12 ' HB ' ' A' ' 143' ' ' VAL . 19.1 pt -135.67 164.08 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.301 -0.259 . . . . 1.05 110.301 177.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.19 145.0 50.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.858 0.361 . . . . 0.26000000000000001 110.162 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.536 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 5.3 mt -123.06 142.89 37.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.855 -0.612 . . . . 1.01 110.043 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -127.38 155.44 43.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.291 0.091 . . . . 2.0800000000000001 111.125 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.9 t30 70.48 38.19 1.38 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.947 0.779 . . . . 0.53000000000000003 111.216 173.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.632 HD21 HG22 ' A' ' 110' ' ' ILE . 17.5 mt -79.63 163.44 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.535 -0.757 . . . . 1.04 111.075 175.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -97.16 157.27 16.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.988 -0.551 . . . . 0.70999999999999996 109.976 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -62.79 -28.67 70.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.935 0.398 . . . . 2.7799999999999998 111.204 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.5 m -69.72 -6.52 32.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.267 -0.424 . . . . 1.8 111.936 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.632 HG22 HD21 ' A' ' 106' ' ' LEU . 31.7 mm -89.41 114.2 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.175 0.512 . . . . 1.1000000000000001 110.46 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.53 -173.58 2.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.678 -0.86 . . . . 1.5900000000000001 108.678 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -70.46 -33.11 70.9 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.135 -1.061 . . . . 0.92000000000000004 108.135 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.632 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -66.8 -47.35 72.36 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 113.985 -1.461 . . . . 3.04 109.661 178.054 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.11 97.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.972 -1.467 . . . . 1.03 110.787 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.608 HD12 HG21 ' A' ' 130' ' ' VAL . 4.4 tt -67.07 -47.0 72.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.444 -0.798 . . . . 1.05 109.163 177.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.68 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 75.7 t80 -58.94 -46.61 87.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.078 -0.51 . . . . 1.05 110.997 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -56.77 -40.05 75.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.977 0.417 . . . . 0.40000000000000002 110.886 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.425 HG21 HD23 ' A' ' 163' ' ' LEU . 9.6 m -77.67 -53.88 7.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.944 -0.571 . . . . 1.02 111.825 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.401 ' CD1' HD22 ' A' ' 115' ' ' LEU . 12.0 m-85 -72.42 -29.75 64.0 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.784 0.661 . . . . 0.14999999999999999 112.784 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.6 t -58.64 -28.11 65.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.617 0.246 . . . . 0.56000000000000005 111.174 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.86 -22.12 34.53 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.683 0.278 . . . . 1.04 111.593 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.89 -11.9 35.04 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.899 0.38 . . . . 0.20999999999999999 110.984 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.57 160.88 10.96 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.749 -0.54 . . . . 0.14000000000000001 111.749 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -62.45 139.24 58.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.28999999999999998 110.185 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.422 HG21 ' HB3' ' A' ' 128' ' ' CYS . 67.1 mt -110.89 134.99 51.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.959 -0.564 . . . . 1.0700000000000001 109.857 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.531 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -87.49 -44.05 11.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.635 -0.876 . . . . 1.26 108.635 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.6 m -145.33 127.48 15.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.85 -1.068 . . . . 1.1799999999999999 109.862 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 8.5 p -124.09 137.0 54.63 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.587 -0.523 . . . . 1.49 109.587 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -136.39 129.59 31.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.909 0.385 . . . . 1.6299999999999999 111.788 -173.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.608 HG21 HD12 ' A' ' 115' ' ' LEU . 60.9 t -115.1 110.81 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 107.171 -1.418 . . . . 1.0700000000000001 107.171 170.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 t . . . . . 0 C--N 1.305 -1.337 0 N-CA-C 109.015 -0.735 . . . . 1.1399999999999999 109.015 -175.503 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.684 0 N-CA-C 113.575 0.19 . . . . 0.31 113.575 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -127.21 151.24 48.96 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.491 0.645 . . . . 1.01 111.817 -174.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.1 175.51 25.54 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.236 -0.893 . . . . 0.13 111.338 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -139.76 140.25 36.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.868 0.334 . . . . 0.31 110.688 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.522 HG13 ' CE2' ' A' ' 145' ' ' PHE . 49.5 t -114.69 136.11 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.043 0.449 . . . . 1.03 111.076 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -104.26 106.02 16.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.706 -0.679 . . . . 0.32000000000000001 109.191 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.522 ' CE2' HG13 ' A' ' 143' ' ' VAL . 20.8 m-85 -90.65 136.29 33.16 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.163 0.506 . . . . 0.17000000000000001 111.102 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.531 ' HA ' HD22 ' A' ' 126' ' ' LEU . 38.2 tt0 -49.04 -40.69 32.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.514 -1.221 . . . . 0.56999999999999995 110.682 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.8 p -117.47 147.05 43.09 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.039 -0.982 . . . . 1.1100000000000001 110.731 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -63.11 -33.78 76.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.875 -0.602 . . . . 0.46999999999999997 111.042 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -68.75 -34.84 76.28 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.402 -0.363 . . . . 0.73999999999999999 111.456 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.81 -34.66 78.41 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.156 0.503 . . . . 1.03 110.389 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.494 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.32 -48.46 79.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.483 -0.78 . . . . 1.05 110.639 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.605 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 41.0 mt-10 -58.79 -38.23 78.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.824 -0.625 . . . . 1.4199999999999999 110.841 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 51.4 mtt180 -62.1 -44.59 96.33 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.84 0.352 . . . . 2.0 111.011 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.19 86.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 1.02 110.657 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 151' ' ' ALA . 82.4 mt -61.02 -53.65 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 1.04 110.879 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.5 pt-20 -64.23 -41.73 96.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.957 0.408 . . . . 1.0800000000000001 111.98 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.447 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -81.36 -39.81 24.5 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.888 0.699 . . . . 1.78 112.888 -171.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 92.3 mmm -93.02 -22.78 18.94 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.598 0.592 . . . . 1.03 112.598 -172.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -66.96 123.33 19.91 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.028 -0.731 . . . . 0.60999999999999999 109.028 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.2 13.21 66.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.585 -0.817 . . . . 0.28999999999999998 112.545 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.628 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.2 mmt -101.41 165.18 11.39 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.614 -0.345 . . . . 1.72 111.224 177.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.33 130.46 46.44 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.949 -0.76 . . . . 1.1799999999999999 108.949 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 22.0 mt -116.41 101.1 8.36 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.08 -0.648 . . . . 1.1299999999999999 109.757 171.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 165' ' ' ASP . 55.9 m-20 78.5 -24.62 0.21 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.249 -0.887 . . . . 1.71 112.659 177.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 23.2 t70 166.17 -22.47 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 O-C-N 124.0 0.813 . . . . 0.84999999999999998 111.439 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 -110.71 132.02 54.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.497 -0.32 . . . . 1.27 110.872 -170.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.6 ttmt -77.94 124.15 27.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.416 -0.587 . . . . 1.6499999999999999 109.416 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.5 m -103.22 149.66 7.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.329 0.585 . . . . 1.04 111.573 -174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 43.3 t80 -107.21 120.91 43.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.3 -0.864 . . . . 0.41999999999999998 109.062 177.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.56 125.65 72.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.39 -0.596 . . . . 1.03 109.39 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.22 -173.76 16.8 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.568 -0.825 . . . . 0.17999999999999999 112.218 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 109.836 -0.431 . . . . 2.3599999999999999 109.836 179.897 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 112.889 0.699 . . . . 1.3600000000000001 112.889 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.31 24.34 76.52 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.984 -1.103 . . . . 0.26000000000000001 111.768 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.486 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.0 OUTLIER -86.51 125.21 33.59 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.535 -0.542 . . . . 0.63 109.535 -173.258 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.564 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.9 pt -135.57 160.43 39.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.228 -0.286 . . . . 1.05 110.228 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -125.79 142.78 51.35 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.888 -0.412 . . . . 0.26000000000000001 109.888 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 7.2 mt -121.05 131.27 73.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 1.01 110.251 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -116.06 151.32 35.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.681 -0.236 . . . . 2.0800000000000001 110.561 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.2 t30 74.5 38.09 0.52 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.903 0.752 . . . . 0.53000000000000003 111.834 172.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.539 HD22 HG22 ' A' ' 110' ' ' ILE . 19.3 mt -76.78 158.47 30.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.059 0.457 . . . . 1.04 111.065 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.511 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.0 t70 -84.26 151.69 24.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.553 -0.748 . . . . 0.70999999999999996 111.394 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -53.12 -36.19 60.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.13 -0.941 . . . . 2.7799999999999998 112.368 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -88.18 -2.57 58.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.242 -0.435 . . . . 1.8 112.169 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.539 HG22 HD22 ' A' ' 106' ' ' LEU . 36.4 mm -73.59 124.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.2 0.524 . . . . 1.1000000000000001 110.823 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 113' ' ' LYS . 0.2 OUTLIER -104.11 177.99 4.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.434 -0.803 . . . . 1.5900000000000001 110.865 -178.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -71.23 -33.67 70.08 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 107.56 -1.274 . . . . 0.92000000000000004 107.56 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.716 ' HB3' ' HZ1' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -64.32 -48.87 73.95 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.833 -1.531 . . . . 3.04 108.949 176.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.91 -44.87 96.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.367 -1.288 . . . . 1.03 111.062 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.608 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -64.09 -47.1 81.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.302 -0.863 . . . . 1.05 109.056 177.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.669 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 69.8 t80 -59.61 -49.3 78.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.936 -0.575 . . . . 1.05 111.135 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -58.3 -35.07 71.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.939 0.399 . . . . 0.40000000000000002 111.166 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 24.9 m -78.8 -54.45 6.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.319 -0.401 . . . . 1.02 112.022 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.428 ' CD1' HD23 ' A' ' 115' ' ' LEU . 8.6 m-85 -72.78 -29.72 63.52 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.665 0.617 . . . . 0.14999999999999999 112.665 -173.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.2 t -58.76 -28.06 65.56 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.668 0.271 . . . . 0.56000000000000005 111.454 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.56 -22.87 36.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.937 0.398 . . . . 1.04 111.236 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -90.32 -19.04 24.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.20999999999999999 110.811 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.76 168.43 29.88 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 121.132 -0.556 . . . . 0.14000000000000001 111.89 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -69.58 139.9 53.74 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.099 -0.334 . . . . 0.28999999999999998 110.099 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.415 HG21 ' HB3' ' A' ' 128' ' ' CYS . 73.5 mt -111.78 133.78 56.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.389 -0.369 . . . . 1.0700000000000001 110.526 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -91.94 -38.06 12.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.442 0.639 . . . . 1.26 109.431 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 75.4 m -155.68 102.82 2.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.46 -0.791 . . . . 1.1799999999999999 110.942 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 9.3 p -106.12 142.64 35.48 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.848 -0.427 . . . . 1.49 109.848 173.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -135.43 130.82 35.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.875 -0.602 . . . . 1.6299999999999999 110.797 -173.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.608 HG22 HD12 ' A' ' 115' ' ' LEU . 63.3 t -114.91 110.08 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 106.838 -1.541 . . . . 1.0700000000000001 106.838 170.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.305 -1.334 0 N-CA-C 108.637 -0.875 . . . . 1.1399999999999999 108.637 -175.871 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.69 0 CA-C-O 120.359 -0.134 . . . . 0.31 113.265 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -129.14 148.32 51.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.535 0.668 . . . . 1.01 111.875 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.28 170.99 25.25 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.05 -0.977 . . . . 0.13 111.433 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -137.77 137.57 38.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.757 0.278 . . . . 0.31 110.578 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.564 ' HB ' HG12 ' A' ' 101' ' ' ILE . 36.5 t -113.42 130.89 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 120.889 0.376 . . . . 1.03 110.814 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.458 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 0.4 OUTLIER -100.61 105.95 17.4 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.019 -0.734 . . . . 0.32000000000000001 109.019 166.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.53 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 12.4 m-85 -89.36 137.32 32.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.266 0.555 . . . . 0.17000000000000001 111.209 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.563 ' HA ' HD23 ' A' ' 126' ' ' LEU . 41.5 tt0 -47.88 -48.75 31.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.235 -1.348 . . . . 0.56999999999999995 110.556 176.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 p -110.63 144.51 39.41 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.379 -1.282 . . . . 1.1100000000000001 111.218 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -61.77 -37.7 85.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.665 -0.698 . . . . 0.46999999999999997 110.996 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.0 pt-20 -69.91 -34.36 73.39 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.615 -0.266 . . . . 0.73999999999999999 111.682 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.55 77.61 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.154 0.502 . . . . 1.03 110.403 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.53 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.97 -44.69 95.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.488 -0.778 . . . . 1.05 110.501 176.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 49.1 mt-10 -59.53 -40.55 87.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 1.4199999999999999 110.541 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.506 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 50.1 mtt180 -62.3 -39.93 94.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 2.0 110.823 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.02 -38.5 86.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.472 -0.331 . . . . 1.02 110.423 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 151' ' ' ALA . 81.2 mt -58.68 -54.04 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 1.04 111.167 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.0 OUTLIER -61.05 -44.25 97.67 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.149 0.499 . . . . 1.0800000000000001 112.028 -178.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.456 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.23 -38.7 24.12 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.48 -0.782 . . . . 1.78 112.802 -169.002 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 92.9 mmm -91.23 -24.28 19.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.254 0.464 . . . . 1.03 112.254 -173.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 59.9 t30 -67.72 123.02 19.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.215 -0.594 . . . . 0.60999999999999999 109.507 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.0 8.83 64.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.732 -0.747 . . . . 0.28999999999999998 112.786 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.728 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.4 mmt -92.01 163.81 13.85 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.692 0.282 . . . . 1.72 111.425 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 15.7 mt -105.55 107.21 18.07 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.536 -0.542 . . . . 1.1799999999999999 109.536 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.408 HD21 ' HA ' ' A' ' 163' ' ' LEU . 18.3 mt -94.61 108.55 20.52 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.793 -0.763 . . . . 1.1299999999999999 109.245 172.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 94.4 m-20 72.11 -62.35 0.47 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.137 -0.938 . . . . 1.71 112.127 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -163.88 12.78 0.05 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.787 -0.642 . . . . 0.84999999999999998 111.438 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.511 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.1 mtt180 -134.41 129.85 35.96 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.966 -0.459 . . . . 1.27 110.481 -174.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.728 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.2 ttmt -78.7 120.12 22.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.588 -0.733 . . . . 1.6499999999999999 109.157 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.73 146.58 9.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.619 0.723 . . . . 1.04 111.231 -172.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 75.2 t80 -106.9 118.38 36.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.729 -1.123 . . . . 0.41999999999999998 109.341 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.418 ' CG1' HD11 ' A' ' 101' ' ' ILE . 41.1 t -115.22 125.06 72.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.104 -0.702 . . . . 1.03 109.104 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.76 -174.46 17.96 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.512 -0.851 . . . . 0.17999999999999999 112.098 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.964 0.412 . . . . 2.3599999999999999 110.246 -179.595 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.5 t . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 121.51 0.671 . . . . 1.3600000000000001 111.857 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.27 24.15 75.98 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.181 -1.009 . . . . 0.26000000000000001 112.084 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.504 ' N ' HD21 ' A' ' 100' ' ' ASN . 0.9 OUTLIER -88.58 125.41 34.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.357 -0.608 . . . . 0.63 109.357 -174.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.502 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.4 pt -135.31 159.73 40.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.087 -0.338 . . . . 1.05 110.087 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.39 138.18 54.62 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.899 -0.408 . . . . 0.26000000000000001 109.899 176.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 5.7 mt -116.71 131.49 69.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.548 -0.751 . . . . 1.01 110.076 -177.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -113.66 152.56 30.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.493 -0.321 . . . . 2.0800000000000001 110.588 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.8 t30 75.58 33.99 0.62 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.014 0.821 . . . . 0.53000000000000003 111.683 170.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.489 HD23 HG23 ' A' ' 110' ' ' ILE . 25.4 mt -75.64 156.82 34.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 1.04 111.446 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 15.0 t70 -83.15 153.14 24.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.519 -0.764 . . . . 0.70999999999999996 111.36 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 109' ' ' SER . 55.1 pttt -54.09 -37.66 64.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.485 -0.78 . . . . 2.7799999999999998 112.501 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.413 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 13.7 m -80.86 -8.76 59.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.848 0.314 . . . . 1.8 111.848 -172.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.499 ' O ' HG12 ' A' ' 130' ' ' VAL . 34.6 mm -71.16 120.17 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.013 0.435 . . . . 1.1000000000000001 110.376 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -109.27 -179.67 3.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.016 -0.735 . . . . 1.5900000000000001 109.016 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.58 -40.98 98.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.269 -0.641 . . . . 0.92000000000000004 109.269 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.91 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -59.97 -49.39 77.87 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.277 -0.874 . . . . 3.04 110.567 178.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.9 98.19 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.265 -1.334 . . . . 1.03 111.396 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.611 HD12 HG21 ' A' ' 130' ' ' VAL . 4.0 tt -65.03 -47.15 78.42 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.952 -0.758 . . . . 1.05 108.952 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.744 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 64.4 t80 -57.54 -48.23 79.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.916 -0.584 . . . . 1.05 111.009 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.25 -37.55 72.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.968 0.413 . . . . 0.40000000000000002 110.828 -175.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 m -77.88 -54.42 6.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.151 -0.477 . . . . 1.02 111.815 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.431 ' CD1' HD22 ' A' ' 115' ' ' LEU . 10.2 m-85 -73.02 -28.82 62.58 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.881 0.696 . . . . 0.14999999999999999 112.881 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -57.57 -28.23 63.38 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.777 0.322 . . . . 0.56000000000000005 110.875 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.45 -21.74 27.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.355 -0.384 . . . . 1.04 111.618 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -92.98 -17.41 23.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.989 0.423 . . . . 0.20999999999999999 110.918 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.72 162.51 14.74 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.977 -0.556 . . . . 0.14000000000000001 111.796 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -61.67 132.45 53.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.057 0.456 . . . . 0.28999999999999998 110.538 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 128' ' ' CYS . 68.3 mt -106.35 133.68 50.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.808 -0.633 . . . . 1.0700000000000001 109.747 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.552 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.28 -40.31 13.72 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.01 -0.737 . . . . 1.26 109.01 -177.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.3 m -147.68 129.66 15.37 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.973 -1.012 . . . . 1.1799999999999999 109.915 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.744 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 5.8 p -129.44 124.67 34.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.265 -0.643 . . . . 1.49 109.265 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -123.95 127.93 48.67 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.906 0.384 . . . . 1.6299999999999999 111.327 -173.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.611 HG21 HD12 ' A' ' 115' ' ' LEU . 54.8 t -114.48 109.55 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 106.856 -1.535 . . . . 1.0700000000000001 106.856 170.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 t . . . . . 0 C--N 1.302 -1.458 0 N-CA-C 108.611 -0.885 . . . . 1.1399999999999999 108.611 -175.142 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 CA-C-O 120.279 -0.179 . . . . 0.31 113.314 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -133.03 148.8 52.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.368 0.584 . . . . 1.01 111.654 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.86 168.56 25.93 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.24 -0.891 . . . . 0.13 111.377 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -136.47 136.49 39.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.059 0.43 . . . . 0.31 110.801 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.522 HG12 ' CE2' ' A' ' 145' ' ' PHE . 48.7 t -111.0 136.45 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.957 0.408 . . . . 1.03 111.145 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.447 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 1.3 m170 -105.57 105.63 15.76 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.104 -0.702 . . . . 0.32000000000000001 109.104 166.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.522 ' CE2' HG12 ' A' ' 143' ' ' VAL . 17.5 m-85 -88.79 138.59 31.28 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.042 0.448 . . . . 0.17000000000000001 110.938 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.552 ' HA ' HD21 ' A' ' 126' ' ' LEU . 28.5 tt0 -45.87 -45.39 15.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.526 -1.215 . . . . 0.56999999999999995 110.923 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.3 p -119.8 150.78 39.86 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.938 -1.028 . . . . 1.1100000000000001 110.839 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -61.46 -33.41 73.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.49 -0.777 . . . . 0.46999999999999997 110.865 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.76 -35.65 75.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.73999999999999999 111.83 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.59 -34.23 76.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.093 0.473 . . . . 1.03 110.498 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -64.2 -44.25 92.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.632 -0.713 . . . . 1.05 110.688 176.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 31.8 mt-10 -58.96 -38.61 79.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 1.4199999999999999 110.471 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 92.2 mtt180 -62.77 -43.51 98.6 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.03 0.443 . . . . 2.0 110.969 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.75 -37.29 85.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 1.02 110.405 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 151' ' ' ALA . 90.6 mt -59.17 -52.74 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 1.04 111.248 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.6 pt-20 -64.02 -46.24 85.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.09 0.472 . . . . 1.0800000000000001 111.809 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.452 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -80.86 -38.47 28.1 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.147 0.795 . . . . 1.78 113.147 -168.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 92.0 mmm -93.29 -20.22 20.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.458 0.54 . . . . 1.03 112.458 -173.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.417 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 53.8 t30 -68.58 123.75 21.71 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.221 -0.592 . . . . 0.60999999999999999 109.652 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.52 64.48 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.777 -0.725 . . . . 0.28999999999999998 112.539 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.716 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.7 mmt -96.07 162.5 13.52 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.678 0.239 . . . . 1.72 110.976 177.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.9 mt -103.35 105.04 15.22 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.345 -0.613 . . . . 1.1799999999999999 109.345 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 18.0 mt -91.04 108.93 20.19 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.925 -0.71 . . . . 1.1299999999999999 109.256 173.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 93.9 m-20 73.57 -60.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.302 -0.863 . . . . 1.71 111.827 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -172.61 22.9 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.549 -0.75 . . . . 0.84999999999999998 110.798 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.7 mtt180 -138.29 132.75 32.14 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.006 -0.434 . . . . 1.27 109.96 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.716 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.2 tttt -84.19 115.02 22.21 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.441 -0.577 . . . . 1.6499999999999999 109.441 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.6 m -100.12 147.83 7.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.599 0.714 . . . . 1.04 111.485 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 75.8 t80 -106.58 120.49 42.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.735 -1.121 . . . . 0.41999999999999998 109.365 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.454 ' CG1' HD13 ' A' ' 101' ' ' ILE . 42.3 t -115.48 125.58 72.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.154 -0.684 . . . . 1.03 109.154 177.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.53 -171.5 16.68 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.351 -0.928 . . . . 0.17999999999999999 112.235 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 . . . . . 0 C--N 1.325 -0.464 0 N-CA-C 109.426 -0.583 . . . . 2.3599999999999999 109.426 -179.793 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 120.93 0.395 . . . . 1.3600000000000001 111.908 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.08 24.08 69.93 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.218 -0.991 . . . . 0.26000000000000001 111.877 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 143' ' ' VAL . 2.2 m120 -87.45 125.8 34.51 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.969 -0.752 . . . . 0.63 108.969 -176.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.548 HG12 ' HB ' ' A' ' 143' ' ' VAL . 23.8 pt -135.02 163.55 36.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.477 -0.329 . . . . 1.05 110.283 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.14 147.28 49.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.83 -0.433 . . . . 0.26000000000000001 109.83 175.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 140' ' ' TYR . 4.4 mt -119.26 139.29 47.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.679 -0.691 . . . . 1.01 109.811 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -117.16 153.22 33.2 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.952 0.158 . . . . 2.0800000000000001 110.637 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.0 t30 71.39 39.73 0.9 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.863 0.727 . . . . 0.53000000000000003 112.16 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.5 mt -81.82 164.73 21.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.807 0.337 . . . . 1.04 111.056 176.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -96.7 157.53 15.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.70999999999999996 109.813 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -61.51 -26.4 67.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.484 0.659 . . . . 2.7799999999999998 109.681 172.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 m -59.78 -23.12 63.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.632 -1.167 . . . . 1.8 112.596 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.518 HG23 HG22 ' A' ' 130' ' ' VAL . 40.2 mm -86.43 131.32 34.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.407 0.622 . . . . 1.1000000000000001 111.502 -174.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 16.8 t70 -117.37 -175.39 2.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.235 -1.024 . . . . 1.5900000000000001 108.235 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.445 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 90.9 m-20 -69.07 -29.68 67.85 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.608 -0.886 . . . . 0.92000000000000004 108.608 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -49.46 65.18 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.457 -1.247 . . . . 3.04 109.404 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.78 85.47 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.7 -1.136 . . . . 1.03 110.691 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.609 HD13 HG23 ' A' ' 130' ' ' VAL . 3.5 tt -70.72 -48.05 56.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.47 -0.786 . . . . 1.05 109.35 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.616 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 80.2 t80 -61.05 -45.12 96.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 1.05 110.833 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.43 -41.83 77.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.014 0.435 . . . . 0.40000000000000002 110.884 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 24.0 m -77.66 -53.66 7.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 1.02 112.072 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.427 ' CD1' HD23 ' A' ' 115' ' ' LEU . 17.7 m-85 -72.17 -29.46 64.04 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.46 0.541 . . . . 0.14999999999999999 112.46 -173.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.6 t -58.67 -28.93 66.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.595 0.236 . . . . 0.56000000000000005 111.201 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.38 -22.62 43.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 1.04 111.554 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -93.64 -11.94 30.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 0.20999999999999999 110.875 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.95 164.06 15.14 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.929 -0.653 . . . . 0.14000000000000001 111.846 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -67.05 137.5 56.48 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.932 0.396 . . . . 0.28999999999999998 110.178 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.412 HG23 ' HB3' ' A' ' 128' ' ' CYS . 72.1 mt -110.21 129.57 64.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.119 -0.491 . . . . 1.0700000000000001 109.927 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.14 -35.37 20.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.054 -0.721 . . . . 1.26 109.054 -177.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 65.8 m -154.31 128.72 9.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.17 -0.923 . . . . 1.1799999999999999 109.849 -177.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 2.6 p -134.14 144.85 48.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.802 0.334 . . . . 1.49 110.247 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -143.78 133.15 23.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.299 -0.41 . . . . 1.6299999999999999 111.59 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.609 HG23 HD13 ' A' ' 115' ' ' LEU . 59.6 t -113.23 111.11 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 106.383 -1.71 . . . . 1.0700000000000001 106.383 168.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 C--N 1.301 -1.52 0 N-CA-C 108.804 -0.813 . . . . 1.1399999999999999 108.804 -174.567 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.832 0 CA-C-O 120.317 -0.157 . . . . 0.31 113.113 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 22.2 p90 -125.88 148.78 49.09 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.457 0.629 . . . . 1.01 111.984 -174.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.36 173.81 23.2 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.002 -0.999 . . . . 0.13 111.358 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -136.11 141.85 44.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.032 0.416 . . . . 0.31 110.848 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.548 ' HB ' HG12 ' A' ' 101' ' ' ILE . 28.1 t -117.23 135.95 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.106 0.479 . . . . 1.03 110.84 172.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.4 OUTLIER -107.2 106.17 16.5 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.031 -0.729 . . . . 0.32000000000000001 109.031 168.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.538 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.2 m-85 -90.49 139.06 31.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.596 0.713 . . . . 0.17000000000000001 111.936 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.523 ' HA ' HD21 ' A' ' 126' ' ' LEU . 46.5 tt0 -49.05 -40.79 32.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.912 -1.495 . . . . 0.56999999999999995 110.86 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.2 p -123.93 154.59 39.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.887 -1.051 . . . . 1.1100000000000001 110.513 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -66.14 -33.5 75.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.177 -0.465 . . . . 0.46999999999999997 110.902 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.07 -35.86 77.0 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.365 -0.379 . . . . 0.73999999999999999 111.518 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.19 -34.51 78.24 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.168 0.508 . . . . 1.03 110.402 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.538 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.81 -48.01 80.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.523 -0.762 . . . . 1.05 110.606 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 29.3 mt-10 -58.64 -42.13 87.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.005 -0.543 . . . . 1.4199999999999999 110.696 177.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 72.5 mtt180 -58.65 -41.62 86.49 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.944 0.402 . . . . 2.0 110.949 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.22 -40.36 86.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.359 -0.382 . . . . 1.02 110.612 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 151' ' ' ALA . 91.1 mt -60.33 -49.59 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.056 -0.52 . . . . 1.04 111.176 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.9 pt-20 -64.07 -45.69 87.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.175 0.512 . . . . 1.0800000000000001 111.704 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.48 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -80.73 -38.58 28.5 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.329 0.863 . . . . 1.78 113.329 -169.261 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' A' ' 161' ' ' MET . 88.9 mmm -95.77 -17.12 21.44 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.709 0.633 . . . . 1.03 112.709 -172.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.06 123.06 20.61 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.197 -0.601 . . . . 0.60999999999999999 109.613 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.04 22.69 54.45 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.865 -0.684 . . . . 0.28999999999999998 112.419 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.551 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.5 OUTLIER -106.48 161.57 14.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.724 0.297 . . . . 1.72 111.622 -179.091 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 75.4 mt -104.17 106.75 17.36 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.908 -0.775 . . . . 1.1799999999999999 108.908 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.6 mt -92.6 22.17 4.89 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.015 -0.674 . . . . 1.1299999999999999 111.864 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.7 p30 169.92 -79.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.823 0.849 . . . . 1.71 109.153 -175.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -150.93 12.28 0.67 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.747 -1.115 . . . . 0.84999999999999998 109.536 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -124.04 135.04 53.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.589 -0.732 . . . . 1.27 109.096 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.621 ' HZ3' ' HB2' ' A' ' 167' ' ' LYS . 3.9 ttmp? -84.19 117.25 23.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.173 -0.677 . . . . 1.6499999999999999 109.173 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.1 m -99.79 143.28 13.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.541 0.686 . . . . 1.04 110.565 -172.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 39.7 t80 -106.53 122.18 45.78 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.882 -1.054 . . . . 0.41999999999999998 109.417 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.481 ' CG1' HD12 ' A' ' 101' ' ' ILE . 43.1 t -115.94 125.75 73.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.476 -0.564 . . . . 1.03 109.476 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.04 -167.23 12.1 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.319 -0.712 . . . . 0.17999999999999999 111.319 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 . . . . . 0 C--N 1.322 -0.614 0 N-CA-C 108.833 -0.803 . . . . 2.3599999999999999 108.833 179.79 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.3 t . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.45 0.643 . . . . 1.3600000000000001 112.531 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.32 24.87 74.37 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 119.873 -1.155 . . . . 0.26000000000000001 111.455 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.508 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.3 m120 -89.95 124.17 34.5 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.955 -0.757 . . . . 0.63 108.955 -173.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.426 HD11 ' CG1' ' A' ' 170' ' ' VAL . 17.1 pt -136.07 163.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.942 -0.392 . . . . 1.05 109.942 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.94 143.22 51.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.1 0.476 . . . . 0.26000000000000001 109.775 176.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.1 mt -119.33 136.38 56.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.355 -0.839 . . . . 1.01 109.876 -177.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -120.15 154.1 35.26 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 121.438 -0.105 . . . . 2.0800000000000001 110.913 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.0 t30 73.73 32.79 1.09 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.878 0.871 . . . . 0.53000000000000003 111.528 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.657 HD23 HG21 ' A' ' 110' ' ' ILE . 30.7 mt -73.99 154.31 39.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.408 . . . . 1.04 111.255 177.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.461 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 25.6 t70 -83.17 152.3 25.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.675 . . . . 0.70999999999999996 110.681 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -56.15 -34.66 66.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.625 . . . . 2.7799999999999998 112.014 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.3 m -80.14 -2.83 46.33 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.416 0.524 . . . . 1.8 112.416 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.657 HG21 HD23 ' A' ' 106' ' ' LEU . 31.6 mm -78.91 116.43 22.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.615 -0.434 . . . . 1.1000000000000001 110.057 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -105.85 -176.7 3.15 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.95 -0.759 . . . . 1.5900000000000001 108.95 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -68.81 -31.01 69.7 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.111 -0.7 . . . . 0.92000000000000004 109.111 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -48.33 66.15 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.634 -1.166 . . . . 3.04 109.238 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.6 -41.6 97.66 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.269 -1.332 . . . . 1.03 110.796 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 130' ' ' VAL . 3.9 tt -67.5 -47.37 70.21 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.243 -0.89 . . . . 1.05 108.994 177.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.712 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 62.3 t80 -58.34 -47.81 82.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.179 -0.464 . . . . 1.05 111.155 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -56.74 -39.27 73.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.068 0.461 . . . . 0.40000000000000002 110.86 -174.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 m -78.48 -53.59 7.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.84 -0.618 . . . . 1.02 112.181 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.429 ' CD1' HD22 ' A' ' 115' ' ' LEU . 8.3 m-85 -72.52 -28.29 62.77 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.802 0.667 . . . . 0.14999999999999999 112.802 -174.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.5 t -57.05 -28.39 62.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.749 0.309 . . . . 0.56000000000000005 111.428 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.35 -22.45 42.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.699 0.285 . . . . 1.04 111.748 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.401 ' HZ ' ' HE2' ' A' ' 157' ' ' LYS . 23.9 m-85 -90.38 -18.23 25.84 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.968 0.413 . . . . 0.20999999999999999 111.102 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 165.31 166.93 25.11 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.901 -0.59 . . . . 0.14000000000000001 111.632 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -67.7 129.75 40.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.927 0.394 . . . . 0.28999999999999998 110.268 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.417 HG21 ' HB3' ' A' ' 128' ' ' CYS . 71.8 mt -100.48 131.97 47.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.134 -0.485 . . . . 1.0700000000000001 110.281 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.53 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.61 -44.73 11.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.497 -0.927 . . . . 1.26 108.497 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.5 m -147.33 111.65 5.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.912 -1.04 . . . . 1.1799999999999999 110.544 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.4 p -107.22 145.12 33.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.254 -0.647 . . . . 1.49 109.254 173.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -144.83 128.79 17.47 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.407 -0.517 . . . . 1.6299999999999999 111.932 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.613 HG21 HD13 ' A' ' 115' ' ' LEU . 48.6 t -114.81 110.64 32.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 106.627 -1.62 . . . . 1.0700000000000001 106.627 168.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.303 -1.435 0 N-CA-C 108.985 -0.746 . . . . 1.1399999999999999 108.985 -174.926 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.644 0 CA-C-O 120.488 -0.062 . . . . 0.31 113.182 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 25.7 p90 -127.19 150.59 49.45 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.207 0.527 . . . . 1.01 111.646 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.18 170.6 25.33 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.302 -0.863 . . . . 0.13 111.222 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -137.78 138.79 39.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.147 0.473 . . . . 0.31 110.841 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.549 HG11 ' CE2' ' A' ' 145' ' ' PHE . 42.6 t -113.74 135.45 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 120.962 0.41 . . . . 1.03 110.8 173.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -105.2 106.23 16.62 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.086 -0.709 . . . . 0.32000000000000001 109.086 166.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.549 ' CE2' HG11 ' A' ' 143' ' ' VAL . 17.4 m-85 -90.24 139.98 30.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.265 0.555 . . . . 0.17000000000000001 111.079 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.53 ' HA ' HD22 ' A' ' 126' ' ' LEU . 42.3 tt0 -50.57 -37.56 40.37 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.524 -1.216 . . . . 0.56999999999999995 110.93 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.8 p -121.68 155.87 34.25 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.023 -0.989 . . . . 1.1100000000000001 110.515 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -68.48 -36.31 78.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.104 -0.498 . . . . 0.46999999999999997 110.447 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.35 -34.81 75.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.598 . . . . 0.73999999999999999 112.014 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.83 -36.77 79.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.153 0.502 . . . . 1.03 110.454 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.467 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -65.04 -40.91 95.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.561 -0.745 . . . . 1.05 110.433 177.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 51.9 mt-10 -59.88 -37.35 79.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.636 -0.711 . . . . 1.4199999999999999 110.822 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 98.2 mtt180 -65.5 -43.99 88.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.352 -0.385 . . . . 2.0 110.876 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.43 83.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.222 -0.445 . . . . 1.02 110.532 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 151' ' ' ALA . 92.8 mt -60.65 -53.49 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 1.04 111.287 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.4 pt-20 -64.16 -43.4 95.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.182 0.515 . . . . 1.0800000000000001 111.902 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.52 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -81.26 -39.09 25.84 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.887 0.699 . . . . 1.78 112.887 -169.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 92.7 mmm -94.86 -20.22 19.63 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.686 0.625 . . . . 1.03 112.686 -172.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -68.05 123.39 20.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.392 -0.596 . . . . 0.60999999999999999 109.392 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.53 16.89 63.16 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.656 -0.783 . . . . 0.28999999999999998 112.667 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.589 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 4.4 mmt -98.48 156.23 16.87 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.718 -0.283 . . . . 1.72 111.072 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.485 HD21 ' O ' ' A' ' 165' ' ' ASP . 17.5 mt -98.77 103.75 15.73 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.626 -0.509 . . . . 1.1799999999999999 109.626 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 22.4 mt -91.01 104.28 16.89 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 120.054 -0.658 . . . . 1.1299999999999999 109.401 174.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 79.9 m-20 76.78 -27.75 0.18 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.129 -0.942 . . . . 1.71 112.519 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.485 ' O ' HD21 ' A' ' 162' ' ' LEU . 32.7 t70 163.94 -20.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.083 0.864 . . . . 0.84999999999999998 111.402 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.4 mtt180 -102.17 130.18 48.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.331 -0.395 . . . . 1.27 110.846 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 161' ' ' MET . 19.5 tttt -78.7 115.03 18.13 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.395 -0.594 . . . . 1.6499999999999999 109.395 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.4 HG13 HD21 ' A' ' 106' ' ' LEU . 12.9 m -100.56 149.57 6.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.614 0.721 . . . . 1.04 111.366 -172.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 77.4 t80 -106.33 118.93 37.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.834 -1.076 . . . . 0.41999999999999998 109.612 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.426 ' CG1' HD11 ' A' ' 101' ' ' ILE . 39.4 t -115.74 126.36 73.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.435 -0.58 . . . . 1.03 109.435 176.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.24 -176.32 23.17 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.78 -0.724 . . . . 0.17999999999999999 111.524 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 109.457 -0.571 . . . . 2.3599999999999999 109.457 177.866 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.731 0.777 . . . . 1.3600000000000001 112.627 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.29 23.98 77.47 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.64 -1.267 . . . . 0.26000000000000001 111.507 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.403 ' N ' HD21 ' A' ' 100' ' ' ASN . 0.9 OUTLIER -84.28 126.44 33.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.887 -0.412 . . . . 0.63 109.887 -174.274 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.562 HG12 ' HB ' ' A' ' 143' ' ' VAL . 32.2 pt -134.55 155.8 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.708 -0.678 . . . . 1.05 109.631 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.96 139.68 53.37 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.631 -0.507 . . . . 0.26000000000000001 109.631 178.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 8.6 mt -118.03 137.36 52.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.79 -0.641 . . . . 1.01 110.197 -176.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -124.2 152.52 42.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.638 -0.256 . . . . 2.0800000000000001 110.403 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' A' ' 167' ' ' LYS . 5.2 t30 74.69 45.32 0.17 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.806 0.813 . . . . 0.53000000000000003 110.847 170.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.474 HD22 HG22 ' A' ' 110' ' ' ILE . 20.1 mt -88.38 166.83 13.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.963 -1.017 . . . . 1.04 110.795 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -97.06 162.69 13.26 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.603 -0.517 . . . . 0.70999999999999996 109.603 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -66.27 -25.03 66.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.277 0.561 . . . . 2.7799999999999998 109.618 173.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.0 m -60.67 -16.19 36.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.122 -0.944 . . . . 1.8 112.074 175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.474 HG22 HD22 ' A' ' 106' ' ' LEU . 44.9 mm -93.07 128.38 44.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.332 0.587 . . . . 1.1000000000000001 111.166 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -118.65 -178.09 3.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.283 -1.006 . . . . 1.5900000000000001 108.283 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -61.81 -35.0 76.91 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.37 -0.604 . . . . 0.92000000000000004 109.37 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 1.038 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -61.76 -50.17 73.45 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.205 -0.907 . . . . 3.04 110.583 177.457 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.15 -42.9 99.39 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.576 -1.193 . . . . 1.03 110.968 -176.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.591 HD12 HG22 ' A' ' 130' ' ' VAL . 3.5 tt -65.51 -47.94 74.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.636 -0.711 . . . . 1.05 109.474 178.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.795 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.8 t80 -59.52 -44.71 93.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.442 . . . . 1.05 110.71 176.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.73 -42.67 79.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.178 -0.464 . . . . 0.40000000000000002 111.154 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.5 m -78.05 -53.37 7.48 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.352 0.501 . . . . 1.02 112.352 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.468 ' CD1' HD22 ' A' ' 115' ' ' LEU . 7.4 m-85 -71.12 -28.12 64.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.548 0.573 . . . . 0.14999999999999999 112.548 -172.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.3 t -57.89 -29.93 65.45 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.722 0.296 . . . . 0.56000000000000005 111.351 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.42 -22.67 44.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 1.04 111.361 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -91.07 -20.28 22.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.868 0.366 . . . . 0.20999999999999999 111.024 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.63 169.32 31.01 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.321 -0.711 . . . . 0.14000000000000001 111.321 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -69.72 141.63 53.46 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.96 -0.385 . . . . 0.28999999999999998 109.96 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.436 HG21 ' HB3' ' A' ' 128' ' ' CYS . 74.6 mt -112.43 135.94 50.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.241 -0.436 . . . . 1.0700000000000001 110.297 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.533 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -90.93 -41.73 10.98 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.635 -0.876 . . . . 1.26 108.635 179.573 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 144' ' ' HIS . 95.7 p -145.5 126.96 15.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.287 -0.87 . . . . 1.1799999999999999 109.966 176.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.795 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.6 p -122.97 116.04 22.91 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.149 -0.685 . . . . 1.49 109.149 174.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -117.82 128.61 55.02 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.17 0.509 . . . . 1.6299999999999999 111.438 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.591 HG22 HD12 ' A' ' 115' ' ' LEU . 99.3 t -114.67 109.34 28.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 106.45 -1.685 . . . . 1.0700000000000001 106.45 170.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.9 t . . . . . 0 C--N 1.305 -1.339 0 N-CA-C 108.553 -0.906 . . . . 1.1399999999999999 108.553 -175.142 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 113.941 0.336 . . . . 0.31 113.941 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -130.63 152.55 49.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.875 0.837 . . . . 1.01 112.071 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.73 173.34 26.98 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.252 -0.885 . . . . 0.13 112.094 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -141.62 138.31 32.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.243 0.217 . . . . 0.31 110.818 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.562 ' HB ' HG12 ' A' ' 101' ' ' ILE . 33.2 t -115.56 130.73 69.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.849 0.356 . . . . 1.03 111.277 175.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.463 ' HB2' ' OG ' ' A' ' 127' ' ' SER . 1.6 m170 -97.88 106.76 19.11 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.608 -0.886 . . . . 0.32000000000000001 108.608 165.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.536 ' CE2' HG11 ' A' ' 143' ' ' VAL . 7.8 m-85 -90.11 135.9 33.38 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.347 -0.541 . . . . 0.17000000000000001 111.196 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.533 ' HA ' HD22 ' A' ' 126' ' ' LEU . 36.2 tt0 -47.93 -40.26 21.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.531 -1.213 . . . . 0.56999999999999995 110.72 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.8 p -122.5 146.87 47.0 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.844 -1.071 . . . . 1.1100000000000001 110.765 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -64.18 -37.9 89.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.742 -0.663 . . . . 0.46999999999999997 111.149 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.35 -34.75 77.97 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.168 0.433 . . . . 0.73999999999999999 112.168 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.95 78.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.168 0.509 . . . . 1.03 110.826 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.528 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.8 -44.75 95.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.532 -0.758 . . . . 1.05 111.046 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 47.7 mt-10 -59.4 -39.41 83.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.912 -0.585 . . . . 1.4199999999999999 111.012 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 157' ' ' LYS . 62.2 mtt85 -61.03 -42.06 97.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.799 0.333 . . . . 2.0 110.664 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.34 -38.19 90.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.271 -0.422 . . . . 1.02 110.207 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.3 mt -61.55 -54.27 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.172 -0.467 . . . . 1.04 111.244 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.3 pt-20 -64.18 -44.08 93.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.118 0.485 . . . . 1.0800000000000001 111.706 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -78.04 -38.99 43.33 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.919 0.711 . . . . 1.78 112.919 -171.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.2 mmm -94.66 -27.51 15.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.907 0.706 . . . . 1.03 112.907 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -64.52 124.22 21.28 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.675 -0.41 . . . . 0.60999999999999999 110.529 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.25 15.68 60.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.083 -0.579 . . . . 0.28999999999999998 113.296 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.692 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 79.5 mmm -109.45 162.62 14.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.897 0.349 . . . . 1.72 111.806 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.8 mt -99.13 104.77 16.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.621 -0.881 . . . . 1.1799999999999999 108.621 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.05 22.44 2.4 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.141 -0.624 . . . . 1.1299999999999999 111.534 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.4 p30 171.35 -80.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.047 0.939 . . . . 1.71 108.54 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -150.32 17.6 0.84 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.45 -1.25 . . . . 0.84999999999999998 108.581 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -131.16 127.19 37.5 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.853 -1.067 . . . . 1.27 109.768 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.692 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.3 tttt -76.41 121.93 23.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.807 -0.633 . . . . 1.6499999999999999 109.654 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 17.8 m -101.29 142.17 16.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.282 0.563 . . . . 1.04 110.955 -174.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.62 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 76.5 t80 -106.25 118.08 35.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.27 -0.877 . . . . 0.41999999999999998 109.509 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.451 ' CG1' HD13 ' A' ' 101' ' ' ILE . 39.0 t -115.24 125.16 72.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.283 -0.636 . . . . 1.03 109.283 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -141.64 -170.82 12.55 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.672 -0.775 . . . . 0.17999999999999999 112.13 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 . . . . . 0 C--N 1.326 -0.44 0 N-CA-C 110.246 -0.279 . . . . 2.3599999999999999 110.246 -177.002 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 121.419 0.628 . . . . 1.3600000000000001 112.218 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 24.18 76.49 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.143 -1.027 . . . . 0.26000000000000001 111.39 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.512 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.3 m120 -88.36 124.64 34.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.858 -0.793 . . . . 0.63 108.858 -173.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.543 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.0 pt -136.26 163.7 33.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.628 -0.26 . . . . 1.05 110.374 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.3 143.92 50.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.061 0.458 . . . . 0.26000000000000001 110.143 175.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.9 mt -119.39 138.85 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.466 -0.788 . . . . 1.01 109.861 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -119.7 154.05 34.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.688 -0.233 . . . . 2.0800000000000001 110.556 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 35.0 t30 72.27 34.84 1.3 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.89 0.744 . . . . 0.53000000000000003 111.653 171.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.576 HD22 HG23 ' A' ' 110' ' ' ILE . 23.8 mt -74.73 160.19 31.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.122 0.486 . . . . 1.04 111.0 177.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -91.3 156.33 17.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.54 -0.755 . . . . 0.70999999999999996 109.805 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -60.78 -28.82 69.03 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.248 0.342 . . . . 2.7799999999999998 111.26 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.5 p -66.78 -26.77 67.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 1.8 111.859 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.576 HG23 HD22 ' A' ' 106' ' ' LEU . 47.8 mm -70.94 121.72 21.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.315 0.578 . . . . 1.1000000000000001 111.305 -172.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -111.79 -175.63 2.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.44 -0.948 . . . . 1.5900000000000001 108.44 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -69.71 -33.07 71.99 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 109.091 -0.707 . . . . 0.92000000000000004 109.091 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -48.24 72.39 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.861 -1.063 . . . . 3.04 109.056 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.12 96.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.146 -1.388 . . . . 1.03 110.878 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.628 HD13 HG22 ' A' ' 130' ' ' VAL . 3.1 tt -66.82 -47.38 72.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.843 -0.799 . . . . 1.05 108.843 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.682 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 52.2 t80 -59.36 -47.03 86.97 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.857 -0.611 . . . . 1.05 110.733 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.12 -41.78 75.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 0.40000000000000002 110.83 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.449 HG22 HD21 ' A' ' 163' ' ' LEU . 7.4 m -77.53 -53.66 7.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.805 -0.634 . . . . 1.02 112.001 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.466 ' CD1' HD23 ' A' ' 115' ' ' LEU . 10.9 m-85 -73.11 -29.3 62.81 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.427 0.529 . . . . 0.14999999999999999 112.427 -174.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 36.2 t -58.19 -27.76 64.16 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.678 0.275 . . . . 0.56000000000000005 111.15 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.73 -21.41 27.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.42 -0.355 . . . . 1.04 111.396 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -93.04 -20.75 20.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.20999999999999999 110.869 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 167.76 166.14 26.33 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.634 -0.586 . . . . 0.14000000000000001 111.634 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -66.01 139.96 58.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.052 0.453 . . . . 0.28999999999999998 110.514 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.427 HG21 ' HB3' ' A' ' 128' ' ' CYS . 79.6 mt -111.84 135.78 50.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.988 -0.551 . . . . 1.0700000000000001 109.969 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.552 HD23 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -89.01 -43.86 10.81 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.84 -0.8 . . . . 1.26 108.84 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.5 m -147.74 113.8 5.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.076 -0.966 . . . . 1.1799999999999999 110.423 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 4.7 p -110.86 139.89 45.79 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.432 -0.581 . . . . 1.49 109.432 174.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -138.63 128.23 24.78 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.014 0.435 . . . . 1.6299999999999999 111.306 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.628 HG22 HD13 ' A' ' 115' ' ' LEU . 59.2 t -114.37 109.3 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 106.194 -1.78 . . . . 1.0700000000000001 106.194 169.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 t . . . . . 0 C--N 1.301 -1.523 0 N-CA-C 108.368 -0.975 . . . . 1.1399999999999999 108.368 -175.583 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 113.878 0.311 . . . . 0.31 113.878 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -128.26 154.7 45.59 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.393 0.597 . . . . 1.01 111.842 -173.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.29 171.06 25.85 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.276 -0.875 . . . . 0.13 111.53 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -139.63 138.37 36.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.703 0.251 . . . . 0.31 110.535 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.588 HG12 ' CE2' ' A' ' 145' ' ' PHE . 42.9 t -114.43 136.1 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.201 0.524 . . . . 1.03 111.142 174.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.426 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.6 m170 -104.71 105.79 16.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.625 -0.716 . . . . 0.32000000000000001 109.07 165.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.588 ' CE2' HG12 ' A' ' 143' ' ' VAL . 13.3 m-85 -90.17 137.55 32.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.039 0.447 . . . . 0.17000000000000001 110.949 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.552 ' HA ' HD23 ' A' ' 126' ' ' LEU . 34.9 tt0 -48.24 -46.07 35.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.673 -1.148 . . . . 0.56999999999999995 110.587 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.8 p -114.0 148.39 37.04 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.911 -1.04 . . . . 1.1100000000000001 111.037 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -63.61 -36.12 82.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.612 -0.722 . . . . 0.46999999999999997 111.05 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -69.09 -35.32 76.34 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.324 -0.398 . . . . 0.73999999999999999 111.678 -176.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.13 79.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.049 0.452 . . . . 1.03 110.622 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.565 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.63 -43.76 98.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.645 -0.707 . . . . 1.05 110.558 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.2 mt-10 -60.83 -37.28 81.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.496 -0.774 . . . . 1.4199999999999999 110.804 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 157' ' ' LYS . 91.4 mtt180 -63.17 -46.18 88.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.927 0.394 . . . . 2.0 110.623 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.08 -38.82 80.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 1.02 110.532 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 170' ' ' VAL . 91.5 mt -60.13 -54.2 38.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.692 -0.686 . . . . 1.04 111.477 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.2 pt-20 -65.5 -42.45 92.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.196 0.522 . . . . 1.0800000000000001 112.251 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -77.42 -39.21 47.7 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 113.038 0.755 . . . . 1.78 113.038 -170.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 92.9 mmm -95.27 -16.44 22.45 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.519 0.563 . . . . 1.03 112.519 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 155' ' ' ILE . 49.2 t-20 -66.84 124.35 22.7 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.304 -0.558 . . . . 0.60999999999999999 109.621 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.25 18.57 68.85 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.911 -0.661 . . . . 0.28999999999999998 112.228 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 8.6 tpp -105.05 156.51 17.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 1.72 110.444 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 89.8 mt -100.66 102.52 13.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.872 -0.604 . . . . 1.1799999999999999 109.566 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.449 HD21 HG22 ' A' ' 118' ' ' THR . 4.5 mt -81.75 11.66 4.65 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.745 0.646 . . . . 1.1299999999999999 112.745 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.28 -64.2 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.806 0.812 . . . . 1.71 109.189 -174.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -168.62 23.97 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.811 -1.54 . . . . 0.84999999999999998 109.294 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -139.82 133.66 30.66 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.898 -0.778 . . . . 1.27 108.898 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.4 mttm -77.77 122.42 25.37 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.326 0.391 . . . . 1.6499999999999999 109.968 176.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.3 m -101.49 140.1 21.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.316 0.579 . . . . 1.04 110.926 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 46.8 t80 -105.38 118.64 37.08 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.316 -0.856 . . . . 0.41999999999999998 109.178 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.492 ' O ' HG22 ' A' ' 155' ' ' ILE . 34.0 t -115.35 127.79 72.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.412 -0.588 . . . . 1.03 109.412 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.99 -172.7 19.01 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.072 -0.585 . . . . 0.17999999999999999 111.68 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 35.8 mmt-85 . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 2.3599999999999999 110.129 177.609 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 121.093 0.473 . . . . 1.3600000000000001 111.6 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.14 23.51 77.85 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 119.834 -1.174 . . . . 0.26000000000000001 111.433 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.479 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.1 m-80 -88.2 125.59 34.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.423 -0.584 . . . . 0.63 109.423 -174.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.471 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.6 pt -134.9 162.13 39.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.589 -0.522 . . . . 1.05 109.589 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.06 140.61 52.74 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.862 -0.421 . . . . 0.26000000000000001 109.862 177.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.1 mt -117.16 141.86 33.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.588 -0.733 . . . . 1.01 109.615 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -126.66 154.99 43.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.696 -0.229 . . . . 2.0800000000000001 110.577 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.4 t30 73.56 32.63 1.16 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.969 0.793 . . . . 0.53000000000000003 111.389 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.419 HD21 HG21 ' A' ' 110' ' ' ILE . 30.1 mt -76.67 162.92 27.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.033 0.444 . . . . 1.04 111.136 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -102.52 151.47 22.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.713 -0.676 . . . . 0.70999999999999996 109.467 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -22.4 63.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.636 -0.256 . . . . 2.7799999999999998 111.646 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.4 p -69.13 -11.05 60.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.648 -0.251 . . . . 1.8 111.449 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.538 HG22 HG22 ' A' ' 130' ' ' VAL . 49.2 mm -92.18 122.83 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.856 0.36 . . . . 1.1000000000000001 110.158 177.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -109.7 -177.25 3.22 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.518 -0.919 . . . . 1.5900000000000001 108.518 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.22 -34.56 78.37 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.192 -0.669 . . . . 0.92000000000000004 109.192 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.967 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -62.54 -50.49 71.14 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.19 -0.913 . . . . 3.04 110.348 178.083 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.17 98.5 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.076 -1.42 . . . . 1.03 111.253 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.407 HD13 HG23 ' A' ' 130' ' ' VAL . 4.0 tt -66.75 -46.79 74.28 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.189 -0.914 . . . . 1.05 108.934 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.751 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 66.1 t80 -59.42 -46.48 88.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 1.05 110.925 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -55.97 -40.92 73.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.008 0.433 . . . . 0.40000000000000002 111.059 -176.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.513 HG22 HD21 ' A' ' 163' ' ' LEU . 15.3 m -78.0 -53.71 7.11 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.754 -0.657 . . . . 1.02 112.127 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -72.55 -29.1 63.27 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.305 0.483 . . . . 0.14999999999999999 112.305 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.3 t -58.13 -28.63 64.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.651 0.263 . . . . 0.56000000000000005 111.091 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.64 37.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.725 0.298 . . . . 1.04 111.293 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -91.82 -21.53 20.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.382 -0.372 . . . . 0.20999999999999999 111.002 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 169.24 166.1 27.72 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.86 -0.686 . . . . 0.14000000000000001 112.183 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -62.53 133.93 55.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.012 0.434 . . . . 0.28999999999999998 110.553 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.4 mt -109.04 128.8 64.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.899 -0.592 . . . . 1.0700000000000001 110.187 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -82.23 -38.9 23.83 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.702 -0.851 . . . . 1.26 108.702 -178.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 m -153.32 129.95 10.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.094 -0.957 . . . . 1.1799999999999999 110.455 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.751 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.0 p -126.81 149.52 49.65 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.332 -0.618 . . . . 1.49 109.332 176.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -150.73 131.65 14.21 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.437 -0.505 . . . . 1.6299999999999999 112.175 -174.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 110' ' ' ILE . 69.1 t -110.99 110.42 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 106.359 -1.719 . . . . 1.0700000000000001 106.359 167.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.305 -1.36 0 N-CA-C 109.08 -0.711 . . . . 1.1399999999999999 109.08 -174.943 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 114.025 0.37 . . . . 0.31 114.025 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -125.49 156.58 38.75 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 117.501 0.65 . . . . 1.01 111.912 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.79 172.41 28.95 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.353 -0.839 . . . . 0.13 111.598 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -137.92 140.84 40.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.015 0.407 . . . . 0.31 110.757 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.565 HG13 ' CE2' ' A' ' 145' ' ' PHE . 43.8 t -113.68 135.87 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.01 0.433 . . . . 1.03 110.685 172.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.408 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 1.1 m170 -105.98 105.76 15.95 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.095 -0.706 . . . . 0.32000000000000001 109.095 167.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.565 ' CE2' HG13 ' A' ' 143' ' ' VAL . 15.8 m-85 -90.7 136.61 32.95 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.126 0.489 . . . . 0.17000000000000001 111.24 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.547 ' HA ' HD23 ' A' ' 126' ' ' LEU . 41.7 tt0 -49.31 -42.84 42.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.457 -1.247 . . . . 0.56999999999999995 110.726 178.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.8 p -115.28 144.85 43.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.64 -1.164 . . . . 1.1100000000000001 111.241 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -63.09 -36.97 85.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.498 -0.774 . . . . 0.46999999999999997 110.939 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 9.8 pt-20 -69.39 -35.11 75.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.389 -0.368 . . . . 0.73999999999999999 111.747 -177.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.64 -34.66 76.07 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.083 0.468 . . . . 1.03 110.556 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.521 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -64.57 -43.04 95.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.6 -0.727 . . . . 1.05 110.883 177.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 53.5 mt-10 -59.53 -40.08 86.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.511 . . . . 1.4199999999999999 110.28 176.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.491 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 95.4 mtt180 -60.59 -40.75 92.89 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.186 -0.461 . . . . 2.0 110.943 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.62 -36.32 82.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 1.02 110.568 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 151' ' ' ALA . 80.6 mt -62.53 -54.42 34.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 1.04 110.995 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.3 pt-20 -60.78 -43.43 98.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.174 0.511 . . . . 1.0800000000000001 111.677 -179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.416 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.74 -39.05 22.42 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 113.062 0.764 . . . . 1.78 113.062 -170.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 89.6 mmm -92.26 -24.51 18.97 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.78 0.659 . . . . 1.03 112.78 -172.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.464 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 53.3 t30 -67.17 124.27 22.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.215 -0.594 . . . . 0.60999999999999999 110.206 -178.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.04 11.12 63.65 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.833 -0.698 . . . . 0.28999999999999998 112.609 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.644 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 30.8 mmt -97.63 159.65 14.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.885 0.374 . . . . 1.72 111.713 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.9 mt -102.49 101.14 11.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.952 -0.759 . . . . 1.1799999999999999 108.952 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.513 HD21 HG22 ' A' ' 118' ' ' THR . 2.8 mt -78.16 13.52 1.45 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.042 0.756 . . . . 1.1299999999999999 113.042 -175.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 167.48 -59.57 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.883 0.849 . . . . 1.71 109.368 -174.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -169.74 24.66 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.798 -1.546 . . . . 0.84999999999999998 109.433 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 166' ' ' ARG . 46.9 mtt180 -140.29 127.22 20.72 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.583 -0.735 . . . . 1.27 109.381 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 161' ' ' MET . 13.6 tttt -76.77 116.47 17.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.18 -0.674 . . . . 1.6499999999999999 109.18 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.2 m -100.33 144.79 12.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.383 0.611 . . . . 1.04 110.846 -174.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 73.6 t80 -106.14 119.71 39.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.185 -0.916 . . . . 0.41999999999999998 109.517 -179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.406 ' CG1' HD11 ' A' ' 101' ' ' ILE . 42.0 t -114.93 125.64 72.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.988 -0.745 . . . . 1.03 108.988 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.18 -178.82 21.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.498 -0.858 . . . . 0.17999999999999999 112.413 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.8 mmt-85 . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 2.3599999999999999 111.384 179.325 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 121.914 0.864 . . . . 1.3600000000000001 112.547 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.25 23.85 77.31 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.941 -1.123 . . . . 0.26000000000000001 110.688 -175.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.498 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.0 OUTLIER -94.06 126.82 39.5 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.539 -0.541 . . . . 0.63 109.539 -173.33 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.496 HG23 ' HB2' ' A' ' 151' ' ' ALA . 20.8 pt -134.8 161.16 40.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.066 -0.346 . . . . 1.05 110.066 175.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.72 142.66 51.24 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.836 -0.431 . . . . 0.26000000000000001 109.836 177.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.4 mt -119.52 135.69 59.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.707 -0.679 . . . . 1.01 110.065 -177.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -117.48 153.26 33.44 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.468 -0.197 . . . . 2.0800000000000001 110.468 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.0 t30 72.54 37.52 0.88 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.01 0.819 . . . . 0.53000000000000003 111.797 172.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.639 HD21 HG22 ' A' ' 110' ' ' ILE . 20.4 mt -76.89 153.83 34.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.359 -0.382 . . . . 1.04 110.843 177.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.498 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 13.4 t70 -83.09 149.26 27.02 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.643 -0.502 . . . . 0.70999999999999996 109.643 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -56.94 -31.16 64.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.079 -0.51 . . . . 2.7799999999999998 111.659 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.4 p -71.42 -9.09 57.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 1.8 112.015 -179.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.639 HG22 HD21 ' A' ' 106' ' ' LEU . 46.6 mm -82.48 113.4 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.071 0.462 . . . . 1.1000000000000001 110.622 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 17.6 t70 -102.75 -176.15 3.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.687 -0.857 . . . . 1.5900000000000001 108.687 176.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.429 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 2.1 m-20 -61.97 -41.32 97.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.879 -0.786 . . . . 0.92000000000000004 108.879 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.957 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -58.97 -49.94 75.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.305 -0.861 . . . . 3.04 110.583 178.093 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.15 -42.27 99.09 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.133 -1.394 . . . . 1.03 111.266 -177.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.479 HD11 HG23 ' A' ' 130' ' ' VAL . 4.0 tt -66.51 -46.63 75.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.33 -0.85 . . . . 1.05 108.994 177.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.614 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 67.9 t80 -58.63 -46.88 86.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.033 -0.531 . . . . 1.05 110.917 175.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.32 -38.83 71.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.153 0.501 . . . . 0.40000000000000002 110.82 -175.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.638 HG22 HD23 ' A' ' 163' ' ' LEU . 9.3 m -77.93 -54.15 6.63 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.785 -0.643 . . . . 1.02 112.147 -178.341 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -73.07 -28.04 62.08 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.981 0.734 . . . . 0.14999999999999999 112.981 -174.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.4 t -57.08 -29.4 63.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.764 0.316 . . . . 0.56000000000000005 111.643 -176.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.42 -21.6 37.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.364 -0.38 . . . . 1.04 111.744 178.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -92.67 -18.37 23.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.20999999999999999 111.393 -177.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 166.68 171.61 33.01 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.994 -0.622 . . . . 0.14000000000000001 111.85 -178.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -72.57 135.93 45.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.797 0.332 . . . . 0.28999999999999998 110.342 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.411 HG22 ' HB3' ' A' ' 128' ' ' CYS . 66.3 mt -111.24 134.88 52.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.401 -0.363 . . . . 1.0700000000000001 110.323 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -91.28 -49.18 6.5 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.801 -0.815 . . . . 1.26 108.801 179.543 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 66.5 m -141.77 100.19 3.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.901 -1.045 . . . . 1.1799999999999999 110.915 -175.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.614 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 13.2 p -95.97 148.41 22.67 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.795 -0.817 . . . . 1.49 108.795 172.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -146.68 129.14 15.92 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.645 -0.422 . . . . 1.6299999999999999 111.546 -174.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.479 HG23 HD11 ' A' ' 115' ' ' LEU . 75.4 t -110.06 110.2 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 106.606 -1.627 . . . . 1.0700000000000001 106.606 169.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.6 t . . . . . 0 C--N 1.301 -1.506 0 CA-C-N 115.653 -0.703 . . . . 1.1399999999999999 109.565 -172.625 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 113.597 0.199 . . . . 0.31 113.597 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -132.4 157.01 45.63 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.24 0.52 . . . . 1.01 111.186 -176.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.91 177.21 25.36 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.759 -0.655 . . . . 0.13 111.824 -177.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -136.35 143.12 43.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.494 -0.187 . . . . 0.31 110.494 -176.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.506 HG11 ' CE2' ' A' ' 145' ' ' PHE . 45.9 t -115.44 129.78 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.06 0.457 . . . . 1.03 110.493 171.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.9 OUTLIER -100.73 105.32 16.65 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.079 -0.712 . . . . 0.32000000000000001 109.079 167.216 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.544 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.6 m-85 -88.13 140.92 29.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.264 0.554 . . . . 0.17000000000000001 110.693 178.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.547 ' HA ' HD21 ' A' ' 126' ' ' LEU . 24.6 tt0 -50.88 -41.13 58.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.324 -1.307 . . . . 0.56999999999999995 110.479 177.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.0 p -122.98 148.31 45.65 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.606 -1.179 . . . . 1.1100000000000001 111.229 -178.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -60.55 -36.55 78.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.441 -0.799 . . . . 0.46999999999999997 111.368 179.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 9.7 pt-20 -67.45 -35.97 80.27 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.0 0.37 . . . . 0.73999999999999999 112.0 -176.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.43 78.06 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.09 0.471 . . . . 1.03 110.372 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.19 -44.63 96.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.516 -0.765 . . . . 1.05 110.86 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.932 ' HG2' HH12 ' A' ' 172' ' ' ARG . 28.1 mt-10 -59.5 -42.27 91.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 1.4199999999999999 110.707 178.183 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.516 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 46.8 mtt180 -59.47 -41.06 88.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.127 -0.488 . . . . 2.0 110.569 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.76 -37.15 84.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.088 -0.505 . . . . 1.02 110.674 178.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.7 mt -60.01 -52.99 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 1.04 110.988 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 0.7 OUTLIER -63.43 -45.47 90.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.01 0.433 . . . . 1.0800000000000001 111.877 -179.399 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -80.39 -39.19 28.86 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.884 0.698 . . . . 1.78 112.884 -169.148 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 89.3 mmm -93.08 -15.85 25.62 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.277 0.473 . . . . 1.03 112.277 -173.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -70.29 123.27 21.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.566 -0.901 . . . . 0.60999999999999999 108.566 176.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.76 11.98 78.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.562 -0.828 . . . . 0.28999999999999998 111.967 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -93.09 150.7 20.34 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.827 -0.805 . . . . 1.72 108.827 178.443 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 23.3 mt -97.11 124.57 41.17 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.92 -0.77 . . . . 1.1799999999999999 108.92 177.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.638 HD23 HG22 ' A' ' 118' ' ' THR . 27.3 mt -110.05 99.35 8.46 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.796 -0.761 . . . . 1.1299999999999999 109.838 173.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 70.5 m-20 78.29 -23.14 0.25 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.98 -1.009 . . . . 1.71 112.812 176.406 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 33.7 t70 167.77 -22.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.815 0.697 . . . . 0.84999999999999998 112.069 -177.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.498 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.1 mtt180 -109.81 136.78 48.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.797 0.332 . . . . 1.27 110.875 -170.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -84.88 118.74 24.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.689 -0.687 . . . . 1.6499999999999999 109.39 -178.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.3 m -101.27 148.43 7.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.7 0.762 . . . . 1.04 111.791 -171.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 55.3 t80 -106.97 119.18 38.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.659 -1.155 . . . . 0.41999999999999998 109.318 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.417 ' CG1' HD12 ' A' ' 101' ' ' ILE . 39.4 t -115.72 125.85 73.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.574 -0.528 . . . . 1.03 109.574 178.208 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.6 -175.15 20.14 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.715 -0.755 . . . . 0.17999999999999999 112.278 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.932 HH12 ' HG2' ' A' ' 152' ' ' GLU . 24.4 mmt180 . . . . . 0 C--N 1.324 -0.508 0 O-C-N 123.548 0.205 . . . . 2.3599999999999999 110.53 179.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 121.181 0.515 . . . . 1.3600000000000001 111.925 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.31 24.02 76.15 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.027 -1.082 . . . . 0.26000000000000001 111.535 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.518 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.3 m120 -88.63 125.3 34.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.933 -0.766 . . . . 0.63 108.933 -174.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.506 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.4 pt -135.74 163.53 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.533 -0.303 . . . . 1.05 110.188 177.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.24 145.27 50.83 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.851 -0.425 . . . . 0.26000000000000001 109.851 175.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.2 mt -118.38 148.32 21.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.776 -0.647 . . . . 1.01 110.019 -177.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -131.25 149.43 52.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.35 -0.386 . . . . 2.0800000000000001 110.601 -172.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 64.1 t30 67.63 35.68 3.97 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.639 0.587 . . . . 0.53000000000000003 111.794 173.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.456 HD23 HG21 ' A' ' 110' ' ' ILE . 20.1 mt -72.33 152.91 41.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.083 0.468 . . . . 1.04 111.133 176.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.51 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.4 t70 -77.19 150.4 35.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.466 -0.788 . . . . 0.70999999999999996 110.565 177.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -62.14 -33.92 75.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.053 -0.522 . . . . 2.7799999999999998 111.106 -177.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 t -76.05 -4.85 43.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.381 -0.372 . . . . 1.8 111.057 -176.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.456 HG21 HD23 ' A' ' 106' ' ' LEU . 36.0 mm -78.82 127.19 39.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.898 0.38 . . . . 1.1000000000000001 110.433 178.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -111.6 -179.97 3.85 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.592 -0.521 . . . . 1.5900000000000001 109.592 -179.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.625 ' OD1' ' HA ' ' A' ' 129' ' ' LYS . 67.8 m-80 -65.4 -37.81 88.07 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.19 -0.67 . . . . 0.92000000000000004 109.19 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 1.003 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.76 -49.19 78.5 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.976 -1.011 . . . . 3.04 110.017 177.618 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.29 97.41 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.772 -1.558 . . . . 1.03 111.463 -177.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.596 HD11 HG22 ' A' ' 130' ' ' VAL . 4.2 tt -63.84 -47.3 81.3 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.993 -0.743 . . . . 1.05 108.993 177.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.709 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 63.8 t80 -60.2 -47.5 85.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.036 -0.529 . . . . 1.05 110.846 176.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.57 -39.08 75.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.91 0.386 . . . . 0.40000000000000002 110.79 -175.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.5 m -77.21 -52.91 8.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 1.02 111.724 -178.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -71.93 -28.32 63.39 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.385 0.513 . . . . 0.14999999999999999 112.385 -175.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.2 t -57.45 -28.95 63.8 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.457 0.169 . . . . 0.56000000000000005 111.457 -177.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.82 -21.76 31.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.846 0.355 . . . . 1.04 111.386 177.291 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -92.21 -10.76 37.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.20999999999999999 111.205 -178.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.59 163.75 12.7 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.128 -0.558 . . . . 0.14000000000000001 111.725 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.95 137.82 58.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.185 0.517 . . . . 0.28999999999999998 110.171 177.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 128' ' ' CYS . 82.2 mt -110.54 132.73 58.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.71 -0.677 . . . . 1.0700000000000001 109.877 -178.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.07 -39.13 14.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.87 -0.789 . . . . 1.26 108.87 -177.429 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 144' ' ' HIS . 82.5 p -146.53 134.11 20.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.291 -0.868 . . . . 1.1799999999999999 109.681 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.709 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.3 p -133.81 130.28 37.74 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.285 -0.635 . . . . 1.49 109.285 176.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.625 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 58.0 tptt -132.33 134.84 45.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.159 0.504 . . . . 1.6299999999999999 111.891 -174.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.596 HG22 HD11 ' A' ' 115' ' ' LEU . 95.2 t -114.01 109.6 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 106.355 -1.72 . . . . 1.0700000000000001 106.355 170.028 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.308 -1.222 0 CA-C-N 115.917 -0.583 . . . . 1.1399999999999999 109.798 -172.019 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.287 0 N-CA-C 114.051 0.38 . . . . 0.31 114.051 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -122.26 155.26 36.27 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 117.523 0.661 . . . . 1.01 111.315 -174.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -147.85 173.66 27.83 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.13 111.964 -178.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.37 136.73 36.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.826 0.313 . . . . 0.31 110.706 -177.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.52 HG12 ' CE2' ' A' ' 145' ' ' PHE . 38.5 t -114.56 134.98 55.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.02 0.438 . . . . 1.03 111.002 173.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.445 ' HB2' ' OG ' ' A' ' 127' ' ' SER . 1.5 m170 -103.25 106.71 17.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.736 -0.665 . . . . 0.32000000000000001 109.212 167.218 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.52 ' CE2' HG12 ' A' ' 143' ' ' VAL . 14.4 m-85 -89.91 135.92 33.35 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.323 0.583 . . . . 0.17000000000000001 111.372 179.082 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.565 ' HA ' HD21 ' A' ' 126' ' ' LEU . 44.5 tt0 -46.36 -43.54 16.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.919 -1.492 . . . . 0.56999999999999995 111.017 177.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.4 p -116.4 147.37 41.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.937 -1.029 . . . . 1.1100000000000001 111.046 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -60.23 -39.81 87.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.887 -0.597 . . . . 0.46999999999999997 110.917 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.22 -33.44 73.33 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.319 -0.4 . . . . 0.73999999999999999 111.678 -177.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.59 74.22 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.149 0.499 . . . . 1.03 110.318 177.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -67.34 -41.96 84.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.62 -0.718 . . . . 1.05 110.369 176.224 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 44.0 mt-10 -58.57 -40.26 82.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 1.4199999999999999 110.305 177.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 65.3 mtt180 -59.5 -50.14 75.08 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 120.882 0.372 . . . . 2.0 110.623 174.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.42 -38.85 81.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 1.02 110.88 -178.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 151' ' ' ALA . 84.9 mt -60.98 -54.88 29.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.251 -0.431 . . . . 1.04 110.864 178.108 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 3.2 pt-20 -64.22 -44.76 90.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.169 0.509 . . . . 1.0800000000000001 111.774 -178.737 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -76.37 -39.06 54.83 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.926 0.713 . . . . 1.78 112.926 -170.739 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 91.4 mmm -94.26 -22.3 18.48 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.602 0.593 . . . . 1.03 112.602 -173.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.49 123.65 20.21 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.221 -0.592 . . . . 0.60999999999999999 109.823 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.478 ' O ' ' HE2' ' A' ' 167' ' ' LYS . . . 83.89 22.55 55.12 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.786 -0.721 . . . . 0.28999999999999998 112.513 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 2.7 mmt -109.26 160.31 16.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.76 0.314 . . . . 1.72 111.159 177.061 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 29.7 mt -100.57 107.12 18.71 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.915 -0.584 . . . . 1.1799999999999999 109.976 -176.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 17.4 mt -90.99 109.67 20.91 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.686 -0.806 . . . . 1.1299999999999999 109.163 172.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 82.8 m-20 73.08 -67.01 0.28 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.108 -0.951 . . . . 1.71 111.421 -175.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -163.66 18.61 0.07 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.873 -0.603 . . . . 0.84999999999999998 111.018 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.51 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 88.7 mtt180 -131.77 130.87 42.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.969 -0.457 . . . . 1.27 109.971 -177.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 161' ' ' MET . 22.6 tttt -82.09 118.24 22.88 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.528 -0.545 . . . . 1.6499999999999999 109.528 -177.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 16.9 m -100.8 145.87 10.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.547 0.689 . . . . 1.04 111.161 -173.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -106.47 125.1 50.57 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.97 -1.014 . . . . 0.41999999999999998 109.388 176.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.418 ' CG1' HD13 ' A' ' 101' ' ' ILE . 39.8 t -116.45 131.65 68.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.306 -0.627 . . . . 1.03 109.306 177.071 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.26 -173.26 19.71 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.606 -0.807 . . . . 0.17999999999999999 111.966 179.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 121.023 0.439 . . . . 2.3599999999999999 110.47 -178.07 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 121.086 0.47 . . . . 1.3600000000000001 111.195 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.0 23.46 77.83 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.124 -1.036 . . . . 0.26000000000000001 111.068 -178.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.493 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.0 OUTLIER -90.39 124.89 35.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.544 -0.539 . . . . 0.63 109.544 -173.451 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.441 HD13 ' CG1' ' A' ' 170' ' ' VAL . 17.3 pt -135.98 163.71 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.299 -0.409 . . . . 1.05 110.227 178.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.39 143.1 50.8 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.784 -0.45 . . . . 0.26000000000000001 109.784 175.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.2 mt -119.4 134.97 61.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.652 -0.703 . . . . 1.01 110.016 -177.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -113.87 150.1 34.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.617 -0.265 . . . . 2.0800000000000001 110.623 -179.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.3 t30 72.01 39.0 0.85 Allowed 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.974 0.796 . . . . 0.53000000000000003 111.77 171.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.531 HD23 HG22 ' A' ' 110' ' ' ILE . 21.8 mt -76.43 153.83 35.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.093 0.473 . . . . 1.04 110.864 176.438 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.476 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 6.5 t70 -75.51 144.53 41.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.52 -0.764 . . . . 0.70999999999999996 110.163 175.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -61.48 -28.44 69.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 2.7799999999999998 111.398 -176.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.1 t -80.49 -7.84 59.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.276 -0.42 . . . . 1.8 110.652 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.531 HG22 HD23 ' A' ' 106' ' ' LEU . 30.8 mm -74.39 116.87 17.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.851 -0.426 . . . . 1.1000000000000001 109.851 176.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -103.1 -174.16 2.48 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.741 -0.837 . . . . 1.5900000000000001 108.741 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -67.86 -31.14 70.75 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.564 -0.902 . . . . 0.92000000000000004 108.564 -178.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -48.61 66.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.499 -1.228 . . . . 3.04 109.236 178.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.82 -44.15 97.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.212 -1.358 . . . . 1.03 110.703 -177.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.531 HD11 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -64.97 -46.79 80.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.068 -0.969 . . . . 1.05 109.138 177.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.762 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 65.6 t80 -58.86 -47.22 85.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 1.05 111.084 175.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.75 -37.81 71.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.915 0.388 . . . . 0.40000000000000002 110.957 -176.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.502 HG23 HD21 ' A' ' 163' ' ' LEU . 7.0 m -78.55 -54.76 5.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.992 -0.549 . . . . 1.02 112.138 -178.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -72.98 -27.92 62.08 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.248 0.832 . . . . 0.14999999999999999 113.248 -173.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 t -57.0 -28.79 62.75 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 111.78 0.289 . . . . 0.56000000000000005 111.78 -175.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.04 -22.12 36.5 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.856 0.36 . . . . 1.04 111.755 178.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -89.43 -23.12 22.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.808 0.337 . . . . 0.20999999999999999 111.14 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 170.88 166.4 29.69 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.956 -0.565 . . . . 0.14000000000000001 111.736 -178.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -67.69 129.07 38.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.28999999999999998 110.11 179.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.407 HG21 ' HB3' ' A' ' 128' ' ' CYS . 78.8 mt -98.91 132.0 45.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.175 -0.466 . . . . 1.0700000000000001 109.995 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.532 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -84.68 -40.57 17.22 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.666 -0.864 . . . . 1.26 108.666 -179.822 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 69.5 m -152.68 122.14 6.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.861 -1.063 . . . . 1.1799999999999999 110.27 -178.149 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.4 p -117.2 137.63 52.22 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.641 -0.503 . . . . 1.49 109.641 176.045 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -138.2 132.97 32.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.193 0.52 . . . . 1.6299999999999999 112.003 -174.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.531 HG22 HD11 ' A' ' 115' ' ' LEU . 86.1 t -114.33 109.87 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 106.582 -1.636 . . . . 1.0700000000000001 106.582 169.311 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.5 t . . . . . 0 C--N 1.305 -1.351 0 CA-C-N 115.931 -0.577 . . . . 1.1399999999999999 109.524 -173.479 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 CA-C-O 120.356 -0.136 . . . . 0.31 113.356 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -129.69 154.02 47.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 117.21 0.505 . . . . 1.01 111.45 -177.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.29 175.18 25.0 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.688 -0.687 . . . . 0.13 111.895 -178.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -136.58 137.73 40.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.72 0.26 . . . . 0.31 110.65 -175.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.547 HG11 ' CE2' ' A' ' 145' ' ' PHE . 49.2 t -110.94 136.05 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.996 0.427 . . . . 1.03 110.865 172.47 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 127' ' ' SER . 2.5 m170 -104.13 106.09 16.48 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.658 -0.701 . . . . 0.32000000000000001 109.303 167.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.547 ' CE2' HG11 ' A' ' 143' ' ' VAL . 14.8 m-85 -92.04 137.31 32.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.081 0.467 . . . . 0.17000000000000001 110.827 178.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.532 ' HA ' HD22 ' A' ' 126' ' ' LEU . 39.0 tt0 -47.83 -41.42 23.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.522 -1.217 . . . . 0.56999999999999995 111.131 179.572 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.8 p -119.32 151.14 38.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.325 -0.852 . . . . 1.1100000000000001 110.825 179.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -62.31 -35.96 80.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.46999999999999997 110.72 179.039 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.36 -34.67 74.93 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.33 -0.396 . . . . 0.73999999999999999 111.948 -178.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.08 -34.74 78.24 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.005 0.431 . . . . 1.03 110.678 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.494 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.68 -41.38 98.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 1.05 110.359 176.321 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.478 ' CD ' HH21 ' A' ' 172' ' ' ARG . 7.2 mm-40 -59.27 -40.41 85.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.689 -0.687 . . . . 1.4199999999999999 110.923 177.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.575 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 96.8 mtt180 -60.86 -43.2 98.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.566 -0.743 . . . . 2.0 111.059 177.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.75 83.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.222 -0.445 . . . . 1.02 110.521 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.446 HG12 HG11 ' A' ' 170' ' ' VAL . 66.7 mt -62.51 -52.41 60.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.227 -0.442 . . . . 1.04 111.106 178.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 0.1 OUTLIER -62.57 -44.31 96.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.192 0.52 . . . . 1.0800000000000001 111.941 179.931 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.436 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -82.68 -38.7 23.05 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.243 0.831 . . . . 1.78 113.243 -168.722 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 92.2 mmm -93.93 -16.28 24.14 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.439 0.533 . . . . 1.03 112.439 -173.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -67.03 122.93 18.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.302 -0.629 . . . . 0.60999999999999999 109.302 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.09 70.34 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.911 -0.661 . . . . 0.28999999999999998 112.865 178.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.649 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 30.3 mmt -96.21 163.03 13.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.997 0.399 . . . . 1.72 111.494 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 20.8 mt -104.61 111.83 24.68 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.868 -0.605 . . . . 1.1799999999999999 109.879 -177.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.502 HD21 HG23 ' A' ' 118' ' ' THR . 19.0 mt -100.15 100.87 11.77 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 120.073 -0.651 . . . . 1.1299999999999999 109.758 174.334 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 87.6 m-20 78.58 -23.59 0.24 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 114.883 -1.053 . . . . 1.71 112.615 178.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 21.0 t70 166.15 -23.07 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.174 0.921 . . . . 0.84999999999999998 111.724 -177.552 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.0 mtt180 -106.65 132.38 52.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.82 0.343 . . . . 1.27 111.112 -169.244 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 161' ' ' MET . 8.3 ttmm -77.11 118.59 19.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.468 -0.787 . . . . 1.6499999999999999 109.385 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.7 m -100.83 146.23 9.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.562 0.696 . . . . 1.04 111.149 -174.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 40.4 t80 -110.62 121.96 46.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.908 -1.042 . . . . 0.41999999999999998 109.267 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.446 HG11 HG12 ' A' ' 155' ' ' ILE . 41.4 t -115.7 127.07 73.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.981 -0.378 . . . . 1.03 109.981 -178.322 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.08 176.86 27.66 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.876 -0.678 . . . . 0.17999999999999999 112.361 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.478 HH21 ' CD ' ' A' ' 152' ' ' GLU . 14.6 mmt85 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.029 0.442 . . . . 2.3599999999999999 111.148 -179.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 121.126 0.489 . . . . 1.3600000000000001 111.924 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.03 24.51 63.96 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.912 -1.137 . . . . 0.26000000000000001 112.883 174.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -89.92 126.08 35.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.532 -0.544 . . . . 0.63 109.532 -175.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.467 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.2 pt -134.24 163.73 36.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.237 -0.438 . . . . 1.05 109.909 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.14 147.49 49.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.99 -0.374 . . . . 0.26000000000000001 109.99 177.51 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 5.2 mt -122.4 148.16 26.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.83 -0.623 . . . . 1.01 110.144 -176.286 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -128.04 157.29 41.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.524 -0.307 . . . . 2.0800000000000001 110.962 -175.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.0 t30 67.44 31.61 6.24 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.738 0.649 . . . . 0.53000000000000003 111.698 172.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.65 HD21 HG23 ' A' ' 110' ' ' ILE . 42.6 mt -75.62 148.61 38.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 1.04 111.354 178.208 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -80.18 153.74 28.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.792 -0.64 . . . . 0.70999999999999996 110.364 178.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -55.16 -34.27 63.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.842 -0.617 . . . . 2.7799999999999998 111.983 178.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.4 t -76.06 -4.51 41.81 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.464 -0.335 . . . . 1.8 111.718 -177.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.65 HG23 HD21 ' A' ' 106' ' ' LEU . 45.7 mm -81.55 113.83 21.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 122.069 -0.394 . . . . 1.1000000000000001 110.067 175.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -106.84 -177.76 3.45 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.212 -0.662 . . . . 1.5900000000000001 109.212 178.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -60.54 -37.85 82.57 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.746 -0.464 . . . . 0.92000000000000004 109.746 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.916 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -62.29 -50.55 71.21 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.477 -0.783 . . . . 3.04 110.673 178.381 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.54 95.72 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.174 -1.375 . . . . 1.03 111.079 -176.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.6 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -67.05 -47.22 71.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.471 -0.786 . . . . 1.05 109.174 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.743 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 72.7 t80 -58.96 -47.13 86.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.528 . . . . 1.05 110.848 176.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.36 -37.93 73.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.158 0.504 . . . . 0.40000000000000002 111.017 -176.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.607 HG22 HD23 ' A' ' 163' ' ' LEU . 13.4 m -78.24 -54.36 6.31 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.057 -0.519 . . . . 1.02 112.065 -178.505 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -73.65 -29.79 62.54 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.007 0.743 . . . . 0.14999999999999999 113.007 -174.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.2 t -58.59 -27.2 64.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.685 0.278 . . . . 0.56000000000000005 111.332 -176.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.99 -22.3 25.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.603 0.24 . . . . 1.04 111.344 177.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -92.45 -17.62 24.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.531 -0.304 . . . . 0.20999999999999999 111.352 -178.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.71 174.55 37.46 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.999 -0.62 . . . . 0.14000000000000001 111.875 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -76.69 139.71 40.61 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.836 -0.431 . . . . 0.28999999999999998 109.836 -179.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.422 HG23 ' HB3' ' A' ' 128' ' ' CYS . 71.0 mt -112.13 135.3 51.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.366 -0.379 . . . . 1.0700000000000001 110.223 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.542 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -90.69 -42.85 10.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.774 -0.824 . . . . 1.26 108.774 179.748 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 67.5 m -146.1 111.31 5.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.249 -0.887 . . . . 1.1799999999999999 110.659 -178.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.743 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.6 p -108.52 137.84 45.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.255 -0.646 . . . . 1.49 109.255 172.633 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -136.58 131.24 33.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.957 0.408 . . . . 1.6299999999999999 111.418 -174.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.6 HG22 HD12 ' A' ' 115' ' ' LEU . 91.0 t -114.78 113.74 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 106.738 -1.579 . . . . 1.0700000000000001 106.738 170.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.304 -1.386 0 N-CA-C 108.718 -0.845 . . . . 1.1399999999999999 108.718 -176.473 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 114.076 0.391 . . . . 0.31 114.076 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -126.34 152.52 46.12 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.373 0.587 . . . . 1.01 111.753 -174.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.43 174.14 25.56 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.538 -0.755 . . . . 0.13 111.694 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -139.5 139.3 36.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.877 0.339 . . . . 0.31 110.728 -177.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.521 HG11 ' CE2' ' A' ' 145' ' ' PHE . 42.6 t -113.85 133.81 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.05 0.452 . . . . 1.03 110.854 172.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.6 OUTLIER -105.37 106.09 16.43 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.708 -0.678 . . . . 0.32000000000000001 109.186 167.986 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.547 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 14.6 m-85 -89.68 140.04 29.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.336 0.589 . . . . 0.17000000000000001 111.264 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.542 ' HA ' HD21 ' A' ' 126' ' ' LEU . 36.5 tt0 -53.43 -43.18 67.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.54 -1.209 . . . . 0.56999999999999995 110.087 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.5 p -114.28 144.52 43.1 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.405 -1.27 . . . . 1.1100000000000001 111.337 -178.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -62.4 -38.02 88.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.376 -0.829 . . . . 0.46999999999999997 111.064 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.27 -35.95 76.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.451 -0.341 . . . . 0.73999999999999999 111.83 -176.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.83 -34.69 78.5 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.344 0.592 . . . . 1.03 110.33 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.547 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.21 -40.88 97.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 1.05 111.194 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 1.9 mm-40 -68.37 -36.32 79.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.018 -0.537 . . . . 1.4199999999999999 110.278 -179.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 90.4 mtt180 -60.21 -42.89 96.11 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-N 116.099 -0.5 . . . . 2.0 110.362 175.096 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.34 87.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.96 -0.563 . . . . 1.02 110.651 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 151' ' ' ALA . 76.1 mt -63.02 -53.99 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.542 -0.299 . . . . 1.04 110.921 178.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.9 pt-20 -61.55 -43.09 99.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.066 0.46 . . . . 1.0800000000000001 111.764 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -81.6 -39.04 25.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.172 0.804 . . . . 1.78 113.172 -171.415 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 90.9 mmm -93.22 -18.98 21.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.616 0.599 . . . . 1.03 112.616 -172.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.5 122.56 19.91 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.615 -0.834 . . . . 0.60999999999999999 109.096 176.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.35 77.09 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.715 -0.755 . . . . 0.28999999999999998 112.009 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.8 tpt -93.16 151.4 19.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.157 -0.682 . . . . 1.72 109.157 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 162' ' ' LEU . 18.1 mt -96.45 107.46 19.86 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.437 -0.579 . . . . 1.1799999999999999 109.437 179.158 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.607 HD23 HG22 ' A' ' 118' ' ' THR . 11.5 mt -92.38 108.1 19.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.489 -0.884 . . . . 1.1299999999999999 109.369 172.416 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 5.4 m-20 77.41 -33.43 0.19 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.397 -0.82 . . . . 1.71 111.986 176.246 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 163' ' ' LEU . 27.1 t70 168.54 -19.78 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.115 -0.948 . . . . 0.84999999999999998 111.889 -174.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -107.45 136.72 46.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.644 0.259 . . . . 1.27 110.478 -172.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -80.83 116.38 20.79 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.359 -0.608 . . . . 1.6499999999999999 109.359 -178.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.45 146.68 8.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.677 0.751 . . . . 1.04 111.124 -173.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 55.6 t80 -105.98 119.19 38.55 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.718 -1.128 . . . . 0.41999999999999998 109.083 179.355 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.1 129.7 72.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.077 0.465 . . . . 1.03 109.849 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.6 177.72 25.69 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 111.04 -0.824 . . . . 0.17999999999999999 111.04 176.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 N-CA-C 110.156 -0.313 . . . . 2.3599999999999999 110.156 179.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 112.763 0.653 . . . . 1.3600000000000001 112.763 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.58 25.26 74.59 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.655 -1.26 . . . . 0.26000000000000001 111.433 176.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.492 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.0 OUTLIER -88.4 124.17 33.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.594 -0.521 . . . . 0.63 109.594 -172.65 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.584 HG12 ' HB ' ' A' ' 143' ' ' VAL . 34.8 pt -135.05 151.75 31.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.765 -0.457 . . . . 1.05 109.765 176.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.81 141.23 49.69 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.566 -0.531 . . . . 0.26000000000000001 109.566 178.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 5.2 mt -119.34 129.54 75.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.653 -0.703 . . . . 1.01 110.064 -176.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -112.45 151.62 29.67 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.682 -0.235 . . . . 2.0800000000000001 110.616 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.9 t30 73.69 36.7 0.73 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.97 0.794 . . . . 0.53000000000000003 111.629 172.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.603 HD22 HG21 ' A' ' 110' ' ' ILE . 18.3 mt -76.15 154.36 35.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 1.04 111.261 177.089 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.46 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 13.5 t70 -78.33 149.98 33.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.465 -0.789 . . . . 0.70999999999999996 109.514 174.003 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -68.63 -26.65 65.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.924 0.392 . . . . 2.7799999999999998 110.881 -175.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 m -72.65 -7.87 52.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 1.8 111.292 178.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.603 HG21 HD22 ' A' ' 106' ' ' LEU . 31.9 mm -79.12 113.75 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.106 0.479 . . . . 1.1000000000000001 109.95 178.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -99.3 -176.25 3.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.679 -0.692 . . . . 1.5900000000000001 109.223 -178.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -66.96 -34.45 77.79 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.08 -1.081 . . . . 0.92000000000000004 108.08 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -47.83 66.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.137 -1.392 . . . . 3.04 109.269 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.05 97.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.047 -1.433 . . . . 1.03 110.963 -178.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.574 HD12 HG23 ' A' ' 130' ' ' VAL . 3.9 tt -65.82 -46.74 77.47 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.361 -0.836 . . . . 1.05 109.238 177.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.748 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 49.1 t80 -59.93 -46.95 87.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 1.05 110.831 176.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.46 -41.45 76.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.96 0.409 . . . . 0.40000000000000002 110.985 -175.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.413 HG22 HD22 ' A' ' 163' ' ' LEU . 19.2 m -77.18 -52.66 8.87 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.86 -0.609 . . . . 1.02 111.902 -176.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -72.91 -28.26 62.36 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.46 0.541 . . . . 0.14999999999999999 112.46 -174.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.8 t -57.81 -28.43 64.03 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.649 0.262 . . . . 0.56000000000000005 111.444 -177.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.41 -21.18 23.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.835 0.35 . . . . 1.04 111.499 177.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -94.95 -14.15 24.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.20999999999999999 111.066 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.65 166.55 22.68 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 116.037 -0.529 . . . . 0.14000000000000001 111.898 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -69.49 138.7 53.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.896 -0.409 . . . . 0.28999999999999998 109.896 178.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.421 HG22 ' HB3' ' A' ' 128' ' ' CYS . 67.7 mt -111.11 134.09 54.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.98 -0.554 . . . . 1.0700000000000001 109.751 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.18 -50.65 6.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.435 -0.95 . . . . 1.26 108.435 179.93 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.3 m -138.01 99.14 3.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.801 -1.091 . . . . 1.1799999999999999 110.72 -176.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.748 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 0.8 OUTLIER -97.98 139.95 33.05 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.165 -0.679 . . . . 1.49 109.165 172.512 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -139.2 129.3 25.22 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.507 -0.477 . . . . 1.6299999999999999 111.634 -172.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.574 HG23 HD12 ' A' ' 115' ' ' LEU . 95.8 t -114.14 109.27 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 106.573 -1.64 . . . . 1.0700000000000001 106.573 168.148 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 C--N 1.305 -1.349 0 CA-C-N 115.693 -0.685 . . . . 1.1399999999999999 109.783 -172.121 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 CA-C-O 120.49 -0.061 . . . . 0.31 113.243 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -133.99 155.32 50.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.85 0.357 . . . . 1.01 111.001 -177.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.6 175.28 24.4 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.81 -0.632 . . . . 0.13 111.938 -178.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -137.06 139.33 41.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.547 0.173 . . . . 0.31 110.838 -177.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.584 ' HB ' HG12 ' A' ' 101' ' ' ILE . 41.9 t -112.09 132.93 59.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.881 0.372 . . . . 1.03 110.578 171.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' HIS . . . . . 0.413 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 0.8 OUTLIER -104.16 106.05 16.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.082 -0.71 . . . . 0.32000000000000001 109.082 167.405 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.527 ' CE2' HG13 ' A' ' 143' ' ' VAL . 20.0 m-85 -87.7 138.62 31.31 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.331 0.586 . . . . 0.17000000000000001 111.155 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.518 ' HA ' HD22 ' A' ' 126' ' ' LEU . 38.9 tt0 -49.01 -39.47 27.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.038 -1.437 . . . . 0.56999999999999995 110.715 178.205 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.5 p -125.61 152.62 44.9 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.833 -1.076 . . . . 1.1100000000000001 110.663 -179.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -66.94 -31.07 71.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.915 -0.584 . . . . 0.46999999999999997 110.977 -177.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.65 -35.15 74.92 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.039 0.385 . . . . 0.73999999999999999 112.039 -178.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.8 -34.61 78.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.11 0.481 . . . . 1.03 110.711 -178.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.97 -43.85 94.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.506 -0.77 . . . . 1.05 111.252 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 33.5 mt-10 -58.68 -41.9 87.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 1.4199999999999999 110.638 179.242 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 153' ' ' ARG . 65.2 mtt85 -61.27 -44.52 97.1 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.259 -0.428 . . . . 2.0 111.285 177.354 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.74 -37.4 84.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.374 -0.376 . . . . 1.02 110.713 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 151' ' ' ALA . 87.3 mt -62.41 -54.48 33.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.381 -0.372 . . . . 1.04 111.081 178.154 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.9 pt-20 -62.72 -40.24 96.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.983 0.42 . . . . 1.0800000000000001 111.814 -177.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -82.35 -38.66 23.9 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.872 0.693 . . . . 1.78 112.872 -172.746 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 90.5 mmm -93.2 -26.8 17.22 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.549 0.574 . . . . 1.03 112.549 -173.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -64.85 123.4 19.3 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.131 -0.628 . . . . 0.60999999999999999 109.383 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.79 19.51 56.07 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.635 -0.793 . . . . 0.28999999999999998 112.557 -179.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.599 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.4 mmt -105.15 156.35 18.17 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.788 -0.243 . . . . 1.72 110.861 176.716 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.4 mt -98.27 97.45 8.84 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.455 -0.572 . . . . 1.1799999999999999 109.455 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 18.1 mt -81.82 105.07 12.66 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 119.469 -0.893 . . . . 1.1299999999999999 109.068 174.382 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 86.4 m-20 74.1 -66.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.974 -1.012 . . . . 1.71 111.909 -177.652 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -156.47 6.84 0.19 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.854 -0.612 . . . . 0.84999999999999998 111.686 -177.184 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.46 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.2 mtt180 -134.39 128.34 33.41 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 121.769 -0.582 . . . . 1.27 110.255 -172.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 161' ' ' MET . 17.0 tttt -76.66 119.77 20.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.836 -0.62 . . . . 1.6499999999999999 109.483 -178.016 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.9 m -100.73 144.51 12.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.491 0.662 . . . . 1.04 111.365 -172.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 72.9 t80 -106.82 119.76 40.21 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.687 -1.142 . . . . 0.41999999999999998 109.325 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 40.6 t -115.63 128.82 72.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.501 -0.555 . . . . 1.03 109.501 178.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.28 -175.02 19.79 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.64 -0.79 . . . . 0.17999999999999999 112.356 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 120.895 0.378 . . . . 2.3599999999999999 110.729 -177.744 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 111.855 -0.498 . . . . 15.130000000000001 111.855 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -119.76 -65.29 1.17 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.969 0.414 . . . . 13.73 110.117 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -170.08 117.43 0.51 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.832 -0.622 . . . . 11.300000000000001 110.351 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.55 -4.16 13.91 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.591 2.194 . . . . 11.93 112.219 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.63 ' HB2' ' HE1' ' A' ' 144' ' ' HIS . 1.1 m -84.84 13.34 5.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.983 -0.553 . . . . 9.5199999999999996 111.155 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 93.7 mt -80.4 56.12 2.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.523 0.678 . . . . 8.2100000000000009 110.441 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -137.43 -150.51 0.36 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.045 -0.979 . . . . 8.4100000000000001 108.366 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.776 ' HB3' ' HB1' ' A' ' 181' ' ' ALA . 43.7 tttm -99.28 1.06 44.26 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.83 -0.804 . . . . 2.6600000000000001 108.83 171.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 p -105.85 19.74 20.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.384 -0.826 . . . . 2.3500000000000001 111.811 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.12 6.16 83.8 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.52 -0.848 . . . . 1.02 111.799 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.42 HG13 ' OE1' ' A' ' 148' ' ' GLN . 73.2 t 60.35 121.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.118 0.967 . . . . 1.3600000000000001 112.664 -173.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.406 ' HA2' ' CB ' ' A' ' 151' ' ' ALA . . . 72.24 25.62 74.07 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 119.732 -1.223 . . . . 0.26000000000000001 112.406 172.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.52 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.2 m120 -85.58 123.85 31.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.806 -0.813 . . . . 0.63 108.806 -174.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.497 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.1 pt -135.72 159.93 39.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 110.319 -0.252 . . . . 1.05 110.319 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.05 141.35 52.12 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.815 -0.439 . . . . 0.26000000000000001 109.815 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 7.2 mt -117.95 137.61 51.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.58 -0.737 . . . . 1.01 110.07 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -120.72 151.57 39.37 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.679 -0.237 . . . . 2.0800000000000001 110.522 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 t30 69.77 54.37 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.86 0.725 . . . . 0.53000000000000003 111.307 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.671 HD22 HG23 ' A' ' 110' ' ' ILE . 14.6 mt -91.61 162.88 14.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.426 -0.807 . . . . 1.04 111.169 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.466 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 14.0 t70 -87.38 155.74 19.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.70999999999999996 109.936 177.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.933 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 62.8 pttt -62.24 -31.39 71.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.388 -0.369 . . . . 2.7799999999999998 111.417 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.8 p -72.32 -4.59 30.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.186 -0.461 . . . . 1.8 111.936 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.671 HG23 HD22 ' A' ' 106' ' ' LEU . 45.1 mm -84.57 118.4 31.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.482 . . . . 1.1000000000000001 110.776 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -108.73 -175.27 2.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.297 -1.001 . . . . 1.5900000000000001 108.297 177.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -67.66 -32.52 73.25 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.478 -0.934 . . . . 0.92000000000000004 108.478 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -48.72 71.14 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.624 -1.171 . . . . 3.04 109.263 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.43 -43.03 99.79 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.274 -1.33 . . . . 1.03 110.84 -177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.632 HD13 HG21 ' A' ' 130' ' ' VAL . 3.5 tt -65.73 -47.79 74.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.172 -0.677 . . . . 1.05 109.172 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.648 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 55.3 t80 -59.26 -46.3 88.87 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.743 -0.662 . . . . 1.05 110.486 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.84 -39.85 74.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.505 -0.316 . . . . 0.40000000000000002 111.232 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.448 HG23 HD23 ' A' ' 163' ' ' LEU . 91.3 m -77.73 -53.78 7.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.264 0.468 . . . . 1.02 112.264 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.434 ' CD1' HD22 ' A' ' 115' ' ' LEU . 6.5 m-85 -71.76 -28.09 63.42 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.54 0.57 . . . . 0.14999999999999999 112.54 -173.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.5 t -57.71 -28.86 64.22 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.571 0.224 . . . . 0.56000000000000005 111.296 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.33 -22.86 45.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.678 0.275 . . . . 1.04 111.385 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -89.76 -26.22 20.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.038 0.447 . . . . 0.20999999999999999 110.546 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.89 169.77 35.82 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.125 -0.79 . . . . 0.14000000000000001 111.125 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -71.04 143.59 50.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.65 -0.5 . . . . 0.28999999999999998 109.65 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.423 HG23 ' HB3' ' A' ' 128' ' ' CYS . 76.2 mt -114.76 134.93 56.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 116.014 -0.539 . . . . 1.0700000000000001 110.015 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -93.02 -36.45 12.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 1.26 109.508 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.1 m -156.18 97.61 1.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.733 -0.667 . . . . 1.1799999999999999 111.365 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.648 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.7 p -103.84 153.54 20.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.355 -0.609 . . . . 1.49 109.355 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -150.61 132.44 15.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.818 0.342 . . . . 1.6299999999999999 111.255 -175.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.632 HG21 HD13 ' A' ' 115' ' ' LEU . 57.5 t -114.28 110.31 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 107.183 -1.414 . . . . 1.0700000000000001 107.183 171.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.67 114.5 19.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.432 -0.951 . . . . 1.1399999999999999 108.432 -175.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.858 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 3.6 p -105.79 135.03 47.94 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.759 0.652 . . . . 2.3399999999999999 112.759 -164.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.33 174.45 8.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.919 -0.771 . . . . 2.0800000000000001 108.919 172.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -55.11 -31.86 61.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.013 0.375 . . . . 2.4500000000000002 112.013 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -86.23 -12.3 50.05 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.621 0.248 . . . . 1.6499999999999999 110.974 -175.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.933 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 151.22 -50.19 0.53 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.07 -1.062 . . . . 1.23 113.834 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.858 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 38.2 t -160.96 145.99 14.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.476 0.638 . . . . 1.99 111.51 -176.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -78.18 -12.96 60.03 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.3 0.571 . . . . 2.0600000000000001 110.297 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.66 22.83 9.87 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.203 -0.999 . . . . 0.31 113.877 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -161.18 153.93 20.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.742 0.771 . . . . 1.01 111.285 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.29 174.06 28.09 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.457 -0.792 . . . . 0.13 111.625 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.43 ' CD1' ' HE2' ' A' ' 173' ' ' PHE . 44.5 m-85 -139.93 142.65 36.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.928 0.364 . . . . 0.31 110.555 -177.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.5 HG13 ' CE2' ' A' ' 145' ' ' PHE . 24.6 t -118.34 133.96 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.105 0.479 . . . . 1.03 111.362 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.63 ' HE1' ' HB2' ' A' ' 92' ' ' SER . 0.1 OUTLIER -106.45 106.58 17.16 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.851 -0.796 . . . . 0.32000000000000001 108.851 167.396 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.5 ' CE2' HG13 ' A' ' 143' ' ' VAL . 8.7 m-85 -89.28 139.76 30.17 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.284 0.564 . . . . 0.17000000000000001 111.915 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.538 ' HA ' HD23 ' A' ' 126' ' ' LEU . 43.8 tt0 -52.48 -48.74 65.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.112 -1.404 . . . . 0.56999999999999995 110.07 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.2 p -111.77 144.45 41.03 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.137 -1.392 . . . . 1.1100000000000001 111.062 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.42 ' OE1' HG13 ' A' ' 98' ' ' VAL . 54.3 tp60 -61.92 -40.32 95.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.299 -0.864 . . . . 0.46999999999999997 111.026 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.8 pt-20 -67.68 -35.18 78.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.73999999999999999 111.408 -175.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.84 78.43 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.241 0.543 . . . . 1.03 110.489 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.482 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.97 -44.72 91.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.388 -0.824 . . . . 1.05 110.86 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 37.7 mt-10 -62.06 -37.33 84.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.646 -0.707 . . . . 1.4199999999999999 110.356 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 149' ' ' GLU . 88.8 mtt180 -62.54 -47.05 85.57 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.332 -0.394 . . . . 2.0 110.592 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.78 81.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.997 -0.547 . . . . 1.02 111.012 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.0 mt -61.21 -53.77 44.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.239 -0.437 . . . . 1.04 111.131 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 4.2 pt-20 -64.69 -45.01 88.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.186 0.517 . . . . 1.0800000000000001 111.919 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -75.52 -38.92 59.07 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.483 -0.78 . . . . 1.78 112.893 -170.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 83.8 mmm -93.51 -26.23 17.25 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.917 0.71 . . . . 1.03 112.917 -173.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -64.79 123.74 20.15 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.549 -0.46 . . . . 0.60999999999999999 110.15 -177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.42 11.65 62.27 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.816 -0.706 . . . . 0.28999999999999998 113.184 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.67 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 75.2 mmm -105.39 164.25 12.0 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.568 -0.372 . . . . 1.72 111.508 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 167' ' ' LYS . 19.8 mt -96.33 123.21 39.89 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.928 -0.768 . . . . 1.1799999999999999 108.928 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.517 HD11 HG12 ' A' ' 168' ' ' VAL . 24.9 mt -106.43 100.21 9.75 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.934 -0.706 . . . . 1.1299999999999999 109.659 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 94.5 m-20 77.72 -28.82 0.16 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.871 -1.059 . . . . 1.71 112.725 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 163' ' ' LEU . 35.7 t70 174.44 -23.85 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.772 -0.649 . . . . 0.84999999999999998 112.221 -174.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.466 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.7 mtt180 -115.96 134.93 54.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.935 0.397 . . . . 1.27 111.602 -173.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.67 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.5 ttmt -76.92 123.83 26.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.418 -0.81 . . . . 1.6499999999999999 109.171 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.517 HG12 HD11 ' A' ' 163' ' ' LEU . 23.2 m -103.05 146.6 10.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.434 0.635 . . . . 1.04 111.528 -174.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 73.5 t80 -107.51 119.26 38.94 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.016 -0.993 . . . . 0.41999999999999998 109.116 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.425 ' CG1' HD12 ' A' ' 101' ' ' ILE . 43.0 t -114.82 128.04 72.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.467 -0.568 . . . . 1.03 109.467 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.61 -177.44 22.86 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.365 -0.922 . . . . 0.17999999999999999 112.714 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.477 ' HA ' ' HE ' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -73.01 133.45 44.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.889 0.376 . . . . 2.3599999999999999 110.795 -177.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.43 ' HE2' ' CD1' ' A' ' 142' ' ' PHE . 17.6 t80 -78.21 91.03 4.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.685 -0.689 . . . . 1.4399999999999999 110.077 -175.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -92.54 96.52 10.26 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.798 -0.815 . . . . 5.1399999999999997 108.798 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.4 ' HB3' ' HE1' ' A' ' 173' ' ' PHE . 0.8 OUTLIER -61.8 -42.03 98.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.536 -0.756 . . . . 3.8100000000000001 111.827 -174.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -170.83 -82.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.673 0.273 . . . . 8.2799999999999994 110.964 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -169.65 72.76 0.08 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.411 -0.589 . . . . 9.0099999999999998 109.411 -174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -110.06 148.81 31.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.166 -0.47 . . . . 8.6500000000000004 110.865 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.531 ' HA ' ' NE ' ' A' ' 179' ' ' ARG . 3.2 mmp_? -76.26 -39.46 54.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.969 -0.56 . . . . 12.789999999999999 109.749 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -88.51 101.48 13.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.284 -0.871 . . . . 12.699999999999999 109.399 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.776 ' HB1' ' HB3' ' A' ' 95' ' ' LYS . . . -164.43 141.79 6.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.909 -0.587 . . . . 13.800000000000001 110.459 -177.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 . . . . . 0 C--O 1.242 0.7 0 CA-C-O 118.122 -0.942 . . . . 15.050000000000001 109.797 176.76 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.704 0 N-CA-C 111.933 -0.467 . . . . 15.130000000000001 111.933 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.63 -42.56 82.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 13.73 110.999 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.534 ' HB3' ' HE2' ' A' ' 95' ' ' LYS . 2.9 m-20 -123.32 81.46 52.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.131 -0.486 . . . . 11.300000000000001 110.335 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -93.83 94.28 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.33 2.687 . . . . 11.93 111.416 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.3 p 46.78 50.33 13.46 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.63 0.729 . . . . 9.5199999999999996 109.925 -172.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.729 ' HG ' ' HG3' ' A' ' 94' ' ' ARG . 60.8 tp -125.13 121.67 34.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.898 -1.046 . . . . 8.2100000000000009 111.081 -172.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.729 ' HG3' ' HG ' ' A' ' 93' ' ' LEU . 46.6 mtm180 67.68 21.74 9.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.055 0.542 . . . . 8.4100000000000001 112.093 173.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 93' ' ' LEU . 35.3 mttm -136.39 171.91 13.79 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.777 -0.369 . . . . 2.6600000000000001 110.966 -176.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.2 t -120.92 -32.31 4.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.102 0.477 . . . . 2.3500000000000001 109.875 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.497 ' HA3' ' OD1' ' A' ' 100' ' ' ASN . . . -66.59 -47.2 70.47 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.7 -0.682 . . . . 1.02 112.837 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER 63.88 134.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.353 1.061 . . . . 1.3600000000000001 111.781 -174.03 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.89 22.71 78.9 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.265 -0.969 . . . . 0.26000000000000001 111.217 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.497 ' OD1' ' HA3' ' A' ' 97' ' ' GLY . 2.7 m120 -96.18 128.38 43.04 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.14 -0.689 . . . . 0.63 109.14 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.471 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.8 pt -133.31 162.5 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.162 -0.472 . . . . 1.05 109.864 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.24 144.63 50.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.006 0.431 . . . . 0.26000000000000001 109.908 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 5.7 mt -119.92 135.49 60.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.588 -0.733 . . . . 1.01 110.071 -177.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -116.66 152.37 34.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.732 -0.213 . . . . 2.0800000000000001 110.652 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 t30 71.58 40.65 0.78 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.942 0.777 . . . . 0.53000000000000003 111.79 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.637 HD23 HG22 ' A' ' 110' ' ' ILE . 20.6 mt -78.24 158.55 28.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.389 0.614 . . . . 1.04 111.755 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.473 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 25.1 t70 -81.93 150.76 27.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.359 -0.837 . . . . 0.70999999999999996 110.916 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -55.72 -36.88 67.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.599 -0.728 . . . . 2.7799999999999998 112.131 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.6 m -84.02 -3.87 58.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.89 0.33 . . . . 1.8 111.89 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.637 HG22 HD23 ' A' ' 106' ' ' LEU . 27.9 mm -71.87 117.14 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.091 0.472 . . . . 1.1000000000000001 110.183 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 15.6 t70 -105.64 -171.74 1.96 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.798 -0.815 . . . . 1.5900000000000001 108.798 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.457 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 87.3 m-20 -72.17 -32.61 67.01 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.319 -0.993 . . . . 0.92000000000000004 108.319 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.607 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -68.68 -45.05 72.71 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.039 -1.437 . . . . 3.04 109.661 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.76 -44.25 97.26 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.662 -1.608 . . . . 1.03 110.574 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.572 HD12 HG21 ' A' ' 130' ' ' VAL . 4.1 tt -67.4 -47.19 71.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.165 -0.925 . . . . 1.05 109.378 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.795 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 83.5 t80 -58.98 -45.31 90.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.893 -0.594 . . . . 1.05 111.165 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.85 -40.89 76.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.852 0.358 . . . . 0.40000000000000002 110.877 -175.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 58.8 m -77.41 -53.71 7.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.238 -0.437 . . . . 1.02 112.136 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.409 ' CD1' HD21 ' A' ' 115' ' ' LEU . 14.1 m-85 -71.59 -28.43 63.81 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.657 0.614 . . . . 0.14999999999999999 112.657 -173.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -57.75 -28.42 63.91 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.609 0.243 . . . . 0.56000000000000005 111.078 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.78 -22.68 37.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.804 0.298 . . . . 1.04 111.804 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -91.88 -15.54 27.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.997 0.427 . . . . 0.20999999999999999 111.038 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.19 166.79 22.6 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.531 -0.628 . . . . 0.14000000000000001 111.531 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -67.57 139.44 56.91 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.033 0.444 . . . . 0.28999999999999998 110.201 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.419 HG23 ' HB3' ' A' ' 128' ' ' CYS . 65.9 mt -113.37 133.91 57.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.725 -0.671 . . . . 1.0700000000000001 109.723 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -90.37 -43.7 10.15 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.884 -0.784 . . . . 1.26 108.884 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 55.7 m -145.65 99.75 3.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.231 -0.895 . . . . 1.1799999999999999 110.962 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.795 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.6 p -97.53 145.9 25.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.17 -0.678 . . . . 1.49 109.17 171.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -148.79 134.27 18.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.063 0.459 . . . . 1.6299999999999999 111.8 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.613 HG23 HG23 ' A' ' 110' ' ' ILE . 99.1 t -114.02 115.07 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 106.587 -1.634 . . . . 1.0700000000000001 106.587 170.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.2 t -82.72 115.09 24.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.709 -0.848 . . . . 1.1399999999999999 108.709 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 58.5 m -104.22 141.09 36.88 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.523 -0.762 . . . . 2.3399999999999999 111.495 -169.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -85.6 160.9 19.5 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.669 -1.234 . . . . 2.0800000000000001 107.669 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -64.2 -19.01 65.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 118.681 0.673 . . . . 2.4500000000000002 110.208 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -92.17 2.32 56.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.94 -0.573 . . . . 1.6499999999999999 110.686 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.539 ' O ' ' HB3' ' A' ' 132' ' ' CYS . . . 143.08 -80.19 0.24 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.766 -0.73 . . . . 1.23 113.711 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.741 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 32.5 t -141.94 153.4 44.32 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 117.973 0.886 . . . . 1.99 109.62 -176.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -88.0 -11.19 48.09 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.153 0.502 . . . . 2.0600000000000001 110.266 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.22 -24.41 22.84 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.455 -0.878 . . . . 0.31 113.35 176.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -123.68 152.84 41.6 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.457 0.646 . . . . 1.01 111.976 -172.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.89 174.36 23.63 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.954 -1.021 . . . . 0.13 111.309 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -138.72 140.99 38.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.01 0.405 . . . . 0.31 110.72 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.494 HG12 ' CE2' ' A' ' 145' ' ' PHE . 43.0 t -115.45 129.17 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 120.946 0.403 . . . . 1.03 110.492 172.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.1 m170 -100.47 105.19 16.62 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.267 -0.642 . . . . 0.32000000000000001 109.267 167.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.559 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 18.8 m-85 -87.25 142.97 27.5 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.078 0.466 . . . . 0.17000000000000001 110.392 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.546 ' HA ' HD23 ' A' ' 126' ' ' LEU . 35.5 tt0 -52.89 -34.45 54.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.426 -1.261 . . . . 0.56999999999999995 110.706 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.6 p -129.94 152.38 49.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.348 -0.842 . . . . 1.1100000000000001 111.277 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -62.18 -36.02 80.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.694 -0.684 . . . . 0.46999999999999997 111.204 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.26 -35.66 76.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.008 0.373 . . . . 0.73999999999999999 112.008 -175.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.88 -34.67 78.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 1.03 110.553 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.559 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -65.3 -41.72 93.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.722 -0.672 . . . . 1.05 110.944 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 32.4 mt-10 -59.33 -40.19 85.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 1.4199999999999999 110.775 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 70.8 mtt180 -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 2.0 111.192 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.68 84.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.438 -0.346 . . . . 1.02 110.451 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.1 mt -62.26 -53.25 49.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.242 -0.435 . . . . 1.04 111.168 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 0.9 OUTLIER -64.27 -41.86 96.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.07 0.462 . . . . 1.0800000000000001 111.899 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.483 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.23 -38.69 24.14 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.084 0.772 . . . . 1.78 113.084 -171.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 92.8 mmm -93.81 -20.52 20.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.843 0.683 . . . . 1.03 112.843 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.443 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 58.2 t30 -68.5 123.83 21.89 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.965 -0.694 . . . . 0.60999999999999999 109.495 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.53 17.01 57.78 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.742 -0.742 . . . . 0.28999999999999998 112.721 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.725 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.4 mmt -100.91 163.4 12.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.675 0.274 . . . . 1.72 111.54 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 mt -104.3 105.21 15.27 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.983 -0.553 . . . . 1.1799999999999999 109.826 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 18.8 mt -93.04 105.97 17.99 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.974 -0.691 . . . . 1.1299999999999999 109.881 175.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 93.3 m-20 75.09 -51.23 0.67 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.124 -0.944 . . . . 1.71 111.843 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -178.63 22.09 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.88 -0.6 . . . . 0.84999999999999998 111.729 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.4 mtt180 -138.76 135.48 34.72 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.681 -0.637 . . . . 1.27 109.957 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.2 ttmt -83.08 117.68 23.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.497 -0.557 . . . . 1.6499999999999999 109.497 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.5 m -100.52 148.39 6.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.588 0.709 . . . . 1.04 111.448 -171.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.566 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 69.2 t80 -106.46 120.61 42.35 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.647 -1.16 . . . . 0.41999999999999998 109.292 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.466 ' CG1' HD11 ' A' ' 101' ' ' ILE . 43.2 t -115.65 126.24 73.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.448 -0.575 . . . . 1.03 109.448 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.06 -175.9 21.89 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.745 -0.741 . . . . 0.17999999999999999 111.548 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -62.24 141.74 58.07 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.3 -0.63 . . . . 2.3599999999999999 109.3 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -57.88 104.71 0.21 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.591 -0.522 . . . . 1.4399999999999999 109.591 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -68.13 118.98 11.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.263 0.554 . . . . 5.1399999999999997 110.956 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.8 m -84.37 91.31 7.76 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.448 -0.796 . . . . 3.8100000000000001 109.366 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -75.19 149.37 38.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.011 -0.54 . . . . 8.2799999999999994 111.453 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 177' ' ' LYS . 74.8 tttt -157.86 20.73 0.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.03 -0.729 . . . . 9.0099999999999998 109.03 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.01 113.36 2.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.259 -0.882 . . . . 8.6500000000000004 110.864 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.404 ' HB2' ' H ' ' A' ' 180' ' ' GLU . 18.7 mmm180 -102.38 -92.11 0.33 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.039 0.447 . . . . 12.789999999999999 109.98 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.404 ' H ' ' HB2' ' A' ' 179' ' ' ARG . 43.1 tt0 -156.38 116.23 3.58 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.582 -0.895 . . . . 12.699999999999999 108.582 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 60.51 21.83 11.55 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.313 0.578 . . . . 13.800000000000001 110.524 -172.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--O 1.251 1.132 0 CA-C-N 115.407 -0.815 . . . . 15.050000000000001 108.994 -178.315 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 112.016 -0.434 . . . . 15.130000000000001 112.016 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.448 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -152.13 -178.35 6.73 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.295 -0.261 . . . . 13.73 110.295 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.19 102.57 12.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.264 -0.643 . . . . 11.300000000000001 109.264 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 89' ' ' ALA . 34.8 Cg_exo -58.19 -58.92 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.191 2.594 . . . . 11.93 113.29 -172.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.4 m -83.13 12.34 5.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.207 0.447 . . . . 9.5199999999999996 112.207 -174.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 47.2 tp -107.71 -39.77 5.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.662 0.268 . . . . 8.2100000000000009 110.52 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.657 ' O ' ' HD2' ' A' ' 95' ' ' LYS . 95.1 mtt180 -69.4 -42.44 75.11 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.37 -0.377 . . . . 8.4100000000000001 110.345 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.695 ' HE2' ' HB3' ' A' ' 172' ' ' ARG . 0.5 OUTLIER -151.22 174.51 13.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.061 -0.348 . . . . 2.6600000000000001 110.061 173.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 98' ' ' VAL . 18.0 m -99.92 158.83 15.53 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.183 -1.043 . . . . 2.3500000000000001 108.183 174.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.9 -26.17 1.75 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.38 -0.914 . . . . 1.02 111.738 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 96' ' ' SER . 78.9 t 63.87 126.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.328 1.051 . . . . 1.3600000000000001 112.25 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.8 24.05 76.78 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 119.974 -1.107 . . . . 0.26000000000000001 111.605 177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.48 ' N ' HD21 ' A' ' 100' ' ' ASN . 0.9 OUTLIER -88.74 125.96 35.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.273 -0.64 . . . . 0.63 109.273 -174.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.524 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.6 pt -135.46 161.43 39.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.989 -0.374 . . . . 1.05 109.989 175.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.23 137.87 54.11 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.88 -0.415 . . . . 0.26000000000000001 109.88 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 5.1 mt -115.21 135.05 56.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.612 -0.722 . . . . 1.01 110.013 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -117.12 152.95 33.65 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.292 -0.262 . . . . 2.0800000000000001 110.292 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.3 t30 74.89 35.1 0.65 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.818 0.699 . . . . 0.53000000000000003 111.474 171.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.445 HD22 HG23 ' A' ' 110' ' ' ILE . 30.7 mt -79.79 159.54 26.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.12 0.486 . . . . 1.04 111.185 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -92.66 150.71 20.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.596 -0.729 . . . . 0.70999999999999996 110.414 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.538 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 65.2 pttt -52.1 -31.98 33.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.758 -0.656 . . . . 2.7799999999999998 112.213 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.5 m -71.78 -17.32 62.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.096 0.406 . . . . 1.8 112.096 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.543 HG21 HG22 ' A' ' 130' ' ' VAL . 28.5 mm -71.43 123.52 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.251 0.548 . . . . 1.1000000000000001 110.835 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 26.5 t70 -107.87 -177.98 3.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.279 -0.873 . . . . 1.5900000000000001 109.056 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.466 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 4.6 m-20 -69.61 -35.09 74.96 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.344 -0.984 . . . . 0.92000000000000004 108.344 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -45.66 71.68 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.628 -1.169 . . . . 3.04 109.052 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.24 91.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.006 -1.452 . . . . 1.03 110.669 -178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.553 HD13 HG23 ' A' ' 130' ' ' VAL . 3.8 tt -68.87 -47.02 66.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.199 -0.91 . . . . 1.05 109.231 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.72 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 65.6 t80 -60.64 -45.1 95.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 1.05 111.132 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -56.8 -40.61 76.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.03 0.443 . . . . 0.40000000000000002 110.543 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.559 HG23 HD21 ' A' ' 163' ' ' LEU . 20.4 m -77.52 -53.81 7.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.747 -0.661 . . . . 1.02 111.822 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.404 ' CD1' HD22 ' A' ' 115' ' ' LEU . 11.1 m-85 -72.48 -28.16 62.73 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.743 0.646 . . . . 0.14999999999999999 112.743 -174.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.6 t -57.57 -29.05 64.12 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.58 0.229 . . . . 0.56000000000000005 111.207 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.35 39.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.928 0.394 . . . . 1.04 111.716 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.418 ' HZ ' ' HE3' ' A' ' 157' ' ' LYS . 33.0 m-85 -92.83 -14.83 27.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.414 -0.357 . . . . 0.20999999999999999 111.019 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.5 169.83 26.43 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.624 -0.59 . . . . 0.14000000000000001 111.624 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -73.15 138.65 45.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.108 0.48 . . . . 0.28999999999999998 110.247 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.401 HG23 ' HB3' ' A' ' 128' ' ' CYS . 69.2 mt -111.03 132.09 60.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.718 -0.673 . . . . 1.0700000000000001 110.038 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.551 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -84.57 -43.27 14.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.569 -0.9 . . . . 1.26 108.569 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.3 m -146.5 131.78 18.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.819 -1.082 . . . . 1.1799999999999999 110.255 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.5 p -128.69 134.67 48.56 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.117 -0.698 . . . . 1.49 109.117 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -133.76 133.33 41.6 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.586 -0.446 . . . . 1.6299999999999999 111.776 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.553 HG23 HD13 ' A' ' 115' ' ' LEU . 83.9 t -114.56 110.44 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 107.012 -1.477 . . . . 1.0700000000000001 107.012 170.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 t -79.6 116.35 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.971 -0.752 . . . . 1.1399999999999999 108.971 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.776 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 61.7 m -106.85 135.94 47.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.723 -0.671 . . . . 2.3399999999999999 112.567 -164.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -86.35 164.69 16.91 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.063 -0.971 . . . . 2.0800000000000001 108.733 172.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -61.66 -22.54 65.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.039 0.447 . . . . 2.4500000000000002 110.544 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -88.09 -2.68 58.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.898 -0.592 . . . . 1.6499999999999999 110.491 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.538 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 140.34 -68.95 0.47 Allowed Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.728 -0.749 . . . . 1.23 113.249 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.776 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 38.4 t -144.51 153.3 41.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.436 0.618 . . . . 1.99 110.493 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 35.2 mtpt -84.32 -10.13 57.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.159 0.504 . . . . 2.0600000000000001 109.683 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 105.5 -10.35 45.99 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.286 -0.959 . . . . 0.31 113.527 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 29.9 p90 -132.79 150.75 52.12 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.359 0.6 . . . . 1.01 111.854 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.22 167.14 26.18 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.036 -0.984 . . . . 0.13 111.341 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -133.99 136.97 44.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.937 0.368 . . . . 0.31 110.738 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.561 HG12 ' CE2' ' A' ' 145' ' ' PHE . 42.7 t -110.79 136.16 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 1.03 110.644 174.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.454 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 1.2 m170 -105.95 105.37 15.38 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.774 -0.824 . . . . 0.32000000000000001 108.774 166.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.582 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 17.8 m-85 -88.71 140.8 29.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.099 0.476 . . . . 0.17000000000000001 110.732 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.551 ' HA ' HD21 ' A' ' 126' ' ' LEU . 34.7 tt0 -51.7 -41.33 61.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.749 -1.114 . . . . 0.56999999999999995 110.361 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 78.2 p -115.24 150.52 36.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.701 -1.136 . . . . 1.1100000000000001 110.157 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -65.65 -36.12 82.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.132 -0.485 . . . . 0.46999999999999997 110.593 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 12.5 pt-20 -69.04 -35.0 76.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.73999999999999999 111.828 -176.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.29 79.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.067 0.46 . . . . 1.03 110.639 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.582 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -64.02 -46.31 85.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.705 -0.68 . . . . 1.05 110.507 177.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.506 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 42.7 mt-10 -61.74 -34.55 76.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.328 -0.851 . . . . 1.4199999999999999 110.91 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.497 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 95.9 mtt180 -61.82 -47.63 84.21 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.106 0.479 . . . . 2.0 110.543 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.8 -35.8 77.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.86 -0.609 . . . . 1.02 110.587 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.5 mt -60.61 -54.41 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 1.04 111.225 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 0.8 OUTLIER -64.04 -42.44 97.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.53 . . . . 1.0800000000000001 111.768 -177.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.418 ' HE3' ' HZ ' ' A' ' 122' ' ' PHE . 0.0 OUTLIER -80.25 -37.97 31.88 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.486 -0.779 . . . . 1.78 112.819 -170.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 91.9 mmm -96.41 -16.93 20.95 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.818 0.673 . . . . 1.03 112.818 -173.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -70.0 124.04 23.05 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.09 -0.644 . . . . 0.60999999999999999 109.882 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.19 15.56 74.13 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.166 -0.47 . . . . 0.28999999999999998 112.088 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 11.7 tpp -99.91 157.6 16.41 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.065 -0.346 . . . . 1.72 110.065 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.0 mt -96.94 110.92 23.34 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 109.349 -0.612 . . . . 1.1799999999999999 109.349 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.559 HD21 HG23 ' A' ' 118' ' ' THR . 20.8 mt -98.02 105.18 17.29 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.981 -0.687 . . . . 1.1299999999999999 109.539 173.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 61.3 m-20 77.11 -29.62 0.17 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.22 -0.9 . . . . 1.71 112.681 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 21.1 t70 168.19 -22.18 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.701 0.625 . . . . 0.84999999999999998 111.864 -170.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 80.5 mtt-85 -113.3 137.78 50.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.867 0.365 . . . . 1.27 111.118 -170.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 161' ' ' MET . 8.0 tttm -81.5 112.96 19.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.669 -0.696 . . . . 1.6499999999999999 109.307 -177.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.15 148.48 6.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.599 0.714 . . . . 1.04 111.245 -172.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 68.3 t80 -106.68 119.49 39.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.726 -1.124 . . . . 0.41999999999999998 109.384 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 40.1 t -114.57 125.46 71.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.983 -0.747 . . . . 1.03 108.983 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -144.41 -171.68 14.52 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.577 -0.821 . . . . 0.17999999999999999 112.095 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.695 ' HB3' ' HE2' ' A' ' 95' ' ' LYS . 20.0 mmt180 -70.47 122.4 19.6 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.879 -0.415 . . . . 2.3599999999999999 109.879 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.582 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 56.1 t80 -59.85 127.9 34.25 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.809 -0.441 . . . . 1.4399999999999999 109.809 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -74.49 89.15 2.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.229 0.538 . . . . 5.1399999999999997 110.734 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.2 m -98.12 29.38 3.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.188 -0.915 . . . . 3.8100000000000001 109.895 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -76.83 81.49 3.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.86 -0.609 . . . . 8.2799999999999994 110.739 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.752 ' HE2' ' HA ' ' A' ' 177' ' ' LYS . 0.6 OUTLIER -90.27 2.95 54.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.878 -0.601 . . . . 9.0099999999999998 109.461 176.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -164.64 160.17 19.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.558 -0.746 . . . . 8.6500000000000004 109.772 -174.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -58.66 -35.42 72.54 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.947 0.351 . . . . 12.789999999999999 111.947 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -85.56 12.97 7.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.995 0.426 . . . . 12.699999999999999 111.397 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -111.61 61.19 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.624 -0.51 . . . . 13.800000000000001 109.624 173.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.56 -0.733 . . . . 15.050000000000001 110.813 -175.463 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 111.66 -0.576 . . . . 15.130000000000001 111.66 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.62 165.92 16.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.795 0.331 . . . . 13.73 110.888 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -117.57 102.04 52.08 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.957 0.408 . . . . 11.300000000000001 110.03 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.09 -30.04 89.05 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.878 2.386 . . . . 11.93 112.553 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.615 ' HA ' ' HD3' ' A' ' 95' ' ' LYS . 24.6 m -61.35 -23.53 65.81 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.267 0.469 . . . . 9.5199999999999996 112.267 -177.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.49 -18.83 65.62 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.026 0.441 . . . . 8.2100000000000009 110.943 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.421 ' HD2' ' N ' ' A' ' 94' ' ' ARG . 9.5 mpt_? -88.54 -5.27 58.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.215 0.531 . . . . 8.4100000000000001 110.193 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.615 ' HD3' ' HA ' ' A' ' 92' ' ' SER . 2.3 mptp? -112.27 70.6 0.72 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.75 -0.834 . . . . 2.6600000000000001 108.75 175.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.8 t -62.05 -12.3 18.31 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.09 0.404 . . . . 2.3500000000000001 112.09 -175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.567 ' C ' HD22 ' A' ' 100' ' ' ASN . . . -69.94 -20.74 76.41 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.819 -0.705 . . . . 1.02 111.845 175.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.4 t 64.32 122.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.032 0.933 . . . . 1.3600000000000001 112.505 -176.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.69 24.18 73.13 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.384 -0.912 . . . . 0.26000000000000001 112.117 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.567 HD22 ' C ' ' A' ' 97' ' ' GLY . 1.6 m120 -86.88 124.26 32.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.445 -0.576 . . . . 0.63 109.445 -174.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.478 HG12 ' HB ' ' A' ' 143' ' ' VAL . 20.2 pt -135.67 161.88 37.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.995 -0.548 . . . . 1.05 109.803 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.42 144.11 50.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.864 -0.421 . . . . 0.26000000000000001 109.864 176.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 4.5 mt -118.82 130.99 72.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.613 -0.721 . . . . 1.01 110.166 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -109.65 152.25 25.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.587 -0.278 . . . . 2.0800000000000001 110.702 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.6 t30 72.14 33.65 1.55 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.926 0.766 . . . . 0.53000000000000003 111.861 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.441 HD23 HG23 ' A' ' 110' ' ' ILE . 17.3 mt -72.64 155.39 40.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.063 0.459 . . . . 1.04 111.446 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.472 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 23.3 t70 -75.25 146.91 40.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.732 -0.667 . . . . 0.70999999999999996 109.832 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -60.47 -31.72 70.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.108 -0.496 . . . . 2.7799999999999998 111.796 -176.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t -79.04 -4.29 49.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.575 -0.284 . . . . 1.8 111.499 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.441 HG23 HD23 ' A' ' 106' ' ' LEU . 32.0 mm -73.03 127.14 34.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.419 . . . . 1.1000000000000001 110.393 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.42 ' H ' ' HB2' ' A' ' 114' ' ' ALA . 10.5 t70 -110.89 -177.15 3.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.748 -0.66 . . . . 1.5900000000000001 109.28 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.586 ' OD1' ' HA ' ' A' ' 129' ' ' LYS . 69.1 m-80 -72.06 -32.08 66.73 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.565 -0.902 . . . . 0.92000000000000004 108.565 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -47.95 74.35 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.675 -1.148 . . . . 3.04 108.797 176.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.42 ' HB2' ' H ' ' A' ' 111' ' ' ASP . . . -61.63 -43.57 98.6 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.039 -1.437 . . . . 1.03 111.103 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.496 HD12 HG21 ' A' ' 130' ' ' VAL . 3.2 tt -66.54 -46.58 75.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.478 -0.783 . . . . 1.05 109.27 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.417 ' CE1' ' HB ' ' A' ' 125' ' ' ILE . 62.3 t80 -60.52 -46.35 90.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 1.05 110.658 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -56.55 -39.49 73.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.858 0.361 . . . . 0.40000000000000002 111.044 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 m -78.1 -54.02 6.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.001 -0.545 . . . . 1.02 112.087 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.405 ' CD1' HD21 ' A' ' 115' ' ' LEU . 9.2 m-85 -72.15 -28.39 63.21 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.683 0.623 . . . . 0.14999999999999999 112.683 -173.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.8 t -57.67 -28.46 63.78 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.826 0.346 . . . . 0.56000000000000005 110.809 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.4 36.01 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.227 -0.442 . . . . 1.04 111.637 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -89.74 -31.99 17.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.984 0.421 . . . . 0.20999999999999999 110.723 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.49 165.41 34.08 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.392 -0.683 . . . . 0.14000000000000001 111.392 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -62.19 140.84 58.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.971 0.415 . . . . 0.28999999999999998 109.972 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.746 HD12 ' SG ' ' A' ' 128' ' ' CYS . 94.8 mt -114.34 133.96 58.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.937 -0.574 . . . . 1.0700000000000001 110.637 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -91.05 -37.12 13.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.076 -0.712 . . . . 1.26 109.076 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 70.5 m -159.54 111.11 2.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.529 -0.759 . . . . 1.1799999999999999 111.227 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.794 ' SG ' HG11 ' A' ' 143' ' ' VAL . 54.2 m -109.12 144.9 36.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.527 -0.546 . . . . 1.49 109.527 169.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.586 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 53.1 tptt -135.62 131.96 36.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.157 -0.474 . . . . 1.6299999999999999 111.416 -175.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.496 HG21 HD12 ' A' ' 115' ' ' LEU . 88.5 t -114.19 110.13 31.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 106.539 -1.652 . . . . 1.0700000000000001 106.539 168.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.9 t -79.3 135.9 24.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.55 -0.75 . . . . 1.1399999999999999 109.976 -171.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.401 ' C ' ' HG2' ' A' ' 138' ' ' LYS . 6.6 p -95.43 134.14 38.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.626 0.726 . . . . 2.3399999999999999 111.629 -169.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.518 ' HB2' ' HA ' ' A' ' 138' ' ' LYS . 17.0 t70 -87.92 165.92 14.9 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.716 -1.129 . . . . 2.0800000000000001 108.842 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.0 -26.36 64.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.261 0.553 . . . . 2.4500000000000002 109.702 171.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -93.27 4.5 53.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.614 -0.721 . . . . 1.6499999999999999 110.902 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.39 -61.9 0.62 Allowed Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.363 -0.922 . . . . 1.23 113.938 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.455 ' C ' ' HB2' ' A' ' 133' ' ' ASP . 68.3 m -137.89 129.65 28.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 117.352 0.576 . . . . 1.99 111.349 -173.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.518 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 18.0 mmmt -66.67 -35.51 80.31 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.086 0.47 . . . . 2.0600000000000001 112.045 -172.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.2 -13.22 10.4 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.466 -0.874 . . . . 0.31 113.114 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.508 ' OH ' ' HE2' ' A' ' 138' ' ' LYS . 25.6 p90 -132.34 153.44 50.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.835 0.35 . . . . 1.01 110.907 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.7 173.35 24.02 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.87 -0.605 . . . . 0.13 111.898 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -135.59 143.99 45.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.731 0.265 . . . . 0.31 110.722 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.794 HG11 ' SG ' ' A' ' 128' ' ' CYS . 40.1 t -118.58 136.45 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 1.03 111.142 173.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.1 m170 -106.46 106.38 16.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.19 -0.67 . . . . 0.32000000000000001 109.19 166.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.583 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.5 m-85 -89.4 137.61 32.17 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.329 0.585 . . . . 0.17000000000000001 111.354 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.516 ' HA ' HD21 ' A' ' 126' ' ' LEU . 43.7 tt0 -47.86 -40.25 20.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.19 -1.368 . . . . 0.56999999999999995 110.951 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.1 p -120.3 153.0 37.01 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.276 -0.875 . . . . 1.1100000000000001 110.914 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -67.35 -34.95 78.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 0.46999999999999997 110.453 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 12.1 pt-20 -70.04 -34.74 73.64 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.261 -0.427 . . . . 0.73999999999999999 111.737 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.05 -34.84 77.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.998 0.427 . . . . 1.03 110.649 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.583 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.82 -46.5 84.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.681 -0.691 . . . . 1.05 110.717 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.577 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 40.3 mt-10 -59.18 -37.7 78.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.781 -0.645 . . . . 1.4199999999999999 111.003 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 86.6 mtt180 -59.58 -44.89 93.2 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.983 0.42 . . . . 2.0 110.54 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.79 85.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.984 -0.553 . . . . 1.02 110.452 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 151' ' ' ALA . 78.1 mt -62.76 -54.17 37.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.209 -0.45 . . . . 1.04 111.063 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.3 pt-20 -60.59 -44.04 96.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 1.0800000000000001 111.613 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.431 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -82.04 -39.42 23.52 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.211 0.819 . . . . 1.78 113.211 -170.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 95.4 mmm -92.61 -23.33 19.05 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.618 0.599 . . . . 1.03 112.618 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -66.85 123.49 20.31 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.225 -0.59 . . . . 0.60999999999999999 109.695 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.84 8.57 69.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.912 -0.661 . . . . 0.28999999999999998 112.626 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.609 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 29.2 mmt -96.53 170.75 9.0 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 120.886 0.374 . . . . 1.72 111.541 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 33.3 mt -105.22 126.79 52.48 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.571 -0.74 . . . . 1.1799999999999999 109.377 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 11.5 mt -109.92 108.07 18.22 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.916 -0.772 . . . . 1.1299999999999999 108.916 168.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 4.7 m-20 78.83 -33.75 0.16 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.166 0.916 . . . . 1.71 111.817 176.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.432 ' H ' ' C ' ' A' ' 163' ' ' LEU . 33.4 t70 168.77 -20.87 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.13 -0.941 . . . . 0.84999999999999998 111.754 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.472 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 97.6 mtt180 -100.9 138.67 37.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.714 -0.221 . . . . 1.27 110.504 -174.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 161' ' ' MET . 3.5 ttmp? -83.96 120.6 26.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.414 -0.587 . . . . 1.6499999999999999 109.414 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 17.1 m -102.64 148.98 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.579 0.704 . . . . 1.04 111.615 -174.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 58.4 t80 -107.84 122.42 46.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.862 -1.063 . . . . 0.41999999999999998 109.101 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.444 ' CG1' HD11 ' A' ' 101' ' ' ILE . 47.1 t -115.14 125.42 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.205 -0.665 . . . . 1.03 109.205 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -146.83 -171.46 16.12 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.573 -0.822 . . . . 0.17999999999999999 111.984 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -68.64 136.14 52.51 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.741 -0.466 . . . . 2.3599999999999999 109.741 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.596 ' HE1' ' HB3' ' A' ' 176' ' ' ARG . 4.2 t80 -60.06 103.52 0.23 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.407 -0.36 . . . . 1.4399999999999999 110.624 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -124.95 10.46 8.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.16 -0.473 . . . . 5.1399999999999997 110.212 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.2 m -115.67 89.29 3.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.076 -0.511 . . . . 3.8100000000000001 111.597 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.596 ' HB3' ' HE1' ' A' ' 173' ' ' PHE . 5.8 ptp180 -133.58 154.69 50.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.07 -0.513 . . . . 8.2799999999999994 110.272 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -120.81 -39.01 2.77 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.898 -0.779 . . . . 9.0099999999999998 108.898 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -137.5 158.42 44.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.835 -1.075 . . . . 8.6500000000000004 108.102 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -103.14 65.29 0.86 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.255 -0.578 . . . . 12.789999999999999 112.013 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.58 158.48 23.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.665 -0.865 . . . . 12.699999999999999 108.665 169.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 63.64 24.88 14.11 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.078 0.466 . . . . 13.800000000000001 111.101 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.611 -0.709 . . . . 15.050000000000001 109.175 178.657 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 112.089 -0.404 . . . . 15.130000000000001 112.089 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.03 24.73 5.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.561 0.696 . . . . 13.73 110.011 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.588 ' HB2' ' HG ' ' A' ' 93' ' ' LEU . 12.8 p-10 -102.15 129.1 26.99 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.369 -0.832 . . . . 11.300000000000001 111.149 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.55 -66.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.36 2.04 . . . . 11.93 110.372 170.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 56.2 m -156.68 90.23 1.15 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.53 -0.759 . . . . 9.5199999999999996 109.34 172.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.588 ' HG ' ' HB2' ' A' ' 90' ' ' ASP . 84.4 mt -77.53 128.61 34.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.491 -0.322 . . . . 8.2100000000000009 110.155 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.662 ' HD2' ' HG3' ' A' ' 177' ' ' LYS . 90.0 mtt-85 -107.57 28.73 7.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.41 0.624 . . . . 8.4100000000000001 110.258 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -78.98 80.38 5.32 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.402 -0.962 . . . . 2.6600000000000001 108.402 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.8 m -61.11 -18.09 56.14 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.943 0.72 . . . . 2.3500000000000001 112.943 -171.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.99 -26.24 74.84 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.364 -0.922 . . . . 1.02 111.79 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t 65.87 125.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.673 0.789 . . . . 1.3600000000000001 112.22 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.23 23.99 77.11 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.809 -1.186 . . . . 0.26000000000000001 111.48 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.48 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.1 m120 -88.27 125.96 34.92 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.982 -0.747 . . . . 0.63 108.982 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.509 HG12 ' HB ' ' A' ' 143' ' ' VAL . 22.8 pt -135.4 162.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.096 -0.335 . . . . 1.05 110.096 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.81 140.55 52.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.93 0.395 . . . . 0.26000000000000001 109.991 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 5.8 mt -115.19 141.16 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.626 -0.715 . . . . 1.01 110.033 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.568 ' HZ2' ' HB3' ' A' ' 104' ' ' LYS . 3.0 ttpm? -123.02 148.78 45.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.901 -0.136 . . . . 2.0800000000000001 110.709 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.9 t30 72.43 48.36 0.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.664 0.786 . . . . 0.53000000000000003 111.856 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.53 HD22 HG23 ' A' ' 110' ' ' ILE . 32.3 mt -90.01 160.85 16.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.249 -0.432 . . . . 1.04 110.765 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -93.9 155.57 17.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.70999999999999996 109.988 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.55 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 43.2 pttt -59.93 -28.01 67.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.428 -0.351 . . . . 2.7799999999999998 111.82 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -72.64 -8.47 55.46 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.85 0.315 . . . . 1.8 111.85 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.544 HG21 HG23 ' A' ' 130' ' ' VAL . 30.9 mm -83.83 117.66 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.417 . . . . 1.1000000000000001 110.353 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -108.96 -175.62 2.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.397 -0.964 . . . . 1.5900000000000001 108.397 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -67.09 -30.37 70.38 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.947 -0.76 . . . . 0.92000000000000004 108.947 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -49.54 60.32 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.432 -1.258 . . . . 3.04 109.457 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.71 -39.69 92.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.369 -1.287 . . . . 1.03 110.628 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.608 HD13 HG21 ' A' ' 130' ' ' VAL . 3.6 tt -67.44 -47.5 70.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.322 -0.854 . . . . 1.05 109.113 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.697 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 61.3 t80 -59.52 -46.43 88.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.919 -0.582 . . . . 1.05 110.775 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -56.09 -39.14 71.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.282 -0.417 . . . . 0.40000000000000002 111.137 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.636 HG21 HD22 ' A' ' 163' ' ' LEU . 26.4 m -78.54 -54.25 6.35 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.436 0.532 . . . . 1.02 112.436 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -73.0 -27.2 61.64 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.093 0.775 . . . . 0.14999999999999999 113.093 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.3 t -56.13 -28.84 59.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.818 0.303 . . . . 0.56000000000000005 111.818 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.02 37.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.887 0.328 . . . . 1.04 111.887 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -92.2 -12.86 31.61 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.538 0.199 . . . . 0.20999999999999999 111.538 -176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.2 172.93 28.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.075 -0.583 . . . . 0.14000000000000001 111.646 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -71.84 138.78 48.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.06 0.457 . . . . 0.28999999999999998 110.408 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.413 HG23 ' HB3' ' A' ' 128' ' ' CYS . 72.7 mt -111.92 129.25 67.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.79 -0.641 . . . . 1.0700000000000001 109.862 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.571 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.89 -39.63 15.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.53 0.681 . . . . 1.26 109.188 -178.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 50.8 m -151.58 105.06 3.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.286 -0.87 . . . . 1.1799999999999999 111.034 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 4.6 p -104.1 142.04 35.17 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.35 -0.611 . . . . 1.49 109.35 174.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -143.59 130.94 20.92 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.432 -0.507 . . . . 1.6299999999999999 112.038 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.608 HG21 HD13 ' A' ' 115' ' ' LEU . 57.8 t -114.26 110.66 32.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 106.808 -1.553 . . . . 1.0700000000000001 106.808 170.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t -76.4 120.61 26.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.729 -0.669 . . . . 1.1399999999999999 109.324 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 16.6 p -97.17 134.47 40.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.79 0.805 . . . . 2.3399999999999999 112.926 -165.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -87.28 167.26 14.24 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.618 -1.174 . . . . 2.0800000000000001 108.134 174.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -58.45 -25.67 62.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.039 0.447 . . . . 2.4500000000000002 110.088 172.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -92.13 -1.86 56.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.716 -0.675 . . . . 1.6499999999999999 111.112 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.55 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 137.59 -67.09 0.53 Allowed Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.304 -0.951 . . . . 1.23 113.651 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.639 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 47.3 t -142.45 148.53 37.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.496 0.648 . . . . 1.99 110.767 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -83.02 -5.95 59.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.355 0.597 . . . . 2.0600000000000001 110.435 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.42 -21.12 29.13 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.394 -0.907 . . . . 0.31 113.572 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -128.56 151.88 48.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 117.32 0.56 . . . . 1.01 111.582 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.42 172.14 24.0 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.375 -0.83 . . . . 0.13 111.616 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.464 ' CD1' ' HE2' ' A' ' 173' ' ' PHE . 34.5 m-85 -135.73 138.17 42.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.995 0.398 . . . . 0.31 110.923 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.569 HG13 ' CE2' ' A' ' 145' ' ' PHE . 47.1 t -110.33 133.89 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 120.985 0.421 . . . . 1.03 110.686 172.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.49 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.5 OUTLIER -104.22 105.23 15.31 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.964 -0.754 . . . . 0.32000000000000001 108.964 167.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.569 ' CE2' HG13 ' A' ' 143' ' ' VAL . 14.4 m-85 -89.8 139.53 30.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.048 0.452 . . . . 0.17000000000000001 110.693 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.571 ' HA ' HD22 ' A' ' 126' ' ' LEU . 33.2 tt0 -52.3 -44.06 64.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.749 -1.114 . . . . 0.56999999999999995 110.214 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 63.4 p -111.78 150.47 30.26 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.666 -1.152 . . . . 1.1100000000000001 110.837 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -68.42 -35.55 77.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.968 -0.56 . . . . 0.46999999999999997 110.572 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -69.33 -34.34 74.5 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.237 -0.438 . . . . 0.73999999999999999 111.799 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.89 79.45 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.115 0.483 . . . . 1.03 110.59 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.51 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.64 -45.54 92.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.485 -0.779 . . . . 1.05 110.845 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.0 mt-10 -59.06 -37.4 76.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.95 -0.568 . . . . 1.4199999999999999 110.778 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.3 mtt180 -62.4 -45.59 92.43 Favored 'General case' 0 CA--C 1.523 -0.064 0 CA-C-O 120.986 0.422 . . . . 2.0 110.411 176.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.15 80.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.513 . . . . 1.02 110.517 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 151' ' ' ALA . 89.4 mt -61.68 -54.47 34.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.066 -0.515 . . . . 1.04 111.324 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.1 pt-20 -64.35 -43.16 95.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.329 0.585 . . . . 1.0800000000000001 111.98 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -78.98 -38.42 36.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.23 -0.895 . . . . 1.78 112.773 -169.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.0 mmm -93.1 -24.21 18.35 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.47 0.545 . . . . 1.03 112.47 -175.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -64.75 123.74 20.14 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.464 -0.494 . . . . 0.60999999999999999 109.811 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.24 14.75 61.69 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.869 -0.681 . . . . 0.28999999999999998 112.909 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.592 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.6 mmt -106.83 162.65 13.61 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.523 -0.398 . . . . 1.72 111.792 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.9 mt -98.78 108.76 21.53 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.863 -0.608 . . . . 1.1799999999999999 109.7 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.636 HD22 HG21 ' A' ' 118' ' ' THR . 17.3 mt -93.98 110.02 21.72 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.824 -0.751 . . . . 1.1299999999999999 109.114 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 91.7 m-20 73.01 -67.62 0.26 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.323 -0.853 . . . . 1.71 110.919 -175.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -161.79 14.54 0.09 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.854 -0.612 . . . . 0.84999999999999998 111.491 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -131.34 133.2 45.09 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.813 -0.554 . . . . 1.27 109.889 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 161' ' ' MET . 17.6 ttmt -78.64 119.47 21.95 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.41 -0.589 . . . . 1.6499999999999999 109.41 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 18.9 m -101.57 141.98 17.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.348 0.594 . . . . 1.04 111.183 -173.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -106.74 121.85 45.2 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.07 -0.968 . . . . 0.41999999999999998 109.406 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 155' ' ' ILE . 37.7 t -116.07 125.98 73.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.549 -0.537 . . . . 1.03 109.549 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -140.05 -165.96 10.48 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.651 -0.785 . . . . 0.17999999999999999 112.02 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -77.26 137.81 39.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.834 -0.432 . . . . 2.3599999999999999 109.834 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.464 ' HE2' ' CD1' ' A' ' 142' ' ' PHE . 40.3 t80 -75.85 132.04 40.1 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.425 -0.583 . . . . 1.4399999999999999 109.425 -178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.448 ' HB3' ' NZ ' ' A' ' 174' ' ' LYS . 7.2 mtpm? -53.78 -52.12 61.24 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.373 0.421 . . . . 5.1399999999999997 111.815 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.1 t 72.25 166.95 0.31 Allowed 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.876 0.735 . . . . 3.8100000000000001 110.051 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 177' ' ' LYS . 34.4 mmt180 -81.72 -41.06 21.82 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.087 -0.338 . . . . 8.2799999999999994 110.087 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.662 ' HG3' ' HD2' ' A' ' 94' ' ' ARG . 29.5 tttm 74.17 -37.96 0.38 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.516 0.51 . . . . 9.0099999999999998 112.181 175.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -75.15 29.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.013 0.435 . . . . 8.6500000000000004 111.471 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.477 ' H ' ' C ' ' A' ' 177' ' ' LYS . 22.3 ttt180 -89.57 -11.19 43.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.713 0.768 . . . . 12.789999999999999 108.954 173.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -164.36 106.63 0.89 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.821 -1.081 . . . . 12.699999999999999 109.47 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -81.86 120.04 24.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.975 -0.557 . . . . 13.800000000000001 111.857 -172.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.523 ' HB3' ' NH2' ' A' ' 94' ' ' ARG . 10.3 tp10 . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.305 -0.855 . . . . 15.050000000000001 109.457 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.828 0 N-CA-C 112.087 -0.405 . . . . 15.130000000000001 112.087 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.78 61.54 5.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.382 0.611 . . . . 13.73 109.895 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -159.02 146.19 13.02 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.224 -0.898 . . . . 11.300000000000001 109.332 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -62.2 -62.93 0.1 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.165 1.91 . . . . 11.93 111.888 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.641 ' HB3' ' O ' ' A' ' 175' ' ' SER . 68.4 m -146.1 47.04 1.24 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.995 0.369 . . . . 9.5199999999999996 111.995 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.7 mt -101.57 21.22 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.133 -0.355 . . . . 8.2100000000000009 110.98 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -65.29 -11.94 46.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.762 0.315 . . . . 8.4100000000000001 111.089 176.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.501 ' HB2' ' OG ' ' A' ' 175' ' ' SER . 89.2 tttt -89.71 -13.32 37.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.24 -0.436 . . . . 2.6600000000000001 110.541 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.6 t -84.72 21.31 1.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.289 0.566 . . . . 2.3500000000000001 110.948 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.42 2.63 87.72 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.797 -0.716 . . . . 1.02 111.442 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.8 t 64.62 119.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.802 0.841 . . . . 1.3600000000000001 112.008 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.36 25.51 65.7 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.057 -1.068 . . . . 0.26000000000000001 112.063 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.548 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.2 m120 -89.03 123.84 33.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.232 -0.655 . . . . 0.63 109.232 -172.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.555 HG12 ' HB ' ' A' ' 143' ' ' VAL . 17.3 pt -136.43 164.44 31.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.445 -0.343 . . . . 1.05 110.301 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.55 147.81 49.81 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.925 -0.398 . . . . 0.26000000000000001 109.925 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 5.3 mt -122.18 137.37 55.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.786 -0.643 . . . . 1.01 110.195 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -116.62 151.15 36.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.745 -0.207 . . . . 2.0800000000000001 110.739 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 t30 73.97 38.4 0.58 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.938 0.774 . . . . 0.53000000000000003 111.543 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.404 HD22 HG23 ' A' ' 110' ' ' ILE . 23.2 mt -77.97 158.16 29.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.118 0.485 . . . . 1.04 111.399 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.457 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 20.5 t70 -84.91 151.11 24.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.491 -0.777 . . . . 0.70999999999999996 110.561 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.691 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 14.1 pttm -58.52 -29.99 66.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.751 -0.658 . . . . 2.7799999999999998 112.681 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.5 m -82.84 -3.92 57.4 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.168 0.433 . . . . 1.8 112.168 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.527 HG21 HG22 ' A' ' 130' ' ' VAL . 31.5 mm -73.97 127.44 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.135 0.493 . . . . 1.1000000000000001 110.905 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.7 -178.06 3.3 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.049 -0.723 . . . . 1.5900000000000001 109.049 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.95 -32.43 69.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.889 -0.782 . . . . 0.92000000000000004 108.889 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -47.59 72.15 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.802 -1.09 . . . . 3.04 109.01 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.72 -44.16 97.45 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 114.029 -1.441 . . . . 1.03 110.904 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.625 HD11 HG23 ' A' ' 130' ' ' VAL . 3.8 tt -65.07 -46.63 80.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.985 -0.746 . . . . 1.05 108.985 177.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.629 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 52.7 t80 -59.81 -49.63 76.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.859 -0.61 . . . . 1.05 110.911 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -57.46 -38.69 74.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.394 . . . . 0.40000000000000002 110.774 -174.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.2 m -76.76 -53.65 7.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.881 -0.6 . . . . 1.02 111.507 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.88 -28.24 63.39 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.241 0.459 . . . . 0.14999999999999999 112.241 -175.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 33.7 t -57.62 -29.09 64.25 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.305 0.242 . . . . 0.56000000000000005 111.314 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.55 -22.21 43.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.798 0.332 . . . . 1.04 111.475 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.406 ' CE2' ' HG2' ' A' ' 158' ' ' MET . 22.4 m-85 -90.3 -20.36 23.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.189 0.518 . . . . 0.20999999999999999 110.437 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 165.87 162.21 16.66 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.855 -0.898 . . . . 0.14000000000000001 110.855 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.06 142.98 58.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.192 0.52 . . . . 0.28999999999999998 110.03 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.444 ' HB ' ' CD2' ' A' ' 116' ' ' TYR . 76.5 mt -113.44 134.42 56.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.791 -0.641 . . . . 1.0700000000000001 110.014 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.78 -48.25 7.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.881 -0.785 . . . . 1.26 108.881 -178.24 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.2 m -143.86 102.43 3.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.062 -0.972 . . . . 1.1799999999999999 110.749 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.5 p -102.12 150.91 22.78 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.729 -0.471 . . . . 1.49 109.729 174.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -149.81 131.95 15.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.132 0.491 . . . . 1.6299999999999999 111.304 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.625 HG23 HD11 ' A' ' 115' ' ' LEU . 59.6 t -114.66 110.19 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.868 -1.53 . . . . 1.0700000000000001 106.868 171.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.4 t -77.43 116.53 20.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 109.097 -0.705 . . . . 1.1399999999999999 109.097 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.754 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 25.4 p -100.86 136.39 40.79 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.015 0.746 . . . . 2.3399999999999999 113.015 -163.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -86.63 165.42 16.16 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.843 -1.169 . . . . 2.0800000000000001 107.843 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.0 pm0 -64.47 -21.87 66.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 118.555 0.616 . . . . 2.4500000000000002 110.242 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -90.49 -0.3 57.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.978 -0.555 . . . . 1.6499999999999999 110.71 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.691 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 142.66 -73.41 0.36 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.739 -0.743 . . . . 1.23 113.062 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.754 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 32.2 t -142.08 150.97 41.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.421 0.611 . . . . 1.99 109.965 -177.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -81.9 -10.4 59.3 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.121 0.486 . . . . 2.0600000000000001 110.041 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.81 -14.19 34.74 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.397 -0.906 . . . . 0.31 113.365 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 25.7 p90 -130.04 148.13 51.86 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.485 0.643 . . . . 1.01 111.868 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.55 174.5 23.41 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.154 -0.93 . . . . 0.13 111.379 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -138.86 143.68 38.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.864 0.332 . . . . 0.31 110.504 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.588 HG12 ' CE2' ' A' ' 145' ' ' PHE . 39.6 t -119.0 135.41 59.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.877 0.37 . . . . 1.03 111.043 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.402 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 0.9 OUTLIER -104.49 106.33 16.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.844 -0.799 . . . . 0.32000000000000001 108.844 166.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.588 ' CE2' HG12 ' A' ' 143' ' ' VAL . 11.4 m-85 -89.77 135.37 33.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.21 0.529 . . . . 0.17000000000000001 111.41 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.516 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.8 tt0 -47.29 -44.29 23.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.348 -1.297 . . . . 0.56999999999999995 110.245 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.7 p -115.05 141.3 48.19 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.422 -1.263 . . . . 1.1100000000000001 111.001 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -60.4 -39.71 88.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.52 -0.764 . . . . 0.46999999999999997 111.048 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.1 -33.06 73.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.384 -0.371 . . . . 0.73999999999999999 111.728 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.34 -34.95 77.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.137 0.494 . . . . 1.03 110.423 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.565 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -61.59 -47.86 83.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.466 -0.788 . . . . 1.05 110.527 177.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.592 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.9 mt-10 -59.13 -39.98 84.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.833 -0.621 . . . . 1.4199999999999999 110.889 177.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.469 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 87.1 mtt180 -58.93 -43.46 91.17 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.95 0.405 . . . . 2.0 110.708 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.72 92.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 1.02 110.663 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.45 HG21 ' O ' ' A' ' 170' ' ' VAL . 87.5 mt -61.3 -51.92 67.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.978 -0.555 . . . . 1.04 111.109 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.592 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.5 pt-20 -64.23 -43.58 94.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.085 0.469 . . . . 1.0800000000000001 111.897 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -81.81 -39.47 23.99 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 113.028 0.751 . . . . 1.78 113.028 -169.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.406 ' HG2' ' CE2' ' A' ' 122' ' ' PHE . 93.9 mmm -90.56 -20.73 22.3 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.51 -0.476 . . . . 1.03 112.217 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -64.9 123.99 20.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.102 -0.703 . . . . 0.60999999999999999 109.102 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.95 25.98 43.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.563 -0.827 . . . . 0.28999999999999998 112.95 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.576 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 4.1 mmt -113.56 156.71 23.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.596 0.198 . . . . 1.72 110.791 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 16.7 mt -95.76 110.76 22.86 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 109.552 -0.536 . . . . 1.1799999999999999 109.552 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 21.8 mt -96.86 100.28 11.81 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.706 -0.798 . . . . 1.1299999999999999 109.626 173.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 84.4 m-20 77.49 -25.64 0.2 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.021 -0.99 . . . . 1.71 113.184 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 33.3 t70 170.12 -23.43 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 O-C-N 123.623 0.577 . . . . 0.84999999999999998 111.918 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.457 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 91.2 mtt180 -111.19 135.49 51.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.441 -0.345 . . . . 1.27 110.977 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.1 ttmt -81.81 117.78 22.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.696 -0.684 . . . . 1.6499999999999999 109.23 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.3 m -100.15 147.29 7.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.862 0.839 . . . . 1.04 111.765 -171.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.481 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 52.1 t80 -105.84 119.81 40.11 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.415 -1.266 . . . . 0.41999999999999998 108.915 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.45 ' O ' HG21 ' A' ' 155' ' ' ILE . 41.3 t -114.49 125.34 71.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 1.03 108.82 177.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.72 -170.43 14.51 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.846 -0.692 . . . . 0.17999999999999999 111.62 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -70.08 145.08 51.91 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.996 -0.742 . . . . 2.3599999999999999 108.996 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -53.94 141.17 28.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.21 0.528 . . . . 1.4399999999999999 111.115 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -76.85 12.82 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.767 1.025 . . . . 5.1399999999999997 113.767 -166.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.641 ' O ' ' HB3' ' A' ' 92' ' ' SER . 72.0 p -79.92 3.21 20.59 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.852 -0.53 . . . . 3.8100000000000001 110.84 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -78.22 -1.53 33.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.044 0.45 . . . . 8.2799999999999994 110.306 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -86.11 79.58 9.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.281 0.562 . . . . 9.0099999999999998 110.837 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -139.11 -36.8 0.52 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.095 -1.076 . . . . 8.6500000000000004 108.095 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -124.77 104.84 8.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.512 -1.222 . . . . 12.789999999999999 108.212 171.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -115.1 91.13 3.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.24 0.543 . . . . 12.699999999999999 111.041 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -118.47 33.19 5.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.419 -0.81 . . . . 13.800000000000001 109.466 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--O 1.25 1.104 0 CA-C-N 115.465 -0.789 . . . . 15.050000000000001 109.965 -176.229 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.001 0 N-CA-C 112.447 -0.261 . . . . 15.130000000000001 112.447 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.93 32.33 4.78 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.256 -1.016 . . . . 13.73 108.256 175.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -153.74 144.47 15.98 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 114.35 -1.295 . . . . 11.300000000000001 109.741 -170.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -61.39 -56.76 0.74 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.067 1.845 . . . . 11.93 110.439 171.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.2 t -167.21 91.02 0.38 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.505 -0.77 . . . . 9.5199999999999996 109.953 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 65.1 mt -57.49 140.07 51.61 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.519 -0.548 . . . . 8.2100000000000009 109.519 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 94' ' ' ARG . 13.5 mtp180 -68.8 -29.77 68.21 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.989 0.366 . . . . 8.4100000000000001 111.989 -172.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.552 ' HG2' ' HA ' ' A' ' 174' ' ' LYS . 53.2 mttp 62.93 88.77 0.09 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 123.425 0.453 . . . . 2.6600000000000001 111.014 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.3 p -64.56 -14.12 56.11 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.881 -0.512 . . . . 2.3500000000000001 112.004 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.579 ' C ' HD22 ' A' ' 100' ' ' ASN . . . -74.99 -30.02 59.88 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.89 -0.671 . . . . 1.02 111.459 174.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t 62.61 124.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.149 0.98 . . . . 1.3600000000000001 113.088 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.62 22.61 76.96 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.357 -0.838 . . . . 0.26000000000000001 111.935 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.579 HD22 ' C ' ' A' ' 97' ' ' GLY . 1.2 m120 -85.48 124.69 32.35 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.094 -0.706 . . . . 0.63 109.094 -175.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.567 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.7 pt -135.86 151.96 30.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.71 -0.478 . . . . 1.05 109.71 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.78 ' HB3' ' HB2' ' A' ' 173' ' ' PHE . 0.0 OUTLIER -116.61 137.09 52.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.905 -0.406 . . . . 0.26000000000000001 109.905 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.5 mt -116.0 134.66 58.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.503 -0.771 . . . . 1.01 109.983 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -118.94 151.62 37.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.69 -0.232 . . . . 2.0800000000000001 110.534 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.5 t30 76.91 34.7 0.41 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.045 0.841 . . . . 0.53000000000000003 111.282 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.519 HD22 HG23 ' A' ' 110' ' ' ILE . 22.7 mt -77.06 162.09 27.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.217 -0.447 . . . . 1.04 110.925 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -92.57 152.13 19.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.499 . . . . 0.70999999999999996 110.122 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.43 ' HA ' ' HB2' ' A' ' 137' ' ' SER . 55.5 pttt -57.11 -29.13 63.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.902 -0.59 . . . . 2.7799999999999998 112.16 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.0 m -72.43 -14.96 61.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.427 -0.351 . . . . 1.8 111.741 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.519 HG23 HD22 ' A' ' 106' ' ' LEU . 37.6 mm -76.61 123.18 32.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.2 0.524 . . . . 1.1000000000000001 111.137 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 27.3 t70 -109.31 -177.37 3.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.376 -0.829 . . . . 1.5900000000000001 109.043 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.467 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 88.3 m-20 -71.43 -33.22 69.21 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.79 -0.818 . . . . 0.92000000000000004 108.79 -177.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -46.89 75.09 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.547 -1.206 . . . . 3.04 108.949 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.28 -44.19 97.64 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.973 -1.467 . . . . 1.03 110.83 -179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 130' ' ' VAL . 3.6 tt -64.21 -46.84 82.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.443 -0.799 . . . . 1.05 109.056 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.731 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 41.6 t80 -59.14 -49.25 78.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 1.05 110.573 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -57.0 -37.42 71.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.937 0.399 . . . . 0.40000000000000002 111.22 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.543 HG21 HD21 ' A' ' 163' ' ' LEU . 9.1 m -77.98 -53.58 7.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.138 -0.483 . . . . 1.02 111.832 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.412 ' CD1' HD22 ' A' ' 115' ' ' LEU . 9.9 m-85 -72.97 -27.5 61.85 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.754 0.649 . . . . 0.14999999999999999 112.754 -174.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.0 t -56.89 -28.35 61.8 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.498 0.319 . . . . 0.56000000000000005 111.633 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.95 -22.57 38.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.833 0.349 . . . . 1.04 111.46 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.56 ' HZ ' ' HE2' ' A' ' 157' ' ' LYS . 34.2 m-85 -91.95 -11.72 35.39 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.83 0.348 . . . . 0.20999999999999999 111.086 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.95 169.1 20.47 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.796 -0.522 . . . . 0.14000000000000001 111.796 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -69.17 138.35 54.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.942 0.401 . . . . 0.28999999999999998 110.438 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.407 HG22 ' HB3' ' A' ' 128' ' ' CYS . 76.0 mt -110.17 132.71 57.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.928 -0.578 . . . . 1.0700000000000001 109.988 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.563 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.27 -45.55 11.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.603 -0.888 . . . . 1.26 108.603 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.1 m -144.73 109.27 4.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.103 -0.953 . . . . 1.1799999999999999 110.75 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.731 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.8 p -103.68 138.4 40.37 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.176 -0.676 . . . . 1.49 109.176 172.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.416 ' HZ3' ' HA ' ' A' ' 131' ' ' VAL . 27.4 tptp -136.23 126.9 27.19 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.938 0.399 . . . . 1.6299999999999999 111.078 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.597 HG21 HD11 ' A' ' 115' ' ' LEU . 89.8 t -111.03 109.82 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 105.983 -1.858 . . . . 1.0700000000000001 105.983 168.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.465 HG12 ' HG3' ' A' ' 138' ' ' LYS . 9.0 t -75.16 115.11 16.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.688 -0.856 . . . . 1.1399999999999999 108.688 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.622 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 4.1 p -98.59 135.93 39.41 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.595 -0.729 . . . . 2.3399999999999999 111.396 -169.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -85.89 163.34 18.13 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.432 -0.951 . . . . 2.0800000000000001 108.432 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -57.52 -26.05 60.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.016 0.436 . . . . 2.4500000000000002 110.458 173.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -92.17 -2.61 56.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.107 -0.497 . . . . 1.6499999999999999 110.899 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 143.46 -75.68 0.31 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.54 -0.838 . . . . 1.23 113.695 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 11.1 t -138.78 147.48 42.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.946 0.873 . . . . 1.99 110.942 -175.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.465 ' HG3' HG12 ' A' ' 131' ' ' VAL . 4.8 mmpt? -84.25 -13.74 51.81 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.145 0.498 . . . . 2.0600000000000001 110.487 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 105.35 -14.73 47.24 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.395 -0.907 . . . . 0.31 113.547 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -132.99 158.7 42.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.337 0.568 . . . . 1.01 111.701 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.88 174.77 28.41 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.496 -0.774 . . . . 0.13 112.165 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -138.92 139.02 37.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.666 0.233 . . . . 0.31 110.541 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.567 ' HB ' HG12 ' A' ' 101' ' ' ILE . 47.7 t -111.64 136.52 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.829 0.347 . . . . 1.03 110.651 173.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -106.1 106.05 16.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.119 -0.697 . . . . 0.32000000000000001 109.119 166.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.6 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.5 m-85 -89.02 137.41 32.34 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.125 0.488 . . . . 0.17000000000000001 110.856 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.563 ' HA ' HD21 ' A' ' 126' ' ' LEU . 43.3 tt0 -47.54 -43.95 25.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.348 -1.296 . . . . 0.56999999999999995 110.528 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.9 p -114.57 146.26 40.98 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.642 -1.163 . . . . 1.1100000000000001 111.191 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -62.37 -37.68 86.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.569 -0.741 . . . . 0.46999999999999997 111.191 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.93 -34.32 73.31 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.559 -0.292 . . . . 0.73999999999999999 111.774 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.21 76.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.125 0.488 . . . . 1.03 110.297 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.6 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.53 -44.12 95.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.439 -0.8 . . . . 1.05 110.51 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -59.46 -44.04 93.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.921 -0.582 . . . . 1.4199999999999999 110.214 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -58.55 -39.58 80.63 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.904 0.383 . . . . 2.0 110.641 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.65 84.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 1.02 110.368 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 151' ' ' ALA . 80.4 mt -61.68 -56.24 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.406 -0.361 . . . . 1.04 111.32 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -43.79 77.83 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.23 0.538 . . . . 1.0800000000000001 111.278 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.56 ' HE2' ' HZ ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -83.14 -39.53 20.94 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.517 -0.765 . . . . 1.78 112.541 -169.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 89.6 mmm -91.85 -24.44 19.35 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.527 -0.469 . . . . 1.03 112.028 -172.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -66.78 123.63 20.67 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.424 -0.584 . . . . 0.60999999999999999 109.424 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.6 62.04 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.765 -0.731 . . . . 0.28999999999999998 112.732 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.663 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 29.5 mmt -106.1 166.13 10.72 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 120.74 0.305 . . . . 1.72 111.186 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 20.7 mt -101.25 122.13 43.11 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 109.368 -0.604 . . . . 1.1799999999999999 109.368 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.543 HD21 HG21 ' A' ' 118' ' ' THR . 21.6 mt -107.04 102.15 11.52 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.874 -0.731 . . . . 1.1299999999999999 109.212 170.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 57.5 m-20 78.61 -26.39 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.976 0.798 . . . . 1.71 112.584 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 20.2 t70 165.38 -23.65 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.289 0.636 . . . . 0.84999999999999998 111.332 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -101.68 134.15 45.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.269 -0.423 . . . . 1.27 110.578 -172.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.663 ' HA ' ' O ' ' A' ' 161' ' ' MET . 16.7 ttmt -81.96 118.26 22.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.316 -0.624 . . . . 1.6499999999999999 109.316 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.7 m -101.3 146.95 8.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.568 0.699 . . . . 1.04 111.37 -172.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 72.6 t80 -106.57 120.78 42.84 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.781 -1.1 . . . . 0.41999999999999998 109.186 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.3 t -115.17 124.93 72.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.188 -0.671 . . . . 1.03 109.188 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -142.92 -170.89 13.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.497 -0.859 . . . . 0.17999999999999999 112.47 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -77.38 120.84 22.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.136 0.494 . . . . 2.3599999999999999 110.954 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.78 ' HB2' ' HB3' ' A' ' 102' ' ' PHE . 15.6 t80 -121.27 145.45 47.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.732 -0.667 . . . . 1.4399999999999999 109.27 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.552 ' HA ' ' HG2' ' A' ' 95' ' ' LYS . 44.6 pttt -92.27 -167.1 1.69 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.556 0.217 . . . . 5.1399999999999997 110.855 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 26.1 t -83.21 -36.5 24.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.84 0.352 . . . . 3.8100000000000001 110.708 -175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -110.09 116.49 31.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.36 -0.382 . . . . 8.2799999999999994 109.981 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.66 144.95 55.73 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.685 -0.487 . . . . 9.0099999999999998 109.685 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -161.21 112.28 1.76 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.46 -0.57 . . . . 8.6500000000000004 109.46 -174.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -52.79 109.8 0.45 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.773 0.797 . . . . 12.789999999999999 112.026 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -129.3 122.23 29.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.127 -0.942 . . . . 12.699999999999999 108.764 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 64.85 29.05 12.71 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.561 0.538 . . . . 13.800000000000001 110.868 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.543 -0.741 . . . . 15.050000000000001 109.06 179.817 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 N-CA-C 111.688 -0.565 . . . . 15.130000000000001 111.688 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.55 -47.7 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.966 0.413 . . . . 13.73 110.502 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -161.66 111.14 1.2 Allowed Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.922 -0.581 . . . . 11.300000000000001 109.822 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -69.93 -27.27 25.85 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.079 1.853 . . . . 11.93 113.042 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.6 m -81.76 -43.1 18.85 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.733 0.642 . . . . 9.5199999999999996 112.733 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.573 HD22 ' HB3' ' A' ' 96' ' ' SER . 46.7 tp -97.44 -14.9 20.9 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.833 -0.542 . . . . 8.2100000000000009 110.771 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.42 -92.05 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.616 -0.72 . . . . 8.4100000000000001 110.431 -176.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -138.57 109.39 6.69 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.328 -0.619 . . . . 2.6600000000000001 109.328 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.573 ' HB3' HD22 ' A' ' 93' ' ' LEU . 3.2 p -71.92 -22.2 61.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.708 0.685 . . . . 2.3500000000000001 110.851 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.51 ' C ' HD22 ' A' ' 100' ' ' ASN . . . -64.14 -41.46 98.4 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.743 -0.662 . . . . 1.02 112.286 176.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.1 t 66.35 127.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.469 0.708 . . . . 1.3600000000000001 112.343 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.27 23.08 78.16 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.635 -0.793 . . . . 0.26000000000000001 112.255 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.51 HD22 ' C ' ' A' ' 97' ' ' GLY . 1.2 m120 -85.02 123.96 31.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.377 -0.601 . . . . 0.63 109.377 -176.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.475 HG12 ' HB ' ' A' ' 143' ' ' VAL . 19.5 pt -135.67 163.47 35.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.704 -0.48 . . . . 1.05 109.704 176.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.25 145.18 50.51 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.462 -0.495 . . . . 0.26000000000000001 109.858 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 5.5 mt -118.19 131.64 70.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.642 -0.708 . . . . 1.01 109.863 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -109.21 148.72 30.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.538 -0.301 . . . . 2.0800000000000001 110.66 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.7 t30 70.46 39.93 1.15 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.919 0.762 . . . . 0.53000000000000003 112.148 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.647 HD23 HG21 ' A' ' 110' ' ' ILE . 21.7 mt -73.77 157.36 36.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.081 0.467 . . . . 1.04 111.383 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.54 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 24.5 t70 -81.14 148.98 29.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.381 -0.827 . . . . 0.70999999999999996 111.05 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -52.78 -37.57 59.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.048 -0.978 . . . . 2.7799999999999998 112.419 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.2 m -81.8 -4.74 57.16 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.08 0.4 . . . . 1.8 112.08 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.647 HG21 HD23 ' A' ' 106' ' ' LEU . 28.4 mm -74.47 120.44 23.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.242 0.544 . . . . 1.1000000000000001 110.766 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.402 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 8.1 t70 -109.04 -176.15 2.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.33 -0.85 . . . . 1.5900000000000001 108.882 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -69.4 -33.97 73.82 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.799 -0.815 . . . . 0.92000000000000004 108.799 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -45.98 74.34 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.539 -1.209 . . . . 3.04 108.896 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.402 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.56 -43.8 98.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.687 -1.597 . . . . 1.03 110.646 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.571 HD12 HG21 ' A' ' 130' ' ' VAL . 3.7 tt -65.46 -47.38 76.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.536 -0.756 . . . . 1.05 109.386 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.735 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.6 t80 -59.2 -46.6 88.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.549 . . . . 1.05 110.963 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.93 -40.09 75.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.697 0.284 . . . . 0.40000000000000002 111.087 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 50.9 m -78.46 -53.62 7.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.37 0.508 . . . . 1.02 112.37 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.452 ' CD1' HD21 ' A' ' 115' ' ' LEU . 9.4 m-85 -71.9 -28.09 63.27 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.688 0.625 . . . . 0.14999999999999999 112.688 -173.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.8 t -57.67 -28.96 64.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.539 0.209 . . . . 0.56000000000000005 111.366 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.23 -22.26 39.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.751 0.31 . . . . 1.04 111.645 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -89.84 -20.57 23.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.20999999999999999 111.122 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.4 168.97 30.35 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.584 -0.606 . . . . 0.14000000000000001 111.584 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -68.77 132.59 47.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.28999999999999998 110.092 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.414 HG23 ' HB3' ' A' ' 128' ' ' CYS . 73.5 mt -104.96 126.8 59.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.106 -0.497 . . . . 1.0700000000000001 109.993 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.537 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -83.2 -35.25 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.9 -0.778 . . . . 1.26 108.9 -178.162 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.0 m -159.06 119.63 3.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.129 -0.941 . . . . 1.1799999999999999 110.412 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.735 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.9 p -118.97 142.34 47.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.567 -0.531 . . . . 1.49 109.567 176.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -139.94 132.28 28.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.889 0.376 . . . . 1.6299999999999999 111.485 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.571 HG21 HD12 ' A' ' 115' ' ' LEU . 96.1 t -114.3 109.37 28.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 106.556 -1.646 . . . . 1.0700000000000001 106.556 169.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 t -76.36 117.3 20.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.159 -0.682 . . . . 1.1399999999999999 109.159 -173.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 58.7 m -101.0 137.75 38.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.539 -0.755 . . . . 2.3399999999999999 112.271 -166.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -85.44 162.12 19.12 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.825 -1.176 . . . . 2.0800000000000001 107.825 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.7 pm0 -64.17 -19.67 65.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.284 0.493 . . . . 2.4500000000000002 110.275 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -92.21 -4.3 54.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.992 -0.549 . . . . 1.6499999999999999 110.856 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 146.96 -72.89 0.31 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.402 -0.904 . . . . 1.23 113.935 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.655 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 43.3 t -143.75 147.04 33.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.724 0.762 . . . . 1.99 110.558 -174.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp -87.19 -7.56 57.82 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.111 0.482 . . . . 2.0600000000000001 110.257 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 104.68 -20.85 38.12 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.412 -0.899 . . . . 0.31 113.747 174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -125.03 150.58 46.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 117.3 0.55 . . . . 1.01 111.727 -173.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -140.07 170.94 24.12 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.361 -0.836 . . . . 0.13 111.49 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -135.83 141.05 44.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.927 0.363 . . . . 0.31 110.535 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.522 HG13 ' CE2' ' A' ' 145' ' ' PHE . 30.8 t -115.32 135.49 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 1.03 110.714 173.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.42 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.4 OUTLIER -103.62 106.17 16.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.906 -0.776 . . . . 0.32000000000000001 108.906 166.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.522 ' CE2' HG13 ' A' ' 143' ' ' VAL . 12.6 m-85 -91.44 137.39 32.4 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.15 0.5 . . . . 0.17000000000000001 111.08 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.537 ' HA ' HD21 ' A' ' 126' ' ' LEU . 41.8 tt0 -45.73 -42.23 11.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.206 -1.361 . . . . 0.56999999999999995 111.273 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.7 p -121.05 155.76 33.68 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.182 -0.917 . . . . 1.1100000000000001 110.565 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -67.2 -32.01 72.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.852 -0.613 . . . . 0.46999999999999997 110.206 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 152' ' ' GLU . 10.3 pt-20 -70.67 -34.78 72.36 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.2 -0.455 . . . . 0.73999999999999999 111.964 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 145' ' ' PHE . . . -62.3 -34.85 77.4 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.047 0.451 . . . . 1.03 110.22 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.478 ' O ' HG13 ' A' ' 155' ' ' ILE . . . -63.43 -41.08 98.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.648 -0.705 . . . . 1.05 110.171 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 13.0 mm-40 -58.56 -43.43 89.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.545 -0.752 . . . . 1.4199999999999999 111.303 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.509 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 44.8 mtt180 -64.14 -40.06 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 2.0 110.97 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.79 86.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.522 -0.308 . . . . 1.02 110.46 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 151' ' ' ALA . 81.9 mt -59.54 -51.88 67.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 1.04 111.251 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.1 pt-20 -63.75 -44.65 92.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.006 0.431 . . . . 1.0800000000000001 111.771 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.42 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.06 -39.29 23.66 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.173 0.805 . . . . 1.78 113.173 -168.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 91.5 mmm -91.25 -20.0 22.39 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.224 0.453 . . . . 1.03 112.224 -173.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.02 122.74 19.95 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.049 -0.66 . . . . 0.60999999999999999 109.353 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.71 17.87 61.01 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.599 -0.81 . . . . 0.28999999999999998 112.458 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.462 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -103.63 164.91 11.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.233 -0.654 . . . . 1.72 109.233 176.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 25.7 mt -103.04 132.18 49.5 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.859 -0.793 . . . . 1.1799999999999999 108.859 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 19.7 mt -116.56 104.2 11.17 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 120.226 -0.59 . . . . 1.1299999999999999 109.641 171.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 83.2 m-20 76.44 -27.39 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.129 -0.941 . . . . 1.71 113.063 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 20.5 t70 167.86 -24.5 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 O-C-N 123.938 0.774 . . . . 0.84999999999999998 111.712 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.54 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 94.3 mtt180 -107.2 135.92 47.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.787 0.327 . . . . 1.27 110.852 -171.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 161' ' ' MET . 23.5 tttt -84.3 119.76 25.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.703 -0.68 . . . . 1.6499999999999999 109.207 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.3 m -101.45 151.1 5.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.766 0.793 . . . . 1.04 111.409 -172.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 35.8 t80 -109.93 120.82 43.66 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.665 -1.152 . . . . 0.41999999999999998 109.123 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.439 ' CG1' HD11 ' A' ' 101' ' ' ILE . 42.3 t -115.32 125.72 72.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.28 -0.637 . . . . 1.03 109.28 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.49 -176.76 22.19 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.62 -0.8 . . . . 0.17999999999999999 111.64 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -58.21 142.22 48.21 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.024 -0.732 . . . . 2.3599999999999999 109.024 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.439 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 39.8 t80 -59.65 -20.29 55.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.556 -0.293 . . . . 1.4399999999999999 111.5 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 173' ' ' PHE . 61.3 tttp 76.96 -52.82 0.57 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.495 0.718 . . . . 5.1399999999999997 110.906 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.2 t -106.66 -163.26 0.9 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.372 -0.603 . . . . 3.8100000000000001 109.372 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.521 ' O ' ' HG3' ' A' ' 176' ' ' ARG . 18.2 ptt85 -139.72 91.14 2.45 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.116 -0.698 . . . . 8.2799999999999994 109.116 170.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -92.71 36.14 1.02 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.158 0.504 . . . . 9.0099999999999998 110.036 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.417 ' OE1' ' HB2' ' A' ' 176' ' ' ARG . 0.9 OUTLIER -56.3 126.59 26.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.536 -0.756 . . . . 8.6500000000000004 111.339 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.507 ' HA ' ' HE ' ' A' ' 179' ' ' ARG . 0.3 OUTLIER -104.93 116.95 32.83 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.782 -0.645 . . . . 12.789999999999999 109.705 178.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -128.88 70.33 1.4 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.749 0.785 . . . . 12.699999999999999 109.83 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.85 21.96 2.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.41 -0.814 . . . . 13.800000000000001 111.23 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--O 1.247 0.952 0 CA-C-N 115.597 -0.729 . . . . 15.050000000000001 109.694 178.506 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 111.738 -0.545 . . . . 15.130000000000001 111.738 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.89 163.8 16.95 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.325 -0.25 . . . . 13.73 110.325 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -129.4 103.84 17.91 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.562 0.22 . . . . 11.300000000000001 110.578 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.72 -26.39 60.7 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 121.971 1.781 . . . . 11.93 110.976 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.3 m -91.88 26.24 2.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.351 -0.841 . . . . 9.5199999999999996 110.655 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.546 ' O ' HD21 ' A' ' 93' ' ' LEU . 6.2 tt -69.72 -26.99 64.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.499 -0.926 . . . . 8.2100000000000009 108.499 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.527 ' H ' ' HD2' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -126.44 -178.59 4.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.375 -0.83 . . . . 8.4100000000000001 109.015 175.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -145.7 70.67 1.25 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.885 -0.326 . . . . 2.6600000000000001 111.307 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.4 p -74.17 174.89 8.1 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.475 -0.565 . . . . 2.3500000000000001 109.475 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.49 -48.47 3.66 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.224 -0.988 . . . . 1.02 110.829 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t 65.3 127.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.95 0.9 . . . . 1.3600000000000001 111.987 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.78 24.18 77.01 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.74 -1.219 . . . . 0.26000000000000001 111.634 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.463 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.1 m-80 -85.12 124.02 31.3 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.29 -0.633 . . . . 0.63 109.29 -173.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.559 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.3 pt -135.66 159.98 39.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.015 -0.365 . . . . 1.05 110.015 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.51 143.22 50.79 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.605 -0.517 . . . . 0.26000000000000001 109.605 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.1 mt -118.56 133.81 64.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.854 -0.612 . . . . 1.01 110.37 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -114.25 150.07 34.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.25 -0.432 . . . . 2.0800000000000001 110.318 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 67.99 54.68 0.6 Allowed 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.844 0.715 . . . . 0.53000000000000003 111.63 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.534 HD21 HG22 ' A' ' 110' ' ' ILE . 12.1 mt -89.78 159.53 16.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.614 -0.721 . . . . 1.04 111.264 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.561 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 14.9 t70 -77.75 151.09 34.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.70999999999999996 109.95 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.471 ' HA ' ' OG ' ' A' ' 137' ' ' SER . 24.5 pttm -63.65 -31.88 73.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.617 -0.72 . . . . 2.7799999999999998 111.663 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.4 p -76.41 -4.68 43.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.796 0.331 . . . . 1.8 111.753 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.534 HG22 HD21 ' A' ' 106' ' ' LEU . 40.4 mm -77.26 121.55 29.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.216 0.532 . . . . 1.1000000000000001 110.734 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.466 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 26.9 t70 -108.15 -178.68 3.67 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.751 -0.833 . . . . 1.5900000000000001 108.751 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.466 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 2.8 m-20 -63.48 -38.95 93.09 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.639 -0.875 . . . . 0.92000000000000004 108.639 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.993 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.87 -49.28 78.11 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.006 -0.997 . . . . 3.04 110.359 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.66 98.44 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.296 -1.32 . . . . 1.03 111.412 -178.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.515 HD13 HG22 ' A' ' 130' ' ' VAL . 4.3 tt -64.49 -47.5 78.7 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.198 -0.667 . . . . 1.05 109.198 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.705 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 68.7 t80 -59.84 -46.7 88.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.989 -0.55 . . . . 1.05 110.608 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -57.03 -39.16 74.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.316 -0.402 . . . . 0.40000000000000002 110.989 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.634 HG22 HD22 ' A' ' 163' ' ' LEU . 20.7 m -77.04 -53.39 7.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.047 -0.524 . . . . 1.02 111.681 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -72.52 -29.0 63.21 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.434 0.531 . . . . 0.14999999999999999 112.434 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.3 t -57.97 -28.05 63.99 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.6 0.238 . . . . 0.56000000000000005 111.003 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.49 -22.73 34.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.461 -0.336 . . . . 1.04 111.345 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -93.02 -13.92 28.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.456 -0.338 . . . . 0.20999999999999999 111.099 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.04 169.08 22.88 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.848 -0.692 . . . . 0.14000000000000001 112.137 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -66.23 137.71 57.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.915 0.388 . . . . 0.28999999999999998 110.54 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.482 ' HB ' ' CE1' ' A' ' 116' ' ' TYR . 76.3 mt -113.34 132.34 62.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.739 -0.664 . . . . 1.0700000000000001 109.711 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.546 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -85.89 -42.34 14.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.869 -0.789 . . . . 1.26 108.869 -178.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.8 m -149.34 125.09 10.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.782 -1.099 . . . . 1.1799999999999999 110.279 -177.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.705 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 19.8 p -122.32 151.74 40.83 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.173 -0.677 . . . . 1.49 109.173 174.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -143.14 129.72 20.19 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.627 -0.429 . . . . 1.6299999999999999 111.727 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.515 HG22 HD13 ' A' ' 115' ' ' LEU . 70.8 t -114.87 109.67 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 106.796 -1.557 . . . . 1.0700000000000001 106.796 168.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.419 HG13 ' HG3' ' A' ' 138' ' ' LYS . 5.6 t -77.23 127.08 38.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.775 -0.648 . . . . 1.1399999999999999 109.373 -174.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 18.6 m -96.77 135.97 37.98 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.826 -0.624 . . . . 2.3399999999999999 111.238 -168.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.665 ' HA ' ' HD2' ' A' ' 138' ' ' LYS . 25.5 t70 -85.27 166.32 16.6 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.491 -0.929 . . . . 2.0800000000000001 108.491 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -62.44 -26.16 68.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.4 -0.593 . . . . 2.4500000000000002 109.4 173.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -93.2 4.26 54.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.685 -0.688 . . . . 1.6499999999999999 110.742 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 133.08 -66.11 0.58 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.055 -1.069 . . . . 1.23 114.245 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 108' ' ' LYS . 11.0 p -138.35 131.41 29.94 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 117.42 0.61 . . . . 1.99 111.869 -170.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.665 ' HD2' ' HA ' ' A' ' 133' ' ' ASP . 13.3 mmmt -70.54 -36.83 73.92 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.479 0.657 . . . . 2.0600000000000001 111.028 -176.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.96 -11.26 10.06 Favored Glycine 0 C--N 1.314 -0.679 0 CA-C-N 115.184 -0.917 . . . . 0.31 113.75 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -133.01 156.62 47.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.243 0.521 . . . . 1.01 110.913 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.56 177.22 26.94 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.893 -0.594 . . . . 0.13 112.012 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -140.82 143.75 34.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.867 0.333 . . . . 0.31 111.174 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.575 HG13 ' CE2' ' A' ' 145' ' ' PHE . 38.8 t -119.21 133.04 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.981 0.42 . . . . 1.03 111.154 172.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.7 OUTLIER -103.47 105.82 16.18 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.775 -0.824 . . . . 0.32000000000000001 108.775 165.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.575 ' CE2' HG13 ' A' ' 143' ' ' VAL . 13.7 m-85 -88.19 138.5 31.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.94 0.4 . . . . 0.17000000000000001 111.008 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.546 ' HA ' HD22 ' A' ' 126' ' ' LEU . 26.4 tt0 -48.48 -47.33 38.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.903 -1.044 . . . . 0.56999999999999995 110.433 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 p -109.98 151.65 26.87 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.62 -1.173 . . . . 1.1100000000000001 110.672 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -67.89 -36.14 79.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.959 -0.564 . . . . 0.46999999999999997 110.719 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 14.0 pt-20 -70.04 -35.38 74.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.352 0.501 . . . . 0.73999999999999999 112.352 -176.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.45 -34.89 77.7 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.043 0.449 . . . . 1.03 110.403 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.514 ' O ' HG13 ' A' ' 155' ' ' ILE . . . -63.6 -43.61 96.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.666 -0.697 . . . . 1.05 110.448 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 33.5 mt-10 -58.89 -37.75 77.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 1.4199999999999999 110.722 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 92.2 mtt180 -66.72 -44.31 81.94 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.805 0.336 . . . . 2.0 110.634 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.12 -38.92 90.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 1.02 110.631 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 151' ' ' ALA . 84.4 mt -59.16 -53.99 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 1.04 111.533 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.1 pt-20 -64.91 -44.63 88.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.332 0.587 . . . . 1.0800000000000001 111.967 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.458 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -77.62 -38.27 48.34 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.311 -0.859 . . . . 1.78 112.665 -169.054 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.408 ' O ' ' HB2' ' A' ' 161' ' ' MET . 89.0 mmm -94.09 -17.75 22.5 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.496 -0.482 . . . . 1.03 112.256 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 52.5 t30 -69.66 123.33 21.09 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.919 -0.712 . . . . 0.60999999999999999 109.113 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.61 8.79 79.76 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.687 -0.768 . . . . 0.28999999999999998 112.061 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.7 OUTLIER -91.32 159.63 15.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.725 0.297 . . . . 1.72 110.248 178.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 15.2 mt -104.49 108.23 19.55 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.644 -0.502 . . . . 1.1799999999999999 109.644 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.634 HD22 HG22 ' A' ' 118' ' ' THR . 22.5 mt -93.42 105.75 17.78 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 119.75 -0.78 . . . . 1.1299999999999999 109.395 173.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 73.06 -58.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.165 -0.925 . . . . 1.71 112.474 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -166.97 14.61 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.288 -0.414 . . . . 0.84999999999999998 111.894 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.561 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 92.7 mtt180 -135.54 134.66 39.65 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.713 -0.395 . . . . 1.27 110.423 -175.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.3 tttt -82.18 121.57 26.77 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.707 -0.679 . . . . 1.6499999999999999 109.236 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.04 143.36 14.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.467 0.651 . . . . 1.04 111.3 -173.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.414 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 63.2 t80 -106.32 119.88 40.4 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.231 -0.895 . . . . 0.41999999999999998 109.062 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.43 ' CG1' HD12 ' A' ' 101' ' ' ILE . 43.9 t -115.16 126.57 72.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.234 -0.654 . . . . 1.03 109.234 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.63 -178.91 21.51 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.529 -0.843 . . . . 0.17999999999999999 112.199 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -67.39 126.78 30.36 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.226 -0.287 . . . . 2.3599999999999999 110.226 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.882 ' HD1' ' H ' ' A' ' 175' ' ' SER . 4.6 t80 -66.15 138.5 57.75 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.423 -0.954 . . . . 1.4399999999999999 108.423 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -69.86 -11.36 60.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.679 0.622 . . . . 5.1399999999999997 112.679 -173.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.882 ' H ' ' HD1' ' A' ' 173' ' ' PHE . 67.0 m 60.76 88.65 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.617 0.722 . . . . 3.8100000000000001 111.225 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -145.75 -66.03 0.31 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.393 -0.821 . . . . 8.2799999999999994 110.132 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.593 ' HE3' ' HG2' ' A' ' 182' ' ' GLU . 2.6 tmmm? -94.61 129.91 41.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.732 -0.47 . . . . 9.0099999999999998 109.732 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.505 ' N ' ' HD2' ' A' ' 177' ' ' LYS . 9.1 pt-20 -165.95 104.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.152 -0.684 . . . . 8.6500000000000004 109.152 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -119.85 -75.2 0.59 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.946 0.403 . . . . 12.789999999999999 111.706 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -145.71 105.37 3.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.033 -0.531 . . . . 12.699999999999999 109.963 -171.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 56.48 23.63 7.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.318 0.58 . . . . 13.800000000000001 110.601 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.593 ' HG2' ' HE3' ' A' ' 177' ' ' LYS . 33.7 tt0 . . . . . 0 C--O 1.247 0.928 0 CA-C-N 115.348 -0.842 . . . . 15.050000000000001 108.793 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 111.454 -0.659 . . . . 15.130000000000001 111.454 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.62 -42.22 18.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.748 0.309 . . . . 13.73 110.787 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.432 ' HB2' ' HG ' ' A' ' 93' ' ' LEU . 2.0 p-10 -148.41 138.32 12.69 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.253 -0.431 . . . . 11.300000000000001 110.302 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.03 45.05 1.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.661 2.241 . . . . 11.93 111.482 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 m 69.66 76.28 0.22 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.24 -0.891 . . . . 9.5199999999999996 110.362 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' ' 90' ' ' ASP . 79.3 mt -94.48 -42.41 8.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.37 -0.832 . . . . 8.2100000000000009 110.575 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 53.73 -166.24 0.08 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.962 -0.563 . . . . 8.4100000000000001 111.7 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -116.55 20.2 14.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.539 0.685 . . . . 2.6600000000000001 109.613 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.3 m -68.49 -11.23 59.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.336 -0.847 . . . . 2.3500000000000001 111.62 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.09 -31.71 75.45 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.053 -0.594 . . . . 1.02 112.213 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 59.22 135.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.325 1.05 . . . . 1.3600000000000001 112.587 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.1 23.0 78.63 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.84 -1.172 . . . . 0.26000000000000001 110.739 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.499 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.2 m120 -94.23 127.49 40.12 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.931 -0.766 . . . . 0.63 108.931 -174.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.564 HG12 ' HB ' ' A' ' 143' ' ' VAL . 27.4 pt -134.51 161.36 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.277 -0.268 . . . . 1.05 110.277 177.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.96 143.24 50.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.938 -0.393 . . . . 0.26000000000000001 109.938 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 8.7 mt -116.6 146.73 20.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.756 -0.656 . . . . 1.01 109.953 -178.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.513 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 44.8 tttp -129.61 147.91 51.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.288 -0.415 . . . . 2.0800000000000001 110.342 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.8 t30 64.81 47.7 2.64 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.549 0.74 . . . . 0.53000000000000003 111.954 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.663 HD22 HG22 ' A' ' 110' ' ' ILE . 23.0 mt -80.07 151.84 29.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.167 0.508 . . . . 1.04 111.447 176.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.531 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 17.9 t70 -77.97 150.95 33.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.476 -0.784 . . . . 0.70999999999999996 111.313 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.534 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 22.3 pttp -51.7 -38.64 55.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.137 -0.938 . . . . 2.7799999999999998 112.946 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.3 m -85.09 -4.24 59.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.054 0.39 . . . . 1.8 112.054 -173.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.663 HG22 HD22 ' A' ' 106' ' ' LEU . 33.5 mm -71.88 116.21 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.099 0.476 . . . . 1.1000000000000001 110.23 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -103.72 -179.36 3.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.637 -0.875 . . . . 1.5900000000000001 108.637 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -63.96 -37.25 86.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.736 -0.839 . . . . 0.92000000000000004 108.736 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 1.062 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -61.37 -49.66 76.02 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.168 -0.924 . . . . 3.04 110.712 178.2 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.3 99.12 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.194 -1.366 . . . . 1.03 111.068 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.629 HD12 HG21 ' A' ' 130' ' ' VAL . 3.8 tt -63.94 -47.87 78.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.419 -0.81 . . . . 1.05 109.105 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.641 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 51.5 t80 -58.69 -48.45 81.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.869 -0.605 . . . . 1.05 110.914 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.3 -38.82 74.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.938 0.399 . . . . 0.40000000000000002 110.59 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.6 m -77.47 -54.17 6.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.148 -0.478 . . . . 1.02 111.875 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.422 ' CD1' HD22 ' A' ' 115' ' ' LEU . 7.2 m-85 -72.19 -27.87 62.84 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.248 0.462 . . . . 0.14999999999999999 112.248 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 28.7 t -57.41 -28.03 62.91 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 111.629 0.233 . . . . 0.56000000000000005 111.629 -177.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.83 -22.88 39.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.016 0.436 . . . . 1.04 111.345 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -90.19 -22.29 21.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.113 -0.494 . . . . 0.20999999999999999 110.777 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 169.36 169.02 32.16 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.89 -0.595 . . . . 0.14000000000000001 111.784 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -70.65 139.55 51.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.018 0.437 . . . . 0.28999999999999998 109.893 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 74.1 mt -112.88 131.93 63.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.907 -0.588 . . . . 1.0700000000000001 110.024 -177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.528 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -88.5 -41.06 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.922 -0.77 . . . . 1.26 108.922 -177.8 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 72.1 m -147.7 119.6 8.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.163 -0.926 . . . . 1.1799999999999999 110.314 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.641 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 9.2 p -117.53 144.95 44.59 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.526 -0.546 . . . . 1.49 109.526 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -142.19 129.3 20.89 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.67 -0.412 . . . . 1.6299999999999999 111.503 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.629 HG21 HD12 ' A' ' 115' ' ' LEU . 61.2 t -115.55 110.7 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 106.848 -1.538 . . . . 1.0700000000000001 106.848 170.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t -80.25 115.39 22.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.848 -0.797 . . . . 1.1399999999999999 108.848 -175.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.72 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 7.7 p -99.29 135.74 40.26 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.211 0.819 . . . . 2.3399999999999999 113.211 -164.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -86.89 163.88 16.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.771 -1.104 . . . . 2.0800000000000001 108.923 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.09 -29.59 60.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.735 0.302 . . . . 2.4500000000000002 111.065 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -88.94 -5.89 57.66 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.934 0.397 . . . . 1.6499999999999999 110.944 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 149.03 -74.01 0.28 Allowed Glycine 0 C--O 1.225 -0.442 0 C-N-CA 120.484 -0.865 . . . . 1.23 112.95 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.72 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 42.5 t -138.75 145.92 40.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.621 0.71 . . . . 1.99 110.335 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -77.49 -11.74 59.88 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.383 0.611 . . . . 2.0600000000000001 109.808 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 111.47 -19.24 24.4 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.177 -0.92 . . . . 0.31 113.324 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -126.07 149.37 48.94 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 121.855 -0.791 . . . . 1.01 111.874 -173.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.86 174.81 24.1 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.077 -0.965 . . . . 0.13 111.348 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -141.57 137.44 31.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.019 0.41 . . . . 0.31 110.615 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.564 ' HB ' HG12 ' A' ' 101' ' ' ILE . 43.2 t -112.88 133.68 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.081 0.467 . . . . 1.03 111.147 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.1 m170 -103.12 105.91 16.31 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.626 -0.715 . . . . 0.32000000000000001 109.143 166.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 12.5 m-85 -88.79 142.55 27.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.261 0.553 . . . . 0.17000000000000001 110.751 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.528 ' HA ' HD22 ' A' ' 126' ' ' LEU . 42.8 tt0 -51.67 -38.32 54.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.277 -1.329 . . . . 0.56999999999999995 110.542 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.6 p -125.32 150.38 47.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.307 -0.86 . . . . 1.1100000000000001 111.443 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -60.65 -37.76 82.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.603 -0.726 . . . . 0.46999999999999997 111.24 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.6 pt-20 -67.82 -35.38 78.5 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.56 -0.291 . . . . 0.73999999999999999 111.645 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.53 78.35 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.21 0.529 . . . . 1.03 110.278 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.586 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.56 -46.57 85.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.339 -0.846 . . . . 1.05 110.565 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.504 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 42.6 mt-10 -58.96 -40.19 83.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 1.4199999999999999 110.526 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.519 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 88.8 mtt180 -58.96 -44.76 91.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.005 0.431 . . . . 2.0 110.719 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.4 94.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.968 -0.56 . . . . 1.02 110.598 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.505 HG13 ' O ' ' A' ' 151' ' ' ALA . 88.6 mt -58.97 -53.56 46.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.889 -0.596 . . . . 1.04 111.401 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 0.6 OUTLIER -63.64 -41.83 98.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.091 0.472 . . . . 1.0800000000000001 111.808 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.415 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -81.8 -39.98 23.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.681 -0.691 . . . . 1.78 112.82 -169.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 91.3 mmm -91.24 -19.12 23.36 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.262 0.468 . . . . 1.03 112.262 -173.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -66.54 122.78 18.35 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.396 -0.521 . . . . 0.60999999999999999 109.826 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.48 26.81 37.87 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.91 -0.662 . . . . 0.28999999999999998 113.01 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.698 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 74.5 mmm -112.64 157.06 21.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.958 0.379 . . . . 1.72 110.891 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.476 HD21 ' N ' ' A' ' 167' ' ' LYS . 19.6 mt -94.15 102.38 14.42 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.002 -0.74 . . . . 1.1799999999999999 109.002 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 16.7 mt -83.91 101.47 11.7 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 119.278 -0.969 . . . . 1.1299999999999999 108.645 172.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 98.8 m-20 73.94 -70.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.856 -1.065 . . . . 1.71 111.467 -175.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -147.2 -0.57 0.68 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.425 -0.807 . . . . 0.84999999999999998 112.192 -173.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.531 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 91.6 mtt180 -132.1 128.76 38.84 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.955 -0.466 . . . . 1.27 110.473 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.698 ' HA ' ' O ' ' A' ' 161' ' ' MET . 13.3 tttt -76.45 122.04 23.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.849 -0.614 . . . . 1.6499999999999999 109.35 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 16.0 m -101.18 140.06 20.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.391 0.615 . . . . 1.04 111.056 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -106.08 121.7 44.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.18 -0.918 . . . . 0.41999999999999998 108.871 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.436 HG11 HD13 ' A' ' 101' ' ' ILE . 39.6 t -115.88 130.15 71.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.976 -0.557 . . . . 1.03 109.565 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -142.87 -165.37 10.59 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.773 -0.727 . . . . 0.17999999999999999 111.949 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.678 ' HB2' ' HE3' ' A' ' 174' ' ' LYS . 16.4 mmt180 -75.57 134.49 40.7 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.61 -0.515 . . . . 2.3599999999999999 109.61 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -63.73 -61.81 2.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 1.4399999999999999 111.193 -174.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.678 ' HE3' ' HB2' ' A' ' 172' ' ' ARG . 81.9 mttt 70.24 -58.78 0.53 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.802 0.689 . . . . 5.1399999999999997 111.022 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.3 p 168.72 -67.83 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.617 -1.253 . . . . 3.8100000000000001 107.617 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -160.8 15.9 0.12 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.77 -1.559 . . . . 8.2799999999999994 108.011 172.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 182' ' ' GLU . 58.5 tttm -82.0 52.37 1.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.391 -1.277 . . . . 9.0099999999999998 111.438 -169.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.737 ' HG3' ' HB3' ' A' ' 182' ' ' GLU . 29.0 tt0 -159.73 13.43 0.14 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.751 0.786 . . . . 8.6500000000000004 109.006 171.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -79.0 94.08 5.22 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.161 -0.927 . . . . 12.789999999999999 109.129 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 71.63 -44.53 0.59 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.825 0.703 . . . . 12.699999999999999 111.263 -174.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -123.35 128.41 49.86 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.67 -0.492 . . . . 13.800000000000001 109.67 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' A' ' 178' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 119.151 -0.452 . . . . 15.050000000000001 110.901 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.792 0 N-CA-C 112.426 -0.27 . . . . 15.130000000000001 112.426 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.96 -19.21 60.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.101 0.477 . . . . 13.73 110.767 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.544 ' HB2' ' HG ' ' A' ' 93' ' ' LEU . 7.5 p-10 -93.85 142.97 25.76 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.508 -0.769 . . . . 11.300000000000001 109.848 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.43 -55.71 1.67 Allowed 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.22 1.947 . . . . 11.93 110.829 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.3 p -170.9 86.72 0.1 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.589 -0.732 . . . . 9.5199999999999996 110.712 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.544 ' HG ' ' HB2' ' A' ' 90' ' ' ASP . 91.0 mt -75.63 128.67 35.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.377 -0.601 . . . . 8.2100000000000009 109.377 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -58.53 -49.49 77.2 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 111.591 0.219 . . . . 8.4100000000000001 111.591 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -151.23 -0.47 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.132 0.492 . . . . 2.6600000000000001 110.606 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.1 m -80.74 0.28 35.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.54 . . . . 2.3500000000000001 110.514 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -65.27 -26.9 71.86 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.611 -0.722 . . . . 1.02 112.153 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.2 t 69.07 124.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.466 0.706 . . . . 1.3600000000000001 111.923 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.18 23.05 78.36 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.481 -0.866 . . . . 0.26000000000000001 111.856 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 143' ' ' VAL . 1.8 m120 -89.32 126.2 35.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.335 -0.617 . . . . 0.63 109.335 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.497 HG12 ' HB ' ' A' ' 143' ' ' VAL . 22.0 pt -134.65 163.37 36.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.734 -0.666 . . . . 1.05 109.547 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.07 146.45 50.36 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.564 -0.455 . . . . 0.26000000000000001 109.817 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 4.2 mt -118.22 138.37 49.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.688 -0.687 . . . . 1.01 109.714 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -120.85 152.78 37.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.691 -0.231 . . . . 2.0800000000000001 110.4 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.8 t30 70.57 41.07 0.98 Allowed 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.818 0.699 . . . . 0.53000000000000003 111.699 172.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.529 HD22 HG21 ' A' ' 110' ' ' ILE . 20.0 mt -79.4 164.83 23.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.217 0.532 . . . . 1.04 111.907 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.466 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.8 t70 -89.01 155.55 19.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.406 -0.815 . . . . 0.70999999999999996 110.799 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.686 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 20.0 pttp -59.99 -36.68 77.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.228 -0.442 . . . . 2.7799999999999998 111.724 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.431 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 16.7 m -80.85 -3.21 50.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.243 -0.435 . . . . 1.8 111.891 -173.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.529 HG21 HD22 ' A' ' 106' ' ' LEU . 34.5 mm -76.02 118.53 22.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 1.1000000000000001 110.254 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -108.66 -175.52 2.79 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.128 -0.693 . . . . 1.5900000000000001 109.128 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -69.39 -32.76 71.99 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.081 -0.711 . . . . 0.92000000000000004 109.081 -176.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -67.13 -48.47 67.97 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.54 -1.209 . . . . 3.04 109.253 178.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.2 -41.42 96.78 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.198 -1.365 . . . . 1.03 110.83 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.603 HD13 HG23 ' A' ' 130' ' ' VAL . 3.8 tt -66.98 -47.66 70.86 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.039 -0.726 . . . . 1.05 109.039 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.678 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.6 t80 -59.38 -46.45 88.62 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.933 -0.576 . . . . 1.05 110.81 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.3 -41.08 75.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.09 0.471 . . . . 0.40000000000000002 110.978 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.437 HG22 HD22 ' A' ' 163' ' ' LEU . 18.0 m -77.07 -52.76 8.76 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.787 -0.642 . . . . 1.02 111.691 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.425 ' CD1' HD21 ' A' ' 115' ' ' LEU . 10.6 m-85 -72.69 -28.24 62.57 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.638 0.607 . . . . 0.14999999999999999 112.638 -175.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.8 t -57.3 -28.8 63.35 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.563 0.221 . . . . 0.56000000000000005 111.388 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.57 -24.13 45.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.896 0.379 . . . . 1.04 111.226 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -89.17 -18.18 27.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.20999999999999999 111.408 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.44 173.55 32.27 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.033 -0.604 . . . . 0.14000000000000001 112.024 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -69.46 135.37 50.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.914 0.387 . . . . 0.28999999999999998 110.33 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 70.8 mt -110.67 124.29 67.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.217 -0.447 . . . . 1.0700000000000001 110.597 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.525 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -79.97 -36.37 36.21 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.777 -0.823 . . . . 1.26 108.777 -176.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.4 m -154.97 141.49 18.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.86 -1.063 . . . . 1.1799999999999999 109.694 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.6 p -143.5 135.42 26.62 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.803 -0.443 . . . . 1.49 109.803 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -140.76 133.25 28.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.112 0.482 . . . . 1.6299999999999999 111.887 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.603 HG23 HD13 ' A' ' 115' ' ' LEU . 78.1 t -114.26 117.46 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 N-CA-C 106.717 -1.586 . . . . 1.0700000000000001 106.717 169.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 t -86.48 115.82 28.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.811 -0.811 . . . . 1.1399999999999999 108.811 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 60.2 m -109.85 139.54 44.81 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.024 0.75 . . . . 2.3399999999999999 113.024 -164.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -85.31 160.2 19.87 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.938 -1.028 . . . . 2.0800000000000001 108.439 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -58.51 -22.8 56.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.913 0.387 . . . . 2.4500000000000002 110.774 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -92.41 4.14 54.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.072 -0.513 . . . . 1.6499999999999999 110.673 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.686 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 140.25 -75.52 0.35 Allowed Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.763 -0.732 . . . . 1.23 113.443 177.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.741 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 30.7 t -144.07 156.33 44.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.753 0.777 . . . . 1.99 110.312 -176.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -89.21 -11.39 43.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.383 0.611 . . . . 2.0600000000000001 109.494 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 110.81 -21.54 22.94 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.37 -0.832 . . . . 0.31 113.742 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -122.6 152.39 40.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 117.421 0.611 . . . . 1.01 112.208 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.67 175.25 24.47 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.01 -0.996 . . . . 0.13 111.438 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -140.52 142.24 35.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.088 0.444 . . . . 0.31 111.113 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.531 HG11 ' CE2' ' A' ' 145' ' ' PHE . 39.2 t -119.53 135.55 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-O 121.009 0.433 . . . . 1.03 110.873 172.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -104.9 106.22 16.61 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.985 -0.746 . . . . 0.32000000000000001 108.985 166.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.546 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.7 m-85 -90.1 137.34 32.42 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.022 0.439 . . . . 0.17000000000000001 110.993 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.525 ' HA ' HD22 ' A' ' 126' ' ' LEU . 38.8 tt0 -45.81 -43.83 13.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.42 -1.264 . . . . 0.56999999999999995 111.021 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.3 p -116.8 153.39 32.54 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.266 -0.879 . . . . 1.1100000000000001 110.33 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -64.61 -36.95 85.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.939 -0.573 . . . . 0.46999999999999997 110.303 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 13.4 pt-20 -70.35 -34.37 72.56 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.035 -0.529 . . . . 0.73999999999999999 112.293 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.72 -35.76 77.14 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.981 0.42 . . . . 1.03 110.52 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.546 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.82 -42.51 97.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.742 -0.663 . . . . 1.05 110.502 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.6 mt-10 -59.85 -40.55 88.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.884 -0.598 . . . . 1.4199999999999999 110.437 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.483 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 61.5 mtt180 -60.1 -42.09 93.93 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.455 0.472 . . . . 2.0 110.861 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.35 -39.41 85.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 1.02 110.693 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 151' ' ' ALA . 88.2 mt -58.94 -53.61 45.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.119 -0.491 . . . . 1.04 111.075 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.603 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.5 pt-20 -60.41 -45.36 93.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.926 0.394 . . . . 1.0800000000000001 111.796 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.461 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -80.93 -38.98 26.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.979 0.733 . . . . 1.78 112.979 -169.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.449 ' O ' ' HB2' ' A' ' 161' ' ' MET . 95.1 mmm -95.23 -17.84 21.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.67 0.619 . . . . 1.03 112.67 -171.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -70.12 122.09 18.77 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.683 -0.807 . . . . 0.60999999999999999 109.187 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.79 23.55 55.52 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.602 -0.809 . . . . 0.28999999999999998 112.178 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.612 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.8 OUTLIER -102.92 158.73 16.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.532 0.206 . . . . 1.72 110.536 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.403 HD21 ' HA ' ' A' ' 162' ' ' LEU . 21.7 mt -102.68 98.13 8.21 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.416 -0.356 . . . . 1.1799999999999999 110.128 -178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 18.6 mt -85.83 107.81 17.84 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 120.041 -0.664 . . . . 1.1299999999999999 109.363 175.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 98.2 m-20 74.32 -61.86 0.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.164 -0.926 . . . . 1.71 111.599 -176.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -172.26 25.23 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.552 -0.749 . . . . 0.84999999999999998 110.658 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.466 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.2 mtt180 -137.82 129.55 28.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.396 -0.366 . . . . 1.27 110.053 -178.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.612 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.9 tttt -79.89 118.88 22.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.82 -0.627 . . . . 1.6499999999999999 109.377 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.3 m -102.33 150.78 6.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.294 0.569 . . . . 1.04 111.668 -173.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 64.7 t80 -106.59 120.57 42.29 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.277 -0.874 . . . . 0.41999999999999998 109.278 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.474 ' CG1' HD13 ' A' ' 101' ' ' ILE . 45.4 t -115.44 125.78 72.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.27 -0.641 . . . . 1.03 109.27 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.48 -174.29 20.06 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.708 -0.758 . . . . 0.17999999999999999 111.404 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -60.75 138.61 58.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.796 -0.816 . . . . 2.3599999999999999 108.796 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -50.35 111.74 0.58 Allowed 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.597 -0.52 . . . . 1.4399999999999999 109.597 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -79.08 81.77 5.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.762 -0.654 . . . . 5.1399999999999997 110.795 -172.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 12.4 p -130.6 84.56 2.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.441 -0.8 . . . . 3.8100000000000001 110.13 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -129.02 140.19 51.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.098 -0.501 . . . . 8.2799999999999994 110.969 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -136.14 163.63 29.9 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.563 -0.903 . . . . 9.0099999999999998 108.563 175.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -85.7 41.22 0.89 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.009 0.433 . . . . 8.6500000000000004 109.834 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 34.4 ttp85 -67.8 113.51 5.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.97 -0.559 . . . . 12.789999999999999 110.037 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -97.69 -22.46 16.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.734 -0.666 . . . . 12.699999999999999 110.148 -175.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -89.19 133.0 34.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.722 -0.672 . . . . 13.800000000000001 110.608 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.505 -0.76 . . . . 15.050000000000001 109.506 -179.731 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.667 0 N-CA-C 111.598 -0.601 . . . . 15.130000000000001 111.598 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.36 62.49 5.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.342 0.591 . . . . 13.73 110.243 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -145.54 138.08 13.68 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.679 -0.691 . . . . 11.300000000000001 110.066 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.53 61.72 5.3 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.581 2.187 . . . . 11.93 111.425 172.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 p 49.36 70.47 0.48 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.545 -0.752 . . . . 9.5199999999999996 110.884 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 83.7 mt -104.77 134.95 47.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.902 -0.59 . . . . 8.2100000000000009 110.452 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 66.29 -79.91 0.03 OUTLIER 'General case' 0 C--N 1.344 0.347 0 C-N-CA 123.069 0.548 . . . . 8.4100000000000001 109.594 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.443 ' HD3' ' HB3' ' A' ' 173' ' ' PHE . 1.3 mtmm 177.67 33.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.788 0.835 . . . . 2.6600000000000001 109.308 171.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.2 t -63.39 -15.66 58.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.368 -0.833 . . . . 2.3500000000000001 111.29 -175.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.14 -24.42 60.9 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.957 -0.639 . . . . 1.02 112.021 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.8 t 63.76 128.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.729 0.812 . . . . 1.3600000000000001 112.44 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.02 23.81 77.11 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.963 -1.113 . . . . 0.26000000000000001 111.012 -179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.505 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.2 m120 -89.62 124.97 35.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.009 -0.737 . . . . 0.63 109.009 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.552 HG12 ' HB ' ' A' ' 143' ' ' VAL . 22.9 pt -135.62 163.41 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.545 -0.298 . . . . 1.05 110.242 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.38 146.47 48.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.882 0.372 . . . . 0.26000000000000001 110.054 176.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.8 mt -124.48 144.92 32.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.765 -0.652 . . . . 1.01 109.788 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -129.94 156.42 44.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.46 0.171 . . . . 2.0800000000000001 111.073 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.7 t30 71.54 36.12 1.34 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.044 0.938 . . . . 0.53000000000000003 111.357 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.565 HD21 HG23 ' A' ' 110' ' ' ILE . 31.7 mt -76.59 143.36 40.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.187 -0.461 . . . . 1.04 110.779 175.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.44 151.28 41.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.706 -0.679 . . . . 0.70999999999999996 110.923 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -52.84 -32.77 46.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.499 -0.773 . . . . 2.7799999999999998 112.321 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -80.45 -7.47 59.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.006 0.372 . . . . 1.8 112.006 -175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.565 HG23 HD21 ' A' ' 106' ' ' LEU . 28.2 mm -76.07 127.38 37.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.078 0.466 . . . . 1.1000000000000001 110.928 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -115.64 -179.25 3.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.536 -0.756 . . . . 1.5900000000000001 109.026 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -65.71 -36.39 83.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.507 -0.553 . . . . 0.92000000000000004 109.507 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.998 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.98 -49.63 76.68 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.862 0.839 . . . . 3.04 109.986 178.057 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.6 98.56 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.771 -1.559 . . . . 1.03 111.315 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.629 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -64.76 -47.18 79.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.973 -0.751 . . . . 1.05 108.973 177.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.732 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 55.6 t80 -58.65 -49.1 78.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 1.05 111.127 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.68 -37.51 73.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.863 0.363 . . . . 0.40000000000000002 110.922 -174.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.672 HG21 HD22 ' A' ' 163' ' ' LEU . 6.7 m -78.29 -53.9 6.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.521 . . . . 1.02 111.823 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CD1' HD21 ' A' ' 115' ' ' LEU . 21.2 m-85 -72.01 -28.29 63.29 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.31 0.485 . . . . 0.14999999999999999 112.31 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.9 t -57.82 -27.53 63.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.529 0.204 . . . . 0.56000000000000005 111.51 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.58 -21.83 29.41 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.762 0.315 . . . . 1.04 111.736 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -93.12 -9.78 38.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.20999999999999999 110.932 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.29 161.46 10.85 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.743 -0.662 . . . . 0.14000000000000001 111.665 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -61.24 132.23 52.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.24 0.543 . . . . 0.28999999999999998 110.363 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.417 ' HB ' ' CD1' ' A' ' 116' ' ' TYR . 76.8 mt -100.84 134.9 39.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.62 -0.718 . . . . 1.0700000000000001 109.715 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.498 HD12 ' HA ' ' A' ' 146' ' ' GLU . 19.9 mt -89.66 -39.14 13.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.847 0.832 . . . . 1.26 108.867 -176.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.7 m -155.95 129.42 8.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.496 -1.229 . . . . 1.1799999999999999 109.502 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.732 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 8.5 p -123.84 149.71 45.43 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.192 -0.67 . . . . 1.49 109.192 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -148.51 128.02 13.17 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.308 -0.557 . . . . 1.6299999999999999 111.704 -177.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.629 HG22 HD12 ' A' ' 115' ' ' LEU . 59.7 t -111.31 109.59 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 106.195 -1.78 . . . . 1.0700000000000001 106.195 169.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.47 HG11 ' HG3' ' A' ' 138' ' ' LYS . 14.8 t -74.44 116.52 17.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.714 -0.847 . . . . 1.1399999999999999 108.714 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 62.9 m -96.59 135.95 37.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.702 -0.681 . . . . 2.3399999999999999 111.666 -166.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -86.28 161.4 18.78 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.144 -1.058 . . . . 2.0800000000000001 108.144 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -56.58 -28.79 61.06 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.084 0.468 . . . . 2.4500000000000002 110.028 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -92.24 1.06 57.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 1.6499999999999999 110.899 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 139.08 -73.08 0.42 Allowed Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.371 -0.919 . . . . 1.23 114.003 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 34.5 t -137.58 140.14 40.81 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.934 0.867 . . . . 1.99 111.379 -174.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.47 ' HG3' HG11 ' A' ' 131' ' ' VAL . 3.9 mmpt? -79.01 -9.92 59.68 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.275 0.56 . . . . 2.0600000000000001 110.089 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 103.26 -22.05 37.64 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.393 -0.822 . . . . 0.31 113.361 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -126.04 152.94 45.12 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.424 0.612 . . . . 1.01 111.811 -173.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.65 174.64 26.43 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.352 -0.84 . . . . 0.13 111.619 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -139.97 136.88 34.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.947 0.374 . . . . 0.31 110.862 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.552 ' HB ' HG12 ' A' ' 101' ' ' ILE . 47.5 t -111.23 134.46 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.036 0.446 . . . . 1.03 111.094 174.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -102.51 107.04 17.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.681 -0.69 . . . . 0.32000000000000001 109.159 165.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.515 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 21.2 m-85 -87.36 142.07 28.16 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.286 0.565 . . . . 0.17000000000000001 110.697 176.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.498 ' HA ' HD12 ' A' ' 126' ' ' LEU . 39.4 tt0 -51.7 -35.01 41.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.521 -1.218 . . . . 0.56999999999999995 111.001 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.1 p -130.04 150.06 51.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.582 -1.19 . . . . 1.1100000000000001 111.181 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -62.75 -38.43 90.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.665 -0.698 . . . . 0.46999999999999997 111.04 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -65.19 -33.75 76.75 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.113 -0.494 . . . . 0.73999999999999999 112.285 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.67 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 1.03 110.298 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.515 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -64.62 -43.13 94.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.335 -0.848 . . . . 1.05 111.097 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 28.2 mt-10 -58.44 -40.69 83.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.851 -0.613 . . . . 1.4199999999999999 110.865 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 58.8 mtt85 -64.82 -42.33 95.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.74 0.305 . . . . 2.0 110.784 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.45 94.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.4 -0.364 . . . . 1.02 110.605 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.7 mt -58.81 -54.47 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 1.04 111.013 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.5 pt-20 -64.1 -45.52 88.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.188 0.518 . . . . 1.0800000000000001 111.841 -177.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -77.36 -38.58 49.86 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.479 -0.782 . . . . 1.78 112.617 -170.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -25.46 20.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.17 0.433 . . . . 1.03 112.17 -174.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.416 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 59.0 t30 -66.36 123.4 19.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.25 -0.648 . . . . 0.60999999999999999 109.25 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.98 12.67 63.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.613 -0.803 . . . . 0.28999999999999998 112.638 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.604 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.8 mmt -101.6 158.05 16.37 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.634 -0.333 . . . . 1.72 111.137 177.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 30.7 mt -98.34 107.61 20.12 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 109.207 -0.664 . . . . 1.1799999999999999 109.207 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.672 HD22 HG21 ' A' ' 118' ' ' THR . 17.2 mt -90.77 107.64 19.31 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.853 -0.795 . . . . 1.1299999999999999 108.853 171.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 82.5 m-20 72.78 -67.22 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.246 -0.888 . . . . 1.71 111.61 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -157.03 7.71 0.17 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.328 -0.851 . . . . 0.84999999999999998 111.742 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -130.56 134.35 46.94 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.592 -0.692 . . . . 1.27 110.924 -175.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.6 tttt -79.01 118.97 21.5 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.898 -0.779 . . . . 1.6499999999999999 108.898 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 5.7 m -100.19 146.81 8.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.596 0.712 . . . . 1.04 111.046 -172.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 74.1 t80 -106.58 117.84 35.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.699 -1.137 . . . . 0.41999999999999998 109.369 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 39.4 t -115.61 131.03 69.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.425 -0.583 . . . . 1.03 109.425 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -151.85 -176.92 25.07 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.595 -0.812 . . . . 0.17999999999999999 112.195 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -64.37 142.63 58.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.389 . . . . 2.3599999999999999 110.284 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.443 ' HB3' ' HD3' ' A' ' 95' ' ' LYS . 73.5 t80 -70.44 138.79 51.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.72 -0.673 . . . . 1.4399999999999999 110.314 -174.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' HD3' ' HG2' ' A' ' 177' ' ' LYS . 64.5 mttp -75.0 -71.62 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.671 0.272 . . . . 5.1399999999999997 111.354 -177.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 40.9 t 69.19 -64.63 0.33 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.373 -0.83 . . . . 3.8100000000000001 110.247 -170.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -104.97 106.81 17.46 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.169 -0.468 . . . . 8.2799999999999994 109.743 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.467 ' HG2' ' HD3' ' A' ' 174' ' ' LYS . 34.3 mtmm -81.41 -18.32 45.85 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.608 -0.886 . . . . 9.0099999999999998 108.608 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -136.94 134.28 36.58 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.457 -1.247 . . . . 8.6500000000000004 107.733 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -52.63 133.45 36.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.832 0.349 . . . . 12.789999999999999 111.609 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -139.38 156.11 47.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.674 -0.694 . . . . 12.699999999999999 110.43 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 65.49 89.04 0.1 Allowed 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.001 0.813 . . . . 13.800000000000001 113.081 170.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 7.8 mp0 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.508 -0.758 . . . . 15.050000000000001 109.101 172.456 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.618 0 N-CA-C 112.002 -0.439 . . . . 15.130000000000001 112.002 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.45 162.56 17.21 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.889 -0.412 . . . . 13.73 109.889 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.684 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 15.4 t70 -164.29 140.84 5.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.7 -0.481 . . . . 11.300000000000001 109.7 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.14 -29.06 54.22 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.478 2.119 . . . . 11.93 112.54 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 m -114.0 50.31 0.94 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.461 -0.336 . . . . 9.5199999999999996 110.813 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.826 HD21 ' HB3' ' A' ' 176' ' ' ARG . 71.6 mt -60.52 151.17 29.21 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 110.086 -0.339 . . . . 8.2100000000000009 110.086 175.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.54 ' HG2' ' H ' ' A' ' 95' ' ' LYS . 20.1 ttp180 66.44 -176.85 0.19 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.82 -0.807 . . . . 8.4100000000000001 108.82 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.54 ' H ' ' HG2' ' A' ' 94' ' ' ARG . 20.7 pttm -137.84 45.85 2.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 121.581 -0.699 . . . . 2.6600000000000001 110.705 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.9 t -75.79 5.94 5.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.262 -0.881 . . . . 2.3500000000000001 110.394 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -71.08 -12.18 71.38 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 116.003 -0.544 . . . . 1.02 112.049 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.4 t 65.49 125.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.61 0.764 . . . . 1.3600000000000001 111.958 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.25 24.08 76.15 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.167 -1.016 . . . . 0.26000000000000001 111.551 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.517 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.2 m120 -88.13 125.23 34.49 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.005 -0.739 . . . . 0.63 109.005 -173.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.459 HG12 ' HB ' ' A' ' 143' ' ' VAL . 19.1 pt -135.67 164.08 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.301 -0.259 . . . . 1.05 110.301 177.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.19 145.0 50.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.858 0.361 . . . . 0.26000000000000001 110.162 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.536 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 5.3 mt -123.06 142.89 37.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.855 -0.612 . . . . 1.01 110.043 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -127.38 155.44 43.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.291 0.091 . . . . 2.0800000000000001 111.125 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.9 t30 70.48 38.19 1.38 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.947 0.779 . . . . 0.53000000000000003 111.216 173.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.632 HD21 HG22 ' A' ' 110' ' ' ILE . 17.5 mt -79.63 163.44 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.535 -0.757 . . . . 1.04 111.075 175.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -97.16 157.27 16.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.988 -0.551 . . . . 0.70999999999999996 109.976 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.468 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 51.7 pttt -62.79 -28.67 70.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.935 0.398 . . . . 2.7799999999999998 111.204 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.5 m -69.72 -6.52 32.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.267 -0.424 . . . . 1.8 111.936 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.632 HG22 HD21 ' A' ' 106' ' ' LEU . 31.7 mm -89.41 114.2 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.175 0.512 . . . . 1.1000000000000001 110.46 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.53 -173.58 2.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.678 -0.86 . . . . 1.5900000000000001 108.678 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -70.46 -33.11 70.9 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.135 -1.061 . . . . 0.92000000000000004 108.135 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.632 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -66.8 -47.35 72.36 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 113.985 -1.461 . . . . 3.04 109.661 178.054 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.11 97.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.972 -1.467 . . . . 1.03 110.787 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.608 HD12 HG21 ' A' ' 130' ' ' VAL . 4.4 tt -67.07 -47.0 72.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.444 -0.798 . . . . 1.05 109.163 177.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.68 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 75.7 t80 -58.94 -46.61 87.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.078 -0.51 . . . . 1.05 110.997 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -56.77 -40.05 75.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.977 0.417 . . . . 0.40000000000000002 110.886 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.425 HG21 HD23 ' A' ' 163' ' ' LEU . 9.6 m -77.67 -53.88 7.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.944 -0.571 . . . . 1.02 111.825 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.401 ' CD1' HD22 ' A' ' 115' ' ' LEU . 12.0 m-85 -72.42 -29.75 64.0 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.784 0.661 . . . . 0.14999999999999999 112.784 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.6 t -58.64 -28.11 65.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.617 0.246 . . . . 0.56000000000000005 111.174 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.86 -22.12 34.53 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.683 0.278 . . . . 1.04 111.593 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.89 -11.9 35.04 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.899 0.38 . . . . 0.20999999999999999 110.984 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.57 160.88 10.96 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.749 -0.54 . . . . 0.14000000000000001 111.749 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -62.45 139.24 58.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.28999999999999998 110.185 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.422 HG21 ' HB3' ' A' ' 128' ' ' CYS . 67.1 mt -110.89 134.99 51.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.959 -0.564 . . . . 1.0700000000000001 109.857 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.531 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -87.49 -44.05 11.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.635 -0.876 . . . . 1.26 108.635 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.6 m -145.33 127.48 15.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.85 -1.068 . . . . 1.1799999999999999 109.862 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 8.5 p -124.09 137.0 54.63 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.587 -0.523 . . . . 1.49 109.587 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -136.39 129.59 31.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.909 0.385 . . . . 1.6299999999999999 111.788 -173.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.608 HG21 HD12 ' A' ' 115' ' ' LEU . 60.9 t -115.1 110.81 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 107.171 -1.418 . . . . 1.0700000000000001 107.171 170.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 t -79.74 115.67 22.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.015 -0.735 . . . . 1.1399999999999999 109.015 -175.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.747 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 26.0 p -100.74 140.76 34.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.481 -0.781 . . . . 2.3399999999999999 112.398 -166.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.407 ' H ' ' CA ' ' A' ' 137' ' ' SER . 29.0 t70 -86.15 160.27 19.28 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.811 -1.181 . . . . 2.0800000000000001 107.811 169.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -57.73 -22.81 48.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.045 0.45 . . . . 2.4500000000000002 110.934 176.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -90.03 -7.84 52.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 1.6499999999999999 110.882 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 151.83 -71.38 0.29 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.488 -0.863 . . . . 1.23 113.213 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.747 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 34.3 t -145.32 153.77 41.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.536 0.668 . . . . 1.99 110.564 -177.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -87.63 -9.02 55.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.217 0.532 . . . . 2.0600000000000001 110.297 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 105.25 -18.73 41.63 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.169 -1.015 . . . . 0.31 113.575 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -127.21 151.24 48.96 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.491 0.645 . . . . 1.01 111.817 -174.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.1 175.51 25.54 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.236 -0.893 . . . . 0.13 111.338 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -139.76 140.25 36.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.868 0.334 . . . . 0.31 110.688 -176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.522 HG13 ' CE2' ' A' ' 145' ' ' PHE . 49.5 t -114.69 136.11 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.043 0.449 . . . . 1.03 111.076 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -104.26 106.02 16.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.706 -0.679 . . . . 0.32000000000000001 109.191 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.522 ' CE2' HG13 ' A' ' 143' ' ' VAL . 20.8 m-85 -90.65 136.29 33.16 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.163 0.506 . . . . 0.17000000000000001 111.102 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.531 ' HA ' HD22 ' A' ' 126' ' ' LEU . 38.2 tt0 -49.04 -40.69 32.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.514 -1.221 . . . . 0.56999999999999995 110.682 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.8 p -117.47 147.05 43.09 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.039 -0.982 . . . . 1.1100000000000001 110.731 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -63.11 -33.78 76.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.875 -0.602 . . . . 0.46999999999999997 111.042 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -68.75 -34.84 76.28 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.402 -0.363 . . . . 0.73999999999999999 111.456 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.81 -34.66 78.41 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.156 0.503 . . . . 1.03 110.389 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.494 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.32 -48.46 79.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.483 -0.78 . . . . 1.05 110.639 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.605 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 41.0 mt-10 -58.79 -38.23 78.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.824 -0.625 . . . . 1.4199999999999999 110.841 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 51.4 mtt180 -62.1 -44.59 96.33 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.84 0.352 . . . . 2.0 111.011 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.19 86.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 1.02 110.657 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 151' ' ' ALA . 82.4 mt -61.02 -53.65 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 1.04 110.879 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.5 pt-20 -64.23 -41.73 96.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.957 0.408 . . . . 1.0800000000000001 111.98 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.447 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -81.36 -39.81 24.5 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.888 0.699 . . . . 1.78 112.888 -171.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 92.3 mmm -93.02 -22.78 18.94 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.598 0.592 . . . . 1.03 112.598 -172.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -66.96 123.33 19.91 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.028 -0.731 . . . . 0.60999999999999999 109.028 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.2 13.21 66.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.585 -0.817 . . . . 0.28999999999999998 112.545 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.628 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.2 mmt -101.41 165.18 11.39 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.614 -0.345 . . . . 1.72 111.224 177.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.33 130.46 46.44 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.949 -0.76 . . . . 1.1799999999999999 108.949 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 22.0 mt -116.41 101.1 8.36 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.08 -0.648 . . . . 1.1299999999999999 109.757 171.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 165' ' ' ASP . 55.9 m-20 78.5 -24.62 0.21 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.249 -0.887 . . . . 1.71 112.659 177.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.492 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 23.2 t70 166.17 -22.47 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 O-C-N 124.0 0.813 . . . . 0.84999999999999998 111.439 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 -110.71 132.02 54.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.497 -0.32 . . . . 1.27 110.872 -170.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.628 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.6 ttmt -77.94 124.15 27.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.416 -0.587 . . . . 1.6499999999999999 109.416 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 18.5 m -103.22 149.66 7.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.329 0.585 . . . . 1.04 111.573 -174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 43.3 t80 -107.21 120.91 43.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.3 -0.864 . . . . 0.41999999999999998 109.062 177.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 41.0 t -115.56 125.65 72.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.39 -0.596 . . . . 1.03 109.39 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.22 -173.76 16.8 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.568 -0.825 . . . . 0.17999999999999999 112.218 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -65.4 145.13 56.55 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.836 -0.431 . . . . 2.3599999999999999 109.836 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.52 ' HD2' ' HB3' ' A' ' 95' ' ' LYS . 72.6 t80 -68.59 133.88 49.16 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.953 -0.567 . . . . 1.4399999999999999 110.907 -172.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.688 ' HB3' ' HZ3' ' A' ' 174' ' ' LYS . 0.4 OUTLIER -141.14 79.47 1.69 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.947 -0.57 . . . . 5.1399999999999997 111.266 -178.759 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.9 p -66.26 -57.52 7.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.811 -0.631 . . . . 3.8100000000000001 109.642 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.826 ' HB3' HD21 ' A' ' 93' ' ' LEU . 6.6 ptm180 -88.58 147.83 24.39 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.702 -0.851 . . . . 8.2799999999999994 108.702 173.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -125.66 7.92 7.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.217 0.532 . . . . 9.0099999999999998 110.561 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -101.76 143.88 31.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.757 -0.656 . . . . 8.6500000000000004 109.823 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -94.06 -28.43 15.73 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.214 -0.661 . . . . 12.789999999999999 109.214 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 70.66 121.24 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.283 -0.871 . . . . 12.699999999999999 111.278 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.3 92.68 8.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.036 0.446 . . . . 13.800000000000001 110.429 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.644 -0.693 . . . . 15.050000000000001 110.226 -177.734 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.776 0 N-CA-C 112.18 -0.368 . . . . 15.130000000000001 112.18 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.13 -30.81 17.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.009 0.433 . . . . 13.73 110.391 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -83.05 122.91 77.95 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.866 -0.606 . . . . 11.300000000000001 109.495 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.32 -72.16 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.591 2.194 . . . . 11.93 112.255 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.2 m -156.84 94.46 1.44 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.389 -0.369 . . . . 9.5199999999999996 110.7 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 99.4 mt -99.26 120.98 40.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.128 -0.323 . . . . 8.2100000000000009 110.128 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -102.51 -41.91 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.378 0.609 . . . . 8.4100000000000001 109.962 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -96.4 93.67 6.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.281 -0.872 . . . . 2.6600000000000001 109.855 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.2 m -62.74 -14.03 39.78 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 112.182 0.438 . . . . 2.3500000000000001 112.182 -177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.06 -29.33 66.95 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.872 -0.68 . . . . 1.02 111.943 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.4 t 61.13 127.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.868 0.867 . . . . 1.3600000000000001 112.889 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.31 24.34 76.52 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.984 -1.103 . . . . 0.26000000000000001 111.768 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.486 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.0 OUTLIER -86.51 125.21 33.59 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.535 -0.542 . . . . 0.63 109.535 -173.258 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.564 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.9 pt -135.57 160.43 39.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.228 -0.286 . . . . 1.05 110.228 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -125.79 142.78 51.35 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.888 -0.412 . . . . 0.26000000000000001 109.888 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.573 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 7.2 mt -121.05 131.27 73.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 1.01 110.251 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -116.06 151.32 35.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.681 -0.236 . . . . 2.0800000000000001 110.561 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.2 t30 74.5 38.09 0.52 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.903 0.752 . . . . 0.53000000000000003 111.834 172.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.539 HD22 HG22 ' A' ' 110' ' ' ILE . 19.3 mt -76.78 158.47 30.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.059 0.457 . . . . 1.04 111.065 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.511 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.0 t70 -84.26 151.69 24.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.553 -0.748 . . . . 0.70999999999999996 111.394 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -53.12 -36.19 60.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.13 -0.941 . . . . 2.7799999999999998 112.368 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -88.18 -2.57 58.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.242 -0.435 . . . . 1.8 112.169 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.539 HG22 HD22 ' A' ' 106' ' ' LEU . 36.4 mm -73.59 124.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.2 0.524 . . . . 1.1000000000000001 110.823 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 113' ' ' LYS . 0.2 OUTLIER -104.11 177.99 4.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.434 -0.803 . . . . 1.5900000000000001 110.865 -178.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -71.23 -33.67 70.08 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 107.56 -1.274 . . . . 0.92000000000000004 107.56 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.716 ' HB3' ' HZ1' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -64.32 -48.87 73.95 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.833 -1.531 . . . . 3.04 108.949 176.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.91 -44.87 96.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.367 -1.288 . . . . 1.03 111.062 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.608 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -64.09 -47.1 81.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.302 -0.863 . . . . 1.05 109.056 177.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.669 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 69.8 t80 -59.61 -49.3 78.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.936 -0.575 . . . . 1.05 111.135 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -58.3 -35.07 71.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.939 0.399 . . . . 0.40000000000000002 111.166 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 24.9 m -78.8 -54.45 6.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.319 -0.401 . . . . 1.02 112.022 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.428 ' CD1' HD23 ' A' ' 115' ' ' LEU . 8.6 m-85 -72.78 -29.72 63.52 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.665 0.617 . . . . 0.14999999999999999 112.665 -173.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.2 t -58.76 -28.06 65.56 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.668 0.271 . . . . 0.56000000000000005 111.454 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.56 -22.87 36.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.937 0.398 . . . . 1.04 111.236 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -90.32 -19.04 24.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.20999999999999999 110.811 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.76 168.43 29.88 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 121.132 -0.556 . . . . 0.14000000000000001 111.89 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -69.58 139.9 53.74 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.099 -0.334 . . . . 0.28999999999999998 110.099 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.415 HG21 ' HB3' ' A' ' 128' ' ' CYS . 73.5 mt -111.78 133.78 56.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.389 -0.369 . . . . 1.0700000000000001 110.526 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -91.94 -38.06 12.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.442 0.639 . . . . 1.26 109.431 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 75.4 m -155.68 102.82 2.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.46 -0.791 . . . . 1.1799999999999999 110.942 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 9.3 p -106.12 142.64 35.48 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.848 -0.427 . . . . 1.49 109.848 173.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -135.43 130.82 35.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.875 -0.602 . . . . 1.6299999999999999 110.797 -173.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.608 HG22 HD12 ' A' ' 115' ' ' LEU . 63.3 t -114.91 110.08 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 106.838 -1.541 . . . . 1.0700000000000001 106.838 170.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 t -79.08 115.29 21.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.637 -0.875 . . . . 1.1399999999999999 108.637 -175.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.758 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 8.8 p -103.54 135.83 44.4 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.733 0.642 . . . . 2.3399999999999999 112.733 -167.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.6 169.78 12.44 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.974 -1.012 . . . . 2.0800000000000001 108.878 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.31 -29.49 68.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.069 0.461 . . . . 2.4500000000000002 109.971 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -85.14 -1.35 56.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.953 -0.567 . . . . 1.6499999999999999 111.317 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 139.46 -69.64 0.47 Allowed Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.407 -0.902 . . . . 1.23 112.986 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.758 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 33.3 t -141.13 149.83 42.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.388 0.594 . . . . 1.99 109.877 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 138' ' ' LYS . 18.2 mtpp -80.9 -13.78 58.6 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.287 0.565 . . . . 2.0600000000000001 109.721 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 109.53 -14.75 32.58 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.446 -0.883 . . . . 0.31 113.265 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -129.14 148.32 51.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.535 0.668 . . . . 1.01 111.875 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.28 170.99 25.25 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.05 -0.977 . . . . 0.13 111.433 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -137.77 137.57 38.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.757 0.278 . . . . 0.31 110.578 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.564 ' HB ' HG12 ' A' ' 101' ' ' ILE . 36.5 t -113.42 130.89 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 120.889 0.376 . . . . 1.03 110.814 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.458 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 0.4 OUTLIER -100.61 105.95 17.4 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.019 -0.734 . . . . 0.32000000000000001 109.019 166.397 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.53 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 12.4 m-85 -89.36 137.32 32.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.266 0.555 . . . . 0.17000000000000001 111.209 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.563 ' HA ' HD23 ' A' ' 126' ' ' LEU . 41.5 tt0 -47.88 -48.75 31.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.235 -1.348 . . . . 0.56999999999999995 110.556 176.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 p -110.63 144.51 39.41 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.379 -1.282 . . . . 1.1100000000000001 111.218 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -61.77 -37.7 85.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.665 -0.698 . . . . 0.46999999999999997 110.996 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.0 pt-20 -69.91 -34.36 73.39 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.615 -0.266 . . . . 0.73999999999999999 111.682 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.55 77.61 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.154 0.502 . . . . 1.03 110.403 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.53 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.97 -44.69 95.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.488 -0.778 . . . . 1.05 110.501 176.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 49.1 mt-10 -59.53 -40.55 87.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 1.4199999999999999 110.541 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.506 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 50.1 mtt180 -62.3 -39.93 94.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 2.0 110.823 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.02 -38.5 86.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.472 -0.331 . . . . 1.02 110.423 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 151' ' ' ALA . 81.2 mt -58.68 -54.04 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 1.04 111.167 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.0 OUTLIER -61.05 -44.25 97.67 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.149 0.499 . . . . 1.0800000000000001 112.028 -178.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.456 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.23 -38.7 24.12 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.48 -0.782 . . . . 1.78 112.802 -169.002 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 92.9 mmm -91.23 -24.28 19.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.254 0.464 . . . . 1.03 112.254 -173.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 59.9 t30 -67.72 123.02 19.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.215 -0.594 . . . . 0.60999999999999999 109.507 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.0 8.83 64.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.732 -0.747 . . . . 0.28999999999999998 112.786 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.728 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.4 mmt -92.01 163.81 13.85 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.692 0.282 . . . . 1.72 111.425 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 15.7 mt -105.55 107.21 18.07 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.536 -0.542 . . . . 1.1799999999999999 109.536 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.408 HD21 ' HA ' ' A' ' 163' ' ' LEU . 18.3 mt -94.61 108.55 20.52 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.793 -0.763 . . . . 1.1299999999999999 109.245 172.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 94.4 m-20 72.11 -62.35 0.47 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.137 -0.938 . . . . 1.71 112.127 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -163.88 12.78 0.05 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.787 -0.642 . . . . 0.84999999999999998 111.438 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.511 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.1 mtt180 -134.41 129.85 35.96 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.966 -0.459 . . . . 1.27 110.481 -174.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.728 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.2 ttmt -78.7 120.12 22.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.588 -0.733 . . . . 1.6499999999999999 109.157 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.73 146.58 9.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.619 0.723 . . . . 1.04 111.231 -172.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 75.2 t80 -106.9 118.38 36.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.729 -1.123 . . . . 0.41999999999999998 109.341 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.418 ' CG1' HD11 ' A' ' 101' ' ' ILE . 41.1 t -115.22 125.06 72.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.104 -0.702 . . . . 1.03 109.104 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.76 -174.46 17.96 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.512 -0.851 . . . . 0.17999999999999999 112.098 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 -67.86 120.02 13.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.964 0.412 . . . . 2.3599999999999999 110.246 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.45 ' HD2' ' HG ' ' A' ' 175' ' ' SER . 69.8 t80 -58.2 127.78 33.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.445 -0.798 . . . . 1.4399999999999999 111.015 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -66.56 95.61 0.34 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.025 -0.732 . . . . 5.1399999999999997 109.025 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.45 ' HG ' ' HD2' ' A' ' 173' ' ' PHE . 12.8 m -94.73 -22.64 17.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.553 -0.749 . . . . 3.8100000000000001 110.376 -173.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 40.1 ttt180 65.05 -91.67 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.963 0.789 . . . . 8.2799999999999994 109.735 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm 174.43 -38.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.62 -0.881 . . . . 9.0099999999999998 108.62 175.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.682 ' HG3' ' H ' ' A' ' 180' ' ' GLU . 12.2 tp10 -82.21 135.56 35.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.087 -0.961 . . . . 8.6500000000000004 109.734 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -99.51 8.7 44.29 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.319 -0.623 . . . . 12.789999999999999 109.319 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.682 ' H ' ' HG3' ' A' ' 178' ' ' GLU . 7.0 mm-40 74.93 -41.37 0.46 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.005 -0.998 . . . . 12.699999999999999 111.976 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.43 95.22 5.52 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.838 0.352 . . . . 13.800000000000001 110.449 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.46 -0.781 . . . . 15.050000000000001 109.818 -179.545 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.693 0 N-CA-C 112.007 -0.437 . . . . 15.130000000000001 112.007 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.66 156.56 28.96 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.845 -0.209 . . . . 13.73 110.467 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.467 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 29.1 t70 -83.15 128.47 64.85 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.776 0.322 . . . . 11.300000000000001 110.557 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 21.1 Cg_exo -66.05 -10.47 27.22 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.233 2.622 . . . . 11.93 113.138 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.635 ' HB3' ' HA ' ' A' ' 176' ' ' ARG . 25.3 m -108.01 67.48 0.68 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.337 0.589 . . . . 9.5199999999999996 111.139 -177.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 83.3 mt -141.14 109.17 5.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.501 -0.772 . . . . 8.2100000000000009 108.979 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 54.96 -153.57 0.31 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.343 -0.614 . . . . 8.4100000000000001 109.343 -171.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.751 ' HE2' ' HB3' ' A' ' 172' ' ' ARG . 12.5 mptt -92.86 167.91 11.52 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.608 -0.437 . . . . 2.6600000000000001 110.241 173.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.507 ' C ' ' H ' ' A' ' 98' ' ' VAL . 7.0 p -154.82 -179.22 7.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.674 -0.862 . . . . 2.3500000000000001 108.674 -177.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.71 -26.22 1.39 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.979 -0.629 . . . . 1.02 111.898 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.507 ' H ' ' C ' ' A' ' 96' ' ' SER . 71.5 t 66.13 124.11 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 C-N-CA 124.165 0.986 . . . . 1.3600000000000001 111.857 -176.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.27 24.15 75.98 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.181 -1.009 . . . . 0.26000000000000001 112.084 177.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.504 ' N ' HD21 ' A' ' 100' ' ' ASN . 0.9 OUTLIER -88.58 125.41 34.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.357 -0.608 . . . . 0.63 109.357 -174.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.502 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.4 pt -135.31 159.73 40.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.087 -0.338 . . . . 1.05 110.087 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.39 138.18 54.62 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.899 -0.408 . . . . 0.26000000000000001 109.899 176.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 5.7 mt -116.71 131.49 69.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.548 -0.751 . . . . 1.01 110.076 -177.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -113.66 152.56 30.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.493 -0.321 . . . . 2.0800000000000001 110.588 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.8 t30 75.58 33.99 0.62 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.014 0.821 . . . . 0.53000000000000003 111.683 170.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.489 HD23 HG23 ' A' ' 110' ' ' ILE . 25.4 mt -75.64 156.82 34.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 1.04 111.446 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 15.0 t70 -83.15 153.14 24.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.519 -0.764 . . . . 0.70999999999999996 111.36 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.413 ' HG3' ' N ' ' A' ' 109' ' ' SER . 55.1 pttt -54.09 -37.66 64.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.485 -0.78 . . . . 2.7799999999999998 112.501 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.413 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 13.7 m -80.86 -8.76 59.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.848 0.314 . . . . 1.8 111.848 -172.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.499 ' O ' HG12 ' A' ' 130' ' ' VAL . 34.6 mm -71.16 120.17 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.013 0.435 . . . . 1.1000000000000001 110.376 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -109.27 -179.67 3.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.016 -0.735 . . . . 1.5900000000000001 109.016 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.58 -40.98 98.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.269 -0.641 . . . . 0.92000000000000004 109.269 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.91 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -59.97 -49.39 77.87 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.277 -0.874 . . . . 3.04 110.567 178.416 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.9 98.19 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.265 -1.334 . . . . 1.03 111.396 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.611 HD12 HG21 ' A' ' 130' ' ' VAL . 4.0 tt -65.03 -47.15 78.42 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.952 -0.758 . . . . 1.05 108.952 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.744 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 64.4 t80 -57.54 -48.23 79.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.916 -0.584 . . . . 1.05 111.009 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.25 -37.55 72.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.968 0.413 . . . . 0.40000000000000002 110.828 -175.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 m -77.88 -54.42 6.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.151 -0.477 . . . . 1.02 111.815 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.431 ' CD1' HD22 ' A' ' 115' ' ' LEU . 10.2 m-85 -73.02 -28.82 62.58 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.881 0.696 . . . . 0.14999999999999999 112.881 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -57.57 -28.23 63.38 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.777 0.322 . . . . 0.56000000000000005 110.875 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.45 -21.74 27.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.355 -0.384 . . . . 1.04 111.618 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -92.98 -17.41 23.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.989 0.423 . . . . 0.20999999999999999 110.918 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.72 162.51 14.74 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.977 -0.556 . . . . 0.14000000000000001 111.796 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -61.67 132.45 53.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.057 0.456 . . . . 0.28999999999999998 110.538 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 128' ' ' CYS . 68.3 mt -106.35 133.68 50.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.808 -0.633 . . . . 1.0700000000000001 109.747 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.552 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.28 -40.31 13.72 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.01 -0.737 . . . . 1.26 109.01 -177.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.3 m -147.68 129.66 15.37 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.973 -1.012 . . . . 1.1799999999999999 109.915 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.744 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 5.8 p -129.44 124.67 34.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.265 -0.643 . . . . 1.49 109.265 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -123.95 127.93 48.67 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.906 0.384 . . . . 1.6299999999999999 111.327 -173.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.611 HG21 HD12 ' A' ' 115' ' ' LEU . 54.8 t -114.48 109.55 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 106.856 -1.535 . . . . 1.0700000000000001 106.856 170.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.414 HG11 ' HG3' ' A' ' 138' ' ' LYS . 6.4 t -75.77 115.91 17.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.611 -0.885 . . . . 1.1399999999999999 108.611 -175.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 3.2 p -97.15 134.56 40.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.732 -0.667 . . . . 2.3399999999999999 112.443 -165.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -87.56 163.95 16.36 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.225 -1.028 . . . . 2.0800000000000001 108.225 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -56.25 -27.42 55.03 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.806 0.336 . . . . 2.4500000000000002 110.538 174.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -92.34 -1.24 57.18 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.261 -0.427 . . . . 1.6499999999999999 111.134 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.401 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 142.35 -69.11 0.44 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.516 -0.85 . . . . 1.23 113.656 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.639 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 34.3 t -142.2 145.87 34.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.292 0.546 . . . . 1.99 110.538 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.414 ' HG3' HG11 ' A' ' 131' ' ' VAL . 4.2 mmpt? -76.07 -15.65 60.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.325 0.583 . . . . 2.0600000000000001 110.279 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 112.28 -12.4 26.23 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.186 -0.916 . . . . 0.31 113.314 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -133.03 148.8 52.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.368 0.584 . . . . 1.01 111.654 -176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.86 168.56 25.93 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.24 -0.891 . . . . 0.13 111.377 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -136.47 136.49 39.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.059 0.43 . . . . 0.31 110.801 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.522 HG12 ' CE2' ' A' ' 145' ' ' PHE . 48.7 t -111.0 136.45 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.957 0.408 . . . . 1.03 111.145 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.447 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 1.3 m170 -105.57 105.63 15.76 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.104 -0.702 . . . . 0.32000000000000001 109.104 166.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.522 ' CE2' HG12 ' A' ' 143' ' ' VAL . 17.5 m-85 -88.79 138.59 31.28 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.042 0.448 . . . . 0.17000000000000001 110.938 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.552 ' HA ' HD21 ' A' ' 126' ' ' LEU . 28.5 tt0 -45.87 -45.39 15.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.526 -1.215 . . . . 0.56999999999999995 110.923 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.3 p -119.8 150.78 39.86 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.938 -1.028 . . . . 1.1100000000000001 110.839 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -61.46 -33.41 73.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.49 -0.777 . . . . 0.46999999999999997 110.865 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.76 -35.65 75.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.73999999999999999 111.83 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.59 -34.23 76.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.093 0.473 . . . . 1.03 110.498 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -64.2 -44.25 92.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.632 -0.713 . . . . 1.05 110.688 176.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 31.8 mt-10 -58.96 -38.61 79.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 1.4199999999999999 110.471 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 92.2 mtt180 -62.77 -43.51 98.6 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.03 0.443 . . . . 2.0 110.969 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.75 -37.29 85.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 1.02 110.405 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 151' ' ' ALA . 90.6 mt -59.17 -52.74 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 1.04 111.248 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.53 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.6 pt-20 -64.02 -46.24 85.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.09 0.472 . . . . 1.0800000000000001 111.809 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.452 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -80.86 -38.47 28.1 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.147 0.795 . . . . 1.78 113.147 -168.462 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 92.0 mmm -93.29 -20.22 20.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.458 0.54 . . . . 1.03 112.458 -173.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.417 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 53.8 t30 -68.58 123.75 21.71 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.221 -0.592 . . . . 0.60999999999999999 109.652 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.52 64.48 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.777 -0.725 . . . . 0.28999999999999998 112.539 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.716 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.7 mmt -96.07 162.5 13.52 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.678 0.239 . . . . 1.72 110.976 177.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.9 mt -103.35 105.04 15.22 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.345 -0.613 . . . . 1.1799999999999999 109.345 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 18.0 mt -91.04 108.93 20.19 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.925 -0.71 . . . . 1.1299999999999999 109.256 173.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 93.9 m-20 73.57 -60.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.302 -0.863 . . . . 1.71 111.827 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -172.61 22.9 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.549 -0.75 . . . . 0.84999999999999998 110.798 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.7 mtt180 -138.29 132.75 32.14 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.006 -0.434 . . . . 1.27 109.96 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.716 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.2 tttt -84.19 115.02 22.21 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.441 -0.577 . . . . 1.6499999999999999 109.441 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.6 m -100.12 147.83 7.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.599 0.714 . . . . 1.04 111.485 -170.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 75.8 t80 -106.58 120.49 42.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.735 -1.121 . . . . 0.41999999999999998 109.365 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.454 ' CG1' HD13 ' A' ' 101' ' ' ILE . 42.3 t -115.48 125.58 72.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.154 -0.684 . . . . 1.03 109.154 177.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.53 -171.5 16.68 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.351 -0.928 . . . . 0.17999999999999999 112.235 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.751 ' HB3' ' HE2' ' A' ' 95' ' ' LYS . 25.9 mmt180 -69.3 131.19 44.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.426 -0.583 . . . . 2.3599999999999999 109.426 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.543 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 49.4 t80 -63.97 128.62 36.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.052 -0.522 . . . . 1.4399999999999999 110.296 -176.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -82.53 85.44 6.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.116 0.484 . . . . 5.1399999999999997 110.086 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.426 ' OG ' ' HA ' ' A' ' 95' ' ' LYS . 0.5 OUTLIER -84.89 -16.81 39.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.885 -0.598 . . . . 3.8100000000000001 111.85 -177.27 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.635 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 19.2 ttp180 -109.72 -90.1 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.543 -0.463 . . . . 8.2799999999999994 110.635 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -142.38 -170.56 3.21 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.194 -0.298 . . . . 9.0099999999999998 110.194 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -125.09 127.05 46.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.574 -0.899 . . . . 8.6500000000000004 108.574 173.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 180' ' ' GLU . 40.9 ttm180 -90.86 -74.59 0.49 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.852 -0.339 . . . . 12.789999999999999 111.231 -174.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 179' ' ' ARG . 36.9 tt0 163.13 -37.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.609 -0.886 . . . . 12.699999999999999 108.609 -173.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.33 101.3 3.88 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.513 -1.221 . . . . 13.800000000000001 109.185 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-N 115.631 -0.713 . . . . 15.050000000000001 110.136 -175.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.976 0 N-CA-C 112.278 -0.329 . . . . 15.130000000000001 112.278 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -137.1 31.04 2.69 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.015 -0.735 . . . . 13.73 109.015 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.718 ' HB2' ' HB3' ' A' ' 93' ' ' LEU . 2.7 m-20 -102.73 110.31 62.95 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.847 -1.07 . . . . 11.300000000000001 110.611 -172.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.569 ' HA ' ' HB2' ' A' ' 175' ' ' SER . 50.7 Cg_exo -56.4 -50.8 10.84 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.085 2.523 . . . . 11.93 112.76 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.2 m -82.13 11.23 5.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.451 -0.34 . . . . 9.5199999999999996 111.822 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.718 ' HB3' ' HB2' ' A' ' 90' ' ' ASP . 3.2 tm? -117.64 -50.31 2.52 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.032 -0.358 . . . . 8.2100000000000009 110.032 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 2.6 mmp_? -65.86 -51.12 61.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 8.4100000000000001 111.605 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.94 11.02 24.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.784 0.326 . . . . 2.6600000000000001 111.268 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.8 t -79.05 -6.26 55.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.276 0.56 . . . . 2.3500000000000001 110.31 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.8 -22.72 73.89 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.782 -0.644 . . . . 1.02 111.923 176.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.2 t 72.06 117.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.711 0.804 . . . . 1.3600000000000001 111.908 -176.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.08 24.08 69.93 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.218 -0.991 . . . . 0.26000000000000001 111.877 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 173' ' ' PHE . 2.2 m120 -87.45 125.8 34.51 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.969 -0.752 . . . . 0.63 108.969 -176.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.548 HG12 ' HB ' ' A' ' 143' ' ' VAL . 23.8 pt -135.02 163.55 36.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.477 -0.329 . . . . 1.05 110.283 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.14 147.28 49.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.83 -0.433 . . . . 0.26000000000000001 109.83 175.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 140' ' ' TYR . 4.4 mt -119.26 139.29 47.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.679 -0.691 . . . . 1.01 109.811 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -117.16 153.22 33.2 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.952 0.158 . . . . 2.0800000000000001 110.637 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.0 t30 71.39 39.73 0.9 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.863 0.727 . . . . 0.53000000000000003 112.16 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.5 mt -81.82 164.73 21.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.807 0.337 . . . . 1.04 111.056 176.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -96.7 157.53 15.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.70999999999999996 109.813 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.811 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 22.2 pttp -61.51 -26.4 67.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.484 0.659 . . . . 2.7799999999999998 109.681 172.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 m -59.78 -23.12 63.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.632 -1.167 . . . . 1.8 112.596 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.518 HG23 HG22 ' A' ' 130' ' ' VAL . 40.2 mm -86.43 131.32 34.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.407 0.622 . . . . 1.1000000000000001 111.502 -174.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 16.8 t70 -117.37 -175.39 2.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.235 -1.024 . . . . 1.5900000000000001 108.235 176.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.445 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 90.9 m-20 -69.07 -29.68 67.85 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.608 -0.886 . . . . 0.92000000000000004 108.608 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -49.46 65.18 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.457 -1.247 . . . . 3.04 109.404 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.78 85.47 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.7 -1.136 . . . . 1.03 110.691 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.609 HD13 HG23 ' A' ' 130' ' ' VAL . 3.5 tt -70.72 -48.05 56.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.47 -0.786 . . . . 1.05 109.35 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.616 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 80.2 t80 -61.05 -45.12 96.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 1.05 110.833 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.43 -41.83 77.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.014 0.435 . . . . 0.40000000000000002 110.884 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 24.0 m -77.66 -53.66 7.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 1.02 112.072 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.427 ' CD1' HD23 ' A' ' 115' ' ' LEU . 17.7 m-85 -72.17 -29.46 64.04 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.46 0.541 . . . . 0.14999999999999999 112.46 -173.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.6 t -58.67 -28.93 66.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.595 0.236 . . . . 0.56000000000000005 111.201 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.38 -22.62 43.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 1.04 111.554 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -93.64 -11.94 30.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 0.20999999999999999 110.875 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.95 164.06 15.14 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.929 -0.653 . . . . 0.14000000000000001 111.846 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -67.05 137.5 56.48 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.932 0.396 . . . . 0.28999999999999998 110.178 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.412 HG23 ' HB3' ' A' ' 128' ' ' CYS . 72.1 mt -110.21 129.57 64.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.119 -0.491 . . . . 1.0700000000000001 109.927 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.14 -35.37 20.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.054 -0.721 . . . . 1.26 109.054 -177.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.492 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 65.8 m -154.31 128.72 9.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.17 -0.923 . . . . 1.1799999999999999 109.849 -177.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 2.6 p -134.14 144.85 48.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.802 0.334 . . . . 1.49 110.247 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -143.78 133.15 23.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.299 -0.41 . . . . 1.6299999999999999 111.59 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.609 HG23 HD13 ' A' ' 115' ' ' LEU . 59.6 t -113.23 111.11 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 106.383 -1.71 . . . . 1.0700000000000001 106.383 168.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 t -79.99 115.86 23.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.804 -0.813 . . . . 1.1399999999999999 108.804 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 5.6 p -99.5 135.88 40.26 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.759 0.652 . . . . 2.3399999999999999 112.759 -166.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -86.1 163.29 17.97 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.962 -1.017 . . . . 2.0800000000000001 108.818 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -54.83 -31.33 59.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.791 0.329 . . . . 2.4500000000000002 110.7 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -86.28 -6.62 58.92 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.196 -0.456 . . . . 1.6499999999999999 110.979 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.811 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 148.4 -71.1 0.32 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.743 -0.741 . . . . 1.23 113.271 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.718 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 27.6 t -142.81 146.27 34.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.336 0.568 . . . . 1.99 110.409 -176.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.523 ' CE ' ' HH ' ' A' ' 140' ' ' TYR . 37.5 mtpt -78.65 -8.1 58.32 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.342 0.591 . . . . 2.0600000000000001 110.137 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 102.94 -19.93 45.15 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.466 -0.873 . . . . 0.31 113.113 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.523 ' HH ' ' CE ' ' A' ' 138' ' ' LYS . 22.2 p90 -125.88 148.78 49.09 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.457 0.629 . . . . 1.01 111.984 -174.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.36 173.81 23.2 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.002 -0.999 . . . . 0.13 111.358 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -136.11 141.85 44.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.032 0.416 . . . . 0.31 110.848 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.548 ' HB ' HG12 ' A' ' 101' ' ' ILE . 28.1 t -117.23 135.95 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.106 0.479 . . . . 1.03 110.84 172.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.4 OUTLIER -107.2 106.17 16.5 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.031 -0.729 . . . . 0.32000000000000001 109.031 168.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.538 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.2 m-85 -90.49 139.06 31.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.596 0.713 . . . . 0.17000000000000001 111.936 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.523 ' HA ' HD21 ' A' ' 126' ' ' LEU . 46.5 tt0 -49.05 -40.79 32.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.912 -1.495 . . . . 0.56999999999999995 110.86 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.2 p -123.93 154.59 39.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.887 -1.051 . . . . 1.1100000000000001 110.513 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -66.14 -33.5 75.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.177 -0.465 . . . . 0.46999999999999997 110.902 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.07 -35.86 77.0 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.365 -0.379 . . . . 0.73999999999999999 111.518 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.19 -34.51 78.24 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.168 0.508 . . . . 1.03 110.402 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.538 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.81 -48.01 80.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.523 -0.762 . . . . 1.05 110.606 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 29.3 mt-10 -58.64 -42.13 87.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.005 -0.543 . . . . 1.4199999999999999 110.696 177.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 72.5 mtt180 -58.65 -41.62 86.49 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.944 0.402 . . . . 2.0 110.949 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.22 -40.36 86.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.359 -0.382 . . . . 1.02 110.612 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 151' ' ' ALA . 91.1 mt -60.33 -49.59 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.056 -0.52 . . . . 1.04 111.176 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.9 pt-20 -64.07 -45.69 87.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.175 0.512 . . . . 1.0800000000000001 111.704 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.48 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -80.73 -38.58 28.5 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.329 0.863 . . . . 1.78 113.329 -169.261 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' A' ' 161' ' ' MET . 88.9 mmm -95.77 -17.12 21.44 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.709 0.633 . . . . 1.03 112.709 -172.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.06 123.06 20.61 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.197 -0.601 . . . . 0.60999999999999999 109.613 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.04 22.69 54.45 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.865 -0.684 . . . . 0.28999999999999998 112.419 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.551 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.5 OUTLIER -106.48 161.57 14.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.724 0.297 . . . . 1.72 111.622 -179.091 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 75.4 mt -104.17 106.75 17.36 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.908 -0.775 . . . . 1.1799999999999999 108.908 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.6 mt -92.6 22.17 4.89 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.015 -0.674 . . . . 1.1299999999999999 111.864 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.7 p30 169.92 -79.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.823 0.849 . . . . 1.71 109.153 -175.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -150.93 12.28 0.67 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.747 -1.115 . . . . 0.84999999999999998 109.536 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -124.04 135.04 53.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.589 -0.732 . . . . 1.27 109.096 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.621 ' HZ3' ' HB2' ' A' ' 167' ' ' LYS . 3.9 ttmp? -84.19 117.25 23.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.173 -0.677 . . . . 1.6499999999999999 109.173 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 19.1 m -99.79 143.28 13.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.541 0.686 . . . . 1.04 110.565 -172.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 39.7 t80 -106.53 122.18 45.78 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.882 -1.054 . . . . 0.41999999999999998 109.417 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.481 ' CG1' HD12 ' A' ' 101' ' ' ILE . 43.1 t -115.94 125.75 73.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.476 -0.564 . . . . 1.03 109.476 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.04 -167.23 12.1 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.319 -0.712 . . . . 0.17999999999999999 111.319 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -68.97 136.43 52.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.833 -0.803 . . . . 2.3599999999999999 108.833 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.516 ' O ' ' HB2' ' A' ' 174' ' ' LYS . 68.0 t80 -38.18 -87.48 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.507 1.129 . . . . 1.4399999999999999 113.434 -169.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 173' ' ' PHE . 63.8 tttm 162.49 105.19 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.895 -0.78 . . . . 5.1399999999999997 108.895 -178.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.569 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 0.1 OUTLIER -94.35 -64.6 1.06 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.68 0.276 . . . . 3.8100000000000001 111.174 -176.654 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -113.18 -55.24 2.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.414 0.626 . . . . 8.2799999999999994 110.132 -177.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -179.15 -32.39 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.673 -1.149 . . . . 9.0099999999999998 108.322 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 61.22 82.15 0.17 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.507 -1.224 . . . . 8.6500000000000004 110.717 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -73.49 111.24 8.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.183 -0.917 . . . . 12.789999999999999 109.464 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -127.3 -4.34 6.12 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.425 -0.352 . . . . 12.699999999999999 111.35 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -81.51 93.21 6.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.927 0.394 . . . . 13.800000000000001 110.485 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.538 -0.744 . . . . 15.050000000000001 109.641 -178.968 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.558 0 N-CA-C 112.056 -0.418 . . . . 15.130000000000001 112.056 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.36 -176.04 2.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.418 -0.586 . . . . 13.73 109.418 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -106.38 128.53 26.09 Favored Pre-proline 0 C--N 1.321 -0.668 0 C-N-CA 120.743 -0.383 . . . . 11.300000000000001 110.323 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.26 -35.2 98.95 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.861 2.374 . . . . 11.93 111.735 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.1 m -119.83 78.33 1.32 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.172 -0.677 . . . . 9.5199999999999996 109.172 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 23.5 tp -73.08 -32.64 65.13 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.151 -0.685 . . . . 8.2100000000000009 109.151 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -84.77 157.67 20.94 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.31 -1.367 . . . . 8.4100000000000001 107.31 164.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -93.08 153.24 18.8 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.722 -0.791 . . . . 2.6600000000000001 111.114 -166.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 p -79.49 -27.9 41.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.873 0.368 . . . . 2.3500000000000001 110.97 -172.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.86 -29.89 70.66 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.597 -0.811 . . . . 1.02 111.183 175.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.3 t 61.47 127.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.847 0.859 . . . . 1.3600000000000001 112.531 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.32 24.87 74.37 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 119.873 -1.155 . . . . 0.26000000000000001 111.455 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.508 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.3 m120 -89.95 124.17 34.5 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.955 -0.757 . . . . 0.63 108.955 -173.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.426 HD11 ' CG1' ' A' ' 170' ' ' VAL . 17.1 pt -136.07 163.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.942 -0.392 . . . . 1.05 109.942 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.94 143.22 51.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.1 0.476 . . . . 0.26000000000000001 109.775 176.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.1 mt -119.33 136.38 56.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.355 -0.839 . . . . 1.01 109.876 -177.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -120.15 154.1 35.26 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 121.438 -0.105 . . . . 2.0800000000000001 110.913 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.0 t30 73.73 32.79 1.09 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.878 0.871 . . . . 0.53000000000000003 111.528 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.657 HD23 HG21 ' A' ' 110' ' ' ILE . 30.7 mt -73.99 154.31 39.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.408 . . . . 1.04 111.255 177.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.461 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 25.6 t70 -83.17 152.3 25.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.675 . . . . 0.70999999999999996 110.681 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.642 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 63.6 pttt -56.15 -34.66 66.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.625 . . . . 2.7799999999999998 112.014 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.3 m -80.14 -2.83 46.33 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.416 0.524 . . . . 1.8 112.416 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.657 HG21 HD23 ' A' ' 106' ' ' LEU . 31.6 mm -78.91 116.43 22.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.615 -0.434 . . . . 1.1000000000000001 110.057 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -105.85 -176.7 3.15 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.95 -0.759 . . . . 1.5900000000000001 108.95 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -68.81 -31.01 69.7 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.111 -0.7 . . . . 0.92000000000000004 109.111 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -48.33 66.15 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.634 -1.166 . . . . 3.04 109.238 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.6 -41.6 97.66 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.269 -1.332 . . . . 1.03 110.796 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.613 HD13 HG21 ' A' ' 130' ' ' VAL . 3.9 tt -67.5 -47.37 70.21 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.243 -0.89 . . . . 1.05 108.994 177.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.712 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 62.3 t80 -58.34 -47.81 82.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.179 -0.464 . . . . 1.05 111.155 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -56.74 -39.27 73.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.068 0.461 . . . . 0.40000000000000002 110.86 -174.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 m -78.48 -53.59 7.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.84 -0.618 . . . . 1.02 112.181 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.429 ' CD1' HD22 ' A' ' 115' ' ' LEU . 8.3 m-85 -72.52 -28.29 62.77 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.802 0.667 . . . . 0.14999999999999999 112.802 -174.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.5 t -57.05 -28.39 62.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.749 0.309 . . . . 0.56000000000000005 111.428 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.35 -22.45 42.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.699 0.285 . . . . 1.04 111.748 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.401 ' HZ ' ' HE2' ' A' ' 157' ' ' LYS . 23.9 m-85 -90.38 -18.23 25.84 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.968 0.413 . . . . 0.20999999999999999 111.102 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 165.31 166.93 25.11 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.901 -0.59 . . . . 0.14000000000000001 111.632 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -67.7 129.75 40.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.927 0.394 . . . . 0.28999999999999998 110.268 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.417 HG21 ' HB3' ' A' ' 128' ' ' CYS . 71.8 mt -100.48 131.97 47.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.134 -0.485 . . . . 1.0700000000000001 110.281 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.53 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.61 -44.73 11.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.497 -0.927 . . . . 1.26 108.497 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.5 m -147.33 111.65 5.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.912 -1.04 . . . . 1.1799999999999999 110.544 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.4 p -107.22 145.12 33.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.254 -0.647 . . . . 1.49 109.254 173.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -144.83 128.79 17.47 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.407 -0.517 . . . . 1.6299999999999999 111.932 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.613 HG21 HD13 ' A' ' 115' ' ' LEU . 48.6 t -114.81 110.64 32.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 106.627 -1.62 . . . . 1.0700000000000001 106.627 168.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.67 121.08 32.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.985 -0.746 . . . . 1.1399999999999999 108.985 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 58.9 m -96.24 134.79 38.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.694 0.759 . . . . 2.3399999999999999 112.642 -165.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -87.35 163.62 16.7 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.702 -1.135 . . . . 2.0800000000000001 107.995 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.39 -25.9 62.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.024 0.44 . . . . 2.4500000000000002 110.607 173.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -91.61 -0.63 57.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 1.6499999999999999 110.341 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.642 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 138.98 -71.37 0.45 Allowed Glycine 0 C--O 1.226 -0.401 0 C-N-CA 120.653 -0.784 . . . . 1.23 113.367 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 37.1 t -139.44 144.47 38.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.432 0.616 . . . . 1.99 110.081 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.457 ' CE ' ' HH ' ' A' ' 140' ' ' TYR . 37.8 mtpt -76.87 -9.01 58.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.367 0.603 . . . . 2.0600000000000001 110.237 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.32 -17.56 34.09 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.422 -0.808 . . . . 0.31 113.182 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.457 ' HH ' ' CE ' ' A' ' 138' ' ' LYS . 25.7 p90 -127.19 150.59 49.45 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.207 0.527 . . . . 1.01 111.646 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.18 170.6 25.33 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.302 -0.863 . . . . 0.13 111.222 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -137.78 138.79 39.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.147 0.473 . . . . 0.31 110.841 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.549 HG11 ' CE2' ' A' ' 145' ' ' PHE . 42.6 t -113.74 135.45 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 120.962 0.41 . . . . 1.03 110.8 173.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -105.2 106.23 16.62 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.086 -0.709 . . . . 0.32000000000000001 109.086 166.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.549 ' CE2' HG11 ' A' ' 143' ' ' VAL . 17.4 m-85 -90.24 139.98 30.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.265 0.555 . . . . 0.17000000000000001 111.079 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.53 ' HA ' HD22 ' A' ' 126' ' ' LEU . 42.3 tt0 -50.57 -37.56 40.37 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.524 -1.216 . . . . 0.56999999999999995 110.93 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.8 p -121.68 155.87 34.25 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.023 -0.989 . . . . 1.1100000000000001 110.515 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -68.48 -36.31 78.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.104 -0.498 . . . . 0.46999999999999997 110.447 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.35 -34.81 75.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.598 . . . . 0.73999999999999999 112.014 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.83 -36.77 79.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.153 0.502 . . . . 1.03 110.454 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.467 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -65.04 -40.91 95.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.561 -0.745 . . . . 1.05 110.433 177.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 51.9 mt-10 -59.88 -37.35 79.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.636 -0.711 . . . . 1.4199999999999999 110.822 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 98.2 mtt180 -65.5 -43.99 88.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.352 -0.385 . . . . 2.0 110.876 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.43 83.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.222 -0.445 . . . . 1.02 110.532 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 151' ' ' ALA . 92.8 mt -60.65 -53.49 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 1.04 111.287 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.4 pt-20 -64.16 -43.4 95.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.182 0.515 . . . . 1.0800000000000001 111.902 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.52 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -81.26 -39.09 25.84 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.887 0.699 . . . . 1.78 112.887 -169.899 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 92.7 mmm -94.86 -20.22 19.63 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.686 0.625 . . . . 1.03 112.686 -172.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -68.05 123.39 20.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.392 -0.596 . . . . 0.60999999999999999 109.392 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.53 16.89 63.16 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.656 -0.783 . . . . 0.28999999999999998 112.667 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.589 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 4.4 mmt -98.48 156.23 16.87 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.718 -0.283 . . . . 1.72 111.072 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.485 HD21 ' O ' ' A' ' 165' ' ' ASP . 17.5 mt -98.77 103.75 15.73 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.626 -0.509 . . . . 1.1799999999999999 109.626 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 22.4 mt -91.01 104.28 16.89 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 120.054 -0.658 . . . . 1.1299999999999999 109.401 174.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 79.9 m-20 76.78 -27.75 0.18 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.129 -0.942 . . . . 1.71 112.519 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.485 ' O ' HD21 ' A' ' 162' ' ' LEU . 32.7 t70 163.94 -20.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.083 0.864 . . . . 0.84999999999999998 111.402 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.4 mtt180 -102.17 130.18 48.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.331 -0.395 . . . . 1.27 110.846 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 161' ' ' MET . 19.5 tttt -78.7 115.03 18.13 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.395 -0.594 . . . . 1.6499999999999999 109.395 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.4 HG13 HD21 ' A' ' 106' ' ' LEU . 12.9 m -100.56 149.57 6.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.614 0.721 . . . . 1.04 111.366 -172.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 77.4 t80 -106.33 118.93 37.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.834 -1.076 . . . . 0.41999999999999998 109.612 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.426 ' CG1' HD11 ' A' ' 101' ' ' ILE . 39.4 t -115.74 126.36 73.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.435 -0.58 . . . . 1.03 109.435 176.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.24 -176.32 23.17 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.78 -0.724 . . . . 0.17999999999999999 111.524 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -59.33 137.96 57.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.457 -0.571 . . . . 2.3599999999999999 109.457 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -61.29 94.6 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.973 -0.38 . . . . 1.4399999999999999 109.973 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.29 139.55 58.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.064 -0.517 . . . . 5.1399999999999997 110.596 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.1 m -78.28 52.7 1.15 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.601 0.715 . . . . 3.8100000000000001 110.288 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -121.6 12.29 10.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.465 -0.789 . . . . 8.2799999999999994 109.597 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -115.78 81.59 1.62 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.79 -0.641 . . . . 9.0099999999999998 109.73 176.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -118.71 -5.54 10.67 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.814 -0.81 . . . . 8.6500000000000004 108.814 174.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 38.3 ttp85 -81.59 100.36 9.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.957 -1.02 . . . . 12.789999999999999 109.339 172.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -101.91 -5.9 24.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.675 -0.693 . . . . 12.699999999999999 110.254 -175.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.42 33.77 0.16 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.618 -0.719 . . . . 13.800000000000001 112.196 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 117.96 -1.019 . . . . 15.050000000000001 108.995 174.13 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 111.941 -0.463 . . . . 15.130000000000001 111.941 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.44 -19.36 23.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.641 0.258 . . . . 13.73 111.252 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.565 ' HB2' ' HE ' ' A' ' 176' ' ' ARG . 34.5 m-20 -93.87 114.92 64.36 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.504 -0.316 . . . . 11.300000000000001 110.478 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.4 -67.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.653 2.236 . . . . 11.93 111.963 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.2 m -145.32 109.53 4.89 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.441 -0.345 . . . . 9.5199999999999996 111.085 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 84.2 mt -120.77 -41.54 2.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.886 0.374 . . . . 8.2100000000000009 110.813 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -147.6 -178.35 6.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.016 -0.538 . . . . 8.4100000000000001 109.857 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.562 ' HB2' ' HZ2' ' A' ' 95' ' ' LYS . 4.9 ttmp? -107.27 75.81 1.05 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.447 -0.575 . . . . 2.6600000000000001 109.447 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.474 ' HA ' ' HG2' ' A' ' 182' ' ' GLU . 2.8 p -73.86 162.51 29.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.909 -0.494 . . . . 2.3500000000000001 110.482 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.12 -39.71 2.69 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.37 -1.092 . . . . 1.02 110.37 -172.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.3 t 61.0 128.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.932 0.893 . . . . 1.3600000000000001 112.627 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.29 23.98 77.47 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.64 -1.267 . . . . 0.26000000000000001 111.507 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 173' ' ' PHE . 0.9 OUTLIER -84.28 126.44 33.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.887 -0.412 . . . . 0.63 109.887 -174.274 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.562 HG12 ' HB ' ' A' ' 143' ' ' VAL . 32.2 pt -134.55 155.8 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.708 -0.678 . . . . 1.05 109.631 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.96 139.68 53.37 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.631 -0.507 . . . . 0.26000000000000001 109.631 178.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 8.6 mt -118.03 137.36 52.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.79 -0.641 . . . . 1.01 110.197 -176.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -124.2 152.52 42.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.638 -0.256 . . . . 2.0800000000000001 110.403 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.446 ' HB3' ' O ' ' A' ' 167' ' ' LYS . 5.2 t30 74.69 45.32 0.17 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.806 0.813 . . . . 0.53000000000000003 110.847 170.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.474 HD22 HG22 ' A' ' 110' ' ' ILE . 20.1 mt -88.38 166.83 13.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.963 -1.017 . . . . 1.04 110.795 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -97.06 162.69 13.26 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.603 -0.517 . . . . 0.70999999999999996 109.603 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.7 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 17.3 pttm -66.27 -25.03 66.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.277 0.561 . . . . 2.7799999999999998 109.618 173.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.0 m -60.67 -16.19 36.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.122 -0.944 . . . . 1.8 112.074 175.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.474 HG22 HD22 ' A' ' 106' ' ' LEU . 44.9 mm -93.07 128.38 44.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.332 0.587 . . . . 1.1000000000000001 111.166 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -118.65 -178.09 3.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.283 -1.006 . . . . 1.5900000000000001 108.283 175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -61.81 -35.0 76.91 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.37 -0.604 . . . . 0.92000000000000004 109.37 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 1.038 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -61.76 -50.17 73.45 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.205 -0.907 . . . . 3.04 110.583 177.457 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.15 -42.9 99.39 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.576 -1.193 . . . . 1.03 110.968 -176.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.591 HD12 HG22 ' A' ' 130' ' ' VAL . 3.5 tt -65.51 -47.94 74.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.636 -0.711 . . . . 1.05 109.474 178.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.795 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.8 t80 -59.52 -44.71 93.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.442 . . . . 1.05 110.71 176.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.73 -42.67 79.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.178 -0.464 . . . . 0.40000000000000002 111.154 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.5 m -78.05 -53.37 7.48 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.352 0.501 . . . . 1.02 112.352 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.468 ' CD1' HD22 ' A' ' 115' ' ' LEU . 7.4 m-85 -71.12 -28.12 64.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.548 0.573 . . . . 0.14999999999999999 112.548 -172.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.3 t -57.89 -29.93 65.45 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.722 0.296 . . . . 0.56000000000000005 111.351 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.42 -22.67 44.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 1.04 111.361 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -91.07 -20.28 22.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.868 0.366 . . . . 0.20999999999999999 111.024 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.63 169.32 31.01 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.321 -0.711 . . . . 0.14000000000000001 111.321 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -69.72 141.63 53.46 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.96 -0.385 . . . . 0.28999999999999998 109.96 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.436 HG21 ' HB3' ' A' ' 128' ' ' CYS . 74.6 mt -112.43 135.94 50.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.241 -0.436 . . . . 1.0700000000000001 110.297 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.533 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -90.93 -41.73 10.98 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.635 -0.876 . . . . 1.26 108.635 179.573 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.463 ' OG ' ' HB2' ' A' ' 144' ' ' HIS . 95.7 p -145.5 126.96 15.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.287 -0.87 . . . . 1.1799999999999999 109.966 176.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.795 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.6 p -122.97 116.04 22.91 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.149 -0.685 . . . . 1.49 109.149 174.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -117.82 128.61 55.02 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.17 0.509 . . . . 1.6299999999999999 111.438 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.591 HG22 HD12 ' A' ' 115' ' ' LEU . 99.3 t -114.67 109.34 28.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 106.45 -1.685 . . . . 1.0700000000000001 106.45 170.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.9 t -76.14 115.6 17.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.553 -0.906 . . . . 1.1399999999999999 108.553 -175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.752 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 19.7 p -106.91 137.74 44.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.53 -0.759 . . . . 2.3399999999999999 112.685 -164.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -85.25 161.35 19.59 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.147 -1.056 . . . . 2.0800000000000001 108.147 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -58.83 -22.29 58.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.832 0.348 . . . . 2.4500000000000002 110.861 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -90.83 -5.91 54.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.013 0.435 . . . . 1.6499999999999999 110.649 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.7 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 149.66 -72.44 0.29 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.471 -0.871 . . . . 1.23 113.297 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.752 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 37.7 t -147.09 154.73 41.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.461 0.631 . . . . 1.99 110.736 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 36.6 mtpt -88.42 -10.36 49.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.073 0.463 . . . . 2.0600000000000001 110.611 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 107.09 -13.61 40.69 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.359 -0.924 . . . . 0.31 113.941 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -130.63 152.55 49.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.875 0.837 . . . . 1.01 112.071 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.73 173.34 26.98 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.252 -0.885 . . . . 0.13 112.094 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -141.62 138.31 32.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.243 0.217 . . . . 0.31 110.818 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.562 ' HB ' HG12 ' A' ' 101' ' ' ILE . 33.2 t -115.56 130.73 69.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.849 0.356 . . . . 1.03 111.277 175.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.463 ' HB2' ' OG ' ' A' ' 127' ' ' SER . 1.6 m170 -97.88 106.76 19.11 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.608 -0.886 . . . . 0.32000000000000001 108.608 165.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.536 ' CE2' HG11 ' A' ' 143' ' ' VAL . 7.8 m-85 -90.11 135.9 33.38 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.347 -0.541 . . . . 0.17000000000000001 111.196 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.533 ' HA ' HD22 ' A' ' 126' ' ' LEU . 36.2 tt0 -47.93 -40.26 21.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.531 -1.213 . . . . 0.56999999999999995 110.72 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.8 p -122.5 146.87 47.0 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.844 -1.071 . . . . 1.1100000000000001 110.765 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -64.18 -37.9 89.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.742 -0.663 . . . . 0.46999999999999997 111.149 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.35 -34.75 77.97 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.168 0.433 . . . . 0.73999999999999999 112.168 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.95 78.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.168 0.509 . . . . 1.03 110.826 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.528 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.8 -44.75 95.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.532 -0.758 . . . . 1.05 111.046 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 47.7 mt-10 -59.4 -39.41 83.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.912 -0.585 . . . . 1.4199999999999999 111.012 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 157' ' ' LYS . 62.2 mtt85 -61.03 -42.06 97.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.799 0.333 . . . . 2.0 110.664 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.34 -38.19 90.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.271 -0.422 . . . . 1.02 110.207 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.3 mt -61.55 -54.27 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.172 -0.467 . . . . 1.04 111.244 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.3 pt-20 -64.18 -44.08 93.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.118 0.485 . . . . 1.0800000000000001 111.706 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -78.04 -38.99 43.33 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.919 0.711 . . . . 1.78 112.919 -171.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 82.2 mmm -94.66 -27.51 15.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.907 0.706 . . . . 1.03 112.907 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -64.52 124.22 21.28 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.675 -0.41 . . . . 0.60999999999999999 110.529 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.25 15.68 60.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.083 -0.579 . . . . 0.28999999999999998 113.296 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.692 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 79.5 mmm -109.45 162.62 14.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.897 0.349 . . . . 1.72 111.806 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.8 mt -99.13 104.77 16.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.621 -0.881 . . . . 1.1799999999999999 108.621 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.05 22.44 2.4 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.141 -0.624 . . . . 1.1299999999999999 111.534 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.4 p30 171.35 -80.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.047 0.939 . . . . 1.71 108.54 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -150.32 17.6 0.84 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.45 -1.25 . . . . 0.84999999999999998 108.581 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -131.16 127.19 37.5 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.853 -1.067 . . . . 1.27 109.768 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.692 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.3 tttt -76.41 121.93 23.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.807 -0.633 . . . . 1.6499999999999999 109.654 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 17.8 m -101.29 142.17 16.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.282 0.563 . . . . 1.04 110.955 -174.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.62 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 76.5 t80 -106.25 118.08 35.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.27 -0.877 . . . . 0.41999999999999998 109.509 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.451 ' CG1' HD13 ' A' ' 101' ' ' ILE . 39.0 t -115.24 125.16 72.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.283 -0.636 . . . . 1.03 109.283 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -141.64 -170.82 12.55 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.672 -0.775 . . . . 0.17999999999999999 112.13 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -73.88 130.97 40.98 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.246 -0.279 . . . . 2.3599999999999999 110.246 -177.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.469 ' HB3' ' HB3' ' A' ' 100' ' ' ASN . 1.5 t80 -110.48 112.41 24.3 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.456 -0.572 . . . . 1.4399999999999999 109.456 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.5 ' HA ' ' HG3' ' A' ' 95' ' ' LYS . 83.2 tttt -97.48 96.1 8.1 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.775 -0.454 . . . . 5.1399999999999997 109.775 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 11.7 t -100.02 134.27 43.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.037 -0.529 . . . . 3.8100000000000001 110.843 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.565 ' HE ' ' HB2' ' A' ' 90' ' ' ASP . 30.8 tpt180 -137.89 4.41 2.53 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.287 0.565 . . . . 8.2799999999999994 110.14 176.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.557 ' HG3' ' HG2' ' A' ' 178' ' ' GLU . 13.3 ptmm? -59.65 -23.44 63.05 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.306 -0.406 . . . . 9.0099999999999998 111.048 178.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.557 ' HG2' ' HG3' ' A' ' 177' ' ' LYS . 11.0 pt-20 -173.23 139.44 0.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.021 -0.536 . . . . 8.6500000000000004 109.641 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.541 ' HG3' ' HB2' ' A' ' 182' ' ' GLU . 13.1 ttp180 -85.39 91.87 8.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.156 0.503 . . . . 12.789999999999999 110.275 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -90.88 -9.31 46.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.724 -0.671 . . . . 12.699999999999999 110.291 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 182' ' ' GLU . . . -170.32 102.25 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 13.800000000000001 110.732 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.541 ' HB2' ' HG3' ' A' ' 179' ' ' ARG . 4.0 mm-40 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 124.023 0.929 . . . . 15.050000000000001 108.818 173.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 112.227 -0.349 . . . . 15.130000000000001 112.227 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.29 -165.99 1.04 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.793 -0.447 . . . . 13.73 109.793 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -76.43 129.87 78.67 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.984 0.421 . . . . 11.300000000000001 110.689 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -83.73 -18.53 5.53 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.541 2.161 . . . . 11.93 111.168 172.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 93' ' ' LEU . 12.3 p 170.3 -63.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.671 -1.15 . . . . 9.5199999999999996 109.695 -174.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 92' ' ' SER . 56.7 mt 73.89 160.1 0.23 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.144 -0.935 . . . . 8.2100000000000009 111.035 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -129.12 -30.15 2.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.666 -0.697 . . . . 8.4100000000000001 110.5 -176.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.413 ' HB3' ' HB2' ' A' ' 100' ' ' ASN . 2.1 mptp? -122.51 45.87 2.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.555 -0.906 . . . . 2.6600000000000001 108.555 175.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.1 p -59.93 -19.17 50.38 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.211 -0.904 . . . . 2.3500000000000001 112.744 -173.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.26 -15.04 62.74 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.905 -0.664 . . . . 1.02 112.311 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.2 t 66.15 126.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.861 0.864 . . . . 1.3600000000000001 112.218 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 24.18 76.49 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.143 -1.027 . . . . 0.26000000000000001 111.39 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.512 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.3 m120 -88.36 124.64 34.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.858 -0.793 . . . . 0.63 108.858 -173.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.543 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.0 pt -136.26 163.7 33.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.628 -0.26 . . . . 1.05 110.374 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.3 143.92 50.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.061 0.458 . . . . 0.26000000000000001 110.143 175.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.9 mt -119.39 138.85 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.466 -0.788 . . . . 1.01 109.861 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -119.7 154.05 34.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.688 -0.233 . . . . 2.0800000000000001 110.556 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 35.0 t30 72.27 34.84 1.3 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.89 0.744 . . . . 0.53000000000000003 111.653 171.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.576 HD22 HG23 ' A' ' 110' ' ' ILE . 23.8 mt -74.73 160.19 31.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.122 0.486 . . . . 1.04 111.0 177.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -91.3 156.33 17.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.54 -0.755 . . . . 0.70999999999999996 109.805 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.652 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 15.6 pttp -60.78 -28.82 69.03 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.248 0.342 . . . . 2.7799999999999998 111.26 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.5 p -66.78 -26.77 67.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 1.8 111.859 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.576 HG23 HD22 ' A' ' 106' ' ' LEU . 47.8 mm -70.94 121.72 21.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.315 0.578 . . . . 1.1000000000000001 111.305 -172.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -111.79 -175.63 2.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.44 -0.948 . . . . 1.5900000000000001 108.44 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -69.71 -33.07 71.99 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 109.091 -0.707 . . . . 0.92000000000000004 109.091 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -48.24 72.39 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.861 -1.063 . . . . 3.04 109.056 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.12 96.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.146 -1.388 . . . . 1.03 110.878 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.628 HD13 HG22 ' A' ' 130' ' ' VAL . 3.1 tt -66.82 -47.38 72.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.843 -0.799 . . . . 1.05 108.843 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.682 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 52.2 t80 -59.36 -47.03 86.97 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.857 -0.611 . . . . 1.05 110.733 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.12 -41.78 75.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 0.40000000000000002 110.83 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.449 HG22 HD21 ' A' ' 163' ' ' LEU . 7.4 m -77.53 -53.66 7.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.805 -0.634 . . . . 1.02 112.001 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.466 ' CD1' HD23 ' A' ' 115' ' ' LEU . 10.9 m-85 -73.11 -29.3 62.81 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.427 0.529 . . . . 0.14999999999999999 112.427 -174.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 36.2 t -58.19 -27.76 64.16 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.678 0.275 . . . . 0.56000000000000005 111.15 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.73 -21.41 27.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.42 -0.355 . . . . 1.04 111.396 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -93.04 -20.75 20.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.20999999999999999 110.869 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 167.76 166.14 26.33 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.634 -0.586 . . . . 0.14000000000000001 111.634 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -66.01 139.96 58.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.052 0.453 . . . . 0.28999999999999998 110.514 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.427 HG21 ' HB3' ' A' ' 128' ' ' CYS . 79.6 mt -111.84 135.78 50.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.988 -0.551 . . . . 1.0700000000000001 109.969 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.552 HD23 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -89.01 -43.86 10.81 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.84 -0.8 . . . . 1.26 108.84 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.5 m -147.74 113.8 5.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.076 -0.966 . . . . 1.1799999999999999 110.423 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.682 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 4.7 p -110.86 139.89 45.79 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.432 -0.581 . . . . 1.49 109.432 174.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -138.63 128.23 24.78 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.014 0.435 . . . . 1.6299999999999999 111.306 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.628 HG22 HD13 ' A' ' 115' ' ' LEU . 59.2 t -114.37 109.3 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 106.194 -1.78 . . . . 1.0700000000000001 106.194 169.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.436 HG13 ' HG3' ' A' ' 138' ' ' LYS . 15.5 t -74.63 114.6 14.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.368 -0.975 . . . . 1.1399999999999999 108.368 -175.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 8.6 p -101.56 137.64 39.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.404 -0.816 . . . . 2.3399999999999999 112.438 -165.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.56 164.4 16.9 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.004 -1.11 . . . . 2.0800000000000001 108.004 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.67 -23.81 67.53 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.079 0.466 . . . . 2.4500000000000002 110.058 175.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -91.96 3.62 54.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 1.6499999999999999 110.376 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.652 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 139.77 -74.73 0.37 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.481 -0.866 . . . . 1.23 113.792 177.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.658 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 34.8 t -142.01 151.19 42.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.735 0.767 . . . . 1.99 110.924 -174.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.436 ' HG3' HG13 ' A' ' 131' ' ' VAL . 3.1 mmpt? -87.39 -4.96 59.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.31 0.576 . . . . 2.0600000000000001 110.081 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.02 -20.55 30.92 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.403 -0.817 . . . . 0.31 113.878 173.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -128.26 154.7 45.59 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.393 0.597 . . . . 1.01 111.842 -173.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.29 171.06 25.85 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.276 -0.875 . . . . 0.13 111.53 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -139.63 138.37 36.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.703 0.251 . . . . 0.31 110.535 -177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.588 HG12 ' CE2' ' A' ' 145' ' ' PHE . 42.9 t -114.43 136.1 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.201 0.524 . . . . 1.03 111.142 174.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.426 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.6 m170 -104.71 105.79 16.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.625 -0.716 . . . . 0.32000000000000001 109.07 165.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.588 ' CE2' HG12 ' A' ' 143' ' ' VAL . 13.3 m-85 -90.17 137.55 32.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.039 0.447 . . . . 0.17000000000000001 110.949 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.552 ' HA ' HD23 ' A' ' 126' ' ' LEU . 34.9 tt0 -48.24 -46.07 35.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.673 -1.148 . . . . 0.56999999999999995 110.587 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.8 p -114.0 148.39 37.04 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.911 -1.04 . . . . 1.1100000000000001 111.037 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -63.61 -36.12 82.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.612 -0.722 . . . . 0.46999999999999997 111.05 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -69.09 -35.32 76.34 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.324 -0.398 . . . . 0.73999999999999999 111.678 -176.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.13 79.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.049 0.452 . . . . 1.03 110.622 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.565 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.63 -43.76 98.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.645 -0.707 . . . . 1.05 110.558 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.2 mt-10 -60.83 -37.28 81.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.496 -0.774 . . . . 1.4199999999999999 110.804 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 157' ' ' LYS . 91.4 mtt180 -63.17 -46.18 88.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.927 0.394 . . . . 2.0 110.623 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.08 -38.82 80.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 1.02 110.532 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 170' ' ' VAL . 91.5 mt -60.13 -54.2 38.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.692 -0.686 . . . . 1.04 111.477 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.2 pt-20 -65.5 -42.45 92.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.196 0.522 . . . . 1.0800000000000001 112.251 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -77.42 -39.21 47.7 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 113.038 0.755 . . . . 1.78 113.038 -170.589 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 92.9 mmm -95.27 -16.44 22.45 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.519 0.563 . . . . 1.03 112.519 -173.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 155' ' ' ILE . 49.2 t-20 -66.84 124.35 22.7 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.304 -0.558 . . . . 0.60999999999999999 109.621 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.25 18.57 68.85 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.911 -0.661 . . . . 0.28999999999999998 112.228 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.437 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 8.6 tpp -105.05 156.51 17.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 1.72 110.444 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 89.8 mt -100.66 102.52 13.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.872 -0.604 . . . . 1.1799999999999999 109.566 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.449 HD21 HG22 ' A' ' 118' ' ' THR . 4.5 mt -81.75 11.66 4.65 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.745 0.646 . . . . 1.1299999999999999 112.745 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.28 -64.2 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.806 0.812 . . . . 1.71 109.189 -174.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -168.62 23.97 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.811 -1.54 . . . . 0.84999999999999998 109.294 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -139.82 133.66 30.66 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.898 -0.778 . . . . 1.27 108.898 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.4 mttm -77.77 122.42 25.37 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.326 0.391 . . . . 1.6499999999999999 109.968 176.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.3 m -101.49 140.1 21.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.316 0.579 . . . . 1.04 110.926 -178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 46.8 t80 -105.38 118.64 37.08 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.316 -0.856 . . . . 0.41999999999999998 109.178 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.492 ' O ' HG22 ' A' ' 155' ' ' ILE . 34.0 t -115.35 127.79 72.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.412 -0.588 . . . . 1.03 109.412 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.99 -172.7 19.01 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.072 -0.585 . . . . 0.17999999999999999 111.68 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 35.8 mmt-85 -60.28 141.76 55.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 2.3599999999999999 110.129 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -63.78 102.97 0.51 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.7 -0.682 . . . . 1.4399999999999999 111.591 -175.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -79.72 150.13 30.96 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.762 -0.829 . . . . 5.1399999999999997 108.762 173.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.8 m -65.89 89.9 0.12 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.264 0.554 . . . . 3.8100000000000001 111.09 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.468 ' HA ' ' NH1' ' A' ' 176' ' ' ARG . 8.0 mmm180 -128.01 48.17 2.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.74 -0.663 . . . . 8.2799999999999994 109.338 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 64.27 -166.83 0.22 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.659 -0.701 . . . . 9.0099999999999998 110.136 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.74 27.67 16.99 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.066 0.46 . . . . 8.6500000000000004 111.915 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -77.09 -23.47 51.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 12.789999999999999 110.169 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -89.9 6.7 40.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 12.699999999999999 111.047 -177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 61.96 27.74 16.84 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.988 -0.551 . . . . 13.800000000000001 112.159 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.653 -0.689 . . . . 15.050000000000001 109.966 179.251 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.803 0 N-CA-C 111.638 -0.585 . . . . 15.130000000000001 111.638 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.68 -18.48 62.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.604 0.716 . . . . 13.73 109.705 174.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 8.7 p-10 -82.29 123.39 79.27 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 114.816 -1.084 . . . . 11.300000000000001 110.476 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 24.3 Cg_exo -64.56 -74.15 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.731 2.287 . . . . 11.93 112.269 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.4 p -144.9 116.69 8.21 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.819 -0.437 . . . . 9.5199999999999996 109.819 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.625 ' HB3' ' HA ' ' A' ' 96' ' ' SER . 75.7 mt -99.44 97.23 8.28 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.043 -0.411 . . . . 8.2100000000000009 111.124 -174.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.54 ' HB2' ' OE1' ' A' ' 180' ' ' GLU . 14.3 mtm180 -72.41 -46.71 53.96 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.726 -1.583 . . . . 8.4100000000000001 106.726 167.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.959 ' HB2' ' HG2' ' A' ' 180' ' ' GLU . 47.5 tttp -86.9 80.52 8.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.234 -1.348 . . . . 2.6600000000000001 108.638 168.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.625 ' HA ' ' HB3' ' A' ' 93' ' ' LEU . 11.6 p -71.66 -177.84 2.03 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.108 0.48 . . . . 2.3500000000000001 112.15 -174.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.419 ' O ' ' HB ' ' A' ' 98' ' ' VAL . . . 85.93 -53.21 4.64 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.218 -0.753 . . . . 1.02 111.218 -174.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 97' ' ' GLY . 42.9 t 72.05 127.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.609 0.764 . . . . 1.3600000000000001 111.6 -174.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.14 23.51 77.85 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 119.834 -1.174 . . . . 0.26000000000000001 111.433 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.479 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.1 m-80 -88.2 125.59 34.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.423 -0.584 . . . . 0.63 109.423 -174.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.471 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.6 pt -134.9 162.13 39.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.589 -0.522 . . . . 1.05 109.589 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.06 140.61 52.74 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.862 -0.421 . . . . 0.26000000000000001 109.862 177.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.1 mt -117.16 141.86 33.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.588 -0.733 . . . . 1.01 109.615 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -126.66 154.99 43.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.696 -0.229 . . . . 2.0800000000000001 110.577 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.4 t30 73.56 32.63 1.16 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.969 0.793 . . . . 0.53000000000000003 111.389 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.419 HD21 HG21 ' A' ' 110' ' ' ILE . 30.1 mt -76.67 162.92 27.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.033 0.444 . . . . 1.04 111.136 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -102.52 151.47 22.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.713 -0.676 . . . . 0.70999999999999996 109.467 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -22.4 63.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.636 -0.256 . . . . 2.7799999999999998 111.646 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.4 p -69.13 -11.05 60.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.648 -0.251 . . . . 1.8 111.449 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.538 HG22 HG22 ' A' ' 130' ' ' VAL . 49.2 mm -92.18 122.83 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.856 0.36 . . . . 1.1000000000000001 110.158 177.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -109.7 -177.25 3.22 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.518 -0.919 . . . . 1.5900000000000001 108.518 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.22 -34.56 78.37 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.192 -0.669 . . . . 0.92000000000000004 109.192 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.967 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -62.54 -50.49 71.14 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.19 -0.913 . . . . 3.04 110.348 178.083 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.17 98.5 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.076 -1.42 . . . . 1.03 111.253 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.407 HD13 HG23 ' A' ' 130' ' ' VAL . 4.0 tt -66.75 -46.79 74.28 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.189 -0.914 . . . . 1.05 108.934 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.751 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 66.1 t80 -59.42 -46.48 88.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 1.05 110.925 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -55.97 -40.92 73.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.008 0.433 . . . . 0.40000000000000002 111.059 -176.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.513 HG22 HD21 ' A' ' 163' ' ' LEU . 15.3 m -78.0 -53.71 7.11 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.754 -0.657 . . . . 1.02 112.127 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -72.55 -29.1 63.27 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.305 0.483 . . . . 0.14999999999999999 112.305 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.3 t -58.13 -28.63 64.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.651 0.263 . . . . 0.56000000000000005 111.091 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.64 37.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.725 0.298 . . . . 1.04 111.293 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -91.82 -21.53 20.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.382 -0.372 . . . . 0.20999999999999999 111.002 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 169.24 166.1 27.72 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.86 -0.686 . . . . 0.14000000000000001 112.183 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -62.53 133.93 55.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.012 0.434 . . . . 0.28999999999999998 110.553 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 75.4 mt -109.04 128.8 64.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.899 -0.592 . . . . 1.0700000000000001 110.187 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -82.23 -38.9 23.83 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.702 -0.851 . . . . 1.26 108.702 -178.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 m -153.32 129.95 10.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.094 -0.957 . . . . 1.1799999999999999 110.455 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.751 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.0 p -126.81 149.52 49.65 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.332 -0.618 . . . . 1.49 109.332 176.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -150.73 131.65 14.21 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.437 -0.505 . . . . 1.6299999999999999 112.175 -174.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 110' ' ' ILE . 69.1 t -110.99 110.42 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 106.359 -1.719 . . . . 1.0700000000000001 106.359 167.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.2 t -80.96 115.67 23.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.08 -0.711 . . . . 1.1399999999999999 109.08 -174.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.758 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 71.9 m -105.98 146.56 29.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.355 -0.839 . . . . 2.3399999999999999 111.689 -170.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.443 ' H ' ' CA ' ' A' ' 137' ' ' SER . 34.4 t70 -85.01 158.63 20.42 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.166 -1.05 . . . . 2.0800000000000001 108.166 173.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -55.23 -29.65 58.42 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.789 0.328 . . . . 2.4500000000000002 110.352 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -91.58 4.15 53.31 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.449 -0.341 . . . . 1.6499999999999999 111.315 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 132' ' ' CYS . . . 149.78 -72.87 0.29 Allowed Glycine 0 CA--C 1.522 0.514 0 C-N-CA 119.735 -1.222 . . . . 1.23 114.939 176.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.758 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 23.6 p -155.19 146.65 23.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.735 0.768 . . . . 1.99 110.594 -169.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.531 ' CE ' ' HH ' ' A' ' 140' ' ' TYR . 35.1 mtpt -93.06 -14.8 26.87 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.015 0.436 . . . . 2.0600000000000001 111.147 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 106.49 -19.71 36.1 Favored Glycine 0 C--N 1.314 -0.674 0 C-N-CA 120.095 -1.05 . . . . 0.31 114.025 174.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.531 ' HH ' ' CE ' ' A' ' 138' ' ' LYS . 26.8 p90 -125.49 156.58 38.75 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 117.501 0.65 . . . . 1.01 111.912 -173.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.79 172.41 28.95 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.353 -0.839 . . . . 0.13 111.598 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -137.92 140.84 40.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.015 0.407 . . . . 0.31 110.757 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.565 HG13 ' CE2' ' A' ' 145' ' ' PHE . 43.8 t -113.68 135.87 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.01 0.433 . . . . 1.03 110.685 172.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.408 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 1.1 m170 -105.98 105.76 15.95 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.095 -0.706 . . . . 0.32000000000000001 109.095 167.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.565 ' CE2' HG13 ' A' ' 143' ' ' VAL . 15.8 m-85 -90.7 136.61 32.95 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.126 0.489 . . . . 0.17000000000000001 111.24 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.547 ' HA ' HD23 ' A' ' 126' ' ' LEU . 41.7 tt0 -49.31 -42.84 42.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.457 -1.247 . . . . 0.56999999999999995 110.726 178.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.8 p -115.28 144.85 43.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.64 -1.164 . . . . 1.1100000000000001 111.241 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -63.09 -36.97 85.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.498 -0.774 . . . . 0.46999999999999997 110.939 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 9.8 pt-20 -69.39 -35.11 75.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.389 -0.368 . . . . 0.73999999999999999 111.747 -177.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.64 -34.66 76.07 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.083 0.468 . . . . 1.03 110.556 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.521 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -64.57 -43.04 95.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.6 -0.727 . . . . 1.05 110.883 177.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 53.5 mt-10 -59.53 -40.08 86.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.511 . . . . 1.4199999999999999 110.28 176.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.491 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 95.4 mtt180 -60.59 -40.75 92.89 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.186 -0.461 . . . . 2.0 110.943 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.62 -36.32 82.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 1.02 110.568 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 151' ' ' ALA . 80.6 mt -62.53 -54.42 34.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 1.04 110.995 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.3 pt-20 -60.78 -43.43 98.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.174 0.511 . . . . 1.0800000000000001 111.677 -179.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.416 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.74 -39.05 22.42 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 113.062 0.764 . . . . 1.78 113.062 -170.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 89.6 mmm -92.26 -24.51 18.97 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.78 0.659 . . . . 1.03 112.78 -172.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.464 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 53.3 t30 -67.17 124.27 22.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.215 -0.594 . . . . 0.60999999999999999 110.206 -178.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.04 11.12 63.65 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.833 -0.698 . . . . 0.28999999999999998 112.609 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.644 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 30.8 mmt -97.63 159.65 14.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.885 0.374 . . . . 1.72 111.713 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.9 mt -102.49 101.14 11.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.952 -0.759 . . . . 1.1799999999999999 108.952 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.513 HD21 HG22 ' A' ' 118' ' ' THR . 2.8 mt -78.16 13.52 1.45 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.042 0.756 . . . . 1.1299999999999999 113.042 -175.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 167.48 -59.57 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.883 0.849 . . . . 1.71 109.368 -174.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -169.74 24.66 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.798 -1.546 . . . . 0.84999999999999998 109.433 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 166' ' ' ARG . 46.9 mtt180 -140.29 127.22 20.72 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.583 -0.735 . . . . 1.27 109.381 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 161' ' ' MET . 13.6 tttt -76.77 116.47 17.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.18 -0.674 . . . . 1.6499999999999999 109.18 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.2 m -100.33 144.79 12.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.383 0.611 . . . . 1.04 110.846 -174.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 73.6 t80 -106.14 119.71 39.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.185 -0.916 . . . . 0.41999999999999998 109.517 -179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.406 ' CG1' HD11 ' A' ' 101' ' ' ILE . 42.0 t -114.93 125.64 72.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.988 -0.745 . . . . 1.03 108.988 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.18 -178.82 21.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.498 -0.858 . . . . 0.17999999999999999 112.413 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.8 mmt-85 -60.54 126.87 29.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 2.3599999999999999 111.384 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -77.06 122.9 25.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.327 -1.36 . . . . 1.4399999999999999 107.327 170.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.536 ' HD3' ' HG3' ' A' ' 178' ' ' GLU . 51.5 mttp -68.34 -70.41 0.27 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.792 -0.363 . . . . 5.1399999999999997 110.743 -173.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.513 ' HB3' ' O ' ' A' ' 177' ' ' LYS . 22.6 t 175.67 -158.1 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.321 -0.992 . . . . 3.8100000000000001 108.321 -176.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.498 ' HD3' ' H ' ' A' ' 176' ' ' ARG . 0.1 OUTLIER -70.96 -25.36 62.69 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.649 -0.871 . . . . 8.2799999999999994 108.649 172.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.58 ' HD3' ' N ' ' A' ' 178' ' ' GLU . 1.7 tmtp? -143.61 155.41 44.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.315 -1.365 . . . . 9.0099999999999998 107.315 175.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.58 ' N ' ' HD3' ' A' ' 177' ' ' LYS . 38.8 tt0 -65.86 91.39 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.268 0.556 . . . . 8.6500000000000004 110.697 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -131.99 3.53 4.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.601 -0.727 . . . . 12.789999999999999 110.83 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.959 ' HG2' ' HB2' ' A' ' 95' ' ' LYS . 9.1 tp10 -133.44 21.28 3.98 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.551 0.691 . . . . 12.699999999999999 110.337 -173.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -111.06 71.79 0.76 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.855 -0.611 . . . . 13.800000000000001 110.032 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.641 -0.695 . . . . 15.050000000000001 109.859 -178.21 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.487 0 N-CA-C 111.768 -0.533 . . . . 15.130000000000001 111.768 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.32 -59.3 0.49 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.981 0.419 . . . . 13.73 110.261 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.45 113.95 3.8 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.747 -0.66 . . . . 11.300000000000001 110.383 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.64 -23.97 63.11 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.799 2.333 . . . . 11.93 111.883 177.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.1 m -125.73 101.69 6.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.059 -0.519 . . . . 9.5199999999999996 110.373 178.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 52.9 mt -114.52 -43.43 3.17 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.049 0.452 . . . . 8.2100000000000009 110.38 177.12 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 94' ' ' ARG . 57.4 mtp180 -113.12 -172.34 2.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.78 -0.645 . . . . 8.4100000000000001 109.648 -177.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -100.6 6.4 44.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.422 0.629 . . . . 2.6600000000000001 110.106 -176.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.0 m -71.47 2.53 4.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.69 -0.686 . . . . 2.3500000000000001 111.653 -177.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.54 -23.63 64.58 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.178 -0.534 . . . . 1.02 111.909 174.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 59.14 136.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.624 1.169 . . . . 1.3600000000000001 112.547 -174.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.25 23.85 77.31 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.941 -1.123 . . . . 0.26000000000000001 110.688 -175.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.498 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.0 OUTLIER -94.06 126.82 39.5 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.539 -0.541 . . . . 0.63 109.539 -173.33 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.496 HG23 ' HB2' ' A' ' 151' ' ' ALA . 20.8 pt -134.8 161.16 40.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.066 -0.346 . . . . 1.05 110.066 175.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.72 142.66 51.24 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.836 -0.431 . . . . 0.26000000000000001 109.836 177.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.4 mt -119.52 135.69 59.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.707 -0.679 . . . . 1.01 110.065 -177.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -117.48 153.26 33.44 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.468 -0.197 . . . . 2.0800000000000001 110.468 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.0 t30 72.54 37.52 0.88 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.01 0.819 . . . . 0.53000000000000003 111.797 172.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.639 HD21 HG22 ' A' ' 110' ' ' ILE . 20.4 mt -76.89 153.83 34.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.359 -0.382 . . . . 1.04 110.843 177.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.498 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 13.4 t70 -83.09 149.26 27.02 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.643 -0.502 . . . . 0.70999999999999996 109.643 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -56.94 -31.16 64.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.079 -0.51 . . . . 2.7799999999999998 111.659 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.4 p -71.42 -9.09 57.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 1.8 112.015 -179.034 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.639 HG22 HD21 ' A' ' 106' ' ' LEU . 46.6 mm -82.48 113.4 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.071 0.462 . . . . 1.1000000000000001 110.622 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 17.6 t70 -102.75 -176.15 3.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.687 -0.857 . . . . 1.5900000000000001 108.687 176.38 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.429 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 2.1 m-20 -61.97 -41.32 97.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.879 -0.786 . . . . 0.92000000000000004 108.879 179.651 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.957 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -58.97 -49.94 75.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.305 -0.861 . . . . 3.04 110.583 178.093 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.15 -42.27 99.09 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.133 -1.394 . . . . 1.03 111.266 -177.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.479 HD11 HG23 ' A' ' 130' ' ' VAL . 4.0 tt -66.51 -46.63 75.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.33 -0.85 . . . . 1.05 108.994 177.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.614 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 67.9 t80 -58.63 -46.88 86.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.033 -0.531 . . . . 1.05 110.917 175.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.32 -38.83 71.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.153 0.501 . . . . 0.40000000000000002 110.82 -175.725 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.638 HG22 HD23 ' A' ' 163' ' ' LEU . 9.3 m -77.93 -54.15 6.63 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.785 -0.643 . . . . 1.02 112.147 -178.341 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -73.07 -28.04 62.08 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.981 0.734 . . . . 0.14999999999999999 112.981 -174.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.4 t -57.08 -29.4 63.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.764 0.316 . . . . 0.56000000000000005 111.643 -176.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.42 -21.6 37.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.364 -0.38 . . . . 1.04 111.744 178.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -92.67 -18.37 23.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.20999999999999999 111.393 -177.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 166.68 171.61 33.01 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.994 -0.622 . . . . 0.14000000000000001 111.85 -178.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -72.57 135.93 45.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.797 0.332 . . . . 0.28999999999999998 110.342 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.411 HG22 ' HB3' ' A' ' 128' ' ' CYS . 66.3 mt -111.24 134.88 52.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.401 -0.363 . . . . 1.0700000000000001 110.323 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.547 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -91.28 -49.18 6.5 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.801 -0.815 . . . . 1.26 108.801 179.543 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 66.5 m -141.77 100.19 3.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.901 -1.045 . . . . 1.1799999999999999 110.915 -175.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.614 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 13.2 p -95.97 148.41 22.67 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.795 -0.817 . . . . 1.49 108.795 172.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -146.68 129.14 15.92 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.645 -0.422 . . . . 1.6299999999999999 111.546 -174.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.479 HG23 HD11 ' A' ' 115' ' ' LEU . 75.4 t -110.06 110.2 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 106.606 -1.627 . . . . 1.0700000000000001 106.606 169.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.6 t -76.64 120.28 26.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 115.653 -0.703 . . . . 1.1399999999999999 109.565 -172.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 3.8 p -96.0 137.06 35.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.1 -0.954 . . . . 2.3399999999999999 111.278 -168.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -86.01 161.98 18.71 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.773 -0.825 . . . . 2.0800000000000001 108.773 178.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.37 -28.95 60.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.059 0.457 . . . . 2.4500000000000002 110.108 171.373 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -88.6 0.52 56.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.01 -0.541 . . . . 1.6499999999999999 110.502 178.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 132.43 -66.34 0.58 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.646 -0.787 . . . . 1.23 113.97 -179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.5 p -138.86 130.28 27.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.423 0.612 . . . . 1.99 110.858 -172.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -74.43 -36.66 63.42 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.155 0.502 . . . . 2.0600000000000001 111.038 -175.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.14 -14.91 8.29 Favored Glycine 0 C--N 1.309 -0.953 0 C-N-CA 120.15 -1.024 . . . . 0.31 113.597 -179.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -132.4 157.01 45.63 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.24 0.52 . . . . 1.01 111.186 -176.254 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.91 177.21 25.36 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.759 -0.655 . . . . 0.13 111.824 -177.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -136.35 143.12 43.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.494 -0.187 . . . . 0.31 110.494 -176.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.506 HG11 ' CE2' ' A' ' 145' ' ' PHE . 45.9 t -115.44 129.78 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.06 0.457 . . . . 1.03 110.493 171.055 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.9 OUTLIER -100.73 105.32 16.65 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.079 -0.712 . . . . 0.32000000000000001 109.079 167.216 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.544 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.6 m-85 -88.13 140.92 29.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.264 0.554 . . . . 0.17000000000000001 110.693 178.674 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.547 ' HA ' HD21 ' A' ' 126' ' ' LEU . 24.6 tt0 -50.88 -41.13 58.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.324 -1.307 . . . . 0.56999999999999995 110.479 177.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.0 p -122.98 148.31 45.65 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.606 -1.179 . . . . 1.1100000000000001 111.229 -178.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -60.55 -36.55 78.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.441 -0.799 . . . . 0.46999999999999997 111.368 179.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 9.7 pt-20 -67.45 -35.97 80.27 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.0 0.37 . . . . 0.73999999999999999 112.0 -176.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.43 78.06 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.09 0.471 . . . . 1.03 110.372 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.544 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.19 -44.63 96.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.516 -0.765 . . . . 1.05 110.86 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.932 ' HG2' HH12 ' A' ' 172' ' ' ARG . 28.1 mt-10 -59.5 -42.27 91.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 1.4199999999999999 110.707 178.183 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.516 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 46.8 mtt180 -59.47 -41.06 88.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.127 -0.488 . . . . 2.0 110.569 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.76 -37.15 84.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.088 -0.505 . . . . 1.02 110.674 178.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.7 mt -60.01 -52.99 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 1.04 110.988 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 0.7 OUTLIER -63.43 -45.47 90.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.01 0.433 . . . . 1.0800000000000001 111.877 -179.399 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -80.39 -39.19 28.86 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.884 0.698 . . . . 1.78 112.884 -169.148 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 89.3 mmm -93.08 -15.85 25.62 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.277 0.473 . . . . 1.03 112.277 -173.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -70.29 123.27 21.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.566 -0.901 . . . . 0.60999999999999999 108.566 176.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.76 11.98 78.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.562 -0.828 . . . . 0.28999999999999998 111.967 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -93.09 150.7 20.34 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.827 -0.805 . . . . 1.72 108.827 178.443 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 23.3 mt -97.11 124.57 41.17 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.92 -0.77 . . . . 1.1799999999999999 108.92 177.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.638 HD23 HG22 ' A' ' 118' ' ' THR . 27.3 mt -110.05 99.35 8.46 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.796 -0.761 . . . . 1.1299999999999999 109.838 173.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 70.5 m-20 78.29 -23.14 0.25 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.98 -1.009 . . . . 1.71 112.812 176.406 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 33.7 t70 167.77 -22.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.815 0.697 . . . . 0.84999999999999998 112.069 -177.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.498 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.1 mtt180 -109.81 136.78 48.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.797 0.332 . . . . 1.27 110.875 -170.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 26.6 tttt -84.88 118.74 24.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.689 -0.687 . . . . 1.6499999999999999 109.39 -178.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.3 m -101.27 148.43 7.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.7 0.762 . . . . 1.04 111.791 -171.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.547 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 55.3 t80 -106.97 119.18 38.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.659 -1.155 . . . . 0.41999999999999998 109.318 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.417 ' CG1' HD12 ' A' ' 101' ' ' ILE . 39.4 t -115.72 125.85 73.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.574 -0.528 . . . . 1.03 109.574 178.208 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.6 -175.15 20.14 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.715 -0.755 . . . . 0.17999999999999999 112.278 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.932 HH12 ' HG2' ' A' ' 152' ' ' GLU . 24.4 mmt180 -61.71 139.45 58.31 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.548 0.205 . . . . 2.3599999999999999 110.53 179.08 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -85.08 113.44 21.48 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.709 -0.848 . . . . 1.4399999999999999 108.709 174.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.594 ' HB3' ' HZ3' ' A' ' 174' ' ' LYS . 0.4 OUTLIER -138.63 139.86 38.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.215 0.531 . . . . 5.1399999999999997 111.258 -178.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.5 t -78.12 169.88 17.54 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.308 -1.367 . . . . 3.8100000000000001 107.308 168.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -60.58 -32.99 72.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.248 0.547 . . . . 8.2799999999999994 109.787 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -108.89 89.17 2.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.733 -0.667 . . . . 9.0099999999999998 110.027 168.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -79.54 87.07 5.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.951 -0.759 . . . . 8.6500000000000004 108.951 175.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -134.99 136.92 42.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.586 -0.733 . . . . 12.789999999999999 110.217 -176.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -136.32 103.88 5.44 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.668 -0.493 . . . . 12.699999999999999 109.668 175.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.82 84.34 4.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.055 0.455 . . . . 13.800000000000001 110.894 -177.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.66 -0.686 . . . . 15.050000000000001 109.211 -179.839 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 112.15 -0.38 . . . . 15.130000000000001 112.15 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.4 -4.82 59.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.274 0.559 . . . . 13.73 110.422 178.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.647 ' HB2' ' HG ' ' A' ' 93' ' ' LEU . 11.6 p-10 -83.35 123.63 76.74 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.492 -0.776 . . . . 11.300000000000001 110.356 178.394 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 14.5 Cg_exo -68.75 -71.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.474 2.116 . . . . 11.93 111.144 177.308 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.1 m -144.65 90.27 2.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.155 -0.475 . . . . 9.5199999999999996 110.103 175.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.647 ' HG ' ' HB2' ' A' ' 90' ' ' ASP . 82.9 mt -78.46 145.84 34.79 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.37 -0.604 . . . . 8.2100000000000009 109.37 176.018 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.545 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 73.3 mtt180 -78.49 -34.53 47.4 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.976 0.172 . . . . 8.4100000000000001 110.624 -177.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 79.8 tttt 166.21 -9.18 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.265 0.978 . . . . 2.6600000000000001 109.272 177.544 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 p -73.17 14.95 0.25 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.218 -0.901 . . . . 2.3500000000000001 112.735 -176.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA3' ' OD1' ' A' ' 100' ' ' ASN . . . -70.93 -27.62 71.93 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.8 -0.714 . . . . 1.02 111.58 176.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 97' ' ' GLY . 42.4 t 71.55 123.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.416 0.687 . . . . 1.3600000000000001 111.925 -175.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.31 24.02 76.15 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.027 -1.082 . . . . 0.26000000000000001 111.535 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.518 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.3 m120 -88.63 125.3 34.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.933 -0.766 . . . . 0.63 108.933 -174.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.506 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.4 pt -135.74 163.53 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.533 -0.303 . . . . 1.05 110.188 177.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.24 145.27 50.83 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.851 -0.425 . . . . 0.26000000000000001 109.851 175.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 6.2 mt -118.38 148.32 21.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.776 -0.647 . . . . 1.01 110.019 -177.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -131.25 149.43 52.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.35 -0.386 . . . . 2.0800000000000001 110.601 -172.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 64.1 t30 67.63 35.68 3.97 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.639 0.587 . . . . 0.53000000000000003 111.794 173.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.456 HD23 HG21 ' A' ' 110' ' ' ILE . 20.1 mt -72.33 152.91 41.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.083 0.468 . . . . 1.04 111.133 176.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.51 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.4 t70 -77.19 150.4 35.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.466 -0.788 . . . . 0.70999999999999996 110.565 177.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.466 ' NZ ' ' HA3' ' A' ' 136' ' ' GLY . 3.4 tptt -62.14 -33.92 75.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.053 -0.522 . . . . 2.7799999999999998 111.106 -177.019 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 t -76.05 -4.85 43.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.381 -0.372 . . . . 1.8 111.057 -176.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.456 HG21 HD23 ' A' ' 106' ' ' LEU . 36.0 mm -78.82 127.19 39.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.898 0.38 . . . . 1.1000000000000001 110.433 178.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -111.6 -179.97 3.85 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.592 -0.521 . . . . 1.5900000000000001 109.592 -179.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.625 ' OD1' ' HA ' ' A' ' 129' ' ' LYS . 67.8 m-80 -65.4 -37.81 88.07 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.19 -0.67 . . . . 0.92000000000000004 109.19 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 1.003 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.76 -49.19 78.5 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.976 -1.011 . . . . 3.04 110.017 177.618 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.29 97.41 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.772 -1.558 . . . . 1.03 111.463 -177.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.596 HD11 HG22 ' A' ' 130' ' ' VAL . 4.2 tt -63.84 -47.3 81.3 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.993 -0.743 . . . . 1.05 108.993 177.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.709 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 63.8 t80 -60.2 -47.5 85.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.036 -0.529 . . . . 1.05 110.846 176.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.57 -39.08 75.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.91 0.386 . . . . 0.40000000000000002 110.79 -175.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.5 m -77.21 -52.91 8.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 1.02 111.724 -178.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -71.93 -28.32 63.39 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.385 0.513 . . . . 0.14999999999999999 112.385 -175.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.2 t -57.45 -28.95 63.8 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.457 0.169 . . . . 0.56000000000000005 111.457 -177.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.82 -21.76 31.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.846 0.355 . . . . 1.04 111.386 177.291 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -92.21 -10.76 37.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.20999999999999999 111.205 -178.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.59 163.75 12.7 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.128 -0.558 . . . . 0.14000000000000001 111.725 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.95 137.82 58.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.185 0.517 . . . . 0.28999999999999998 110.171 177.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.434 HG22 ' HB3' ' A' ' 128' ' ' CYS . 82.2 mt -110.54 132.73 58.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.71 -0.677 . . . . 1.0700000000000001 109.877 -178.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.07 -39.13 14.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.87 -0.789 . . . . 1.26 108.87 -177.429 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 144' ' ' HIS . 82.5 p -146.53 134.11 20.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.291 -0.868 . . . . 1.1799999999999999 109.681 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.709 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.3 p -133.81 130.28 37.74 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.285 -0.635 . . . . 1.49 109.285 176.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.625 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 58.0 tptt -132.33 134.84 45.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.159 0.504 . . . . 1.6299999999999999 111.891 -174.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.596 HG22 HD11 ' A' ' 115' ' ' LEU . 95.2 t -114.01 109.6 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 106.355 -1.72 . . . . 1.0700000000000001 106.355 170.028 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.99 121.04 27.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.917 -0.583 . . . . 1.1399999999999999 109.798 -172.019 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.78 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 58.6 m -97.51 135.29 39.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.186 -0.915 . . . . 2.3399999999999999 112.204 -165.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.423 ' H ' ' CA ' ' A' ' 137' ' ' SER . 0.2 OUTLIER -87.33 175.01 8.21 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.074 -0.713 . . . . 2.0800000000000001 109.074 174.384 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.28 -33.17 52.06 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.756 0.28 . . . . 2.4500000000000002 111.756 177.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -92.12 -7.76 47.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 1.6499999999999999 111.438 -178.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.466 ' HA3' ' NZ ' ' A' ' 108' ' ' LYS . . . 148.01 -44.61 0.77 Allowed Glycine 0 C--O 1.225 -0.45 0 C-N-CA 119.461 -1.352 . . . . 1.23 115.135 175.457 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.78 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 45.8 m -155.15 133.46 11.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.04 0.92 . . . . 1.99 111.895 -172.213 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 33.5 mtpt -79.66 -36.47 37.7 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.041 0.448 . . . . 2.0600000000000001 111.602 -176.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 131.57 -19.85 4.72 Favored Glycine 0 C--N 1.311 -0.806 0 C-N-CA 120.135 -1.031 . . . . 0.31 114.051 -178.789 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -122.26 155.26 36.27 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 117.523 0.661 . . . . 1.01 111.315 -174.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -147.85 173.66 27.83 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.13 111.964 -178.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.37 136.73 36.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.826 0.313 . . . . 0.31 110.706 -177.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.52 HG12 ' CE2' ' A' ' 145' ' ' PHE . 38.5 t -114.56 134.98 55.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.02 0.438 . . . . 1.03 111.002 173.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.445 ' HB2' ' OG ' ' A' ' 127' ' ' SER . 1.5 m170 -103.25 106.71 17.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.736 -0.665 . . . . 0.32000000000000001 109.212 167.218 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.52 ' CE2' HG12 ' A' ' 143' ' ' VAL . 14.4 m-85 -89.91 135.92 33.35 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.323 0.583 . . . . 0.17000000000000001 111.372 179.082 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.565 ' HA ' HD21 ' A' ' 126' ' ' LEU . 44.5 tt0 -46.36 -43.54 16.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.919 -1.492 . . . . 0.56999999999999995 111.017 177.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.4 p -116.4 147.37 41.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.937 -1.029 . . . . 1.1100000000000001 111.046 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -60.23 -39.81 87.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.887 -0.597 . . . . 0.46999999999999997 110.917 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.22 -33.44 73.33 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.319 -0.4 . . . . 0.73999999999999999 111.678 -177.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.59 74.22 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.149 0.499 . . . . 1.03 110.318 177.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -67.34 -41.96 84.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.62 -0.718 . . . . 1.05 110.369 176.224 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 44.0 mt-10 -58.57 -40.26 82.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 1.4199999999999999 110.305 177.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.445 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 65.3 mtt180 -59.5 -50.14 75.08 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 120.882 0.372 . . . . 2.0 110.623 174.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.42 -38.85 81.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 1.02 110.88 -178.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 151' ' ' ALA . 84.9 mt -60.98 -54.88 29.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.251 -0.431 . . . . 1.04 110.864 178.108 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 3.2 pt-20 -64.22 -44.76 90.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.169 0.509 . . . . 1.0800000000000001 111.774 -178.737 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -76.37 -39.06 54.83 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.926 0.713 . . . . 1.78 112.926 -170.739 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 91.4 mmm -94.26 -22.3 18.48 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.602 0.593 . . . . 1.03 112.602 -173.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.49 123.65 20.21 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.221 -0.592 . . . . 0.60999999999999999 109.823 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.478 ' O ' ' HE2' ' A' ' 167' ' ' LYS . . . 83.89 22.55 55.12 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.786 -0.721 . . . . 0.28999999999999998 112.513 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 2.7 mmt -109.26 160.31 16.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.76 0.314 . . . . 1.72 111.159 177.061 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 29.7 mt -100.57 107.12 18.71 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.915 -0.584 . . . . 1.1799999999999999 109.976 -176.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 17.4 mt -90.99 109.67 20.91 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.686 -0.806 . . . . 1.1299999999999999 109.163 172.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 82.8 m-20 73.08 -67.01 0.28 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.108 -0.951 . . . . 1.71 111.421 -175.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -163.66 18.61 0.07 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.873 -0.603 . . . . 0.84999999999999998 111.018 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.51 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 88.7 mtt180 -131.77 130.87 42.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.969 -0.457 . . . . 1.27 109.971 -177.875 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 161' ' ' MET . 22.6 tttt -82.09 118.24 22.88 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.528 -0.545 . . . . 1.6499999999999999 109.528 -177.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 16.9 m -100.8 145.87 10.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.547 0.689 . . . . 1.04 111.161 -173.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -106.47 125.1 50.57 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.97 -1.014 . . . . 0.41999999999999998 109.388 176.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.418 ' CG1' HD13 ' A' ' 101' ' ' ILE . 39.8 t -116.45 131.65 68.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.306 -0.627 . . . . 1.03 109.306 177.071 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.26 -173.26 19.71 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.606 -0.807 . . . . 0.17999999999999999 111.966 179.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -66.93 145.43 55.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.023 0.439 . . . . 2.3599999999999999 110.47 -178.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -80.84 114.76 19.95 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.927 -0.579 . . . . 1.4399999999999999 110.325 -176.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -120.78 88.76 3.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.356 -0.384 . . . . 5.1399999999999997 110.564 178.278 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 11.2 p -80.54 -29.99 37.14 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.485 -0.932 . . . . 3.8100000000000001 108.485 170.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.492 ' O ' ' HB2' ' A' ' 177' ' ' LYS . 5.2 tpm_? -135.37 -87.07 0.36 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.315 -1.311 . . . . 8.2799999999999994 108.442 173.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 176' ' ' ARG . 9.9 ttmt 169.04 1.77 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.952 0.782 . . . . 9.0099999999999998 109.364 177.516 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -118.24 137.12 53.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.516 -0.765 . . . . 8.6500000000000004 111.427 -166.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 179' ' ' ARG . 38.7 ttm180 -75.14 -58.98 2.95 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.464 -0.569 . . . . 12.789999999999999 109.464 169.419 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -155.46 -33.58 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.372 -0.831 . . . . 12.699999999999999 108.896 176.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -126.73 122.33 34.57 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.032 -0.986 . . . . 13.800000000000001 109.897 173.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.414 -0.803 . . . . 15.050000000000001 108.948 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.996 -0.442 . . . . 15.130000000000001 111.996 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.93 59.12 3.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.091 0.472 . . . . 13.73 110.273 178.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -165.06 111.11 0.82 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.694 -0.684 . . . . 11.300000000000001 110.883 -175.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -76.16 -28.36 7.4 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.025 2.484 . . . . 11.93 112.071 175.009 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.4 m -151.47 133.68 15.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.187 -0.461 . . . . 9.5199999999999996 110.461 178.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.4 mt -110.34 -179.39 3.76 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.153 -0.314 . . . . 8.2100000000000009 110.153 178.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -98.24 -68.62 0.79 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.756 -0.831 . . . . 8.4100000000000001 108.756 177.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.61 ' HE3' ' O ' ' A' ' 173' ' ' PHE . 57.3 mttp -146.75 177.9 8.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.304 -0.862 . . . . 2.6600000000000001 109.081 173.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.3 p -154.33 -178.92 7.46 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.222 -0.659 . . . . 2.3500000000000001 109.222 179.04 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 98' ' ' VAL . . . 77.65 -49.88 3.15 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.774 -0.726 . . . . 1.02 111.707 -176.413 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 97' ' ' GLY . 42.0 t 75.16 130.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.792 0.837 . . . . 1.3600000000000001 111.195 -175.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.0 23.46 77.83 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.124 -1.036 . . . . 0.26000000000000001 111.068 -178.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.493 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.0 OUTLIER -90.39 124.89 35.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.544 -0.539 . . . . 0.63 109.544 -173.451 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.441 HD13 ' CG1' ' A' ' 170' ' ' VAL . 17.3 pt -135.98 163.71 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.299 -0.409 . . . . 1.05 110.227 178.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.39 143.1 50.8 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.784 -0.45 . . . . 0.26000000000000001 109.784 175.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 6.2 mt -119.4 134.97 61.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.652 -0.703 . . . . 1.01 110.016 -177.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -113.87 150.1 34.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.617 -0.265 . . . . 2.0800000000000001 110.623 -179.284 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.3 t30 72.01 39.0 0.85 Allowed 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.974 0.796 . . . . 0.53000000000000003 111.77 171.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.531 HD23 HG22 ' A' ' 110' ' ' ILE . 21.8 mt -76.43 153.83 35.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.093 0.473 . . . . 1.04 110.864 176.438 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.476 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 6.5 t70 -75.51 144.53 41.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.52 -0.764 . . . . 0.70999999999999996 110.163 175.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -61.48 -28.44 69.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 2.7799999999999998 111.398 -176.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.1 t -80.49 -7.84 59.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.276 -0.42 . . . . 1.8 110.652 -179.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.531 HG22 HD23 ' A' ' 106' ' ' LEU . 30.8 mm -74.39 116.87 17.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.851 -0.426 . . . . 1.1000000000000001 109.851 176.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -103.1 -174.16 2.48 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.741 -0.837 . . . . 1.5900000000000001 108.741 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -67.86 -31.14 70.75 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.564 -0.902 . . . . 0.92000000000000004 108.564 -178.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -48.61 66.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.499 -1.228 . . . . 3.04 109.236 178.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.82 -44.15 97.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.212 -1.358 . . . . 1.03 110.703 -177.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.531 HD11 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -64.97 -46.79 80.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.068 -0.969 . . . . 1.05 109.138 177.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.762 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 65.6 t80 -58.86 -47.22 85.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 1.05 111.084 175.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.75 -37.81 71.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.915 0.388 . . . . 0.40000000000000002 110.957 -176.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.502 HG23 HD21 ' A' ' 163' ' ' LEU . 7.0 m -78.55 -54.76 5.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.992 -0.549 . . . . 1.02 112.138 -178.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -72.98 -27.92 62.08 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.248 0.832 . . . . 0.14999999999999999 113.248 -173.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 t -57.0 -28.79 62.75 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 111.78 0.289 . . . . 0.56000000000000005 111.78 -175.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.04 -22.12 36.5 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.856 0.36 . . . . 1.04 111.755 178.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -89.43 -23.12 22.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.808 0.337 . . . . 0.20999999999999999 111.14 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 170.88 166.4 29.69 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.956 -0.565 . . . . 0.14000000000000001 111.736 -178.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -67.69 129.07 38.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.28999999999999998 110.11 179.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.407 HG21 ' HB3' ' A' ' 128' ' ' CYS . 78.8 mt -98.91 132.0 45.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.175 -0.466 . . . . 1.0700000000000001 109.995 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.532 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -84.68 -40.57 17.22 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.666 -0.864 . . . . 1.26 108.666 -179.822 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 69.5 m -152.68 122.14 6.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.861 -1.063 . . . . 1.1799999999999999 110.27 -178.149 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.4 p -117.2 137.63 52.22 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.641 -0.503 . . . . 1.49 109.641 176.045 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -138.2 132.97 32.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.193 0.52 . . . . 1.6299999999999999 112.003 -174.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.531 HG22 HD11 ' A' ' 115' ' ' LEU . 86.1 t -114.33 109.87 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 106.582 -1.636 . . . . 1.0700000000000001 106.582 169.311 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.457 HG11 ' HG3' ' A' ' 138' ' ' LYS . 16.5 t -75.48 116.4 18.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.931 -0.577 . . . . 1.1399999999999999 109.524 -173.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.732 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 4.7 p -99.82 135.74 40.79 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.419 -0.809 . . . . 2.3399999999999999 111.761 -170.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.37 160.92 22.7 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.333 -0.988 . . . . 2.0800000000000001 108.333 173.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -53.84 -28.14 33.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.858 0.361 . . . . 2.4500000000000002 110.935 175.125 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -90.81 -6.01 54.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.434 -0.348 . . . . 1.6499999999999999 111.048 -178.261 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 151.8 -67.99 0.32 Allowed Glycine 0 CA--C 1.523 0.584 0 C-N-CA 119.961 -1.114 . . . . 1.23 114.325 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.732 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 69.1 m -152.49 145.47 24.49 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.114 -0.639 . . . . 1.99 110.827 -174.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.457 ' HG3' HG11 ' A' ' 131' ' ' VAL . 3.3 mmpt? -81.63 -28.94 33.41 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.128 0.489 . . . . 2.0600000000000001 111.32 -178.162 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 115.14 -14.31 18.93 Favored Glycine 0 C--N 1.311 -0.841 0 C-N-CA 120.587 -0.816 . . . . 0.31 113.356 178.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -129.69 154.02 47.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 117.21 0.505 . . . . 1.01 111.45 -177.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.29 175.18 25.0 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.688 -0.687 . . . . 0.13 111.895 -178.194 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -136.58 137.73 40.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.72 0.26 . . . . 0.31 110.65 -175.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.547 HG11 ' CE2' ' A' ' 145' ' ' PHE . 49.2 t -110.94 136.05 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.996 0.427 . . . . 1.03 110.865 172.47 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 127' ' ' SER . 2.5 m170 -104.13 106.09 16.48 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.658 -0.701 . . . . 0.32000000000000001 109.303 167.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.547 ' CE2' HG11 ' A' ' 143' ' ' VAL . 14.8 m-85 -92.04 137.31 32.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.081 0.467 . . . . 0.17000000000000001 110.827 178.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.532 ' HA ' HD22 ' A' ' 126' ' ' LEU . 39.0 tt0 -47.83 -41.42 23.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.522 -1.217 . . . . 0.56999999999999995 111.131 179.572 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.8 p -119.32 151.14 38.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.325 -0.852 . . . . 1.1100000000000001 110.825 179.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -62.31 -35.96 80.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.46999999999999997 110.72 179.039 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.36 -34.67 74.93 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.33 -0.396 . . . . 0.73999999999999999 111.948 -178.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.08 -34.74 78.24 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.005 0.431 . . . . 1.03 110.678 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.494 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.68 -41.38 98.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 1.05 110.359 176.321 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.478 ' CD ' HH21 ' A' ' 172' ' ' ARG . 7.2 mm-40 -59.27 -40.41 85.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.689 -0.687 . . . . 1.4199999999999999 110.923 177.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.575 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 96.8 mtt180 -60.86 -43.2 98.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.566 -0.743 . . . . 2.0 111.059 177.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.75 83.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.222 -0.445 . . . . 1.02 110.521 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.446 HG12 HG11 ' A' ' 170' ' ' VAL . 66.7 mt -62.51 -52.41 60.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.227 -0.442 . . . . 1.04 111.106 178.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 0.1 OUTLIER -62.57 -44.31 96.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.192 0.52 . . . . 1.0800000000000001 111.941 179.931 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.436 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -82.68 -38.7 23.05 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.243 0.831 . . . . 1.78 113.243 -168.722 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 92.2 mmm -93.93 -16.28 24.14 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.439 0.533 . . . . 1.03 112.439 -173.053 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -67.03 122.93 18.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.302 -0.629 . . . . 0.60999999999999999 109.302 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.09 70.34 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.911 -0.661 . . . . 0.28999999999999998 112.865 178.529 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.649 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 30.3 mmt -96.21 163.03 13.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.997 0.399 . . . . 1.72 111.494 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 20.8 mt -104.61 111.83 24.68 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.868 -0.605 . . . . 1.1799999999999999 109.879 -177.645 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.502 HD21 HG23 ' A' ' 118' ' ' THR . 19.0 mt -100.15 100.87 11.77 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 120.073 -0.651 . . . . 1.1299999999999999 109.758 174.334 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 87.6 m-20 78.58 -23.59 0.24 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 114.883 -1.053 . . . . 1.71 112.615 178.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 21.0 t70 166.15 -23.07 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.174 0.921 . . . . 0.84999999999999998 111.724 -177.552 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.0 mtt180 -106.65 132.38 52.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.82 0.343 . . . . 1.27 111.112 -169.244 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.649 ' HA ' ' O ' ' A' ' 161' ' ' MET . 8.3 ttmm -77.11 118.59 19.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.468 -0.787 . . . . 1.6499999999999999 109.385 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 14.7 m -100.83 146.23 9.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.562 0.696 . . . . 1.04 111.149 -174.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 40.4 t80 -110.62 121.96 46.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.908 -1.042 . . . . 0.41999999999999998 109.267 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.446 HG11 HG12 ' A' ' 155' ' ' ILE . 41.4 t -115.7 127.07 73.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.981 -0.378 . . . . 1.03 109.981 -178.322 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.08 176.86 27.66 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.876 -0.678 . . . . 0.17999999999999999 112.361 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.478 HH21 ' CD ' ' A' ' 152' ' ' GLU . 14.6 mmt85 -61.31 129.48 41.45 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.029 0.442 . . . . 2.3599999999999999 111.148 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.61 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 62.1 t80 -60.34 134.83 57.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.423 -0.808 . . . . 1.4399999999999999 111.154 -179.018 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -90.73 132.27 35.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.92 0.39 . . . . 5.1399999999999997 110.485 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 11.5 p -98.64 11.47 38.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.025 0.44 . . . . 3.8100000000000001 111.063 -178.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -97.17 174.49 6.71 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.183 -0.462 . . . . 8.2799999999999994 110.345 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.4 tptt 71.5 -58.61 0.57 Allowed 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.817 0.698 . . . . 9.0099999999999998 111.573 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -114.9 101.4 9.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.09 0.471 . . . . 8.6500000000000004 109.873 -179.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -116.35 104.42 11.46 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.824 -0.625 . . . . 12.789999999999999 110.884 -177.049 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -119.88 99.19 6.48 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.165 -0.68 . . . . 12.699999999999999 109.165 172.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -155.49 98.82 1.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.058 -0.519 . . . . 13.800000000000001 110.942 -177.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.37 -0.824 . . . . 15.050000000000001 109.453 175.979 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.802 0 N-CA-C 111.972 -0.451 . . . . 15.130000000000001 111.972 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.66 -33.05 9.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 13.73 110.506 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -72.19 122.26 86.9 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 11.300000000000001 110.885 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.75 -165.61 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.582 2.188 . . . . 11.93 110.957 173.533 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.9 m -68.87 87.83 0.37 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.007 0.432 . . . . 9.5199999999999996 110.747 177.134 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.6 mt -119.48 -21.51 7.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 8.2100000000000009 110.503 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 66.5 179.68 0.21 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.599 -0.728 . . . . 8.4100000000000001 111.138 -174.525 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -146.25 116.62 7.49 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.156 -0.683 . . . . 2.6600000000000001 109.156 -178.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.0 p -66.57 -18.62 65.47 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.054 0.843 . . . . 2.3500000000000001 112.248 -173.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.564 ' HA3' ' OD1' ' A' ' 100' ' ' ASN . . . -63.67 -34.57 90.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.813 -0.708 . . . . 1.02 111.798 175.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.8 t 66.36 116.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.208 0.603 . . . . 1.3600000000000001 111.924 -174.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.03 24.51 63.96 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.912 -1.137 . . . . 0.26000000000000001 112.883 174.336 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.564 ' OD1' ' HA3' ' A' ' 97' ' ' GLY . 1.7 m120 -89.92 126.08 35.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.532 -0.544 . . . . 0.63 109.532 -175.024 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.467 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.2 pt -134.24 163.73 36.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.237 -0.438 . . . . 1.05 109.909 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.14 147.49 49.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.99 -0.374 . . . . 0.26000000000000001 109.99 177.51 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 5.2 mt -122.4 148.16 26.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.83 -0.623 . . . . 1.01 110.144 -176.286 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -128.04 157.29 41.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.524 -0.307 . . . . 2.0800000000000001 110.962 -175.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.0 t30 67.44 31.61 6.24 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.738 0.649 . . . . 0.53000000000000003 111.698 172.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.65 HD21 HG23 ' A' ' 110' ' ' ILE . 42.6 mt -75.62 148.61 38.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 1.04 111.354 178.208 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -80.18 153.74 28.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.792 -0.64 . . . . 0.70999999999999996 110.364 178.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.679 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 65.7 pttt -55.16 -34.27 63.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.842 -0.617 . . . . 2.7799999999999998 111.983 178.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.4 t -76.06 -4.51 41.81 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.464 -0.335 . . . . 1.8 111.718 -177.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.65 HG23 HD21 ' A' ' 106' ' ' LEU . 45.7 mm -81.55 113.83 21.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 122.069 -0.394 . . . . 1.1000000000000001 110.067 175.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -106.84 -177.76 3.45 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.212 -0.662 . . . . 1.5900000000000001 109.212 178.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -60.54 -37.85 82.57 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.746 -0.464 . . . . 0.92000000000000004 109.746 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.916 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -62.29 -50.55 71.21 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.477 -0.783 . . . . 3.04 110.673 178.381 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.54 95.72 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.174 -1.375 . . . . 1.03 111.079 -176.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.6 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -67.05 -47.22 71.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.471 -0.786 . . . . 1.05 109.174 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.743 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 72.7 t80 -58.96 -47.13 86.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.528 . . . . 1.05 110.848 176.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.36 -37.93 73.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.158 0.504 . . . . 0.40000000000000002 111.017 -176.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.607 HG22 HD23 ' A' ' 163' ' ' LEU . 13.4 m -78.24 -54.36 6.31 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.057 -0.519 . . . . 1.02 112.065 -178.505 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -73.65 -29.79 62.54 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.007 0.743 . . . . 0.14999999999999999 113.007 -174.154 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.2 t -58.59 -27.2 64.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.685 0.278 . . . . 0.56000000000000005 111.332 -176.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.99 -22.3 25.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.603 0.24 . . . . 1.04 111.344 177.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -92.45 -17.62 24.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.531 -0.304 . . . . 0.20999999999999999 111.352 -178.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.71 174.55 37.46 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.999 -0.62 . . . . 0.14000000000000001 111.875 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -76.69 139.71 40.61 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.836 -0.431 . . . . 0.28999999999999998 109.836 -179.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.422 HG23 ' HB3' ' A' ' 128' ' ' CYS . 71.0 mt -112.13 135.3 51.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.366 -0.379 . . . . 1.0700000000000001 110.223 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.542 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -90.69 -42.85 10.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.774 -0.824 . . . . 1.26 108.774 179.748 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 67.5 m -146.1 111.31 5.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.249 -0.887 . . . . 1.1799999999999999 110.659 -178.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.743 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.6 p -108.52 137.84 45.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.255 -0.646 . . . . 1.49 109.255 172.633 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -136.58 131.24 33.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.957 0.408 . . . . 1.6299999999999999 111.418 -174.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.6 HG22 HD12 ' A' ' 115' ' ' LEU . 91.0 t -114.78 113.74 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 106.738 -1.579 . . . . 1.0700000000000001 106.738 170.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.9 t -82.61 114.61 23.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.718 -0.845 . . . . 1.1399999999999999 108.718 -176.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.887 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 64.3 m -109.13 141.62 41.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.457 -0.792 . . . . 2.3399999999999999 112.759 -165.503 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.41 171.74 10.34 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.104 -1.073 . . . . 2.0800000000000001 108.104 170.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -61.2 -25.21 66.88 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.008 0.373 . . . . 2.4500000000000002 112.008 -177.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -92.71 -12.28 31.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.827 -0.349 . . . . 1.6499999999999999 111.242 -177.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.679 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 165.64 -68.0 0.2 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.923 -1.132 . . . . 1.23 114.241 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.887 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 33.3 t -156.62 153.8 29.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.721 0.761 . . . . 1.99 111.261 -174.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -88.08 -8.6 55.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.079 0.466 . . . . 2.0600000000000001 110.21 178.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 107.42 -16.64 37.74 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.45 -0.881 . . . . 0.31 114.076 174.029 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -126.34 152.52 46.12 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.373 0.587 . . . . 1.01 111.753 -174.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.43 174.14 25.56 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.538 -0.755 . . . . 0.13 111.694 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -139.5 139.3 36.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.877 0.339 . . . . 0.31 110.728 -177.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.521 HG11 ' CE2' ' A' ' 145' ' ' PHE . 42.6 t -113.85 133.81 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.05 0.452 . . . . 1.03 110.854 172.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.6 OUTLIER -105.37 106.09 16.43 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.708 -0.678 . . . . 0.32000000000000001 109.186 167.986 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.547 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 14.6 m-85 -89.68 140.04 29.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.336 0.589 . . . . 0.17000000000000001 111.264 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.542 ' HA ' HD21 ' A' ' 126' ' ' LEU . 36.5 tt0 -53.43 -43.18 67.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.54 -1.209 . . . . 0.56999999999999995 110.087 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.5 p -114.28 144.52 43.1 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.405 -1.27 . . . . 1.1100000000000001 111.337 -178.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -62.4 -38.02 88.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.376 -0.829 . . . . 0.46999999999999997 111.064 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.27 -35.95 76.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.451 -0.341 . . . . 0.73999999999999999 111.83 -176.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.83 -34.69 78.5 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.344 0.592 . . . . 1.03 110.33 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.547 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.21 -40.88 97.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 1.05 111.194 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 1.9 mm-40 -68.37 -36.32 79.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.018 -0.537 . . . . 1.4199999999999999 110.278 -179.082 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.459 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 90.4 mtt180 -60.21 -42.89 96.11 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-N 116.099 -0.5 . . . . 2.0 110.362 175.096 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.34 87.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.96 -0.563 . . . . 1.02 110.651 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 151' ' ' ALA . 76.1 mt -63.02 -53.99 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.542 -0.299 . . . . 1.04 110.921 178.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.582 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.9 pt-20 -61.55 -43.09 99.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.066 0.46 . . . . 1.0800000000000001 111.764 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -81.6 -39.04 25.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.172 0.804 . . . . 1.78 113.172 -171.415 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 90.9 mmm -93.22 -18.98 21.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.616 0.599 . . . . 1.03 112.616 -172.802 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.5 122.56 19.91 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.615 -0.834 . . . . 0.60999999999999999 109.096 176.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.35 77.09 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.715 -0.755 . . . . 0.28999999999999998 112.009 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.8 tpt -93.16 151.4 19.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.157 -0.682 . . . . 1.72 109.157 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.4 ' HA ' HD22 ' A' ' 162' ' ' LEU . 18.1 mt -96.45 107.46 19.86 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.437 -0.579 . . . . 1.1799999999999999 109.437 179.158 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.607 HD23 HG22 ' A' ' 118' ' ' THR . 11.5 mt -92.38 108.1 19.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.489 -0.884 . . . . 1.1299999999999999 109.369 172.416 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 5.4 m-20 77.41 -33.43 0.19 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.397 -0.82 . . . . 1.71 111.986 176.246 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 163' ' ' LEU . 27.1 t70 168.54 -19.78 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.115 -0.948 . . . . 0.84999999999999998 111.889 -174.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -107.45 136.72 46.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.644 0.259 . . . . 1.27 110.478 -172.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -80.83 116.38 20.79 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.359 -0.608 . . . . 1.6499999999999999 109.359 -178.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.45 146.68 8.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.677 0.751 . . . . 1.04 111.124 -173.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 55.6 t80 -105.98 119.19 38.55 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.718 -1.128 . . . . 0.41999999999999998 109.083 179.355 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 43.4 t -116.1 129.7 72.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.077 0.465 . . . . 1.03 109.849 179.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.6 177.72 25.69 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 111.04 -0.824 . . . . 0.17999999999999999 111.04 176.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.95 141.99 56.82 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.156 -0.313 . . . . 2.3599999999999999 110.156 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -56.56 100.63 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.361 0.413 . . . . 1.4399999999999999 110.213 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -83.11 148.63 27.38 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.125 0.488 . . . . 5.1399999999999997 111.957 -172.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 6.4 m -88.33 -169.85 2.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.311 -0.996 . . . . 3.8100000000000001 108.311 170.19 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 76.37 -8.2 1.69 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.133 0.492 . . . . 8.2799999999999994 111.161 172.425 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -62.05 -20.63 64.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.479 0.657 . . . . 9.0099999999999998 109.483 172.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.55 146.64 46.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.125 -0.943 . . . . 8.6500000000000004 109.33 172.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -104.39 -9.49 18.42 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.447 -0.575 . . . . 12.789999999999999 109.447 174.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 68.94 17.84 8.58 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.053 -0.976 . . . . 12.699999999999999 109.253 -173.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -165.94 111.0 0.84 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.245 -0.889 . . . . 13.800000000000001 109.793 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.749 -0.643 . . . . 15.050000000000001 110.093 -178.032 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.513 0 N-CA-C 112.069 -0.412 . . . . 15.130000000000001 112.069 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.91 174.87 10.14 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.025 -0.361 . . . . 13.73 110.025 178.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -107.06 98.55 22.37 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.688 -0.486 . . . . 11.300000000000001 109.688 178.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 93' ' ' LEU . 88.5 Cg_endo -84.97 156.66 11.47 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.275 1.983 . . . . 11.93 111.94 -179.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.7 m 69.71 -36.87 0.36 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.061 0.545 . . . . 9.5199999999999996 112.208 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.479 HD23 ' HB3' ' A' ' 96' ' ' SER . 36.2 tp -85.77 132.46 34.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.029 -0.73 . . . . 8.2100000000000009 109.029 178.473 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.455 HH11 ' HD2' ' A' ' 94' ' ' ARG . 39.2 ttm180 -102.72 -56.33 2.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.637 -0.425 . . . . 8.4100000000000001 111.005 -171.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -125.49 83.79 2.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.314 -0.403 . . . . 2.6600000000000001 110.359 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.479 ' HB3' HD23 ' A' ' 93' ' ' LEU . 10.2 p -63.03 -27.19 69.24 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 111.762 0.282 . . . . 2.3500000000000001 111.762 -178.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.02 -35.17 91.03 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.926 -0.654 . . . . 1.02 112.761 179.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.6 t 61.51 126.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.366 0.666 . . . . 1.3600000000000001 112.763 -176.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.58 25.26 74.59 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.655 -1.26 . . . . 0.26000000000000001 111.433 176.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.492 ' N ' HD21 ' A' ' 100' ' ' ASN . 1.0 OUTLIER -88.4 124.17 33.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.594 -0.521 . . . . 0.63 109.594 -172.65 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.584 HG12 ' HB ' ' A' ' 143' ' ' VAL . 34.8 pt -135.05 151.75 31.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.765 -0.457 . . . . 1.05 109.765 176.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.611 ' HB3' ' HB2' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -119.81 141.23 49.69 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.566 -0.531 . . . . 0.26000000000000001 109.566 178.633 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 5.2 mt -119.34 129.54 75.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.653 -0.703 . . . . 1.01 110.064 -176.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -112.45 151.62 29.67 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.682 -0.235 . . . . 2.0800000000000001 110.616 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.9 t30 73.69 36.7 0.73 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.97 0.794 . . . . 0.53000000000000003 111.629 172.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.603 HD22 HG21 ' A' ' 110' ' ' ILE . 18.3 mt -76.15 154.36 35.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 1.04 111.261 177.089 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.46 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 13.5 t70 -78.33 149.98 33.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.465 -0.789 . . . . 0.70999999999999996 109.514 174.003 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -68.63 -26.65 65.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.924 0.392 . . . . 2.7799999999999998 110.881 -175.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 m -72.65 -7.87 52.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 1.8 111.292 178.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.603 HG21 HD22 ' A' ' 106' ' ' LEU . 31.9 mm -79.12 113.75 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.106 0.479 . . . . 1.1000000000000001 109.95 178.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -99.3 -176.25 3.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.679 -0.692 . . . . 1.5900000000000001 109.223 -178.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -66.96 -34.45 77.79 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.08 -1.081 . . . . 0.92000000000000004 108.08 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -47.83 66.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.137 -1.392 . . . . 3.04 109.269 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.05 97.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.047 -1.433 . . . . 1.03 110.963 -178.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.574 HD12 HG23 ' A' ' 130' ' ' VAL . 3.9 tt -65.82 -46.74 77.47 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.361 -0.836 . . . . 1.05 109.238 177.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.748 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 49.1 t80 -59.93 -46.95 87.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 1.05 110.831 176.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.46 -41.45 76.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.96 0.409 . . . . 0.40000000000000002 110.985 -175.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.413 HG22 HD22 ' A' ' 163' ' ' LEU . 19.2 m -77.18 -52.66 8.87 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.86 -0.609 . . . . 1.02 111.902 -176.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -72.91 -28.26 62.36 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.46 0.541 . . . . 0.14999999999999999 112.46 -174.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.8 t -57.81 -28.43 64.03 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.649 0.262 . . . . 0.56000000000000005 111.444 -177.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.41 -21.18 23.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.835 0.35 . . . . 1.04 111.499 177.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -94.95 -14.15 24.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.20999999999999999 111.066 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.65 166.55 22.68 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 116.037 -0.529 . . . . 0.14000000000000001 111.898 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -69.49 138.7 53.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.896 -0.409 . . . . 0.28999999999999998 109.896 178.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.421 HG22 ' HB3' ' A' ' 128' ' ' CYS . 67.7 mt -111.11 134.09 54.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.98 -0.554 . . . . 1.0700000000000001 109.751 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.18 -50.65 6.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.435 -0.95 . . . . 1.26 108.435 179.93 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.3 m -138.01 99.14 3.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.801 -1.091 . . . . 1.1799999999999999 110.72 -176.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.748 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 0.8 OUTLIER -97.98 139.95 33.05 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.165 -0.679 . . . . 1.49 109.165 172.512 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -139.2 129.3 25.22 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.507 -0.477 . . . . 1.6299999999999999 111.634 -172.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.574 HG23 HD12 ' A' ' 115' ' ' LEU . 95.8 t -114.14 109.27 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 106.573 -1.64 . . . . 1.0700000000000001 106.573 168.148 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 t -79.1 131.41 34.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.693 -0.685 . . . . 1.1399999999999999 109.783 -172.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 1.5 p -95.24 133.87 38.63 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.773 0.796 . . . . 2.3399999999999999 111.394 -170.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.635 ' HB2' ' HA ' ' A' ' 138' ' ' LYS . 16.7 t70 -87.61 164.85 15.84 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.443 -1.253 . . . . 2.0800000000000001 108.579 -178.596 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.3 -25.4 65.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.378 0.609 . . . . 2.4500000000000002 109.494 171.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -92.51 4.32 53.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.291 -0.868 . . . . 1.6499999999999999 110.736 178.281 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 127.82 -71.35 0.49 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.579 -0.82 . . . . 1.23 113.765 -179.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 30.5 m -134.85 132.34 38.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 117.582 0.691 . . . . 1.99 109.801 -176.109 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.635 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 29.7 mtpt -70.82 -20.29 62.58 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.462 0.542 . . . . 2.0600000000000001 112.462 -169.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 109.08 -13.15 34.17 Favored Glycine 0 C--N 1.313 -0.732 0 C-N-CA 120.397 -0.906 . . . . 0.31 113.243 177.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.621 ' HH ' ' CE ' ' A' ' 138' ' ' LYS . 30.2 p90 -133.99 155.32 50.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.85 0.357 . . . . 1.01 111.001 -177.043 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.6 175.28 24.4 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.81 -0.632 . . . . 0.13 111.938 -178.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -137.06 139.33 41.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.547 0.173 . . . . 0.31 110.838 -177.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.584 ' HB ' HG12 ' A' ' 101' ' ' ILE . 41.9 t -112.09 132.93 59.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.881 0.372 . . . . 1.03 110.578 171.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . 0.413 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 0.8 OUTLIER -104.16 106.05 16.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.082 -0.71 . . . . 0.32000000000000001 109.082 167.405 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.527 ' CE2' HG13 ' A' ' 143' ' ' VAL . 20.0 m-85 -87.7 138.62 31.31 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.331 0.586 . . . . 0.17000000000000001 111.155 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.518 ' HA ' HD22 ' A' ' 126' ' ' LEU . 38.9 tt0 -49.01 -39.47 27.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.038 -1.437 . . . . 0.56999999999999995 110.715 178.205 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.5 p -125.61 152.62 44.9 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.833 -1.076 . . . . 1.1100000000000001 110.663 -179.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -66.94 -31.07 71.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.915 -0.584 . . . . 0.46999999999999997 110.977 -177.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.65 -35.15 74.92 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.039 0.385 . . . . 0.73999999999999999 112.039 -178.126 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.8 -34.61 78.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.11 0.481 . . . . 1.03 110.711 -178.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.97 -43.85 94.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.506 -0.77 . . . . 1.05 111.252 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.562 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 33.5 mt-10 -58.68 -41.9 87.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 1.4199999999999999 110.638 179.242 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 153' ' ' ARG . 65.2 mtt85 -61.27 -44.52 97.1 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.259 -0.428 . . . . 2.0 111.285 177.354 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.74 -37.4 84.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.374 -0.376 . . . . 1.02 110.713 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 151' ' ' ALA . 87.3 mt -62.41 -54.48 33.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.381 -0.372 . . . . 1.04 111.081 178.154 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.9 pt-20 -62.72 -40.24 96.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.983 0.42 . . . . 1.0800000000000001 111.814 -177.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -82.35 -38.66 23.9 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.872 0.693 . . . . 1.78 112.872 -172.746 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 90.5 mmm -93.2 -26.8 17.22 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.549 0.574 . . . . 1.03 112.549 -173.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -64.85 123.4 19.3 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.131 -0.628 . . . . 0.60999999999999999 109.383 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.79 19.51 56.07 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.635 -0.793 . . . . 0.28999999999999998 112.557 -179.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.599 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.4 mmt -105.15 156.35 18.17 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.788 -0.243 . . . . 1.72 110.861 176.716 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 14.4 mt -98.27 97.45 8.84 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.455 -0.572 . . . . 1.1799999999999999 109.455 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.439 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 18.1 mt -81.82 105.07 12.66 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 119.469 -0.893 . . . . 1.1299999999999999 109.068 174.382 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 86.4 m-20 74.1 -66.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.974 -1.012 . . . . 1.71 111.909 -177.652 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -156.47 6.84 0.19 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.854 -0.612 . . . . 0.84999999999999998 111.686 -177.184 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.46 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.2 mtt180 -134.39 128.34 33.41 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 121.769 -0.582 . . . . 1.27 110.255 -172.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 161' ' ' MET . 17.0 tttt -76.66 119.77 20.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.836 -0.62 . . . . 1.6499999999999999 109.483 -178.016 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.9 m -100.73 144.51 12.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.491 0.662 . . . . 1.04 111.365 -172.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 72.9 t80 -106.82 119.76 40.21 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.687 -1.142 . . . . 0.41999999999999998 109.325 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 40.6 t -115.63 128.82 72.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.501 -0.555 . . . . 1.03 109.501 178.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.28 -175.02 19.79 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.64 -0.79 . . . . 0.17999999999999999 112.356 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -70.33 119.5 14.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.895 0.378 . . . . 2.3599999999999999 110.729 -177.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' PHE . . . . . 0.611 ' HB2' ' HB3' ' A' ' 102' ' ' PHE . 4.3 t80 -105.12 116.82 32.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.753 -0.658 . . . . 1.4399999999999999 109.732 -179.375 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.55 147.61 25.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.854 -0.612 . . . . 5.1399999999999997 111.102 -178.372 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.7 p -71.12 -39.89 71.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.661 -0.699 . . . . 3.8100000000000001 111.534 -177.072 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 60.8 -101.44 0.11 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.629 0.372 . . . . 8.2799999999999994 110.71 -178.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -119.72 5.81 10.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.632 0.73 . . . . 9.0099999999999998 109.52 176.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -98.65 68.08 1.78 Allowed 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.273 -0.876 . . . . 8.6500000000000004 110.006 -177.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -105.03 42.48 1.21 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.255 -1.017 . . . . 12.789999999999999 108.255 175.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -89.16 -34.52 16.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.926 -1.034 . . . . 12.699999999999999 110.994 -174.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.07 109.24 5.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.165 -0.471 . . . . 13.800000000000001 109.921 -179.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.205 -0.902 . . . . 15.050000000000001 109.803 -175.661 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.2 t . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 112.664 0.616 . . . . 0.71 112.664 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.429 ' HA2' ' CB ' ' A' ' 151' ' ' ALA . . . 72.24 25.62 74.07 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 119.732 -1.223 . . . . 0.21 112.406 172.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.41 ' ND2' ' NE2' ' A' ' 144' ' ' HIS . 13.3 m-20 -85.58 123.85 31.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.806 -0.813 . . . . 0.63 108.806 -174.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.515 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.1 pt -135.72 159.93 39.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 110.319 -0.252 . . . . 0.15 110.319 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.05 141.35 52.12 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.815 -0.439 . . . . 0.21 109.815 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.649 HG12 HG22 ' A' ' 170' ' ' VAL . 7.2 mt -117.95 137.61 51.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.58 -0.737 . . . . 0.15 110.07 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -120.72 151.57 39.37 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.679 -0.237 . . . . 1.46 110.522 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 t30 69.77 54.37 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.86 0.725 . . . . 0.49 111.307 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.67 HD22 HG21 ' A' ' 110' ' ' ILE . 14.6 mt -91.61 162.88 14.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.426 -0.807 . . . . 0.26 111.169 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.465 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 14.0 t70 -87.38 155.74 19.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.71 109.936 177.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -62.24 -31.39 71.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.388 -0.369 . . . . 2.2 111.417 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.8 p -72.32 -4.59 30.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.186 -0.461 . . . . 1.41 111.936 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.698 HG22 HG21 ' A' ' 130' ' ' VAL . 45.1 mm -84.57 118.4 31.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.482 . . . . 0.26 110.776 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.462 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 15.6 t70 -108.73 -175.27 2.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.297 -1.001 . . . . 1.59 108.297 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -67.66 -32.52 73.25 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.478 -0.934 . . . . 0.6 108.478 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -48.72 71.14 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.624 -1.171 . . . . 2.58 109.263 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.462 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -62.43 -43.03 99.79 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.274 -1.33 . . . . 0.15 110.84 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.73 HD12 HG22 ' A' ' 130' ' ' VAL . 3.5 tt -65.73 -47.79 74.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.172 -0.677 . . . . 0.16 109.172 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.651 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 55.3 t80 -59.26 -46.3 88.87 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.743 -0.662 . . . . 0.3 110.486 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.84 -39.85 74.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.505 -0.316 . . . . 0.4 111.232 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.448 HG21 HD21 ' A' ' 163' ' ' LEU . 91.3 m -77.73 -53.78 7.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.264 0.468 . . . . 0.22 112.264 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.46 ' CD1' HD23 ' A' ' 115' ' ' LEU . 6.5 m-85 -71.76 -28.09 63.42 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.54 0.57 . . . . 0.11 112.54 -173.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.5 t -57.71 -28.86 64.22 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.571 0.224 . . . . 0.19 111.296 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.33 -22.86 45.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.678 0.275 . . . . 0.14 111.385 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.401 ' HZ ' ' HE3' ' A' ' 157' ' ' LYS . 26.7 m-85 -89.76 -26.22 20.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.038 0.447 . . . . 0.18 110.546 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.89 169.77 35.82 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.125 -0.79 . . . . 0.11 111.125 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -71.04 143.59 50.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.65 -0.5 . . . . 0.25 109.65 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.436 HG21 ' HB3' ' A' ' 128' ' ' CYS . 76.2 mt -114.76 134.93 56.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 116.014 -0.539 . . . . 0.14 110.015 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -93.02 -36.45 12.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 0.54 109.508 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.1 m -156.18 97.61 1.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.733 -0.667 . . . . 0.76 111.365 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.7 p -103.84 153.54 20.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.355 -0.609 . . . . 0.72 109.355 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -150.61 132.44 15.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.818 0.342 . . . . 1.0 111.255 -175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.73 HG22 HD12 ' A' ' 115' ' ' LEU . 57.5 t -114.28 110.31 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 107.183 -1.414 . . . . 0.28 107.183 171.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.302 -1.493 0 N-CA-C 108.432 -0.951 . . . . 0.34 108.432 -175.456 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.693 0 CA-C-O 119.911 -0.383 . . . . 0.31 113.877 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -161.18 153.93 20.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.742 0.771 . . . . 0.49 111.285 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.29 174.06 28.09 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.457 -0.792 . . . . 0.12 111.625 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -139.93 142.65 36.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.928 0.364 . . . . 0.25 110.555 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.515 ' HB ' HG12 ' A' ' 101' ' ' ILE . 24.6 t -118.34 133.96 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.105 0.479 . . . . 0.1 111.362 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.54 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.1 OUTLIER -106.45 106.58 17.16 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.851 -0.796 . . . . 0.21 108.851 167.396 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 8.7 m-85 -89.28 139.76 30.17 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.284 0.564 . . . . 0.17 111.915 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.666 ' HA ' HD21 ' A' ' 126' ' ' LEU . 43.8 tt0 -52.48 -48.74 65.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.112 -1.404 . . . . 0.57 110.07 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.2 p -111.77 144.45 41.03 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.137 -1.392 . . . . 0.4 111.062 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -61.92 -40.32 95.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.299 -0.864 . . . . 0.47 111.026 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.8 pt-20 -67.68 -35.18 78.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.74 111.408 -175.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.84 78.43 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.241 0.543 . . . . 0.18 110.489 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.475 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.97 -44.72 91.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.388 -0.824 . . . . 0.16 110.86 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 37.7 mt-10 -62.06 -37.33 84.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.646 -0.707 . . . . 1.42 110.356 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 157' ' ' LYS . 88.8 mtt180 -62.54 -47.05 85.57 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.332 -0.394 . . . . 1.48 110.592 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.78 81.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.997 -0.547 . . . . 0.1 111.012 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.0 mt -61.21 -53.77 44.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.239 -0.437 . . . . 0.15 111.131 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 4.2 pt-20 -64.69 -45.01 88.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.186 0.517 . . . . 1.08 111.919 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -75.52 -38.92 59.07 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.483 -0.78 . . . . 1.16 112.893 -170.575 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.459 ' HB2' HG21 ' A' ' 170' ' ' VAL . 83.8 mmm -93.51 -26.23 17.25 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.917 0.71 . . . . 0.35 112.917 -173.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.401 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 52.7 t30 -64.79 123.74 20.15 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.549 -0.46 . . . . 0.44 110.15 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.42 11.65 62.27 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.816 -0.706 . . . . 0.29 113.184 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.676 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 75.2 mmm -105.39 164.25 12.0 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.568 -0.372 . . . . 1.18 111.508 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.442 HD23 ' N ' ' A' ' 167' ' ' LYS . 19.8 mt -96.33 123.21 39.89 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.928 -0.768 . . . . 0.44 108.928 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.53 HD12 HG11 ' A' ' 168' ' ' VAL . 24.9 mt -106.43 100.21 9.75 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.934 -0.706 . . . . 1.02 109.659 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 94.5 m-20 77.72 -28.82 0.16 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.871 -1.059 . . . . 1.71 112.725 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 35.7 t70 174.44 -23.85 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.772 -0.649 . . . . 0.85 112.221 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.7 mtt180 -115.96 134.93 54.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.935 0.397 . . . . 0.96 111.602 -173.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.5 ttmt -76.92 123.83 26.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.418 -0.81 . . . . 1.0 109.171 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.53 HG11 HD12 ' A' ' 163' ' ' LEU . 23.2 m -103.05 146.6 10.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.434 0.635 . . . . 0.17 111.528 -174.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 73.5 t80 -107.51 119.26 38.94 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.016 -0.993 . . . . 0.3 109.116 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.649 HG22 HG12 ' A' ' 103' ' ' ILE . 43.0 t -114.82 128.04 72.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.467 -0.568 . . . . 0.13 109.467 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.61 -177.44 22.86 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.365 -0.922 . . . . 0.18 112.714 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 172' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 120.889 0.376 . . . . 1.93 110.795 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 121.701 0.762 . . . . 0.71 111.781 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.89 22.71 78.9 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.265 -0.969 . . . . 0.21 111.217 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -96.18 128.38 43.04 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.14 -0.689 . . . . 0.63 109.14 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.486 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.8 pt -133.31 162.5 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.162 -0.472 . . . . 0.15 109.864 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.24 144.63 50.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.006 0.431 . . . . 0.21 109.908 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.627 HG12 HG22 ' A' ' 170' ' ' VAL . 5.7 mt -119.92 135.49 60.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.588 -0.733 . . . . 0.15 110.071 -177.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -116.66 152.37 34.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.732 -0.213 . . . . 1.46 110.652 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 t30 71.58 40.65 0.78 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.942 0.777 . . . . 0.49 111.79 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.622 HD22 HG21 ' A' ' 110' ' ' ILE . 20.6 mt -78.24 158.55 28.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.389 0.614 . . . . 0.26 111.755 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.477 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 25.1 t70 -81.93 150.76 27.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.359 -0.837 . . . . 0.71 110.916 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -55.72 -36.88 67.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.599 -0.728 . . . . 2.2 112.131 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.6 m -84.02 -3.87 58.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.89 0.33 . . . . 1.41 111.89 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.671 HG22 HG21 ' A' ' 130' ' ' VAL . 27.9 mm -71.87 117.14 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.091 0.472 . . . . 0.26 110.183 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 15.6 t70 -105.64 -171.74 1.96 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.798 -0.815 . . . . 1.59 108.798 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.413 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 87.3 m-20 -72.17 -32.61 67.01 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.319 -0.993 . . . . 0.6 108.319 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.63 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -68.68 -45.05 72.71 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.039 -1.437 . . . . 2.58 109.661 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.76 -44.25 97.26 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.662 -1.608 . . . . 0.15 110.574 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 130' ' ' VAL . 4.1 tt -67.4 -47.19 71.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.165 -0.925 . . . . 0.16 109.378 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.802 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 83.5 t80 -58.98 -45.31 90.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.893 -0.594 . . . . 0.3 111.165 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.85 -40.89 76.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.852 0.358 . . . . 0.4 110.877 -175.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 58.8 m -77.41 -53.71 7.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.238 -0.437 . . . . 0.22 112.136 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.429 ' CD1' HD23 ' A' ' 115' ' ' LEU . 14.1 m-85 -71.59 -28.43 63.81 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.657 0.614 . . . . 0.11 112.657 -173.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -57.75 -28.42 63.91 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.609 0.243 . . . . 0.19 111.078 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.78 -22.68 37.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.804 0.298 . . . . 0.14 111.804 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -91.88 -15.54 27.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.997 0.427 . . . . 0.18 111.038 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.19 166.79 22.6 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.531 -0.628 . . . . 0.11 111.531 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -67.57 139.44 56.91 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.033 0.444 . . . . 0.25 110.201 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.457 HG21 ' HB3' ' A' ' 128' ' ' CYS . 65.9 mt -113.37 133.91 57.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.725 -0.671 . . . . 0.14 109.723 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.615 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -90.37 -43.7 10.15 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.884 -0.784 . . . . 0.54 108.884 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 55.7 m -145.65 99.75 3.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.231 -0.895 . . . . 0.76 110.962 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.802 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.6 p -97.53 145.9 25.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.17 -0.678 . . . . 0.72 109.17 171.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -148.79 134.27 18.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.063 0.459 . . . . 1.0 111.8 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.671 HG21 HG22 ' A' ' 110' ' ' ILE . 99.1 t -114.02 115.07 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 106.587 -1.634 . . . . 0.28 106.587 170.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.2 t . . . . . 0 C--N 1.301 -1.514 0 N-CA-C 108.709 -0.848 . . . . 0.34 108.709 -176.64 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.696 0 N-CA-C 113.35 0.1 . . . . 0.31 113.35 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -123.68 152.84 41.6 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.457 0.646 . . . . 0.49 111.976 -172.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.89 174.36 23.63 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.954 -1.021 . . . . 0.12 111.309 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -138.72 140.99 38.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.01 0.405 . . . . 0.25 110.72 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.486 ' HB ' HG12 ' A' ' 101' ' ' ILE . 43.0 t -115.45 129.17 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 120.946 0.403 . . . . 0.1 110.492 172.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.1 m170 -100.47 105.19 16.62 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.267 -0.642 . . . . 0.21 109.267 167.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.555 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 18.8 m-85 -87.25 142.97 27.5 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.078 0.466 . . . . 0.17 110.392 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.615 ' HA ' HD21 ' A' ' 126' ' ' LEU . 35.5 tt0 -52.89 -34.45 54.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.426 -1.261 . . . . 0.57 110.706 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.6 p -129.94 152.38 49.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.348 -0.842 . . . . 0.4 111.277 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -62.18 -36.02 80.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.694 -0.684 . . . . 0.47 111.204 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.26 -35.66 76.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.008 0.373 . . . . 0.74 112.008 -175.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.88 -34.67 78.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 0.18 110.553 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.555 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -65.3 -41.72 93.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.722 -0.672 . . . . 0.16 110.944 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 32.4 mt-10 -59.33 -40.19 85.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 1.42 110.775 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 70.8 mtt180 -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 1.48 111.192 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.68 84.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.438 -0.346 . . . . 0.1 110.451 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.1 mt -62.26 -53.25 49.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.242 -0.435 . . . . 0.15 111.168 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 0.9 OUTLIER -64.27 -41.86 96.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.07 0.462 . . . . 1.08 111.899 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.479 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.23 -38.69 24.14 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.084 0.772 . . . . 1.16 113.084 -171.173 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.462 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.8 mmm -93.81 -20.52 20.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.843 0.683 . . . . 0.35 112.843 -172.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 58.2 t30 -68.5 123.83 21.89 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.965 -0.694 . . . . 0.44 109.495 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.53 17.01 57.78 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.742 -0.742 . . . . 0.29 112.721 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.729 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.4 mmt -100.91 163.4 12.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.675 0.274 . . . . 1.18 111.54 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 mt -104.3 105.21 15.27 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.983 -0.553 . . . . 0.44 109.826 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 163' ' ' LEU . 18.8 mt -93.04 105.97 17.99 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.974 -0.691 . . . . 1.02 109.881 175.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 93.3 m-20 75.09 -51.23 0.67 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.124 -0.944 . . . . 1.71 111.843 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -178.63 22.09 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.88 -0.6 . . . . 0.85 111.729 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.477 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.4 mtt180 -138.76 135.48 34.72 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.681 -0.637 . . . . 0.96 109.957 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.729 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.2 ttmt -83.08 117.68 23.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.479 HG11 HD23 ' A' ' 106' ' ' LEU . 11.5 m -100.52 148.39 6.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.588 0.709 . . . . 0.17 111.448 -171.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 69.2 t80 -106.46 120.61 42.35 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.647 -1.16 . . . . 0.3 109.292 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.627 HG22 HG12 ' A' ' 103' ' ' ILE . 43.2 t -115.65 126.24 73.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.448 -0.575 . . . . 0.13 109.448 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.06 -175.9 21.89 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.745 -0.741 . . . . 0.18 111.548 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.3 -0.63 . . . . 1.93 109.3 -179.848 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.9 t . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 121.552 0.692 . . . . 0.71 112.25 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.437 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 72.8 24.05 76.78 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 119.974 -1.107 . . . . 0.21 111.605 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -88.74 125.96 35.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.273 -0.64 . . . . 0.63 109.273 -174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.596 HG23 ' HB1' ' A' ' 151' ' ' ALA . 21.6 pt -135.46 161.43 39.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.989 -0.374 . . . . 0.15 109.989 175.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.23 137.87 54.11 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.88 -0.415 . . . . 0.21 109.88 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.56 HG12 HG22 ' A' ' 170' ' ' VAL . 5.1 mt -115.21 135.05 56.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.612 -0.722 . . . . 0.15 110.013 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -117.12 152.95 33.65 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.292 -0.262 . . . . 1.46 110.292 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.3 t30 74.89 35.1 0.65 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.818 0.699 . . . . 0.49 111.474 171.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.433 HD22 HG21 ' A' ' 110' ' ' ILE . 30.7 mt -79.79 159.54 26.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.12 0.486 . . . . 0.26 111.185 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -92.66 150.71 20.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.596 -0.729 . . . . 0.71 110.414 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -52.1 -31.98 33.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.758 -0.656 . . . . 2.2 112.213 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.5 m -71.78 -17.32 62.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.096 0.406 . . . . 1.41 112.096 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.575 HG22 HG21 ' A' ' 130' ' ' VAL . 28.5 mm -71.43 123.52 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.251 0.548 . . . . 0.26 110.835 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.473 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 26.5 t70 -107.87 -177.98 3.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.279 -0.873 . . . . 1.59 109.056 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -69.61 -35.09 74.96 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.344 -0.984 . . . . 0.6 108.344 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -45.66 71.68 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.628 -1.169 . . . . 2.58 109.052 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.473 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -60.75 -40.24 91.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.006 -1.452 . . . . 0.15 110.669 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.589 HD12 HG22 ' A' ' 130' ' ' VAL . 3.8 tt -68.87 -47.02 66.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.199 -0.91 . . . . 0.16 109.231 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.727 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 65.6 t80 -60.64 -45.1 95.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.3 111.132 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -56.8 -40.61 76.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.03 0.443 . . . . 0.4 110.543 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.575 HG21 HD21 ' A' ' 163' ' ' LEU . 20.4 m -77.52 -53.81 7.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.747 -0.661 . . . . 0.22 111.822 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.411 ' CD1' HD23 ' A' ' 115' ' ' LEU . 11.1 m-85 -72.48 -28.16 62.73 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.743 0.646 . . . . 0.11 112.743 -174.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.6 t -57.57 -29.05 64.12 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.58 0.229 . . . . 0.19 111.207 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.35 39.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.928 0.394 . . . . 0.14 111.716 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -92.83 -14.83 27.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.414 -0.357 . . . . 0.18 111.019 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.5 169.83 26.43 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.624 -0.59 . . . . 0.11 111.624 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -73.15 138.65 45.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.108 0.48 . . . . 0.25 110.247 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.406 HG21 ' HB3' ' A' ' 128' ' ' CYS . 69.2 mt -111.03 132.09 60.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.718 -0.673 . . . . 0.14 110.038 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.602 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -84.57 -43.27 14.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.569 -0.9 . . . . 0.54 108.569 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.3 m -146.5 131.78 18.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.819 -1.082 . . . . 0.76 110.255 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.727 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.5 p -128.69 134.67 48.56 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.117 -0.698 . . . . 0.72 109.117 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -133.76 133.33 41.6 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.586 -0.446 . . . . 1.0 111.776 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.589 HG22 HD12 ' A' ' 115' ' ' LEU . 83.9 t -114.56 110.44 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 107.012 -1.477 . . . . 0.28 107.012 170.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 t . . . . . 0 C--N 1.304 -1.379 0 N-CA-C 108.971 -0.752 . . . . 0.34 108.971 -175.13 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 120.253 -0.193 . . . . 0.31 113.527 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 29.9 p90 -132.79 150.75 52.12 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.359 0.6 . . . . 0.49 111.854 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.22 167.14 26.18 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.036 -0.984 . . . . 0.12 111.341 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -133.99 136.97 44.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.937 0.368 . . . . 0.25 110.738 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.54 ' HB ' HG12 ' A' ' 101' ' ' ILE . 42.7 t -110.79 136.16 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.1 110.644 174.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -105.95 105.37 15.38 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.774 -0.824 . . . . 0.21 108.774 166.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.576 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 17.8 m-85 -88.71 140.8 29.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.099 0.476 . . . . 0.17 110.732 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.602 ' HA ' HD21 ' A' ' 126' ' ' LEU . 34.7 tt0 -51.7 -41.33 61.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.749 -1.114 . . . . 0.57 110.361 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 78.2 p -115.24 150.52 36.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.701 -1.136 . . . . 0.4 110.157 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -65.65 -36.12 82.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.132 -0.485 . . . . 0.47 110.593 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 12.5 pt-20 -69.04 -35.0 76.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.74 111.828 -176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.29 79.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.067 0.46 . . . . 0.18 110.639 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.596 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -64.02 -46.31 85.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.705 -0.68 . . . . 0.16 110.507 177.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 42.7 mt-10 -61.74 -34.55 76.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.328 -0.851 . . . . 1.42 110.91 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 95.9 mtt180 -61.82 -47.63 84.21 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.106 0.479 . . . . 1.48 110.543 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.8 -35.8 77.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.86 -0.609 . . . . 0.1 110.587 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.5 mt -60.61 -54.41 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.15 111.225 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 0.8 OUTLIER -64.04 -42.44 97.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.53 . . . . 1.08 111.768 -177.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -37.97 31.88 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.486 -0.779 . . . . 1.16 112.819 -170.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.468 ' HB2' HG21 ' A' ' 170' ' ' VAL . 91.9 mmm -96.41 -16.93 20.95 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.818 0.673 . . . . 0.35 112.818 -173.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -70.0 124.04 23.05 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.09 -0.644 . . . . 0.44 109.882 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.19 15.56 74.13 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.166 -0.47 . . . . 0.29 112.088 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.484 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 11.7 tpp -99.91 157.6 16.41 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.065 -0.346 . . . . 1.18 110.065 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.0 mt -96.94 110.92 23.34 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 109.349 -0.612 . . . . 0.44 109.349 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.575 HD21 HG21 ' A' ' 118' ' ' THR . 20.8 mt -98.02 105.18 17.29 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.981 -0.687 . . . . 1.02 109.539 173.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 61.3 m-20 77.11 -29.62 0.17 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.22 -0.9 . . . . 1.71 112.681 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 21.1 t70 168.19 -22.18 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.701 0.625 . . . . 0.85 111.864 -170.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 80.5 mtt-85 -113.3 137.78 50.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.867 0.365 . . . . 0.96 111.118 -170.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 161' ' ' MET . 8.0 tttm -81.5 112.96 19.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.307 -177.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.412 HG11 HD23 ' A' ' 106' ' ' LEU . 16.0 m -100.15 148.48 6.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.599 0.714 . . . . 0.17 111.245 -172.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 68.3 t80 -106.68 119.49 39.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.726 -1.124 . . . . 0.3 109.384 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.56 HG22 HG12 ' A' ' 103' ' ' ILE . 40.1 t -114.57 125.46 71.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.983 -0.747 . . . . 0.13 108.983 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -144.41 -171.68 14.52 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.577 -0.821 . . . . 0.18 112.095 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 . . . . . 0 C--N 1.321 -0.658 0 N-CA-C 109.879 -0.415 . . . . 1.93 109.879 -178.434 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.4 t . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 121.401 0.62 . . . . 0.71 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.69 24.18 73.13 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.384 -0.912 . . . . 0.21 112.117 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -86.88 124.26 32.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.445 -0.576 . . . . 0.63 109.445 -174.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.493 HG12 ' HB ' ' A' ' 143' ' ' VAL . 20.2 pt -135.67 161.88 37.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.995 -0.548 . . . . 0.15 109.803 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.42 144.11 50.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.864 -0.421 . . . . 0.21 109.864 176.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.615 HG12 HG22 ' A' ' 170' ' ' VAL . 4.5 mt -118.82 130.99 72.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.613 -0.721 . . . . 0.15 110.166 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -109.65 152.25 25.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.587 -0.278 . . . . 1.46 110.702 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.6 t30 72.14 33.65 1.55 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.926 0.766 . . . . 0.49 111.861 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.453 HD23 HG11 ' A' ' 168' ' ' VAL . 17.3 mt -72.64 155.39 40.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.063 0.459 . . . . 0.26 111.446 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.486 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 23.3 t70 -75.25 146.91 40.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.732 -0.667 . . . . 0.71 109.832 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -60.47 -31.72 70.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.108 -0.496 . . . . 2.2 111.796 -176.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t -79.04 -4.29 49.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.575 -0.284 . . . . 1.41 111.499 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.467 HG12 ' HB3' ' A' ' 107' ' ' ASP . 32.0 mm -73.03 127.14 34.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.419 . . . . 0.26 110.393 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.503 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 10.5 t70 -110.89 -177.15 3.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.748 -0.66 . . . . 1.59 109.28 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.6 ' OD1' ' HA ' ' A' ' 129' ' ' LYS . 69.1 m-80 -72.06 -32.08 66.73 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.565 -0.902 . . . . 0.6 108.565 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -47.95 74.35 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.675 -1.148 . . . . 2.58 108.797 176.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.503 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.63 -43.57 98.6 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.039 -1.437 . . . . 0.15 111.103 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.523 HD12 HG22 ' A' ' 130' ' ' VAL . 3.2 tt -66.54 -46.58 75.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.478 -0.783 . . . . 0.16 109.27 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.432 ' CE1' ' HB ' ' A' ' 125' ' ' ILE . 62.3 t80 -60.52 -46.35 90.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.3 110.658 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -56.55 -39.49 73.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.858 0.361 . . . . 0.4 111.044 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 m -78.1 -54.02 6.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.001 -0.545 . . . . 0.22 112.087 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.401 ' CD1' HD23 ' A' ' 115' ' ' LEU . 9.2 m-85 -72.15 -28.39 63.21 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.683 0.623 . . . . 0.11 112.683 -173.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.8 t -57.67 -28.46 63.78 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.826 0.346 . . . . 0.19 110.809 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.4 36.01 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.227 -0.442 . . . . 0.14 111.637 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -89.74 -31.99 17.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.984 0.421 . . . . 0.18 110.723 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.49 165.41 34.08 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.392 -0.683 . . . . 0.11 111.392 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -62.19 140.84 58.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.971 0.415 . . . . 0.25 109.972 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.753 HD13 ' SG ' ' A' ' 128' ' ' CYS . 94.8 mt -114.34 133.96 58.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.937 -0.574 . . . . 0.14 110.637 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.539 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -91.05 -37.12 13.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.076 -0.712 . . . . 0.54 109.076 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 70.5 m -159.54 111.11 2.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.529 -0.759 . . . . 0.76 111.227 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.794 ' SG ' HG13 ' A' ' 143' ' ' VAL . 54.2 m -109.12 144.9 36.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.527 -0.546 . . . . 0.72 109.527 169.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.6 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 53.1 tptt -135.62 131.96 36.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.416 -175.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 115' ' ' LEU . 88.5 t -114.19 110.13 31.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 106.539 -1.652 . . . . 0.28 106.539 168.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 C--N 1.308 -1.216 0 CA-C-N 115.55 -0.75 . . . . 0.34 109.976 -171.995 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 CA-C-O 120.529 -0.04 . . . . 0.31 113.114 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -132.34 153.44 50.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.835 0.35 . . . . 0.49 110.907 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.7 173.35 24.02 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.87 -0.605 . . . . 0.12 111.898 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -135.59 143.99 45.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.731 0.265 . . . . 0.25 110.722 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.794 HG13 ' SG ' ' A' ' 128' ' ' CYS . 40.1 t -118.58 136.45 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.1 111.142 173.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.1 OUTLIER -106.46 106.38 16.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.19 -0.67 . . . . 0.21 109.19 166.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.575 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.5 m-85 -89.4 137.61 32.17 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.329 0.585 . . . . 0.17 111.354 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.539 ' HA ' HD21 ' A' ' 126' ' ' LEU . 43.7 tt0 -47.86 -40.25 20.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.19 -1.368 . . . . 0.57 110.951 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.1 p -120.3 153.0 37.01 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.276 -0.875 . . . . 0.4 110.914 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -67.35 -34.95 78.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 0.47 110.453 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 12.1 pt-20 -70.04 -34.74 73.64 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.261 -0.427 . . . . 0.74 111.737 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.05 -34.84 77.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.998 0.427 . . . . 0.18 110.649 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.575 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.82 -46.5 84.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.681 -0.691 . . . . 0.16 110.717 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 40.3 mt-10 -59.18 -37.7 78.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.781 -0.645 . . . . 1.42 111.003 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 86.6 mtt180 -59.58 -44.89 93.2 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.983 0.42 . . . . 1.48 110.54 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.79 85.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.984 -0.553 . . . . 0.1 110.452 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 151' ' ' ALA . 78.1 mt -62.76 -54.17 37.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.209 -0.45 . . . . 0.15 111.063 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.3 pt-20 -60.59 -44.04 96.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 1.08 111.613 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.427 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -82.04 -39.42 23.52 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.211 0.819 . . . . 1.16 113.211 -170.475 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 95.4 mmm -92.61 -23.33 19.05 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.618 0.599 . . . . 0.35 112.618 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 54.9 t30 -66.85 123.49 20.31 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.225 -0.59 . . . . 0.44 109.695 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.84 8.57 69.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.912 -0.661 . . . . 0.29 112.626 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 29.2 mmt -96.53 170.75 9.0 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 120.886 0.374 . . . . 1.18 111.541 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 33.3 mt -105.22 126.79 52.48 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.571 -0.74 . . . . 0.44 109.377 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 11.5 mt -109.92 108.07 18.22 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.916 -0.772 . . . . 1.02 108.916 168.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 4.7 m-20 78.83 -33.75 0.16 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.166 0.916 . . . . 1.71 111.817 176.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 33.4 t70 168.77 -20.87 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.13 -0.941 . . . . 0.85 111.754 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.486 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 97.6 mtt180 -100.9 138.67 37.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.714 -0.221 . . . . 0.96 110.504 -174.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 161' ' ' MET . 3.5 ttmp? -83.96 120.6 26.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.453 HG11 HD23 ' A' ' 106' ' ' LEU . 17.1 m -102.64 148.98 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.579 0.704 . . . . 0.17 111.615 -174.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 58.4 t80 -107.84 122.42 46.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.862 -1.063 . . . . 0.3 109.101 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.615 HG22 HG12 ' A' ' 103' ' ' ILE . 47.1 t -115.14 125.42 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.205 -0.665 . . . . 0.13 109.205 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -146.83 -171.46 16.12 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.573 -0.822 . . . . 0.18 111.984 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 109.741 -0.466 . . . . 1.93 109.741 -178.429 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 121.118 0.485 . . . . 0.71 112.22 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.23 23.99 77.11 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.809 -1.186 . . . . 0.21 111.48 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -88.27 125.96 34.92 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.982 -0.747 . . . . 0.63 108.982 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.527 HG23 ' HB1' ' A' ' 151' ' ' ALA . 22.8 pt -135.4 162.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.096 -0.335 . . . . 0.15 110.096 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.81 140.55 52.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.93 0.395 . . . . 0.21 109.991 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 170' ' ' VAL . 5.8 mt -115.19 141.16 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.626 -0.715 . . . . 0.15 110.033 -177.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 3.0 ttpm? -123.02 148.78 45.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.901 -0.136 . . . . 1.46 110.709 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.9 t30 72.43 48.36 0.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.664 0.786 . . . . 0.49 111.856 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.544 HD22 HG21 ' A' ' 110' ' ' ILE . 32.3 mt -90.01 160.85 16.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.249 -0.432 . . . . 0.26 110.765 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -93.9 155.57 17.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.71 109.988 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -59.93 -28.01 67.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.428 -0.351 . . . . 2.2 111.82 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -72.64 -8.47 55.46 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.85 0.315 . . . . 1.41 111.85 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.613 HG22 HG21 ' A' ' 130' ' ' VAL . 30.9 mm -83.83 117.66 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.417 . . . . 0.26 110.353 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -108.96 -175.62 2.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.397 -0.964 . . . . 1.59 108.397 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -67.09 -30.37 70.38 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.947 -0.76 . . . . 0.6 108.947 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -49.54 60.32 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.432 -1.258 . . . . 2.58 109.457 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.71 -39.69 92.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.369 -1.287 . . . . 0.15 110.628 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 130' ' ' VAL . 3.6 tt -67.44 -47.5 70.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.322 -0.854 . . . . 0.16 109.113 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.711 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 61.3 t80 -59.52 -46.43 88.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.919 -0.582 . . . . 0.3 110.775 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -56.09 -39.14 71.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.282 -0.417 . . . . 0.4 111.137 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.655 HG21 HD21 ' A' ' 163' ' ' LEU . 26.4 m -78.54 -54.25 6.35 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.436 0.532 . . . . 0.22 112.436 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.413 ' CD1' HD23 ' A' ' 115' ' ' LEU . 14.0 m-85 -73.0 -27.2 61.64 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.093 0.775 . . . . 0.11 113.093 -173.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.3 t -56.13 -28.84 59.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.818 0.303 . . . . 0.19 111.818 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.02 37.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.887 0.328 . . . . 0.14 111.887 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -92.2 -12.86 31.61 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.538 0.199 . . . . 0.18 111.538 -176.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.2 172.93 28.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.075 -0.583 . . . . 0.11 111.646 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -71.84 138.78 48.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.06 0.457 . . . . 0.25 110.408 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.424 HG21 ' HB3' ' A' ' 128' ' ' CYS . 72.7 mt -111.92 129.25 67.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.79 -0.641 . . . . 0.14 109.862 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.709 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.89 -39.63 15.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.53 0.681 . . . . 0.54 109.188 -178.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 50.8 m -151.58 105.06 3.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.286 -0.87 . . . . 0.76 111.034 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.711 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 4.6 p -104.1 142.04 35.17 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.35 -0.611 . . . . 0.72 109.35 174.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -143.59 130.94 20.92 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.432 -0.507 . . . . 1.0 112.038 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.703 HG22 HD12 ' A' ' 115' ' ' LEU . 57.8 t -114.26 110.66 32.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 106.808 -1.553 . . . . 0.28 106.808 170.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.304 -1.371 0 CA-C-N 115.729 -0.669 . . . . 0.34 109.324 -173.513 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.683 0 N-CA-C 113.572 0.189 . . . . 0.31 113.572 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -128.56 151.88 48.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 117.32 0.56 . . . . 0.49 111.582 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.42 172.14 24.0 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.375 -0.83 . . . . 0.12 111.616 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -135.73 138.17 42.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.995 0.398 . . . . 0.25 110.923 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.525 ' HB ' HG12 ' A' ' 101' ' ' ILE . 47.1 t -110.33 133.89 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 120.985 0.421 . . . . 0.1 110.686 172.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.5 OUTLIER -104.22 105.23 15.31 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.964 -0.754 . . . . 0.21 108.964 167.405 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.524 ' CE2' HG11 ' A' ' 143' ' ' VAL . 14.4 m-85 -89.8 139.53 30.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.048 0.452 . . . . 0.17 110.693 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.709 ' HA ' HD21 ' A' ' 126' ' ' LEU . 33.2 tt0 -52.3 -44.06 64.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.749 -1.114 . . . . 0.57 110.214 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 63.4 p -111.78 150.47 30.26 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.666 -1.152 . . . . 0.4 110.837 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -68.42 -35.55 77.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.968 -0.56 . . . . 0.47 110.572 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.2 pt-20 -69.33 -34.34 74.5 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.237 -0.438 . . . . 0.74 111.799 -176.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.89 79.45 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.115 0.483 . . . . 0.18 110.59 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.527 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -62.64 -45.54 92.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.485 -0.779 . . . . 0.16 110.845 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.0 mt-10 -59.06 -37.4 76.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.95 -0.568 . . . . 1.42 110.778 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.486 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.3 mtt180 -62.4 -45.59 92.43 Favored 'General case' 0 CA--C 1.523 -0.064 0 CA-C-O 120.986 0.422 . . . . 1.48 110.411 176.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.15 80.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.513 . . . . 0.1 110.517 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 151' ' ' ALA . 89.4 mt -61.68 -54.47 34.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.066 -0.515 . . . . 0.15 111.324 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.1 pt-20 -64.35 -43.16 95.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.329 0.585 . . . . 1.08 111.98 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -78.98 -38.42 36.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.23 -0.895 . . . . 1.16 112.773 -169.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.0 mmm -93.1 -24.21 18.35 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.47 0.545 . . . . 0.35 112.47 -175.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -64.75 123.74 20.14 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.464 -0.494 . . . . 0.44 109.811 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.24 14.75 61.69 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.869 -0.681 . . . . 0.29 112.909 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.597 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.6 mmt -106.83 162.65 13.61 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.523 -0.398 . . . . 1.18 111.792 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.9 mt -98.78 108.76 21.53 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.863 -0.608 . . . . 0.44 109.7 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 118' ' ' THR . 17.3 mt -93.98 110.02 21.72 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.824 -0.751 . . . . 1.02 109.114 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 91.7 m-20 73.01 -67.62 0.26 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.323 -0.853 . . . . 1.71 110.919 -175.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -161.79 14.54 0.09 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.854 -0.612 . . . . 0.85 111.491 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -131.34 133.2 45.09 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.813 -0.554 . . . . 0.96 109.889 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 161' ' ' MET . 17.6 ttmt -78.64 119.47 21.95 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 18.9 m -101.57 141.98 17.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.348 0.594 . . . . 0.17 111.183 -173.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -106.74 121.85 45.2 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.07 -0.968 . . . . 0.3 109.406 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.508 HG22 HG12 ' A' ' 103' ' ' ILE . 37.7 t -116.07 125.98 73.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.549 -0.537 . . . . 0.13 109.549 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -140.05 -165.96 10.48 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.651 -0.785 . . . . 0.18 112.02 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 109.834 -0.432 . . . . 1.93 109.834 -177.432 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 121.537 0.684 . . . . 0.71 112.008 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.36 25.51 65.7 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.057 -1.068 . . . . 0.21 112.063 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -89.03 123.84 33.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.232 -0.655 . . . . 0.63 109.232 -172.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.565 HG12 ' HB ' ' A' ' 143' ' ' VAL . 17.3 pt -136.43 164.44 31.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.445 -0.343 . . . . 0.15 110.301 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.55 147.81 49.81 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.925 -0.398 . . . . 0.21 109.925 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.596 HG12 HG22 ' A' ' 170' ' ' VAL . 5.3 mt -122.18 137.37 55.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.786 -0.643 . . . . 0.15 110.195 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -116.62 151.15 36.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.745 -0.207 . . . . 1.46 110.739 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 t30 73.97 38.4 0.58 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.938 0.774 . . . . 0.49 111.543 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.496 HD23 HG11 ' A' ' 168' ' ' VAL . 23.2 mt -77.97 158.16 29.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.118 0.485 . . . . 0.26 111.399 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 20.5 t70 -84.91 151.11 24.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.491 -0.777 . . . . 0.71 110.561 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.1 pttm -58.52 -29.99 66.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.751 -0.658 . . . . 2.2 112.681 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.5 m -82.84 -3.92 57.4 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.168 0.433 . . . . 1.41 112.168 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.587 HG22 HG21 ' A' ' 130' ' ' VAL . 31.5 mm -73.97 127.44 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.135 0.493 . . . . 0.26 110.905 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.7 -178.06 3.3 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.049 -0.723 . . . . 1.59 109.049 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.95 -32.43 69.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.889 -0.782 . . . . 0.6 108.889 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -47.59 72.15 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.802 -1.09 . . . . 2.58 109.01 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.72 -44.16 97.45 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 114.029 -1.441 . . . . 0.15 110.904 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.731 HD12 HG22 ' A' ' 130' ' ' VAL . 3.8 tt -65.07 -46.63 80.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.985 -0.746 . . . . 0.16 108.985 177.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.635 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 52.7 t80 -59.81 -49.63 76.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.859 -0.61 . . . . 0.3 110.911 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -57.46 -38.69 74.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.394 . . . . 0.4 110.774 -174.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.2 m -76.76 -53.65 7.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.881 -0.6 . . . . 0.22 111.507 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.88 -28.24 63.39 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.241 0.459 . . . . 0.11 112.241 -175.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 33.7 t -57.62 -29.09 64.25 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.305 0.242 . . . . 0.19 111.314 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.55 -22.21 43.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.798 0.332 . . . . 0.14 111.475 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.422 ' CE2' ' HG2' ' A' ' 158' ' ' MET . 22.4 m-85 -90.3 -20.36 23.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.189 0.518 . . . . 0.18 110.437 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 165.87 162.21 16.66 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.855 -0.898 . . . . 0.11 110.855 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.06 142.98 58.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.192 0.52 . . . . 0.25 110.03 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.46 ' HB ' ' CD2' ' A' ' 116' ' ' TYR . 76.5 mt -113.44 134.42 56.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.791 -0.641 . . . . 0.14 110.014 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.525 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.78 -48.25 7.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.881 -0.785 . . . . 0.54 108.881 -178.24 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.2 m -143.86 102.43 3.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.062 -0.972 . . . . 0.76 110.749 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.5 p -102.12 150.91 22.78 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.729 -0.471 . . . . 0.72 109.729 174.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -149.81 131.95 15.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.132 0.491 . . . . 1.0 111.304 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.731 HG22 HD12 ' A' ' 115' ' ' LEU . 59.6 t -114.66 110.19 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.868 -1.53 . . . . 0.28 106.868 171.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 109.097 -0.705 . . . . 0.34 109.097 -174.734 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.745 0 CA-C-O 120.278 -0.179 . . . . 0.31 113.365 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 25.7 p90 -130.04 148.13 51.86 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.485 0.643 . . . . 0.49 111.868 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.55 174.5 23.41 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.154 -0.93 . . . . 0.12 111.379 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -138.86 143.68 38.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.864 0.332 . . . . 0.25 110.504 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.565 ' HB ' HG12 ' A' ' 101' ' ' ILE . 39.6 t -119.0 135.41 59.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.877 0.37 . . . . 0.1 111.043 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -104.49 106.33 16.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.844 -0.799 . . . . 0.21 108.844 166.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.56 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 11.4 m-85 -89.77 135.37 33.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.21 0.529 . . . . 0.17 111.41 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.525 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.8 tt0 -47.29 -44.29 23.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.348 -1.297 . . . . 0.57 110.245 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.7 p -115.05 141.3 48.19 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.422 -1.263 . . . . 0.4 111.001 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -60.4 -39.71 88.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.52 -0.764 . . . . 0.47 111.048 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.1 -33.06 73.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.384 -0.371 . . . . 0.74 111.728 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.34 -34.95 77.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.137 0.494 . . . . 0.18 110.423 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.56 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -61.59 -47.86 83.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.466 -0.788 . . . . 0.16 110.527 177.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.616 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.9 mt-10 -59.13 -39.98 84.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.833 -0.621 . . . . 1.42 110.889 177.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 87.1 mtt180 -58.93 -43.46 91.17 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.95 0.405 . . . . 1.48 110.708 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.72 92.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 0.1 110.663 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 170' ' ' VAL . 87.5 mt -61.3 -51.92 67.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.978 -0.555 . . . . 0.15 111.109 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.5 pt-20 -64.23 -43.58 94.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.085 0.469 . . . . 1.08 111.897 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.489 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -81.81 -39.47 23.99 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 113.028 0.751 . . . . 1.16 113.028 -169.595 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.604 ' HB2' HG21 ' A' ' 170' ' ' VAL . 93.9 mmm -90.56 -20.73 22.3 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.51 -0.476 . . . . 0.35 112.217 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -64.9 123.99 20.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.102 -0.703 . . . . 0.44 109.102 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.95 25.98 43.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.563 -0.827 . . . . 0.29 112.95 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.589 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 4.1 mmt -113.56 156.71 23.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.596 0.198 . . . . 1.18 110.791 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 16.7 mt -95.76 110.76 22.86 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 109.552 -0.536 . . . . 0.44 109.552 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 21.8 mt -96.86 100.28 11.81 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.706 -0.798 . . . . 1.02 109.626 173.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 84.4 m-20 77.49 -25.64 0.2 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.021 -0.99 . . . . 1.71 113.184 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 33.3 t70 170.12 -23.43 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 O-C-N 123.623 0.577 . . . . 0.85 111.918 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 91.2 mtt180 -111.19 135.49 51.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.441 -0.345 . . . . 0.96 110.977 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.1 ttmt -81.81 117.78 22.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.23 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.496 HG11 HD23 ' A' ' 106' ' ' LEU . 15.3 m -100.15 147.29 7.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.862 0.839 . . . . 0.17 111.765 -171.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 52.1 t80 -105.84 119.81 40.11 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.415 -1.266 . . . . 0.3 108.915 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.604 HG21 ' HB2' ' A' ' 158' ' ' MET . 41.3 t -114.49 125.34 71.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 0.13 108.82 177.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.72 -170.43 14.51 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.846 -0.692 . . . . 0.18 111.62 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 . . . . . 0 C--N 1.319 -0.753 0 N-CA-C 108.996 -0.742 . . . . 1.93 108.996 -179.499 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 113.088 0.773 . . . . 0.71 113.088 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.62 22.61 76.96 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.357 -0.838 . . . . 0.21 111.935 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 143' ' ' VAL . 2.4 m-20 -85.48 124.69 32.35 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.094 -0.706 . . . . 0.63 109.094 -175.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.583 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.7 pt -135.86 151.96 30.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.71 -0.478 . . . . 0.15 109.71 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -116.61 137.09 52.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.905 -0.406 . . . . 0.21 109.905 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.596 HG12 HG22 ' A' ' 170' ' ' VAL . 6.5 mt -116.0 134.66 58.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.503 -0.771 . . . . 0.15 109.983 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -118.94 151.62 37.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.69 -0.232 . . . . 1.46 110.534 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.5 t30 76.91 34.7 0.41 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.045 0.841 . . . . 0.49 111.282 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.536 HD22 HG21 ' A' ' 110' ' ' ILE . 22.7 mt -77.06 162.09 27.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.217 -0.447 . . . . 0.26 110.925 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -92.57 152.13 19.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.499 . . . . 0.71 110.122 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -57.11 -29.13 63.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.902 -0.59 . . . . 2.2 112.16 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.0 m -72.43 -14.96 61.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.427 -0.351 . . . . 1.41 111.741 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.536 HG21 HD22 ' A' ' 106' ' ' LEU . 37.6 mm -76.61 123.18 32.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.2 0.524 . . . . 0.26 111.137 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 27.3 t70 -109.31 -177.37 3.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.376 -0.829 . . . . 1.59 109.043 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -71.43 -33.22 69.21 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.79 -0.818 . . . . 0.6 108.79 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -46.89 75.09 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.547 -1.206 . . . . 2.58 108.949 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.28 -44.19 97.64 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.973 -1.467 . . . . 0.15 110.83 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.684 HD12 HG22 ' A' ' 130' ' ' VAL . 3.6 tt -64.21 -46.84 82.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.443 -0.799 . . . . 0.16 109.056 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.745 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 41.6 t80 -59.14 -49.25 78.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 0.3 110.573 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -57.0 -37.42 71.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.937 0.399 . . . . 0.4 111.22 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.551 HG21 HD21 ' A' ' 163' ' ' LEU . 9.1 m -77.98 -53.58 7.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.138 -0.483 . . . . 0.22 111.832 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.426 ' CD1' HD23 ' A' ' 115' ' ' LEU . 9.9 m-85 -72.97 -27.5 61.85 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.754 0.649 . . . . 0.11 112.754 -174.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.0 t -56.89 -28.35 61.8 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.498 0.319 . . . . 0.19 111.633 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.95 -22.57 38.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.833 0.349 . . . . 0.14 111.46 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.569 ' HZ ' ' HE2' ' A' ' 157' ' ' LYS . 34.2 m-85 -91.95 -11.72 35.39 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.83 0.348 . . . . 0.18 111.086 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.95 169.1 20.47 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.796 -0.522 . . . . 0.11 111.796 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -69.17 138.35 54.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.942 0.401 . . . . 0.25 110.438 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 128' ' ' CYS . 76.0 mt -110.17 132.71 57.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.928 -0.578 . . . . 0.14 109.988 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.615 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.27 -45.55 11.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.603 -0.888 . . . . 0.54 108.603 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.1 m -144.73 109.27 4.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.103 -0.953 . . . . 0.76 110.75 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.745 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.8 p -103.68 138.4 40.37 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.176 -0.676 . . . . 0.72 109.176 172.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -136.23 126.9 27.19 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.938 0.399 . . . . 1.0 111.078 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.684 HG22 HD12 ' A' ' 115' ' ' LEU . 89.8 t -111.03 109.82 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 105.983 -1.858 . . . . 0.28 105.983 168.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.0 t . . . . . 0 C--N 1.302 -1.483 0 N-CA-C 108.688 -0.856 . . . . 0.34 108.688 -173.878 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 120.255 -0.192 . . . . 0.31 113.547 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -132.99 158.7 42.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.337 0.568 . . . . 0.49 111.701 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.88 174.77 28.41 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.496 -0.774 . . . . 0.12 112.165 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -138.92 139.02 37.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.666 0.233 . . . . 0.25 110.541 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.583 ' HB ' HG12 ' A' ' 101' ' ' ILE . 47.7 t -111.64 136.52 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.829 0.347 . . . . 0.1 110.651 173.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.1 106.05 16.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.119 -0.697 . . . . 0.21 109.119 166.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.5 m-85 -89.02 137.41 32.34 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.125 0.488 . . . . 0.17 110.856 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.615 ' HA ' HD21 ' A' ' 126' ' ' LEU . 43.3 tt0 -47.54 -43.95 25.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.348 -1.296 . . . . 0.57 110.528 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.9 p -114.57 146.26 40.98 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.642 -1.163 . . . . 0.4 111.191 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -62.37 -37.68 86.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.569 -0.741 . . . . 0.47 111.191 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.93 -34.32 73.31 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.559 -0.292 . . . . 0.74 111.774 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.21 76.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.125 0.488 . . . . 0.18 110.297 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.597 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.53 -44.12 95.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.439 -0.8 . . . . 0.16 110.51 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -59.46 -44.04 93.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.921 -0.582 . . . . 1.42 110.214 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -58.55 -39.58 80.63 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.904 0.383 . . . . 1.48 110.641 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.65 84.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 0.1 110.368 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 151' ' ' ALA . 80.4 mt -61.68 -56.24 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.406 -0.361 . . . . 0.15 111.32 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -43.79 77.83 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.23 0.538 . . . . 1.08 111.278 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.569 ' HE2' ' HZ ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -83.14 -39.53 20.94 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.517 -0.765 . . . . 1.16 112.541 -169.133 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.519 ' HB2' HG21 ' A' ' 170' ' ' VAL . 89.6 mmm -91.85 -24.44 19.35 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.527 -0.469 . . . . 0.35 112.028 -172.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -66.78 123.63 20.67 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.424 -0.584 . . . . 0.44 109.424 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.6 62.04 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.765 -0.731 . . . . 0.29 112.732 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.672 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 29.5 mmt -106.1 166.13 10.72 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 120.74 0.305 . . . . 1.18 111.186 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 20.7 mt -101.25 122.13 43.11 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 109.368 -0.604 . . . . 0.44 109.368 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.551 HD21 HG21 ' A' ' 118' ' ' THR . 21.6 mt -107.04 102.15 11.52 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.874 -0.731 . . . . 1.02 109.212 170.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 57.5 m-20 78.61 -26.39 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.976 0.798 . . . . 1.71 112.584 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 20.2 t70 165.38 -23.65 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.289 0.636 . . . . 0.85 111.332 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -101.68 134.15 45.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.269 -0.423 . . . . 0.96 110.578 -172.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 161' ' ' MET . 16.7 ttmt -81.96 118.26 22.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.436 HG11 HD23 ' A' ' 106' ' ' LEU . 15.7 m -101.3 146.95 8.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.568 0.699 . . . . 0.17 111.37 -172.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 72.6 t80 -106.57 120.78 42.84 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.781 -1.1 . . . . 0.3 109.186 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.596 HG22 HG12 ' A' ' 103' ' ' ILE . 44.3 t -115.17 124.93 72.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.188 -0.671 . . . . 0.13 109.188 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -142.92 -170.89 13.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.497 -0.859 . . . . 0.18 112.47 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 121.136 0.494 . . . . 1.93 110.954 -175.939 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.1 t . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 121.394 0.616 . . . . 0.71 112.343 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 73.27 23.08 78.16 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.635 -0.793 . . . . 0.21 112.255 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -85.02 123.96 31.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.377 -0.601 . . . . 0.63 109.377 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.485 HG12 ' HB ' ' A' ' 143' ' ' VAL . 19.5 pt -135.67 163.47 35.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.704 -0.48 . . . . 0.15 109.704 176.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.25 145.18 50.51 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.462 -0.495 . . . . 0.21 109.858 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 170' ' ' VAL . 5.5 mt -118.19 131.64 70.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.642 -0.708 . . . . 0.15 109.863 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -109.21 148.72 30.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.538 -0.301 . . . . 1.46 110.66 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.7 t30 70.46 39.93 1.15 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.919 0.762 . . . . 0.49 112.148 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.631 HD22 HG21 ' A' ' 110' ' ' ILE . 21.7 mt -73.77 157.36 36.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.081 0.467 . . . . 0.26 111.383 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.545 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 24.5 t70 -81.14 148.98 29.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.381 -0.827 . . . . 0.71 111.05 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -52.78 -37.57 59.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.048 -0.978 . . . . 2.2 112.419 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.2 m -81.8 -4.74 57.16 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.08 0.4 . . . . 1.41 112.08 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.631 HG21 HD22 ' A' ' 106' ' ' LEU . 28.4 mm -74.47 120.44 23.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.242 0.544 . . . . 0.26 110.766 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.492 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 8.1 t70 -109.04 -176.15 2.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.33 -0.85 . . . . 1.59 108.882 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -69.4 -33.97 73.82 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.799 -0.815 . . . . 0.6 108.799 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -45.98 74.34 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.539 -1.209 . . . . 2.58 108.896 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.56 -43.8 98.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.687 -1.597 . . . . 0.15 110.646 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.641 HD12 HG22 ' A' ' 130' ' ' VAL . 3.7 tt -65.46 -47.38 76.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.536 -0.756 . . . . 0.16 109.386 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.742 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.6 t80 -59.2 -46.6 88.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.549 . . . . 0.3 110.963 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.93 -40.09 75.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.697 0.284 . . . . 0.4 111.087 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 50.9 m -78.46 -53.62 7.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.37 0.508 . . . . 0.22 112.37 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.463 ' CD1' HD23 ' A' ' 115' ' ' LEU . 9.4 m-85 -71.9 -28.09 63.27 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.688 0.625 . . . . 0.11 112.688 -173.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.8 t -57.67 -28.96 64.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.539 0.209 . . . . 0.19 111.366 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.23 -22.26 39.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.751 0.31 . . . . 0.14 111.645 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -89.84 -20.57 23.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.18 111.122 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.4 168.97 30.35 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.584 -0.606 . . . . 0.11 111.584 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -68.77 132.59 47.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.25 110.092 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 128' ' ' CYS . 73.5 mt -104.96 126.8 59.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.106 -0.497 . . . . 0.14 109.993 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.588 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -83.2 -35.25 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.9 -0.778 . . . . 0.54 108.9 -178.162 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.0 m -159.06 119.63 3.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.129 -0.941 . . . . 0.76 110.412 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.742 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.9 p -118.97 142.34 47.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.567 -0.531 . . . . 0.72 109.567 176.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -139.94 132.28 28.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.889 0.376 . . . . 1.0 111.485 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.641 HG22 HD12 ' A' ' 115' ' ' LEU . 96.1 t -114.3 109.37 28.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 106.556 -1.646 . . . . 0.28 106.556 169.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 C--N 1.305 -1.355 0 N-CA-C 109.159 -0.682 . . . . 0.34 109.159 -173.825 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 113.747 0.259 . . . . 0.31 113.747 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 18.3 p90 -125.03 150.58 46.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 117.3 0.55 . . . . 0.49 111.727 -173.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -140.07 170.94 24.12 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.361 -0.836 . . . . 0.12 111.49 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -135.83 141.05 44.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.927 0.363 . . . . 0.25 110.535 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.491 HG11 ' CE2' ' A' ' 145' ' ' PHE . 30.8 t -115.32 135.49 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 0.1 110.714 173.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.427 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -103.62 106.17 16.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.906 -0.776 . . . . 0.21 108.906 166.433 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.491 ' CE2' HG11 ' A' ' 143' ' ' VAL . 12.6 m-85 -91.44 137.39 32.4 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.15 0.5 . . . . 0.17 111.08 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.588 ' HA ' HD21 ' A' ' 126' ' ' LEU . 41.8 tt0 -45.73 -42.23 11.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.206 -1.361 . . . . 0.57 111.273 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.7 p -121.05 155.76 33.68 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.182 -0.917 . . . . 0.4 110.565 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -67.2 -32.01 72.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.852 -0.613 . . . . 0.47 110.206 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 152' ' ' GLU . 10.3 pt-20 -70.67 -34.78 72.36 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.2 -0.455 . . . . 0.74 111.964 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 145' ' ' PHE . . . -62.3 -34.85 77.4 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.047 0.451 . . . . 0.18 110.22 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.477 ' O ' HG13 ' A' ' 155' ' ' ILE . . . -63.43 -41.08 98.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.648 -0.705 . . . . 0.16 110.171 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 13.0 mm-40 -58.56 -43.43 89.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.545 -0.752 . . . . 1.42 111.303 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 44.8 mtt180 -64.14 -40.06 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 1.48 110.97 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.79 86.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.522 -0.308 . . . . 0.1 110.46 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 151' ' ' ALA . 81.9 mt -59.54 -51.88 67.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.15 111.251 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.1 pt-20 -63.75 -44.65 92.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.006 0.431 . . . . 1.08 111.771 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.403 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.06 -39.29 23.66 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.173 0.805 . . . . 1.16 113.173 -168.735 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.47 ' HB2' HG21 ' A' ' 170' ' ' VAL . 91.5 mmm -91.25 -20.0 22.39 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.224 0.453 . . . . 0.35 112.224 -173.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.02 122.74 19.95 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.049 -0.66 . . . . 0.44 109.353 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.71 17.87 61.01 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.599 -0.81 . . . . 0.29 112.458 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -103.63 164.91 11.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.233 -0.654 . . . . 1.18 109.233 176.93 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.417 HD23 ' CA ' ' A' ' 167' ' ' LYS . 25.7 mt -103.04 132.18 49.5 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.859 -0.793 . . . . 0.44 108.859 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 19.7 mt -116.56 104.2 11.17 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 120.226 -0.59 . . . . 1.02 109.641 171.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 83.2 m-20 76.44 -27.39 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.129 -0.941 . . . . 1.71 113.063 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 20.5 t70 167.86 -24.5 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 O-C-N 123.938 0.774 . . . . 0.85 111.712 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.545 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 94.3 mtt180 -107.2 135.92 47.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.787 0.327 . . . . 0.96 110.852 -171.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 161' ' ' MET . 23.5 tttt -84.3 119.76 25.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.703 -0.68 . . . . 1.0 109.207 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.502 HG11 HD23 ' A' ' 106' ' ' LEU . 14.3 m -101.45 151.1 5.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.766 0.793 . . . . 0.17 111.409 -172.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 35.8 t80 -109.93 120.82 43.66 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.665 -1.152 . . . . 0.3 109.123 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.587 HG22 HG12 ' A' ' 103' ' ' ILE . 42.3 t -115.32 125.72 72.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.28 -0.637 . . . . 0.13 109.28 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.49 -176.76 22.19 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.62 -0.8 . . . . 0.18 111.64 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 . . . . . 0 C--N 1.324 -0.541 0 N-CA-C 109.024 -0.732 . . . . 1.93 109.024 176.443 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 121.525 0.679 . . . . 0.71 111.987 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.78 24.18 77.01 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.74 -1.219 . . . . 0.21 111.634 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.1 m-20 -85.12 124.02 31.3 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.29 -0.633 . . . . 0.63 109.29 -173.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.578 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.3 pt -135.66 159.98 39.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.015 -0.365 . . . . 0.15 110.015 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.51 143.22 50.79 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.605 -0.517 . . . . 0.21 109.605 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 170' ' ' VAL . 6.1 mt -118.56 133.81 64.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.854 -0.612 . . . . 0.15 110.37 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -114.25 150.07 34.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.25 -0.432 . . . . 1.46 110.318 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 67.99 54.68 0.6 Allowed 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.844 0.715 . . . . 0.49 111.63 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.534 HD22 HG21 ' A' ' 110' ' ' ILE . 12.1 mt -89.78 159.53 16.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.614 -0.721 . . . . 0.26 111.264 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.572 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 14.9 t70 -77.75 151.09 34.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.71 109.95 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -63.65 -31.88 73.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.617 -0.72 . . . . 2.2 111.663 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.4 p -76.41 -4.68 43.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.796 0.331 . . . . 1.41 111.753 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.534 HG21 HD22 ' A' ' 106' ' ' LEU . 40.4 mm -77.26 121.55 29.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.216 0.532 . . . . 0.26 110.734 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 26.9 t70 -108.15 -178.68 3.67 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.751 -0.833 . . . . 1.59 108.751 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.412 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 2.8 m-20 -63.48 -38.95 93.09 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.639 -0.875 . . . . 0.6 108.639 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.961 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.87 -49.28 78.11 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.006 -0.997 . . . . 2.58 110.359 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.403 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.66 -43.66 98.44 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.296 -1.32 . . . . 0.15 111.412 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 130' ' ' VAL . 4.3 tt -64.49 -47.5 78.7 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.198 -0.667 . . . . 0.16 109.198 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.717 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 68.7 t80 -59.84 -46.7 88.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.989 -0.55 . . . . 0.3 110.608 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -57.03 -39.16 74.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.316 -0.402 . . . . 0.4 110.989 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.658 HG21 HD21 ' A' ' 163' ' ' LEU . 20.7 m -77.04 -53.39 7.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.047 -0.524 . . . . 0.22 111.681 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -72.52 -29.0 63.21 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.434 0.531 . . . . 0.11 112.434 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.3 t -57.97 -28.05 63.99 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.6 0.238 . . . . 0.19 111.003 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.49 -22.73 34.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.461 -0.336 . . . . 0.14 111.345 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -93.02 -13.92 28.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.456 -0.338 . . . . 0.18 111.099 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.04 169.08 22.88 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.848 -0.692 . . . . 0.11 112.137 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -66.23 137.71 57.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.915 0.388 . . . . 0.25 110.54 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.493 ' HB ' ' CE1' ' A' ' 116' ' ' TYR . 76.3 mt -113.34 132.34 62.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.739 -0.664 . . . . 0.14 109.711 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -85.89 -42.34 14.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.869 -0.789 . . . . 0.54 108.869 -178.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.8 m -149.34 125.09 10.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.782 -1.099 . . . . 0.76 110.279 -177.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.717 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 19.8 p -122.32 151.74 40.83 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.173 -0.677 . . . . 0.72 109.173 174.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -143.14 129.72 20.19 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.627 -0.429 . . . . 1.0 111.727 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.553 HG22 HD12 ' A' ' 115' ' ' LEU . 70.8 t -114.87 109.67 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 106.796 -1.557 . . . . 0.28 106.796 168.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.6 t . . . . . 0 C--N 1.305 -1.349 0 CA-C-N 115.775 -0.648 . . . . 0.34 109.373 -174.072 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.335 0 N-CA-C 113.75 0.26 . . . . 0.31 113.75 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -133.01 156.62 47.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.243 0.521 . . . . 0.49 110.913 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.56 177.22 26.94 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.893 -0.594 . . . . 0.12 112.012 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -140.82 143.75 34.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.867 0.333 . . . . 0.25 111.174 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.578 ' HB ' HG12 ' A' ' 101' ' ' ILE . 38.8 t -119.21 133.04 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.981 0.42 . . . . 0.1 111.154 172.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.7 OUTLIER -103.47 105.82 16.18 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.775 -0.824 . . . . 0.21 108.775 165.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.519 ' CE2' HG11 ' A' ' 143' ' ' VAL . 13.7 m-85 -88.19 138.5 31.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.94 0.4 . . . . 0.17 111.008 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.625 ' HA ' HD21 ' A' ' 126' ' ' LEU . 26.4 tt0 -48.48 -47.33 38.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.903 -1.044 . . . . 0.57 110.433 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 p -109.98 151.65 26.87 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.62 -1.173 . . . . 0.4 110.672 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -67.89 -36.14 79.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.959 -0.564 . . . . 0.47 110.719 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 14.0 pt-20 -70.04 -35.38 74.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.352 0.501 . . . . 0.74 112.352 -176.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.45 -34.89 77.7 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.043 0.449 . . . . 0.18 110.403 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 155' ' ' ILE . . . -63.6 -43.61 96.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.666 -0.697 . . . . 0.16 110.448 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 33.5 mt-10 -58.89 -37.75 77.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 1.42 110.722 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 92.2 mtt180 -66.72 -44.31 81.94 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.805 0.336 . . . . 1.48 110.634 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.12 -38.92 90.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 0.1 110.631 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 151' ' ' ALA . 84.4 mt -59.16 -53.99 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.15 111.533 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.1 pt-20 -64.91 -44.63 88.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.332 0.587 . . . . 1.08 111.967 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.453 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -77.62 -38.27 48.34 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.311 -0.859 . . . . 1.16 112.665 -169.054 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.43 ' O ' ' HB2' ' A' ' 161' ' ' MET . 89.0 mmm -94.09 -17.75 22.5 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.496 -0.482 . . . . 0.35 112.256 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.432 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 52.5 t30 -69.66 123.33 21.09 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.919 -0.712 . . . . 0.44 109.113 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.61 8.79 79.76 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.687 -0.768 . . . . 0.29 112.061 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.7 OUTLIER -91.32 159.63 15.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.725 0.297 . . . . 1.18 110.248 178.783 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 15.2 mt -104.49 108.23 19.55 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.644 -0.502 . . . . 0.44 109.644 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.658 HD21 HG21 ' A' ' 118' ' ' THR . 22.5 mt -93.42 105.75 17.78 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 119.75 -0.78 . . . . 1.02 109.395 173.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 73.06 -58.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.165 -0.925 . . . . 1.71 112.474 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -166.97 14.61 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.288 -0.414 . . . . 0.85 111.894 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.572 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 92.7 mtt180 -135.54 134.66 39.65 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.713 -0.395 . . . . 0.96 110.423 -175.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.3 tttt -82.18 121.57 26.77 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.236 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.04 143.36 14.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.467 0.651 . . . . 0.17 111.3 -173.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.432 ' HA ' ' OD1' ' A' ' 159' ' ' ASN . 63.2 t80 -106.32 119.88 40.4 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.231 -0.895 . . . . 0.3 109.062 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.552 HG22 HG12 ' A' ' 103' ' ' ILE . 43.9 t -115.16 126.57 72.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.234 -0.654 . . . . 0.13 109.234 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.63 -178.91 21.51 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.529 -0.843 . . . . 0.18 112.199 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 . . . . . 0 C--N 1.324 -0.535 0 N-CA-C 110.226 -0.287 . . . . 1.93 110.226 -178.169 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 121.804 0.811 . . . . 0.71 112.587 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.1 23.0 78.63 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.84 -1.172 . . . . 0.21 110.739 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.0 m-20 -94.23 127.49 40.12 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.931 -0.766 . . . . 0.63 108.931 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.597 HG23 ' HB1' ' A' ' 151' ' ' ALA . 27.4 pt -134.51 161.36 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.277 -0.268 . . . . 0.15 110.277 177.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.96 143.24 50.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.938 -0.393 . . . . 0.21 109.938 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.514 HG12 HG22 ' A' ' 170' ' ' VAL . 8.7 mt -116.6 146.73 20.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.756 -0.656 . . . . 0.15 109.953 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 44.8 tttp -129.61 147.91 51.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.288 -0.415 . . . . 1.46 110.342 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.8 t30 64.81 47.7 2.64 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.549 0.74 . . . . 0.49 111.954 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.664 HD22 HG21 ' A' ' 110' ' ' ILE . 23.0 mt -80.07 151.84 29.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.167 0.508 . . . . 0.26 111.447 176.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.533 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 17.9 t70 -77.97 150.95 33.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.476 -0.784 . . . . 0.71 111.313 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -51.7 -38.64 55.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.137 -0.938 . . . . 2.2 112.946 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.3 m -85.09 -4.24 59.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.054 0.39 . . . . 1.41 112.054 -173.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.664 HG21 HD22 ' A' ' 106' ' ' LEU . 33.5 mm -71.88 116.21 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.099 0.476 . . . . 0.26 110.23 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -103.72 -179.36 3.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.637 -0.875 . . . . 1.59 108.637 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -63.96 -37.25 86.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.736 -0.839 . . . . 0.6 108.736 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 1.034 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -61.37 -49.66 76.02 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.168 -0.924 . . . . 2.58 110.712 178.2 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.3 99.12 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.194 -1.366 . . . . 0.15 111.068 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.762 HD12 HG22 ' A' ' 130' ' ' VAL . 3.8 tt -63.94 -47.87 78.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.419 -0.81 . . . . 0.16 109.105 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.657 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 51.5 t80 -58.69 -48.45 81.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.869 -0.605 . . . . 0.3 110.914 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.3 -38.82 74.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.938 0.399 . . . . 0.4 110.59 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.6 m -77.47 -54.17 6.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.148 -0.478 . . . . 0.22 111.875 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.446 ' CD1' HD23 ' A' ' 115' ' ' LEU . 7.2 m-85 -72.19 -27.87 62.84 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.248 0.462 . . . . 0.11 112.248 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 28.7 t -57.41 -28.03 62.91 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 111.629 0.233 . . . . 0.19 111.629 -177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.83 -22.88 39.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.016 0.436 . . . . 0.14 111.345 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -90.19 -22.29 21.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.113 -0.494 . . . . 0.18 110.777 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 169.36 169.02 32.16 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.89 -0.595 . . . . 0.11 111.784 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -70.65 139.55 51.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.018 0.437 . . . . 0.25 109.893 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.419 HG21 ' HB3' ' A' ' 128' ' ' CYS . 74.1 mt -112.88 131.93 63.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.907 -0.588 . . . . 0.14 110.024 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -88.5 -41.06 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.922 -0.77 . . . . 0.54 108.922 -177.8 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 72.1 m -147.7 119.6 8.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.163 -0.926 . . . . 0.76 110.314 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 9.2 p -117.53 144.95 44.59 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.526 -0.546 . . . . 0.72 109.526 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -142.19 129.3 20.89 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.503 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.762 HG22 HD12 ' A' ' 115' ' ' LEU . 61.2 t -115.55 110.7 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 106.848 -1.538 . . . . 0.28 106.848 170.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.303 -1.416 0 N-CA-C 108.848 -0.797 . . . . 0.34 108.848 -175.368 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 N-CA-C 113.324 0.09 . . . . 0.31 113.324 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -126.07 149.37 48.94 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 121.855 -0.791 . . . . 0.49 111.874 -173.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.86 174.81 24.1 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.077 -0.965 . . . . 0.12 111.348 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -141.57 137.44 31.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.019 0.41 . . . . 0.25 110.615 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.583 ' HB ' HG12 ' A' ' 101' ' ' ILE . 43.2 t -112.88 133.68 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.1 111.147 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.1 m170 -103.12 105.91 16.31 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.626 -0.715 . . . . 0.21 109.143 166.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.581 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 12.5 m-85 -88.79 142.55 27.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.261 0.553 . . . . 0.17 110.751 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.572 ' HA ' HD21 ' A' ' 126' ' ' LEU . 42.8 tt0 -51.67 -38.32 54.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.277 -1.329 . . . . 0.57 110.542 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.6 p -125.32 150.38 47.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.307 -0.86 . . . . 0.4 111.443 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -60.65 -37.76 82.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.603 -0.726 . . . . 0.47 111.24 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.6 pt-20 -67.82 -35.38 78.5 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.56 -0.291 . . . . 0.74 111.645 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.53 78.35 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.21 0.529 . . . . 0.18 110.278 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.597 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -63.56 -46.57 85.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.339 -0.846 . . . . 0.16 110.565 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 42.6 mt-10 -58.96 -40.19 83.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 1.42 110.526 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 88.8 mtt180 -58.96 -44.76 91.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.005 0.431 . . . . 1.48 110.719 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.4 94.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.968 -0.56 . . . . 0.1 110.598 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 151' ' ' ALA . 88.6 mt -58.97 -53.56 46.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.889 -0.596 . . . . 0.15 111.401 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 0.6 OUTLIER -63.64 -41.83 98.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.091 0.472 . . . . 1.08 111.808 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.418 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -81.8 -39.98 23.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.681 -0.691 . . . . 1.16 112.82 -169.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 91.3 mmm -91.24 -19.12 23.36 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.262 0.468 . . . . 0.35 112.262 -173.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -66.54 122.78 18.35 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.396 -0.521 . . . . 0.44 109.826 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.48 26.81 37.87 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.91 -0.662 . . . . 0.29 113.01 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.705 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 74.5 mmm -112.64 157.06 21.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.958 0.379 . . . . 1.18 110.891 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 167' ' ' LYS . 19.6 mt -94.15 102.38 14.42 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.002 -0.74 . . . . 0.44 109.002 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 163' ' ' LEU . 16.7 mt -83.91 101.47 11.7 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 119.278 -0.969 . . . . 1.02 108.645 172.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 98.8 m-20 73.94 -70.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.856 -1.065 . . . . 1.71 111.467 -175.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -147.2 -0.57 0.68 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.425 -0.807 . . . . 0.85 112.192 -173.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.533 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 91.6 mtt180 -132.1 128.76 38.84 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.955 -0.466 . . . . 0.96 110.473 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.705 ' HA ' ' O ' ' A' ' 161' ' ' MET . 13.3 tttt -76.45 122.04 23.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.35 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 16.0 m -101.18 140.06 20.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.391 0.615 . . . . 0.17 111.056 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -106.08 121.7 44.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.18 -0.918 . . . . 0.3 108.871 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.514 HG22 HG12 ' A' ' 103' ' ' ILE . 39.6 t -115.88 130.15 71.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.976 -0.557 . . . . 0.13 109.565 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -142.87 -165.37 10.59 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.773 -0.727 . . . . 0.18 111.949 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 . . . . . 0 C--N 1.323 -0.566 0 N-CA-C 109.61 -0.515 . . . . 1.93 109.61 -178.055 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 121.221 0.534 . . . . 0.71 111.923 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.18 23.05 78.36 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.481 -0.866 . . . . 0.21 111.856 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 143' ' ' VAL . 4.0 m-20 -89.32 126.2 35.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.335 -0.617 . . . . 0.63 109.335 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.512 HG12 ' HB ' ' A' ' 143' ' ' VAL . 22.0 pt -134.65 163.37 36.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.734 -0.666 . . . . 0.15 109.547 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.07 146.45 50.36 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.564 -0.455 . . . . 0.21 109.817 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.561 HG12 HG22 ' A' ' 170' ' ' VAL . 4.2 mt -118.22 138.37 49.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.688 -0.687 . . . . 0.15 109.714 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -120.85 152.78 37.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.691 -0.231 . . . . 1.46 110.4 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.8 t30 70.57 41.07 0.98 Allowed 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.818 0.699 . . . . 0.49 111.699 172.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.54 HD22 HG21 ' A' ' 110' ' ' ILE . 20.0 mt -79.4 164.83 23.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.217 0.532 . . . . 0.26 111.907 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.461 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.8 t70 -89.01 155.55 19.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.406 -0.815 . . . . 0.71 110.799 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.44 ' HG3' ' N ' ' A' ' 109' ' ' SER . 20.0 pttp -59.99 -36.68 77.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.228 -0.442 . . . . 2.2 111.724 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.44 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 16.7 m -80.85 -3.21 50.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.243 -0.435 . . . . 1.41 111.891 -173.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.554 HG22 HG21 ' A' ' 130' ' ' VAL . 34.5 mm -76.02 118.53 22.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.26 110.254 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -108.66 -175.52 2.79 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.128 -0.693 . . . . 1.59 109.128 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -69.39 -32.76 71.99 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.081 -0.711 . . . . 0.6 109.081 -176.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.412 ' O ' ' HD2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -67.13 -48.47 67.97 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.54 -1.209 . . . . 2.58 109.253 178.707 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.2 -41.42 96.78 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.198 -1.365 . . . . 0.15 110.83 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.71 HD12 HG22 ' A' ' 130' ' ' VAL . 3.8 tt -66.98 -47.66 70.86 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.039 -0.726 . . . . 0.16 109.039 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.681 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.6 t80 -59.38 -46.45 88.62 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.933 -0.576 . . . . 0.3 110.81 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.3 -41.08 75.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.09 0.471 . . . . 0.4 110.978 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.469 HG21 HD21 ' A' ' 163' ' ' LEU . 18.0 m -77.07 -52.76 8.76 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.787 -0.642 . . . . 0.22 111.691 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.434 ' CD1' HD23 ' A' ' 115' ' ' LEU . 10.6 m-85 -72.69 -28.24 62.57 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.638 0.607 . . . . 0.11 112.638 -175.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.8 t -57.3 -28.8 63.35 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.563 0.221 . . . . 0.19 111.388 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.57 -24.13 45.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.896 0.379 . . . . 0.14 111.226 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -89.17 -18.18 27.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.18 111.408 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.44 173.55 32.27 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.033 -0.604 . . . . 0.11 112.024 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -69.46 135.37 50.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.914 0.387 . . . . 0.25 110.33 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 70.8 mt -110.67 124.29 67.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.217 -0.447 . . . . 0.14 110.597 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -79.97 -36.37 36.21 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.777 -0.823 . . . . 0.54 108.777 -176.617 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.4 m -154.97 141.49 18.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.86 -1.063 . . . . 0.76 109.694 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.6 p -143.5 135.42 26.62 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.803 -0.443 . . . . 0.72 109.803 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -140.76 133.25 28.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.112 0.482 . . . . 1.0 111.887 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.71 HG22 HD12 ' A' ' 115' ' ' LEU . 78.1 t -114.26 117.46 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 N-CA-C 106.717 -1.586 . . . . 0.28 106.717 169.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 C--N 1.303 -1.433 0 N-CA-C 108.811 -0.811 . . . . 0.34 108.811 -176.343 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 113.742 0.257 . . . . 0.31 113.742 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -122.6 152.39 40.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 117.421 0.611 . . . . 0.49 112.208 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.67 175.25 24.47 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.01 -0.996 . . . . 0.12 111.438 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -140.52 142.24 35.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.088 0.444 . . . . 0.25 111.113 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.512 ' HB ' HG12 ' A' ' 101' ' ' ILE . 39.2 t -119.53 135.55 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-O 121.009 0.433 . . . . 0.1 110.873 172.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.9 106.22 16.61 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.985 -0.746 . . . . 0.21 108.985 166.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.54 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.7 m-85 -90.1 137.34 32.42 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.022 0.439 . . . . 0.17 110.993 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.572 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.8 tt0 -45.81 -43.83 13.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.42 -1.264 . . . . 0.57 111.021 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.3 p -116.8 153.39 32.54 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.266 -0.879 . . . . 0.4 110.33 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -64.61 -36.95 85.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.939 -0.573 . . . . 0.47 110.303 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 13.4 pt-20 -70.35 -34.37 72.56 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.035 -0.529 . . . . 0.74 112.293 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.72 -35.76 77.14 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.981 0.42 . . . . 0.18 110.52 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.54 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.82 -42.51 97.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.742 -0.663 . . . . 0.16 110.502 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.6 mt-10 -59.85 -40.55 88.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.884 -0.598 . . . . 1.42 110.437 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 61.5 mtt180 -60.1 -42.09 93.93 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.455 0.472 . . . . 1.48 110.861 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.35 -39.41 85.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.1 110.693 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 151' ' ' ALA . 88.2 mt -58.94 -53.61 45.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.119 -0.491 . . . . 0.15 111.075 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.5 pt-20 -60.41 -45.36 93.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.926 0.394 . . . . 1.08 111.796 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.461 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -80.93 -38.98 26.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.979 0.733 . . . . 1.16 112.979 -169.541 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.469 ' O ' ' HB2' ' A' ' 161' ' ' MET . 95.1 mmm -95.23 -17.84 21.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.67 0.619 . . . . 0.35 112.67 -171.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -70.12 122.09 18.77 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.683 -0.807 . . . . 0.44 109.187 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.79 23.55 55.52 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.602 -0.809 . . . . 0.29 112.178 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.624 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.8 OUTLIER -102.92 158.73 16.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.532 0.206 . . . . 1.18 110.536 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 21.7 mt -102.68 98.13 8.21 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.416 -0.356 . . . . 0.44 110.128 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.469 HD21 HG21 ' A' ' 118' ' ' THR . 18.6 mt -85.83 107.81 17.84 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 120.041 -0.664 . . . . 1.02 109.363 175.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 98.2 m-20 74.32 -61.86 0.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.164 -0.926 . . . . 1.71 111.599 -176.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -172.26 25.23 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.552 -0.749 . . . . 0.85 110.658 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.2 mtt180 -137.82 129.55 28.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.396 -0.366 . . . . 0.96 110.053 -178.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.9 tttt -79.89 118.88 22.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.82 -0.627 . . . . 1.0 109.377 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.482 HG11 HD23 ' A' ' 106' ' ' LEU . 19.3 m -102.33 150.78 6.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.294 0.569 . . . . 0.17 111.668 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 64.7 t80 -106.59 120.57 42.29 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.277 -0.874 . . . . 0.3 109.278 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.561 HG22 HG12 ' A' ' 103' ' ' ILE . 45.4 t -115.44 125.78 72.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.27 -0.641 . . . . 0.13 109.27 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.48 -174.29 20.06 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.708 -0.758 . . . . 0.18 111.404 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 108.796 -0.816 . . . . 1.93 108.796 178.463 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 121.633 0.73 . . . . 0.71 112.44 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.02 23.81 77.11 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.963 -1.113 . . . . 0.21 111.012 -179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -89.62 124.97 35.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.009 -0.737 . . . . 0.63 109.009 -173.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.568 HG12 ' HB ' ' A' ' 143' ' ' VAL . 22.9 pt -135.62 163.41 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.545 -0.298 . . . . 0.15 110.242 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.38 146.47 48.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.882 0.372 . . . . 0.21 110.054 176.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.643 HG12 HG22 ' A' ' 170' ' ' VAL . 6.8 mt -124.48 144.92 32.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.765 -0.652 . . . . 0.15 109.788 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -129.94 156.42 44.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.46 0.171 . . . . 1.46 111.073 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.7 t30 71.54 36.12 1.34 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.044 0.938 . . . . 0.49 111.357 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.586 HD22 HG21 ' A' ' 110' ' ' ILE . 31.7 mt -76.59 143.36 40.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.187 -0.461 . . . . 0.26 110.779 175.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.44 151.28 41.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.706 -0.679 . . . . 0.71 110.923 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -52.84 -32.77 46.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.499 -0.773 . . . . 2.2 112.321 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -80.45 -7.47 59.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.006 0.372 . . . . 1.41 112.006 -175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.621 HG22 HG21 ' A' ' 130' ' ' VAL . 28.2 mm -76.07 127.38 37.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.078 0.466 . . . . 0.26 110.928 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -115.64 -179.25 3.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.536 -0.756 . . . . 1.59 109.026 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -65.71 -36.39 83.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.507 -0.553 . . . . 0.6 109.507 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.983 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.98 -49.63 76.68 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.862 0.839 . . . . 2.58 109.986 178.057 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.6 98.56 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.771 -1.559 . . . . 0.15 111.315 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.743 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -64.76 -47.18 79.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.973 -0.751 . . . . 0.16 108.973 177.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.746 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 55.6 t80 -58.65 -49.1 78.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.3 111.127 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.68 -37.51 73.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.863 0.363 . . . . 0.4 110.922 -174.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.709 HG21 HD21 ' A' ' 163' ' ' LEU . 6.7 m -78.29 -53.9 6.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.521 . . . . 0.22 111.823 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 115' ' ' LEU . 21.2 m-85 -72.01 -28.29 63.29 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.31 0.485 . . . . 0.11 112.31 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.9 t -57.82 -27.53 63.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.529 0.204 . . . . 0.19 111.51 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.58 -21.83 29.41 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.762 0.315 . . . . 0.14 111.736 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -93.12 -9.78 38.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.18 110.932 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.29 161.46 10.85 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.743 -0.662 . . . . 0.11 111.665 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -61.24 132.23 52.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.24 0.543 . . . . 0.25 110.363 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.434 ' HB ' ' CD1' ' A' ' 116' ' ' TYR . 76.8 mt -100.84 134.9 39.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.62 -0.718 . . . . 0.14 109.715 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 146' ' ' GLU . 19.9 mt -89.66 -39.14 13.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.847 0.832 . . . . 0.54 108.867 -176.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.7 m -155.95 129.42 8.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.496 -1.229 . . . . 0.76 109.502 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.746 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 8.5 p -123.84 149.71 45.43 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.192 -0.67 . . . . 0.72 109.192 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -148.51 128.02 13.17 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.308 -0.557 . . . . 1.0 111.704 -177.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.743 HG22 HD12 ' A' ' 115' ' ' LEU . 59.7 t -111.31 109.59 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 106.195 -1.78 . . . . 0.28 106.195 169.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 t . . . . . 0 C--N 1.299 -1.604 0 N-CA-C 108.714 -0.847 . . . . 0.34 108.714 -174.903 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.792 0 CA-C-O 120.315 -0.158 . . . . 0.31 113.361 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -126.04 152.94 45.12 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.424 0.612 . . . . 0.49 111.811 -173.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.65 174.64 26.43 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.352 -0.84 . . . . 0.12 111.619 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -139.97 136.88 34.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.947 0.374 . . . . 0.25 110.862 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.568 ' HB ' HG12 ' A' ' 101' ' ' ILE . 47.5 t -111.23 134.46 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.036 0.446 . . . . 0.1 111.094 174.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -102.51 107.04 17.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.681 -0.69 . . . . 0.21 109.159 165.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 21.2 m-85 -87.36 142.07 28.16 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.286 0.565 . . . . 0.17 110.697 176.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.503 ' HA ' HD11 ' A' ' 126' ' ' LEU . 39.4 tt0 -51.7 -35.01 41.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.521 -1.218 . . . . 0.57 111.001 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.1 p -130.04 150.06 51.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.582 -1.19 . . . . 0.4 111.181 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -62.75 -38.43 90.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.665 -0.698 . . . . 0.47 111.04 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -65.19 -33.75 76.75 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.113 -0.494 . . . . 0.74 112.285 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.67 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 0.18 110.298 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -64.62 -43.13 94.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.335 -0.848 . . . . 0.16 111.097 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 28.2 mt-10 -58.44 -40.69 83.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.851 -0.613 . . . . 1.42 110.865 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 58.8 mtt85 -64.82 -42.33 95.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.74 0.305 . . . . 1.48 110.784 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.45 94.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.4 -0.364 . . . . 0.1 110.605 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.7 mt -58.81 -54.47 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.15 111.013 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.5 pt-20 -64.1 -45.52 88.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.188 0.518 . . . . 1.08 111.841 -177.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.2 OUTLIER -77.36 -38.58 49.86 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.479 -0.782 . . . . 1.16 112.617 -170.54 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.479 ' HB2' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -90.05 -25.46 20.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.17 0.433 . . . . 0.35 112.17 -174.176 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 59.0 t30 -66.36 123.4 19.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.25 -0.648 . . . . 0.44 109.25 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.98 12.67 63.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.613 -0.803 . . . . 0.29 112.638 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.8 mmt -101.6 158.05 16.37 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.634 -0.333 . . . . 1.18 111.137 177.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 30.7 mt -98.34 107.61 20.12 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 109.207 -0.664 . . . . 0.44 109.207 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.709 HD21 HG21 ' A' ' 118' ' ' THR . 17.2 mt -90.77 107.64 19.31 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.853 -0.795 . . . . 1.02 108.853 171.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 82.5 m-20 72.78 -67.22 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.246 -0.888 . . . . 1.71 111.61 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -157.03 7.71 0.17 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.328 -0.851 . . . . 0.85 111.742 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -130.56 134.35 46.94 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.592 -0.692 . . . . 0.96 110.924 -175.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.6 tttt -79.01 118.97 21.5 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.421 HG11 HD23 ' A' ' 106' ' ' LEU . 5.7 m -100.19 146.81 8.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.596 0.712 . . . . 0.17 111.046 -172.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 74.1 t80 -106.58 117.84 35.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.699 -1.137 . . . . 0.3 109.369 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.643 HG22 HG12 ' A' ' 103' ' ' ILE . 39.4 t -115.61 131.03 69.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.425 -0.583 . . . . 0.13 109.425 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -151.85 -176.92 25.07 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.595 -0.812 . . . . 0.18 112.195 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.389 . . . . 1.93 110.284 -179.983 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 121.535 0.683 . . . . 0.71 111.958 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 73.25 24.08 76.15 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.167 -1.016 . . . . 0.21 111.551 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -88.13 125.23 34.49 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.005 -0.739 . . . . 0.63 109.005 -173.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.527 HG23 ' HB1' ' A' ' 151' ' ' ALA . 19.1 pt -135.67 164.08 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.301 -0.259 . . . . 0.15 110.301 177.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -125.19 145.0 50.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.858 0.361 . . . . 0.21 110.162 176.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.604 HG12 HG22 ' A' ' 170' ' ' VAL . 5.3 mt -123.06 142.89 37.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.855 -0.612 . . . . 0.15 110.043 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -127.38 155.44 43.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.291 0.091 . . . . 1.46 111.125 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.9 t30 70.48 38.19 1.38 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.947 0.779 . . . . 0.49 111.216 173.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.654 HD22 HG21 ' A' ' 110' ' ' ILE . 17.5 mt -79.63 163.44 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.535 -0.757 . . . . 0.26 111.075 175.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -97.16 157.27 16.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.988 -0.551 . . . . 0.71 109.976 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -62.79 -28.67 70.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.935 0.398 . . . . 2.2 111.204 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.5 m -69.72 -6.52 32.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.267 -0.424 . . . . 1.41 111.936 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.654 HG21 HD22 ' A' ' 106' ' ' LEU . 31.7 mm -89.41 114.2 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.175 0.512 . . . . 0.26 110.46 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.53 -173.58 2.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.678 -0.86 . . . . 1.59 108.678 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -70.46 -33.11 70.9 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.135 -1.061 . . . . 0.6 108.135 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.654 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -66.8 -47.35 72.36 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 113.985 -1.461 . . . . 2.58 109.661 178.054 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.11 97.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.972 -1.467 . . . . 0.15 110.787 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.682 HD12 HG22 ' A' ' 130' ' ' VAL . 4.4 tt -67.07 -47.0 72.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.444 -0.798 . . . . 0.16 109.163 177.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.693 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 75.7 t80 -58.94 -46.61 87.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.078 -0.51 . . . . 0.3 110.997 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -56.77 -40.05 75.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.977 0.417 . . . . 0.4 110.886 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.442 HG21 HD21 ' A' ' 163' ' ' LEU . 9.6 m -77.67 -53.88 7.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.944 -0.571 . . . . 0.22 111.825 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.41 ' CD1' HD23 ' A' ' 115' ' ' LEU . 12.0 m-85 -72.42 -29.75 64.0 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.784 0.661 . . . . 0.11 112.784 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.6 t -58.64 -28.11 65.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.617 0.246 . . . . 0.19 111.174 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.86 -22.12 34.53 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.683 0.278 . . . . 0.14 111.593 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.89 -11.9 35.04 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.899 0.38 . . . . 0.18 110.984 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.57 160.88 10.96 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.749 -0.54 . . . . 0.11 111.749 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -62.45 139.24 58.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.25 110.185 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.436 HG21 ' HB3' ' A' ' 128' ' ' CYS . 67.1 mt -110.89 134.99 51.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.959 -0.564 . . . . 0.14 109.857 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.577 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -87.49 -44.05 11.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.635 -0.876 . . . . 0.54 108.635 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.6 m -145.33 127.48 15.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.85 -1.068 . . . . 0.76 109.862 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.693 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 8.5 p -124.09 137.0 54.63 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.587 -0.523 . . . . 0.72 109.587 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -136.39 129.59 31.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.909 0.385 . . . . 1.0 111.788 -173.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.682 HG22 HD12 ' A' ' 115' ' ' LEU . 60.9 t -115.1 110.81 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 107.171 -1.418 . . . . 0.28 107.171 170.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 t . . . . . 0 C--N 1.305 -1.337 0 N-CA-C 109.015 -0.735 . . . . 0.34 109.015 -175.503 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.684 0 N-CA-C 113.575 0.19 . . . . 0.31 113.575 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -127.21 151.24 48.96 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.491 0.645 . . . . 0.49 111.817 -174.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.1 175.51 25.54 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.236 -0.893 . . . . 0.12 111.338 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 102' ' ' PHE . 55.2 m-85 -139.76 140.25 36.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.868 0.334 . . . . 0.25 110.688 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.473 ' HB ' HG12 ' A' ' 101' ' ' ILE . 49.5 t -114.69 136.11 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.043 0.449 . . . . 0.1 111.076 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -104.26 106.02 16.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.706 -0.679 . . . . 0.21 109.191 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.487 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 20.8 m-85 -90.65 136.29 33.16 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.163 0.506 . . . . 0.17 111.102 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.577 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.2 tt0 -49.04 -40.69 32.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.514 -1.221 . . . . 0.57 110.682 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.8 p -117.47 147.05 43.09 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.039 -0.982 . . . . 0.4 110.731 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -63.11 -33.78 76.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.875 -0.602 . . . . 0.47 111.042 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -68.75 -34.84 76.28 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.402 -0.363 . . . . 0.74 111.456 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.81 -34.66 78.41 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.156 0.503 . . . . 0.18 110.389 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.527 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -62.32 -48.46 79.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.483 -0.78 . . . . 0.16 110.639 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.632 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 41.0 mt-10 -58.79 -38.23 78.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.824 -0.625 . . . . 1.42 110.841 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 51.4 mtt180 -62.1 -44.59 96.33 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.84 0.352 . . . . 1.48 111.011 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.19 86.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 0.1 110.657 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 151' ' ' ALA . 82.4 mt -61.02 -53.65 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.15 110.879 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.5 pt-20 -64.23 -41.73 96.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.957 0.408 . . . . 1.08 111.98 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -81.36 -39.81 24.5 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.888 0.699 . . . . 1.16 112.888 -171.544 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.533 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.3 mmm -93.02 -22.78 18.94 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.598 0.592 . . . . 0.35 112.598 -172.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -66.96 123.33 19.91 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.028 -0.731 . . . . 0.44 109.028 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.2 13.21 66.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.585 -0.817 . . . . 0.29 112.545 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.64 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.2 mmt -101.41 165.18 11.39 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.614 -0.345 . . . . 1.18 111.224 177.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.33 130.46 46.44 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.949 -0.76 . . . . 0.44 108.949 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 22.0 mt -116.41 101.1 8.36 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.08 -0.648 . . . . 1.02 109.757 171.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 165' ' ' ASP . 55.9 m-20 78.5 -24.62 0.21 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.249 -0.887 . . . . 1.71 112.659 177.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 23.2 t70 166.17 -22.47 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 O-C-N 124.0 0.813 . . . . 0.85 111.439 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 -110.71 132.02 54.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.497 -0.32 . . . . 0.96 110.872 -170.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.64 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.6 ttmt -77.94 124.15 27.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.456 HG11 HD23 ' A' ' 106' ' ' LEU . 18.5 m -103.22 149.66 7.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.329 0.585 . . . . 0.17 111.573 -174.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 43.3 t80 -107.21 120.91 43.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.3 -0.864 . . . . 0.3 109.062 177.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.604 HG22 HG12 ' A' ' 103' ' ' ILE . 41.0 t -115.56 125.65 72.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.39 -0.596 . . . . 0.13 109.39 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.22 -173.76 16.8 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.568 -0.825 . . . . 0.18 112.218 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 109.836 -0.431 . . . . 1.93 109.836 179.897 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 112.889 0.699 . . . . 0.71 112.889 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 72.31 24.34 76.52 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.984 -1.103 . . . . 0.21 111.768 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -86.51 125.21 33.59 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.535 -0.542 . . . . 0.63 109.535 -173.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.581 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.9 pt -135.57 160.43 39.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.228 -0.286 . . . . 0.15 110.228 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -125.79 142.78 51.35 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.888 -0.412 . . . . 0.21 109.888 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.648 HG12 HG22 ' A' ' 170' ' ' VAL . 7.2 mt -121.05 131.27 73.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 0.15 110.251 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -116.06 151.32 35.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.681 -0.236 . . . . 1.46 110.561 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.2 t30 74.5 38.09 0.52 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.903 0.752 . . . . 0.49 111.834 172.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.556 HD22 HG21 ' A' ' 110' ' ' ILE . 19.3 mt -76.78 158.47 30.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.059 0.457 . . . . 0.26 111.065 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.504 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.0 t70 -84.26 151.69 24.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.553 -0.748 . . . . 0.71 111.394 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -53.12 -36.19 60.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.13 -0.941 . . . . 2.2 112.368 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -88.18 -2.57 58.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.242 -0.435 . . . . 1.41 112.169 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.556 HG21 HD22 ' A' ' 106' ' ' LEU . 36.4 mm -73.59 124.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.2 0.524 . . . . 0.26 110.823 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.518 ' OD2' ' HB3' ' A' ' 113' ' ' LYS . 0.2 OUTLIER -104.11 177.99 4.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.434 -0.803 . . . . 1.59 110.865 -178.1 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -71.23 -33.67 70.08 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 107.56 -1.274 . . . . 0.6 107.56 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.642 ' HZ3' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -64.32 -48.87 73.95 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.833 -1.531 . . . . 2.58 108.949 176.032 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -60.91 -44.87 96.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.367 -1.288 . . . . 0.15 111.062 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.723 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -64.09 -47.1 81.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.302 -0.863 . . . . 0.16 109.056 177.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.674 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 69.8 t80 -59.61 -49.3 78.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.936 -0.575 . . . . 0.3 111.135 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -58.3 -35.07 71.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.939 0.399 . . . . 0.4 111.166 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 24.9 m -78.8 -54.45 6.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.319 -0.401 . . . . 0.22 112.022 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.438 ' CD1' HD23 ' A' ' 115' ' ' LEU . 8.6 m-85 -72.78 -29.72 63.52 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.665 0.617 . . . . 0.11 112.665 -173.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.2 t -58.76 -28.06 65.56 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.668 0.271 . . . . 0.19 111.454 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.56 -22.87 36.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.937 0.398 . . . . 0.14 111.236 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -90.32 -19.04 24.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.18 110.811 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.76 168.43 29.88 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 121.132 -0.556 . . . . 0.11 111.89 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -69.58 139.9 53.74 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.099 -0.334 . . . . 0.25 110.099 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 128' ' ' CYS . 73.5 mt -111.78 133.78 56.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.389 -0.369 . . . . 0.14 110.526 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.641 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -91.94 -38.06 12.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.442 0.639 . . . . 0.54 109.431 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 75.4 m -155.68 102.82 2.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.46 -0.791 . . . . 0.76 110.942 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.674 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 9.3 p -106.12 142.64 35.48 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.848 -0.427 . . . . 0.72 109.848 173.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -135.43 130.82 35.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.797 -173.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.723 HG22 HD12 ' A' ' 115' ' ' LEU . 63.3 t -114.91 110.08 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 106.838 -1.541 . . . . 0.28 106.838 170.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.305 -1.334 0 N-CA-C 108.637 -0.875 . . . . 0.34 108.637 -175.871 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.69 0 CA-C-O 120.359 -0.134 . . . . 0.31 113.265 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -129.14 148.32 51.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.535 0.668 . . . . 0.49 111.875 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.28 170.99 25.25 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.05 -0.977 . . . . 0.12 111.433 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -137.77 137.57 38.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.757 0.278 . . . . 0.25 110.578 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.581 ' HB ' HG12 ' A' ' 101' ' ' ILE . 36.5 t -113.42 130.89 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 120.889 0.376 . . . . 0.1 110.814 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.4 OUTLIER -100.61 105.95 17.4 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.019 -0.734 . . . . 0.21 109.019 166.397 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.525 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 12.4 m-85 -89.36 137.32 32.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.266 0.555 . . . . 0.17 111.209 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.641 ' HA ' HD21 ' A' ' 126' ' ' LEU . 41.5 tt0 -47.88 -48.75 31.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.235 -1.348 . . . . 0.57 110.556 176.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 p -110.63 144.51 39.41 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.379 -1.282 . . . . 0.4 111.218 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -61.77 -37.7 85.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.665 -0.698 . . . . 0.47 110.996 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.0 pt-20 -69.91 -34.36 73.39 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.615 -0.266 . . . . 0.74 111.682 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.55 77.61 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.154 0.502 . . . . 0.18 110.403 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.526 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -62.97 -44.69 95.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.488 -0.778 . . . . 0.16 110.501 176.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 49.1 mt-10 -59.53 -40.55 87.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 1.42 110.541 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.521 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 50.1 mtt180 -62.3 -39.93 94.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 1.48 110.823 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.02 -38.5 86.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.472 -0.331 . . . . 0.1 110.423 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 151' ' ' ALA . 81.2 mt -58.68 -54.04 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 0.15 111.167 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.0 OUTLIER -61.05 -44.25 97.67 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.149 0.499 . . . . 1.08 112.028 -178.462 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.439 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.23 -38.7 24.12 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.48 -0.782 . . . . 1.16 112.802 -169.002 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.47 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.9 mmm -91.23 -24.28 19.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.254 0.464 . . . . 0.35 112.254 -173.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 59.9 t30 -67.72 123.02 19.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.215 -0.594 . . . . 0.44 109.507 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.0 8.83 64.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.732 -0.747 . . . . 0.29 112.786 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.742 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.4 mmt -92.01 163.81 13.85 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.692 0.282 . . . . 1.18 111.425 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 15.7 mt -105.55 107.21 18.07 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.536 -0.542 . . . . 0.44 109.536 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 163' ' ' LEU . 18.3 mt -94.61 108.55 20.52 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.793 -0.763 . . . . 1.02 109.245 172.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 94.4 m-20 72.11 -62.35 0.47 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.137 -0.938 . . . . 1.71 112.127 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -163.88 12.78 0.05 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.787 -0.642 . . . . 0.85 111.438 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.504 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.1 mtt180 -134.41 129.85 35.96 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.966 -0.459 . . . . 0.96 110.481 -174.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.742 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.2 ttmt -78.7 120.12 22.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.157 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.461 HG11 HD23 ' A' ' 106' ' ' LEU . 14.5 m -100.73 146.58 9.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.619 0.723 . . . . 0.17 111.231 -172.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.583 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 75.2 t80 -106.9 118.38 36.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.729 -1.123 . . . . 0.3 109.341 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.648 HG22 HG12 ' A' ' 103' ' ' ILE . 41.1 t -115.22 125.06 72.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.104 -0.702 . . . . 0.13 109.104 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.76 -174.46 17.96 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.512 -0.851 . . . . 0.18 112.098 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.964 0.412 . . . . 1.93 110.246 -179.595 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.5 t . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 121.51 0.671 . . . . 0.71 111.857 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 73.27 24.15 75.98 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.181 -1.009 . . . . 0.21 112.084 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -88.58 125.41 34.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.357 -0.608 . . . . 0.63 109.357 -174.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.522 HG23 ' HB1' ' A' ' 151' ' ' ALA . 21.4 pt -135.31 159.73 40.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.087 -0.338 . . . . 0.15 110.087 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.39 138.18 54.62 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.899 -0.408 . . . . 0.21 109.899 176.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.632 HG12 HG22 ' A' ' 170' ' ' VAL . 5.7 mt -116.71 131.49 69.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.548 -0.751 . . . . 0.15 110.076 -177.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -113.66 152.56 30.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.493 -0.321 . . . . 1.46 110.588 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.8 t30 75.58 33.99 0.62 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.014 0.821 . . . . 0.49 111.683 170.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.485 HD23 HG11 ' A' ' 168' ' ' VAL . 25.4 mt -75.64 156.82 34.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 0.26 111.446 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.464 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 15.0 t70 -83.15 153.14 24.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.519 -0.764 . . . . 0.71 111.36 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' A' ' 109' ' ' SER . 55.1 pttt -54.09 -37.66 64.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.485 -0.78 . . . . 2.2 112.501 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.421 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 13.7 m -80.86 -8.76 59.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.848 0.314 . . . . 1.41 111.848 -172.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.502 ' O ' HG11 ' A' ' 130' ' ' VAL . 34.6 mm -71.16 120.17 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.013 0.435 . . . . 0.26 110.376 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -109.27 -179.67 3.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.016 -0.735 . . . . 1.59 109.016 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.58 -40.98 98.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.269 -0.641 . . . . 0.6 109.269 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.884 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -59.97 -49.39 77.87 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.277 -0.874 . . . . 2.58 110.567 178.416 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.9 98.19 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.265 -1.334 . . . . 0.15 111.396 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.762 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -65.03 -47.15 78.42 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.952 -0.758 . . . . 0.16 108.952 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 64.4 t80 -57.54 -48.23 79.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.916 -0.584 . . . . 0.3 111.009 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.25 -37.55 72.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.968 0.413 . . . . 0.4 110.828 -175.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 m -77.88 -54.42 6.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.151 -0.477 . . . . 0.22 111.815 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.434 ' CD1' HD23 ' A' ' 115' ' ' LEU . 10.2 m-85 -73.02 -28.82 62.58 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.881 0.696 . . . . 0.11 112.881 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -57.57 -28.23 63.38 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.777 0.322 . . . . 0.19 110.875 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.45 -21.74 27.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.355 -0.384 . . . . 0.14 111.618 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -92.98 -17.41 23.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.989 0.423 . . . . 0.18 110.918 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.72 162.51 14.74 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.977 -0.556 . . . . 0.11 111.796 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -61.67 132.45 53.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.057 0.456 . . . . 0.25 110.538 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 128' ' ' CYS . 68.3 mt -106.35 133.68 50.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.808 -0.633 . . . . 0.14 109.747 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.602 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.28 -40.31 13.72 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.01 -0.737 . . . . 0.54 109.01 -177.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.3 m -147.68 129.66 15.37 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.973 -1.012 . . . . 0.76 109.915 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 5.8 p -129.44 124.67 34.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.265 -0.643 . . . . 0.72 109.265 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -123.95 127.93 48.67 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.906 0.384 . . . . 1.0 111.327 -173.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.762 HG22 HD12 ' A' ' 115' ' ' LEU . 54.8 t -114.48 109.55 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 106.856 -1.535 . . . . 0.28 106.856 170.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 t . . . . . 0 C--N 1.302 -1.458 0 N-CA-C 108.611 -0.885 . . . . 0.34 108.611 -175.142 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 CA-C-O 120.279 -0.179 . . . . 0.31 113.314 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 24.0 p90 -133.03 148.8 52.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.368 0.584 . . . . 0.49 111.654 -176.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.86 168.56 25.93 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.24 -0.891 . . . . 0.12 111.377 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -136.47 136.49 39.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.059 0.43 . . . . 0.25 110.801 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.518 ' HB ' HG12 ' A' ' 101' ' ' ILE . 48.7 t -111.0 136.45 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.957 0.408 . . . . 0.1 111.145 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -105.57 105.63 15.76 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.104 -0.702 . . . . 0.21 109.104 166.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.472 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 17.5 m-85 -88.79 138.59 31.28 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.042 0.448 . . . . 0.17 110.938 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.602 ' HA ' HD21 ' A' ' 126' ' ' LEU . 28.5 tt0 -45.87 -45.39 15.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.526 -1.215 . . . . 0.57 110.923 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.3 p -119.8 150.78 39.86 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.938 -1.028 . . . . 0.4 110.839 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -61.46 -33.41 73.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.49 -0.777 . . . . 0.47 110.865 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.76 -35.65 75.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.74 111.83 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.59 -34.23 76.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.093 0.473 . . . . 0.18 110.498 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -64.2 -44.25 92.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.632 -0.713 . . . . 0.16 110.688 176.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 31.8 mt-10 -58.96 -38.61 79.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 1.42 110.471 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.544 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 92.2 mtt180 -62.77 -43.51 98.6 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.03 0.443 . . . . 1.48 110.969 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.75 -37.29 85.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 0.1 110.405 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 151' ' ' ALA . 90.6 mt -59.17 -52.74 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.15 111.248 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.6 pt-20 -64.02 -46.24 85.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.09 0.472 . . . . 1.08 111.809 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -80.86 -38.47 28.1 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.147 0.795 . . . . 1.16 113.147 -168.462 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.419 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.0 mmm -93.29 -20.22 20.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.458 0.54 . . . . 0.35 112.458 -173.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 53.8 t30 -68.58 123.75 21.71 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.221 -0.592 . . . . 0.44 109.652 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.52 64.48 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.777 -0.725 . . . . 0.29 112.539 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.729 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.7 mmt -96.07 162.5 13.52 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.678 0.239 . . . . 1.18 110.976 177.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.9 mt -103.35 105.04 15.22 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.345 -0.613 . . . . 0.44 109.345 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 18.0 mt -91.04 108.93 20.19 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.925 -0.71 . . . . 1.02 109.256 173.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 93.9 m-20 73.57 -60.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.302 -0.863 . . . . 1.71 111.827 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -172.61 22.9 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.549 -0.75 . . . . 0.85 110.798 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.7 mtt180 -138.29 132.75 32.14 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.006 -0.434 . . . . 0.96 109.96 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.729 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.2 tttt -84.19 115.02 22.21 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.485 HG11 HD23 ' A' ' 106' ' ' LEU . 15.6 m -100.12 147.83 7.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.599 0.714 . . . . 0.17 111.485 -170.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 75.8 t80 -106.58 120.49 42.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.735 -1.121 . . . . 0.3 109.365 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.632 HG22 HG12 ' A' ' 103' ' ' ILE . 42.3 t -115.48 125.58 72.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.154 -0.684 . . . . 0.13 109.154 177.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.53 -171.5 16.68 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.351 -0.928 . . . . 0.18 112.235 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 . . . . . 0 C--N 1.325 -0.464 0 N-CA-C 109.426 -0.583 . . . . 1.93 109.426 -179.793 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 120.93 0.395 . . . . 0.71 111.908 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.08 24.08 69.93 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.218 -0.991 . . . . 0.21 111.877 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 143' ' ' VAL . 5.2 m-20 -87.45 125.8 34.51 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.969 -0.752 . . . . 0.63 108.969 -176.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.563 HG12 ' HB ' ' A' ' 143' ' ' VAL . 23.8 pt -135.02 163.55 36.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.477 -0.329 . . . . 0.15 110.283 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.14 147.28 49.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.83 -0.433 . . . . 0.21 109.83 175.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.561 HG12 HG22 ' A' ' 170' ' ' VAL . 4.4 mt -119.26 139.29 47.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.679 -0.691 . . . . 0.15 109.811 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -117.16 153.22 33.2 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.952 0.158 . . . . 1.46 110.637 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.0 t30 71.39 39.73 0.9 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.863 0.727 . . . . 0.49 112.16 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.434 HD23 HG11 ' A' ' 168' ' ' VAL . 33.5 mt -81.82 164.73 21.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.807 0.337 . . . . 0.26 111.056 176.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -96.7 157.53 15.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.71 109.813 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -61.51 -26.4 67.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.484 0.659 . . . . 2.2 109.681 172.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 m -59.78 -23.12 63.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.632 -1.167 . . . . 1.41 112.596 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.608 HG22 HG21 ' A' ' 130' ' ' VAL . 40.2 mm -86.43 131.32 34.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.407 0.622 . . . . 0.26 111.502 -174.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -117.37 -175.39 2.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.235 -1.024 . . . . 1.59 108.235 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -69.07 -29.68 67.85 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.608 -0.886 . . . . 0.6 108.608 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -49.46 65.18 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.457 -1.247 . . . . 2.58 109.404 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.78 85.47 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.7 -1.136 . . . . 0.15 110.691 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.742 HD12 HG22 ' A' ' 130' ' ' VAL . 3.5 tt -70.72 -48.05 56.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.47 -0.786 . . . . 0.16 109.35 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.622 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 80.2 t80 -61.05 -45.12 96.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 0.3 110.833 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.43 -41.83 77.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.014 0.435 . . . . 0.4 110.884 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.418 HG21 HD21 ' A' ' 163' ' ' LEU . 24.0 m -77.66 -53.66 7.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 0.22 112.072 -177.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.455 ' CD1' HD23 ' A' ' 115' ' ' LEU . 17.7 m-85 -72.17 -29.46 64.04 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.46 0.541 . . . . 0.11 112.46 -173.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.6 t -58.67 -28.93 66.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.595 0.236 . . . . 0.19 111.201 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.38 -22.62 43.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 0.14 111.554 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -93.64 -11.94 30.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 0.18 110.875 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.95 164.06 15.14 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.929 -0.653 . . . . 0.11 111.846 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -67.05 137.5 56.48 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.932 0.396 . . . . 0.25 110.178 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.416 HG21 ' HB3' ' A' ' 128' ' ' CYS . 72.1 mt -110.21 129.57 64.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.119 -0.491 . . . . 0.14 109.927 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.14 -35.37 20.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.054 -0.721 . . . . 0.54 109.054 -177.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 65.8 m -154.31 128.72 9.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.17 -0.923 . . . . 0.76 109.849 -177.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 2.6 p -134.14 144.85 48.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.802 0.334 . . . . 0.72 110.247 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -143.78 133.15 23.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.59 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.742 HG22 HD12 ' A' ' 115' ' ' LEU . 59.6 t -113.23 111.11 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 106.383 -1.71 . . . . 0.28 106.383 168.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 C--N 1.301 -1.52 0 N-CA-C 108.804 -0.813 . . . . 0.34 108.804 -174.567 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.832 0 CA-C-O 120.317 -0.157 . . . . 0.31 113.113 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 22.2 p90 -125.88 148.78 49.09 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.457 0.629 . . . . 0.49 111.984 -174.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.36 173.81 23.2 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.002 -0.999 . . . . 0.12 111.358 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -136.11 141.85 44.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.032 0.416 . . . . 0.25 110.848 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.563 ' HB ' HG12 ' A' ' 101' ' ' ILE . 28.1 t -117.23 135.95 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.106 0.479 . . . . 0.1 110.84 172.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -107.2 106.17 16.5 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.031 -0.729 . . . . 0.21 109.031 168.431 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.2 m-85 -90.49 139.06 31.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.596 0.713 . . . . 0.17 111.936 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.576 ' HA ' HD21 ' A' ' 126' ' ' LEU . 46.5 tt0 -49.05 -40.79 32.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.912 -1.495 . . . . 0.57 110.86 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.2 p -123.93 154.59 39.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.887 -1.051 . . . . 0.4 110.513 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -66.14 -33.5 75.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.177 -0.465 . . . . 0.47 110.902 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.07 -35.86 77.0 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.365 -0.379 . . . . 0.74 111.518 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.19 -34.51 78.24 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.168 0.508 . . . . 0.18 110.402 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.529 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.81 -48.01 80.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.523 -0.762 . . . . 0.16 110.606 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.634 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 29.3 mt-10 -58.64 -42.13 87.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.005 -0.543 . . . . 1.42 110.696 177.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 72.5 mtt180 -58.65 -41.62 86.49 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.944 0.402 . . . . 1.48 110.949 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.22 -40.36 86.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.359 -0.382 . . . . 0.1 110.612 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 151' ' ' ALA . 91.1 mt -60.33 -49.59 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.056 -0.52 . . . . 0.15 111.176 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.9 pt-20 -64.07 -45.69 87.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.175 0.512 . . . . 1.08 111.704 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.473 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -80.73 -38.58 28.5 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.329 0.863 . . . . 1.16 113.329 -169.261 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.426 ' HB2' HG21 ' A' ' 170' ' ' VAL . 88.9 mmm -95.77 -17.12 21.44 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.709 0.633 . . . . 0.35 112.709 -172.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.06 123.06 20.61 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.197 -0.601 . . . . 0.44 109.613 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.04 22.69 54.45 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.865 -0.684 . . . . 0.29 112.419 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.564 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.5 OUTLIER -106.48 161.57 14.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.724 0.297 . . . . 1.18 111.622 -179.091 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 75.4 mt -104.17 106.75 17.36 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.908 -0.775 . . . . 0.44 108.908 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.418 HD21 HG21 ' A' ' 118' ' ' THR . 2.6 mt -92.6 22.17 4.89 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.015 -0.674 . . . . 1.02 111.864 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.7 p30 169.92 -79.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.823 0.849 . . . . 1.71 109.153 -175.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -150.93 12.28 0.67 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.747 -1.115 . . . . 0.85 109.536 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -124.04 135.04 53.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.589 -0.732 . . . . 0.96 109.096 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 161' ' ' MET . 3.9 ttmp? -84.19 117.25 23.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.434 HG11 HD23 ' A' ' 106' ' ' LEU . 19.1 m -99.79 143.28 13.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.541 0.686 . . . . 0.17 110.565 -172.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 39.7 t80 -106.53 122.18 45.78 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.882 -1.054 . . . . 0.3 109.417 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.561 HG22 HG12 ' A' ' 103' ' ' ILE . 43.1 t -115.94 125.75 73.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.476 -0.564 . . . . 0.13 109.476 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.04 -167.23 12.1 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.319 -0.712 . . . . 0.18 111.319 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 . . . . . 0 C--N 1.322 -0.614 0 N-CA-C 108.833 -0.803 . . . . 1.93 108.833 179.79 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.3 t . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.45 0.643 . . . . 0.71 112.531 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.32 24.87 74.37 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 119.873 -1.155 . . . . 0.21 111.455 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 -89.95 124.17 34.5 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.955 -0.757 . . . . 0.63 108.955 -173.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.482 HG23 ' HB1' ' A' ' 151' ' ' ALA . 17.1 pt -136.07 163.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.942 -0.392 . . . . 0.15 109.942 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.94 143.22 51.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.1 0.476 . . . . 0.21 109.775 176.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.662 HG12 HG22 ' A' ' 170' ' ' VAL . 6.1 mt -119.33 136.38 56.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.355 -0.839 . . . . 0.15 109.876 -177.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -120.15 154.1 35.26 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 121.438 -0.105 . . . . 1.46 110.913 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.0 t30 73.73 32.79 1.09 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.878 0.871 . . . . 0.49 111.528 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 110' ' ' ILE . 30.7 mt -73.99 154.31 39.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.408 . . . . 0.26 111.255 177.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.46 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 25.6 t70 -83.17 152.3 25.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.675 . . . . 0.71 110.681 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -56.15 -34.66 66.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.625 . . . . 2.2 112.014 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.3 m -80.14 -2.83 46.33 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.416 0.524 . . . . 1.41 112.416 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.645 HG21 HD22 ' A' ' 106' ' ' LEU . 31.6 mm -78.91 116.43 22.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.615 -0.434 . . . . 0.26 110.057 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -105.85 -176.7 3.15 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.95 -0.759 . . . . 1.59 108.95 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -68.81 -31.01 69.7 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.111 -0.7 . . . . 0.6 109.111 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -48.33 66.15 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.634 -1.166 . . . . 2.58 109.238 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.6 -41.6 97.66 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.269 -1.332 . . . . 0.15 110.796 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.711 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -67.5 -47.37 70.21 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.243 -0.89 . . . . 0.16 108.994 177.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.724 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 62.3 t80 -58.34 -47.81 82.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.179 -0.464 . . . . 0.3 111.155 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -56.74 -39.27 73.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.068 0.461 . . . . 0.4 110.86 -174.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 m -78.48 -53.59 7.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.84 -0.618 . . . . 0.22 112.181 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 115' ' ' LEU . 8.3 m-85 -72.52 -28.29 62.77 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.802 0.667 . . . . 0.11 112.802 -174.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.5 t -57.05 -28.39 62.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.749 0.309 . . . . 0.19 111.428 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.35 -22.45 42.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.699 0.285 . . . . 0.14 111.748 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.408 ' HZ ' ' HE2' ' A' ' 157' ' ' LYS . 23.9 m-85 -90.38 -18.23 25.84 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.968 0.413 . . . . 0.18 111.102 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 165.31 166.93 25.11 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.901 -0.59 . . . . 0.11 111.632 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -67.7 129.75 40.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.927 0.394 . . . . 0.25 110.268 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.429 HG21 ' HB3' ' A' ' 128' ' ' CYS . 71.8 mt -100.48 131.97 47.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.134 -0.485 . . . . 0.14 110.281 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.545 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.61 -44.73 11.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.497 -0.927 . . . . 0.54 108.497 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.5 m -147.33 111.65 5.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.912 -1.04 . . . . 0.76 110.544 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.4 p -107.22 145.12 33.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.254 -0.647 . . . . 0.72 109.254 173.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -144.83 128.79 17.47 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.932 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.711 HG22 HD12 ' A' ' 115' ' ' LEU . 48.6 t -114.81 110.64 32.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 106.627 -1.62 . . . . 0.28 106.627 168.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.303 -1.435 0 N-CA-C 108.985 -0.746 . . . . 0.34 108.985 -174.926 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.644 0 CA-C-O 120.488 -0.062 . . . . 0.31 113.182 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 25.7 p90 -127.19 150.59 49.45 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.207 0.527 . . . . 0.49 111.646 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.18 170.6 25.33 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.302 -0.863 . . . . 0.12 111.222 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -137.78 138.79 39.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.147 0.473 . . . . 0.25 110.841 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.501 HG11 ' CE2' ' A' ' 145' ' ' PHE . 42.6 t -113.74 135.45 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 120.962 0.41 . . . . 0.1 110.8 173.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -105.2 106.23 16.62 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.086 -0.709 . . . . 0.21 109.086 166.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.501 ' CE2' HG11 ' A' ' 143' ' ' VAL . 17.4 m-85 -90.24 139.98 30.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.265 0.555 . . . . 0.17 111.079 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.545 ' HA ' HD21 ' A' ' 126' ' ' LEU . 42.3 tt0 -50.57 -37.56 40.37 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.524 -1.216 . . . . 0.57 110.93 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.8 p -121.68 155.87 34.25 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.023 -0.989 . . . . 0.4 110.515 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -68.48 -36.31 78.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.104 -0.498 . . . . 0.47 110.447 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.35 -34.81 75.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.598 . . . . 0.74 112.014 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.83 -36.77 79.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.153 0.502 . . . . 0.18 110.454 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.482 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -65.04 -40.91 95.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.561 -0.745 . . . . 0.16 110.433 177.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 51.9 mt-10 -59.88 -37.35 79.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.636 -0.711 . . . . 1.42 110.822 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 98.2 mtt180 -65.5 -43.99 88.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.352 -0.385 . . . . 1.48 110.876 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.43 83.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.222 -0.445 . . . . 0.1 110.532 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 151' ' ' ALA . 92.8 mt -60.65 -53.49 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 0.15 111.287 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.4 pt-20 -64.16 -43.4 95.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.182 0.515 . . . . 1.08 111.902 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -81.26 -39.09 25.84 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.887 0.699 . . . . 1.16 112.887 -169.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.511 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.7 mmm -94.86 -20.22 19.63 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.686 0.625 . . . . 0.35 112.686 -172.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -68.05 123.39 20.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.392 -0.596 . . . . 0.44 109.392 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.53 16.89 63.16 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.656 -0.783 . . . . 0.29 112.667 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.6 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 4.4 mmt -98.48 156.23 16.87 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.718 -0.283 . . . . 1.18 111.072 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.48 HD22 ' O ' ' A' ' 165' ' ' ASP . 17.5 mt -98.77 103.75 15.73 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.626 -0.509 . . . . 0.44 109.626 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 22.4 mt -91.01 104.28 16.89 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 120.054 -0.658 . . . . 1.02 109.401 174.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 79.9 m-20 76.78 -27.75 0.18 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.129 -0.942 . . . . 1.71 112.519 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.48 ' O ' HD22 ' A' ' 162' ' ' LEU . 32.7 t70 163.94 -20.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.083 0.864 . . . . 0.85 111.402 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.46 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.4 mtt180 -102.17 130.18 48.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.331 -0.395 . . . . 0.96 110.846 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 161' ' ' MET . 19.5 tttt -78.7 115.03 18.13 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.395 -0.594 . . . . 1.0 109.395 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.529 HG11 HD23 ' A' ' 106' ' ' LEU . 12.9 m -100.56 149.57 6.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.614 0.721 . . . . 0.17 111.366 -172.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 77.4 t80 -106.33 118.93 37.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.834 -1.076 . . . . 0.3 109.612 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.662 HG22 HG12 ' A' ' 103' ' ' ILE . 39.4 t -115.74 126.36 73.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.435 -0.58 . . . . 0.13 109.435 176.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.24 -176.32 23.17 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.78 -0.724 . . . . 0.18 111.524 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 109.457 -0.571 . . . . 1.93 109.457 177.866 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.731 0.777 . . . . 0.71 112.627 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.29 23.98 77.47 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.64 -1.267 . . . . 0.21 111.507 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -84.28 126.44 33.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.887 -0.412 . . . . 0.63 109.887 -174.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.577 HG12 ' HB ' ' A' ' 143' ' ' VAL . 32.2 pt -134.55 155.8 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.708 -0.678 . . . . 0.15 109.631 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.96 139.68 53.37 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.631 -0.507 . . . . 0.21 109.631 178.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.677 HG12 HG22 ' A' ' 170' ' ' VAL . 8.6 mt -118.03 137.36 52.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.79 -0.641 . . . . 0.15 110.197 -176.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -124.2 152.52 42.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.638 -0.256 . . . . 1.46 110.403 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 167' ' ' LYS . 5.2 t30 74.69 45.32 0.17 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.806 0.813 . . . . 0.49 110.847 170.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.466 HD22 HG21 ' A' ' 110' ' ' ILE . 20.1 mt -88.38 166.83 13.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.963 -1.017 . . . . 0.26 110.795 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -97.06 162.69 13.26 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.603 -0.517 . . . . 0.71 109.603 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -66.27 -25.03 66.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.277 0.561 . . . . 2.2 109.618 173.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.0 m -60.67 -16.19 36.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.122 -0.944 . . . . 1.41 112.074 175.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.492 HG22 HG21 ' A' ' 130' ' ' VAL . 44.9 mm -93.07 128.38 44.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.332 0.587 . . . . 0.26 111.166 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.419 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 8.7 t70 -118.65 -178.09 3.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.283 -1.006 . . . . 1.59 108.283 175.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -61.81 -35.0 76.91 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.37 -0.604 . . . . 0.6 109.37 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 1.006 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -61.76 -50.17 73.45 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.205 -0.907 . . . . 2.58 110.583 177.457 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.419 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.15 -42.9 99.39 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.576 -1.193 . . . . 0.15 110.968 -176.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.697 HD12 HG22 ' A' ' 130' ' ' VAL . 3.5 tt -65.51 -47.94 74.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.636 -0.711 . . . . 0.16 109.474 178.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.799 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.8 t80 -59.52 -44.71 93.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.442 . . . . 0.3 110.71 176.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.73 -42.67 79.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.178 -0.464 . . . . 0.4 111.154 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.5 m -78.05 -53.37 7.48 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.352 0.501 . . . . 0.22 112.352 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.483 ' CD1' HD23 ' A' ' 115' ' ' LEU . 7.4 m-85 -71.12 -28.12 64.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.548 0.573 . . . . 0.11 112.548 -172.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.3 t -57.89 -29.93 65.45 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.722 0.296 . . . . 0.19 111.351 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.42 -22.67 44.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 0.14 111.361 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -91.07 -20.28 22.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.868 0.366 . . . . 0.18 111.024 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.63 169.32 31.01 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.321 -0.711 . . . . 0.11 111.321 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -69.72 141.63 53.46 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.96 -0.385 . . . . 0.25 109.96 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.446 HG21 ' HB3' ' A' ' 128' ' ' CYS . 74.6 mt -112.43 135.94 50.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.241 -0.436 . . . . 0.14 110.297 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.552 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -90.93 -41.73 10.98 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.635 -0.876 . . . . 0.54 108.635 179.573 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' A' ' 144' ' ' HIS . 95.7 p -145.5 126.96 15.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.287 -0.87 . . . . 0.76 109.966 176.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.6 p -122.97 116.04 22.91 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.149 -0.685 . . . . 0.72 109.149 174.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -117.82 128.61 55.02 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.17 0.509 . . . . 1.0 111.438 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.697 HG22 HD12 ' A' ' 115' ' ' LEU . 99.3 t -114.67 109.34 28.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 106.45 -1.685 . . . . 0.28 106.45 170.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.9 t . . . . . 0 C--N 1.305 -1.339 0 N-CA-C 108.553 -0.906 . . . . 0.34 108.553 -175.142 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 113.941 0.336 . . . . 0.31 113.941 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -130.63 152.55 49.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.875 0.837 . . . . 0.49 112.071 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.73 173.34 26.98 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.252 -0.885 . . . . 0.12 112.094 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -141.62 138.31 32.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.243 0.217 . . . . 0.25 110.818 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.577 ' HB ' HG12 ' A' ' 101' ' ' ILE . 33.2 t -115.56 130.73 69.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.849 0.356 . . . . 0.1 111.277 175.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.456 ' HB2' ' OG ' ' A' ' 127' ' ' SER . 1.6 m170 -97.88 106.76 19.11 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.608 -0.886 . . . . 0.21 108.608 165.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.519 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 7.8 m-85 -90.11 135.9 33.38 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.347 -0.541 . . . . 0.17 111.196 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.552 ' HA ' HD21 ' A' ' 126' ' ' LEU . 36.2 tt0 -47.93 -40.26 21.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.531 -1.213 . . . . 0.57 110.72 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.8 p -122.5 146.87 47.0 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.844 -1.071 . . . . 0.4 110.765 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -64.18 -37.9 89.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.742 -0.663 . . . . 0.47 111.149 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.35 -34.75 77.97 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.168 0.433 . . . . 0.74 112.168 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.95 78.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.168 0.509 . . . . 0.18 110.826 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.519 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.8 -44.75 95.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.532 -0.758 . . . . 0.16 111.046 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 47.7 mt-10 -59.4 -39.41 83.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.912 -0.585 . . . . 1.42 111.012 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 157' ' ' LYS . 62.2 mtt85 -61.03 -42.06 97.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.799 0.333 . . . . 1.48 110.664 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.34 -38.19 90.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.271 -0.422 . . . . 0.1 110.207 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.3 mt -61.55 -54.27 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.172 -0.467 . . . . 0.15 111.244 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.3 pt-20 -64.18 -44.08 93.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.118 0.485 . . . . 1.08 111.706 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -78.04 -38.99 43.33 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.919 0.711 . . . . 1.16 112.919 -171.754 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.504 ' HB2' HG21 ' A' ' 170' ' ' VAL . 82.2 mmm -94.66 -27.51 15.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.907 0.706 . . . . 0.35 112.907 -172.227 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -64.52 124.22 21.28 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.675 -0.41 . . . . 0.44 110.529 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.25 15.68 60.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.083 -0.579 . . . . 0.29 113.296 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.695 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 79.5 mmm -109.45 162.62 14.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.897 0.349 . . . . 1.18 111.806 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.8 mt -99.13 104.77 16.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.621 -0.881 . . . . 0.44 108.621 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.05 22.44 2.4 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.141 -0.624 . . . . 1.02 111.534 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.4 p30 171.35 -80.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.047 0.939 . . . . 1.71 108.54 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -150.32 17.6 0.84 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.45 -1.25 . . . . 0.85 108.581 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -131.16 127.19 37.5 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.853 -1.067 . . . . 0.96 109.768 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.3 tttt -76.41 121.93 23.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.654 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.429 HG11 HD23 ' A' ' 106' ' ' LEU . 17.8 m -101.29 142.17 16.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.282 0.563 . . . . 0.17 110.955 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.628 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 76.5 t80 -106.25 118.08 35.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.27 -0.877 . . . . 0.3 109.509 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 103' ' ' ILE . 39.0 t -115.24 125.16 72.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.283 -0.636 . . . . 0.13 109.283 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -141.64 -170.82 12.55 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.672 -0.775 . . . . 0.18 112.13 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 . . . . . 0 C--N 1.326 -0.44 0 N-CA-C 110.246 -0.279 . . . . 1.93 110.246 -177.002 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 121.419 0.628 . . . . 0.71 112.218 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 24.18 76.49 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.143 -1.027 . . . . 0.21 111.39 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -88.36 124.64 34.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.858 -0.793 . . . . 0.63 108.858 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.554 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.0 pt -136.26 163.7 33.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.628 -0.26 . . . . 0.15 110.374 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.411 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -125.3 143.92 50.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.061 0.458 . . . . 0.21 110.143 175.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.581 HG12 HG22 ' A' ' 170' ' ' VAL . 6.9 mt -119.39 138.85 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.466 -0.788 . . . . 0.15 109.861 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -119.7 154.05 34.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.688 -0.233 . . . . 1.46 110.556 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 167' ' ' LYS . 35.0 t30 72.27 34.84 1.3 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.89 0.744 . . . . 0.49 111.653 171.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.581 HD22 HG21 ' A' ' 110' ' ' ILE . 23.8 mt -74.73 160.19 31.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.122 0.486 . . . . 0.26 111.0 177.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -91.3 156.33 17.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.54 -0.755 . . . . 0.71 109.805 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -60.78 -28.82 69.03 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.248 0.342 . . . . 2.2 111.26 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.5 p -66.78 -26.77 67.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 1.41 111.859 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.581 HG21 HD22 ' A' ' 106' ' ' LEU . 47.8 mm -70.94 121.72 21.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.315 0.578 . . . . 0.26 111.305 -172.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -111.79 -175.63 2.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.44 -0.948 . . . . 1.59 108.44 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -69.71 -33.07 71.99 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 109.091 -0.707 . . . . 0.6 109.091 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -48.24 72.39 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.861 -1.063 . . . . 2.58 109.056 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.12 96.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.146 -1.388 . . . . 0.15 110.878 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.743 HD12 HG22 ' A' ' 130' ' ' VAL . 3.1 tt -66.82 -47.38 72.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.843 -0.799 . . . . 0.16 108.843 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.692 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 52.2 t80 -59.36 -47.03 86.97 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.857 -0.611 . . . . 0.3 110.733 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.12 -41.78 75.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 0.4 110.83 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.466 HG21 HD21 ' A' ' 163' ' ' LEU . 7.4 m -77.53 -53.66 7.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.805 -0.634 . . . . 0.22 112.001 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.488 ' CD1' HD23 ' A' ' 115' ' ' LEU . 10.9 m-85 -73.11 -29.3 62.81 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.427 0.529 . . . . 0.11 112.427 -174.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 36.2 t -58.19 -27.76 64.16 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.678 0.275 . . . . 0.19 111.15 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.73 -21.41 27.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.42 -0.355 . . . . 0.14 111.396 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -93.04 -20.75 20.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.18 110.869 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 167.76 166.14 26.33 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.634 -0.586 . . . . 0.11 111.634 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -66.01 139.96 58.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.052 0.453 . . . . 0.25 110.514 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.442 HG21 ' HB3' ' A' ' 128' ' ' CYS . 79.6 mt -111.84 135.78 50.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.988 -0.551 . . . . 0.14 109.969 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -89.01 -43.86 10.81 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.84 -0.8 . . . . 0.54 108.84 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.5 m -147.74 113.8 5.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.076 -0.966 . . . . 0.76 110.423 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.692 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 4.7 p -110.86 139.89 45.79 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.432 -0.581 . . . . 0.72 109.432 174.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -138.63 128.23 24.78 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.014 0.435 . . . . 1.0 111.306 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.743 HG22 HD12 ' A' ' 115' ' ' LEU . 59.2 t -114.37 109.3 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 106.194 -1.78 . . . . 0.28 106.194 169.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 t . . . . . 0 C--N 1.301 -1.523 0 N-CA-C 108.368 -0.975 . . . . 0.34 108.368 -175.583 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 113.878 0.311 . . . . 0.31 113.878 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -128.26 154.7 45.59 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.393 0.597 . . . . 0.49 111.842 -173.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.29 171.06 25.85 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.276 -0.875 . . . . 0.12 111.53 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.411 ' CE1' ' HB2' ' A' ' 102' ' ' PHE . 66.1 m-85 -139.63 138.37 36.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.703 0.251 . . . . 0.25 110.535 -177.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.554 ' HB ' HG12 ' A' ' 101' ' ' ILE . 42.9 t -114.43 136.1 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.201 0.524 . . . . 0.1 111.142 174.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.6 m170 -104.71 105.79 16.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.625 -0.716 . . . . 0.21 109.07 165.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.561 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.3 m-85 -90.17 137.55 32.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.039 0.447 . . . . 0.17 110.949 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.596 ' HA ' HD21 ' A' ' 126' ' ' LEU . 34.9 tt0 -48.24 -46.07 35.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.673 -1.148 . . . . 0.57 110.587 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.8 p -114.0 148.39 37.04 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.911 -1.04 . . . . 0.4 111.037 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -63.61 -36.12 82.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.612 -0.722 . . . . 0.47 111.05 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -69.09 -35.32 76.34 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.324 -0.398 . . . . 0.74 111.678 -176.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.13 79.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.049 0.452 . . . . 0.18 110.622 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.561 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.63 -43.76 98.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.645 -0.707 . . . . 0.16 110.558 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.2 mt-10 -60.83 -37.28 81.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.496 -0.774 . . . . 1.42 110.804 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.428 ' O ' ' HB2' ' A' ' 157' ' ' LYS . 91.4 mtt180 -63.17 -46.18 88.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.927 0.394 . . . . 1.48 110.623 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.08 -38.82 80.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 0.1 110.532 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 170' ' ' VAL . 91.5 mt -60.13 -54.2 38.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.692 -0.686 . . . . 0.15 111.477 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.2 pt-20 -65.5 -42.45 92.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.196 0.522 . . . . 1.08 112.251 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -77.42 -39.21 47.7 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 113.038 0.755 . . . . 1.16 113.038 -170.589 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.483 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.9 mmm -95.27 -16.44 22.45 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.519 0.563 . . . . 0.35 112.519 -173.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 155' ' ' ILE . 49.2 t-20 -66.84 124.35 22.7 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.304 -0.558 . . . . 0.44 109.621 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.25 18.57 68.85 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.911 -0.661 . . . . 0.29 112.228 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 8.6 tpp -105.05 156.51 17.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 1.18 110.444 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 89.8 mt -100.66 102.52 13.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.872 -0.604 . . . . 0.44 109.566 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.466 HD21 HG21 ' A' ' 118' ' ' THR . 4.5 mt -81.75 11.66 4.65 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.745 0.646 . . . . 1.02 112.745 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.28 -64.2 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.806 0.812 . . . . 1.71 109.189 -174.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -168.62 23.97 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.811 -1.54 . . . . 0.85 109.294 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -139.82 133.66 30.66 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.898 -0.778 . . . . 0.96 108.898 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.4 mttm -77.77 122.42 25.37 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.326 0.391 . . . . 1.0 109.968 176.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.485 HG11 HD23 ' A' ' 106' ' ' LEU . 11.3 m -101.49 140.1 21.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.316 0.579 . . . . 0.17 110.926 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 46.8 t80 -105.38 118.64 37.08 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.316 -0.856 . . . . 0.3 109.178 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.581 HG22 HG12 ' A' ' 103' ' ' ILE . 34.0 t -115.35 127.79 72.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.412 -0.588 . . . . 0.13 109.412 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.99 -172.7 19.01 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.072 -0.585 . . . . 0.18 111.68 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 35.8 mmt-85 . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 1.93 110.129 177.609 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 121.093 0.473 . . . . 0.71 111.6 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.14 23.51 77.85 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 119.834 -1.174 . . . . 0.21 111.433 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -88.2 125.59 34.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.423 -0.584 . . . . 0.63 109.423 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.552 HG23 ' HB1' ' A' ' 151' ' ' ALA . 21.6 pt -134.9 162.13 39.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.589 -0.522 . . . . 0.15 109.589 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.06 140.61 52.74 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.862 -0.421 . . . . 0.21 109.862 177.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.615 HG12 HG22 ' A' ' 170' ' ' VAL . 6.1 mt -117.16 141.86 33.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.588 -0.733 . . . . 0.15 109.615 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -126.66 154.99 43.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.696 -0.229 . . . . 1.46 110.577 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.4 t30 73.56 32.63 1.16 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.969 0.793 . . . . 0.49 111.389 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.485 HD23 HG11 ' A' ' 168' ' ' VAL . 30.1 mt -76.67 162.92 27.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.033 0.444 . . . . 0.26 111.136 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -102.52 151.47 22.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.713 -0.676 . . . . 0.71 109.467 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -22.4 63.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.636 -0.256 . . . . 2.2 111.646 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.4 p -69.13 -11.05 60.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.648 -0.251 . . . . 1.41 111.449 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.579 HG22 HG21 ' A' ' 130' ' ' VAL . 49.2 mm -92.18 122.83 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.26 110.158 177.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -109.7 -177.25 3.22 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.518 -0.919 . . . . 1.59 108.518 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.22 -34.56 78.37 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.192 -0.669 . . . . 0.6 109.192 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.938 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -62.54 -50.49 71.14 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.19 -0.913 . . . . 2.58 110.348 178.083 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.17 98.5 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.076 -1.42 . . . . 0.15 111.253 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.473 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -66.75 -46.79 74.28 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.189 -0.914 . . . . 0.16 108.934 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.763 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 66.1 t80 -59.42 -46.48 88.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 0.3 110.925 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -55.97 -40.92 73.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.008 0.433 . . . . 0.4 111.059 -176.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.527 HG21 HD21 ' A' ' 163' ' ' LEU . 15.3 m -78.0 -53.71 7.11 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.754 -0.657 . . . . 0.22 112.127 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -72.55 -29.1 63.27 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.305 0.483 . . . . 0.11 112.305 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.3 t -58.13 -28.63 64.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.651 0.263 . . . . 0.19 111.091 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.64 37.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.725 0.298 . . . . 0.14 111.293 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -91.82 -21.53 20.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.382 -0.372 . . . . 0.18 111.002 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 169.24 166.1 27.72 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.86 -0.686 . . . . 0.11 112.183 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -62.53 133.93 55.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.012 0.434 . . . . 0.25 110.553 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.404 HG21 ' HB3' ' A' ' 128' ' ' CYS . 75.4 mt -109.04 128.8 64.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.899 -0.592 . . . . 0.14 110.187 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.623 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -82.23 -38.9 23.83 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.702 -0.851 . . . . 0.54 108.702 -178.796 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 m -153.32 129.95 10.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.094 -0.957 . . . . 0.76 110.455 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.763 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.0 p -126.81 149.52 49.65 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.332 -0.618 . . . . 0.72 109.332 176.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -150.73 131.65 14.21 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.437 -0.505 . . . . 1.0 112.175 -174.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.579 HG21 HG22 ' A' ' 110' ' ' ILE . 69.1 t -110.99 110.42 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 106.359 -1.719 . . . . 0.28 106.359 167.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.305 -1.36 0 N-CA-C 109.08 -0.711 . . . . 0.34 109.08 -174.943 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 114.025 0.37 . . . . 0.31 114.025 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -125.49 156.58 38.75 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 117.501 0.65 . . . . 0.49 111.912 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.79 172.41 28.95 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.353 -0.839 . . . . 0.12 111.598 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -137.92 140.84 40.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.015 0.407 . . . . 0.25 110.757 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.514 HG11 ' CE2' ' A' ' 145' ' ' PHE . 43.8 t -113.68 135.87 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.01 0.433 . . . . 0.1 110.685 172.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -105.98 105.76 15.95 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.095 -0.706 . . . . 0.21 109.095 167.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.514 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 15.8 m-85 -90.7 136.61 32.95 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.126 0.489 . . . . 0.17 111.24 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.623 ' HA ' HD21 ' A' ' 126' ' ' LEU . 41.7 tt0 -49.31 -42.84 42.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.457 -1.247 . . . . 0.57 110.726 178.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.8 p -115.28 144.85 43.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.64 -1.164 . . . . 0.4 111.241 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -63.09 -36.97 85.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.498 -0.774 . . . . 0.47 110.939 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 9.8 pt-20 -69.39 -35.11 75.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.389 -0.368 . . . . 0.74 111.747 -177.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.64 -34.66 76.07 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.083 0.468 . . . . 0.18 110.556 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.552 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -64.57 -43.04 95.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.6 -0.727 . . . . 0.16 110.883 177.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.583 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 53.5 mt-10 -59.53 -40.08 86.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.511 . . . . 1.42 110.28 176.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.506 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 95.4 mtt180 -60.59 -40.75 92.89 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.186 -0.461 . . . . 1.48 110.943 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.62 -36.32 82.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 0.1 110.568 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 151' ' ' ALA . 80.6 mt -62.53 -54.42 34.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.15 110.995 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.3 pt-20 -60.78 -43.43 98.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.174 0.511 . . . . 1.08 111.677 -179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -82.74 -39.05 22.42 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 113.062 0.764 . . . . 1.16 113.062 -170.773 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 89.6 mmm -92.26 -24.51 18.97 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.78 0.659 . . . . 0.35 112.78 -172.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 53.3 t30 -67.17 124.27 22.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.215 -0.594 . . . . 0.44 110.206 -178.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.04 11.12 63.65 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.833 -0.698 . . . . 0.29 112.609 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.653 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 30.8 mmt -97.63 159.65 14.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.885 0.374 . . . . 1.18 111.713 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.9 mt -102.49 101.14 11.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.952 -0.759 . . . . 0.44 108.952 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.527 HD21 HG21 ' A' ' 118' ' ' THR . 2.8 mt -78.16 13.52 1.45 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.042 0.756 . . . . 1.02 113.042 -175.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 167.48 -59.57 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.883 0.849 . . . . 1.71 109.368 -174.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -169.74 24.66 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.798 -1.546 . . . . 0.85 109.433 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 166' ' ' ARG . 46.9 mtt180 -140.29 127.22 20.72 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.583 -0.735 . . . . 0.96 109.381 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 161' ' ' MET . 13.6 tttt -76.77 116.47 17.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.485 HG11 HD23 ' A' ' 106' ' ' LEU . 13.2 m -100.33 144.79 12.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.383 0.611 . . . . 0.17 110.846 -174.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 73.6 t80 -106.14 119.71 39.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.185 -0.916 . . . . 0.3 109.517 -179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.615 HG22 HG12 ' A' ' 103' ' ' ILE . 42.0 t -114.93 125.64 72.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.988 -0.745 . . . . 0.13 108.988 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.18 -178.82 21.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.498 -0.858 . . . . 0.18 112.413 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.8 mmt-85 . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 1.93 111.384 179.325 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 121.914 0.864 . . . . 0.71 112.547 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.25 23.85 77.31 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.941 -1.123 . . . . 0.21 110.688 -175.716 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.418 ' ND2' ' NE2' ' A' ' 144' ' ' HIS . 9.9 m-20 -94.06 126.82 39.5 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.539 -0.541 . . . . 0.63 109.539 -173.33 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 151' ' ' ALA . 20.8 pt -134.8 161.16 40.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.066 -0.346 . . . . 0.15 110.066 175.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.72 142.66 51.24 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.836 -0.431 . . . . 0.21 109.836 177.017 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.563 HG12 HG22 ' A' ' 170' ' ' VAL . 6.4 mt -119.52 135.69 59.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.707 -0.679 . . . . 0.15 110.065 -177.318 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -117.48 153.26 33.44 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.468 -0.197 . . . . 1.46 110.468 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.0 t30 72.54 37.52 0.88 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.01 0.819 . . . . 0.49 111.797 172.15 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.647 HD22 HG21 ' A' ' 110' ' ' ILE . 20.4 mt -76.89 153.83 34.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.359 -0.382 . . . . 0.26 110.843 177.307 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.501 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 13.4 t70 -83.09 149.26 27.02 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.643 -0.502 . . . . 0.71 109.643 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -56.94 -31.16 64.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.079 -0.51 . . . . 2.2 111.659 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.4 p -71.42 -9.09 57.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 1.41 112.015 -179.034 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.647 HG21 HD22 ' A' ' 106' ' ' LEU . 46.6 mm -82.48 113.4 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.071 0.462 . . . . 0.26 110.622 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -102.75 -176.15 3.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.687 -0.857 . . . . 1.59 108.687 176.38 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -61.97 -41.32 97.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.879 -0.786 . . . . 0.6 108.879 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.93 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -58.97 -49.94 75.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.305 -0.861 . . . . 2.58 110.583 178.093 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.15 -42.27 99.09 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.133 -1.394 . . . . 0.15 111.266 -177.489 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.522 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -66.51 -46.63 75.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.33 -0.85 . . . . 0.16 108.994 177.413 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.629 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 67.9 t80 -58.63 -46.88 86.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.033 -0.531 . . . . 0.3 110.917 175.726 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.32 -38.83 71.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.153 0.501 . . . . 0.4 110.82 -175.725 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.654 HG21 HD21 ' A' ' 163' ' ' LEU . 9.3 m -77.93 -54.15 6.63 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.785 -0.643 . . . . 0.22 112.147 -178.341 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -73.07 -28.04 62.08 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.981 0.734 . . . . 0.11 112.981 -174.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.4 t -57.08 -29.4 63.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.764 0.316 . . . . 0.19 111.643 -176.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.42 -21.6 37.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.364 -0.38 . . . . 0.14 111.744 178.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -92.67 -18.37 23.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.18 111.393 -177.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 166.68 171.61 33.01 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.994 -0.622 . . . . 0.11 111.85 -178.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -72.57 135.93 45.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.797 0.332 . . . . 0.25 110.342 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.424 HG21 ' HB3' ' A' ' 128' ' ' CYS . 66.3 mt -111.24 134.88 52.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.401 -0.363 . . . . 0.14 110.323 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -91.28 -49.18 6.5 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.801 -0.815 . . . . 0.54 108.801 179.543 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 66.5 m -141.77 100.19 3.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.901 -1.045 . . . . 0.76 110.915 -175.332 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 13.2 p -95.97 148.41 22.67 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.795 -0.817 . . . . 0.72 108.795 172.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -146.68 129.14 15.92 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.645 -0.422 . . . . 1.0 111.546 -174.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.522 HG22 HD12 ' A' ' 115' ' ' LEU . 75.4 t -110.06 110.2 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 106.606 -1.627 . . . . 0.28 106.606 169.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.6 t . . . . . 0 C--N 1.301 -1.506 0 CA-C-N 115.653 -0.703 . . . . 0.34 109.565 -172.625 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 113.597 0.199 . . . . 0.31 113.597 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -132.4 157.01 45.63 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.24 0.52 . . . . 0.49 111.186 -176.254 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.91 177.21 25.36 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.759 -0.655 . . . . 0.12 111.824 -177.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -136.35 143.12 43.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.494 -0.187 . . . . 0.25 110.494 -176.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.495 ' HB ' HG12 ' A' ' 101' ' ' ILE . 45.9 t -115.44 129.78 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.06 0.457 . . . . 0.1 110.493 171.055 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.9 OUTLIER -100.73 105.32 16.65 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.079 -0.712 . . . . 0.21 109.079 167.216 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.533 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.6 m-85 -88.13 140.92 29.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.264 0.554 . . . . 0.17 110.693 178.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.596 ' HA ' HD21 ' A' ' 126' ' ' LEU . 24.6 tt0 -50.88 -41.13 58.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.324 -1.307 . . . . 0.57 110.479 177.584 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.0 p -122.98 148.31 45.65 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.606 -1.179 . . . . 0.4 111.229 -178.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -60.55 -36.55 78.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.441 -0.799 . . . . 0.47 111.368 179.171 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 9.7 pt-20 -67.45 -35.97 80.27 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.0 0.37 . . . . 0.74 112.0 -176.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.43 78.06 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.09 0.471 . . . . 0.18 110.372 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.546 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -62.19 -44.63 96.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.516 -0.765 . . . . 0.16 110.86 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.963 ' HG2' HH12 ' A' ' 172' ' ' ARG . 28.1 mt-10 -59.5 -42.27 91.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 1.42 110.707 178.183 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.531 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 46.8 mtt180 -59.47 -41.06 88.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.127 -0.488 . . . . 1.48 110.569 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.76 -37.15 84.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.088 -0.505 . . . . 0.1 110.674 178.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.7 mt -60.01 -52.99 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.15 110.988 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 0.7 OUTLIER -63.43 -45.47 90.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.01 0.433 . . . . 1.08 111.877 -179.399 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.443 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -80.39 -39.19 28.86 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.884 0.698 . . . . 1.16 112.884 -169.148 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.567 ' HB2' HG21 ' A' ' 170' ' ' VAL . 89.3 mmm -93.08 -15.85 25.62 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.277 0.473 . . . . 0.35 112.277 -173.143 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -70.29 123.27 21.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.566 -0.901 . . . . 0.44 108.566 176.677 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.76 11.98 78.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.562 -0.828 . . . . 0.29 111.967 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -93.09 150.7 20.34 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.827 -0.805 . . . . 1.18 108.827 178.443 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.414 HD23 ' CA ' ' A' ' 167' ' ' LYS . 23.3 mt -97.11 124.57 41.17 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.92 -0.77 . . . . 0.44 108.92 177.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.654 HD21 HG21 ' A' ' 118' ' ' THR . 27.3 mt -110.05 99.35 8.46 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.796 -0.761 . . . . 1.02 109.838 173.711 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 70.5 m-20 78.29 -23.14 0.25 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.98 -1.009 . . . . 1.71 112.812 176.406 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 33.7 t70 167.77 -22.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.815 0.697 . . . . 0.85 112.069 -177.495 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.1 mtt180 -109.81 136.78 48.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.797 0.332 . . . . 0.96 110.875 -170.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.414 ' CA ' HD23 ' A' ' 162' ' ' LEU . 26.6 tttt -84.88 118.74 24.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.39 -178.751 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.455 HG11 HD23 ' A' ' 106' ' ' LEU . 13.3 m -101.27 148.43 7.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.7 0.762 . . . . 0.17 111.791 -171.636 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 55.3 t80 -106.97 119.18 38.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.659 -1.155 . . . . 0.3 109.318 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.567 HG21 ' HB2' ' A' ' 158' ' ' MET . 39.4 t -115.72 125.85 73.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.574 -0.528 . . . . 0.13 109.574 178.208 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.6 -175.15 20.14 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.715 -0.755 . . . . 0.18 112.278 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.963 HH12 ' HG2' ' A' ' 152' ' ' GLU . 24.4 mmt180 . . . . . 0 C--N 1.324 -0.508 0 O-C-N 123.548 0.205 . . . . 1.93 110.53 179.08 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 121.181 0.515 . . . . 0.71 111.925 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.31 24.02 76.15 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.027 -1.082 . . . . 0.21 111.535 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -88.63 125.3 34.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.933 -0.766 . . . . 0.63 108.933 -174.281 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.522 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.4 pt -135.74 163.53 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.533 -0.303 . . . . 0.15 110.188 177.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.24 145.27 50.83 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.851 -0.425 . . . . 0.21 109.851 175.167 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.521 HG12 HG22 ' A' ' 170' ' ' VAL . 6.2 mt -118.38 148.32 21.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.776 -0.647 . . . . 0.15 110.019 -177.176 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -131.25 149.43 52.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.35 -0.386 . . . . 1.46 110.601 -172.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 64.1 t30 67.63 35.68 3.97 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.639 0.587 . . . . 0.49 111.794 173.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.489 HD22 HG21 ' A' ' 110' ' ' ILE . 20.1 mt -72.33 152.91 41.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.083 0.468 . . . . 0.26 111.133 176.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.4 t70 -77.19 150.4 35.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.466 -0.788 . . . . 0.71 110.565 177.115 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -62.14 -33.92 75.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.053 -0.522 . . . . 2.2 111.106 -177.019 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 t -76.05 -4.85 43.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.381 -0.372 . . . . 1.41 111.057 -176.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.489 HG21 HD22 ' A' ' 106' ' ' LEU . 36.0 mm -78.82 127.19 39.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.898 0.38 . . . . 0.26 110.433 178.122 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -111.6 -179.97 3.85 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.592 -0.521 . . . . 1.59 109.592 -179.211 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.646 ' OD1' ' HA ' ' A' ' 129' ' ' LYS . 67.8 m-80 -65.4 -37.81 88.07 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.19 -0.67 . . . . 0.6 109.19 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.98 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.76 -49.19 78.5 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.976 -1.011 . . . . 2.58 110.017 177.618 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.29 97.41 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.772 -1.558 . . . . 0.15 111.463 -177.119 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.671 HD12 HG22 ' A' ' 130' ' ' VAL . 4.2 tt -63.84 -47.3 81.3 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.993 -0.743 . . . . 0.16 108.993 177.431 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.712 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 63.8 t80 -60.2 -47.5 85.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.036 -0.529 . . . . 0.3 110.846 176.814 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.57 -39.08 75.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.91 0.386 . . . . 0.4 110.79 -175.071 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.5 m -77.21 -52.91 8.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 0.22 111.724 -178.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -71.93 -28.32 63.39 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.385 0.513 . . . . 0.11 112.385 -175.012 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.2 t -57.45 -28.95 63.8 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.457 0.169 . . . . 0.19 111.457 -177.541 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.82 -21.76 31.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.846 0.355 . . . . 0.14 111.386 177.291 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -92.21 -10.76 37.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.18 111.205 -178.596 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.59 163.75 12.7 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.128 -0.558 . . . . 0.11 111.725 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.95 137.82 58.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.185 0.517 . . . . 0.25 110.171 177.44 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 128' ' ' CYS . 82.2 mt -110.54 132.73 58.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.71 -0.677 . . . . 0.14 109.877 -178.475 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.07 -39.13 14.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.87 -0.789 . . . . 0.54 108.87 -177.429 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 144' ' ' HIS . 82.5 p -146.53 134.11 20.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.291 -0.868 . . . . 0.76 109.681 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.3 p -133.81 130.28 37.74 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.285 -0.635 . . . . 0.72 109.285 176.608 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.646 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 58.0 tptt -132.33 134.84 45.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.159 0.504 . . . . 1.0 111.891 -174.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.671 HG22 HD12 ' A' ' 115' ' ' LEU . 95.2 t -114.01 109.6 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 106.355 -1.72 . . . . 0.28 106.355 170.028 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.308 -1.222 0 CA-C-N 115.917 -0.583 . . . . 0.34 109.798 -172.019 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.287 0 N-CA-C 114.051 0.38 . . . . 0.31 114.051 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -122.26 155.26 36.27 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 117.523 0.661 . . . . 0.49 111.315 -174.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -147.85 173.66 27.83 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.12 111.964 -178.091 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.37 136.73 36.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.826 0.313 . . . . 0.25 110.706 -177.347 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.522 ' HB ' HG12 ' A' ' 101' ' ' ILE . 38.5 t -114.56 134.98 55.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.02 0.438 . . . . 0.1 111.002 173.42 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.437 ' HB2' ' OG ' ' A' ' 127' ' ' SER . 1.5 m170 -103.25 106.71 17.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.736 -0.665 . . . . 0.21 109.212 167.218 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 14.4 m-85 -89.91 135.92 33.35 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.323 0.583 . . . . 0.17 111.372 179.082 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.633 ' HA ' HD21 ' A' ' 126' ' ' LEU . 44.5 tt0 -46.36 -43.54 16.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.919 -1.492 . . . . 0.57 111.017 177.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.4 p -116.4 147.37 41.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.937 -1.029 . . . . 0.4 111.046 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -60.23 -39.81 87.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.887 -0.597 . . . . 0.47 110.917 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.22 -33.44 73.33 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.319 -0.4 . . . . 0.74 111.678 -177.516 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.59 74.22 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.149 0.499 . . . . 0.18 110.318 177.532 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.475 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -67.34 -41.96 84.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.62 -0.718 . . . . 0.16 110.369 176.224 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.655 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 44.0 mt-10 -58.57 -40.26 82.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 1.42 110.305 177.212 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 65.3 mtt180 -59.5 -50.14 75.08 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 120.882 0.372 . . . . 1.48 110.623 174.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.42 -38.85 81.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.1 110.88 -178.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 151' ' ' ALA . 84.9 mt -60.98 -54.88 29.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.251 -0.431 . . . . 0.15 110.864 178.108 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 3.2 pt-20 -64.22 -44.76 90.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.169 0.509 . . . . 1.08 111.774 -178.737 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -76.37 -39.06 54.83 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.926 0.713 . . . . 1.16 112.926 -170.739 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 91.4 mmm -94.26 -22.3 18.48 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.602 0.593 . . . . 0.35 112.602 -173.715 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.49 123.65 20.21 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.221 -0.592 . . . . 0.44 109.823 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.496 ' O ' ' HE2' ' A' ' 167' ' ' LYS . . . 83.89 22.55 55.12 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.786 -0.721 . . . . 0.29 112.513 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 2.7 mmt -109.26 160.31 16.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.76 0.314 . . . . 1.18 111.159 177.061 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 29.7 mt -100.57 107.12 18.71 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.915 -0.584 . . . . 0.44 109.976 -176.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 163' ' ' LEU . 17.4 mt -90.99 109.67 20.91 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.686 -0.806 . . . . 1.02 109.163 172.306 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 82.8 m-20 73.08 -67.01 0.28 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.108 -0.951 . . . . 1.71 111.421 -175.206 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -163.66 18.61 0.07 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.873 -0.603 . . . . 0.85 111.018 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 88.7 mtt180 -131.77 130.87 42.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.969 -0.457 . . . . 0.96 109.971 -177.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 161' ' ' MET . 22.6 tttt -82.09 118.24 22.88 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 -177.186 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.478 HG11 HD23 ' A' ' 106' ' ' LEU . 16.9 m -100.8 145.87 10.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.547 0.689 . . . . 0.17 111.161 -173.556 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -106.47 125.1 50.57 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.97 -1.014 . . . . 0.3 109.388 176.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 103' ' ' ILE . 39.8 t -116.45 131.65 68.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.306 -0.627 . . . . 0.13 109.306 177.071 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.26 -173.26 19.71 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.606 -0.807 . . . . 0.18 111.966 179.354 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 121.023 0.439 . . . . 1.93 110.47 -178.07 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 121.086 0.47 . . . . 0.71 111.195 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.0 23.46 77.83 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.124 -1.036 . . . . 0.21 111.068 -178.106 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.446 ' ND2' ' NE2' ' A' ' 144' ' ' HIS . 9.7 m-20 -90.39 124.89 35.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.544 -0.539 . . . . 0.63 109.544 -173.451 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.55 HG23 ' HB1' ' A' ' 151' ' ' ALA . 17.3 pt -135.98 163.71 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.299 -0.409 . . . . 0.15 110.227 178.46 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.39 143.1 50.8 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.784 -0.45 . . . . 0.21 109.784 175.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.572 HG12 HG22 ' A' ' 170' ' ' VAL . 6.2 mt -119.4 134.97 61.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.652 -0.703 . . . . 0.15 110.016 -177.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -113.87 150.1 34.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.617 -0.265 . . . . 1.46 110.623 -179.284 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.3 t30 72.01 39.0 0.85 Allowed 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.974 0.796 . . . . 0.49 111.77 171.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.534 HD22 HG21 ' A' ' 110' ' ' ILE . 21.8 mt -76.43 153.83 35.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.093 0.473 . . . . 0.26 110.864 176.438 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.492 ' HB3' HG12 ' A' ' 110' ' ' ILE . 6.5 t70 -75.51 144.53 41.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.52 -0.764 . . . . 0.71 110.163 175.666 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -61.48 -28.44 69.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 2.2 111.398 -176.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.407 ' HB3' ' OD2' ' A' ' 107' ' ' ASP . 9.1 t -80.49 -7.84 59.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.276 -0.42 . . . . 1.41 110.652 -179.189 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.534 HG21 HD22 ' A' ' 106' ' ' LEU . 30.8 mm -74.39 116.87 17.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.851 -0.426 . . . . 0.26 109.851 176.475 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -103.1 -174.16 2.48 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.741 -0.837 . . . . 1.59 108.741 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -67.86 -31.14 70.75 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.564 -0.902 . . . . 0.6 108.564 -178.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -48.61 66.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.499 -1.228 . . . . 2.58 109.236 178.911 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.82 -44.15 97.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.212 -1.358 . . . . 0.15 110.703 -177.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.566 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -64.97 -46.79 80.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.068 -0.969 . . . . 0.16 109.138 177.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.775 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 65.6 t80 -58.86 -47.22 85.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.3 111.084 175.578 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.75 -37.81 71.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.915 0.388 . . . . 0.4 110.957 -176.101 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.516 HG21 HD21 ' A' ' 163' ' ' LEU . 7.0 m -78.55 -54.76 5.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.992 -0.549 . . . . 0.22 112.138 -178.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.415 ' CD1' HD23 ' A' ' 115' ' ' LEU . 11.9 m-85 -72.98 -27.92 62.08 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.248 0.832 . . . . 0.11 113.248 -173.394 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 t -57.0 -28.79 62.75 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 111.78 0.289 . . . . 0.19 111.78 -175.425 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.04 -22.12 36.5 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.856 0.36 . . . . 0.14 111.755 178.365 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -89.43 -23.12 22.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.808 0.337 . . . . 0.18 111.14 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 170.88 166.4 29.69 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.956 -0.565 . . . . 0.11 111.736 -178.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -67.69 129.07 38.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.25 110.11 179.083 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.413 HG21 ' HB3' ' A' ' 128' ' ' CYS . 78.8 mt -98.91 132.0 45.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.175 -0.466 . . . . 0.14 109.995 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -84.68 -40.57 17.22 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.666 -0.864 . . . . 0.54 108.666 -179.822 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 69.5 m -152.68 122.14 6.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.861 -1.063 . . . . 0.76 110.27 -178.149 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.775 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.4 p -117.2 137.63 52.22 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.641 -0.503 . . . . 0.72 109.641 176.045 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -138.2 132.97 32.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.193 0.52 . . . . 1.0 112.003 -174.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.566 HG22 HD12 ' A' ' 115' ' ' LEU . 86.1 t -114.33 109.87 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 106.582 -1.636 . . . . 0.28 106.582 169.311 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.5 t . . . . . 0 C--N 1.305 -1.351 0 CA-C-N 115.931 -0.577 . . . . 0.34 109.524 -173.479 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 CA-C-O 120.356 -0.136 . . . . 0.31 113.356 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -129.69 154.02 47.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 117.21 0.505 . . . . 0.49 111.45 -177.512 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.29 175.18 25.0 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.688 -0.687 . . . . 0.12 111.895 -178.194 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -136.58 137.73 40.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.72 0.26 . . . . 0.25 110.65 -175.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' A' ' 145' ' ' PHE . 49.2 t -110.94 136.05 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.996 0.427 . . . . 0.1 110.865 172.47 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.446 ' NE2' ' ND2' ' A' ' 100' ' ' ASN . 2.5 m170 -104.13 106.09 16.48 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.658 -0.701 . . . . 0.21 109.303 167.472 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.51 ' CE2' HG11 ' A' ' 143' ' ' VAL . 14.8 m-85 -92.04 137.31 32.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.081 0.467 . . . . 0.17 110.827 178.794 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.591 ' HA ' HD21 ' A' ' 126' ' ' LEU . 39.0 tt0 -47.83 -41.42 23.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.522 -1.217 . . . . 0.57 111.131 179.572 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.8 p -119.32 151.14 38.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.325 -0.852 . . . . 0.4 110.825 179.667 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -62.31 -35.96 80.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.47 110.72 179.039 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.36 -34.67 74.93 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.33 -0.396 . . . . 0.74 111.948 -178.161 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.08 -34.74 78.24 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.005 0.431 . . . . 0.18 110.678 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.55 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -63.68 -41.38 98.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 0.16 110.359 176.321 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.486 ' CD ' HH21 ' A' ' 172' ' ' ARG . 7.2 mm-40 -59.27 -40.41 85.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.689 -0.687 . . . . 1.42 110.923 177.147 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.588 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 96.8 mtt180 -60.86 -43.2 98.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.566 -0.743 . . . . 1.48 111.059 177.548 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.75 83.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.222 -0.445 . . . . 0.1 110.521 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.468 HG12 HG12 ' A' ' 170' ' ' VAL . 66.7 mt -62.51 -52.41 60.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.227 -0.442 . . . . 0.15 111.106 178.472 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 0.1 OUTLIER -62.57 -44.31 96.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.192 0.52 . . . . 1.08 111.941 179.931 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -82.68 -38.7 23.05 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.243 0.831 . . . . 1.16 113.243 -168.722 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.467 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.2 mmm -93.93 -16.28 24.14 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.439 0.533 . . . . 0.35 112.439 -173.053 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 155' ' ' ILE . 47.4 t-20 -67.03 122.93 18.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.302 -0.629 . . . . 0.44 109.302 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.09 70.34 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.911 -0.661 . . . . 0.29 112.865 178.529 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.655 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 30.3 mmt -96.21 163.03 13.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.997 0.399 . . . . 1.18 111.494 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 20.8 mt -104.61 111.83 24.68 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.868 -0.605 . . . . 0.44 109.879 -177.645 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 118' ' ' THR . 19.0 mt -100.15 100.87 11.77 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 120.073 -0.651 . . . . 1.02 109.758 174.334 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 87.6 m-20 78.58 -23.59 0.24 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 114.883 -1.053 . . . . 1.71 112.615 178.644 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 21.0 t70 166.15 -23.07 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.174 0.921 . . . . 0.85 111.724 -177.552 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.0 mtt180 -106.65 132.38 52.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.82 0.343 . . . . 0.96 111.112 -169.244 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 161' ' ' MET . 8.3 ttmm -77.11 118.59 19.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.468 -0.787 . . . . 1.0 109.385 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.468 HG11 HD23 ' A' ' 106' ' ' LEU . 14.7 m -100.83 146.23 9.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.562 0.696 . . . . 0.17 111.149 -174.602 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 40.4 t80 -110.62 121.96 46.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.908 -1.042 . . . . 0.3 109.267 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.572 HG22 HG12 ' A' ' 103' ' ' ILE . 41.4 t -115.7 127.07 73.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.981 -0.378 . . . . 0.13 109.981 -178.322 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.08 176.86 27.66 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.876 -0.678 . . . . 0.18 112.361 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.486 HH21 ' CD ' ' A' ' 152' ' ' GLU . 14.6 mmt85 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.029 0.442 . . . . 1.93 111.148 -179.546 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 121.126 0.489 . . . . 0.71 111.924 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.03 24.51 63.96 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.912 -1.137 . . . . 0.21 112.883 174.336 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -89.92 126.08 35.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.532 -0.544 . . . . 0.63 109.532 -175.024 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.483 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.2 pt -134.24 163.73 36.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.237 -0.438 . . . . 0.15 109.909 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.14 147.49 49.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.99 -0.374 . . . . 0.21 109.99 177.51 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.536 HG12 HG22 ' A' ' 170' ' ' VAL . 5.2 mt -122.4 148.16 26.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.83 -0.623 . . . . 0.15 110.144 -176.286 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -128.04 157.29 41.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.524 -0.307 . . . . 1.46 110.962 -175.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.0 t30 67.44 31.61 6.24 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.738 0.649 . . . . 0.49 111.698 172.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.654 HD22 HG21 ' A' ' 110' ' ' ILE . 42.6 mt -75.62 148.61 38.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 0.26 111.354 178.208 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -80.18 153.74 28.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.792 -0.64 . . . . 0.71 110.364 178.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -55.16 -34.27 63.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.842 -0.617 . . . . 2.2 111.983 178.387 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.4 t -76.06 -4.51 41.81 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.464 -0.335 . . . . 1.41 111.718 -177.745 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.654 HG21 HD22 ' A' ' 106' ' ' LEU . 45.7 mm -81.55 113.83 21.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 122.069 -0.394 . . . . 0.26 110.067 175.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -106.84 -177.76 3.45 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.212 -0.662 . . . . 1.59 109.212 178.235 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -60.54 -37.85 82.57 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.746 -0.464 . . . . 0.6 109.746 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.887 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -62.29 -50.55 71.21 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.477 -0.783 . . . . 2.58 110.673 178.381 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.54 95.72 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.174 -1.375 . . . . 0.15 111.079 -176.666 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.708 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -67.05 -47.22 71.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.471 -0.786 . . . . 0.16 109.174 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 72.7 t80 -58.96 -47.13 86.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.528 . . . . 0.3 110.848 176.684 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.36 -37.93 73.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.158 0.504 . . . . 0.4 111.017 -176.09 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.655 HG21 HD21 ' A' ' 163' ' ' LEU . 13.4 m -78.24 -54.36 6.31 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.057 -0.519 . . . . 0.22 112.065 -178.505 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.409 ' CD1' HD23 ' A' ' 115' ' ' LEU . 19.6 m-85 -73.65 -29.79 62.54 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.007 0.743 . . . . 0.11 113.007 -174.154 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.2 t -58.59 -27.2 64.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.685 0.278 . . . . 0.19 111.332 -176.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.99 -22.3 25.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.603 0.24 . . . . 0.14 111.344 177.043 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -92.45 -17.62 24.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.531 -0.304 . . . . 0.18 111.352 -178.626 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.71 174.55 37.46 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.999 -0.62 . . . . 0.11 111.875 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -76.69 139.71 40.61 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.836 -0.431 . . . . 0.25 109.836 -179.302 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.44 HG21 ' HB3' ' A' ' 128' ' ' CYS . 71.0 mt -112.13 135.3 51.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.366 -0.379 . . . . 0.14 110.223 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -90.69 -42.85 10.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.774 -0.824 . . . . 0.54 108.774 179.748 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 67.5 m -146.1 111.31 5.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.249 -0.887 . . . . 0.76 110.659 -178.472 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.6 p -108.52 137.84 45.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.255 -0.646 . . . . 0.72 109.255 172.633 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -136.58 131.24 33.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.957 0.408 . . . . 1.0 111.418 -174.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.708 HG22 HD12 ' A' ' 115' ' ' LEU . 91.0 t -114.78 113.74 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 106.738 -1.579 . . . . 0.28 106.738 170.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.304 -1.386 0 N-CA-C 108.718 -0.845 . . . . 0.34 108.718 -176.473 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 114.076 0.391 . . . . 0.31 114.076 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -126.34 152.52 46.12 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.373 0.587 . . . . 0.49 111.753 -174.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.43 174.14 25.56 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.538 -0.755 . . . . 0.12 111.694 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -139.5 139.3 36.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.877 0.339 . . . . 0.25 110.728 -177.132 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.483 ' HB ' HG12 ' A' ' 101' ' ' ILE . 42.6 t -113.85 133.81 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.05 0.452 . . . . 0.1 110.854 172.855 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.6 OUTLIER -105.37 106.09 16.43 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.708 -0.678 . . . . 0.21 109.186 167.986 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.541 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 14.6 m-85 -89.68 140.04 29.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.336 0.589 . . . . 0.17 111.264 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.633 ' HA ' HD21 ' A' ' 126' ' ' LEU . 36.5 tt0 -53.43 -43.18 67.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.54 -1.209 . . . . 0.57 110.087 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.5 p -114.28 144.52 43.1 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.405 -1.27 . . . . 0.4 111.337 -178.209 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -62.4 -38.02 88.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.376 -0.829 . . . . 0.47 111.064 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.27 -35.95 76.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.451 -0.341 . . . . 0.74 111.83 -176.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.83 -34.69 78.5 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.344 0.592 . . . . 0.18 110.33 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.541 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.21 -40.88 97.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 0.16 111.194 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.61 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 1.9 mm-40 -68.37 -36.32 79.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.018 -0.537 . . . . 1.42 110.278 -179.082 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 90.4 mtt180 -60.21 -42.89 96.11 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-N 116.099 -0.5 . . . . 1.48 110.362 175.096 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.34 87.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.96 -0.563 . . . . 0.1 110.651 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 151' ' ' ALA . 76.1 mt -63.02 -53.99 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.542 -0.299 . . . . 0.15 110.921 178.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.61 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.9 pt-20 -61.55 -43.09 99.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.066 0.46 . . . . 1.08 111.764 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -81.6 -39.04 25.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.172 0.804 . . . . 1.16 113.172 -171.415 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 90.9 mmm -93.22 -18.98 21.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.616 0.599 . . . . 0.35 112.616 -172.802 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.5 122.56 19.91 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.615 -0.834 . . . . 0.44 109.096 176.647 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.35 77.09 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.715 -0.755 . . . . 0.29 112.009 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.8 tpt -93.16 151.4 19.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.157 -0.682 . . . . 1.18 109.157 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.1 mt -96.45 107.46 19.86 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.437 -0.579 . . . . 0.44 109.437 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 118' ' ' THR . 11.5 mt -92.38 108.1 19.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.489 -0.884 . . . . 1.02 109.369 172.416 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 5.4 m-20 77.41 -33.43 0.19 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.397 -0.82 . . . . 1.71 111.986 176.246 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 163' ' ' LEU . 27.1 t70 168.54 -19.78 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.115 -0.948 . . . . 0.85 111.889 -174.336 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -107.45 136.72 46.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.644 0.259 . . . . 0.96 110.478 -172.217 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -80.83 116.38 20.79 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 -178.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.42 HG11 HD23 ' A' ' 106' ' ' LEU . 16.0 m -100.45 146.68 8.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.677 0.751 . . . . 0.17 111.124 -173.186 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 55.6 t80 -105.98 119.19 38.55 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.718 -1.128 . . . . 0.3 109.083 179.355 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.536 HG22 HG12 ' A' ' 103' ' ' ILE . 43.4 t -116.1 129.7 72.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.077 0.465 . . . . 0.13 109.849 179.101 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.6 177.72 25.69 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 111.04 -0.824 . . . . 0.18 111.04 176.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 N-CA-C 110.156 -0.313 . . . . 1.93 110.156 179.4 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 112.763 0.653 . . . . 0.71 112.763 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.58 25.26 74.59 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.655 -1.26 . . . . 0.21 111.433 176.248 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -88.4 124.17 33.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.594 -0.521 . . . . 0.63 109.594 -172.65 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.598 HG12 ' HB ' ' A' ' 143' ' ' VAL . 34.8 pt -135.05 151.75 31.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.765 -0.457 . . . . 0.15 109.765 176.757 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.81 141.23 49.69 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.566 -0.531 . . . . 0.21 109.566 178.633 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.567 HG12 HG22 ' A' ' 170' ' ' VAL . 5.2 mt -119.34 129.54 75.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.653 -0.703 . . . . 0.15 110.064 -176.085 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -112.45 151.62 29.67 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.682 -0.235 . . . . 1.46 110.616 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.9 t30 73.69 36.7 0.73 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.97 0.794 . . . . 0.49 111.629 172.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 110' ' ' ILE . 18.3 mt -76.15 154.36 35.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 0.26 111.261 177.089 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.452 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 13.5 t70 -78.33 149.98 33.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.465 -0.789 . . . . 0.71 109.514 174.003 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -68.63 -26.65 65.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.924 0.392 . . . . 2.2 110.881 -175.045 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 m -72.65 -7.87 52.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 1.41 111.292 178.156 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 106' ' ' LEU . 31.9 mm -79.12 113.75 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.106 0.479 . . . . 0.26 109.95 178.398 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 11.2 t70 -99.3 -176.25 3.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.679 -0.692 . . . . 1.59 109.223 -178.843 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -66.96 -34.45 77.79 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.08 -1.081 . . . . 0.6 108.08 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -47.83 66.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.137 -1.392 . . . . 2.58 109.269 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -60.84 -44.05 97.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.047 -1.433 . . . . 0.15 110.963 -178.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.609 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -65.82 -46.74 77.47 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.361 -0.836 . . . . 0.16 109.238 177.55 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.747 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 49.1 t80 -59.93 -46.95 87.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.3 110.831 176.63 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.46 -41.45 76.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.96 0.409 . . . . 0.4 110.985 -175.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.409 HG21 HD21 ' A' ' 163' ' ' LEU . 19.2 m -77.18 -52.66 8.87 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.86 -0.609 . . . . 0.22 111.902 -176.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -72.91 -28.26 62.36 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.46 0.541 . . . . 0.11 112.46 -174.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.8 t -57.81 -28.43 64.03 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.649 0.262 . . . . 0.19 111.444 -177.49 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.41 -21.18 23.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.835 0.35 . . . . 0.14 111.499 177.342 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -94.95 -14.15 24.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.18 111.066 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.65 166.55 22.68 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 116.037 -0.529 . . . . 0.11 111.898 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -69.49 138.7 53.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.896 -0.409 . . . . 0.25 109.896 178.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.417 HG21 ' HB3' ' A' ' 128' ' ' CYS . 67.7 mt -111.11 134.09 54.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.98 -0.554 . . . . 0.14 109.751 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.18 -50.65 6.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.435 -0.95 . . . . 0.54 108.435 179.93 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.3 m -138.01 99.14 3.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.801 -1.091 . . . . 0.76 110.72 -176.488 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.747 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 0.8 OUTLIER -97.98 139.95 33.05 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.165 -0.679 . . . . 0.72 109.165 172.512 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -139.2 129.3 25.22 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.634 -172.758 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.609 HG22 HD12 ' A' ' 115' ' ' LEU . 95.8 t -114.14 109.27 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 106.573 -1.64 . . . . 0.28 106.573 168.148 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 C--N 1.305 -1.349 0 CA-C-N 115.693 -0.685 . . . . 0.34 109.783 -172.121 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 CA-C-O 120.49 -0.061 . . . . 0.31 113.243 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -133.99 155.32 50.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.85 0.357 . . . . 0.49 111.001 -177.043 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.6 175.28 24.4 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.81 -0.632 . . . . 0.12 111.938 -178.249 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -137.06 139.33 41.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.547 0.173 . . . . 0.25 110.838 -177.103 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.598 ' HB ' HG12 ' A' ' 101' ' ' ILE . 41.9 t -112.09 132.93 59.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.881 0.372 . . . . 0.1 110.578 171.815 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -104.16 106.05 16.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.082 -0.71 . . . . 0.21 109.082 167.405 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.488 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 20.0 m-85 -87.7 138.62 31.31 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.331 0.586 . . . . 0.17 111.155 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.576 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.9 tt0 -49.01 -39.47 27.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.038 -1.437 . . . . 0.57 110.715 178.205 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.5 p -125.61 152.62 44.9 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.833 -1.076 . . . . 0.4 110.663 -179.686 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -66.94 -31.07 71.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.915 -0.584 . . . . 0.47 110.977 -177.799 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.65 -35.15 74.92 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.039 0.385 . . . . 0.74 112.039 -178.126 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.8 -34.61 78.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.11 0.481 . . . . 0.18 110.711 -178.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.488 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.97 -43.85 94.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.506 -0.77 . . . . 0.16 111.252 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 33.5 mt-10 -58.68 -41.9 87.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 1.42 110.638 179.242 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.457 HH11 ' HD2' ' A' ' 153' ' ' ARG . 65.2 mtt85 -61.27 -44.52 97.1 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.259 -0.428 . . . . 1.48 111.285 177.354 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.74 -37.4 84.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.374 -0.376 . . . . 0.1 110.713 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 151' ' ' ALA . 87.3 mt -62.41 -54.48 33.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.381 -0.372 . . . . 0.15 111.081 178.154 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.9 pt-20 -62.72 -40.24 96.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.983 0.42 . . . . 1.08 111.814 -177.683 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 157' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -82.35 -38.66 23.9 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.872 0.693 . . . . 1.16 112.872 -172.746 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 158' ' ' MET . . . . . 0.409 ' HB2' HG21 ' A' ' 170' ' ' VAL . 90.5 mmm -93.2 -26.8 17.22 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.549 0.574 . . . . 0.35 112.549 -173.266 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -64.85 123.4 19.3 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.131 -0.628 . . . . 0.44 109.383 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.79 19.51 56.07 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.635 -0.793 . . . . 0.29 112.557 -179.304 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.4 mmt -105.15 156.35 18.17 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.788 -0.243 . . . . 1.18 110.861 176.716 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 162' ' ' LEU . 14.4 mt -98.27 97.45 8.84 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.455 -0.572 . . . . 0.44 109.455 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 18.1 mt -81.82 105.07 12.66 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 119.469 -0.893 . . . . 1.02 109.068 174.382 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 164' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 86.4 m-20 74.1 -66.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.974 -1.012 . . . . 1.71 111.909 -177.652 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -156.47 6.84 0.19 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.854 -0.612 . . . . 0.85 111.686 -177.184 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.2 mtt180 -134.39 128.34 33.41 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 121.769 -0.582 . . . . 0.96 110.255 -172.786 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 161' ' ' MET . 17.0 tttt -76.66 119.77 20.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.483 -178.016 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.452 HG11 HD23 ' A' ' 106' ' ' LEU . 15.9 m -100.73 144.51 12.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.491 0.662 . . . . 0.17 111.365 -172.605 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 72.9 t80 -106.82 119.76 40.21 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.687 -1.142 . . . . 0.3 109.325 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.567 HG22 HG12 ' A' ' 103' ' ' ILE . 40.6 t -115.63 128.82 72.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.501 -0.555 . . . . 0.13 109.501 178.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.28 -175.02 19.79 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.64 -0.79 . . . . 0.18 112.356 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 120.895 0.378 . . . . 1.93 110.729 -177.744 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 111.855 -0.498 . . . . 14.85 111.855 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -119.76 -65.29 1.17 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.969 0.414 . . . . 13.5 110.117 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -170.08 117.43 0.51 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.832 -0.622 . . . . 11.25 110.351 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.55 -4.16 13.91 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.591 2.194 . . . . 11.14 112.219 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.666 ' HB2' ' HE1' ' A' ' 144' ' ' HIS . 1.1 m -84.84 13.34 5.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.983 -0.553 . . . . 9.3 111.155 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 93.7 mt -80.4 56.12 2.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.523 0.678 . . . . 7.89 110.441 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -137.43 -150.51 0.36 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.045 -0.979 . . . . 7.78 108.366 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.739 ' HB3' ' HB1' ' A' ' 181' ' ' ALA . 43.7 tttm -99.28 1.06 44.26 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.83 -0.804 . . . . 2.37 108.83 171.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 p -105.85 19.74 20.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.384 -0.826 . . . . 1.79 111.811 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.631 ' HA3' HD22 ' A' ' 100' ' ' ASN . . . -89.12 6.16 83.8 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.52 -0.848 . . . . 0.44 111.799 174.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.2 t 60.35 121.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.118 0.967 . . . . 0.71 112.664 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.429 ' HA2' ' CB ' ' A' ' 151' ' ' ALA . . . 72.24 25.62 74.07 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 119.732 -1.223 . . . . 0.21 112.406 172.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.631 HD22 ' HA3' ' A' ' 97' ' ' GLY . 13.3 m-20 -85.58 123.85 31.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.806 -0.813 . . . . 0.63 108.806 -174.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.515 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.1 pt -135.72 159.93 39.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 110.319 -0.252 . . . . 0.15 110.319 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.05 141.35 52.12 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.815 -0.439 . . . . 0.21 109.815 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.649 HG12 HG22 ' A' ' 170' ' ' VAL . 7.2 mt -117.95 137.61 51.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.58 -0.737 . . . . 0.15 110.07 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -120.72 151.57 39.37 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.679 -0.237 . . . . 1.46 110.522 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 t30 69.77 54.37 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.86 0.725 . . . . 0.49 111.307 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.67 HD22 HG21 ' A' ' 110' ' ' ILE . 14.6 mt -91.61 162.88 14.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.426 -0.807 . . . . 0.26 111.169 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.465 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 14.0 t70 -87.38 155.74 19.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.71 109.936 177.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.948 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 62.8 pttt -62.24 -31.39 71.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.388 -0.369 . . . . 2.2 111.417 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.8 p -72.32 -4.59 30.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.186 -0.461 . . . . 1.41 111.936 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.698 HG22 HG21 ' A' ' 130' ' ' VAL . 45.1 mm -84.57 118.4 31.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.482 . . . . 0.26 110.776 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.462 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 15.6 t70 -108.73 -175.27 2.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.297 -1.001 . . . . 1.59 108.297 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -67.66 -32.52 73.25 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.478 -0.934 . . . . 0.6 108.478 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -48.72 71.14 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.624 -1.171 . . . . 2.58 109.263 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.462 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -62.43 -43.03 99.79 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.274 -1.33 . . . . 0.15 110.84 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.73 HD12 HG22 ' A' ' 130' ' ' VAL . 3.5 tt -65.73 -47.79 74.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.172 -0.677 . . . . 0.16 109.172 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.651 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 55.3 t80 -59.26 -46.3 88.87 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.743 -0.662 . . . . 0.3 110.486 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.84 -39.85 74.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.505 -0.316 . . . . 0.4 111.232 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.448 HG21 HD21 ' A' ' 163' ' ' LEU . 91.3 m -77.73 -53.78 7.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.264 0.468 . . . . 0.22 112.264 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.46 ' CD1' HD23 ' A' ' 115' ' ' LEU . 6.5 m-85 -71.76 -28.09 63.42 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.54 0.57 . . . . 0.11 112.54 -173.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.5 t -57.71 -28.86 64.22 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.571 0.224 . . . . 0.19 111.296 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.33 -22.86 45.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.678 0.275 . . . . 0.14 111.385 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.401 ' HZ ' ' HE3' ' A' ' 157' ' ' LYS . 26.7 m-85 -89.76 -26.22 20.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.038 0.447 . . . . 0.18 110.546 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.89 169.77 35.82 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.125 -0.79 . . . . 0.11 111.125 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -71.04 143.59 50.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.65 -0.5 . . . . 0.25 109.65 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.436 HG21 ' HB3' ' A' ' 128' ' ' CYS . 76.2 mt -114.76 134.93 56.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 116.014 -0.539 . . . . 0.14 110.015 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -93.02 -36.45 12.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 0.54 109.508 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.1 m -156.18 97.61 1.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.733 -0.667 . . . . 0.76 111.365 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.7 p -103.84 153.54 20.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.355 -0.609 . . . . 0.72 109.355 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -150.61 132.44 15.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.818 0.342 . . . . 1.0 111.255 -175.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.73 HG22 HD12 ' A' ' 115' ' ' LEU . 57.5 t -114.28 110.31 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 107.183 -1.414 . . . . 0.28 107.183 171.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.67 114.5 19.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.432 -0.951 . . . . 0.34 108.432 -175.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.887 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 3.6 p -105.79 135.03 47.94 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.759 0.652 . . . . 1.58 112.759 -164.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 135' ' ' ASN . 0.2 OUTLIER -87.33 174.45 8.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.919 -0.771 . . . . 2.08 108.919 172.186 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -55.11 -31.86 61.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.013 0.375 . . . . 2.45 112.013 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.422 ' H ' ' CG ' ' A' ' 133' ' ' ASP . 60.0 m-80 -86.23 -12.3 50.05 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.621 0.248 . . . . 1.65 110.974 -175.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.948 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 151.22 -50.19 0.53 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.07 -1.062 . . . . 1.12 113.834 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.887 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 38.2 t -160.96 145.99 14.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.476 0.638 . . . . 1.61 111.51 -176.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -78.18 -12.96 60.03 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.3 0.571 . . . . 1.51 110.297 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.66 22.83 9.87 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.203 -0.999 . . . . 0.31 113.877 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -161.18 153.93 20.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.742 0.771 . . . . 0.49 111.285 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.29 174.06 28.09 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.457 -0.792 . . . . 0.12 111.625 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.428 ' CD1' ' HE2' ' A' ' 173' ' ' PHE . 44.5 m-85 -139.93 142.65 36.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.928 0.364 . . . . 0.25 110.555 -177.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.515 ' HB ' HG12 ' A' ' 101' ' ' ILE . 24.6 t -118.34 133.96 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.105 0.479 . . . . 0.1 111.362 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.666 ' HE1' ' HB2' ' A' ' 92' ' ' SER . 0.1 OUTLIER -106.45 106.58 17.16 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.851 -0.796 . . . . 0.21 108.851 167.396 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 8.7 m-85 -89.28 139.76 30.17 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.284 0.564 . . . . 0.17 111.915 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.666 ' HA ' HD21 ' A' ' 126' ' ' LEU . 43.8 tt0 -52.48 -48.74 65.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.112 -1.404 . . . . 0.57 110.07 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.2 p -111.77 144.45 41.03 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.137 -1.392 . . . . 0.4 111.062 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -61.92 -40.32 95.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.299 -0.864 . . . . 0.47 111.026 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.8 pt-20 -67.68 -35.18 78.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.74 111.408 -175.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.84 78.43 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.241 0.543 . . . . 0.18 110.489 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.475 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.97 -44.72 91.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.388 -0.824 . . . . 0.16 110.86 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 37.7 mt-10 -62.06 -37.33 84.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.646 -0.707 . . . . 1.42 110.356 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 157' ' ' LYS . 88.8 mtt180 -62.54 -47.05 85.57 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.332 -0.394 . . . . 1.48 110.592 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.78 81.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.997 -0.547 . . . . 0.1 111.012 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.0 mt -61.21 -53.77 44.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.239 -0.437 . . . . 0.15 111.131 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 4.2 pt-20 -64.69 -45.01 88.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.186 0.517 . . . . 1.08 111.919 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -75.52 -38.92 59.07 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.483 -0.78 . . . . 1.16 112.893 -170.575 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.459 ' HB2' HG21 ' A' ' 170' ' ' VAL . 83.8 mmm -93.51 -26.23 17.25 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.917 0.71 . . . . 0.35 112.917 -173.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.401 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 52.7 t30 -64.79 123.74 20.15 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.549 -0.46 . . . . 0.44 110.15 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.42 11.65 62.27 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.816 -0.706 . . . . 0.29 113.184 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.676 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 75.2 mmm -105.39 164.25 12.0 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.568 -0.372 . . . . 1.18 111.508 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.442 HD23 ' N ' ' A' ' 167' ' ' LYS . 19.8 mt -96.33 123.21 39.89 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.928 -0.768 . . . . 0.44 108.928 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.53 HD12 HG11 ' A' ' 168' ' ' VAL . 24.9 mt -106.43 100.21 9.75 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.934 -0.706 . . . . 1.02 109.659 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 94.5 m-20 77.72 -28.82 0.16 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.871 -1.059 . . . . 1.71 112.725 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 35.7 t70 174.44 -23.85 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.772 -0.649 . . . . 0.85 112.221 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.7 mtt180 -115.96 134.93 54.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.935 0.397 . . . . 0.96 111.602 -173.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.5 ttmt -76.92 123.83 26.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.418 -0.81 . . . . 1.0 109.171 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.53 HG11 HD12 ' A' ' 163' ' ' LEU . 23.2 m -103.05 146.6 10.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.434 0.635 . . . . 0.17 111.528 -174.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 73.5 t80 -107.51 119.26 38.94 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.016 -0.993 . . . . 0.3 109.116 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.649 HG22 HG12 ' A' ' 103' ' ' ILE . 43.0 t -114.82 128.04 72.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.467 -0.568 . . . . 0.13 109.467 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.61 -177.44 22.86 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.365 -0.922 . . . . 0.18 112.714 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.496 ' HE ' ' HA ' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -73.01 133.45 44.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.889 0.376 . . . . 1.93 110.795 -177.086 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.428 ' HE2' ' CD1' ' A' ' 142' ' ' PHE . 17.6 t80 -78.21 91.03 4.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.685 -0.689 . . . . 1.44 110.077 -175.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -92.54 96.52 10.26 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.798 -0.815 . . . . 4.66 108.798 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.405 ' HB3' ' HE1' ' A' ' 173' ' ' PHE . 0.8 OUTLIER -61.8 -42.03 98.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.536 -0.756 . . . . 3.6 111.827 -174.62 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -170.83 -82.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.673 0.273 . . . . 7.6 110.964 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -169.65 72.76 0.08 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.411 -0.589 . . . . 8.61 109.411 -174.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -110.06 148.81 31.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.166 -0.47 . . . . 8.55 110.865 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.549 ' NE ' ' HA ' ' A' ' 179' ' ' ARG . 3.2 mmp_? -76.26 -39.46 54.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.969 -0.56 . . . . 12.18 109.749 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -88.51 101.48 13.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.284 -0.871 . . . . 12.7 109.399 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.739 ' HB1' ' HB3' ' A' ' 95' ' ' LYS . . . -164.43 141.79 6.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.909 -0.587 . . . . 13.65 110.459 -177.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 . . . . . 0 C--O 1.242 0.7 0 CA-C-O 118.122 -0.942 . . . . 15.05 109.797 176.76 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.704 0 N-CA-C 111.933 -0.467 . . . . 14.85 111.933 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.63 -42.56 82.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 13.5 110.999 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.565 ' HB3' ' HE2' ' A' ' 95' ' ' LYS . 2.9 m-20 -123.32 81.46 52.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.131 -0.486 . . . . 11.25 110.335 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -93.83 94.28 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.33 2.687 . . . . 11.14 111.416 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.3 p 46.78 50.33 13.46 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.63 0.729 . . . . 9.3 109.925 -172.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.723 ' HG ' ' HG3' ' A' ' 94' ' ' ARG . 60.8 tp -125.13 121.67 34.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.898 -1.046 . . . . 7.89 111.081 -172.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.723 ' HG3' ' HG ' ' A' ' 93' ' ' LEU . 46.6 mtm180 67.68 21.74 9.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.055 0.542 . . . . 7.78 112.093 173.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.565 ' HE2' ' HB3' ' A' ' 90' ' ' ASP . 35.3 mttm -136.39 171.91 13.79 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.777 -0.369 . . . . 2.37 110.966 -176.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.2 t -120.92 -32.31 4.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.102 0.477 . . . . 1.79 109.875 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.485 ' HA3' ' OD1' ' A' ' 100' ' ' ASN . . . -66.59 -47.2 70.47 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.7 -0.682 . . . . 0.44 112.837 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER 63.88 134.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.353 1.061 . . . . 0.71 111.781 -174.03 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.89 22.71 78.9 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.265 -0.969 . . . . 0.21 111.217 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.485 ' OD1' ' HA3' ' A' ' 97' ' ' GLY . 2.7 m120 -96.18 128.38 43.04 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.14 -0.689 . . . . 0.63 109.14 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.486 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.8 pt -133.31 162.5 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.162 -0.472 . . . . 0.15 109.864 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.24 144.63 50.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.006 0.431 . . . . 0.21 109.908 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.627 HG12 HG22 ' A' ' 170' ' ' VAL . 5.7 mt -119.92 135.49 60.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.588 -0.733 . . . . 0.15 110.071 -177.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -116.66 152.37 34.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.732 -0.213 . . . . 1.46 110.652 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 t30 71.58 40.65 0.78 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.942 0.777 . . . . 0.49 111.79 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.622 HD22 HG21 ' A' ' 110' ' ' ILE . 20.6 mt -78.24 158.55 28.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.389 0.614 . . . . 0.26 111.755 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.477 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 25.1 t70 -81.93 150.76 27.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.359 -0.837 . . . . 0.71 110.916 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -55.72 -36.88 67.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.599 -0.728 . . . . 2.2 112.131 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.6 m -84.02 -3.87 58.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.89 0.33 . . . . 1.41 111.89 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.671 HG22 HG21 ' A' ' 130' ' ' VAL . 27.9 mm -71.87 117.14 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.091 0.472 . . . . 0.26 110.183 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 15.6 t70 -105.64 -171.74 1.96 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.798 -0.815 . . . . 1.59 108.798 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.413 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 87.3 m-20 -72.17 -32.61 67.01 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.319 -0.993 . . . . 0.6 108.319 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.63 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -68.68 -45.05 72.71 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.039 -1.437 . . . . 2.58 109.661 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.76 -44.25 97.26 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.662 -1.608 . . . . 0.15 110.574 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 130' ' ' VAL . 4.1 tt -67.4 -47.19 71.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.165 -0.925 . . . . 0.16 109.378 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.802 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 83.5 t80 -58.98 -45.31 90.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.893 -0.594 . . . . 0.3 111.165 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.85 -40.89 76.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.852 0.358 . . . . 0.4 110.877 -175.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 58.8 m -77.41 -53.71 7.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.238 -0.437 . . . . 0.22 112.136 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.429 ' CD1' HD23 ' A' ' 115' ' ' LEU . 14.1 m-85 -71.59 -28.43 63.81 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.657 0.614 . . . . 0.11 112.657 -173.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -57.75 -28.42 63.91 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.609 0.243 . . . . 0.19 111.078 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.78 -22.68 37.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.804 0.298 . . . . 0.14 111.804 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -91.88 -15.54 27.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.997 0.427 . . . . 0.18 111.038 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.19 166.79 22.6 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.531 -0.628 . . . . 0.11 111.531 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -67.57 139.44 56.91 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.033 0.444 . . . . 0.25 110.201 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.457 HG21 ' HB3' ' A' ' 128' ' ' CYS . 65.9 mt -113.37 133.91 57.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.725 -0.671 . . . . 0.14 109.723 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.615 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -90.37 -43.7 10.15 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.884 -0.784 . . . . 0.54 108.884 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 55.7 m -145.65 99.75 3.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.231 -0.895 . . . . 0.76 110.962 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.802 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.6 p -97.53 145.9 25.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.17 -0.678 . . . . 0.72 109.17 171.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -148.79 134.27 18.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.063 0.459 . . . . 1.0 111.8 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.671 HG21 HG22 ' A' ' 110' ' ' ILE . 99.1 t -114.02 115.07 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 106.587 -1.634 . . . . 0.28 106.587 170.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.2 t -82.72 115.09 24.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.709 -0.848 . . . . 0.34 108.709 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.757 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 58.5 m -104.22 141.09 36.88 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.523 -0.762 . . . . 1.58 111.495 -169.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -85.6 160.9 19.5 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.669 -1.234 . . . . 2.08 107.669 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -64.2 -19.01 65.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 118.681 0.673 . . . . 2.45 110.208 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -92.17 2.32 56.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.94 -0.573 . . . . 1.65 110.686 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 132' ' ' CYS . . . 143.08 -80.19 0.24 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.766 -0.73 . . . . 1.12 113.711 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.757 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 32.5 t -141.94 153.4 44.32 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 117.973 0.886 . . . . 1.61 109.62 -176.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -88.0 -11.19 48.09 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.153 0.502 . . . . 1.51 110.266 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.22 -24.41 22.84 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.455 -0.878 . . . . 0.31 113.35 176.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -123.68 152.84 41.6 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.457 0.646 . . . . 0.49 111.976 -172.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.89 174.36 23.63 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.954 -1.021 . . . . 0.12 111.309 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -138.72 140.99 38.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.01 0.405 . . . . 0.25 110.72 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.486 ' HB ' HG12 ' A' ' 101' ' ' ILE . 43.0 t -115.45 129.17 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 120.946 0.403 . . . . 0.1 110.492 172.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -100.47 105.19 16.62 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.267 -0.642 . . . . 0.21 109.267 167.151 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.555 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 18.8 m-85 -87.25 142.97 27.5 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.078 0.466 . . . . 0.17 110.392 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.615 ' HA ' HD21 ' A' ' 126' ' ' LEU . 35.5 tt0 -52.89 -34.45 54.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.426 -1.261 . . . . 0.57 110.706 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.6 p -129.94 152.38 49.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.348 -0.842 . . . . 0.4 111.277 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -62.18 -36.02 80.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.694 -0.684 . . . . 0.47 111.204 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.26 -35.66 76.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.008 0.373 . . . . 0.74 112.008 -175.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.88 -34.67 78.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 0.18 110.553 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.555 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -65.3 -41.72 93.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.722 -0.672 . . . . 0.16 110.944 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 32.4 mt-10 -59.33 -40.19 85.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 1.42 110.775 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 70.8 mtt180 -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 1.48 111.192 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.68 84.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.438 -0.346 . . . . 0.1 110.451 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.1 mt -62.26 -53.25 49.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.242 -0.435 . . . . 0.15 111.168 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 0.9 OUTLIER -64.27 -41.86 96.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.07 0.462 . . . . 1.08 111.899 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.479 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.23 -38.69 24.14 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.084 0.772 . . . . 1.16 113.084 -171.173 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.462 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.8 mmm -93.81 -20.52 20.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.843 0.683 . . . . 0.35 112.843 -172.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 58.2 t30 -68.5 123.83 21.89 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.965 -0.694 . . . . 0.44 109.495 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.53 17.01 57.78 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.742 -0.742 . . . . 0.29 112.721 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.729 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.4 mmt -100.91 163.4 12.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.675 0.274 . . . . 1.18 111.54 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 mt -104.3 105.21 15.27 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.983 -0.553 . . . . 0.44 109.826 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 163' ' ' LEU . 18.8 mt -93.04 105.97 17.99 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.974 -0.691 . . . . 1.02 109.881 175.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 93.3 m-20 75.09 -51.23 0.67 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.124 -0.944 . . . . 1.71 111.843 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -178.63 22.09 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.88 -0.6 . . . . 0.85 111.729 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.477 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.4 mtt180 -138.76 135.48 34.72 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.681 -0.637 . . . . 0.96 109.957 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.729 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.2 ttmt -83.08 117.68 23.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.479 HG11 HD23 ' A' ' 106' ' ' LEU . 11.5 m -100.52 148.39 6.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.588 0.709 . . . . 0.17 111.448 -171.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 69.2 t80 -106.46 120.61 42.35 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.647 -1.16 . . . . 0.3 109.292 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.627 HG22 HG12 ' A' ' 103' ' ' ILE . 43.2 t -115.65 126.24 73.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.448 -0.575 . . . . 0.13 109.448 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.06 -175.9 21.89 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.745 -0.741 . . . . 0.18 111.548 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -62.24 141.74 58.07 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.3 -0.63 . . . . 1.93 109.3 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -57.88 104.71 0.21 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.591 -0.522 . . . . 1.44 109.591 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -68.13 118.98 11.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.263 0.554 . . . . 4.66 110.956 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.8 m -84.37 91.31 7.76 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.448 -0.796 . . . . 3.6 109.366 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -75.19 149.37 38.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.011 -0.54 . . . . 7.6 111.453 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 177' ' ' LYS . 74.8 tttt -157.86 20.73 0.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.03 -0.729 . . . . 8.61 109.03 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.01 113.36 2.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.259 -0.882 . . . . 8.55 110.864 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.412 ' HB2' ' H ' ' A' ' 180' ' ' GLU . 18.7 mmm180 -102.38 -92.11 0.33 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.039 0.447 . . . . 12.18 109.98 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.412 ' H ' ' HB2' ' A' ' 179' ' ' ARG . 43.1 tt0 -156.38 116.23 3.58 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.582 -0.895 . . . . 12.7 108.582 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 60.51 21.83 11.55 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.313 0.578 . . . . 13.65 110.524 -172.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--O 1.251 1.132 0 CA-C-N 115.407 -0.815 . . . . 15.05 108.994 -178.315 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 112.016 -0.434 . . . . 14.85 112.016 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.449 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -152.13 -178.35 6.73 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.295 -0.261 . . . . 13.5 110.295 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.19 102.57 12.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.264 -0.643 . . . . 11.25 109.264 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 89' ' ' ALA . 34.8 Cg_exo -58.19 -58.92 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.191 2.594 . . . . 11.14 113.29 -172.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.4 m -83.13 12.34 5.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.207 0.447 . . . . 9.3 112.207 -174.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 47.2 tp -107.71 -39.77 5.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.662 0.268 . . . . 7.89 110.52 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.665 ' O ' ' HD2' ' A' ' 95' ' ' LYS . 95.1 mtt180 -69.4 -42.44 75.11 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.37 -0.377 . . . . 7.78 110.345 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.729 ' HE2' ' HB3' ' A' ' 172' ' ' ARG . 0.5 OUTLIER -151.22 174.51 13.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.061 -0.348 . . . . 2.37 110.061 173.609 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 98' ' ' VAL . 18.0 m -99.92 158.83 15.53 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.183 -1.043 . . . . 1.79 108.183 174.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.9 -26.17 1.75 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.38 -0.914 . . . . 0.44 111.738 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.465 ' H ' ' C ' ' A' ' 96' ' ' SER . 78.9 t 63.87 126.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.328 1.051 . . . . 0.71 112.25 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.437 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 72.8 24.05 76.78 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 119.974 -1.107 . . . . 0.21 111.605 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -88.74 125.96 35.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.273 -0.64 . . . . 0.63 109.273 -174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.596 HG23 ' HB1' ' A' ' 151' ' ' ALA . 21.6 pt -135.46 161.43 39.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.989 -0.374 . . . . 0.15 109.989 175.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.23 137.87 54.11 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.88 -0.415 . . . . 0.21 109.88 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.56 HG12 HG22 ' A' ' 170' ' ' VAL . 5.1 mt -115.21 135.05 56.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.612 -0.722 . . . . 0.15 110.013 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -117.12 152.95 33.65 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.292 -0.262 . . . . 1.46 110.292 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.3 t30 74.89 35.1 0.65 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.818 0.699 . . . . 0.49 111.474 171.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.433 HD22 HG21 ' A' ' 110' ' ' ILE . 30.7 mt -79.79 159.54 26.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.12 0.486 . . . . 0.26 111.185 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -92.66 150.71 20.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.596 -0.729 . . . . 0.71 110.414 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.566 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 65.2 pttt -52.1 -31.98 33.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.758 -0.656 . . . . 2.2 112.213 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.5 m -71.78 -17.32 62.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.096 0.406 . . . . 1.41 112.096 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.575 HG22 HG21 ' A' ' 130' ' ' VAL . 28.5 mm -71.43 123.52 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.251 0.548 . . . . 0.26 110.835 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.473 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 26.5 t70 -107.87 -177.98 3.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.279 -0.873 . . . . 1.59 109.056 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -69.61 -35.09 74.96 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.344 -0.984 . . . . 0.6 108.344 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -45.66 71.68 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.628 -1.169 . . . . 2.58 109.052 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.473 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -60.75 -40.24 91.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.006 -1.452 . . . . 0.15 110.669 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.589 HD12 HG22 ' A' ' 130' ' ' VAL . 3.8 tt -68.87 -47.02 66.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.199 -0.91 . . . . 0.16 109.231 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.727 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 65.6 t80 -60.64 -45.1 95.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.3 111.132 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -56.8 -40.61 76.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.03 0.443 . . . . 0.4 110.543 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.575 HG21 HD21 ' A' ' 163' ' ' LEU . 20.4 m -77.52 -53.81 7.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.747 -0.661 . . . . 0.22 111.822 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.411 ' CD1' HD23 ' A' ' 115' ' ' LEU . 11.1 m-85 -72.48 -28.16 62.73 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.743 0.646 . . . . 0.11 112.743 -174.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.6 t -57.57 -29.05 64.12 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.58 0.229 . . . . 0.19 111.207 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.35 39.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.928 0.394 . . . . 0.14 111.716 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -92.83 -14.83 27.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.414 -0.357 . . . . 0.18 111.019 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.5 169.83 26.43 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.624 -0.59 . . . . 0.11 111.624 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -73.15 138.65 45.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.108 0.48 . . . . 0.25 110.247 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.406 HG21 ' HB3' ' A' ' 128' ' ' CYS . 69.2 mt -111.03 132.09 60.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.718 -0.673 . . . . 0.14 110.038 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.602 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -84.57 -43.27 14.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.569 -0.9 . . . . 0.54 108.569 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.3 m -146.5 131.78 18.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.819 -1.082 . . . . 0.76 110.255 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.727 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.5 p -128.69 134.67 48.56 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.117 -0.698 . . . . 0.72 109.117 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -133.76 133.33 41.6 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.586 -0.446 . . . . 1.0 111.776 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.589 HG22 HD12 ' A' ' 115' ' ' LEU . 83.9 t -114.56 110.44 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 107.012 -1.477 . . . . 0.28 107.012 170.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 t -79.6 116.35 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.971 -0.752 . . . . 0.34 108.971 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.791 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 61.7 m -106.85 135.94 47.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.723 -0.671 . . . . 1.58 112.567 -164.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.41 ' H ' ' CA ' ' A' ' 137' ' ' SER . 26.8 t70 -86.35 164.69 16.91 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.063 -0.971 . . . . 2.08 108.733 172.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -61.66 -22.54 65.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.039 0.447 . . . . 2.45 110.544 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -88.09 -2.68 58.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.898 -0.592 . . . . 1.65 110.491 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.566 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 140.34 -68.95 0.47 Allowed Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.728 -0.749 . . . . 1.12 113.249 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.791 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 38.4 t -144.51 153.3 41.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.436 0.618 . . . . 1.61 110.493 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 35.2 mtpt -84.32 -10.13 57.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.159 0.504 . . . . 1.51 109.683 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 105.5 -10.35 45.99 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.286 -0.959 . . . . 0.31 113.527 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 29.9 p90 -132.79 150.75 52.12 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.359 0.6 . . . . 0.49 111.854 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.22 167.14 26.18 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.036 -0.984 . . . . 0.12 111.341 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -133.99 136.97 44.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.937 0.368 . . . . 0.25 110.738 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.54 ' HB ' HG12 ' A' ' 101' ' ' ILE . 42.7 t -110.79 136.16 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.1 110.644 174.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -105.95 105.37 15.38 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.774 -0.824 . . . . 0.21 108.774 166.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.576 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 17.8 m-85 -88.71 140.8 29.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.099 0.476 . . . . 0.17 110.732 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.602 ' HA ' HD21 ' A' ' 126' ' ' LEU . 34.7 tt0 -51.7 -41.33 61.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.749 -1.114 . . . . 0.57 110.361 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 78.2 p -115.24 150.52 36.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.701 -1.136 . . . . 0.4 110.157 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -65.65 -36.12 82.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.132 -0.485 . . . . 0.47 110.593 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 12.5 pt-20 -69.04 -35.0 76.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.74 111.828 -176.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.29 79.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.067 0.46 . . . . 0.18 110.639 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.596 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -64.02 -46.31 85.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.705 -0.68 . . . . 0.16 110.507 177.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 42.7 mt-10 -61.74 -34.55 76.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.328 -0.851 . . . . 1.42 110.91 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 95.9 mtt180 -61.82 -47.63 84.21 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.106 0.479 . . . . 1.48 110.543 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.8 -35.8 77.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.86 -0.609 . . . . 0.1 110.587 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.5 mt -60.61 -54.41 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.15 111.225 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 0.8 OUTLIER -64.04 -42.44 97.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.53 . . . . 1.08 111.768 -177.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -37.97 31.88 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.486 -0.779 . . . . 1.16 112.819 -170.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.468 ' HB2' HG21 ' A' ' 170' ' ' VAL . 91.9 mmm -96.41 -16.93 20.95 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.818 0.673 . . . . 0.35 112.818 -173.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -70.0 124.04 23.05 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.09 -0.644 . . . . 0.44 109.882 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.19 15.56 74.13 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.166 -0.47 . . . . 0.29 112.088 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.484 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 11.7 tpp -99.91 157.6 16.41 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.065 -0.346 . . . . 1.18 110.065 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.0 mt -96.94 110.92 23.34 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 109.349 -0.612 . . . . 0.44 109.349 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.575 HD21 HG21 ' A' ' 118' ' ' THR . 20.8 mt -98.02 105.18 17.29 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.981 -0.687 . . . . 1.02 109.539 173.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 61.3 m-20 77.11 -29.62 0.17 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.22 -0.9 . . . . 1.71 112.681 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 21.1 t70 168.19 -22.18 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.701 0.625 . . . . 0.85 111.864 -170.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 80.5 mtt-85 -113.3 137.78 50.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.867 0.365 . . . . 0.96 111.118 -170.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 161' ' ' MET . 8.0 tttm -81.5 112.96 19.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.307 -177.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.412 HG11 HD23 ' A' ' 106' ' ' LEU . 16.0 m -100.15 148.48 6.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.599 0.714 . . . . 0.17 111.245 -172.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 68.3 t80 -106.68 119.49 39.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.726 -1.124 . . . . 0.3 109.384 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.56 HG22 HG12 ' A' ' 103' ' ' ILE . 40.1 t -114.57 125.46 71.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.983 -0.747 . . . . 0.13 108.983 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -144.41 -171.68 14.52 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.577 -0.821 . . . . 0.18 112.095 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.729 ' HB3' ' HE2' ' A' ' 95' ' ' LYS . 20.0 mmt180 -70.47 122.4 19.6 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.879 -0.415 . . . . 1.93 109.879 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.578 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 56.1 t80 -59.85 127.9 34.25 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.809 -0.441 . . . . 1.44 109.809 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -74.49 89.15 2.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.229 0.538 . . . . 4.66 110.734 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.2 m -98.12 29.38 3.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.188 -0.915 . . . . 3.6 109.895 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -76.83 81.49 3.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.86 -0.609 . . . . 7.6 110.739 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.78 ' HA ' ' HE2' ' A' ' 177' ' ' LYS . 0.6 OUTLIER -90.27 2.95 54.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.878 -0.601 . . . . 8.61 109.461 176.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -164.64 160.17 19.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.558 -0.746 . . . . 8.55 109.772 -174.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -58.66 -35.42 72.54 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.947 0.351 . . . . 12.18 111.947 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -85.56 12.97 7.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.995 0.426 . . . . 12.7 111.397 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -111.61 61.19 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.624 -0.51 . . . . 13.65 109.624 173.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.56 -0.733 . . . . 15.05 110.813 -175.463 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 111.66 -0.576 . . . . 14.85 111.66 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.62 165.92 16.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.795 0.331 . . . . 13.5 110.888 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -117.57 102.04 52.08 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.957 0.408 . . . . 11.25 110.03 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.09 -30.04 89.05 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.878 2.386 . . . . 11.14 112.553 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.65 ' HA ' ' HD3' ' A' ' 95' ' ' LYS . 24.6 m -61.35 -23.53 65.81 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.267 0.469 . . . . 9.3 112.267 -177.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.49 -18.83 65.62 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.026 0.441 . . . . 7.89 110.943 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 94' ' ' ARG . 9.5 mpt_? -88.54 -5.27 58.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.215 0.531 . . . . 7.78 110.193 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.65 ' HD3' ' HA ' ' A' ' 92' ' ' SER . 2.3 mptp? -112.27 70.6 0.72 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.75 -0.834 . . . . 2.37 108.75 175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.8 t -62.05 -12.3 18.31 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.09 0.404 . . . . 1.79 112.09 -175.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.637 ' CA ' HD22 ' A' ' 100' ' ' ASN . . . -69.94 -20.74 76.41 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.819 -0.705 . . . . 0.44 111.845 175.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.4 t 64.32 122.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.032 0.933 . . . . 0.71 112.505 -176.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.69 24.18 73.13 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.384 -0.912 . . . . 0.21 112.117 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.637 HD22 ' CA ' ' A' ' 97' ' ' GLY . 3.8 m-20 -86.88 124.26 32.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.445 -0.576 . . . . 0.63 109.445 -174.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.493 HG12 ' HB ' ' A' ' 143' ' ' VAL . 20.2 pt -135.67 161.88 37.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.995 -0.548 . . . . 0.15 109.803 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.42 144.11 50.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.864 -0.421 . . . . 0.21 109.864 176.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.615 HG12 HG22 ' A' ' 170' ' ' VAL . 4.5 mt -118.82 130.99 72.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.613 -0.721 . . . . 0.15 110.166 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -109.65 152.25 25.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.587 -0.278 . . . . 1.46 110.702 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.6 t30 72.14 33.65 1.55 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.926 0.766 . . . . 0.49 111.861 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.453 HD23 HG11 ' A' ' 168' ' ' VAL . 17.3 mt -72.64 155.39 40.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.063 0.459 . . . . 0.26 111.446 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.486 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 23.3 t70 -75.25 146.91 40.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.732 -0.667 . . . . 0.71 109.832 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -60.47 -31.72 70.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.108 -0.496 . . . . 2.2 111.796 -176.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t -79.04 -4.29 49.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.575 -0.284 . . . . 1.41 111.499 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.467 HG12 ' HB3' ' A' ' 107' ' ' ASP . 32.0 mm -73.03 127.14 34.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.419 . . . . 0.26 110.393 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.503 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 10.5 t70 -110.89 -177.15 3.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.748 -0.66 . . . . 1.59 109.28 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.6 ' OD1' ' HA ' ' A' ' 129' ' ' LYS . 69.1 m-80 -72.06 -32.08 66.73 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.565 -0.902 . . . . 0.6 108.565 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -47.95 74.35 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.675 -1.148 . . . . 2.58 108.797 176.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.503 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.63 -43.57 98.6 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.039 -1.437 . . . . 0.15 111.103 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.523 HD12 HG22 ' A' ' 130' ' ' VAL . 3.2 tt -66.54 -46.58 75.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.478 -0.783 . . . . 0.16 109.27 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.432 ' CE1' ' HB ' ' A' ' 125' ' ' ILE . 62.3 t80 -60.52 -46.35 90.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.3 110.658 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -56.55 -39.49 73.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.858 0.361 . . . . 0.4 111.044 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 m -78.1 -54.02 6.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.001 -0.545 . . . . 0.22 112.087 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.401 ' CD1' HD23 ' A' ' 115' ' ' LEU . 9.2 m-85 -72.15 -28.39 63.21 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.683 0.623 . . . . 0.11 112.683 -173.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.8 t -57.67 -28.46 63.78 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.826 0.346 . . . . 0.19 110.809 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.4 36.01 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.227 -0.442 . . . . 0.14 111.637 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -89.74 -31.99 17.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.984 0.421 . . . . 0.18 110.723 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.49 165.41 34.08 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.392 -0.683 . . . . 0.11 111.392 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -62.19 140.84 58.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.971 0.415 . . . . 0.25 109.972 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.753 HD13 ' SG ' ' A' ' 128' ' ' CYS . 94.8 mt -114.34 133.96 58.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.937 -0.574 . . . . 0.14 110.637 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.539 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -91.05 -37.12 13.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.076 -0.712 . . . . 0.54 109.076 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 70.5 m -159.54 111.11 2.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.529 -0.759 . . . . 0.76 111.227 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.794 ' SG ' HG13 ' A' ' 143' ' ' VAL . 54.2 m -109.12 144.9 36.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.527 -0.546 . . . . 0.72 109.527 169.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.6 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 53.1 tptt -135.62 131.96 36.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.416 -175.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 115' ' ' LEU . 88.5 t -114.19 110.13 31.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 106.539 -1.652 . . . . 0.28 106.539 168.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.448 HG12 ' HG3' ' A' ' 138' ' ' LYS . 15.9 t -79.3 135.9 24.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.55 -0.75 . . . . 0.34 109.976 -171.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.412 ' C ' ' HG2' ' A' ' 138' ' ' LYS . 6.6 p -95.43 134.14 38.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.626 0.726 . . . . 1.58 111.629 -169.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.553 ' HB2' ' HA ' ' A' ' 138' ' ' LYS . 17.0 t70 -87.92 165.92 14.9 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.716 -1.129 . . . . 2.08 108.842 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.0 -26.36 64.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.261 0.553 . . . . 2.45 109.702 171.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -93.27 4.5 53.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.614 -0.721 . . . . 1.65 110.902 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.39 -61.9 0.62 Allowed Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.363 -0.922 . . . . 1.12 113.938 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.481 ' C ' ' HB2' ' A' ' 133' ' ' ASP . 68.3 m -137.89 129.65 28.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 117.352 0.576 . . . . 1.61 111.349 -173.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.553 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 18.0 mmmt -66.67 -35.51 80.31 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.086 0.47 . . . . 1.51 112.045 -172.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.2 -13.22 10.4 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.466 -0.874 . . . . 0.31 113.114 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.522 ' OH ' ' HE2' ' A' ' 138' ' ' LYS . 25.6 p90 -132.34 153.44 50.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.835 0.35 . . . . 0.49 110.907 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.7 173.35 24.02 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.87 -0.605 . . . . 0.12 111.898 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -135.59 143.99 45.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.731 0.265 . . . . 0.25 110.722 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.794 HG13 ' SG ' ' A' ' 128' ' ' CYS . 40.1 t -118.58 136.45 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.1 111.142 173.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.1 OUTLIER -106.46 106.38 16.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.19 -0.67 . . . . 0.21 109.19 166.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.575 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.5 m-85 -89.4 137.61 32.17 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.329 0.585 . . . . 0.17 111.354 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.539 ' HA ' HD21 ' A' ' 126' ' ' LEU . 43.7 tt0 -47.86 -40.25 20.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.19 -1.368 . . . . 0.57 110.951 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.1 p -120.3 153.0 37.01 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.276 -0.875 . . . . 0.4 110.914 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -67.35 -34.95 78.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 0.47 110.453 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 12.1 pt-20 -70.04 -34.74 73.64 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.261 -0.427 . . . . 0.74 111.737 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.05 -34.84 77.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.998 0.427 . . . . 0.18 110.649 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.575 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.82 -46.5 84.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.681 -0.691 . . . . 0.16 110.717 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 40.3 mt-10 -59.18 -37.7 78.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.781 -0.645 . . . . 1.42 111.003 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 86.6 mtt180 -59.58 -44.89 93.2 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.983 0.42 . . . . 1.48 110.54 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.79 85.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.984 -0.553 . . . . 0.1 110.452 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 151' ' ' ALA . 78.1 mt -62.76 -54.17 37.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.209 -0.45 . . . . 0.15 111.063 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.3 pt-20 -60.59 -44.04 96.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 1.08 111.613 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.427 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -82.04 -39.42 23.52 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.211 0.819 . . . . 1.16 113.211 -170.475 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 95.4 mmm -92.61 -23.33 19.05 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.618 0.599 . . . . 0.35 112.618 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 54.9 t30 -66.85 123.49 20.31 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.225 -0.59 . . . . 0.44 109.695 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.84 8.57 69.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.912 -0.661 . . . . 0.29 112.626 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 29.2 mmt -96.53 170.75 9.0 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 120.886 0.374 . . . . 1.18 111.541 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 33.3 mt -105.22 126.79 52.48 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.571 -0.74 . . . . 0.44 109.377 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 11.5 mt -109.92 108.07 18.22 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.916 -0.772 . . . . 1.02 108.916 168.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 4.7 m-20 78.83 -33.75 0.16 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.166 0.916 . . . . 1.71 111.817 176.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 33.4 t70 168.77 -20.87 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.13 -0.941 . . . . 0.85 111.754 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.486 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 97.6 mtt180 -100.9 138.67 37.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.714 -0.221 . . . . 0.96 110.504 -174.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 161' ' ' MET . 3.5 ttmp? -83.96 120.6 26.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.453 HG11 HD23 ' A' ' 106' ' ' LEU . 17.1 m -102.64 148.98 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.579 0.704 . . . . 0.17 111.615 -174.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 58.4 t80 -107.84 122.42 46.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.862 -1.063 . . . . 0.3 109.101 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.615 HG22 HG12 ' A' ' 103' ' ' ILE . 47.1 t -115.14 125.42 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.205 -0.665 . . . . 0.13 109.205 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -146.83 -171.46 16.12 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.573 -0.822 . . . . 0.18 111.984 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -68.64 136.14 52.51 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.741 -0.466 . . . . 1.93 109.741 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.591 ' HE1' ' HB3' ' A' ' 176' ' ' ARG . 4.2 t80 -60.06 103.52 0.23 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.407 -0.36 . . . . 1.44 110.624 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -124.95 10.46 8.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.16 -0.473 . . . . 4.66 110.212 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.2 m -115.67 89.29 3.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.076 -0.511 . . . . 3.6 111.597 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.591 ' HB3' ' HE1' ' A' ' 173' ' ' PHE . 5.8 ptp180 -133.58 154.69 50.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.07 -0.513 . . . . 7.6 110.272 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -120.81 -39.01 2.77 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.898 -0.779 . . . . 8.61 108.898 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -137.5 158.42 44.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.835 -1.075 . . . . 8.55 108.102 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -103.14 65.29 0.86 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.255 -0.578 . . . . 12.18 112.013 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.58 158.48 23.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.665 -0.865 . . . . 12.7 108.665 169.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 63.64 24.88 14.11 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.078 0.466 . . . . 13.65 111.101 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.611 -0.709 . . . . 15.05 109.175 178.657 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 112.089 -0.404 . . . . 14.85 112.089 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.03 24.73 5.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.561 0.696 . . . . 13.5 110.011 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.607 ' HB2' ' HG ' ' A' ' 93' ' ' LEU . 12.8 p-10 -102.15 129.1 26.99 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.369 -0.832 . . . . 11.25 111.149 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 8.0 Cg_exo -73.55 -66.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.36 2.04 . . . . 11.14 110.372 170.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 56.2 m -156.68 90.23 1.15 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.53 -0.759 . . . . 9.3 109.34 172.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.607 ' HG ' ' HB2' ' A' ' 90' ' ' ASP . 84.4 mt -77.53 128.61 34.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.491 -0.322 . . . . 7.89 110.155 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.69 ' HD2' ' HG3' ' A' ' 177' ' ' LYS . 90.0 mtt-85 -107.57 28.73 7.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.41 0.624 . . . . 7.78 110.258 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.411 ' HE2' HD22 ' A' ' 93' ' ' LEU . 1.8 mptp? -78.98 80.38 5.32 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.402 -0.962 . . . . 2.37 108.402 170.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.8 m -61.11 -18.09 56.14 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.943 0.72 . . . . 1.79 112.943 -171.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.672 ' HA3' HD22 ' A' ' 100' ' ' ASN . . . -68.99 -26.24 74.84 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.364 -0.922 . . . . 0.44 111.79 175.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t 65.87 125.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.673 0.789 . . . . 0.71 112.22 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.23 23.99 77.11 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.809 -1.186 . . . . 0.21 111.48 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.672 HD22 ' HA3' ' A' ' 97' ' ' GLY . 11.4 m-20 -88.27 125.96 34.92 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.982 -0.747 . . . . 0.63 108.982 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.527 HG23 ' HB1' ' A' ' 151' ' ' ALA . 22.8 pt -135.4 162.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.096 -0.335 . . . . 0.15 110.096 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.81 140.55 52.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.93 0.395 . . . . 0.21 109.991 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 170' ' ' VAL . 5.8 mt -115.19 141.16 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.626 -0.715 . . . . 0.15 110.033 -177.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 3.0 ttpm? -123.02 148.78 45.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.901 -0.136 . . . . 1.46 110.709 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.9 t30 72.43 48.36 0.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.664 0.786 . . . . 0.49 111.856 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.544 HD22 HG21 ' A' ' 110' ' ' ILE . 32.3 mt -90.01 160.85 16.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.249 -0.432 . . . . 0.26 110.765 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -93.9 155.57 17.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.71 109.988 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.58 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 43.2 pttt -59.93 -28.01 67.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.428 -0.351 . . . . 2.2 111.82 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -72.64 -8.47 55.46 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.85 0.315 . . . . 1.41 111.85 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.613 HG22 HG21 ' A' ' 130' ' ' VAL . 30.9 mm -83.83 117.66 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.417 . . . . 0.26 110.353 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -108.96 -175.62 2.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.397 -0.964 . . . . 1.59 108.397 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -67.09 -30.37 70.38 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.947 -0.76 . . . . 0.6 108.947 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -49.54 60.32 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.432 -1.258 . . . . 2.58 109.457 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.71 -39.69 92.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.369 -1.287 . . . . 0.15 110.628 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 130' ' ' VAL . 3.6 tt -67.44 -47.5 70.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.322 -0.854 . . . . 0.16 109.113 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.711 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 61.3 t80 -59.52 -46.43 88.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.919 -0.582 . . . . 0.3 110.775 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -56.09 -39.14 71.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.282 -0.417 . . . . 0.4 111.137 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.655 HG21 HD21 ' A' ' 163' ' ' LEU . 26.4 m -78.54 -54.25 6.35 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.436 0.532 . . . . 0.22 112.436 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.413 ' CD1' HD23 ' A' ' 115' ' ' LEU . 14.0 m-85 -73.0 -27.2 61.64 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.093 0.775 . . . . 0.11 113.093 -173.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.3 t -56.13 -28.84 59.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.818 0.303 . . . . 0.19 111.818 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.02 37.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.887 0.328 . . . . 0.14 111.887 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -92.2 -12.86 31.61 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.538 0.199 . . . . 0.18 111.538 -176.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.2 172.93 28.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.075 -0.583 . . . . 0.11 111.646 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -71.84 138.78 48.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.06 0.457 . . . . 0.25 110.408 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.424 HG21 ' HB3' ' A' ' 128' ' ' CYS . 72.7 mt -111.92 129.25 67.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.79 -0.641 . . . . 0.14 109.862 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.709 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.89 -39.63 15.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.53 0.681 . . . . 0.54 109.188 -178.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 50.8 m -151.58 105.06 3.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.286 -0.87 . . . . 0.76 111.034 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.711 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 4.6 p -104.1 142.04 35.17 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.35 -0.611 . . . . 0.72 109.35 174.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -143.59 130.94 20.92 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.432 -0.507 . . . . 1.0 112.038 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.703 HG22 HD12 ' A' ' 115' ' ' LEU . 57.8 t -114.26 110.66 32.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 106.808 -1.553 . . . . 0.28 106.808 170.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t -76.4 120.61 26.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.729 -0.669 . . . . 0.34 109.324 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 16.6 p -97.17 134.47 40.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.79 0.805 . . . . 1.58 112.926 -165.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -87.28 167.26 14.24 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.618 -1.174 . . . . 2.08 108.134 174.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -58.45 -25.67 62.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.039 0.447 . . . . 2.45 110.088 172.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -92.13 -1.86 56.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.716 -0.675 . . . . 1.65 111.112 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 137.59 -67.09 0.53 Allowed Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.304 -0.951 . . . . 1.12 113.651 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.664 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 47.3 t -142.45 148.53 37.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.496 0.648 . . . . 1.61 110.767 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -83.02 -5.95 59.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.355 0.597 . . . . 1.51 110.435 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.42 -21.12 29.13 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.394 -0.907 . . . . 0.31 113.572 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -128.56 151.88 48.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 117.32 0.56 . . . . 0.49 111.582 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.42 172.14 24.0 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.375 -0.83 . . . . 0.12 111.616 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.488 ' CD1' ' HE2' ' A' ' 173' ' ' PHE . 34.5 m-85 -135.73 138.17 42.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.995 0.398 . . . . 0.25 110.923 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.525 ' HB ' HG12 ' A' ' 101' ' ' ILE . 47.1 t -110.33 133.89 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 120.985 0.421 . . . . 0.1 110.686 172.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.5 OUTLIER -104.22 105.23 15.31 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.964 -0.754 . . . . 0.21 108.964 167.405 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.524 ' CE2' HG11 ' A' ' 143' ' ' VAL . 14.4 m-85 -89.8 139.53 30.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.048 0.452 . . . . 0.17 110.693 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.709 ' HA ' HD21 ' A' ' 126' ' ' LEU . 33.2 tt0 -52.3 -44.06 64.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.749 -1.114 . . . . 0.57 110.214 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 63.4 p -111.78 150.47 30.26 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.666 -1.152 . . . . 0.4 110.837 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -68.42 -35.55 77.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.968 -0.56 . . . . 0.47 110.572 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.2 pt-20 -69.33 -34.34 74.5 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.237 -0.438 . . . . 0.74 111.799 -176.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.89 79.45 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.115 0.483 . . . . 0.18 110.59 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.527 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -62.64 -45.54 92.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.485 -0.779 . . . . 0.16 110.845 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.0 mt-10 -59.06 -37.4 76.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.95 -0.568 . . . . 1.42 110.778 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.486 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.3 mtt180 -62.4 -45.59 92.43 Favored 'General case' 0 CA--C 1.523 -0.064 0 CA-C-O 120.986 0.422 . . . . 1.48 110.411 176.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.15 80.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.513 . . . . 0.1 110.517 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 151' ' ' ALA . 89.4 mt -61.68 -54.47 34.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.066 -0.515 . . . . 0.15 111.324 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.1 pt-20 -64.35 -43.16 95.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.329 0.585 . . . . 1.08 111.98 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -78.98 -38.42 36.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.23 -0.895 . . . . 1.16 112.773 -169.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.0 mmm -93.1 -24.21 18.35 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.47 0.545 . . . . 0.35 112.47 -175.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -64.75 123.74 20.14 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.464 -0.494 . . . . 0.44 109.811 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.24 14.75 61.69 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.869 -0.681 . . . . 0.29 112.909 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.597 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.6 mmt -106.83 162.65 13.61 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.523 -0.398 . . . . 1.18 111.792 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.9 mt -98.78 108.76 21.53 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.863 -0.608 . . . . 0.44 109.7 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 118' ' ' THR . 17.3 mt -93.98 110.02 21.72 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.824 -0.751 . . . . 1.02 109.114 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 91.7 m-20 73.01 -67.62 0.26 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.323 -0.853 . . . . 1.71 110.919 -175.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -161.79 14.54 0.09 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.854 -0.612 . . . . 0.85 111.491 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -131.34 133.2 45.09 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.813 -0.554 . . . . 0.96 109.889 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 161' ' ' MET . 17.6 ttmt -78.64 119.47 21.95 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 18.9 m -101.57 141.98 17.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.348 0.594 . . . . 0.17 111.183 -173.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -106.74 121.85 45.2 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.07 -0.968 . . . . 0.3 109.406 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.508 HG22 HG12 ' A' ' 103' ' ' ILE . 37.7 t -116.07 125.98 73.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.549 -0.537 . . . . 0.13 109.549 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -140.05 -165.96 10.48 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.651 -0.785 . . . . 0.18 112.02 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -77.26 137.81 39.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.834 -0.432 . . . . 1.93 109.834 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.488 ' HE2' ' CD1' ' A' ' 142' ' ' PHE . 40.3 t80 -75.85 132.04 40.1 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.425 -0.583 . . . . 1.44 109.425 -178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.452 ' NZ ' ' HB3' ' A' ' 174' ' ' LYS . 7.2 mtpm? -53.78 -52.12 61.24 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.373 0.421 . . . . 4.66 111.815 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.1 t 72.25 166.95 0.31 Allowed 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.876 0.735 . . . . 3.6 110.051 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 177' ' ' LYS . 34.4 mmt180 -81.72 -41.06 21.82 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.087 -0.338 . . . . 7.6 110.087 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.69 ' HG3' ' HD2' ' A' ' 94' ' ' ARG . 29.5 tttm 74.17 -37.96 0.38 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.516 0.51 . . . . 8.61 112.181 175.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -75.15 29.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.013 0.435 . . . . 8.55 111.471 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 177' ' ' LYS . 22.3 ttt180 -89.57 -11.19 43.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.713 0.768 . . . . 12.18 108.954 173.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.412 ' HG3' HH11 ' A' ' 94' ' ' ARG . 7.2 pt-20 -164.36 106.63 0.89 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.821 -1.081 . . . . 12.7 109.47 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -81.86 120.04 24.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.975 -0.557 . . . . 13.65 111.857 -172.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.528 ' HB3' ' NH2' ' A' ' 94' ' ' ARG . 10.3 tp10 . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.305 -0.855 . . . . 15.05 109.457 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.828 0 N-CA-C 112.087 -0.405 . . . . 14.85 112.087 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.78 61.54 5.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.382 0.611 . . . . 13.5 109.895 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -159.02 146.19 13.02 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.224 -0.898 . . . . 11.25 109.332 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -62.2 -62.93 0.1 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.165 1.91 . . . . 11.14 111.888 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.65 ' HB3' ' O ' ' A' ' 175' ' ' SER . 68.4 m -146.1 47.04 1.24 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.995 0.369 . . . . 9.3 111.995 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.7 mt -101.57 21.22 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.133 -0.355 . . . . 7.89 110.98 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.413 ' HB3' ' CE1' ' A' ' 173' ' ' PHE . 10.8 mpt_? -65.29 -11.94 46.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.762 0.315 . . . . 7.78 111.089 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.519 ' HB2' ' OG ' ' A' ' 175' ' ' SER . 89.2 tttt -89.71 -13.32 37.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.24 -0.436 . . . . 2.37 110.541 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.6 t -84.72 21.31 1.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.289 0.566 . . . . 1.79 110.948 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.678 ' HA3' HD22 ' A' ' 100' ' ' ASN . . . -84.42 2.63 87.72 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.797 -0.716 . . . . 0.44 111.442 174.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.8 t 64.62 119.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.802 0.841 . . . . 0.71 112.008 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.36 25.51 65.7 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.057 -1.068 . . . . 0.21 112.063 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.678 HD22 ' HA3' ' A' ' 97' ' ' GLY . 11.8 m-20 -89.03 123.84 33.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.232 -0.655 . . . . 0.63 109.232 -172.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.565 HG12 ' HB ' ' A' ' 143' ' ' VAL . 17.3 pt -136.43 164.44 31.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.445 -0.343 . . . . 0.15 110.301 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.55 147.81 49.81 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.925 -0.398 . . . . 0.21 109.925 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.596 HG12 HG22 ' A' ' 170' ' ' VAL . 5.3 mt -122.18 137.37 55.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.786 -0.643 . . . . 0.15 110.195 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -116.62 151.15 36.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.745 -0.207 . . . . 1.46 110.739 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 t30 73.97 38.4 0.58 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.938 0.774 . . . . 0.49 111.543 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.496 HD23 HG11 ' A' ' 168' ' ' VAL . 23.2 mt -77.97 158.16 29.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.118 0.485 . . . . 0.26 111.399 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 20.5 t70 -84.91 151.11 24.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.491 -0.777 . . . . 0.71 110.561 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.715 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 14.1 pttm -58.52 -29.99 66.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.751 -0.658 . . . . 2.2 112.681 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.5 m -82.84 -3.92 57.4 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.168 0.433 . . . . 1.41 112.168 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.587 HG22 HG21 ' A' ' 130' ' ' VAL . 31.5 mm -73.97 127.44 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.135 0.493 . . . . 0.26 110.905 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.7 -178.06 3.3 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.049 -0.723 . . . . 1.59 109.049 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.95 -32.43 69.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.889 -0.782 . . . . 0.6 108.889 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -47.59 72.15 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.802 -1.09 . . . . 2.58 109.01 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.72 -44.16 97.45 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 114.029 -1.441 . . . . 0.15 110.904 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.731 HD12 HG22 ' A' ' 130' ' ' VAL . 3.8 tt -65.07 -46.63 80.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.985 -0.746 . . . . 0.16 108.985 177.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.635 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 52.7 t80 -59.81 -49.63 76.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.859 -0.61 . . . . 0.3 110.911 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -57.46 -38.69 74.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.394 . . . . 0.4 110.774 -174.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.2 m -76.76 -53.65 7.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.881 -0.6 . . . . 0.22 111.507 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.88 -28.24 63.39 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.241 0.459 . . . . 0.11 112.241 -175.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 33.7 t -57.62 -29.09 64.25 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.305 0.242 . . . . 0.19 111.314 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.55 -22.21 43.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.798 0.332 . . . . 0.14 111.475 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.422 ' CE2' ' HG2' ' A' ' 158' ' ' MET . 22.4 m-85 -90.3 -20.36 23.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.189 0.518 . . . . 0.18 110.437 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 165.87 162.21 16.66 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.855 -0.898 . . . . 0.11 110.855 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.06 142.98 58.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.192 0.52 . . . . 0.25 110.03 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.46 ' HB ' ' CD2' ' A' ' 116' ' ' TYR . 76.5 mt -113.44 134.42 56.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.791 -0.641 . . . . 0.14 110.014 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.525 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.78 -48.25 7.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.881 -0.785 . . . . 0.54 108.881 -178.24 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.2 m -143.86 102.43 3.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.062 -0.972 . . . . 0.76 110.749 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.5 p -102.12 150.91 22.78 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.729 -0.471 . . . . 0.72 109.729 174.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -149.81 131.95 15.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.132 0.491 . . . . 1.0 111.304 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.731 HG22 HD12 ' A' ' 115' ' ' LEU . 59.6 t -114.66 110.19 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.868 -1.53 . . . . 0.28 106.868 171.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.4 t -77.43 116.53 20.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 109.097 -0.705 . . . . 0.34 109.097 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.78 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 25.4 p -100.86 136.39 40.79 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.015 0.746 . . . . 1.58 113.015 -163.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -86.63 165.42 16.16 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.843 -1.169 . . . . 2.08 107.843 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.0 pm0 -64.47 -21.87 66.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 118.555 0.616 . . . . 2.45 110.242 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -90.49 -0.3 57.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.978 -0.555 . . . . 1.65 110.71 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.715 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 142.66 -73.41 0.36 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.739 -0.743 . . . . 1.12 113.062 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.78 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 32.2 t -142.08 150.97 41.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.421 0.611 . . . . 1.61 109.965 -177.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -81.9 -10.4 59.3 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.121 0.486 . . . . 1.51 110.041 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.81 -14.19 34.74 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.397 -0.906 . . . . 0.31 113.365 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 25.7 p90 -130.04 148.13 51.86 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.485 0.643 . . . . 0.49 111.868 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.55 174.5 23.41 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.154 -0.93 . . . . 0.12 111.379 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -138.86 143.68 38.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.864 0.332 . . . . 0.25 110.504 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.565 ' HB ' HG12 ' A' ' 101' ' ' ILE . 39.6 t -119.0 135.41 59.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.877 0.37 . . . . 0.1 111.043 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -104.49 106.33 16.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.844 -0.799 . . . . 0.21 108.844 166.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.56 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 11.4 m-85 -89.77 135.37 33.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.21 0.529 . . . . 0.17 111.41 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.525 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.8 tt0 -47.29 -44.29 23.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.348 -1.297 . . . . 0.57 110.245 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.7 p -115.05 141.3 48.19 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.422 -1.263 . . . . 0.4 111.001 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -60.4 -39.71 88.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.52 -0.764 . . . . 0.47 111.048 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.1 -33.06 73.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.384 -0.371 . . . . 0.74 111.728 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.34 -34.95 77.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.137 0.494 . . . . 0.18 110.423 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.56 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -61.59 -47.86 83.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.466 -0.788 . . . . 0.16 110.527 177.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.616 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.9 mt-10 -59.13 -39.98 84.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.833 -0.621 . . . . 1.42 110.889 177.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 87.1 mtt180 -58.93 -43.46 91.17 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.95 0.405 . . . . 1.48 110.708 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.72 92.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 0.1 110.663 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 170' ' ' VAL . 87.5 mt -61.3 -51.92 67.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.978 -0.555 . . . . 0.15 111.109 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.5 pt-20 -64.23 -43.58 94.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.085 0.469 . . . . 1.08 111.897 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.489 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -81.81 -39.47 23.99 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 113.028 0.751 . . . . 1.16 113.028 -169.595 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.604 ' HB2' HG21 ' A' ' 170' ' ' VAL . 93.9 mmm -90.56 -20.73 22.3 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.51 -0.476 . . . . 0.35 112.217 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -64.9 123.99 20.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.102 -0.703 . . . . 0.44 109.102 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.95 25.98 43.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.563 -0.827 . . . . 0.29 112.95 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.589 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 4.1 mmt -113.56 156.71 23.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.596 0.198 . . . . 1.18 110.791 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 16.7 mt -95.76 110.76 22.86 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 109.552 -0.536 . . . . 0.44 109.552 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 21.8 mt -96.86 100.28 11.81 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.706 -0.798 . . . . 1.02 109.626 173.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 84.4 m-20 77.49 -25.64 0.2 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.021 -0.99 . . . . 1.71 113.184 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 33.3 t70 170.12 -23.43 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 O-C-N 123.623 0.577 . . . . 0.85 111.918 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 91.2 mtt180 -111.19 135.49 51.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.441 -0.345 . . . . 0.96 110.977 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.1 ttmt -81.81 117.78 22.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.23 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.496 HG11 HD23 ' A' ' 106' ' ' LEU . 15.3 m -100.15 147.29 7.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.862 0.839 . . . . 0.17 111.765 -171.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 52.1 t80 -105.84 119.81 40.11 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.415 -1.266 . . . . 0.3 108.915 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.604 HG21 ' HB2' ' A' ' 158' ' ' MET . 41.3 t -114.49 125.34 71.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 0.13 108.82 177.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.72 -170.43 14.51 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.846 -0.692 . . . . 0.18 111.62 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -70.08 145.08 51.91 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.996 -0.742 . . . . 1.93 108.996 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 94' ' ' ARG . 46.9 t80 -53.94 141.17 28.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.21 0.528 . . . . 1.44 111.115 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -76.85 12.82 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.767 1.025 . . . . 4.66 113.767 -166.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.65 ' O ' ' HB3' ' A' ' 92' ' ' SER . 72.0 p -79.92 3.21 20.59 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.852 -0.53 . . . . 3.6 110.84 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -78.22 -1.53 33.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.044 0.45 . . . . 7.6 110.306 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -86.11 79.58 9.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.281 0.562 . . . . 8.61 110.837 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -139.11 -36.8 0.52 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.095 -1.076 . . . . 8.55 108.095 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -124.77 104.84 8.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.512 -1.222 . . . . 12.18 108.212 171.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -115.1 91.13 3.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.24 0.543 . . . . 12.7 111.041 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -118.47 33.19 5.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.419 -0.81 . . . . 13.65 109.466 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--O 1.25 1.104 0 CA-C-N 115.465 -0.789 . . . . 15.05 109.965 -176.229 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.001 0 N-CA-C 112.447 -0.261 . . . . 14.85 112.447 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.93 32.33 4.78 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.256 -1.016 . . . . 13.5 108.256 175.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -153.74 144.47 15.98 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 114.35 -1.295 . . . . 11.25 109.741 -170.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -61.39 -56.76 0.74 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.067 1.845 . . . . 11.14 110.439 171.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.2 t -167.21 91.02 0.38 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.505 -0.77 . . . . 9.3 109.953 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 65.1 mt -57.49 140.07 51.61 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.519 -0.548 . . . . 7.89 109.519 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 94' ' ' ARG . 13.5 mtp180 -68.8 -29.77 68.21 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.989 0.366 . . . . 7.78 111.989 -172.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.565 ' HG2' ' HA ' ' A' ' 174' ' ' LYS . 53.2 mttp 62.93 88.77 0.09 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 123.425 0.453 . . . . 2.37 111.014 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.3 p -64.56 -14.12 56.11 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.881 -0.512 . . . . 1.79 112.004 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.553 ' CA ' HD22 ' A' ' 100' ' ' ASN . . . -74.99 -30.02 59.88 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.89 -0.671 . . . . 0.44 111.459 174.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t 62.61 124.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.149 0.98 . . . . 0.71 113.088 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.62 22.61 76.96 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.357 -0.838 . . . . 0.21 111.935 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.571 ' HB2' ' O ' ' A' ' 173' ' ' PHE . 2.4 m-20 -85.48 124.69 32.35 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.094 -0.706 . . . . 0.63 109.094 -175.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.583 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.7 pt -135.86 151.96 30.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.71 -0.478 . . . . 0.15 109.71 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.786 ' HB3' ' HB2' ' A' ' 173' ' ' PHE . 0.0 OUTLIER -116.61 137.09 52.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.905 -0.406 . . . . 0.21 109.905 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.596 HG12 HG22 ' A' ' 170' ' ' VAL . 6.5 mt -116.0 134.66 58.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.503 -0.771 . . . . 0.15 109.983 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -118.94 151.62 37.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.69 -0.232 . . . . 1.46 110.534 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.5 t30 76.91 34.7 0.41 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.045 0.841 . . . . 0.49 111.282 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.536 HD22 HG21 ' A' ' 110' ' ' ILE . 22.7 mt -77.06 162.09 27.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.217 -0.447 . . . . 0.26 110.925 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -92.57 152.13 19.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.499 . . . . 0.71 110.122 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 137' ' ' SER . 55.5 pttt -57.11 -29.13 63.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.902 -0.59 . . . . 2.2 112.16 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.0 m -72.43 -14.96 61.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.427 -0.351 . . . . 1.41 111.741 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.536 HG21 HD22 ' A' ' 106' ' ' LEU . 37.6 mm -76.61 123.18 32.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.2 0.524 . . . . 0.26 111.137 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 27.3 t70 -109.31 -177.37 3.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.376 -0.829 . . . . 1.59 109.043 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -71.43 -33.22 69.21 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.79 -0.818 . . . . 0.6 108.79 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -46.89 75.09 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.547 -1.206 . . . . 2.58 108.949 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.28 -44.19 97.64 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.973 -1.467 . . . . 0.15 110.83 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.684 HD12 HG22 ' A' ' 130' ' ' VAL . 3.6 tt -64.21 -46.84 82.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.443 -0.799 . . . . 0.16 109.056 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.745 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 41.6 t80 -59.14 -49.25 78.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 0.3 110.573 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -57.0 -37.42 71.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.937 0.399 . . . . 0.4 111.22 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.551 HG21 HD21 ' A' ' 163' ' ' LEU . 9.1 m -77.98 -53.58 7.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.138 -0.483 . . . . 0.22 111.832 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.426 ' CD1' HD23 ' A' ' 115' ' ' LEU . 9.9 m-85 -72.97 -27.5 61.85 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.754 0.649 . . . . 0.11 112.754 -174.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.0 t -56.89 -28.35 61.8 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.498 0.319 . . . . 0.19 111.633 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.95 -22.57 38.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.833 0.349 . . . . 0.14 111.46 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.569 ' HZ ' ' HE2' ' A' ' 157' ' ' LYS . 34.2 m-85 -91.95 -11.72 35.39 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.83 0.348 . . . . 0.18 111.086 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.95 169.1 20.47 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.796 -0.522 . . . . 0.11 111.796 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -69.17 138.35 54.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.942 0.401 . . . . 0.25 110.438 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 128' ' ' CYS . 76.0 mt -110.17 132.71 57.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.928 -0.578 . . . . 0.14 109.988 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.615 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.27 -45.55 11.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.603 -0.888 . . . . 0.54 108.603 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.1 m -144.73 109.27 4.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.103 -0.953 . . . . 0.76 110.75 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.745 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.8 p -103.68 138.4 40.37 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.176 -0.676 . . . . 0.72 109.176 172.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -136.23 126.9 27.19 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.938 0.399 . . . . 1.0 111.078 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.684 HG22 HD12 ' A' ' 115' ' ' LEU . 89.8 t -111.03 109.82 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 105.983 -1.858 . . . . 0.28 105.983 168.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.59 HG12 ' HG3' ' A' ' 138' ' ' LYS . 9.0 t -75.16 115.11 16.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.688 -0.856 . . . . 0.34 108.688 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 4.1 p -98.59 135.93 39.41 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.595 -0.729 . . . . 1.58 111.396 -169.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -85.89 163.34 18.13 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.432 -0.951 . . . . 2.08 108.432 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -57.52 -26.05 60.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.016 0.436 . . . . 2.45 110.458 173.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -92.17 -2.61 56.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.107 -0.497 . . . . 1.65 110.899 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 143.46 -75.68 0.31 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.54 -0.838 . . . . 1.12 113.695 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.653 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 11.1 t -138.78 147.48 42.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.946 0.873 . . . . 1.61 110.942 -175.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.59 ' HG3' HG12 ' A' ' 131' ' ' VAL . 4.8 mmpt? -84.25 -13.74 51.81 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.145 0.498 . . . . 1.51 110.487 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 105.35 -14.73 47.24 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.395 -0.907 . . . . 0.31 113.547 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -132.99 158.7 42.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.337 0.568 . . . . 0.49 111.701 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.88 174.77 28.41 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.496 -0.774 . . . . 0.12 112.165 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -138.92 139.02 37.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.666 0.233 . . . . 0.25 110.541 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.583 ' HB ' HG12 ' A' ' 101' ' ' ILE . 47.7 t -111.64 136.52 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.829 0.347 . . . . 0.1 110.651 173.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.1 106.05 16.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.119 -0.697 . . . . 0.21 109.119 166.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.5 m-85 -89.02 137.41 32.34 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.125 0.488 . . . . 0.17 110.856 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.615 ' HA ' HD21 ' A' ' 126' ' ' LEU . 43.3 tt0 -47.54 -43.95 25.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.348 -1.296 . . . . 0.57 110.528 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.9 p -114.57 146.26 40.98 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.642 -1.163 . . . . 0.4 111.191 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -62.37 -37.68 86.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.569 -0.741 . . . . 0.47 111.191 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.93 -34.32 73.31 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.559 -0.292 . . . . 0.74 111.774 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.21 76.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.125 0.488 . . . . 0.18 110.297 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.597 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.53 -44.12 95.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.439 -0.8 . . . . 0.16 110.51 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -59.46 -44.04 93.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.921 -0.582 . . . . 1.42 110.214 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -58.55 -39.58 80.63 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.904 0.383 . . . . 1.48 110.641 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.65 84.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 0.1 110.368 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 151' ' ' ALA . 80.4 mt -61.68 -56.24 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.406 -0.361 . . . . 0.15 111.32 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -43.79 77.83 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.23 0.538 . . . . 1.08 111.278 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.569 ' HE2' ' HZ ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -83.14 -39.53 20.94 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.517 -0.765 . . . . 1.16 112.541 -169.133 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.519 ' HB2' HG21 ' A' ' 170' ' ' VAL . 89.6 mmm -91.85 -24.44 19.35 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.527 -0.469 . . . . 0.35 112.028 -172.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -66.78 123.63 20.67 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.424 -0.584 . . . . 0.44 109.424 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.6 62.04 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.765 -0.731 . . . . 0.29 112.732 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.672 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 29.5 mmt -106.1 166.13 10.72 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 120.74 0.305 . . . . 1.18 111.186 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 20.7 mt -101.25 122.13 43.11 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 109.368 -0.604 . . . . 0.44 109.368 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.551 HD21 HG21 ' A' ' 118' ' ' THR . 21.6 mt -107.04 102.15 11.52 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.874 -0.731 . . . . 1.02 109.212 170.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 57.5 m-20 78.61 -26.39 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.976 0.798 . . . . 1.71 112.584 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 20.2 t70 165.38 -23.65 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.289 0.636 . . . . 0.85 111.332 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -101.68 134.15 45.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.269 -0.423 . . . . 0.96 110.578 -172.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 161' ' ' MET . 16.7 ttmt -81.96 118.26 22.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.436 HG11 HD23 ' A' ' 106' ' ' LEU . 15.7 m -101.3 146.95 8.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.568 0.699 . . . . 0.17 111.37 -172.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 72.6 t80 -106.57 120.78 42.84 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.781 -1.1 . . . . 0.3 109.186 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.596 HG22 HG12 ' A' ' 103' ' ' ILE . 44.3 t -115.17 124.93 72.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.188 -0.671 . . . . 0.13 109.188 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -142.92 -170.89 13.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.497 -0.859 . . . . 0.18 112.47 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -77.38 120.84 22.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.136 0.494 . . . . 1.93 110.954 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.786 ' HB2' ' HB3' ' A' ' 102' ' ' PHE . 15.6 t80 -121.27 145.45 47.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.732 -0.667 . . . . 1.44 109.27 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.565 ' HA ' ' HG2' ' A' ' 95' ' ' LYS . 44.6 pttt -92.27 -167.1 1.69 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.556 0.217 . . . . 4.66 110.855 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.422 ' HB2' ' H ' ' A' ' 97' ' ' GLY . 26.1 t -83.21 -36.5 24.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.84 0.352 . . . . 3.6 110.708 -175.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -110.09 116.49 31.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.36 -0.382 . . . . 7.6 109.981 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.66 144.95 55.73 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.685 -0.487 . . . . 8.61 109.685 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -161.21 112.28 1.76 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.46 -0.57 . . . . 8.55 109.46 -174.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -52.79 109.8 0.45 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.773 0.797 . . . . 12.18 112.026 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -129.3 122.23 29.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.127 -0.942 . . . . 12.7 108.764 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 64.85 29.05 12.71 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.561 0.538 . . . . 13.65 110.868 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.543 -0.741 . . . . 15.05 109.06 179.817 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 N-CA-C 111.688 -0.565 . . . . 14.85 111.688 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.55 -47.7 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.966 0.413 . . . . 13.5 110.502 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -161.66 111.14 1.2 Allowed Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.922 -0.581 . . . . 11.25 109.822 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -69.93 -27.27 25.85 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.079 1.853 . . . . 11.14 113.042 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.6 m -81.76 -43.1 18.85 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.733 0.642 . . . . 9.3 112.733 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 96' ' ' SER . 46.7 tp -97.44 -14.9 20.9 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.833 -0.542 . . . . 7.89 110.771 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.42 -92.05 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.616 -0.72 . . . . 7.78 110.431 -176.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.5 ' HB3' ' ND2' ' A' ' 100' ' ' ASN . 57.2 mttm -138.57 109.39 6.69 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.328 -0.619 . . . . 2.37 109.328 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.581 ' HB3' HD21 ' A' ' 93' ' ' LEU . 3.2 p -71.92 -22.2 61.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.708 0.685 . . . . 1.79 110.851 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -64.14 -41.46 98.4 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.743 -0.662 . . . . 0.44 112.286 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.1 t 66.35 127.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.469 0.708 . . . . 0.71 112.343 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 73.27 23.08 78.16 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.635 -0.793 . . . . 0.21 112.255 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.5 ' ND2' ' HB3' ' A' ' 95' ' ' LYS . 1.9 m-20 -85.02 123.96 31.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.377 -0.601 . . . . 0.63 109.377 -176.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.485 HG12 ' HB ' ' A' ' 143' ' ' VAL . 19.5 pt -135.67 163.47 35.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.704 -0.48 . . . . 0.15 109.704 176.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.25 145.18 50.51 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.462 -0.495 . . . . 0.21 109.858 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 170' ' ' VAL . 5.5 mt -118.19 131.64 70.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.642 -0.708 . . . . 0.15 109.863 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -109.21 148.72 30.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.538 -0.301 . . . . 1.46 110.66 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.7 t30 70.46 39.93 1.15 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.919 0.762 . . . . 0.49 112.148 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.631 HD22 HG21 ' A' ' 110' ' ' ILE . 21.7 mt -73.77 157.36 36.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.081 0.467 . . . . 0.26 111.383 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.545 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 24.5 t70 -81.14 148.98 29.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.381 -0.827 . . . . 0.71 111.05 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -52.78 -37.57 59.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.048 -0.978 . . . . 2.2 112.419 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.2 m -81.8 -4.74 57.16 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.08 0.4 . . . . 1.41 112.08 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.631 HG21 HD22 ' A' ' 106' ' ' LEU . 28.4 mm -74.47 120.44 23.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.242 0.544 . . . . 0.26 110.766 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.492 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 8.1 t70 -109.04 -176.15 2.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.33 -0.85 . . . . 1.59 108.882 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -69.4 -33.97 73.82 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.799 -0.815 . . . . 0.6 108.799 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -45.98 74.34 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.539 -1.209 . . . . 2.58 108.896 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.56 -43.8 98.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.687 -1.597 . . . . 0.15 110.646 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.641 HD12 HG22 ' A' ' 130' ' ' VAL . 3.7 tt -65.46 -47.38 76.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.536 -0.756 . . . . 0.16 109.386 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.742 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.6 t80 -59.2 -46.6 88.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.549 . . . . 0.3 110.963 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.93 -40.09 75.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.697 0.284 . . . . 0.4 111.087 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 50.9 m -78.46 -53.62 7.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.37 0.508 . . . . 0.22 112.37 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.463 ' CD1' HD23 ' A' ' 115' ' ' LEU . 9.4 m-85 -71.9 -28.09 63.27 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.688 0.625 . . . . 0.11 112.688 -173.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.8 t -57.67 -28.96 64.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.539 0.209 . . . . 0.19 111.366 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.23 -22.26 39.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.751 0.31 . . . . 0.14 111.645 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -89.84 -20.57 23.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.18 111.122 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.4 168.97 30.35 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.584 -0.606 . . . . 0.11 111.584 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -68.77 132.59 47.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.25 110.092 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 128' ' ' CYS . 73.5 mt -104.96 126.8 59.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.106 -0.497 . . . . 0.14 109.993 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.588 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -83.2 -35.25 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.9 -0.778 . . . . 0.54 108.9 -178.162 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.0 m -159.06 119.63 3.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.129 -0.941 . . . . 0.76 110.412 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.742 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.9 p -118.97 142.34 47.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.567 -0.531 . . . . 0.72 109.567 176.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -139.94 132.28 28.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.889 0.376 . . . . 1.0 111.485 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.641 HG22 HD12 ' A' ' 115' ' ' LEU . 96.1 t -114.3 109.37 28.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 106.556 -1.646 . . . . 0.28 106.556 169.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 t -76.36 117.3 20.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.159 -0.682 . . . . 0.34 109.159 -173.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 58.7 m -101.0 137.75 38.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.539 -0.755 . . . . 1.58 112.271 -166.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.4 ' H ' ' CA ' ' A' ' 137' ' ' SER . 24.3 t70 -85.44 162.12 19.12 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.825 -1.176 . . . . 2.08 107.825 174.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.7 pm0 -64.17 -19.67 65.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.284 0.493 . . . . 2.45 110.275 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -92.21 -4.3 54.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.992 -0.549 . . . . 1.65 110.856 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 146.96 -72.89 0.31 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.402 -0.904 . . . . 1.12 113.935 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.678 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 43.3 t -143.75 147.04 33.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.724 0.762 . . . . 1.61 110.558 -174.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp -87.19 -7.56 57.82 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.111 0.482 . . . . 1.51 110.257 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 104.68 -20.85 38.12 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.412 -0.899 . . . . 0.31 113.747 174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 18.3 p90 -125.03 150.58 46.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 117.3 0.55 . . . . 0.49 111.727 -173.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -140.07 170.94 24.12 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.361 -0.836 . . . . 0.12 111.49 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -135.83 141.05 44.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.927 0.363 . . . . 0.25 110.535 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.491 HG11 ' CE2' ' A' ' 145' ' ' PHE . 30.8 t -115.32 135.49 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 0.1 110.714 173.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.427 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.4 OUTLIER -103.62 106.17 16.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.906 -0.776 . . . . 0.21 108.906 166.433 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.491 ' CE2' HG11 ' A' ' 143' ' ' VAL . 12.6 m-85 -91.44 137.39 32.4 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.15 0.5 . . . . 0.17 111.08 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.588 ' HA ' HD21 ' A' ' 126' ' ' LEU . 41.8 tt0 -45.73 -42.23 11.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.206 -1.361 . . . . 0.57 111.273 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.7 p -121.05 155.76 33.68 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.182 -0.917 . . . . 0.4 110.565 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -67.2 -32.01 72.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.852 -0.613 . . . . 0.47 110.206 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 152' ' ' GLU . 10.3 pt-20 -70.67 -34.78 72.36 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.2 -0.455 . . . . 0.74 111.964 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 145' ' ' PHE . . . -62.3 -34.85 77.4 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.047 0.451 . . . . 0.18 110.22 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.477 ' O ' HG13 ' A' ' 155' ' ' ILE . . . -63.43 -41.08 98.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.648 -0.705 . . . . 0.16 110.171 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 13.0 mm-40 -58.56 -43.43 89.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.545 -0.752 . . . . 1.42 111.303 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 44.8 mtt180 -64.14 -40.06 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 1.48 110.97 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.79 86.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.522 -0.308 . . . . 0.1 110.46 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 151' ' ' ALA . 81.9 mt -59.54 -51.88 67.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.15 111.251 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.1 pt-20 -63.75 -44.65 92.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.006 0.431 . . . . 1.08 111.771 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.403 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.06 -39.29 23.66 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.173 0.805 . . . . 1.16 113.173 -168.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.47 ' HB2' HG21 ' A' ' 170' ' ' VAL . 91.5 mmm -91.25 -20.0 22.39 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.224 0.453 . . . . 0.35 112.224 -173.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.02 122.74 19.95 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.049 -0.66 . . . . 0.44 109.353 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.71 17.87 61.01 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.599 -0.81 . . . . 0.29 112.458 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -103.63 164.91 11.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.233 -0.654 . . . . 1.18 109.233 176.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.417 HD23 ' CA ' ' A' ' 167' ' ' LYS . 25.7 mt -103.04 132.18 49.5 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.859 -0.793 . . . . 0.44 108.859 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 19.7 mt -116.56 104.2 11.17 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 120.226 -0.59 . . . . 1.02 109.641 171.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 83.2 m-20 76.44 -27.39 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.129 -0.941 . . . . 1.71 113.063 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 20.5 t70 167.86 -24.5 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 O-C-N 123.938 0.774 . . . . 0.85 111.712 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.545 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 94.3 mtt180 -107.2 135.92 47.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.787 0.327 . . . . 0.96 110.852 -171.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 161' ' ' MET . 23.5 tttt -84.3 119.76 25.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.703 -0.68 . . . . 1.0 109.207 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.502 HG11 HD23 ' A' ' 106' ' ' LEU . 14.3 m -101.45 151.1 5.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.766 0.793 . . . . 0.17 111.409 -172.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 35.8 t80 -109.93 120.82 43.66 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.665 -1.152 . . . . 0.3 109.123 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.587 HG22 HG12 ' A' ' 103' ' ' ILE . 42.3 t -115.32 125.72 72.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.28 -0.637 . . . . 0.13 109.28 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.49 -176.76 22.19 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.62 -0.8 . . . . 0.18 111.64 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -58.21 142.22 48.21 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.024 -0.732 . . . . 1.93 109.024 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.449 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 39.8 t80 -59.65 -20.29 55.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.556 -0.293 . . . . 1.44 111.5 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 173' ' ' PHE . 61.3 tttp 76.96 -52.82 0.57 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.495 0.718 . . . . 4.66 110.906 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.2 t -106.66 -163.26 0.9 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.372 -0.603 . . . . 3.6 109.372 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.514 ' O ' ' HG3' ' A' ' 176' ' ' ARG . 18.2 ptt85 -139.72 91.14 2.45 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.116 -0.698 . . . . 7.6 109.116 170.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -92.71 36.14 1.02 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.158 0.504 . . . . 8.61 110.036 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.43 ' OE1' ' HB2' ' A' ' 176' ' ' ARG . 0.9 OUTLIER -56.3 126.59 26.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.536 -0.756 . . . . 8.55 111.339 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.501 ' HA ' ' HE ' ' A' ' 179' ' ' ARG . 0.3 OUTLIER -104.93 116.95 32.83 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.782 -0.645 . . . . 12.18 109.705 178.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -128.88 70.33 1.4 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.749 0.785 . . . . 12.7 109.83 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.85 21.96 2.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.41 -0.814 . . . . 13.65 111.23 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--O 1.247 0.952 0 CA-C-N 115.597 -0.729 . . . . 15.05 109.694 178.506 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 111.738 -0.545 . . . . 14.85 111.738 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.89 163.8 16.95 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.325 -0.25 . . . . 13.5 110.325 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -129.4 103.84 17.91 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.562 0.22 . . . . 11.25 110.578 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.72 -26.39 60.7 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 121.971 1.781 . . . . 11.14 110.976 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.3 m -91.88 26.24 2.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.351 -0.841 . . . . 9.3 110.655 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.551 ' O ' HD23 ' A' ' 93' ' ' LEU . 6.2 tt -69.72 -26.99 64.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.499 -0.926 . . . . 7.89 108.499 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.602 ' H ' ' HD2' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -126.44 -178.59 4.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.375 -0.83 . . . . 7.78 109.015 175.413 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -145.7 70.67 1.25 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.885 -0.326 . . . . 2.37 111.307 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.4 p -74.17 174.89 8.1 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.475 -0.565 . . . . 1.79 109.475 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.537 ' HA3' HD22 ' A' ' 100' ' ' ASN . . . 80.49 -48.47 3.66 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.224 -0.988 . . . . 0.44 110.829 -173.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t 65.3 127.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.95 0.9 . . . . 0.71 111.987 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.78 24.18 77.01 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.74 -1.219 . . . . 0.21 111.634 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.537 HD22 ' HA3' ' A' ' 97' ' ' GLY . 11.1 m-20 -85.12 124.02 31.3 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.29 -0.633 . . . . 0.63 109.29 -173.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.578 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.3 pt -135.66 159.98 39.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.015 -0.365 . . . . 0.15 110.015 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.51 143.22 50.79 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.605 -0.517 . . . . 0.21 109.605 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 170' ' ' VAL . 6.1 mt -118.56 133.81 64.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.854 -0.612 . . . . 0.15 110.37 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -114.25 150.07 34.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.25 -0.432 . . . . 1.46 110.318 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 67.99 54.68 0.6 Allowed 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.844 0.715 . . . . 0.49 111.63 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.534 HD22 HG21 ' A' ' 110' ' ' ILE . 12.1 mt -89.78 159.53 16.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.614 -0.721 . . . . 0.26 111.264 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.572 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 14.9 t70 -77.75 151.09 34.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.71 109.95 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.467 ' HA ' ' OG ' ' A' ' 137' ' ' SER . 24.5 pttm -63.65 -31.88 73.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.617 -0.72 . . . . 2.2 111.663 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.4 p -76.41 -4.68 43.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.796 0.331 . . . . 1.41 111.753 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.534 HG21 HD22 ' A' ' 106' ' ' LEU . 40.4 mm -77.26 121.55 29.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.216 0.532 . . . . 0.26 110.734 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 26.9 t70 -108.15 -178.68 3.67 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.751 -0.833 . . . . 1.59 108.751 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.412 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 2.8 m-20 -63.48 -38.95 93.09 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.639 -0.875 . . . . 0.6 108.639 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.961 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.87 -49.28 78.11 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.006 -0.997 . . . . 2.58 110.359 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.403 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.66 -43.66 98.44 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.296 -1.32 . . . . 0.15 111.412 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 130' ' ' VAL . 4.3 tt -64.49 -47.5 78.7 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.198 -0.667 . . . . 0.16 109.198 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.717 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 68.7 t80 -59.84 -46.7 88.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.989 -0.55 . . . . 0.3 110.608 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -57.03 -39.16 74.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.316 -0.402 . . . . 0.4 110.989 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.658 HG21 HD21 ' A' ' 163' ' ' LEU . 20.7 m -77.04 -53.39 7.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.047 -0.524 . . . . 0.22 111.681 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -72.52 -29.0 63.21 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.434 0.531 . . . . 0.11 112.434 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.3 t -57.97 -28.05 63.99 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.6 0.238 . . . . 0.19 111.003 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.49 -22.73 34.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.461 -0.336 . . . . 0.14 111.345 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -93.02 -13.92 28.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.456 -0.338 . . . . 0.18 111.099 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.04 169.08 22.88 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.848 -0.692 . . . . 0.11 112.137 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -66.23 137.71 57.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.915 0.388 . . . . 0.25 110.54 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.493 ' HB ' ' CE1' ' A' ' 116' ' ' TYR . 76.3 mt -113.34 132.34 62.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.739 -0.664 . . . . 0.14 109.711 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -85.89 -42.34 14.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.869 -0.789 . . . . 0.54 108.869 -178.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.8 m -149.34 125.09 10.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.782 -1.099 . . . . 0.76 110.279 -177.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.717 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 19.8 p -122.32 151.74 40.83 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.173 -0.677 . . . . 0.72 109.173 174.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -143.14 129.72 20.19 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.627 -0.429 . . . . 1.0 111.727 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.553 HG22 HD12 ' A' ' 115' ' ' LEU . 70.8 t -114.87 109.67 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 106.796 -1.557 . . . . 0.28 106.796 168.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 138' ' ' LYS . 5.6 t -77.23 127.08 38.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.775 -0.648 . . . . 0.34 109.373 -174.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 18.6 m -96.77 135.97 37.98 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.826 -0.624 . . . . 1.58 111.238 -168.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.706 ' HA ' ' HD2' ' A' ' 138' ' ' LYS . 25.5 t70 -85.27 166.32 16.6 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.491 -0.929 . . . . 2.08 108.491 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -62.44 -26.16 68.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.4 -0.593 . . . . 2.45 109.4 173.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -93.2 4.26 54.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.685 -0.688 . . . . 1.65 110.742 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 133.08 -66.11 0.58 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.055 -1.069 . . . . 1.12 114.245 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.467 ' OG ' ' HA ' ' A' ' 108' ' ' LYS . 11.0 p -138.35 131.41 29.94 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 117.42 0.61 . . . . 1.61 111.869 -170.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.706 ' HD2' ' HA ' ' A' ' 133' ' ' ASP . 13.3 mmmt -70.54 -36.83 73.92 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.479 0.657 . . . . 1.51 111.028 -176.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.96 -11.26 10.06 Favored Glycine 0 C--N 1.314 -0.679 0 CA-C-N 115.184 -0.917 . . . . 0.31 113.75 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -133.01 156.62 47.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.243 0.521 . . . . 0.49 110.913 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.56 177.22 26.94 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.893 -0.594 . . . . 0.12 112.012 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -140.82 143.75 34.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.867 0.333 . . . . 0.25 111.174 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.578 ' HB ' HG12 ' A' ' 101' ' ' ILE . 38.8 t -119.21 133.04 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.981 0.42 . . . . 0.1 111.154 172.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.7 OUTLIER -103.47 105.82 16.18 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.775 -0.824 . . . . 0.21 108.775 165.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.519 ' CE2' HG11 ' A' ' 143' ' ' VAL . 13.7 m-85 -88.19 138.5 31.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.94 0.4 . . . . 0.17 111.008 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.625 ' HA ' HD21 ' A' ' 126' ' ' LEU . 26.4 tt0 -48.48 -47.33 38.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.903 -1.044 . . . . 0.57 110.433 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 p -109.98 151.65 26.87 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.62 -1.173 . . . . 0.4 110.672 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -67.89 -36.14 79.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.959 -0.564 . . . . 0.47 110.719 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 14.0 pt-20 -70.04 -35.38 74.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.352 0.501 . . . . 0.74 112.352 -176.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.45 -34.89 77.7 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.043 0.449 . . . . 0.18 110.403 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 155' ' ' ILE . . . -63.6 -43.61 96.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.666 -0.697 . . . . 0.16 110.448 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 33.5 mt-10 -58.89 -37.75 77.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 1.42 110.722 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 92.2 mtt180 -66.72 -44.31 81.94 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.805 0.336 . . . . 1.48 110.634 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.12 -38.92 90.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 0.1 110.631 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 151' ' ' ALA . 84.4 mt -59.16 -53.99 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.15 111.533 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.1 pt-20 -64.91 -44.63 88.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.332 0.587 . . . . 1.08 111.967 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.453 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -77.62 -38.27 48.34 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.311 -0.859 . . . . 1.16 112.665 -169.054 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.43 ' O ' ' HB2' ' A' ' 161' ' ' MET . 89.0 mmm -94.09 -17.75 22.5 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.496 -0.482 . . . . 0.35 112.256 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.432 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 52.5 t30 -69.66 123.33 21.09 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.919 -0.712 . . . . 0.44 109.113 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.61 8.79 79.76 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.687 -0.768 . . . . 0.29 112.061 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.7 OUTLIER -91.32 159.63 15.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.725 0.297 . . . . 1.18 110.248 178.783 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 15.2 mt -104.49 108.23 19.55 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.644 -0.502 . . . . 0.44 109.644 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.658 HD21 HG21 ' A' ' 118' ' ' THR . 22.5 mt -93.42 105.75 17.78 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 119.75 -0.78 . . . . 1.02 109.395 173.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 73.06 -58.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.165 -0.925 . . . . 1.71 112.474 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -166.97 14.61 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.288 -0.414 . . . . 0.85 111.894 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.572 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 92.7 mtt180 -135.54 134.66 39.65 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.713 -0.395 . . . . 0.96 110.423 -175.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.3 tttt -82.18 121.57 26.77 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.236 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.04 143.36 14.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.467 0.651 . . . . 0.17 111.3 -173.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.432 ' HA ' ' OD1' ' A' ' 159' ' ' ASN . 63.2 t80 -106.32 119.88 40.4 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.231 -0.895 . . . . 0.3 109.062 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.552 HG22 HG12 ' A' ' 103' ' ' ILE . 43.9 t -115.16 126.57 72.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.234 -0.654 . . . . 0.13 109.234 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.63 -178.91 21.51 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.529 -0.843 . . . . 0.18 112.199 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -67.39 126.78 30.36 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.226 -0.287 . . . . 1.93 110.226 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.889 ' HD1' ' H ' ' A' ' 175' ' ' SER . 4.6 t80 -66.15 138.5 57.75 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.423 -0.954 . . . . 1.44 108.423 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -69.86 -11.36 60.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.679 0.622 . . . . 4.66 112.679 -173.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.889 ' H ' ' HD1' ' A' ' 173' ' ' PHE . 67.0 m 60.76 88.65 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.617 0.722 . . . . 3.6 111.225 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -145.75 -66.03 0.31 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.393 -0.821 . . . . 7.6 110.132 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.6 ' HE3' ' HG2' ' A' ' 182' ' ' GLU . 2.6 tmmm? -94.61 129.91 41.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.732 -0.47 . . . . 8.61 109.732 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.505 ' N ' ' HD2' ' A' ' 177' ' ' LYS . 9.1 pt-20 -165.95 104.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.152 -0.684 . . . . 8.55 109.152 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -119.85 -75.2 0.59 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.946 0.403 . . . . 12.18 111.706 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -145.71 105.37 3.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.033 -0.531 . . . . 12.7 109.963 -171.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 56.48 23.63 7.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.318 0.58 . . . . 13.65 110.601 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.6 ' HG2' ' HE3' ' A' ' 177' ' ' LYS . 33.7 tt0 . . . . . 0 C--O 1.247 0.928 0 CA-C-N 115.348 -0.842 . . . . 15.05 108.793 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 111.454 -0.659 . . . . 14.85 111.454 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.62 -42.22 18.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.748 0.309 . . . . 13.5 110.787 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.446 ' HB2' ' HG ' ' A' ' 93' ' ' LEU . 2.0 p-10 -148.41 138.32 12.69 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.253 -0.431 . . . . 11.25 110.302 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.03 45.05 1.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.661 2.241 . . . . 11.14 111.482 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 m 69.66 76.28 0.22 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.24 -0.891 . . . . 9.3 110.362 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.446 ' HG ' ' HB2' ' A' ' 90' ' ' ASP . 79.3 mt -94.48 -42.41 8.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.37 -0.832 . . . . 7.89 110.575 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 53.73 -166.24 0.08 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.962 -0.563 . . . . 7.78 111.7 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -116.55 20.2 14.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.539 0.685 . . . . 2.37 109.613 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.3 m -68.49 -11.23 59.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.336 -0.847 . . . . 1.79 111.62 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.09 -31.71 75.45 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.053 -0.594 . . . . 0.44 112.213 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 59.22 135.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.325 1.05 . . . . 0.71 112.587 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.1 23.0 78.63 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.84 -1.172 . . . . 0.21 110.739 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.521 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.2 m120 -94.23 127.49 40.12 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.931 -0.766 . . . . 0.63 108.931 -174.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.597 HG23 ' HB1' ' A' ' 151' ' ' ALA . 27.4 pt -134.51 161.36 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.277 -0.268 . . . . 0.15 110.277 177.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.96 143.24 50.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.938 -0.393 . . . . 0.21 109.938 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.514 HG12 HG22 ' A' ' 170' ' ' VAL . 8.7 mt -116.6 146.73 20.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.756 -0.656 . . . . 0.15 109.953 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 44.8 tttp -129.61 147.91 51.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.288 -0.415 . . . . 1.46 110.342 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.8 t30 64.81 47.7 2.64 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.549 0.74 . . . . 0.49 111.954 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.664 HD22 HG21 ' A' ' 110' ' ' ILE . 23.0 mt -80.07 151.84 29.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.167 0.508 . . . . 0.26 111.447 176.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.533 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 17.9 t70 -77.97 150.95 33.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.476 -0.784 . . . . 0.71 111.313 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.56 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 22.3 pttp -51.7 -38.64 55.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.137 -0.938 . . . . 2.2 112.946 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.3 m -85.09 -4.24 59.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.054 0.39 . . . . 1.41 112.054 -173.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.664 HG21 HD22 ' A' ' 106' ' ' LEU . 33.5 mm -71.88 116.21 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.099 0.476 . . . . 0.26 110.23 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -103.72 -179.36 3.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.637 -0.875 . . . . 1.59 108.637 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -63.96 -37.25 86.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.736 -0.839 . . . . 0.6 108.736 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 1.034 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -61.37 -49.66 76.02 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.168 -0.924 . . . . 2.58 110.712 178.2 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.3 99.12 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.194 -1.366 . . . . 0.15 111.068 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.762 HD12 HG22 ' A' ' 130' ' ' VAL . 3.8 tt -63.94 -47.87 78.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.419 -0.81 . . . . 0.16 109.105 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.657 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 51.5 t80 -58.69 -48.45 81.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.869 -0.605 . . . . 0.3 110.914 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.3 -38.82 74.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.938 0.399 . . . . 0.4 110.59 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.6 m -77.47 -54.17 6.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.148 -0.478 . . . . 0.22 111.875 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.446 ' CD1' HD23 ' A' ' 115' ' ' LEU . 7.2 m-85 -72.19 -27.87 62.84 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.248 0.462 . . . . 0.11 112.248 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 28.7 t -57.41 -28.03 62.91 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 111.629 0.233 . . . . 0.19 111.629 -177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.83 -22.88 39.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.016 0.436 . . . . 0.14 111.345 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -90.19 -22.29 21.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.113 -0.494 . . . . 0.18 110.777 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 169.36 169.02 32.16 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.89 -0.595 . . . . 0.11 111.784 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -70.65 139.55 51.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.018 0.437 . . . . 0.25 109.893 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.419 HG21 ' HB3' ' A' ' 128' ' ' CYS . 74.1 mt -112.88 131.93 63.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.907 -0.588 . . . . 0.14 110.024 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -88.5 -41.06 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.922 -0.77 . . . . 0.54 108.922 -177.8 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 72.1 m -147.7 119.6 8.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.163 -0.926 . . . . 0.76 110.314 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 9.2 p -117.53 144.95 44.59 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.526 -0.546 . . . . 0.72 109.526 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -142.19 129.3 20.89 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.503 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.762 HG22 HD12 ' A' ' 115' ' ' LEU . 61.2 t -115.55 110.7 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 106.848 -1.538 . . . . 0.28 106.848 170.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t -80.25 115.39 22.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.848 -0.797 . . . . 0.34 108.848 -175.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.748 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 7.7 p -99.29 135.74 40.26 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.211 0.819 . . . . 1.58 113.211 -164.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -86.89 163.88 16.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.771 -1.104 . . . . 2.08 108.923 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.09 -29.59 60.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.735 0.302 . . . . 2.45 111.065 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -88.94 -5.89 57.66 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.934 0.397 . . . . 1.65 110.944 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.56 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 149.03 -74.01 0.28 Allowed Glycine 0 C--O 1.225 -0.442 0 C-N-CA 120.484 -0.865 . . . . 1.12 112.95 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.748 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 42.5 t -138.75 145.92 40.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.621 0.71 . . . . 1.61 110.335 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -77.49 -11.74 59.88 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.383 0.611 . . . . 1.51 109.808 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 111.47 -19.24 24.4 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.177 -0.92 . . . . 0.31 113.324 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -126.07 149.37 48.94 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 121.855 -0.791 . . . . 0.49 111.874 -173.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.86 174.81 24.1 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.077 -0.965 . . . . 0.12 111.348 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -141.57 137.44 31.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.019 0.41 . . . . 0.25 110.615 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.583 ' HB ' HG12 ' A' ' 101' ' ' ILE . 43.2 t -112.88 133.68 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.1 111.147 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.1 m170 -103.12 105.91 16.31 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.626 -0.715 . . . . 0.21 109.143 166.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.581 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 12.5 m-85 -88.79 142.55 27.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.261 0.553 . . . . 0.17 110.751 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.572 ' HA ' HD21 ' A' ' 126' ' ' LEU . 42.8 tt0 -51.67 -38.32 54.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.277 -1.329 . . . . 0.57 110.542 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.6 p -125.32 150.38 47.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.307 -0.86 . . . . 0.4 111.443 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -60.65 -37.76 82.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.603 -0.726 . . . . 0.47 111.24 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.6 pt-20 -67.82 -35.38 78.5 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.56 -0.291 . . . . 0.74 111.645 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.53 78.35 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.21 0.529 . . . . 0.18 110.278 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.597 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -63.56 -46.57 85.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.339 -0.846 . . . . 0.16 110.565 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 42.6 mt-10 -58.96 -40.19 83.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 1.42 110.526 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 88.8 mtt180 -58.96 -44.76 91.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.005 0.431 . . . . 1.48 110.719 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.4 94.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.968 -0.56 . . . . 0.1 110.598 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 151' ' ' ALA . 88.6 mt -58.97 -53.56 46.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.889 -0.596 . . . . 0.15 111.401 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 0.6 OUTLIER -63.64 -41.83 98.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.091 0.472 . . . . 1.08 111.808 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.418 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -81.8 -39.98 23.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.681 -0.691 . . . . 1.16 112.82 -169.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 91.3 mmm -91.24 -19.12 23.36 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.262 0.468 . . . . 0.35 112.262 -173.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -66.54 122.78 18.35 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.396 -0.521 . . . . 0.44 109.826 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.48 26.81 37.87 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.91 -0.662 . . . . 0.29 113.01 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.705 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 74.5 mmm -112.64 157.06 21.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.958 0.379 . . . . 1.18 110.891 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 167' ' ' LYS . 19.6 mt -94.15 102.38 14.42 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.002 -0.74 . . . . 0.44 109.002 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 163' ' ' LEU . 16.7 mt -83.91 101.47 11.7 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 119.278 -0.969 . . . . 1.02 108.645 172.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 98.8 m-20 73.94 -70.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.856 -1.065 . . . . 1.71 111.467 -175.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -147.2 -0.57 0.68 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.425 -0.807 . . . . 0.85 112.192 -173.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.533 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 91.6 mtt180 -132.1 128.76 38.84 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.955 -0.466 . . . . 0.96 110.473 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.705 ' HA ' ' O ' ' A' ' 161' ' ' MET . 13.3 tttt -76.45 122.04 23.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.35 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 16.0 m -101.18 140.06 20.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.391 0.615 . . . . 0.17 111.056 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -106.08 121.7 44.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.18 -0.918 . . . . 0.3 108.871 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.514 HG22 HG12 ' A' ' 103' ' ' ILE . 39.6 t -115.88 130.15 71.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.976 -0.557 . . . . 0.13 109.565 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -142.87 -165.37 10.59 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.773 -0.727 . . . . 0.18 111.949 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.71 ' HB2' ' HE3' ' A' ' 174' ' ' LYS . 16.4 mmt180 -75.57 134.49 40.7 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.61 -0.515 . . . . 1.93 109.61 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -63.73 -61.81 2.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 1.44 111.193 -174.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.71 ' HE3' ' HB2' ' A' ' 172' ' ' ARG . 81.9 mttt 70.24 -58.78 0.53 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.802 0.689 . . . . 4.66 111.022 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.3 p 168.72 -67.83 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.617 -1.253 . . . . 3.6 107.617 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -160.8 15.9 0.12 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.77 -1.559 . . . . 7.6 108.011 172.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 182' ' ' GLU . 58.5 tttm -82.0 52.37 1.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.391 -1.277 . . . . 8.61 111.438 -169.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.742 ' HG3' ' HB3' ' A' ' 182' ' ' GLU . 29.0 tt0 -159.73 13.43 0.14 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.751 0.786 . . . . 8.55 109.006 171.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -79.0 94.08 5.22 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.161 -0.927 . . . . 12.18 109.129 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 71.63 -44.53 0.59 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.825 0.703 . . . . 12.7 111.263 -174.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -123.35 128.41 49.86 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.67 -0.492 . . . . 13.65 109.67 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.742 ' HB3' ' HG3' ' A' ' 178' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 119.151 -0.452 . . . . 15.05 110.901 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.694 ' N ' ' HG ' ' A' ' 127' ' ' SER . . . . . . . . 0 N--CA 1.483 1.792 0 N-CA-C 112.426 -0.27 . . . . 14.85 112.426 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.96 -19.21 60.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.101 0.477 . . . . 13.5 110.767 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.549 ' HB2' ' HG ' ' A' ' 93' ' ' LEU . 7.5 p-10 -93.85 142.97 25.76 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.508 -0.769 . . . . 11.25 109.848 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.43 -55.71 1.67 Allowed 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.22 1.947 . . . . 11.14 110.829 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.3 p -170.9 86.72 0.1 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.589 -0.732 . . . . 9.3 110.712 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.549 ' HG ' ' HB2' ' A' ' 90' ' ' ASP . 91.0 mt -75.63 128.67 35.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.377 -0.601 . . . . 7.89 109.377 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -58.53 -49.49 77.2 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 111.591 0.219 . . . . 7.78 111.591 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -151.23 -0.47 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.132 0.492 . . . . 2.37 110.606 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.1 m -80.74 0.28 35.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.54 . . . . 1.79 110.514 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.417 ' C ' HD21 ' A' ' 100' ' ' ASN . . . -65.27 -26.9 71.86 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.611 -0.722 . . . . 0.44 112.153 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.2 t 69.07 124.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.466 0.706 . . . . 0.71 111.923 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.18 23.05 78.36 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.481 -0.866 . . . . 0.21 111.856 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 143' ' ' VAL . 1.8 m120 -89.32 126.2 35.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.335 -0.617 . . . . 0.63 109.335 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.512 HG12 ' HB ' ' A' ' 143' ' ' VAL . 22.0 pt -134.65 163.37 36.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.734 -0.666 . . . . 0.15 109.547 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.07 146.45 50.36 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.564 -0.455 . . . . 0.21 109.817 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.561 HG12 HG22 ' A' ' 170' ' ' VAL . 4.2 mt -118.22 138.37 49.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.688 -0.687 . . . . 0.15 109.714 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -120.85 152.78 37.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.691 -0.231 . . . . 1.46 110.4 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.8 t30 70.57 41.07 0.98 Allowed 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.818 0.699 . . . . 0.49 111.699 172.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.54 HD22 HG21 ' A' ' 110' ' ' ILE . 20.0 mt -79.4 164.83 23.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.217 0.532 . . . . 0.26 111.907 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.461 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.8 t70 -89.01 155.55 19.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.406 -0.815 . . . . 0.71 110.799 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.711 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 20.0 pttp -59.99 -36.68 77.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.228 -0.442 . . . . 2.2 111.724 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.44 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 16.7 m -80.85 -3.21 50.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.243 -0.435 . . . . 1.41 111.891 -173.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.554 HG22 HG21 ' A' ' 130' ' ' VAL . 34.5 mm -76.02 118.53 22.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.26 110.254 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -108.66 -175.52 2.79 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.128 -0.693 . . . . 1.59 109.128 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -69.39 -32.76 71.99 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.081 -0.711 . . . . 0.6 109.081 -176.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.412 ' O ' ' HD2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -67.13 -48.47 67.97 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.54 -1.209 . . . . 2.58 109.253 178.707 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.2 -41.42 96.78 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.198 -1.365 . . . . 0.15 110.83 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.71 HD12 HG22 ' A' ' 130' ' ' VAL . 3.8 tt -66.98 -47.66 70.86 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.039 -0.726 . . . . 0.16 109.039 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.681 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.6 t80 -59.38 -46.45 88.62 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.933 -0.576 . . . . 0.3 110.81 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.3 -41.08 75.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.09 0.471 . . . . 0.4 110.978 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.469 HG21 HD21 ' A' ' 163' ' ' LEU . 18.0 m -77.07 -52.76 8.76 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.787 -0.642 . . . . 0.22 111.691 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.434 ' CD1' HD23 ' A' ' 115' ' ' LEU . 10.6 m-85 -72.69 -28.24 62.57 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.638 0.607 . . . . 0.11 112.638 -175.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.8 t -57.3 -28.8 63.35 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.563 0.221 . . . . 0.19 111.388 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.57 -24.13 45.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.896 0.379 . . . . 0.14 111.226 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -89.17 -18.18 27.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.18 111.408 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.44 173.55 32.27 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.033 -0.604 . . . . 0.11 112.024 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -69.46 135.37 50.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.914 0.387 . . . . 0.25 110.33 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 70.8 mt -110.67 124.29 67.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.217 -0.447 . . . . 0.14 110.597 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -79.97 -36.37 36.21 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.777 -0.823 . . . . 0.54 108.777 -176.617 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.694 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 73.4 m -154.97 141.49 18.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.86 -1.063 . . . . 0.76 109.694 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.6 p -143.5 135.42 26.62 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.803 -0.443 . . . . 0.72 109.803 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -140.76 133.25 28.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.112 0.482 . . . . 1.0 111.887 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.71 HG22 HD12 ' A' ' 115' ' ' LEU . 78.1 t -114.26 117.46 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 N-CA-C 106.717 -1.586 . . . . 0.28 106.717 169.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 t -86.48 115.82 28.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.811 -0.811 . . . . 0.34 108.811 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.764 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 60.2 m -109.85 139.54 44.81 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.024 0.75 . . . . 1.58 113.024 -164.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.405 ' H ' ' CA ' ' A' ' 137' ' ' SER . 19.8 t70 -85.31 160.2 19.87 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.938 -1.028 . . . . 2.08 108.439 171.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -58.51 -22.8 56.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.913 0.387 . . . . 2.45 110.774 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -92.41 4.14 54.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.072 -0.513 . . . . 1.65 110.673 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.711 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 140.25 -75.52 0.35 Allowed Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.763 -0.732 . . . . 1.12 113.443 177.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.764 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 30.7 t -144.07 156.33 44.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.753 0.777 . . . . 1.61 110.312 -176.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -89.21 -11.39 43.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.383 0.611 . . . . 1.51 109.494 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 110.81 -21.54 22.94 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.37 -0.832 . . . . 0.31 113.742 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -122.6 152.39 40.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 117.421 0.611 . . . . 0.49 112.208 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.67 175.25 24.47 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.01 -0.996 . . . . 0.12 111.438 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -140.52 142.24 35.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.088 0.444 . . . . 0.25 111.113 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.512 ' HB ' HG12 ' A' ' 101' ' ' ILE . 39.2 t -119.53 135.55 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-O 121.009 0.433 . . . . 0.1 110.873 172.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.9 106.22 16.61 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.985 -0.746 . . . . 0.21 108.985 166.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.54 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.7 m-85 -90.1 137.34 32.42 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.022 0.439 . . . . 0.17 110.993 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.572 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.8 tt0 -45.81 -43.83 13.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.42 -1.264 . . . . 0.57 111.021 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.3 p -116.8 153.39 32.54 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.266 -0.879 . . . . 0.4 110.33 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -64.61 -36.95 85.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.939 -0.573 . . . . 0.47 110.303 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 13.4 pt-20 -70.35 -34.37 72.56 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.035 -0.529 . . . . 0.74 112.293 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.72 -35.76 77.14 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.981 0.42 . . . . 0.18 110.52 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.54 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.82 -42.51 97.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.742 -0.663 . . . . 0.16 110.502 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.6 mt-10 -59.85 -40.55 88.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.884 -0.598 . . . . 1.42 110.437 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 61.5 mtt180 -60.1 -42.09 93.93 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.455 0.472 . . . . 1.48 110.861 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.35 -39.41 85.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.1 110.693 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 151' ' ' ALA . 88.2 mt -58.94 -53.61 45.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.119 -0.491 . . . . 0.15 111.075 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.5 pt-20 -60.41 -45.36 93.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.926 0.394 . . . . 1.08 111.796 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.461 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -80.93 -38.98 26.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.979 0.733 . . . . 1.16 112.979 -169.541 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.469 ' O ' ' HB2' ' A' ' 161' ' ' MET . 95.1 mmm -95.23 -17.84 21.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.67 0.619 . . . . 0.35 112.67 -171.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -70.12 122.09 18.77 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.683 -0.807 . . . . 0.44 109.187 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.79 23.55 55.52 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.602 -0.809 . . . . 0.29 112.178 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.624 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.8 OUTLIER -102.92 158.73 16.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.532 0.206 . . . . 1.18 110.536 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 21.7 mt -102.68 98.13 8.21 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.416 -0.356 . . . . 0.44 110.128 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.469 HD21 HG21 ' A' ' 118' ' ' THR . 18.6 mt -85.83 107.81 17.84 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 120.041 -0.664 . . . . 1.02 109.363 175.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 98.2 m-20 74.32 -61.86 0.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.164 -0.926 . . . . 1.71 111.599 -176.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -172.26 25.23 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.552 -0.749 . . . . 0.85 110.658 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.2 mtt180 -137.82 129.55 28.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.396 -0.366 . . . . 0.96 110.053 -178.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.9 tttt -79.89 118.88 22.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.82 -0.627 . . . . 1.0 109.377 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.482 HG11 HD23 ' A' ' 106' ' ' LEU . 19.3 m -102.33 150.78 6.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.294 0.569 . . . . 0.17 111.668 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 64.7 t80 -106.59 120.57 42.29 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.277 -0.874 . . . . 0.3 109.278 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.561 HG22 HG12 ' A' ' 103' ' ' ILE . 45.4 t -115.44 125.78 72.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.27 -0.641 . . . . 0.13 109.27 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.48 -174.29 20.06 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.708 -0.758 . . . . 0.18 111.404 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -60.75 138.61 58.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.796 -0.816 . . . . 1.93 108.796 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -50.35 111.74 0.58 Allowed 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.597 -0.52 . . . . 1.44 109.597 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -79.08 81.77 5.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.762 -0.654 . . . . 4.66 110.795 -172.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 12.4 p -130.6 84.56 2.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.441 -0.8 . . . . 3.6 110.13 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -129.02 140.19 51.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.098 -0.501 . . . . 7.6 110.969 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -136.14 163.63 29.9 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.563 -0.903 . . . . 8.61 108.563 175.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -85.7 41.22 0.89 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.009 0.433 . . . . 8.55 109.834 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 34.4 ttp85 -67.8 113.51 5.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.97 -0.559 . . . . 12.18 110.037 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -97.69 -22.46 16.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.734 -0.666 . . . . 12.7 110.148 -175.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -89.19 133.0 34.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.722 -0.672 . . . . 13.65 110.608 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.505 -0.76 . . . . 15.05 109.506 -179.731 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.667 0 N-CA-C 111.598 -0.601 . . . . 14.85 111.598 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.36 62.49 5.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.342 0.591 . . . . 13.5 110.243 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -145.54 138.08 13.68 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.679 -0.691 . . . . 11.25 110.066 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.53 61.72 5.3 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.581 2.187 . . . . 11.14 111.425 172.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 p 49.36 70.47 0.48 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.545 -0.752 . . . . 9.3 110.884 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 83.7 mt -104.77 134.95 47.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.902 -0.59 . . . . 7.89 110.452 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 66.29 -79.91 0.03 OUTLIER 'General case' 0 C--N 1.344 0.347 0 C-N-CA 123.069 0.548 . . . . 7.78 109.594 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.472 ' HG2' ' HB2' ' A' ' 100' ' ' ASN . 1.3 mtmm 177.67 33.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.788 0.835 . . . . 2.37 109.308 171.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.2 t -63.39 -15.66 58.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.368 -0.833 . . . . 1.79 111.29 -175.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.768 ' HA3' HD22 ' A' ' 100' ' ' ASN . . . -60.14 -24.42 60.9 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.957 -0.639 . . . . 0.44 112.021 174.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.8 t 63.76 128.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.729 0.812 . . . . 0.71 112.44 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.02 23.81 77.11 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.963 -1.113 . . . . 0.21 111.012 -179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.768 HD22 ' HA3' ' A' ' 97' ' ' GLY . 13.2 m-20 -89.62 124.97 35.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.009 -0.737 . . . . 0.63 109.009 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.568 HG12 ' HB ' ' A' ' 143' ' ' VAL . 22.9 pt -135.62 163.41 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.545 -0.298 . . . . 0.15 110.242 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.38 146.47 48.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.882 0.372 . . . . 0.21 110.054 176.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.643 HG12 HG22 ' A' ' 170' ' ' VAL . 6.8 mt -124.48 144.92 32.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.765 -0.652 . . . . 0.15 109.788 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -129.94 156.42 44.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.46 0.171 . . . . 1.46 111.073 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.7 t30 71.54 36.12 1.34 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.044 0.938 . . . . 0.49 111.357 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.586 HD22 HG21 ' A' ' 110' ' ' ILE . 31.7 mt -76.59 143.36 40.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.187 -0.461 . . . . 0.26 110.779 175.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.44 151.28 41.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.706 -0.679 . . . . 0.71 110.923 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -52.84 -32.77 46.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.499 -0.773 . . . . 2.2 112.321 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -80.45 -7.47 59.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.006 0.372 . . . . 1.41 112.006 -175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.621 HG22 HG21 ' A' ' 130' ' ' VAL . 28.2 mm -76.07 127.38 37.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.078 0.466 . . . . 0.26 110.928 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -115.64 -179.25 3.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.536 -0.756 . . . . 1.59 109.026 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -65.71 -36.39 83.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.507 -0.553 . . . . 0.6 109.507 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.983 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.98 -49.63 76.68 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.862 0.839 . . . . 2.58 109.986 178.057 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.6 98.56 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.771 -1.559 . . . . 0.15 111.315 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.743 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -64.76 -47.18 79.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.973 -0.751 . . . . 0.16 108.973 177.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.746 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 55.6 t80 -58.65 -49.1 78.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.3 111.127 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.68 -37.51 73.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.863 0.363 . . . . 0.4 110.922 -174.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.709 HG21 HD21 ' A' ' 163' ' ' LEU . 6.7 m -78.29 -53.9 6.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.521 . . . . 0.22 111.823 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 115' ' ' LEU . 21.2 m-85 -72.01 -28.29 63.29 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.31 0.485 . . . . 0.11 112.31 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.9 t -57.82 -27.53 63.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.529 0.204 . . . . 0.19 111.51 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.58 -21.83 29.41 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.762 0.315 . . . . 0.14 111.736 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -93.12 -9.78 38.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.18 110.932 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.29 161.46 10.85 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.743 -0.662 . . . . 0.11 111.665 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -61.24 132.23 52.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.24 0.543 . . . . 0.25 110.363 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.434 ' HB ' ' CD1' ' A' ' 116' ' ' TYR . 76.8 mt -100.84 134.9 39.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.62 -0.718 . . . . 0.14 109.715 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 146' ' ' GLU . 19.9 mt -89.66 -39.14 13.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.847 0.832 . . . . 0.54 108.867 -176.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.7 m -155.95 129.42 8.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.496 -1.229 . . . . 0.76 109.502 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.746 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 8.5 p -123.84 149.71 45.43 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.192 -0.67 . . . . 0.72 109.192 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -148.51 128.02 13.17 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.308 -0.557 . . . . 1.0 111.704 -177.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.743 HG22 HD12 ' A' ' 115' ' ' LEU . 59.7 t -111.31 109.59 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 106.195 -1.78 . . . . 0.28 106.195 169.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.519 HG12 ' HG3' ' A' ' 138' ' ' LYS . 14.8 t -74.44 116.52 17.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.714 -0.847 . . . . 0.34 108.714 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 62.9 m -96.59 135.95 37.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.702 -0.681 . . . . 1.58 111.666 -166.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -86.28 161.4 18.78 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.144 -1.058 . . . . 2.08 108.144 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -56.58 -28.79 61.06 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.084 0.468 . . . . 2.45 110.028 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -92.24 1.06 57.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 1.65 110.899 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 139.08 -73.08 0.42 Allowed Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.371 -0.919 . . . . 1.12 114.003 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 34.5 t -137.58 140.14 40.81 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.934 0.867 . . . . 1.61 111.379 -174.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.519 ' HG3' HG12 ' A' ' 131' ' ' VAL . 3.9 mmpt? -79.01 -9.92 59.68 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.275 0.56 . . . . 1.51 110.089 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 103.26 -22.05 37.64 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.393 -0.822 . . . . 0.31 113.361 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -126.04 152.94 45.12 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.424 0.612 . . . . 0.49 111.811 -173.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.65 174.64 26.43 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.352 -0.84 . . . . 0.12 111.619 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -139.97 136.88 34.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.947 0.374 . . . . 0.25 110.862 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.568 ' HB ' HG12 ' A' ' 101' ' ' ILE . 47.5 t -111.23 134.46 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.036 0.446 . . . . 0.1 111.094 174.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -102.51 107.04 17.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.681 -0.69 . . . . 0.21 109.159 165.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 21.2 m-85 -87.36 142.07 28.16 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.286 0.565 . . . . 0.17 110.697 176.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.503 ' HA ' HD11 ' A' ' 126' ' ' LEU . 39.4 tt0 -51.7 -35.01 41.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.521 -1.218 . . . . 0.57 111.001 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.1 p -130.04 150.06 51.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.582 -1.19 . . . . 0.4 111.181 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -62.75 -38.43 90.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.665 -0.698 . . . . 0.47 111.04 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -65.19 -33.75 76.75 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.113 -0.494 . . . . 0.74 112.285 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.67 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 0.18 110.298 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -64.62 -43.13 94.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.335 -0.848 . . . . 0.16 111.097 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 28.2 mt-10 -58.44 -40.69 83.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.851 -0.613 . . . . 1.42 110.865 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 58.8 mtt85 -64.82 -42.33 95.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.74 0.305 . . . . 1.48 110.784 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.45 94.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.4 -0.364 . . . . 0.1 110.605 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.7 mt -58.81 -54.47 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.15 111.013 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.5 pt-20 -64.1 -45.52 88.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.188 0.518 . . . . 1.08 111.841 -177.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.2 OUTLIER -77.36 -38.58 49.86 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.479 -0.782 . . . . 1.16 112.617 -170.54 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.479 ' HB2' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -90.05 -25.46 20.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.17 0.433 . . . . 0.35 112.17 -174.176 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 59.0 t30 -66.36 123.4 19.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.25 -0.648 . . . . 0.44 109.25 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.98 12.67 63.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.613 -0.803 . . . . 0.29 112.638 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.8 mmt -101.6 158.05 16.37 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.634 -0.333 . . . . 1.18 111.137 177.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 30.7 mt -98.34 107.61 20.12 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 109.207 -0.664 . . . . 0.44 109.207 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.709 HD21 HG21 ' A' ' 118' ' ' THR . 17.2 mt -90.77 107.64 19.31 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.853 -0.795 . . . . 1.02 108.853 171.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 82.5 m-20 72.78 -67.22 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.246 -0.888 . . . . 1.71 111.61 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -157.03 7.71 0.17 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.328 -0.851 . . . . 0.85 111.742 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -130.56 134.35 46.94 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.592 -0.692 . . . . 0.96 110.924 -175.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.6 tttt -79.01 118.97 21.5 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.421 HG11 HD23 ' A' ' 106' ' ' LEU . 5.7 m -100.19 146.81 8.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.596 0.712 . . . . 0.17 111.046 -172.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 74.1 t80 -106.58 117.84 35.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.699 -1.137 . . . . 0.3 109.369 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.643 HG22 HG12 ' A' ' 103' ' ' ILE . 39.4 t -115.61 131.03 69.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.425 -0.583 . . . . 0.13 109.425 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -151.85 -176.92 25.07 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.595 -0.812 . . . . 0.18 112.195 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -64.37 142.63 58.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.389 . . . . 1.93 110.284 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.453 ' HB3' ' HD3' ' A' ' 95' ' ' LYS . 73.5 t80 -70.44 138.79 51.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.72 -0.673 . . . . 1.44 110.314 -174.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.491 ' HD3' ' HG2' ' A' ' 177' ' ' LYS . 64.5 mttp -75.0 -71.62 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.671 0.272 . . . . 4.66 111.354 -177.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 40.9 t 69.19 -64.63 0.33 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.373 -0.83 . . . . 3.6 110.247 -170.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -104.97 106.81 17.46 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.169 -0.468 . . . . 7.6 109.743 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HG2' ' HD3' ' A' ' 174' ' ' LYS . 34.3 mtmm -81.41 -18.32 45.85 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.608 -0.886 . . . . 8.61 108.608 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -136.94 134.28 36.58 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.457 -1.247 . . . . 8.55 107.733 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.415 HH21 ' HA ' ' A' ' 182' ' ' GLU . 12.1 tpt180 -52.63 133.45 36.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.832 0.349 . . . . 12.18 111.609 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -139.38 156.11 47.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.674 -0.694 . . . . 12.7 110.43 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 65.49 89.04 0.1 Allowed 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.001 0.813 . . . . 13.65 113.081 170.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.415 ' HA ' HH21 ' A' ' 179' ' ' ARG . 7.8 mp0 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.508 -0.758 . . . . 15.05 109.101 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.618 0 N-CA-C 112.002 -0.439 . . . . 14.85 112.002 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.45 162.56 17.21 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.889 -0.412 . . . . 13.5 109.889 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.687 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 15.4 t70 -164.29 140.84 5.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.7 -0.481 . . . . 11.25 109.7 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.14 -29.06 54.22 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.478 2.119 . . . . 11.14 112.54 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 m -114.0 50.31 0.94 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.461 -0.336 . . . . 9.3 110.813 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.851 HD22 ' HB3' ' A' ' 176' ' ' ARG . 71.6 mt -60.52 151.17 29.21 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 110.086 -0.339 . . . . 7.89 110.086 175.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.534 ' HG2' ' H ' ' A' ' 95' ' ' LYS . 20.1 ttp180 66.44 -176.85 0.19 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.82 -0.807 . . . . 7.78 108.82 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.534 ' H ' ' HG2' ' A' ' 94' ' ' ARG . 20.7 pttm -137.84 45.85 2.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 121.581 -0.699 . . . . 2.37 110.705 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.9 t -75.79 5.94 5.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.262 -0.881 . . . . 1.79 110.394 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.671 ' HA3' HD22 ' A' ' 100' ' ' ASN . . . -71.08 -12.18 71.38 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 116.003 -0.544 . . . . 0.44 112.049 176.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.4 t 65.49 125.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.61 0.764 . . . . 0.71 111.958 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 73.25 24.08 76.15 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.167 -1.016 . . . . 0.21 111.551 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.671 HD22 ' HA3' ' A' ' 97' ' ' GLY . 13.2 m-20 -88.13 125.23 34.49 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.005 -0.739 . . . . 0.63 109.005 -173.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.527 HG23 ' HB1' ' A' ' 151' ' ' ALA . 19.1 pt -135.67 164.08 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.301 -0.259 . . . . 0.15 110.301 177.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -125.19 145.0 50.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.858 0.361 . . . . 0.21 110.162 176.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.604 HG12 HG22 ' A' ' 170' ' ' VAL . 5.3 mt -123.06 142.89 37.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.855 -0.612 . . . . 0.15 110.043 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -127.38 155.44 43.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.291 0.091 . . . . 1.46 111.125 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.9 t30 70.48 38.19 1.38 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.947 0.779 . . . . 0.49 111.216 173.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.654 HD22 HG21 ' A' ' 110' ' ' ILE . 17.5 mt -79.63 163.44 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.535 -0.757 . . . . 0.26 111.075 175.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -97.16 157.27 16.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.988 -0.551 . . . . 0.71 109.976 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 137' ' ' SER . 51.7 pttt -62.79 -28.67 70.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.935 0.398 . . . . 2.2 111.204 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.5 m -69.72 -6.52 32.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.267 -0.424 . . . . 1.41 111.936 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.654 HG21 HD22 ' A' ' 106' ' ' LEU . 31.7 mm -89.41 114.2 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.175 0.512 . . . . 0.26 110.46 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.53 -173.58 2.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.678 -0.86 . . . . 1.59 108.678 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -70.46 -33.11 70.9 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.135 -1.061 . . . . 0.6 108.135 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.654 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -66.8 -47.35 72.36 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 113.985 -1.461 . . . . 2.58 109.661 178.054 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.11 97.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.972 -1.467 . . . . 0.15 110.787 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.682 HD12 HG22 ' A' ' 130' ' ' VAL . 4.4 tt -67.07 -47.0 72.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.444 -0.798 . . . . 0.16 109.163 177.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.693 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 75.7 t80 -58.94 -46.61 87.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.078 -0.51 . . . . 0.3 110.997 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -56.77 -40.05 75.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.977 0.417 . . . . 0.4 110.886 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.442 HG21 HD21 ' A' ' 163' ' ' LEU . 9.6 m -77.67 -53.88 7.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.944 -0.571 . . . . 0.22 111.825 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.41 ' CD1' HD23 ' A' ' 115' ' ' LEU . 12.0 m-85 -72.42 -29.75 64.0 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.784 0.661 . . . . 0.11 112.784 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.6 t -58.64 -28.11 65.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.617 0.246 . . . . 0.19 111.174 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.86 -22.12 34.53 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.683 0.278 . . . . 0.14 111.593 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.89 -11.9 35.04 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.899 0.38 . . . . 0.18 110.984 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.57 160.88 10.96 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.749 -0.54 . . . . 0.11 111.749 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -62.45 139.24 58.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.25 110.185 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.436 HG21 ' HB3' ' A' ' 128' ' ' CYS . 67.1 mt -110.89 134.99 51.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.959 -0.564 . . . . 0.14 109.857 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.577 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -87.49 -44.05 11.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.635 -0.876 . . . . 0.54 108.635 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.6 m -145.33 127.48 15.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.85 -1.068 . . . . 0.76 109.862 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.693 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 8.5 p -124.09 137.0 54.63 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.587 -0.523 . . . . 0.72 109.587 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -136.39 129.59 31.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.909 0.385 . . . . 1.0 111.788 -173.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.682 HG22 HD12 ' A' ' 115' ' ' LEU . 60.9 t -115.1 110.81 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 107.171 -1.418 . . . . 0.28 107.171 170.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 t -79.74 115.67 22.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.015 -0.735 . . . . 0.34 109.015 -175.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.756 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 26.0 p -100.74 140.76 34.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.481 -0.781 . . . . 1.58 112.398 -166.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.435 ' H ' ' CA ' ' A' ' 137' ' ' SER . 29.0 t70 -86.15 160.27 19.28 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.811 -1.181 . . . . 2.08 107.811 169.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -57.73 -22.81 48.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.045 0.45 . . . . 2.45 110.934 176.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -90.03 -7.84 52.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 1.65 110.882 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.494 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 151.83 -71.38 0.29 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.488 -0.863 . . . . 1.12 113.213 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.756 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 34.3 t -145.32 153.77 41.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.536 0.668 . . . . 1.61 110.564 -177.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 37.0 mtpt -87.63 -9.02 55.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.217 0.532 . . . . 1.51 110.297 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 105.25 -18.73 41.63 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.169 -1.015 . . . . 0.31 113.575 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -127.21 151.24 48.96 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.491 0.645 . . . . 0.49 111.817 -174.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.1 175.51 25.54 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.236 -0.893 . . . . 0.12 111.338 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 102' ' ' PHE . 55.2 m-85 -139.76 140.25 36.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.868 0.334 . . . . 0.25 110.688 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.473 ' HB ' HG12 ' A' ' 101' ' ' ILE . 49.5 t -114.69 136.11 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.043 0.449 . . . . 0.1 111.076 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -104.26 106.02 16.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.706 -0.679 . . . . 0.21 109.191 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.487 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 20.8 m-85 -90.65 136.29 33.16 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.163 0.506 . . . . 0.17 111.102 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.577 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.2 tt0 -49.04 -40.69 32.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.514 -1.221 . . . . 0.57 110.682 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.8 p -117.47 147.05 43.09 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.039 -0.982 . . . . 0.4 110.731 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -63.11 -33.78 76.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.875 -0.602 . . . . 0.47 111.042 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -68.75 -34.84 76.28 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.402 -0.363 . . . . 0.74 111.456 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.81 -34.66 78.41 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.156 0.503 . . . . 0.18 110.389 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.527 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -62.32 -48.46 79.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.483 -0.78 . . . . 0.16 110.639 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.632 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 41.0 mt-10 -58.79 -38.23 78.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.824 -0.625 . . . . 1.42 110.841 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 51.4 mtt180 -62.1 -44.59 96.33 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.84 0.352 . . . . 1.48 111.011 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.19 86.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 0.1 110.657 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 151' ' ' ALA . 82.4 mt -61.02 -53.65 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.15 110.879 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.5 pt-20 -64.23 -41.73 96.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.957 0.408 . . . . 1.08 111.98 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -81.36 -39.81 24.5 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.888 0.699 . . . . 1.16 112.888 -171.544 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.533 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.3 mmm -93.02 -22.78 18.94 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.598 0.592 . . . . 0.35 112.598 -172.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -66.96 123.33 19.91 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.028 -0.731 . . . . 0.44 109.028 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.2 13.21 66.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.585 -0.817 . . . . 0.29 112.545 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.64 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.2 mmt -101.41 165.18 11.39 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.614 -0.345 . . . . 1.18 111.224 177.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.33 130.46 46.44 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.949 -0.76 . . . . 0.44 108.949 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 22.0 mt -116.41 101.1 8.36 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.08 -0.648 . . . . 1.02 109.757 171.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 165' ' ' ASP . 55.9 m-20 78.5 -24.62 0.21 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.249 -0.887 . . . . 1.71 112.659 177.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 23.2 t70 166.17 -22.47 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 O-C-N 124.0 0.813 . . . . 0.85 111.439 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 -110.71 132.02 54.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.497 -0.32 . . . . 0.96 110.872 -170.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.64 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.6 ttmt -77.94 124.15 27.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.456 HG11 HD23 ' A' ' 106' ' ' LEU . 18.5 m -103.22 149.66 7.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.329 0.585 . . . . 0.17 111.573 -174.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 43.3 t80 -107.21 120.91 43.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.3 -0.864 . . . . 0.3 109.062 177.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.604 HG22 HG12 ' A' ' 103' ' ' ILE . 41.0 t -115.56 125.65 72.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.39 -0.596 . . . . 0.13 109.39 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.22 -173.76 16.8 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.568 -0.825 . . . . 0.18 112.218 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -65.4 145.13 56.55 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.836 -0.431 . . . . 1.93 109.836 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.523 ' HD2' ' HB3' ' A' ' 95' ' ' LYS . 72.6 t80 -68.59 133.88 49.16 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.953 -0.567 . . . . 1.44 110.907 -172.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.432 ' NZ ' ' HB3' ' A' ' 174' ' ' LYS . 0.4 OUTLIER -141.14 79.47 1.69 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.947 -0.57 . . . . 4.66 111.266 -178.759 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.9 p -66.26 -57.52 7.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.811 -0.631 . . . . 3.6 109.642 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.851 ' HB3' HD22 ' A' ' 93' ' ' LEU . 6.6 ptm180 -88.58 147.83 24.39 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.702 -0.851 . . . . 7.6 108.702 173.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -125.66 7.92 7.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.217 0.532 . . . . 8.61 110.561 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -101.76 143.88 31.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.757 -0.656 . . . . 8.55 109.823 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -94.06 -28.43 15.73 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.214 -0.661 . . . . 12.18 109.214 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 70.66 121.24 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.283 -0.871 . . . . 12.7 111.278 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.3 92.68 8.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.036 0.446 . . . . 13.65 110.429 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.644 -0.693 . . . . 15.05 110.226 -177.734 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.776 0 N-CA-C 112.18 -0.368 . . . . 14.85 112.18 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.13 -30.81 17.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.009 0.433 . . . . 13.5 110.391 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -83.05 122.91 77.95 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.866 -0.606 . . . . 11.25 109.495 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.32 -72.16 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.591 2.194 . . . . 11.14 112.255 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.2 m -156.84 94.46 1.44 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.389 -0.369 . . . . 9.3 110.7 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 99.4 mt -99.26 120.98 40.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.128 -0.323 . . . . 7.89 110.128 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -102.51 -41.91 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.378 0.609 . . . . 7.78 109.962 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -96.4 93.67 6.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.281 -0.872 . . . . 2.37 109.855 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.2 m -62.74 -14.03 39.78 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 112.182 0.438 . . . . 1.79 112.182 -177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.516 ' HA3' HD22 ' A' ' 100' ' ' ASN . . . -72.06 -29.33 66.95 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.872 -0.68 . . . . 0.44 111.943 174.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.4 t 61.13 127.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.868 0.867 . . . . 0.71 112.889 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 72.31 24.34 76.52 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.984 -1.103 . . . . 0.21 111.768 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.516 HD22 ' HA3' ' A' ' 97' ' ' GLY . 9.1 m-20 -86.51 125.21 33.59 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.535 -0.542 . . . . 0.63 109.535 -173.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.581 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.9 pt -135.57 160.43 39.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.228 -0.286 . . . . 0.15 110.228 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -125.79 142.78 51.35 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.888 -0.412 . . . . 0.21 109.888 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.648 HG12 HG22 ' A' ' 170' ' ' VAL . 7.2 mt -121.05 131.27 73.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 0.15 110.251 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -116.06 151.32 35.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.681 -0.236 . . . . 1.46 110.561 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.2 t30 74.5 38.09 0.52 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.903 0.752 . . . . 0.49 111.834 172.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.556 HD22 HG21 ' A' ' 110' ' ' ILE . 19.3 mt -76.78 158.47 30.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.059 0.457 . . . . 0.26 111.065 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.504 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.0 t70 -84.26 151.69 24.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.553 -0.748 . . . . 0.71 111.394 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -53.12 -36.19 60.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.13 -0.941 . . . . 2.2 112.368 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -88.18 -2.57 58.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.242 -0.435 . . . . 1.41 112.169 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.556 HG21 HD22 ' A' ' 106' ' ' LEU . 36.4 mm -73.59 124.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.2 0.524 . . . . 0.26 110.823 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.518 ' OD2' ' HB3' ' A' ' 113' ' ' LYS . 0.2 OUTLIER -104.11 177.99 4.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.434 -0.803 . . . . 1.59 110.865 -178.1 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -71.23 -33.67 70.08 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 107.56 -1.274 . . . . 0.6 107.56 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.642 ' HZ3' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -64.32 -48.87 73.95 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.833 -1.531 . . . . 2.58 108.949 176.032 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -60.91 -44.87 96.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.367 -1.288 . . . . 0.15 111.062 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.723 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -64.09 -47.1 81.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.302 -0.863 . . . . 0.16 109.056 177.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.674 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 69.8 t80 -59.61 -49.3 78.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.936 -0.575 . . . . 0.3 111.135 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -58.3 -35.07 71.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.939 0.399 . . . . 0.4 111.166 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 24.9 m -78.8 -54.45 6.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.319 -0.401 . . . . 0.22 112.022 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.438 ' CD1' HD23 ' A' ' 115' ' ' LEU . 8.6 m-85 -72.78 -29.72 63.52 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.665 0.617 . . . . 0.11 112.665 -173.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.2 t -58.76 -28.06 65.56 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.668 0.271 . . . . 0.19 111.454 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.56 -22.87 36.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.937 0.398 . . . . 0.14 111.236 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -90.32 -19.04 24.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.18 110.811 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.76 168.43 29.88 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 121.132 -0.556 . . . . 0.11 111.89 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -69.58 139.9 53.74 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.099 -0.334 . . . . 0.25 110.099 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 128' ' ' CYS . 73.5 mt -111.78 133.78 56.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.389 -0.369 . . . . 0.14 110.526 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.641 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -91.94 -38.06 12.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.442 0.639 . . . . 0.54 109.431 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 75.4 m -155.68 102.82 2.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.46 -0.791 . . . . 0.76 110.942 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.674 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 9.3 p -106.12 142.64 35.48 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.848 -0.427 . . . . 0.72 109.848 173.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -135.43 130.82 35.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.797 -173.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.723 HG22 HD12 ' A' ' 115' ' ' LEU . 63.3 t -114.91 110.08 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 106.838 -1.541 . . . . 0.28 106.838 170.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 t -79.08 115.29 21.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.637 -0.875 . . . . 0.34 108.637 -175.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.799 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 8.8 p -103.54 135.83 44.4 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.733 0.642 . . . . 1.58 112.733 -167.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.406 ' H ' ' CA ' ' A' ' 137' ' ' SER . 20.5 t70 -86.6 169.78 12.44 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.974 -1.012 . . . . 2.08 108.878 175.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.31 -29.49 68.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.069 0.461 . . . . 2.45 109.971 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -85.14 -1.35 56.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.953 -0.567 . . . . 1.65 111.317 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 139.46 -69.64 0.47 Allowed Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.407 -0.902 . . . . 1.12 112.986 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.799 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 33.3 t -141.13 149.83 42.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.388 0.594 . . . . 1.61 109.877 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -80.9 -13.78 58.6 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.287 0.565 . . . . 1.51 109.721 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 109.53 -14.75 32.58 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.446 -0.883 . . . . 0.31 113.265 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -129.14 148.32 51.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.535 0.668 . . . . 0.49 111.875 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.28 170.99 25.25 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.05 -0.977 . . . . 0.12 111.433 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -137.77 137.57 38.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.757 0.278 . . . . 0.25 110.578 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.581 ' HB ' HG12 ' A' ' 101' ' ' ILE . 36.5 t -113.42 130.89 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 120.889 0.376 . . . . 0.1 110.814 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.4 OUTLIER -100.61 105.95 17.4 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.019 -0.734 . . . . 0.21 109.019 166.397 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.525 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 12.4 m-85 -89.36 137.32 32.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.266 0.555 . . . . 0.17 111.209 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.641 ' HA ' HD21 ' A' ' 126' ' ' LEU . 41.5 tt0 -47.88 -48.75 31.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.235 -1.348 . . . . 0.57 110.556 176.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 p -110.63 144.51 39.41 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.379 -1.282 . . . . 0.4 111.218 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -61.77 -37.7 85.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.665 -0.698 . . . . 0.47 110.996 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.0 pt-20 -69.91 -34.36 73.39 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.615 -0.266 . . . . 0.74 111.682 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.55 77.61 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.154 0.502 . . . . 0.18 110.403 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.526 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -62.97 -44.69 95.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.488 -0.778 . . . . 0.16 110.501 176.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 49.1 mt-10 -59.53 -40.55 87.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 1.42 110.541 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.521 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 50.1 mtt180 -62.3 -39.93 94.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 1.48 110.823 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.02 -38.5 86.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.472 -0.331 . . . . 0.1 110.423 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 151' ' ' ALA . 81.2 mt -58.68 -54.04 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 0.15 111.167 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.0 OUTLIER -61.05 -44.25 97.67 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.149 0.499 . . . . 1.08 112.028 -178.462 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.439 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.23 -38.7 24.12 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.48 -0.782 . . . . 1.16 112.802 -169.002 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.47 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.9 mmm -91.23 -24.28 19.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.254 0.464 . . . . 0.35 112.254 -173.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 59.9 t30 -67.72 123.02 19.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.215 -0.594 . . . . 0.44 109.507 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.0 8.83 64.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.732 -0.747 . . . . 0.29 112.786 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.742 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.4 mmt -92.01 163.81 13.85 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.692 0.282 . . . . 1.18 111.425 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 15.7 mt -105.55 107.21 18.07 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.536 -0.542 . . . . 0.44 109.536 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 163' ' ' LEU . 18.3 mt -94.61 108.55 20.52 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.793 -0.763 . . . . 1.02 109.245 172.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 94.4 m-20 72.11 -62.35 0.47 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.137 -0.938 . . . . 1.71 112.127 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -163.88 12.78 0.05 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.787 -0.642 . . . . 0.85 111.438 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.504 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.1 mtt180 -134.41 129.85 35.96 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.966 -0.459 . . . . 0.96 110.481 -174.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.742 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.2 ttmt -78.7 120.12 22.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.157 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.461 HG11 HD23 ' A' ' 106' ' ' LEU . 14.5 m -100.73 146.58 9.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.619 0.723 . . . . 0.17 111.231 -172.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.583 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 75.2 t80 -106.9 118.38 36.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.729 -1.123 . . . . 0.3 109.341 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.648 HG22 HG12 ' A' ' 103' ' ' ILE . 41.1 t -115.22 125.06 72.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.104 -0.702 . . . . 0.13 109.104 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.76 -174.46 17.96 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.512 -0.851 . . . . 0.18 112.098 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 -67.86 120.02 13.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.964 0.412 . . . . 1.93 110.246 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -58.2 127.78 33.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.445 -0.798 . . . . 1.44 111.015 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -66.56 95.61 0.34 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.025 -0.732 . . . . 4.66 109.025 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 12.8 m -94.73 -22.64 17.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.553 -0.749 . . . . 3.6 110.376 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 176' ' ' ARG . 40.1 ttt180 65.05 -91.67 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.963 0.789 . . . . 7.6 109.735 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm 174.43 -38.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.62 -0.881 . . . . 8.61 108.62 175.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.752 ' HG3' ' H ' ' A' ' 180' ' ' GLU . 12.2 tp10 -82.21 135.56 35.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.087 -0.961 . . . . 8.55 109.734 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -99.51 8.7 44.29 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.319 -0.623 . . . . 12.18 109.319 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.752 ' H ' ' HG3' ' A' ' 178' ' ' GLU . 7.0 mm-40 74.93 -41.37 0.46 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.005 -0.998 . . . . 12.7 111.976 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.43 95.22 5.52 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.838 0.352 . . . . 13.65 110.449 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.46 -0.781 . . . . 15.05 109.818 -179.545 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.693 0 N-CA-C 112.007 -0.437 . . . . 14.85 112.007 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.66 156.56 28.96 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.845 -0.209 . . . . 13.5 110.467 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.474 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 29.1 t70 -83.15 128.47 64.85 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.776 0.322 . . . . 11.25 110.557 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 21.1 Cg_exo -66.05 -10.47 27.22 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.233 2.622 . . . . 11.14 113.138 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.645 ' HB3' ' HA ' ' A' ' 176' ' ' ARG . 25.3 m -108.01 67.48 0.68 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.337 0.589 . . . . 9.3 111.139 -177.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 83.3 mt -141.14 109.17 5.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.501 -0.772 . . . . 7.89 108.979 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 54.96 -153.57 0.31 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.343 -0.614 . . . . 7.78 109.343 -171.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.771 ' HE2' ' HB3' ' A' ' 172' ' ' ARG . 12.5 mptt -92.86 167.91 11.52 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.608 -0.437 . . . . 2.37 110.241 173.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 98' ' ' VAL . 7.0 p -154.82 -179.22 7.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.674 -0.862 . . . . 1.79 108.674 -177.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.513 ' HA3' HD22 ' A' ' 100' ' ' ASN . . . 75.71 -26.22 1.39 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.979 -0.629 . . . . 0.44 111.898 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.477 ' H ' ' C ' ' A' ' 96' ' ' SER . 71.5 t 66.13 124.11 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 C-N-CA 124.165 0.986 . . . . 0.71 111.857 -176.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 73.27 24.15 75.98 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.181 -1.009 . . . . 0.21 112.084 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.513 HD22 ' HA3' ' A' ' 97' ' ' GLY . 8.9 m-20 -88.58 125.41 34.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.357 -0.608 . . . . 0.63 109.357 -174.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.522 HG23 ' HB1' ' A' ' 151' ' ' ALA . 21.4 pt -135.31 159.73 40.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.087 -0.338 . . . . 0.15 110.087 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.39 138.18 54.62 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.899 -0.408 . . . . 0.21 109.899 176.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.632 HG12 HG22 ' A' ' 170' ' ' VAL . 5.7 mt -116.71 131.49 69.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.548 -0.751 . . . . 0.15 110.076 -177.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -113.66 152.56 30.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.493 -0.321 . . . . 1.46 110.588 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.8 t30 75.58 33.99 0.62 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.014 0.821 . . . . 0.49 111.683 170.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.485 HD23 HG11 ' A' ' 168' ' ' VAL . 25.4 mt -75.64 156.82 34.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 0.26 111.446 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.464 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 15.0 t70 -83.15 153.14 24.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.519 -0.764 . . . . 0.71 111.36 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.422 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 55.1 pttt -54.09 -37.66 64.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.485 -0.78 . . . . 2.2 112.501 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.421 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 13.7 m -80.86 -8.76 59.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.848 0.314 . . . . 1.41 111.848 -172.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.502 ' O ' HG11 ' A' ' 130' ' ' VAL . 34.6 mm -71.16 120.17 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.013 0.435 . . . . 0.26 110.376 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -109.27 -179.67 3.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.016 -0.735 . . . . 1.59 109.016 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.58 -40.98 98.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.269 -0.641 . . . . 0.6 109.269 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.884 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -59.97 -49.39 77.87 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.277 -0.874 . . . . 2.58 110.567 178.416 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.9 98.19 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.265 -1.334 . . . . 0.15 111.396 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.762 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -65.03 -47.15 78.42 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.952 -0.758 . . . . 0.16 108.952 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 64.4 t80 -57.54 -48.23 79.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.916 -0.584 . . . . 0.3 111.009 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.25 -37.55 72.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.968 0.413 . . . . 0.4 110.828 -175.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 m -77.88 -54.42 6.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.151 -0.477 . . . . 0.22 111.815 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.434 ' CD1' HD23 ' A' ' 115' ' ' LEU . 10.2 m-85 -73.02 -28.82 62.58 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.881 0.696 . . . . 0.11 112.881 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -57.57 -28.23 63.38 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.777 0.322 . . . . 0.19 110.875 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.45 -21.74 27.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.355 -0.384 . . . . 0.14 111.618 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -92.98 -17.41 23.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.989 0.423 . . . . 0.18 110.918 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.72 162.51 14.74 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.977 -0.556 . . . . 0.11 111.796 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -61.67 132.45 53.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.057 0.456 . . . . 0.25 110.538 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 128' ' ' CYS . 68.3 mt -106.35 133.68 50.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.808 -0.633 . . . . 0.14 109.747 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.602 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.28 -40.31 13.72 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.01 -0.737 . . . . 0.54 109.01 -177.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.3 m -147.68 129.66 15.37 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.973 -1.012 . . . . 0.76 109.915 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 5.8 p -129.44 124.67 34.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.265 -0.643 . . . . 0.72 109.265 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -123.95 127.93 48.67 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.906 0.384 . . . . 1.0 111.327 -173.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.762 HG22 HD12 ' A' ' 115' ' ' LEU . 54.8 t -114.48 109.55 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 106.856 -1.535 . . . . 0.28 106.856 170.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.47 HG12 ' HG3' ' A' ' 138' ' ' LYS . 6.4 t -75.77 115.91 17.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.611 -0.885 . . . . 0.34 108.611 -175.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 3.2 p -97.15 134.56 40.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.732 -0.667 . . . . 1.58 112.443 -165.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -87.56 163.95 16.36 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.225 -1.028 . . . . 2.08 108.225 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -56.25 -27.42 55.03 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.806 0.336 . . . . 2.45 110.538 174.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -92.34 -1.24 57.18 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.261 -0.427 . . . . 1.65 111.134 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 142.35 -69.11 0.44 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.516 -0.85 . . . . 1.12 113.656 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.674 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 34.3 t -142.2 145.87 34.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.292 0.546 . . . . 1.61 110.538 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.47 ' HG3' HG12 ' A' ' 131' ' ' VAL . 4.2 mmpt? -76.07 -15.65 60.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.325 0.583 . . . . 1.51 110.279 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 112.28 -12.4 26.23 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.186 -0.916 . . . . 0.31 113.314 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 24.0 p90 -133.03 148.8 52.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.368 0.584 . . . . 0.49 111.654 -176.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.86 168.56 25.93 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.24 -0.891 . . . . 0.12 111.377 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -136.47 136.49 39.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.059 0.43 . . . . 0.25 110.801 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.518 ' HB ' HG12 ' A' ' 101' ' ' ILE . 48.7 t -111.0 136.45 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.957 0.408 . . . . 0.1 111.145 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -105.57 105.63 15.76 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.104 -0.702 . . . . 0.21 109.104 166.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.472 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 17.5 m-85 -88.79 138.59 31.28 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.042 0.448 . . . . 0.17 110.938 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.602 ' HA ' HD21 ' A' ' 126' ' ' LEU . 28.5 tt0 -45.87 -45.39 15.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.526 -1.215 . . . . 0.57 110.923 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.3 p -119.8 150.78 39.86 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.938 -1.028 . . . . 0.4 110.839 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -61.46 -33.41 73.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.49 -0.777 . . . . 0.47 110.865 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.76 -35.65 75.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.74 111.83 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.59 -34.23 76.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.093 0.473 . . . . 0.18 110.498 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -64.2 -44.25 92.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.632 -0.713 . . . . 0.16 110.688 176.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 31.8 mt-10 -58.96 -38.61 79.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 1.42 110.471 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.544 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 92.2 mtt180 -62.77 -43.51 98.6 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.03 0.443 . . . . 1.48 110.969 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.75 -37.29 85.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 0.1 110.405 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 151' ' ' ALA . 90.6 mt -59.17 -52.74 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.15 111.248 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.6 pt-20 -64.02 -46.24 85.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.09 0.472 . . . . 1.08 111.809 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -80.86 -38.47 28.1 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.147 0.795 . . . . 1.16 113.147 -168.462 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.419 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.0 mmm -93.29 -20.22 20.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.458 0.54 . . . . 0.35 112.458 -173.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 53.8 t30 -68.58 123.75 21.71 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.221 -0.592 . . . . 0.44 109.652 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.52 64.48 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.777 -0.725 . . . . 0.29 112.539 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.729 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.7 mmt -96.07 162.5 13.52 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.678 0.239 . . . . 1.18 110.976 177.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.9 mt -103.35 105.04 15.22 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.345 -0.613 . . . . 0.44 109.345 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 18.0 mt -91.04 108.93 20.19 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.925 -0.71 . . . . 1.02 109.256 173.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 93.9 m-20 73.57 -60.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.302 -0.863 . . . . 1.71 111.827 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -172.61 22.9 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.549 -0.75 . . . . 0.85 110.798 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.7 mtt180 -138.29 132.75 32.14 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.006 -0.434 . . . . 0.96 109.96 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.729 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.2 tttt -84.19 115.02 22.21 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.485 HG11 HD23 ' A' ' 106' ' ' LEU . 15.6 m -100.12 147.83 7.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.599 0.714 . . . . 0.17 111.485 -170.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 75.8 t80 -106.58 120.49 42.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.735 -1.121 . . . . 0.3 109.365 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.632 HG22 HG12 ' A' ' 103' ' ' ILE . 42.3 t -115.48 125.58 72.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.154 -0.684 . . . . 0.13 109.154 177.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.53 -171.5 16.68 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.351 -0.928 . . . . 0.18 112.235 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.771 ' HB3' ' HE2' ' A' ' 95' ' ' LYS . 25.9 mmt180 -69.3 131.19 44.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.426 -0.583 . . . . 1.93 109.426 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.562 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 49.4 t80 -63.97 128.62 36.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.052 -0.522 . . . . 1.44 110.296 -176.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -82.53 85.44 6.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.116 0.484 . . . . 4.66 110.086 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 95' ' ' LYS . 0.5 OUTLIER -84.89 -16.81 39.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.885 -0.598 . . . . 3.6 111.85 -177.27 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.645 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 19.2 ttp180 -109.72 -90.1 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.543 -0.463 . . . . 7.6 110.635 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -142.38 -170.56 3.21 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.194 -0.298 . . . . 8.61 110.194 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -125.09 127.05 46.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.574 -0.899 . . . . 8.55 108.574 173.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 180' ' ' GLU . 40.9 ttm180 -90.86 -74.59 0.49 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.852 -0.339 . . . . 12.18 111.231 -174.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 179' ' ' ARG . 36.9 tt0 163.13 -37.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.609 -0.886 . . . . 12.7 108.609 -173.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.33 101.3 3.88 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.513 -1.221 . . . . 13.65 109.185 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-N 115.631 -0.713 . . . . 15.05 110.136 -175.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.976 0 N-CA-C 112.278 -0.329 . . . . 14.85 112.278 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 176' ' ' ARG . . . -137.1 31.04 2.69 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.015 -0.735 . . . . 13.5 109.015 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.748 ' HB2' ' HB3' ' A' ' 93' ' ' LEU . 2.7 m-20 -102.73 110.31 62.95 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.847 -1.07 . . . . 11.25 110.611 -172.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.56 ' HA ' ' HB2' ' A' ' 175' ' ' SER . 50.7 Cg_exo -56.4 -50.8 10.84 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.085 2.523 . . . . 11.14 112.76 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.2 m -82.13 11.23 5.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.451 -0.34 . . . . 9.3 111.822 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.748 ' HB3' ' HB2' ' A' ' 90' ' ' ASP . 3.2 tm? -117.64 -50.31 2.52 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.032 -0.358 . . . . 7.89 110.032 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 2.6 mmp_? -65.86 -51.12 61.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 7.78 111.605 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.94 11.02 24.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.784 0.326 . . . . 2.37 111.268 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.8 t -79.05 -6.26 55.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.276 0.56 . . . . 1.79 110.31 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' A' ' 98' ' ' VAL . . . -67.8 -22.72 73.89 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.782 -0.644 . . . . 0.44 111.923 176.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 97' ' ' GLY . 41.2 t 72.06 117.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.711 0.804 . . . . 0.71 111.908 -176.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.08 24.08 69.93 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.218 -0.991 . . . . 0.21 111.877 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 173' ' ' PHE . 2.2 m120 -87.45 125.8 34.51 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.969 -0.752 . . . . 0.63 108.969 -176.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.563 HG12 ' HB ' ' A' ' 143' ' ' VAL . 23.8 pt -135.02 163.55 36.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.477 -0.329 . . . . 0.15 110.283 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.14 147.28 49.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.83 -0.433 . . . . 0.21 109.83 175.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.561 HG12 HG22 ' A' ' 170' ' ' VAL . 4.4 mt -119.26 139.29 47.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.679 -0.691 . . . . 0.15 109.811 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -117.16 153.22 33.2 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.952 0.158 . . . . 1.46 110.637 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.0 t30 71.39 39.73 0.9 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.863 0.727 . . . . 0.49 112.16 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.434 HD23 HG11 ' A' ' 168' ' ' VAL . 33.5 mt -81.82 164.73 21.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.807 0.337 . . . . 0.26 111.056 176.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -96.7 157.53 15.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.71 109.813 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.843 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 22.2 pttp -61.51 -26.4 67.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.484 0.659 . . . . 2.2 109.681 172.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 m -59.78 -23.12 63.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.632 -1.167 . . . . 1.41 112.596 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.608 HG22 HG21 ' A' ' 130' ' ' VAL . 40.2 mm -86.43 131.32 34.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.407 0.622 . . . . 0.26 111.502 -174.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -117.37 -175.39 2.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.235 -1.024 . . . . 1.59 108.235 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -69.07 -29.68 67.85 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.608 -0.886 . . . . 0.6 108.608 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -49.46 65.18 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.457 -1.247 . . . . 2.58 109.404 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.78 85.47 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.7 -1.136 . . . . 0.15 110.691 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.742 HD12 HG22 ' A' ' 130' ' ' VAL . 3.5 tt -70.72 -48.05 56.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.47 -0.786 . . . . 0.16 109.35 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.622 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 80.2 t80 -61.05 -45.12 96.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 0.3 110.833 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.43 -41.83 77.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.014 0.435 . . . . 0.4 110.884 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.418 HG21 HD21 ' A' ' 163' ' ' LEU . 24.0 m -77.66 -53.66 7.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 0.22 112.072 -177.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.455 ' CD1' HD23 ' A' ' 115' ' ' LEU . 17.7 m-85 -72.17 -29.46 64.04 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.46 0.541 . . . . 0.11 112.46 -173.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.6 t -58.67 -28.93 66.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.595 0.236 . . . . 0.19 111.201 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.38 -22.62 43.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 0.14 111.554 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -93.64 -11.94 30.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 0.18 110.875 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.95 164.06 15.14 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.929 -0.653 . . . . 0.11 111.846 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -67.05 137.5 56.48 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.932 0.396 . . . . 0.25 110.178 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.416 HG21 ' HB3' ' A' ' 128' ' ' CYS . 72.1 mt -110.21 129.57 64.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.119 -0.491 . . . . 0.14 109.927 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.14 -35.37 20.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.054 -0.721 . . . . 0.54 109.054 -177.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 65.8 m -154.31 128.72 9.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.17 -0.923 . . . . 0.76 109.849 -177.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 2.6 p -134.14 144.85 48.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.802 0.334 . . . . 0.72 110.247 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -143.78 133.15 23.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.59 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.742 HG22 HD12 ' A' ' 115' ' ' LEU . 59.6 t -113.23 111.11 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 106.383 -1.71 . . . . 0.28 106.383 168.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 t -79.99 115.86 23.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.804 -0.813 . . . . 0.34 108.804 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 5.6 p -99.5 135.88 40.26 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.759 0.652 . . . . 1.58 112.759 -166.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.41 ' H ' ' CA ' ' A' ' 137' ' ' SER . 31.5 t70 -86.1 163.29 17.97 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.962 -1.017 . . . . 2.08 108.818 174.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -54.83 -31.33 59.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.791 0.329 . . . . 2.45 110.7 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -86.28 -6.62 58.92 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.196 -0.456 . . . . 1.65 110.979 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.843 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 148.4 -71.1 0.32 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.743 -0.741 . . . . 1.12 113.271 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.746 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 27.6 t -142.81 146.27 34.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.336 0.568 . . . . 1.61 110.409 -176.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 37.5 mtpt -78.65 -8.1 58.32 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.342 0.591 . . . . 1.51 110.137 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 102.94 -19.93 45.15 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.466 -0.873 . . . . 0.31 113.113 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 22.2 p90 -125.88 148.78 49.09 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.457 0.629 . . . . 0.49 111.984 -174.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.36 173.81 23.2 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.002 -0.999 . . . . 0.12 111.358 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -136.11 141.85 44.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.032 0.416 . . . . 0.25 110.848 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.563 ' HB ' HG12 ' A' ' 101' ' ' ILE . 28.1 t -117.23 135.95 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.106 0.479 . . . . 0.1 110.84 172.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -107.2 106.17 16.5 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.031 -0.729 . . . . 0.21 109.031 168.431 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.2 m-85 -90.49 139.06 31.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.596 0.713 . . . . 0.17 111.936 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.576 ' HA ' HD21 ' A' ' 126' ' ' LEU . 46.5 tt0 -49.05 -40.79 32.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.912 -1.495 . . . . 0.57 110.86 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.2 p -123.93 154.59 39.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.887 -1.051 . . . . 0.4 110.513 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -66.14 -33.5 75.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.177 -0.465 . . . . 0.47 110.902 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.07 -35.86 77.0 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.365 -0.379 . . . . 0.74 111.518 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.19 -34.51 78.24 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.168 0.508 . . . . 0.18 110.402 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.529 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.81 -48.01 80.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.523 -0.762 . . . . 0.16 110.606 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.634 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 29.3 mt-10 -58.64 -42.13 87.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.005 -0.543 . . . . 1.42 110.696 177.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 72.5 mtt180 -58.65 -41.62 86.49 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.944 0.402 . . . . 1.48 110.949 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.22 -40.36 86.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.359 -0.382 . . . . 0.1 110.612 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 151' ' ' ALA . 91.1 mt -60.33 -49.59 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.056 -0.52 . . . . 0.15 111.176 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.9 pt-20 -64.07 -45.69 87.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.175 0.512 . . . . 1.08 111.704 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.473 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -80.73 -38.58 28.5 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.329 0.863 . . . . 1.16 113.329 -169.261 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.426 ' HB2' HG21 ' A' ' 170' ' ' VAL . 88.9 mmm -95.77 -17.12 21.44 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.709 0.633 . . . . 0.35 112.709 -172.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.06 123.06 20.61 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.197 -0.601 . . . . 0.44 109.613 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.04 22.69 54.45 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.865 -0.684 . . . . 0.29 112.419 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.564 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.5 OUTLIER -106.48 161.57 14.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.724 0.297 . . . . 1.18 111.622 -179.091 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 75.4 mt -104.17 106.75 17.36 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.908 -0.775 . . . . 0.44 108.908 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.418 HD21 HG21 ' A' ' 118' ' ' THR . 2.6 mt -92.6 22.17 4.89 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.015 -0.674 . . . . 1.02 111.864 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.7 p30 169.92 -79.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.823 0.849 . . . . 1.71 109.153 -175.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -150.93 12.28 0.67 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.747 -1.115 . . . . 0.85 109.536 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -124.04 135.04 53.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.589 -0.732 . . . . 0.96 109.096 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 161' ' ' MET . 3.9 ttmp? -84.19 117.25 23.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.434 HG11 HD23 ' A' ' 106' ' ' LEU . 19.1 m -99.79 143.28 13.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.541 0.686 . . . . 0.17 110.565 -172.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 39.7 t80 -106.53 122.18 45.78 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.882 -1.054 . . . . 0.3 109.417 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.561 HG22 HG12 ' A' ' 103' ' ' ILE . 43.1 t -115.94 125.75 73.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.476 -0.564 . . . . 0.13 109.476 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.04 -167.23 12.1 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.319 -0.712 . . . . 0.18 111.319 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -68.97 136.43 52.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.833 -0.803 . . . . 1.93 108.833 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 174' ' ' LYS . 68.0 t80 -38.18 -87.48 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.507 1.129 . . . . 1.44 113.434 -169.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 173' ' ' PHE . 63.8 tttm 162.49 105.19 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.895 -0.78 . . . . 4.66 108.895 -178.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 0.1 OUTLIER -94.35 -64.6 1.06 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.68 0.276 . . . . 3.6 111.174 -176.654 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 39.8 ttm180 -113.18 -55.24 2.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.414 0.626 . . . . 7.6 110.132 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -179.15 -32.39 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.673 -1.149 . . . . 8.61 108.322 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 61.22 82.15 0.17 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.507 -1.224 . . . . 8.55 110.717 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -73.49 111.24 8.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.183 -0.917 . . . . 12.18 109.464 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -127.3 -4.34 6.12 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.425 -0.352 . . . . 12.7 111.35 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -81.51 93.21 6.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.927 0.394 . . . . 13.65 110.485 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.538 -0.744 . . . . 15.05 109.641 -178.968 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.558 0 N-CA-C 112.056 -0.418 . . . . 14.85 112.056 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.36 -176.04 2.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.418 -0.586 . . . . 13.5 109.418 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -106.38 128.53 26.09 Favored Pre-proline 0 C--N 1.321 -0.668 0 C-N-CA 120.743 -0.383 . . . . 11.25 110.323 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.26 -35.2 98.95 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.861 2.374 . . . . 11.14 111.735 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.1 m -119.83 78.33 1.32 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.172 -0.677 . . . . 9.3 109.172 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 23.5 tp -73.08 -32.64 65.13 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.151 -0.685 . . . . 7.89 109.151 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -84.77 157.67 20.94 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.31 -1.367 . . . . 7.78 107.31 164.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -93.08 153.24 18.8 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.722 -0.791 . . . . 2.37 111.114 -166.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 p -79.49 -27.9 41.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.873 0.368 . . . . 1.79 110.97 -172.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.817 ' HA3' HD22 ' A' ' 100' ' ' ASN . . . -69.86 -29.89 70.66 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.597 -0.811 . . . . 0.44 111.183 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.3 t 61.47 127.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.847 0.859 . . . . 0.71 112.531 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.32 24.87 74.37 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 119.873 -1.155 . . . . 0.21 111.455 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.817 HD22 ' HA3' ' A' ' 97' ' ' GLY . 13.6 m-20 -89.95 124.17 34.5 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.955 -0.757 . . . . 0.63 108.955 -173.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.482 HG23 ' HB1' ' A' ' 151' ' ' ALA . 17.1 pt -136.07 163.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.942 -0.392 . . . . 0.15 109.942 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.94 143.22 51.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.1 0.476 . . . . 0.21 109.775 176.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.662 HG12 HG22 ' A' ' 170' ' ' VAL . 6.1 mt -119.33 136.38 56.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.355 -0.839 . . . . 0.15 109.876 -177.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -120.15 154.1 35.26 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 121.438 -0.105 . . . . 1.46 110.913 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.0 t30 73.73 32.79 1.09 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.878 0.871 . . . . 0.49 111.528 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 110' ' ' ILE . 30.7 mt -73.99 154.31 39.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.408 . . . . 0.26 111.255 177.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.46 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 25.6 t70 -83.17 152.3 25.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.675 . . . . 0.71 110.681 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.667 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 63.6 pttt -56.15 -34.66 66.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.625 . . . . 2.2 112.014 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.3 m -80.14 -2.83 46.33 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.416 0.524 . . . . 1.41 112.416 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.645 HG21 HD22 ' A' ' 106' ' ' LEU . 31.6 mm -78.91 116.43 22.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.615 -0.434 . . . . 0.26 110.057 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -105.85 -176.7 3.15 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.95 -0.759 . . . . 1.59 108.95 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -68.81 -31.01 69.7 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.111 -0.7 . . . . 0.6 109.111 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -48.33 66.15 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.634 -1.166 . . . . 2.58 109.238 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.6 -41.6 97.66 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.269 -1.332 . . . . 0.15 110.796 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.711 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -67.5 -47.37 70.21 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.243 -0.89 . . . . 0.16 108.994 177.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.724 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 62.3 t80 -58.34 -47.81 82.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.179 -0.464 . . . . 0.3 111.155 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -56.74 -39.27 73.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.068 0.461 . . . . 0.4 110.86 -174.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 m -78.48 -53.59 7.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.84 -0.618 . . . . 0.22 112.181 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 115' ' ' LEU . 8.3 m-85 -72.52 -28.29 62.77 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.802 0.667 . . . . 0.11 112.802 -174.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.5 t -57.05 -28.39 62.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.749 0.309 . . . . 0.19 111.428 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.35 -22.45 42.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.699 0.285 . . . . 0.14 111.748 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.408 ' HZ ' ' HE2' ' A' ' 157' ' ' LYS . 23.9 m-85 -90.38 -18.23 25.84 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.968 0.413 . . . . 0.18 111.102 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 165.31 166.93 25.11 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.901 -0.59 . . . . 0.11 111.632 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -67.7 129.75 40.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.927 0.394 . . . . 0.25 110.268 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.429 HG21 ' HB3' ' A' ' 128' ' ' CYS . 71.8 mt -100.48 131.97 47.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.134 -0.485 . . . . 0.14 110.281 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.545 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.61 -44.73 11.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.497 -0.927 . . . . 0.54 108.497 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.5 m -147.33 111.65 5.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.912 -1.04 . . . . 0.76 110.544 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.4 p -107.22 145.12 33.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.254 -0.647 . . . . 0.72 109.254 173.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -144.83 128.79 17.47 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.932 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.711 HG22 HD12 ' A' ' 115' ' ' LEU . 48.6 t -114.81 110.64 32.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 106.627 -1.62 . . . . 0.28 106.627 168.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.67 121.08 32.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.985 -0.746 . . . . 0.34 108.985 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 58.9 m -96.24 134.79 38.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.694 0.759 . . . . 1.58 112.642 -165.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -87.35 163.62 16.7 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.702 -1.135 . . . . 2.08 107.995 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.39 -25.9 62.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.024 0.44 . . . . 2.45 110.607 173.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -91.61 -0.63 57.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 1.65 110.341 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.667 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 138.98 -71.37 0.45 Allowed Glycine 0 C--O 1.226 -0.401 0 C-N-CA 120.653 -0.784 . . . . 1.12 113.367 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 37.1 t -139.44 144.47 38.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.432 0.616 . . . . 1.61 110.081 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -76.87 -9.01 58.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.367 0.603 . . . . 1.51 110.237 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.32 -17.56 34.09 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.422 -0.808 . . . . 0.31 113.182 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 25.7 p90 -127.19 150.59 49.45 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.207 0.527 . . . . 0.49 111.646 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.18 170.6 25.33 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.302 -0.863 . . . . 0.12 111.222 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -137.78 138.79 39.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.147 0.473 . . . . 0.25 110.841 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.501 HG11 ' CE2' ' A' ' 145' ' ' PHE . 42.6 t -113.74 135.45 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 120.962 0.41 . . . . 0.1 110.8 173.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -105.2 106.23 16.62 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.086 -0.709 . . . . 0.21 109.086 166.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.501 ' CE2' HG11 ' A' ' 143' ' ' VAL . 17.4 m-85 -90.24 139.98 30.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.265 0.555 . . . . 0.17 111.079 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.545 ' HA ' HD21 ' A' ' 126' ' ' LEU . 42.3 tt0 -50.57 -37.56 40.37 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.524 -1.216 . . . . 0.57 110.93 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.8 p -121.68 155.87 34.25 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.023 -0.989 . . . . 0.4 110.515 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -68.48 -36.31 78.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.104 -0.498 . . . . 0.47 110.447 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.35 -34.81 75.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.598 . . . . 0.74 112.014 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.83 -36.77 79.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.153 0.502 . . . . 0.18 110.454 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.482 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -65.04 -40.91 95.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.561 -0.745 . . . . 0.16 110.433 177.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 51.9 mt-10 -59.88 -37.35 79.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.636 -0.711 . . . . 1.42 110.822 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 98.2 mtt180 -65.5 -43.99 88.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.352 -0.385 . . . . 1.48 110.876 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.43 83.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.222 -0.445 . . . . 0.1 110.532 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 151' ' ' ALA . 92.8 mt -60.65 -53.49 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 0.15 111.287 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.4 pt-20 -64.16 -43.4 95.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.182 0.515 . . . . 1.08 111.902 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -81.26 -39.09 25.84 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.887 0.699 . . . . 1.16 112.887 -169.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.511 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.7 mmm -94.86 -20.22 19.63 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.686 0.625 . . . . 0.35 112.686 -172.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -68.05 123.39 20.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.392 -0.596 . . . . 0.44 109.392 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.53 16.89 63.16 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.656 -0.783 . . . . 0.29 112.667 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.6 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 4.4 mmt -98.48 156.23 16.87 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.718 -0.283 . . . . 1.18 111.072 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.48 HD22 ' O ' ' A' ' 165' ' ' ASP . 17.5 mt -98.77 103.75 15.73 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.626 -0.509 . . . . 0.44 109.626 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 22.4 mt -91.01 104.28 16.89 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 120.054 -0.658 . . . . 1.02 109.401 174.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 79.9 m-20 76.78 -27.75 0.18 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.129 -0.942 . . . . 1.71 112.519 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.48 ' O ' HD22 ' A' ' 162' ' ' LEU . 32.7 t70 163.94 -20.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.083 0.864 . . . . 0.85 111.402 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.46 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.4 mtt180 -102.17 130.18 48.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.331 -0.395 . . . . 0.96 110.846 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 161' ' ' MET . 19.5 tttt -78.7 115.03 18.13 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.395 -0.594 . . . . 1.0 109.395 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.529 HG11 HD23 ' A' ' 106' ' ' LEU . 12.9 m -100.56 149.57 6.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.614 0.721 . . . . 0.17 111.366 -172.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 77.4 t80 -106.33 118.93 37.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.834 -1.076 . . . . 0.3 109.612 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.662 HG22 HG12 ' A' ' 103' ' ' ILE . 39.4 t -115.74 126.36 73.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.435 -0.58 . . . . 0.13 109.435 176.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.24 -176.32 23.17 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.78 -0.724 . . . . 0.18 111.524 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -59.33 137.96 57.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.457 -0.571 . . . . 1.93 109.457 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -61.29 94.6 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.973 -0.38 . . . . 1.44 109.973 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.29 139.55 58.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.064 -0.517 . . . . 4.66 110.596 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.1 m -78.28 52.7 1.15 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.601 0.715 . . . . 3.6 110.288 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -121.6 12.29 10.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.465 -0.789 . . . . 7.6 109.597 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -115.78 81.59 1.62 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.79 -0.641 . . . . 8.61 109.73 176.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -118.71 -5.54 10.67 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.814 -0.81 . . . . 8.55 108.814 174.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 38.3 ttp85 -81.59 100.36 9.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.957 -1.02 . . . . 12.18 109.339 172.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -101.91 -5.9 24.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.675 -0.693 . . . . 12.7 110.254 -175.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.42 33.77 0.16 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.618 -0.719 . . . . 13.65 112.196 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 117.96 -1.019 . . . . 15.05 108.995 174.13 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 111.941 -0.463 . . . . 14.85 111.941 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.44 -19.36 23.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.641 0.258 . . . . 13.5 111.252 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.601 ' HB2' ' HE ' ' A' ' 176' ' ' ARG . 34.5 m-20 -93.87 114.92 64.36 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.504 -0.316 . . . . 11.25 110.478 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.4 -67.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.653 2.236 . . . . 11.14 111.963 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.2 m -145.32 109.53 4.89 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.441 -0.345 . . . . 9.3 111.085 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 84.2 mt -120.77 -41.54 2.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.886 0.374 . . . . 7.89 110.813 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -147.6 -178.35 6.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.016 -0.538 . . . . 7.78 109.857 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HG3' ' HA ' ' A' ' 174' ' ' LYS . 4.9 ttmp? -107.27 75.81 1.05 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.447 -0.575 . . . . 2.37 109.447 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.509 ' HA ' ' HG2' ' A' ' 182' ' ' GLU . 2.8 p -73.86 162.51 29.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.909 -0.494 . . . . 1.79 110.482 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.12 -39.71 2.69 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.37 -1.092 . . . . 0.44 110.37 -172.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.3 t 61.0 128.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.932 0.893 . . . . 0.71 112.627 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.29 23.98 77.47 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.64 -1.267 . . . . 0.21 111.507 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 173' ' ' PHE . 7.6 m-20 -84.28 126.44 33.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.887 -0.412 . . . . 0.63 109.887 -174.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.577 HG12 ' HB ' ' A' ' 143' ' ' VAL . 32.2 pt -134.55 155.8 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.708 -0.678 . . . . 0.15 109.631 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.96 139.68 53.37 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.631 -0.507 . . . . 0.21 109.631 178.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.677 HG12 HG22 ' A' ' 170' ' ' VAL . 8.6 mt -118.03 137.36 52.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.79 -0.641 . . . . 0.15 110.197 -176.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -124.2 152.52 42.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.638 -0.256 . . . . 1.46 110.403 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 167' ' ' LYS . 5.2 t30 74.69 45.32 0.17 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.806 0.813 . . . . 0.49 110.847 170.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.466 HD22 HG21 ' A' ' 110' ' ' ILE . 20.1 mt -88.38 166.83 13.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.963 -1.017 . . . . 0.26 110.795 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -97.06 162.69 13.26 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.603 -0.517 . . . . 0.71 109.603 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.729 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 17.3 pttm -66.27 -25.03 66.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.277 0.561 . . . . 2.2 109.618 173.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.0 m -60.67 -16.19 36.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.122 -0.944 . . . . 1.41 112.074 175.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.492 HG22 HG21 ' A' ' 130' ' ' VAL . 44.9 mm -93.07 128.38 44.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.332 0.587 . . . . 0.26 111.166 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.419 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 8.7 t70 -118.65 -178.09 3.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.283 -1.006 . . . . 1.59 108.283 175.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -61.81 -35.0 76.91 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.37 -0.604 . . . . 0.6 109.37 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 1.006 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -61.76 -50.17 73.45 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.205 -0.907 . . . . 2.58 110.583 177.457 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.419 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.15 -42.9 99.39 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.576 -1.193 . . . . 0.15 110.968 -176.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.697 HD12 HG22 ' A' ' 130' ' ' VAL . 3.5 tt -65.51 -47.94 74.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.636 -0.711 . . . . 0.16 109.474 178.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.799 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.8 t80 -59.52 -44.71 93.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.442 . . . . 0.3 110.71 176.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.73 -42.67 79.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.178 -0.464 . . . . 0.4 111.154 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.5 m -78.05 -53.37 7.48 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.352 0.501 . . . . 0.22 112.352 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.483 ' CD1' HD23 ' A' ' 115' ' ' LEU . 7.4 m-85 -71.12 -28.12 64.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.548 0.573 . . . . 0.11 112.548 -172.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.3 t -57.89 -29.93 65.45 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.722 0.296 . . . . 0.19 111.351 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.42 -22.67 44.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 0.14 111.361 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -91.07 -20.28 22.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.868 0.366 . . . . 0.18 111.024 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.63 169.32 31.01 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.321 -0.711 . . . . 0.11 111.321 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -69.72 141.63 53.46 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.96 -0.385 . . . . 0.25 109.96 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.446 HG21 ' HB3' ' A' ' 128' ' ' CYS . 74.6 mt -112.43 135.94 50.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.241 -0.436 . . . . 0.14 110.297 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.552 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -90.93 -41.73 10.98 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.635 -0.876 . . . . 0.54 108.635 179.573 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' A' ' 144' ' ' HIS . 95.7 p -145.5 126.96 15.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.287 -0.87 . . . . 0.76 109.966 176.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.6 p -122.97 116.04 22.91 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.149 -0.685 . . . . 0.72 109.149 174.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -117.82 128.61 55.02 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.17 0.509 . . . . 1.0 111.438 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.697 HG22 HD12 ' A' ' 115' ' ' LEU . 99.3 t -114.67 109.34 28.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 106.45 -1.685 . . . . 0.28 106.45 170.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.9 t -76.14 115.6 17.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.553 -0.906 . . . . 0.34 108.553 -175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.79 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 19.7 p -106.91 137.74 44.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.53 -0.759 . . . . 1.58 112.685 -164.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -85.25 161.35 19.59 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.147 -1.056 . . . . 2.08 108.147 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -58.83 -22.29 58.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.832 0.348 . . . . 2.45 110.861 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -90.83 -5.91 54.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.013 0.435 . . . . 1.65 110.649 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.729 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 149.66 -72.44 0.29 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.471 -0.871 . . . . 1.12 113.297 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.79 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 37.7 t -147.09 154.73 41.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.461 0.631 . . . . 1.61 110.736 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 36.6 mtpt -88.42 -10.36 49.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.073 0.463 . . . . 1.51 110.611 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 107.09 -13.61 40.69 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.359 -0.924 . . . . 0.31 113.941 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -130.63 152.55 49.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.875 0.837 . . . . 0.49 112.071 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.73 173.34 26.98 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.252 -0.885 . . . . 0.12 112.094 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -141.62 138.31 32.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.243 0.217 . . . . 0.25 110.818 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.577 ' HB ' HG12 ' A' ' 101' ' ' ILE . 33.2 t -115.56 130.73 69.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.849 0.356 . . . . 0.1 111.277 175.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.456 ' HB2' ' OG ' ' A' ' 127' ' ' SER . 1.6 m170 -97.88 106.76 19.11 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.608 -0.886 . . . . 0.21 108.608 165.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.519 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 7.8 m-85 -90.11 135.9 33.38 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.347 -0.541 . . . . 0.17 111.196 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.552 ' HA ' HD21 ' A' ' 126' ' ' LEU . 36.2 tt0 -47.93 -40.26 21.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.531 -1.213 . . . . 0.57 110.72 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.8 p -122.5 146.87 47.0 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.844 -1.071 . . . . 0.4 110.765 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -64.18 -37.9 89.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.742 -0.663 . . . . 0.47 111.149 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.35 -34.75 77.97 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.168 0.433 . . . . 0.74 112.168 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.95 78.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.168 0.509 . . . . 0.18 110.826 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.519 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.8 -44.75 95.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.532 -0.758 . . . . 0.16 111.046 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 47.7 mt-10 -59.4 -39.41 83.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.912 -0.585 . . . . 1.42 111.012 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 157' ' ' LYS . 62.2 mtt85 -61.03 -42.06 97.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.799 0.333 . . . . 1.48 110.664 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.34 -38.19 90.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.271 -0.422 . . . . 0.1 110.207 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.3 mt -61.55 -54.27 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.172 -0.467 . . . . 0.15 111.244 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.3 pt-20 -64.18 -44.08 93.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.118 0.485 . . . . 1.08 111.706 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -78.04 -38.99 43.33 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.919 0.711 . . . . 1.16 112.919 -171.754 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.504 ' HB2' HG21 ' A' ' 170' ' ' VAL . 82.2 mmm -94.66 -27.51 15.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.907 0.706 . . . . 0.35 112.907 -172.227 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -64.52 124.22 21.28 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.675 -0.41 . . . . 0.44 110.529 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.25 15.68 60.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.083 -0.579 . . . . 0.29 113.296 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.695 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 79.5 mmm -109.45 162.62 14.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.897 0.349 . . . . 1.18 111.806 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.8 mt -99.13 104.77 16.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.621 -0.881 . . . . 0.44 108.621 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.05 22.44 2.4 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.141 -0.624 . . . . 1.02 111.534 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.4 p30 171.35 -80.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.047 0.939 . . . . 1.71 108.54 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -150.32 17.6 0.84 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.45 -1.25 . . . . 0.85 108.581 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -131.16 127.19 37.5 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.853 -1.067 . . . . 0.96 109.768 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.3 tttt -76.41 121.93 23.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.654 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.429 HG11 HD23 ' A' ' 106' ' ' LEU . 17.8 m -101.29 142.17 16.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.282 0.563 . . . . 0.17 110.955 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.628 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 76.5 t80 -106.25 118.08 35.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.27 -0.877 . . . . 0.3 109.509 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 103' ' ' ILE . 39.0 t -115.24 125.16 72.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.283 -0.636 . . . . 0.13 109.283 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -141.64 -170.82 12.55 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.672 -0.775 . . . . 0.18 112.13 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -73.88 130.97 40.98 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.246 -0.279 . . . . 1.93 110.246 -177.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.477 ' HB3' ' HB3' ' A' ' 100' ' ' ASN . 1.5 t80 -110.48 112.41 24.3 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.456 -0.572 . . . . 1.44 109.456 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.518 ' HA ' ' HG3' ' A' ' 95' ' ' LYS . 83.2 tttt -97.48 96.1 8.1 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.775 -0.454 . . . . 4.66 109.775 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 11.7 t -100.02 134.27 43.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.037 -0.529 . . . . 3.6 110.843 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.601 ' HE ' ' HB2' ' A' ' 90' ' ' ASP . 30.8 tpt180 -137.89 4.41 2.53 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.287 0.565 . . . . 7.6 110.14 176.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.578 ' HG3' ' HG2' ' A' ' 178' ' ' GLU . 13.3 ptmm? -59.65 -23.44 63.05 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.306 -0.406 . . . . 8.61 111.048 178.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.578 ' HG2' ' HG3' ' A' ' 177' ' ' LYS . 11.0 pt-20 -173.23 139.44 0.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.021 -0.536 . . . . 8.55 109.641 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.563 ' HG3' ' HB2' ' A' ' 182' ' ' GLU . 13.1 ttp180 -85.39 91.87 8.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.156 0.503 . . . . 12.18 110.275 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -90.88 -9.31 46.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.724 -0.671 . . . . 12.7 110.291 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 182' ' ' GLU . . . -170.32 102.25 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 13.65 110.732 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.563 ' HB2' ' HG3' ' A' ' 179' ' ' ARG . 4.0 mm-40 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 124.023 0.929 . . . . 15.05 108.818 173.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 112.227 -0.349 . . . . 14.85 112.227 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.29 -165.99 1.04 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.793 -0.447 . . . . 13.5 109.793 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -76.43 129.87 78.67 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.984 0.421 . . . . 11.25 110.689 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -83.73 -18.53 5.53 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.541 2.161 . . . . 11.14 111.168 172.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 93' ' ' LEU . 12.3 p 170.3 -63.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.671 -1.15 . . . . 9.3 109.695 -174.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 92' ' ' SER . 56.7 mt 73.89 160.1 0.23 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.144 -0.935 . . . . 7.89 111.035 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -129.12 -30.15 2.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.666 -0.697 . . . . 7.78 110.5 -176.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 100' ' ' ASN . 2.1 mptp? -122.51 45.87 2.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.555 -0.906 . . . . 2.37 108.555 175.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.1 p -59.93 -19.17 50.38 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.211 -0.904 . . . . 1.79 112.744 -173.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.783 ' HA3' HD22 ' A' ' 100' ' ' ASN . . . -66.26 -15.04 62.74 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.905 -0.664 . . . . 0.44 112.311 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.2 t 66.15 126.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.861 0.864 . . . . 0.71 112.218 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 24.18 76.49 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.143 -1.027 . . . . 0.21 111.39 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.783 HD22 ' HA3' ' A' ' 97' ' ' GLY . 14.3 m-20 -88.36 124.64 34.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.858 -0.793 . . . . 0.63 108.858 -173.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.554 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.0 pt -136.26 163.7 33.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.628 -0.26 . . . . 0.15 110.374 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.411 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -125.3 143.92 50.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.061 0.458 . . . . 0.21 110.143 175.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.581 HG12 HG22 ' A' ' 170' ' ' VAL . 6.9 mt -119.39 138.85 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.466 -0.788 . . . . 0.15 109.861 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -119.7 154.05 34.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.688 -0.233 . . . . 1.46 110.556 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 167' ' ' LYS . 35.0 t30 72.27 34.84 1.3 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.89 0.744 . . . . 0.49 111.653 171.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.581 HD22 HG21 ' A' ' 110' ' ' ILE . 23.8 mt -74.73 160.19 31.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.122 0.486 . . . . 0.26 111.0 177.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -91.3 156.33 17.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.54 -0.755 . . . . 0.71 109.805 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.678 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 15.6 pttp -60.78 -28.82 69.03 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.248 0.342 . . . . 2.2 111.26 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.5 p -66.78 -26.77 67.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 1.41 111.859 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.581 HG21 HD22 ' A' ' 106' ' ' LEU . 47.8 mm -70.94 121.72 21.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.315 0.578 . . . . 0.26 111.305 -172.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -111.79 -175.63 2.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.44 -0.948 . . . . 1.59 108.44 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -69.71 -33.07 71.99 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 109.091 -0.707 . . . . 0.6 109.091 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -48.24 72.39 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.861 -1.063 . . . . 2.58 109.056 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.12 96.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.146 -1.388 . . . . 0.15 110.878 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.743 HD12 HG22 ' A' ' 130' ' ' VAL . 3.1 tt -66.82 -47.38 72.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.843 -0.799 . . . . 0.16 108.843 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.692 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 52.2 t80 -59.36 -47.03 86.97 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.857 -0.611 . . . . 0.3 110.733 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.12 -41.78 75.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 0.4 110.83 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.466 HG21 HD21 ' A' ' 163' ' ' LEU . 7.4 m -77.53 -53.66 7.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.805 -0.634 . . . . 0.22 112.001 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.488 ' CD1' HD23 ' A' ' 115' ' ' LEU . 10.9 m-85 -73.11 -29.3 62.81 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.427 0.529 . . . . 0.11 112.427 -174.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 36.2 t -58.19 -27.76 64.16 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.678 0.275 . . . . 0.19 111.15 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.73 -21.41 27.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.42 -0.355 . . . . 0.14 111.396 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -93.04 -20.75 20.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.18 110.869 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 167.76 166.14 26.33 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.634 -0.586 . . . . 0.11 111.634 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -66.01 139.96 58.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.052 0.453 . . . . 0.25 110.514 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.442 HG21 ' HB3' ' A' ' 128' ' ' CYS . 79.6 mt -111.84 135.78 50.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.988 -0.551 . . . . 0.14 109.969 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -89.01 -43.86 10.81 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.84 -0.8 . . . . 0.54 108.84 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.5 m -147.74 113.8 5.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.076 -0.966 . . . . 0.76 110.423 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.692 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 4.7 p -110.86 139.89 45.79 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.432 -0.581 . . . . 0.72 109.432 174.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -138.63 128.23 24.78 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.014 0.435 . . . . 1.0 111.306 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.743 HG22 HD12 ' A' ' 115' ' ' LEU . 59.2 t -114.37 109.3 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 106.194 -1.78 . . . . 0.28 106.194 169.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.46 HG12 ' HG3' ' A' ' 138' ' ' LYS . 15.5 t -74.63 114.6 14.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.368 -0.975 . . . . 0.34 108.368 -175.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.691 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 8.6 p -101.56 137.64 39.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.404 -0.816 . . . . 1.58 112.438 -165.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.56 164.4 16.9 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.004 -1.11 . . . . 2.08 108.004 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.67 -23.81 67.53 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.079 0.466 . . . . 2.45 110.058 175.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -91.96 3.62 54.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 1.65 110.376 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.678 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 139.77 -74.73 0.37 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.481 -0.866 . . . . 1.12 113.792 177.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.691 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 34.8 t -142.01 151.19 42.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.735 0.767 . . . . 1.61 110.924 -174.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.46 ' HG3' HG12 ' A' ' 131' ' ' VAL . 3.1 mmpt? -87.39 -4.96 59.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.31 0.576 . . . . 1.51 110.081 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.02 -20.55 30.92 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.403 -0.817 . . . . 0.31 113.878 173.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -128.26 154.7 45.59 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.393 0.597 . . . . 0.49 111.842 -173.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.29 171.06 25.85 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.276 -0.875 . . . . 0.12 111.53 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.411 ' CE1' ' HB2' ' A' ' 102' ' ' PHE . 66.1 m-85 -139.63 138.37 36.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.703 0.251 . . . . 0.25 110.535 -177.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.554 ' HB ' HG12 ' A' ' 101' ' ' ILE . 42.9 t -114.43 136.1 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.201 0.524 . . . . 0.1 111.142 174.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.6 m170 -104.71 105.79 16.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.625 -0.716 . . . . 0.21 109.07 165.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.561 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.3 m-85 -90.17 137.55 32.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.039 0.447 . . . . 0.17 110.949 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.596 ' HA ' HD21 ' A' ' 126' ' ' LEU . 34.9 tt0 -48.24 -46.07 35.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.673 -1.148 . . . . 0.57 110.587 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.8 p -114.0 148.39 37.04 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.911 -1.04 . . . . 0.4 111.037 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -63.61 -36.12 82.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.612 -0.722 . . . . 0.47 111.05 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -69.09 -35.32 76.34 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.324 -0.398 . . . . 0.74 111.678 -176.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.13 79.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.049 0.452 . . . . 0.18 110.622 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.561 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.63 -43.76 98.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.645 -0.707 . . . . 0.16 110.558 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.2 mt-10 -60.83 -37.28 81.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.496 -0.774 . . . . 1.42 110.804 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.428 ' O ' ' HB2' ' A' ' 157' ' ' LYS . 91.4 mtt180 -63.17 -46.18 88.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.927 0.394 . . . . 1.48 110.623 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.08 -38.82 80.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 0.1 110.532 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 170' ' ' VAL . 91.5 mt -60.13 -54.2 38.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.692 -0.686 . . . . 0.15 111.477 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.2 pt-20 -65.5 -42.45 92.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.196 0.522 . . . . 1.08 112.251 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -77.42 -39.21 47.7 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 113.038 0.755 . . . . 1.16 113.038 -170.589 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.483 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.9 mmm -95.27 -16.44 22.45 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.519 0.563 . . . . 0.35 112.519 -173.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 155' ' ' ILE . 49.2 t-20 -66.84 124.35 22.7 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.304 -0.558 . . . . 0.44 109.621 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.25 18.57 68.85 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.911 -0.661 . . . . 0.29 112.228 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 8.6 tpp -105.05 156.51 17.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 1.18 110.444 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 89.8 mt -100.66 102.52 13.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.872 -0.604 . . . . 0.44 109.566 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.466 HD21 HG21 ' A' ' 118' ' ' THR . 4.5 mt -81.75 11.66 4.65 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.745 0.646 . . . . 1.02 112.745 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.28 -64.2 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.806 0.812 . . . . 1.71 109.189 -174.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -168.62 23.97 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.811 -1.54 . . . . 0.85 109.294 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -139.82 133.66 30.66 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.898 -0.778 . . . . 0.96 108.898 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.4 mttm -77.77 122.42 25.37 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.326 0.391 . . . . 1.0 109.968 176.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.485 HG11 HD23 ' A' ' 106' ' ' LEU . 11.3 m -101.49 140.1 21.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.316 0.579 . . . . 0.17 110.926 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 46.8 t80 -105.38 118.64 37.08 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.316 -0.856 . . . . 0.3 109.178 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.581 HG22 HG12 ' A' ' 103' ' ' ILE . 34.0 t -115.35 127.79 72.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.412 -0.588 . . . . 0.13 109.412 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.99 -172.7 19.01 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.072 -0.585 . . . . 0.18 111.68 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 35.8 mmt-85 -60.28 141.76 55.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 1.93 110.129 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.414 ' HB2' ' C ' ' A' ' 100' ' ' ASN . 80.2 t80 -63.78 102.97 0.51 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.7 -0.682 . . . . 1.44 111.591 -175.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -79.72 150.13 30.96 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.762 -0.829 . . . . 4.66 108.762 173.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.8 m -65.89 89.9 0.12 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.264 0.554 . . . . 3.6 111.09 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.483 ' HA ' ' NH1' ' A' ' 176' ' ' ARG . 8.0 mmm180 -128.01 48.17 2.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.74 -0.663 . . . . 7.6 109.338 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 64.27 -166.83 0.22 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.659 -0.701 . . . . 8.61 110.136 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.74 27.67 16.99 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.066 0.46 . . . . 8.55 111.915 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -77.09 -23.47 51.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 12.18 110.169 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -89.9 6.7 40.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 12.7 111.047 -177.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.408 ' HB2' ' CE1' ' A' ' 144' ' ' HIS . . . 61.96 27.74 16.84 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.988 -0.551 . . . . 13.65 112.159 176.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.653 -0.689 . . . . 15.05 109.966 179.251 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.803 0 N-CA-C 111.638 -0.585 . . . . 14.85 111.638 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.68 -18.48 62.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.604 0.716 . . . . 13.5 109.705 174.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 8.7 p-10 -82.29 123.39 79.27 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 114.816 -1.084 . . . . 11.25 110.476 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 24.3 Cg_exo -64.56 -74.15 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.731 2.287 . . . . 11.14 112.269 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.4 p -144.9 116.69 8.21 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.819 -0.437 . . . . 9.3 109.819 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.632 ' HB3' ' HA ' ' A' ' 96' ' ' SER . 75.7 mt -99.44 97.23 8.28 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.043 -0.411 . . . . 7.89 111.124 -174.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.558 ' HB2' ' OE1' ' A' ' 180' ' ' GLU . 14.3 mtm180 -72.41 -46.71 53.96 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.726 -1.583 . . . . 7.78 106.726 167.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.986 ' HB2' ' HG2' ' A' ' 180' ' ' GLU . 47.5 tttp -86.9 80.52 8.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.234 -1.348 . . . . 2.37 108.638 168.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.632 ' HA ' ' HB3' ' A' ' 93' ' ' LEU . 11.6 p -71.66 -177.84 2.03 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.108 0.48 . . . . 1.79 112.15 -174.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.658 ' HA3' HD22 ' A' ' 100' ' ' ASN . . . 85.93 -53.21 4.64 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.218 -0.753 . . . . 0.44 111.218 -174.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 97' ' ' GLY . 42.9 t 72.05 127.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.609 0.764 . . . . 0.71 111.6 -174.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.14 23.51 77.85 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 119.834 -1.174 . . . . 0.21 111.433 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.658 HD22 ' HA3' ' A' ' 97' ' ' GLY . 11.4 m-20 -88.2 125.59 34.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.423 -0.584 . . . . 0.63 109.423 -174.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.552 HG23 ' HB1' ' A' ' 151' ' ' ALA . 21.6 pt -134.9 162.13 39.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.589 -0.522 . . . . 0.15 109.589 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.06 140.61 52.74 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.862 -0.421 . . . . 0.21 109.862 177.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.615 HG12 HG22 ' A' ' 170' ' ' VAL . 6.1 mt -117.16 141.86 33.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.588 -0.733 . . . . 0.15 109.615 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -126.66 154.99 43.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.696 -0.229 . . . . 1.46 110.577 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.4 t30 73.56 32.63 1.16 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.969 0.793 . . . . 0.49 111.389 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.485 HD23 HG11 ' A' ' 168' ' ' VAL . 30.1 mt -76.67 162.92 27.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.033 0.444 . . . . 0.26 111.136 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -102.52 151.47 22.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.713 -0.676 . . . . 0.71 109.467 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -22.4 63.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.636 -0.256 . . . . 2.2 111.646 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.4 p -69.13 -11.05 60.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.648 -0.251 . . . . 1.41 111.449 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.579 HG22 HG21 ' A' ' 130' ' ' VAL . 49.2 mm -92.18 122.83 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.26 110.158 177.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -109.7 -177.25 3.22 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.518 -0.919 . . . . 1.59 108.518 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.22 -34.56 78.37 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.192 -0.669 . . . . 0.6 109.192 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.938 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -62.54 -50.49 71.14 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.19 -0.913 . . . . 2.58 110.348 178.083 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.17 98.5 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.076 -1.42 . . . . 0.15 111.253 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.473 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -66.75 -46.79 74.28 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.189 -0.914 . . . . 0.16 108.934 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.763 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 66.1 t80 -59.42 -46.48 88.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 0.3 110.925 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -55.97 -40.92 73.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.008 0.433 . . . . 0.4 111.059 -176.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.527 HG21 HD21 ' A' ' 163' ' ' LEU . 15.3 m -78.0 -53.71 7.11 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.754 -0.657 . . . . 0.22 112.127 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -72.55 -29.1 63.27 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.305 0.483 . . . . 0.11 112.305 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.3 t -58.13 -28.63 64.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.651 0.263 . . . . 0.19 111.091 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.64 37.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.725 0.298 . . . . 0.14 111.293 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -91.82 -21.53 20.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.382 -0.372 . . . . 0.18 111.002 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 169.24 166.1 27.72 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.86 -0.686 . . . . 0.11 112.183 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -62.53 133.93 55.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.012 0.434 . . . . 0.25 110.553 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.404 HG21 ' HB3' ' A' ' 128' ' ' CYS . 75.4 mt -109.04 128.8 64.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.899 -0.592 . . . . 0.14 110.187 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.623 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -82.23 -38.9 23.83 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.702 -0.851 . . . . 0.54 108.702 -178.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 m -153.32 129.95 10.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.094 -0.957 . . . . 0.76 110.455 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.763 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.0 p -126.81 149.52 49.65 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.332 -0.618 . . . . 0.72 109.332 176.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -150.73 131.65 14.21 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.437 -0.505 . . . . 1.0 112.175 -174.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.579 HG21 HG22 ' A' ' 110' ' ' ILE . 69.1 t -110.99 110.42 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 106.359 -1.719 . . . . 0.28 106.359 167.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.2 t -80.96 115.67 23.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.08 -0.711 . . . . 0.34 109.08 -174.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.786 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 71.9 m -105.98 146.56 29.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.355 -0.839 . . . . 1.58 111.689 -170.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.463 ' H ' ' CA ' ' A' ' 137' ' ' SER . 34.4 t70 -85.01 158.63 20.42 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.166 -1.05 . . . . 2.08 108.166 173.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -55.23 -29.65 58.42 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.789 0.328 . . . . 2.45 110.352 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -91.58 4.15 53.31 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.449 -0.341 . . . . 1.65 111.315 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 132' ' ' CYS . . . 149.78 -72.87 0.29 Allowed Glycine 0 CA--C 1.522 0.514 0 C-N-CA 119.735 -1.222 . . . . 1.12 114.939 176.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.786 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 23.6 p -155.19 146.65 23.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.735 0.768 . . . . 1.61 110.594 -169.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -93.06 -14.8 26.87 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.015 0.436 . . . . 1.51 111.147 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 106.49 -19.71 36.1 Favored Glycine 0 C--N 1.314 -0.674 0 C-N-CA 120.095 -1.05 . . . . 0.31 114.025 174.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -125.49 156.58 38.75 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 117.501 0.65 . . . . 0.49 111.912 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.79 172.41 28.95 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.353 -0.839 . . . . 0.12 111.598 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -137.92 140.84 40.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.015 0.407 . . . . 0.25 110.757 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.514 HG11 ' CE2' ' A' ' 145' ' ' PHE . 43.8 t -113.68 135.87 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.01 0.433 . . . . 0.1 110.685 172.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -105.98 105.76 15.95 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.095 -0.706 . . . . 0.21 109.095 167.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.514 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 15.8 m-85 -90.7 136.61 32.95 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.126 0.489 . . . . 0.17 111.24 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.623 ' HA ' HD21 ' A' ' 126' ' ' LEU . 41.7 tt0 -49.31 -42.84 42.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.457 -1.247 . . . . 0.57 110.726 178.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.8 p -115.28 144.85 43.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.64 -1.164 . . . . 0.4 111.241 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -63.09 -36.97 85.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.498 -0.774 . . . . 0.47 110.939 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 9.8 pt-20 -69.39 -35.11 75.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.389 -0.368 . . . . 0.74 111.747 -177.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.64 -34.66 76.07 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.083 0.468 . . . . 0.18 110.556 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.552 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -64.57 -43.04 95.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.6 -0.727 . . . . 0.16 110.883 177.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.583 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 53.5 mt-10 -59.53 -40.08 86.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.511 . . . . 1.42 110.28 176.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.506 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 95.4 mtt180 -60.59 -40.75 92.89 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.186 -0.461 . . . . 1.48 110.943 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.62 -36.32 82.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 0.1 110.568 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 151' ' ' ALA . 80.6 mt -62.53 -54.42 34.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.15 110.995 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.3 pt-20 -60.78 -43.43 98.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.174 0.511 . . . . 1.08 111.677 -179.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -82.74 -39.05 22.42 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 113.062 0.764 . . . . 1.16 113.062 -170.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 89.6 mmm -92.26 -24.51 18.97 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.78 0.659 . . . . 0.35 112.78 -172.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 53.3 t30 -67.17 124.27 22.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.215 -0.594 . . . . 0.44 110.206 -178.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.04 11.12 63.65 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.833 -0.698 . . . . 0.29 112.609 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.653 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 30.8 mmt -97.63 159.65 14.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.885 0.374 . . . . 1.18 111.713 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.9 mt -102.49 101.14 11.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.952 -0.759 . . . . 0.44 108.952 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.527 HD21 HG21 ' A' ' 118' ' ' THR . 2.8 mt -78.16 13.52 1.45 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.042 0.756 . . . . 1.02 113.042 -175.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 167.48 -59.57 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.883 0.849 . . . . 1.71 109.368 -174.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -169.74 24.66 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.798 -1.546 . . . . 0.85 109.433 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 166' ' ' ARG . 46.9 mtt180 -140.29 127.22 20.72 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.583 -0.735 . . . . 0.96 109.381 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 161' ' ' MET . 13.6 tttt -76.77 116.47 17.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.485 HG11 HD23 ' A' ' 106' ' ' LEU . 13.2 m -100.33 144.79 12.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.383 0.611 . . . . 0.17 110.846 -174.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 73.6 t80 -106.14 119.71 39.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.185 -0.916 . . . . 0.3 109.517 -179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.615 HG22 HG12 ' A' ' 103' ' ' ILE . 42.0 t -114.93 125.64 72.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.988 -0.745 . . . . 0.13 108.988 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.18 -178.82 21.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.498 -0.858 . . . . 0.18 112.413 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.8 mmt-85 -60.54 126.87 29.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 1.93 111.384 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -77.06 122.9 25.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.327 -1.36 . . . . 1.44 107.327 170.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.529 ' HD3' ' HG3' ' A' ' 178' ' ' GLU . 51.5 mttp -68.34 -70.41 0.27 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.792 -0.363 . . . . 4.66 110.743 -173.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 177' ' ' LYS . 22.6 t 175.67 -158.1 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.321 -0.992 . . . . 3.6 108.321 -176.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.527 ' HD3' ' H ' ' A' ' 176' ' ' ARG . 0.1 OUTLIER -70.96 -25.36 62.69 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.649 -0.871 . . . . 7.6 108.649 172.811 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.588 ' HD3' ' N ' ' A' ' 178' ' ' GLU . 1.7 tmtp? -143.61 155.41 44.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.315 -1.365 . . . . 8.61 107.315 175.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.588 ' N ' ' HD3' ' A' ' 177' ' ' LYS . 38.8 tt0 -65.86 91.39 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.268 0.556 . . . . 8.55 110.697 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -131.99 3.53 4.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.601 -0.727 . . . . 12.18 110.83 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.986 ' HG2' ' HB2' ' A' ' 95' ' ' LYS . 9.1 tp10 -133.44 21.28 3.98 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.551 0.691 . . . . 12.7 110.337 -173.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -111.06 71.79 0.76 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.855 -0.611 . . . . 13.65 110.032 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.641 -0.695 . . . . 15.05 109.859 -178.21 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.487 0 N-CA-C 111.768 -0.533 . . . . 14.85 111.768 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.32 -59.3 0.49 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.981 0.419 . . . . 13.5 110.261 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.45 113.95 3.8 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.747 -0.66 . . . . 11.25 110.383 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.64 -23.97 63.11 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.799 2.333 . . . . 11.14 111.883 177.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.1 m -125.73 101.69 6.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.059 -0.519 . . . . 9.3 110.373 178.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 52.9 mt -114.52 -43.43 3.17 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.049 0.452 . . . . 7.89 110.38 177.12 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -113.12 -172.34 2.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.78 -0.645 . . . . 7.78 109.648 -177.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -100.6 6.4 44.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.422 0.629 . . . . 2.37 110.106 -176.286 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.0 m -71.47 2.53 4.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.69 -0.686 . . . . 1.79 111.653 -177.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.572 ' HA3' HD22 ' A' ' 100' ' ' ASN . . . -78.54 -23.63 64.58 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.178 -0.534 . . . . 0.44 111.909 174.491 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 59.14 136.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.624 1.169 . . . . 0.71 112.547 -174.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.25 23.85 77.31 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.941 -1.123 . . . . 0.21 110.688 -175.716 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.572 HD22 ' HA3' ' A' ' 97' ' ' GLY . 9.9 m-20 -94.06 126.82 39.5 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.539 -0.541 . . . . 0.63 109.539 -173.33 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 151' ' ' ALA . 20.8 pt -134.8 161.16 40.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.066 -0.346 . . . . 0.15 110.066 175.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.72 142.66 51.24 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.836 -0.431 . . . . 0.21 109.836 177.017 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.563 HG12 HG22 ' A' ' 170' ' ' VAL . 6.4 mt -119.52 135.69 59.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.707 -0.679 . . . . 0.15 110.065 -177.318 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -117.48 153.26 33.44 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.468 -0.197 . . . . 1.46 110.468 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.0 t30 72.54 37.52 0.88 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.01 0.819 . . . . 0.49 111.797 172.15 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.647 HD22 HG21 ' A' ' 110' ' ' ILE . 20.4 mt -76.89 153.83 34.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.359 -0.382 . . . . 0.26 110.843 177.307 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.501 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 13.4 t70 -83.09 149.26 27.02 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.643 -0.502 . . . . 0.71 109.643 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -56.94 -31.16 64.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.079 -0.51 . . . . 2.2 111.659 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.4 p -71.42 -9.09 57.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 1.41 112.015 -179.034 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.647 HG21 HD22 ' A' ' 106' ' ' LEU . 46.6 mm -82.48 113.4 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.071 0.462 . . . . 0.26 110.622 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -102.75 -176.15 3.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.687 -0.857 . . . . 1.59 108.687 176.38 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -61.97 -41.32 97.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.879 -0.786 . . . . 0.6 108.879 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.93 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -58.97 -49.94 75.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.305 -0.861 . . . . 2.58 110.583 178.093 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.15 -42.27 99.09 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.133 -1.394 . . . . 0.15 111.266 -177.489 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.522 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -66.51 -46.63 75.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.33 -0.85 . . . . 0.16 108.994 177.413 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.629 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 67.9 t80 -58.63 -46.88 86.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.033 -0.531 . . . . 0.3 110.917 175.726 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.32 -38.83 71.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.153 0.501 . . . . 0.4 110.82 -175.725 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.654 HG21 HD21 ' A' ' 163' ' ' LEU . 9.3 m -77.93 -54.15 6.63 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.785 -0.643 . . . . 0.22 112.147 -178.341 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -73.07 -28.04 62.08 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.981 0.734 . . . . 0.11 112.981 -174.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.4 t -57.08 -29.4 63.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.764 0.316 . . . . 0.19 111.643 -176.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.42 -21.6 37.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.364 -0.38 . . . . 0.14 111.744 178.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -92.67 -18.37 23.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.18 111.393 -177.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 166.68 171.61 33.01 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.994 -0.622 . . . . 0.11 111.85 -178.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -72.57 135.93 45.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.797 0.332 . . . . 0.25 110.342 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.424 HG21 ' HB3' ' A' ' 128' ' ' CYS . 66.3 mt -111.24 134.88 52.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.401 -0.363 . . . . 0.14 110.323 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -91.28 -49.18 6.5 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.801 -0.815 . . . . 0.54 108.801 179.543 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 66.5 m -141.77 100.19 3.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.901 -1.045 . . . . 0.76 110.915 -175.332 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 13.2 p -95.97 148.41 22.67 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.795 -0.817 . . . . 0.72 108.795 172.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -146.68 129.14 15.92 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.645 -0.422 . . . . 1.0 111.546 -174.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.522 HG22 HD12 ' A' ' 115' ' ' LEU . 75.4 t -110.06 110.2 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 106.606 -1.627 . . . . 0.28 106.606 169.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.6 t -76.64 120.28 26.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 115.653 -0.703 . . . . 0.34 109.565 -172.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 3.8 p -96.0 137.06 35.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.1 -0.954 . . . . 1.58 111.278 -168.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.417 ' HB2' ' HA ' ' A' ' 138' ' ' LYS . 23.4 t70 -86.01 161.98 18.71 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.773 -0.825 . . . . 2.08 108.773 178.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.37 -28.95 60.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.059 0.457 . . . . 2.45 110.108 171.373 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -88.6 0.52 56.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.01 -0.541 . . . . 1.65 110.502 178.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 132.43 -66.34 0.58 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.646 -0.787 . . . . 1.12 113.97 -179.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.5 p -138.86 130.28 27.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.423 0.612 . . . . 1.61 110.858 -172.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 34.1 mtpt -74.43 -36.66 63.42 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.155 0.502 . . . . 1.51 111.038 -175.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.14 -14.91 8.29 Favored Glycine 0 C--N 1.309 -0.953 0 C-N-CA 120.15 -1.024 . . . . 0.31 113.597 -179.156 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -132.4 157.01 45.63 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.24 0.52 . . . . 0.49 111.186 -176.254 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.91 177.21 25.36 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.759 -0.655 . . . . 0.12 111.824 -177.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -136.35 143.12 43.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.494 -0.187 . . . . 0.25 110.494 -176.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.495 ' HB ' HG12 ' A' ' 101' ' ' ILE . 45.9 t -115.44 129.78 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.06 0.457 . . . . 0.1 110.493 171.055 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.9 OUTLIER -100.73 105.32 16.65 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.079 -0.712 . . . . 0.21 109.079 167.216 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.533 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.6 m-85 -88.13 140.92 29.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.264 0.554 . . . . 0.17 110.693 178.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.596 ' HA ' HD21 ' A' ' 126' ' ' LEU . 24.6 tt0 -50.88 -41.13 58.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.324 -1.307 . . . . 0.57 110.479 177.584 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.0 p -122.98 148.31 45.65 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.606 -1.179 . . . . 0.4 111.229 -178.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -60.55 -36.55 78.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.441 -0.799 . . . . 0.47 111.368 179.171 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 9.7 pt-20 -67.45 -35.97 80.27 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.0 0.37 . . . . 0.74 112.0 -176.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.43 78.06 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.09 0.471 . . . . 0.18 110.372 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.546 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -62.19 -44.63 96.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.516 -0.765 . . . . 0.16 110.86 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.963 ' HG2' HH12 ' A' ' 172' ' ' ARG . 28.1 mt-10 -59.5 -42.27 91.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 1.42 110.707 178.183 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.531 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 46.8 mtt180 -59.47 -41.06 88.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.127 -0.488 . . . . 1.48 110.569 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.76 -37.15 84.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.088 -0.505 . . . . 0.1 110.674 178.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.7 mt -60.01 -52.99 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.15 110.988 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 0.7 OUTLIER -63.43 -45.47 90.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.01 0.433 . . . . 1.08 111.877 -179.399 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.443 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -80.39 -39.19 28.86 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.884 0.698 . . . . 1.16 112.884 -169.148 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.567 ' HB2' HG21 ' A' ' 170' ' ' VAL . 89.3 mmm -93.08 -15.85 25.62 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.277 0.473 . . . . 0.35 112.277 -173.143 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -70.29 123.27 21.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.566 -0.901 . . . . 0.44 108.566 176.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.76 11.98 78.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.562 -0.828 . . . . 0.29 111.967 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -93.09 150.7 20.34 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.827 -0.805 . . . . 1.18 108.827 178.443 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.414 HD23 ' CA ' ' A' ' 167' ' ' LYS . 23.3 mt -97.11 124.57 41.17 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.92 -0.77 . . . . 0.44 108.92 177.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.654 HD21 HG21 ' A' ' 118' ' ' THR . 27.3 mt -110.05 99.35 8.46 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.796 -0.761 . . . . 1.02 109.838 173.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 70.5 m-20 78.29 -23.14 0.25 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.98 -1.009 . . . . 1.71 112.812 176.406 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 33.7 t70 167.77 -22.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.815 0.697 . . . . 0.85 112.069 -177.495 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.1 mtt180 -109.81 136.78 48.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.797 0.332 . . . . 0.96 110.875 -170.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.414 ' CA ' HD23 ' A' ' 162' ' ' LEU . 26.6 tttt -84.88 118.74 24.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.39 -178.751 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.455 HG11 HD23 ' A' ' 106' ' ' LEU . 13.3 m -101.27 148.43 7.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.7 0.762 . . . . 0.17 111.791 -171.636 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 55.3 t80 -106.97 119.18 38.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.659 -1.155 . . . . 0.3 109.318 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.567 HG21 ' HB2' ' A' ' 158' ' ' MET . 39.4 t -115.72 125.85 73.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.574 -0.528 . . . . 0.13 109.574 178.208 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.6 -175.15 20.14 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.715 -0.755 . . . . 0.18 112.278 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.963 HH12 ' HG2' ' A' ' 152' ' ' GLU . 24.4 mmt180 -61.71 139.45 58.31 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.548 0.205 . . . . 1.93 110.53 179.08 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -85.08 113.44 21.48 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.709 -0.848 . . . . 1.44 108.709 174.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.63 139.86 38.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.215 0.531 . . . . 4.66 111.258 -178.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.5 t -78.12 169.88 17.54 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.308 -1.367 . . . . 3.6 107.308 168.607 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -60.58 -32.99 72.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.248 0.547 . . . . 7.6 109.787 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -108.89 89.17 2.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.733 -0.667 . . . . 8.61 110.027 168.546 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -79.54 87.07 5.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.951 -0.759 . . . . 8.55 108.951 175.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -134.99 136.92 42.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.586 -0.733 . . . . 12.18 110.217 -176.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -136.32 103.88 5.44 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.668 -0.493 . . . . 12.7 109.668 175.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.82 84.34 4.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.055 0.455 . . . . 13.65 110.894 -177.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.66 -0.686 . . . . 15.05 109.211 -179.839 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 112.15 -0.38 . . . . 14.85 112.15 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.4 -4.82 59.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.274 0.559 . . . . 13.5 110.422 178.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.664 ' HB2' ' HG ' ' A' ' 93' ' ' LEU . 11.6 p-10 -83.35 123.63 76.74 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.492 -0.776 . . . . 11.25 110.356 178.394 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 14.5 Cg_exo -68.75 -71.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.474 2.116 . . . . 11.14 111.144 177.308 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.1 m -144.65 90.27 2.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.155 -0.475 . . . . 9.3 110.103 175.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.664 ' HG ' ' HB2' ' A' ' 90' ' ' ASP . 82.9 mt -78.46 145.84 34.79 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.37 -0.604 . . . . 7.89 109.37 176.018 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.551 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 73.3 mtt180 -78.49 -34.53 47.4 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.976 0.172 . . . . 7.78 110.624 -177.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 79.8 tttt 166.21 -9.18 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.265 0.978 . . . . 2.37 109.272 177.544 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 p -73.17 14.95 0.25 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.218 -0.901 . . . . 1.79 112.735 -176.631 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 98' ' ' VAL . . . -70.93 -27.62 71.93 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.8 -0.714 . . . . 0.44 111.58 176.206 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 97' ' ' GLY . 42.4 t 71.55 123.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.416 0.687 . . . . 0.71 111.925 -175.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.31 24.02 76.15 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.027 -1.082 . . . . 0.21 111.535 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.537 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.3 m120 -88.63 125.3 34.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.933 -0.766 . . . . 0.63 108.933 -174.281 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.522 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.4 pt -135.74 163.53 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.533 -0.303 . . . . 0.15 110.188 177.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.24 145.27 50.83 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.851 -0.425 . . . . 0.21 109.851 175.167 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.521 HG12 HG22 ' A' ' 170' ' ' VAL . 6.2 mt -118.38 148.32 21.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.776 -0.647 . . . . 0.15 110.019 -177.176 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -131.25 149.43 52.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.35 -0.386 . . . . 1.46 110.601 -172.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 64.1 t30 67.63 35.68 3.97 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.639 0.587 . . . . 0.49 111.794 173.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.489 HD22 HG21 ' A' ' 110' ' ' ILE . 20.1 mt -72.33 152.91 41.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.083 0.468 . . . . 0.26 111.133 176.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.4 t70 -77.19 150.4 35.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.466 -0.788 . . . . 0.71 110.565 177.115 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.478 ' NZ ' ' HA3' ' A' ' 136' ' ' GLY . 3.4 tptt -62.14 -33.92 75.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.053 -0.522 . . . . 2.2 111.106 -177.019 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 t -76.05 -4.85 43.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.381 -0.372 . . . . 1.41 111.057 -176.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.489 HG21 HD22 ' A' ' 106' ' ' LEU . 36.0 mm -78.82 127.19 39.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.898 0.38 . . . . 0.26 110.433 178.122 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -111.6 -179.97 3.85 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.592 -0.521 . . . . 1.59 109.592 -179.211 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.646 ' OD1' ' HA ' ' A' ' 129' ' ' LYS . 67.8 m-80 -65.4 -37.81 88.07 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.19 -0.67 . . . . 0.6 109.19 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.98 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.76 -49.19 78.5 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.976 -1.011 . . . . 2.58 110.017 177.618 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.29 97.41 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.772 -1.558 . . . . 0.15 111.463 -177.119 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.671 HD12 HG22 ' A' ' 130' ' ' VAL . 4.2 tt -63.84 -47.3 81.3 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.993 -0.743 . . . . 0.16 108.993 177.431 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.712 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 63.8 t80 -60.2 -47.5 85.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.036 -0.529 . . . . 0.3 110.846 176.814 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.57 -39.08 75.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.91 0.386 . . . . 0.4 110.79 -175.071 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.5 m -77.21 -52.91 8.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 0.22 111.724 -178.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -71.93 -28.32 63.39 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.385 0.513 . . . . 0.11 112.385 -175.012 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.2 t -57.45 -28.95 63.8 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.457 0.169 . . . . 0.19 111.457 -177.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.82 -21.76 31.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.846 0.355 . . . . 0.14 111.386 177.291 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -92.21 -10.76 37.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.18 111.205 -178.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.59 163.75 12.7 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.128 -0.558 . . . . 0.11 111.725 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.95 137.82 58.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.185 0.517 . . . . 0.25 110.171 177.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 128' ' ' CYS . 82.2 mt -110.54 132.73 58.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.71 -0.677 . . . . 0.14 109.877 -178.475 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.07 -39.13 14.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.87 -0.789 . . . . 0.54 108.87 -177.429 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 144' ' ' HIS . 82.5 p -146.53 134.11 20.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.291 -0.868 . . . . 0.76 109.681 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.3 p -133.81 130.28 37.74 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.285 -0.635 . . . . 0.72 109.285 176.608 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.646 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 58.0 tptt -132.33 134.84 45.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.159 0.504 . . . . 1.0 111.891 -174.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.671 HG22 HD12 ' A' ' 115' ' ' LEU . 95.2 t -114.01 109.6 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 106.355 -1.72 . . . . 0.28 106.355 170.028 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.99 121.04 27.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.917 -0.583 . . . . 0.34 109.798 -172.019 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.813 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 58.6 m -97.51 135.29 39.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.186 -0.915 . . . . 1.58 112.204 -165.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.459 ' H ' ' CA ' ' A' ' 137' ' ' SER . 0.2 OUTLIER -87.33 175.01 8.21 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.074 -0.713 . . . . 2.08 109.074 174.384 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.28 -33.17 52.06 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.756 0.28 . . . . 2.45 111.756 177.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ASN . . . . . 0.403 ' H ' ' CG ' ' A' ' 133' ' ' ASP . 91.2 m-20 -92.12 -7.76 47.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 1.65 111.438 -178.296 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.478 ' HA3' ' NZ ' ' A' ' 108' ' ' LYS . . . 148.01 -44.61 0.77 Allowed Glycine 0 C--O 1.225 -0.45 0 C-N-CA 119.461 -1.352 . . . . 1.12 115.135 175.457 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.813 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 45.8 m -155.15 133.46 11.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.04 0.92 . . . . 1.61 111.895 -172.213 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 33.5 mtpt -79.66 -36.47 37.7 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.041 0.448 . . . . 1.51 111.602 -176.755 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 131.57 -19.85 4.72 Favored Glycine 0 C--N 1.311 -0.806 0 C-N-CA 120.135 -1.031 . . . . 0.31 114.051 -178.789 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -122.26 155.26 36.27 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 117.523 0.661 . . . . 0.49 111.315 -174.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -147.85 173.66 27.83 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.12 111.964 -178.091 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.37 136.73 36.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.826 0.313 . . . . 0.25 110.706 -177.347 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.522 ' HB ' HG12 ' A' ' 101' ' ' ILE . 38.5 t -114.56 134.98 55.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.02 0.438 . . . . 0.1 111.002 173.42 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.437 ' HB2' ' OG ' ' A' ' 127' ' ' SER . 1.5 m170 -103.25 106.71 17.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.736 -0.665 . . . . 0.21 109.212 167.218 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 14.4 m-85 -89.91 135.92 33.35 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.323 0.583 . . . . 0.17 111.372 179.082 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.633 ' HA ' HD21 ' A' ' 126' ' ' LEU . 44.5 tt0 -46.36 -43.54 16.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.919 -1.492 . . . . 0.57 111.017 177.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.4 p -116.4 147.37 41.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.937 -1.029 . . . . 0.4 111.046 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -60.23 -39.81 87.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.887 -0.597 . . . . 0.47 110.917 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.22 -33.44 73.33 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.319 -0.4 . . . . 0.74 111.678 -177.516 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.59 74.22 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.149 0.499 . . . . 0.18 110.318 177.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.475 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -67.34 -41.96 84.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.62 -0.718 . . . . 0.16 110.369 176.224 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.655 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 44.0 mt-10 -58.57 -40.26 82.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 1.42 110.305 177.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 65.3 mtt180 -59.5 -50.14 75.08 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 120.882 0.372 . . . . 1.48 110.623 174.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.42 -38.85 81.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.1 110.88 -178.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 151' ' ' ALA . 84.9 mt -60.98 -54.88 29.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.251 -0.431 . . . . 0.15 110.864 178.108 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 3.2 pt-20 -64.22 -44.76 90.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.169 0.509 . . . . 1.08 111.774 -178.737 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -76.37 -39.06 54.83 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.926 0.713 . . . . 1.16 112.926 -170.739 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 91.4 mmm -94.26 -22.3 18.48 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.602 0.593 . . . . 0.35 112.602 -173.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.49 123.65 20.21 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.221 -0.592 . . . . 0.44 109.823 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.496 ' O ' ' HE2' ' A' ' 167' ' ' LYS . . . 83.89 22.55 55.12 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.786 -0.721 . . . . 0.29 112.513 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 2.7 mmt -109.26 160.31 16.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.76 0.314 . . . . 1.18 111.159 177.061 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 29.7 mt -100.57 107.12 18.71 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.915 -0.584 . . . . 0.44 109.976 -176.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 163' ' ' LEU . 17.4 mt -90.99 109.67 20.91 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.686 -0.806 . . . . 1.02 109.163 172.306 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 82.8 m-20 73.08 -67.01 0.28 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.108 -0.951 . . . . 1.71 111.421 -175.206 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -163.66 18.61 0.07 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.873 -0.603 . . . . 0.85 111.018 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 88.7 mtt180 -131.77 130.87 42.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.969 -0.457 . . . . 0.96 109.971 -177.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 161' ' ' MET . 22.6 tttt -82.09 118.24 22.88 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 -177.186 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.478 HG11 HD23 ' A' ' 106' ' ' LEU . 16.9 m -100.8 145.87 10.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.547 0.689 . . . . 0.17 111.161 -173.556 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -106.47 125.1 50.57 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.97 -1.014 . . . . 0.3 109.388 176.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 103' ' ' ILE . 39.8 t -116.45 131.65 68.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.306 -0.627 . . . . 0.13 109.306 177.071 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.26 -173.26 19.71 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.606 -0.807 . . . . 0.18 111.966 179.354 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -66.93 145.43 55.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.023 0.439 . . . . 1.93 110.47 -178.07 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -80.84 114.76 19.95 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.927 -0.579 . . . . 1.44 110.325 -176.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -120.78 88.76 3.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.356 -0.384 . . . . 4.66 110.564 178.278 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 11.2 p -80.54 -29.99 37.14 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.485 -0.932 . . . . 3.6 108.485 170.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 177' ' ' LYS . 5.2 tpm_? -135.37 -87.07 0.36 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.315 -1.311 . . . . 7.6 108.442 173.856 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 176' ' ' ARG . 9.9 ttmt 169.04 1.77 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.952 0.782 . . . . 8.61 109.364 177.516 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -118.24 137.12 53.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.516 -0.765 . . . . 8.55 111.427 -166.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 179' ' ' ARG . 38.7 ttm180 -75.14 -58.98 2.95 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.464 -0.569 . . . . 12.18 109.464 169.419 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -155.46 -33.58 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.372 -0.831 . . . . 12.7 108.896 176.213 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -126.73 122.33 34.57 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.032 -0.986 . . . . 13.65 109.897 173.213 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.414 -0.803 . . . . 15.05 108.948 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.996 -0.442 . . . . 14.85 111.996 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.93 59.12 3.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.091 0.472 . . . . 13.5 110.273 178.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -165.06 111.11 0.82 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.694 -0.684 . . . . 11.25 110.883 -175.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -76.16 -28.36 7.4 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.025 2.484 . . . . 11.14 112.071 175.009 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.4 m -151.47 133.68 15.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.187 -0.461 . . . . 9.3 110.461 178.044 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.4 mt -110.34 -179.39 3.76 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.153 -0.314 . . . . 7.89 110.153 178.159 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -98.24 -68.62 0.79 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.756 -0.831 . . . . 7.78 108.756 177.167 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.622 ' HE3' ' O ' ' A' ' 173' ' ' PHE . 57.3 mttp -146.75 177.9 8.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.304 -0.862 . . . . 2.37 109.081 173.845 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.3 p -154.33 -178.92 7.46 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.222 -0.659 . . . . 1.79 109.222 179.04 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 98' ' ' VAL . . . 77.65 -49.88 3.15 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.774 -0.726 . . . . 0.44 111.707 -176.413 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 97' ' ' GLY . 42.0 t 75.16 130.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.792 0.837 . . . . 0.71 111.195 -175.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.0 23.46 77.83 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.124 -1.036 . . . . 0.21 111.068 -178.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.51 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -90.39 124.89 35.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.544 -0.539 . . . . 0.63 109.544 -173.451 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.55 HG23 ' HB1' ' A' ' 151' ' ' ALA . 17.3 pt -135.98 163.71 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.299 -0.409 . . . . 0.15 110.227 178.46 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.39 143.1 50.8 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.784 -0.45 . . . . 0.21 109.784 175.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.572 HG12 HG22 ' A' ' 170' ' ' VAL . 6.2 mt -119.4 134.97 61.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.652 -0.703 . . . . 0.15 110.016 -177.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -113.87 150.1 34.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.617 -0.265 . . . . 1.46 110.623 -179.284 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.3 t30 72.01 39.0 0.85 Allowed 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.974 0.796 . . . . 0.49 111.77 171.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.534 HD22 HG21 ' A' ' 110' ' ' ILE . 21.8 mt -76.43 153.83 35.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.093 0.473 . . . . 0.26 110.864 176.438 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.492 ' HB3' HG12 ' A' ' 110' ' ' ILE . 6.5 t70 -75.51 144.53 41.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.52 -0.764 . . . . 0.71 110.163 175.666 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -61.48 -28.44 69.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 2.2 111.398 -176.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.407 ' HB3' ' OD2' ' A' ' 107' ' ' ASP . 9.1 t -80.49 -7.84 59.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.276 -0.42 . . . . 1.41 110.652 -179.189 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.534 HG21 HD22 ' A' ' 106' ' ' LEU . 30.8 mm -74.39 116.87 17.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.851 -0.426 . . . . 0.26 109.851 176.475 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -103.1 -174.16 2.48 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.741 -0.837 . . . . 1.59 108.741 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -67.86 -31.14 70.75 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.564 -0.902 . . . . 0.6 108.564 -178.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -48.61 66.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.499 -1.228 . . . . 2.58 109.236 178.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.82 -44.15 97.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.212 -1.358 . . . . 0.15 110.703 -177.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.566 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -64.97 -46.79 80.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.068 -0.969 . . . . 0.16 109.138 177.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.775 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 65.6 t80 -58.86 -47.22 85.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.3 111.084 175.578 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.75 -37.81 71.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.915 0.388 . . . . 0.4 110.957 -176.101 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.516 HG21 HD21 ' A' ' 163' ' ' LEU . 7.0 m -78.55 -54.76 5.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.992 -0.549 . . . . 0.22 112.138 -178.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.415 ' CD1' HD23 ' A' ' 115' ' ' LEU . 11.9 m-85 -72.98 -27.92 62.08 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.248 0.832 . . . . 0.11 113.248 -173.394 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 t -57.0 -28.79 62.75 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 111.78 0.289 . . . . 0.19 111.78 -175.425 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.04 -22.12 36.5 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.856 0.36 . . . . 0.14 111.755 178.365 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -89.43 -23.12 22.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.808 0.337 . . . . 0.18 111.14 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 170.88 166.4 29.69 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.956 -0.565 . . . . 0.11 111.736 -178.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -67.69 129.07 38.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.25 110.11 179.083 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.413 HG21 ' HB3' ' A' ' 128' ' ' CYS . 78.8 mt -98.91 132.0 45.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.175 -0.466 . . . . 0.14 109.995 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -84.68 -40.57 17.22 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.666 -0.864 . . . . 0.54 108.666 -179.822 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 69.5 m -152.68 122.14 6.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.861 -1.063 . . . . 0.76 110.27 -178.149 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.775 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.4 p -117.2 137.63 52.22 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.641 -0.503 . . . . 0.72 109.641 176.045 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -138.2 132.97 32.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.193 0.52 . . . . 1.0 112.003 -174.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.566 HG22 HD12 ' A' ' 115' ' ' LEU . 86.1 t -114.33 109.87 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 106.582 -1.636 . . . . 0.28 106.582 169.311 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.525 HG12 ' HG3' ' A' ' 138' ' ' LYS . 16.5 t -75.48 116.4 18.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.931 -0.577 . . . . 0.34 109.524 -173.479 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.76 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 4.7 p -99.82 135.74 40.79 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.419 -0.809 . . . . 1.58 111.761 -170.776 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.37 160.92 22.7 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.333 -0.988 . . . . 2.08 108.333 173.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -53.84 -28.14 33.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.858 0.361 . . . . 2.45 110.935 175.125 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -90.81 -6.01 54.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.434 -0.348 . . . . 1.65 111.048 -178.261 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 151.8 -67.99 0.32 Allowed Glycine 0 CA--C 1.523 0.584 0 C-N-CA 119.961 -1.114 . . . . 1.12 114.325 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.76 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 69.1 m -152.49 145.47 24.49 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.114 -0.639 . . . . 1.61 110.827 -174.202 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.525 ' HG3' HG12 ' A' ' 131' ' ' VAL . 3.3 mmpt? -81.63 -28.94 33.41 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.128 0.489 . . . . 1.51 111.32 -178.162 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 115.14 -14.31 18.93 Favored Glycine 0 C--N 1.311 -0.841 0 C-N-CA 120.587 -0.816 . . . . 0.31 113.356 178.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -129.69 154.02 47.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 117.21 0.505 . . . . 0.49 111.45 -177.512 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.29 175.18 25.0 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.688 -0.687 . . . . 0.12 111.895 -178.194 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -136.58 137.73 40.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.72 0.26 . . . . 0.25 110.65 -175.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' A' ' 145' ' ' PHE . 49.2 t -110.94 136.05 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.996 0.427 . . . . 0.1 110.865 172.47 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 127' ' ' SER . 2.5 m170 -104.13 106.09 16.48 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.658 -0.701 . . . . 0.21 109.303 167.472 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.51 ' CE2' HG11 ' A' ' 143' ' ' VAL . 14.8 m-85 -92.04 137.31 32.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.081 0.467 . . . . 0.17 110.827 178.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.591 ' HA ' HD21 ' A' ' 126' ' ' LEU . 39.0 tt0 -47.83 -41.42 23.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.522 -1.217 . . . . 0.57 111.131 179.572 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.8 p -119.32 151.14 38.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.325 -0.852 . . . . 0.4 110.825 179.667 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -62.31 -35.96 80.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.47 110.72 179.039 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.36 -34.67 74.93 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.33 -0.396 . . . . 0.74 111.948 -178.161 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.08 -34.74 78.24 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.005 0.431 . . . . 0.18 110.678 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.55 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -63.68 -41.38 98.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 0.16 110.359 176.321 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.486 ' CD ' HH21 ' A' ' 172' ' ' ARG . 7.2 mm-40 -59.27 -40.41 85.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.689 -0.687 . . . . 1.42 110.923 177.147 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.588 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 96.8 mtt180 -60.86 -43.2 98.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.566 -0.743 . . . . 1.48 111.059 177.548 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.75 83.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.222 -0.445 . . . . 0.1 110.521 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.468 HG12 HG12 ' A' ' 170' ' ' VAL . 66.7 mt -62.51 -52.41 60.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.227 -0.442 . . . . 0.15 111.106 178.472 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 0.1 OUTLIER -62.57 -44.31 96.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.192 0.52 . . . . 1.08 111.941 179.931 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -82.68 -38.7 23.05 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.243 0.831 . . . . 1.16 113.243 -168.722 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.467 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.2 mmm -93.93 -16.28 24.14 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.439 0.533 . . . . 0.35 112.439 -173.053 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 155' ' ' ILE . 47.4 t-20 -67.03 122.93 18.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.302 -0.629 . . . . 0.44 109.302 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.09 70.34 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.911 -0.661 . . . . 0.29 112.865 178.529 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.655 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 30.3 mmt -96.21 163.03 13.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.997 0.399 . . . . 1.18 111.494 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 20.8 mt -104.61 111.83 24.68 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.868 -0.605 . . . . 0.44 109.879 -177.645 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 118' ' ' THR . 19.0 mt -100.15 100.87 11.77 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 120.073 -0.651 . . . . 1.02 109.758 174.334 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 87.6 m-20 78.58 -23.59 0.24 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 114.883 -1.053 . . . . 1.71 112.615 178.644 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 21.0 t70 166.15 -23.07 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.174 0.921 . . . . 0.85 111.724 -177.552 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.0 mtt180 -106.65 132.38 52.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.82 0.343 . . . . 0.96 111.112 -169.244 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 161' ' ' MET . 8.3 ttmm -77.11 118.59 19.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.468 -0.787 . . . . 1.0 109.385 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.468 HG11 HD23 ' A' ' 106' ' ' LEU . 14.7 m -100.83 146.23 9.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.562 0.696 . . . . 0.17 111.149 -174.602 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 40.4 t80 -110.62 121.96 46.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.908 -1.042 . . . . 0.3 109.267 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.572 HG22 HG12 ' A' ' 103' ' ' ILE . 41.4 t -115.7 127.07 73.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.981 -0.378 . . . . 0.13 109.981 -178.322 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.08 176.86 27.66 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.876 -0.678 . . . . 0.18 112.361 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.486 HH21 ' CD ' ' A' ' 152' ' ' GLU . 14.6 mmt85 -61.31 129.48 41.45 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.029 0.442 . . . . 1.93 111.148 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.622 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 62.1 t80 -60.34 134.83 57.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.423 -0.808 . . . . 1.44 111.154 -179.018 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -90.73 132.27 35.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.92 0.39 . . . . 4.66 110.485 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 11.5 p -98.64 11.47 38.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.025 0.44 . . . . 3.6 111.063 -178.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -97.17 174.49 6.71 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.183 -0.462 . . . . 7.6 110.345 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.4 tptt 71.5 -58.61 0.57 Allowed 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.817 0.698 . . . . 8.61 111.573 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -114.9 101.4 9.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.09 0.471 . . . . 8.55 109.873 -179.14 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -116.35 104.42 11.46 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.824 -0.625 . . . . 12.18 110.884 -177.049 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -119.88 99.19 6.48 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.165 -0.68 . . . . 12.7 109.165 172.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -155.49 98.82 1.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.058 -0.519 . . . . 13.65 110.942 -177.096 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.37 -0.824 . . . . 15.05 109.453 175.979 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.802 0 N-CA-C 111.972 -0.451 . . . . 14.85 111.972 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.66 -33.05 9.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 13.5 110.506 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -72.19 122.26 86.9 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 11.25 110.885 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.75 -165.61 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.582 2.188 . . . . 11.14 110.957 173.533 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.9 m -68.87 87.83 0.37 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.007 0.432 . . . . 9.3 110.747 177.134 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.6 mt -119.48 -21.51 7.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 7.89 110.503 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 66.5 179.68 0.21 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.599 -0.728 . . . . 7.78 111.138 -174.525 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -146.25 116.62 7.49 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.156 -0.683 . . . . 2.37 109.156 -178.287 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.0 p -66.57 -18.62 65.47 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.054 0.843 . . . . 1.79 112.248 -173.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.554 ' HA3' ' OD1' ' A' ' 100' ' ' ASN . . . -63.67 -34.57 90.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.813 -0.708 . . . . 0.44 111.798 175.43 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.8 t 66.36 116.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.208 0.603 . . . . 0.71 111.924 -174.593 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.03 24.51 63.96 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.912 -1.137 . . . . 0.21 112.883 174.336 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.554 ' OD1' ' HA3' ' A' ' 97' ' ' GLY . 1.7 m120 -89.92 126.08 35.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.532 -0.544 . . . . 0.63 109.532 -175.024 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.483 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.2 pt -134.24 163.73 36.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.237 -0.438 . . . . 0.15 109.909 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.14 147.49 49.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.99 -0.374 . . . . 0.21 109.99 177.51 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.536 HG12 HG22 ' A' ' 170' ' ' VAL . 5.2 mt -122.4 148.16 26.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.83 -0.623 . . . . 0.15 110.144 -176.286 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -128.04 157.29 41.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.524 -0.307 . . . . 1.46 110.962 -175.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.0 t30 67.44 31.61 6.24 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.738 0.649 . . . . 0.49 111.698 172.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.654 HD22 HG21 ' A' ' 110' ' ' ILE . 42.6 mt -75.62 148.61 38.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 0.26 111.354 178.208 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -80.18 153.74 28.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.792 -0.64 . . . . 0.71 110.364 178.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.702 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 65.7 pttt -55.16 -34.27 63.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.842 -0.617 . . . . 2.2 111.983 178.387 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.4 t -76.06 -4.51 41.81 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.464 -0.335 . . . . 1.41 111.718 -177.745 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.654 HG21 HD22 ' A' ' 106' ' ' LEU . 45.7 mm -81.55 113.83 21.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 122.069 -0.394 . . . . 0.26 110.067 175.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -106.84 -177.76 3.45 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.212 -0.662 . . . . 1.59 109.212 178.235 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -60.54 -37.85 82.57 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.746 -0.464 . . . . 0.6 109.746 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.887 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -62.29 -50.55 71.21 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.477 -0.783 . . . . 2.58 110.673 178.381 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.54 95.72 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.174 -1.375 . . . . 0.15 111.079 -176.666 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.708 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -67.05 -47.22 71.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.471 -0.786 . . . . 0.16 109.174 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 72.7 t80 -58.96 -47.13 86.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.528 . . . . 0.3 110.848 176.684 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.36 -37.93 73.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.158 0.504 . . . . 0.4 111.017 -176.09 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.655 HG21 HD21 ' A' ' 163' ' ' LEU . 13.4 m -78.24 -54.36 6.31 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.057 -0.519 . . . . 0.22 112.065 -178.505 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.409 ' CD1' HD23 ' A' ' 115' ' ' LEU . 19.6 m-85 -73.65 -29.79 62.54 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.007 0.743 . . . . 0.11 113.007 -174.154 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.2 t -58.59 -27.2 64.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.685 0.278 . . . . 0.19 111.332 -176.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.99 -22.3 25.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.603 0.24 . . . . 0.14 111.344 177.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -92.45 -17.62 24.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.531 -0.304 . . . . 0.18 111.352 -178.626 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.71 174.55 37.46 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.999 -0.62 . . . . 0.11 111.875 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -76.69 139.71 40.61 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.836 -0.431 . . . . 0.25 109.836 -179.302 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.44 HG21 ' HB3' ' A' ' 128' ' ' CYS . 71.0 mt -112.13 135.3 51.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.366 -0.379 . . . . 0.14 110.223 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -90.69 -42.85 10.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.774 -0.824 . . . . 0.54 108.774 179.748 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 67.5 m -146.1 111.31 5.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.249 -0.887 . . . . 0.76 110.659 -178.472 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.6 p -108.52 137.84 45.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.255 -0.646 . . . . 0.72 109.255 172.633 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -136.58 131.24 33.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.957 0.408 . . . . 1.0 111.418 -174.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.708 HG22 HD12 ' A' ' 115' ' ' LEU . 91.0 t -114.78 113.74 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 106.738 -1.579 . . . . 0.28 106.738 170.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.9 t -82.61 114.61 23.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.718 -0.845 . . . . 0.34 108.718 -176.473 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.905 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 64.3 m -109.13 141.62 41.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.457 -0.792 . . . . 1.58 112.759 -165.503 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.41 171.74 10.34 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.104 -1.073 . . . . 2.08 108.104 170.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -61.2 -25.21 66.88 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.008 0.373 . . . . 2.45 112.008 -177.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -92.71 -12.28 31.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.827 -0.349 . . . . 1.65 111.242 -177.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.702 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 165.64 -68.0 0.2 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.923 -1.132 . . . . 1.12 114.241 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.905 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 33.3 t -156.62 153.8 29.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.721 0.761 . . . . 1.61 111.261 -174.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -88.08 -8.6 55.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.079 0.466 . . . . 1.51 110.21 178.416 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 107.42 -16.64 37.74 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.45 -0.881 . . . . 0.31 114.076 174.029 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -126.34 152.52 46.12 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.373 0.587 . . . . 0.49 111.753 -174.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.43 174.14 25.56 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.538 -0.755 . . . . 0.12 111.694 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -139.5 139.3 36.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.877 0.339 . . . . 0.25 110.728 -177.132 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.483 ' HB ' HG12 ' A' ' 101' ' ' ILE . 42.6 t -113.85 133.81 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.05 0.452 . . . . 0.1 110.854 172.855 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.6 OUTLIER -105.37 106.09 16.43 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.708 -0.678 . . . . 0.21 109.186 167.986 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.541 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 14.6 m-85 -89.68 140.04 29.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.336 0.589 . . . . 0.17 111.264 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.633 ' HA ' HD21 ' A' ' 126' ' ' LEU . 36.5 tt0 -53.43 -43.18 67.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.54 -1.209 . . . . 0.57 110.087 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.5 p -114.28 144.52 43.1 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.405 -1.27 . . . . 0.4 111.337 -178.209 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -62.4 -38.02 88.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.376 -0.829 . . . . 0.47 111.064 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.27 -35.95 76.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.451 -0.341 . . . . 0.74 111.83 -176.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.83 -34.69 78.5 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.344 0.592 . . . . 0.18 110.33 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.541 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.21 -40.88 97.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 0.16 111.194 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.61 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 1.9 mm-40 -68.37 -36.32 79.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.018 -0.537 . . . . 1.42 110.278 -179.082 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 90.4 mtt180 -60.21 -42.89 96.11 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-N 116.099 -0.5 . . . . 1.48 110.362 175.096 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.34 87.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.96 -0.563 . . . . 0.1 110.651 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 151' ' ' ALA . 76.1 mt -63.02 -53.99 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.542 -0.299 . . . . 0.15 110.921 178.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.61 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.9 pt-20 -61.55 -43.09 99.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.066 0.46 . . . . 1.08 111.764 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -81.6 -39.04 25.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.172 0.804 . . . . 1.16 113.172 -171.415 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 90.9 mmm -93.22 -18.98 21.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.616 0.599 . . . . 0.35 112.616 -172.802 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.5 122.56 19.91 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.615 -0.834 . . . . 0.44 109.096 176.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.35 77.09 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.715 -0.755 . . . . 0.29 112.009 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.8 tpt -93.16 151.4 19.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.157 -0.682 . . . . 1.18 109.157 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.1 mt -96.45 107.46 19.86 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.437 -0.579 . . . . 0.44 109.437 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 118' ' ' THR . 11.5 mt -92.38 108.1 19.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.489 -0.884 . . . . 1.02 109.369 172.416 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 5.4 m-20 77.41 -33.43 0.19 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.397 -0.82 . . . . 1.71 111.986 176.246 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 163' ' ' LEU . 27.1 t70 168.54 -19.78 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.115 -0.948 . . . . 0.85 111.889 -174.336 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -107.45 136.72 46.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.644 0.259 . . . . 0.96 110.478 -172.217 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -80.83 116.38 20.79 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 -178.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.42 HG11 HD23 ' A' ' 106' ' ' LEU . 16.0 m -100.45 146.68 8.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.677 0.751 . . . . 0.17 111.124 -173.186 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 55.6 t80 -105.98 119.19 38.55 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.718 -1.128 . . . . 0.3 109.083 179.355 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.536 HG22 HG12 ' A' ' 103' ' ' ILE . 43.4 t -116.1 129.7 72.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.077 0.465 . . . . 0.13 109.849 179.101 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.6 177.72 25.69 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 111.04 -0.824 . . . . 0.18 111.04 176.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.95 141.99 56.82 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.156 -0.313 . . . . 1.93 110.156 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -56.56 100.63 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.361 0.413 . . . . 1.44 110.213 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -83.11 148.63 27.38 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.125 0.488 . . . . 4.66 111.957 -172.272 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 176' ' ' ARG . 6.4 m -88.33 -169.85 2.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.311 -0.996 . . . . 3.6 108.311 170.19 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 175' ' ' SER . 35.6 ttm180 76.37 -8.2 1.69 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.133 0.492 . . . . 7.6 111.161 172.425 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -62.05 -20.63 64.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.479 0.657 . . . . 8.61 109.483 172.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.55 146.64 46.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.125 -0.943 . . . . 8.55 109.33 172.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -104.39 -9.49 18.42 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.447 -0.575 . . . . 12.18 109.447 174.62 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 68.94 17.84 8.58 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.053 -0.976 . . . . 12.7 109.253 -173.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -165.94 111.0 0.84 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.245 -0.889 . . . . 13.65 109.793 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.749 -0.643 . . . . 15.05 110.093 -178.032 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.513 0 N-CA-C 112.069 -0.412 . . . . 14.85 112.069 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.91 174.87 10.14 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.025 -0.361 . . . . 13.5 110.025 178.56 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -107.06 98.55 22.37 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.688 -0.486 . . . . 11.25 109.688 178.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -84.97 156.66 11.47 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.275 1.983 . . . . 11.14 111.94 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.7 m 69.71 -36.87 0.36 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.061 0.545 . . . . 9.3 112.208 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 96' ' ' SER . 36.2 tp -85.77 132.46 34.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.029 -0.73 . . . . 7.89 109.029 178.473 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.465 HH11 ' HD2' ' A' ' 94' ' ' ARG . 39.2 ttm180 -102.72 -56.33 2.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.637 -0.425 . . . . 7.78 111.005 -171.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -125.49 83.79 2.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.314 -0.403 . . . . 2.37 110.359 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.497 ' HB3' HD21 ' A' ' 93' ' ' LEU . 10.2 p -63.03 -27.19 69.24 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 111.762 0.282 . . . . 1.79 111.762 -178.328 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.644 ' HA3' HD22 ' A' ' 100' ' ' ASN . . . -62.02 -35.17 91.03 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.926 -0.654 . . . . 0.44 112.761 179.3 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.6 t 61.51 126.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.366 0.666 . . . . 0.71 112.763 -176.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.58 25.26 74.59 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.655 -1.26 . . . . 0.21 111.433 176.248 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.644 HD22 ' HA3' ' A' ' 97' ' ' GLY . 9.2 m-20 -88.4 124.17 33.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.594 -0.521 . . . . 0.63 109.594 -172.65 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.598 HG12 ' HB ' ' A' ' 143' ' ' VAL . 34.8 pt -135.05 151.75 31.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.765 -0.457 . . . . 0.15 109.765 176.757 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.613 ' HB3' ' HB2' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -119.81 141.23 49.69 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.566 -0.531 . . . . 0.21 109.566 178.633 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.567 HG12 HG22 ' A' ' 170' ' ' VAL . 5.2 mt -119.34 129.54 75.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.653 -0.703 . . . . 0.15 110.064 -176.085 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -112.45 151.62 29.67 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.682 -0.235 . . . . 1.46 110.616 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.9 t30 73.69 36.7 0.73 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.97 0.794 . . . . 0.49 111.629 172.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 110' ' ' ILE . 18.3 mt -76.15 154.36 35.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 0.26 111.261 177.089 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 13.5 t70 -78.33 149.98 33.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.465 -0.789 . . . . 0.71 109.514 174.003 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -68.63 -26.65 65.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.924 0.392 . . . . 2.2 110.881 -175.045 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 m -72.65 -7.87 52.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 1.41 111.292 178.156 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 106' ' ' LEU . 31.9 mm -79.12 113.75 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.106 0.479 . . . . 0.26 109.95 178.398 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 11.2 t70 -99.3 -176.25 3.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.679 -0.692 . . . . 1.59 109.223 -178.843 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -66.96 -34.45 77.79 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.08 -1.081 . . . . 0.6 108.08 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -47.83 66.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.137 -1.392 . . . . 2.58 109.269 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -60.84 -44.05 97.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.047 -1.433 . . . . 0.15 110.963 -178.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.609 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -65.82 -46.74 77.47 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.361 -0.836 . . . . 0.16 109.238 177.55 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.747 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 49.1 t80 -59.93 -46.95 87.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.3 110.831 176.63 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.46 -41.45 76.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.96 0.409 . . . . 0.4 110.985 -175.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.409 HG21 HD21 ' A' ' 163' ' ' LEU . 19.2 m -77.18 -52.66 8.87 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.86 -0.609 . . . . 0.22 111.902 -176.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -72.91 -28.26 62.36 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.46 0.541 . . . . 0.11 112.46 -174.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.8 t -57.81 -28.43 64.03 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.649 0.262 . . . . 0.19 111.444 -177.49 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.41 -21.18 23.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.835 0.35 . . . . 0.14 111.499 177.342 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -94.95 -14.15 24.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.18 111.066 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.65 166.55 22.68 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 116.037 -0.529 . . . . 0.11 111.898 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -69.49 138.7 53.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.896 -0.409 . . . . 0.25 109.896 178.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.417 HG21 ' HB3' ' A' ' 128' ' ' CYS . 67.7 mt -111.11 134.09 54.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.98 -0.554 . . . . 0.14 109.751 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.18 -50.65 6.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.435 -0.95 . . . . 0.54 108.435 179.93 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.3 m -138.01 99.14 3.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.801 -1.091 . . . . 0.76 110.72 -176.488 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.747 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 0.8 OUTLIER -97.98 139.95 33.05 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.165 -0.679 . . . . 0.72 109.165 172.512 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -139.2 129.3 25.22 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.634 -172.758 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.609 HG22 HD12 ' A' ' 115' ' ' LEU . 95.8 t -114.14 109.27 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 106.573 -1.64 . . . . 0.28 106.573 168.148 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 t -79.1 131.41 34.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.693 -0.685 . . . . 0.34 109.783 -172.121 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 1.5 p -95.24 133.87 38.63 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.773 0.796 . . . . 1.58 111.394 -170.096 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.662 ' HB2' ' HA ' ' A' ' 138' ' ' LYS . 16.7 t70 -87.61 164.85 15.84 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.443 -1.253 . . . . 2.08 108.579 -178.596 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.3 -25.4 65.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.378 0.609 . . . . 2.45 109.494 171.443 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -92.51 4.32 53.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.291 -0.868 . . . . 1.65 110.736 178.281 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 127.82 -71.35 0.49 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.579 -0.82 . . . . 1.12 113.765 -179.216 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 30.5 m -134.85 132.34 38.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 117.582 0.691 . . . . 1.61 109.801 -176.109 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.662 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 29.7 mtpt -70.82 -20.29 62.58 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.462 0.542 . . . . 1.51 112.462 -169.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 109.08 -13.15 34.17 Favored Glycine 0 C--N 1.313 -0.732 0 C-N-CA 120.397 -0.906 . . . . 0.31 113.243 177.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -133.99 155.32 50.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.85 0.357 . . . . 0.49 111.001 -177.043 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.6 175.28 24.4 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.81 -0.632 . . . . 0.12 111.938 -178.249 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -137.06 139.33 41.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.547 0.173 . . . . 0.25 110.838 -177.103 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.598 ' HB ' HG12 ' A' ' 101' ' ' ILE . 41.9 t -112.09 132.93 59.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.881 0.372 . . . . 0.1 110.578 171.815 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -104.16 106.05 16.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.082 -0.71 . . . . 0.21 109.082 167.405 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.488 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 20.0 m-85 -87.7 138.62 31.31 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.331 0.586 . . . . 0.17 111.155 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.576 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.9 tt0 -49.01 -39.47 27.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.038 -1.437 . . . . 0.57 110.715 178.205 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.5 p -125.61 152.62 44.9 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.833 -1.076 . . . . 0.4 110.663 -179.686 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -66.94 -31.07 71.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.915 -0.584 . . . . 0.47 110.977 -177.799 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.65 -35.15 74.92 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.039 0.385 . . . . 0.74 112.039 -178.126 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.8 -34.61 78.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.11 0.481 . . . . 0.18 110.711 -178.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.488 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.97 -43.85 94.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.506 -0.77 . . . . 0.16 111.252 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 33.5 mt-10 -58.68 -41.9 87.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 1.42 110.638 179.242 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.457 HH11 ' HD2' ' A' ' 153' ' ' ARG . 65.2 mtt85 -61.27 -44.52 97.1 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.259 -0.428 . . . . 1.48 111.285 177.354 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.74 -37.4 84.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.374 -0.376 . . . . 0.1 110.713 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 151' ' ' ALA . 87.3 mt -62.41 -54.48 33.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.381 -0.372 . . . . 0.15 111.081 178.154 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.9 pt-20 -62.72 -40.24 96.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.983 0.42 . . . . 1.08 111.814 -177.683 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 157' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -82.35 -38.66 23.9 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.872 0.693 . . . . 1.16 112.872 -172.746 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 158' ' ' MET . . . . . 0.409 ' HB2' HG21 ' A' ' 170' ' ' VAL . 90.5 mmm -93.2 -26.8 17.22 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.549 0.574 . . . . 0.35 112.549 -173.266 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -64.85 123.4 19.3 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.131 -0.628 . . . . 0.44 109.383 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.79 19.51 56.07 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.635 -0.793 . . . . 0.29 112.557 -179.304 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.4 mmt -105.15 156.35 18.17 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.788 -0.243 . . . . 1.18 110.861 176.716 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 162' ' ' LEU . 14.4 mt -98.27 97.45 8.84 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.455 -0.572 . . . . 0.44 109.455 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 18.1 mt -81.82 105.07 12.66 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 119.469 -0.893 . . . . 1.02 109.068 174.382 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 164' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 86.4 m-20 74.1 -66.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.974 -1.012 . . . . 1.71 111.909 -177.652 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -156.47 6.84 0.19 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.854 -0.612 . . . . 0.85 111.686 -177.184 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.2 mtt180 -134.39 128.34 33.41 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 121.769 -0.582 . . . . 0.96 110.255 -172.786 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 161' ' ' MET . 17.0 tttt -76.66 119.77 20.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.483 -178.016 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.452 HG11 HD23 ' A' ' 106' ' ' LEU . 15.9 m -100.73 144.51 12.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.491 0.662 . . . . 0.17 111.365 -172.605 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 72.9 t80 -106.82 119.76 40.21 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.687 -1.142 . . . . 0.3 109.325 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.567 HG22 HG12 ' A' ' 103' ' ' ILE . 40.6 t -115.63 128.82 72.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.501 -0.555 . . . . 0.13 109.501 178.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.28 -175.02 19.79 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.64 -0.79 . . . . 0.18 112.356 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -70.33 119.5 14.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.895 0.378 . . . . 1.93 110.729 -177.744 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 173' ' ' PHE . . . . . 0.613 ' HB2' ' HB3' ' A' ' 102' ' ' PHE . 4.3 t80 -105.12 116.82 32.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.753 -0.658 . . . . 1.44 109.732 -179.375 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.55 147.61 25.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.854 -0.612 . . . . 4.66 111.102 -178.372 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.7 p -71.12 -39.89 71.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.661 -0.699 . . . . 3.6 111.534 -177.072 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 60.8 -101.44 0.11 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.629 0.372 . . . . 7.6 110.71 -178.314 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -119.72 5.81 10.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.632 0.73 . . . . 8.61 109.52 176.521 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -98.65 68.08 1.78 Allowed 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.273 -0.876 . . . . 8.55 110.006 -177.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -105.03 42.48 1.21 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.255 -1.017 . . . . 12.18 108.255 175.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -89.16 -34.52 16.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.926 -1.034 . . . . 12.7 110.994 -174.023 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.07 109.24 5.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.165 -0.471 . . . . 13.65 109.921 -179.342 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.205 -0.902 . . . . 15.05 109.803 -175.661 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.2 t . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 112.664 0.616 . . . . 0.70999999999999996 112.664 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.429 ' HA2' ' CB ' ' A' ' 151' ' ' ALA . . . 72.24 25.62 74.07 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 119.732 -1.223 . . . . 0.20999999999999999 112.406 172.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.541 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.2 m120 -85.58 123.85 31.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.806 -0.813 . . . . 0.63 108.806 -174.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.515 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.1 pt -135.72 159.93 39.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 110.319 -0.252 . . . . 0.14999999999999999 110.319 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.05 141.35 52.12 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.815 -0.439 . . . . 0.20999999999999999 109.815 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.649 HG12 HG22 ' A' ' 170' ' ' VAL . 7.2 mt -117.95 137.61 51.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.58 -0.737 . . . . 0.14999999999999999 110.07 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -120.72 151.57 39.37 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.679 -0.237 . . . . 1.46 110.522 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 t30 69.77 54.37 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.86 0.725 . . . . 0.48999999999999999 111.307 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.67 HD22 HG21 ' A' ' 110' ' ' ILE . 14.6 mt -91.61 162.88 14.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.426 -0.807 . . . . 0.26000000000000001 111.169 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.465 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 14.0 t70 -87.38 155.74 19.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.70999999999999996 109.936 177.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -62.24 -31.39 71.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.388 -0.369 . . . . 2.2000000000000002 111.417 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.8 p -72.32 -4.59 30.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.186 -0.461 . . . . 1.4099999999999999 111.936 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.698 HG22 HG21 ' A' ' 130' ' ' VAL . 45.1 mm -84.57 118.4 31.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.482 . . . . 0.26000000000000001 110.776 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.462 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 15.6 t70 -108.73 -175.27 2.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.297 -1.001 . . . . 1.5900000000000001 108.297 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -67.66 -32.52 73.25 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.478 -0.934 . . . . 0.59999999999999998 108.478 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -48.72 71.14 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.624 -1.171 . . . . 2.5800000000000001 109.263 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.462 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -62.43 -43.03 99.79 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.274 -1.33 . . . . 0.14999999999999999 110.84 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.73 HD12 HG22 ' A' ' 130' ' ' VAL . 3.5 tt -65.73 -47.79 74.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.172 -0.677 . . . . 0.16 109.172 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.651 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 55.3 t80 -59.26 -46.3 88.87 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.743 -0.662 . . . . 0.29999999999999999 110.486 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.84 -39.85 74.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.505 -0.316 . . . . 0.40000000000000002 111.232 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.448 HG21 HD21 ' A' ' 163' ' ' LEU . 91.3 m -77.73 -53.78 7.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.264 0.468 . . . . 0.22 112.264 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.46 ' CD1' HD23 ' A' ' 115' ' ' LEU . 6.5 m-85 -71.76 -28.09 63.42 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.54 0.57 . . . . 0.11 112.54 -173.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.5 t -57.71 -28.86 64.22 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.571 0.224 . . . . 0.19 111.296 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.33 -22.86 45.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.678 0.275 . . . . 0.14000000000000001 111.385 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.401 ' HZ ' ' HE3' ' A' ' 157' ' ' LYS . 26.7 m-85 -89.76 -26.22 20.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.038 0.447 . . . . 0.17999999999999999 110.546 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.89 169.77 35.82 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.125 -0.79 . . . . 0.11 111.125 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -71.04 143.59 50.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.65 -0.5 . . . . 0.25 109.65 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.436 HG21 ' HB3' ' A' ' 128' ' ' CYS . 76.2 mt -114.76 134.93 56.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 116.014 -0.539 . . . . 0.14000000000000001 110.015 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -93.02 -36.45 12.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 0.54000000000000004 109.508 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.1 m -156.18 97.61 1.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.733 -0.667 . . . . 0.76000000000000001 111.365 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.7 p -103.84 153.54 20.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.355 -0.609 . . . . 0.71999999999999997 109.355 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -150.61 132.44 15.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.818 0.342 . . . . 1.0 111.255 -175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.73 HG22 HD12 ' A' ' 115' ' ' LEU . 57.5 t -114.28 110.31 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 107.183 -1.414 . . . . 0.28000000000000003 107.183 171.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 C--N 1.302 -1.493 0 N-CA-C 108.432 -0.951 . . . . 0.34000000000000002 108.432 -175.456 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.693 0 CA-C-O 119.911 -0.383 . . . . 0.31 113.877 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -161.18 153.93 20.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.742 0.771 . . . . 0.48999999999999999 111.285 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.29 174.06 28.09 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.457 -0.792 . . . . 0.12 111.625 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -139.93 142.65 36.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.928 0.364 . . . . 0.25 110.555 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.515 ' HB ' HG12 ' A' ' 101' ' ' ILE . 24.6 t -118.34 133.96 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.105 0.479 . . . . 0.10000000000000001 111.362 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.54 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.1 OUTLIER -106.45 106.58 17.16 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.851 -0.796 . . . . 0.20999999999999999 108.851 167.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 8.7 m-85 -89.28 139.76 30.17 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.284 0.564 . . . . 0.17000000000000001 111.915 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.666 ' HA ' HD21 ' A' ' 126' ' ' LEU . 43.8 tt0 -52.48 -48.74 65.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.112 -1.404 . . . . 0.56999999999999995 110.07 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.2 p -111.77 144.45 41.03 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.137 -1.392 . . . . 0.40000000000000002 111.062 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -61.92 -40.32 95.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.299 -0.864 . . . . 0.46999999999999997 111.026 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.8 pt-20 -67.68 -35.18 78.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.73999999999999999 111.408 -175.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.84 78.43 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.241 0.543 . . . . 0.17999999999999999 110.489 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.475 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.97 -44.72 91.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.388 -0.824 . . . . 0.16 110.86 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 37.7 mt-10 -62.06 -37.33 84.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.646 -0.707 . . . . 1.4199999999999999 110.356 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 157' ' ' LYS . 88.8 mtt180 -62.54 -47.05 85.57 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.332 -0.394 . . . . 1.48 110.592 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.78 81.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.997 -0.547 . . . . 0.10000000000000001 111.012 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.0 mt -61.21 -53.77 44.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.239 -0.437 . . . . 0.14999999999999999 111.131 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 4.2 pt-20 -64.69 -45.01 88.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.186 0.517 . . . . 1.0800000000000001 111.919 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -75.52 -38.92 59.07 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.483 -0.78 . . . . 1.1599999999999999 112.893 -170.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.459 ' HB2' HG21 ' A' ' 170' ' ' VAL . 83.8 mmm -93.51 -26.23 17.25 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.917 0.71 . . . . 0.34999999999999998 112.917 -173.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.401 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 52.7 t30 -64.79 123.74 20.15 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.549 -0.46 . . . . 0.44 110.15 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.42 11.65 62.27 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.816 -0.706 . . . . 0.28999999999999998 113.184 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.676 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 75.2 mmm -105.39 164.25 12.0 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.568 -0.372 . . . . 1.1799999999999999 111.508 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.442 HD23 ' N ' ' A' ' 167' ' ' LYS . 19.8 mt -96.33 123.21 39.89 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.928 -0.768 . . . . 0.44 108.928 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.53 HD12 HG11 ' A' ' 168' ' ' VAL . 24.9 mt -106.43 100.21 9.75 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.934 -0.706 . . . . 1.02 109.659 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 94.5 m-20 77.72 -28.82 0.16 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.871 -1.059 . . . . 1.71 112.725 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 35.7 t70 174.44 -23.85 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.772 -0.649 . . . . 0.84999999999999998 112.221 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.7 mtt180 -115.96 134.93 54.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.935 0.397 . . . . 0.95999999999999996 111.602 -173.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.5 ttmt -76.92 123.83 26.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.418 -0.81 . . . . 1.0 109.171 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.53 HG11 HD12 ' A' ' 163' ' ' LEU . 23.2 m -103.05 146.6 10.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.434 0.635 . . . . 0.17000000000000001 111.528 -174.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 73.5 t80 -107.51 119.26 38.94 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.016 -0.993 . . . . 0.29999999999999999 109.116 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.649 HG22 HG12 ' A' ' 103' ' ' ILE . 43.0 t -114.82 128.04 72.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.467 -0.568 . . . . 0.13 109.467 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.61 -177.44 22.86 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.365 -0.922 . . . . 0.17999999999999999 112.714 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.496 ' HA ' ' HE ' ' A' ' 172' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.549 0 CA-C-O 120.889 0.376 . . . . 1.9299999999999999 110.795 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 121.701 0.762 . . . . 0.70999999999999996 111.781 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.89 22.71 78.9 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.265 -0.969 . . . . 0.20999999999999999 111.217 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -96.18 128.38 43.04 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.14 -0.689 . . . . 0.63 109.14 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.486 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.8 pt -133.31 162.5 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.162 -0.472 . . . . 0.14999999999999999 109.864 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.24 144.63 50.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.006 0.431 . . . . 0.20999999999999999 109.908 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.627 HG12 HG22 ' A' ' 170' ' ' VAL . 5.7 mt -119.92 135.49 60.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.588 -0.733 . . . . 0.14999999999999999 110.071 -177.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -116.66 152.37 34.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.732 -0.213 . . . . 1.46 110.652 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 t30 71.58 40.65 0.78 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.942 0.777 . . . . 0.48999999999999999 111.79 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.622 HD22 HG21 ' A' ' 110' ' ' ILE . 20.6 mt -78.24 158.55 28.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.389 0.614 . . . . 0.26000000000000001 111.755 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.477 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 25.1 t70 -81.93 150.76 27.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.359 -0.837 . . . . 0.70999999999999996 110.916 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -55.72 -36.88 67.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.599 -0.728 . . . . 2.2000000000000002 112.131 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.6 m -84.02 -3.87 58.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.89 0.33 . . . . 1.4099999999999999 111.89 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.671 HG22 HG21 ' A' ' 130' ' ' VAL . 27.9 mm -71.87 117.14 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.091 0.472 . . . . 0.26000000000000001 110.183 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 15.6 t70 -105.64 -171.74 1.96 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.798 -0.815 . . . . 1.5900000000000001 108.798 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.413 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 87.3 m-20 -72.17 -32.61 67.01 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.319 -0.993 . . . . 0.59999999999999998 108.319 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.63 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -68.68 -45.05 72.71 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.039 -1.437 . . . . 2.5800000000000001 109.661 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.76 -44.25 97.26 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.662 -1.608 . . . . 0.14999999999999999 110.574 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 130' ' ' VAL . 4.1 tt -67.4 -47.19 71.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.165 -0.925 . . . . 0.16 109.378 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.802 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 83.5 t80 -58.98 -45.31 90.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.893 -0.594 . . . . 0.29999999999999999 111.165 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.85 -40.89 76.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.852 0.358 . . . . 0.40000000000000002 110.877 -175.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 58.8 m -77.41 -53.71 7.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.238 -0.437 . . . . 0.22 112.136 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.429 ' CD1' HD23 ' A' ' 115' ' ' LEU . 14.1 m-85 -71.59 -28.43 63.81 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.657 0.614 . . . . 0.11 112.657 -173.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -57.75 -28.42 63.91 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.609 0.243 . . . . 0.19 111.078 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.78 -22.68 37.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.804 0.298 . . . . 0.14000000000000001 111.804 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -91.88 -15.54 27.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.997 0.427 . . . . 0.17999999999999999 111.038 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.19 166.79 22.6 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.531 -0.628 . . . . 0.11 111.531 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -67.57 139.44 56.91 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.033 0.444 . . . . 0.25 110.201 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.457 HG21 ' HB3' ' A' ' 128' ' ' CYS . 65.9 mt -113.37 133.91 57.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.725 -0.671 . . . . 0.14000000000000001 109.723 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.615 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -90.37 -43.7 10.15 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.884 -0.784 . . . . 0.54000000000000004 108.884 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 55.7 m -145.65 99.75 3.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.231 -0.895 . . . . 0.76000000000000001 110.962 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.802 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.6 p -97.53 145.9 25.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.17 -0.678 . . . . 0.71999999999999997 109.17 171.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -148.79 134.27 18.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.063 0.459 . . . . 1.0 111.8 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.671 HG21 HG22 ' A' ' 110' ' ' ILE . 99.1 t -114.02 115.07 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 106.587 -1.634 . . . . 0.28000000000000003 106.587 170.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.2 t . . . . . 0 C--N 1.301 -1.514 0 N-CA-C 108.709 -0.848 . . . . 0.34000000000000002 108.709 -176.64 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.696 0 N-CA-C 113.35 0.1 . . . . 0.31 113.35 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -123.68 152.84 41.6 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.457 0.646 . . . . 0.48999999999999999 111.976 -172.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.89 174.36 23.63 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.954 -1.021 . . . . 0.12 111.309 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -138.72 140.99 38.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.01 0.405 . . . . 0.25 110.72 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.486 ' HB ' HG12 ' A' ' 101' ' ' ILE . 43.0 t -115.45 129.17 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 120.946 0.403 . . . . 0.10000000000000001 110.492 172.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.1 m170 -100.47 105.19 16.62 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.267 -0.642 . . . . 0.20999999999999999 109.267 167.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.555 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 18.8 m-85 -87.25 142.97 27.5 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.078 0.466 . . . . 0.17000000000000001 110.392 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.615 ' HA ' HD21 ' A' ' 126' ' ' LEU . 35.5 tt0 -52.89 -34.45 54.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.426 -1.261 . . . . 0.56999999999999995 110.706 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.6 p -129.94 152.38 49.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.348 -0.842 . . . . 0.40000000000000002 111.277 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -62.18 -36.02 80.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.694 -0.684 . . . . 0.46999999999999997 111.204 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.26 -35.66 76.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.008 0.373 . . . . 0.73999999999999999 112.008 -175.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.88 -34.67 78.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 0.17999999999999999 110.553 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.555 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -65.3 -41.72 93.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.722 -0.672 . . . . 0.16 110.944 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 32.4 mt-10 -59.33 -40.19 85.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 1.4199999999999999 110.775 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 70.8 mtt180 -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 1.48 111.192 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.68 84.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.438 -0.346 . . . . 0.10000000000000001 110.451 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.1 mt -62.26 -53.25 49.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.242 -0.435 . . . . 0.14999999999999999 111.168 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 0.9 OUTLIER -64.27 -41.86 96.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.07 0.462 . . . . 1.0800000000000001 111.899 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.479 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.23 -38.69 24.14 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.084 0.772 . . . . 1.1599999999999999 113.084 -171.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.462 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.8 mmm -93.81 -20.52 20.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.843 0.683 . . . . 0.34999999999999998 112.843 -172.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 58.2 t30 -68.5 123.83 21.89 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.965 -0.694 . . . . 0.44 109.495 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.53 17.01 57.78 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.742 -0.742 . . . . 0.28999999999999998 112.721 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.729 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.4 mmt -100.91 163.4 12.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.675 0.274 . . . . 1.1799999999999999 111.54 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 mt -104.3 105.21 15.27 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.983 -0.553 . . . . 0.44 109.826 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 163' ' ' LEU . 18.8 mt -93.04 105.97 17.99 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.974 -0.691 . . . . 1.02 109.881 175.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 93.3 m-20 75.09 -51.23 0.67 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.124 -0.944 . . . . 1.71 111.843 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -178.63 22.09 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.88 -0.6 . . . . 0.84999999999999998 111.729 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.477 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.4 mtt180 -138.76 135.48 34.72 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.681 -0.637 . . . . 0.95999999999999996 109.957 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.729 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.2 ttmt -83.08 117.68 23.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.479 HG11 HD23 ' A' ' 106' ' ' LEU . 11.5 m -100.52 148.39 6.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.588 0.709 . . . . 0.17000000000000001 111.448 -171.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 69.2 t80 -106.46 120.61 42.35 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.647 -1.16 . . . . 0.29999999999999999 109.292 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.627 HG22 HG12 ' A' ' 103' ' ' ILE . 43.2 t -115.65 126.24 73.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.448 -0.575 . . . . 0.13 109.448 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.06 -175.9 21.89 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.745 -0.741 . . . . 0.17999999999999999 111.548 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.3 -0.63 . . . . 1.9299999999999999 109.3 -179.848 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 78.9 t . . . . . 0 N--CA 1.466 0.349 0 CA-C-O 121.552 0.692 . . . . 0.70999999999999996 112.25 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.437 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 72.8 24.05 76.78 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 119.974 -1.107 . . . . 0.20999999999999999 111.605 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.491 HD22 ' N ' ' A' ' 100' ' ' ASN . 0.9 OUTLIER -88.74 125.96 35.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.273 -0.64 . . . . 0.63 109.273 -174.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.596 HG23 ' HB1' ' A' ' 151' ' ' ALA . 21.6 pt -135.46 161.43 39.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.989 -0.374 . . . . 0.14999999999999999 109.989 175.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.23 137.87 54.11 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.88 -0.415 . . . . 0.20999999999999999 109.88 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.56 HG12 HG22 ' A' ' 170' ' ' VAL . 5.1 mt -115.21 135.05 56.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.612 -0.722 . . . . 0.14999999999999999 110.013 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -117.12 152.95 33.65 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.292 -0.262 . . . . 1.46 110.292 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.3 t30 74.89 35.1 0.65 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.818 0.699 . . . . 0.48999999999999999 111.474 171.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.433 HD22 HG21 ' A' ' 110' ' ' ILE . 30.7 mt -79.79 159.54 26.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.12 0.486 . . . . 0.26000000000000001 111.185 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -92.66 150.71 20.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.596 -0.729 . . . . 0.70999999999999996 110.414 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -52.1 -31.98 33.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.758 -0.656 . . . . 2.2000000000000002 112.213 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.5 m -71.78 -17.32 62.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.096 0.406 . . . . 1.4099999999999999 112.096 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.575 HG22 HG21 ' A' ' 130' ' ' VAL . 28.5 mm -71.43 123.52 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.251 0.548 . . . . 0.26000000000000001 110.835 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.473 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 26.5 t70 -107.87 -177.98 3.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.279 -0.873 . . . . 1.5900000000000001 109.056 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -69.61 -35.09 74.96 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.344 -0.984 . . . . 0.59999999999999998 108.344 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -45.66 71.68 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.628 -1.169 . . . . 2.5800000000000001 109.052 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.473 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -60.75 -40.24 91.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.006 -1.452 . . . . 0.14999999999999999 110.669 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.589 HD12 HG22 ' A' ' 130' ' ' VAL . 3.8 tt -68.87 -47.02 66.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.199 -0.91 . . . . 0.16 109.231 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.727 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 65.6 t80 -60.64 -45.1 95.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.29999999999999999 111.132 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -56.8 -40.61 76.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.03 0.443 . . . . 0.40000000000000002 110.543 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.575 HG21 HD21 ' A' ' 163' ' ' LEU . 20.4 m -77.52 -53.81 7.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.747 -0.661 . . . . 0.22 111.822 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.411 ' CD1' HD23 ' A' ' 115' ' ' LEU . 11.1 m-85 -72.48 -28.16 62.73 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.743 0.646 . . . . 0.11 112.743 -174.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.6 t -57.57 -29.05 64.12 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.58 0.229 . . . . 0.19 111.207 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.35 39.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.928 0.394 . . . . 0.14000000000000001 111.716 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -92.83 -14.83 27.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.414 -0.357 . . . . 0.17999999999999999 111.019 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.5 169.83 26.43 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.624 -0.59 . . . . 0.11 111.624 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -73.15 138.65 45.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.108 0.48 . . . . 0.25 110.247 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.406 HG21 ' HB3' ' A' ' 128' ' ' CYS . 69.2 mt -111.03 132.09 60.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.718 -0.673 . . . . 0.14000000000000001 110.038 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.602 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -84.57 -43.27 14.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.569 -0.9 . . . . 0.54000000000000004 108.569 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.3 m -146.5 131.78 18.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.819 -1.082 . . . . 0.76000000000000001 110.255 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.727 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.5 p -128.69 134.67 48.56 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.117 -0.698 . . . . 0.71999999999999997 109.117 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -133.76 133.33 41.6 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.586 -0.446 . . . . 1.0 111.776 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.589 HG22 HD12 ' A' ' 115' ' ' LEU . 83.9 t -114.56 110.44 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 107.012 -1.477 . . . . 0.28000000000000003 107.012 170.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 t . . . . . 0 C--N 1.304 -1.379 0 N-CA-C 108.971 -0.752 . . . . 0.34000000000000002 108.971 -175.13 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.666 0 CA-C-O 120.253 -0.193 . . . . 0.31 113.527 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 29.9 p90 -132.79 150.75 52.12 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.359 0.6 . . . . 0.48999999999999999 111.854 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.22 167.14 26.18 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.036 -0.984 . . . . 0.12 111.341 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -133.99 136.97 44.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.937 0.368 . . . . 0.25 110.738 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.54 ' HB ' HG12 ' A' ' 101' ' ' ILE . 42.7 t -110.79 136.16 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.10000000000000001 110.644 174.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.454 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 1.2 m170 -105.95 105.37 15.38 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.774 -0.824 . . . . 0.20999999999999999 108.774 166.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.576 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 17.8 m-85 -88.71 140.8 29.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.099 0.476 . . . . 0.17000000000000001 110.732 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.602 ' HA ' HD21 ' A' ' 126' ' ' LEU . 34.7 tt0 -51.7 -41.33 61.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.749 -1.114 . . . . 0.56999999999999995 110.361 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 78.2 p -115.24 150.52 36.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.701 -1.136 . . . . 0.40000000000000002 110.157 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -65.65 -36.12 82.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.132 -0.485 . . . . 0.46999999999999997 110.593 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 12.5 pt-20 -69.04 -35.0 76.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.73999999999999999 111.828 -176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.29 79.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.067 0.46 . . . . 0.17999999999999999 110.639 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.596 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -64.02 -46.31 85.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.705 -0.68 . . . . 0.16 110.507 177.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 42.7 mt-10 -61.74 -34.55 76.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.328 -0.851 . . . . 1.4199999999999999 110.91 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 95.9 mtt180 -61.82 -47.63 84.21 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.106 0.479 . . . . 1.48 110.543 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.8 -35.8 77.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.86 -0.609 . . . . 0.10000000000000001 110.587 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.5 mt -60.61 -54.41 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.14999999999999999 111.225 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 0.8 OUTLIER -64.04 -42.44 97.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.53 . . . . 1.0800000000000001 111.768 -177.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -37.97 31.88 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.486 -0.779 . . . . 1.1599999999999999 112.819 -170.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.468 ' HB2' HG21 ' A' ' 170' ' ' VAL . 91.9 mmm -96.41 -16.93 20.95 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.818 0.673 . . . . 0.34999999999999998 112.818 -173.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -70.0 124.04 23.05 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.09 -0.644 . . . . 0.44 109.882 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.19 15.56 74.13 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.166 -0.47 . . . . 0.28999999999999998 112.088 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.484 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 11.7 tpp -99.91 157.6 16.41 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.065 -0.346 . . . . 1.1799999999999999 110.065 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.0 mt -96.94 110.92 23.34 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 109.349 -0.612 . . . . 0.44 109.349 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.575 HD21 HG21 ' A' ' 118' ' ' THR . 20.8 mt -98.02 105.18 17.29 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.981 -0.687 . . . . 1.02 109.539 173.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 61.3 m-20 77.11 -29.62 0.17 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.22 -0.9 . . . . 1.71 112.681 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 21.1 t70 168.19 -22.18 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.701 0.625 . . . . 0.84999999999999998 111.864 -170.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 80.5 mtt-85 -113.3 137.78 50.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.867 0.365 . . . . 0.95999999999999996 111.118 -170.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 161' ' ' MET . 8.0 tttm -81.5 112.96 19.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.307 -177.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.412 HG11 HD23 ' A' ' 106' ' ' LEU . 16.0 m -100.15 148.48 6.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.599 0.714 . . . . 0.17000000000000001 111.245 -172.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 68.3 t80 -106.68 119.49 39.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.726 -1.124 . . . . 0.29999999999999999 109.384 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.56 HG22 HG12 ' A' ' 103' ' ' ILE . 40.1 t -114.57 125.46 71.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.983 -0.747 . . . . 0.13 108.983 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -144.41 -171.68 14.52 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.577 -0.821 . . . . 0.17999999999999999 112.095 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.0 mmt180 . . . . . 0 C--N 1.321 -0.658 0 N-CA-C 109.879 -0.415 . . . . 1.9299999999999999 109.879 -178.434 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.4 t . . . . . 0 N--CA 1.472 0.649 0 CA-C-O 121.401 0.62 . . . . 0.70999999999999996 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.69 24.18 73.13 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.384 -0.912 . . . . 0.20999999999999999 112.117 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -86.88 124.26 32.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.445 -0.576 . . . . 0.63 109.445 -174.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.493 HG12 ' HB ' ' A' ' 143' ' ' VAL . 20.2 pt -135.67 161.88 37.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.995 -0.548 . . . . 0.14999999999999999 109.803 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.42 144.11 50.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.864 -0.421 . . . . 0.20999999999999999 109.864 176.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.615 HG12 HG22 ' A' ' 170' ' ' VAL . 4.5 mt -118.82 130.99 72.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.613 -0.721 . . . . 0.14999999999999999 110.166 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -109.65 152.25 25.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.587 -0.278 . . . . 1.46 110.702 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.6 t30 72.14 33.65 1.55 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.926 0.766 . . . . 0.48999999999999999 111.861 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.453 HD23 HG11 ' A' ' 168' ' ' VAL . 17.3 mt -72.64 155.39 40.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.063 0.459 . . . . 0.26000000000000001 111.446 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.486 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 23.3 t70 -75.25 146.91 40.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.732 -0.667 . . . . 0.70999999999999996 109.832 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -60.47 -31.72 70.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.108 -0.496 . . . . 2.2000000000000002 111.796 -176.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t -79.04 -4.29 49.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.575 -0.284 . . . . 1.4099999999999999 111.499 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.467 HG12 ' HB3' ' A' ' 107' ' ' ASP . 32.0 mm -73.03 127.14 34.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.419 . . . . 0.26000000000000001 110.393 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.503 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 10.5 t70 -110.89 -177.15 3.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.748 -0.66 . . . . 1.5900000000000001 109.28 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.6 ' OD1' ' HA ' ' A' ' 129' ' ' LYS . 69.1 m-80 -72.06 -32.08 66.73 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.565 -0.902 . . . . 0.59999999999999998 108.565 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -47.95 74.35 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.675 -1.148 . . . . 2.5800000000000001 108.797 176.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.503 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.63 -43.57 98.6 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.039 -1.437 . . . . 0.14999999999999999 111.103 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.523 HD12 HG22 ' A' ' 130' ' ' VAL . 3.2 tt -66.54 -46.58 75.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.478 -0.783 . . . . 0.16 109.27 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.432 ' CE1' ' HB ' ' A' ' 125' ' ' ILE . 62.3 t80 -60.52 -46.35 90.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.29999999999999999 110.658 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -56.55 -39.49 73.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.858 0.361 . . . . 0.40000000000000002 111.044 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 m -78.1 -54.02 6.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.001 -0.545 . . . . 0.22 112.087 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.401 ' CD1' HD23 ' A' ' 115' ' ' LEU . 9.2 m-85 -72.15 -28.39 63.21 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.683 0.623 . . . . 0.11 112.683 -173.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.8 t -57.67 -28.46 63.78 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.826 0.346 . . . . 0.19 110.809 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.4 36.01 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.227 -0.442 . . . . 0.14000000000000001 111.637 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -89.74 -31.99 17.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.984 0.421 . . . . 0.17999999999999999 110.723 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.49 165.41 34.08 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.392 -0.683 . . . . 0.11 111.392 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -62.19 140.84 58.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.971 0.415 . . . . 0.25 109.972 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.753 HD13 ' SG ' ' A' ' 128' ' ' CYS . 94.8 mt -114.34 133.96 58.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.937 -0.574 . . . . 0.14000000000000001 110.637 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.539 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -91.05 -37.12 13.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.076 -0.712 . . . . 0.54000000000000004 109.076 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 70.5 m -159.54 111.11 2.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.529 -0.759 . . . . 0.76000000000000001 111.227 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.794 ' SG ' HG13 ' A' ' 143' ' ' VAL . 54.2 m -109.12 144.9 36.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.527 -0.546 . . . . 0.71999999999999997 109.527 169.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.6 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 53.1 tptt -135.62 131.96 36.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.416 -175.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 115' ' ' LEU . 88.5 t -114.19 110.13 31.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 106.539 -1.652 . . . . 0.28000000000000003 106.539 168.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 C--N 1.308 -1.216 0 CA-C-N 115.55 -0.75 . . . . 0.34000000000000002 109.976 -171.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 CA-C-O 120.529 -0.04 . . . . 0.31 113.114 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -132.34 153.44 50.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.835 0.35 . . . . 0.48999999999999999 110.907 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.7 173.35 24.02 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.87 -0.605 . . . . 0.12 111.898 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -135.59 143.99 45.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.731 0.265 . . . . 0.25 110.722 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.794 HG13 ' SG ' ' A' ' 128' ' ' CYS . 40.1 t -118.58 136.45 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.10000000000000001 111.142 173.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.1 m170 -106.46 106.38 16.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.19 -0.67 . . . . 0.20999999999999999 109.19 166.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.575 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.5 m-85 -89.4 137.61 32.17 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.329 0.585 . . . . 0.17000000000000001 111.354 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.539 ' HA ' HD21 ' A' ' 126' ' ' LEU . 43.7 tt0 -47.86 -40.25 20.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.19 -1.368 . . . . 0.56999999999999995 110.951 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.1 p -120.3 153.0 37.01 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.276 -0.875 . . . . 0.40000000000000002 110.914 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -67.35 -34.95 78.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 0.46999999999999997 110.453 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 12.1 pt-20 -70.04 -34.74 73.64 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.261 -0.427 . . . . 0.73999999999999999 111.737 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.05 -34.84 77.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.998 0.427 . . . . 0.17999999999999999 110.649 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.575 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.82 -46.5 84.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.681 -0.691 . . . . 0.16 110.717 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 40.3 mt-10 -59.18 -37.7 78.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.781 -0.645 . . . . 1.4199999999999999 111.003 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 86.6 mtt180 -59.58 -44.89 93.2 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.983 0.42 . . . . 1.48 110.54 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.79 85.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.984 -0.553 . . . . 0.10000000000000001 110.452 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 151' ' ' ALA . 78.1 mt -62.76 -54.17 37.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.209 -0.45 . . . . 0.14999999999999999 111.063 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.3 pt-20 -60.59 -44.04 96.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 1.0800000000000001 111.613 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.427 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -82.04 -39.42 23.52 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.211 0.819 . . . . 1.1599999999999999 113.211 -170.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 95.4 mmm -92.61 -23.33 19.05 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.618 0.599 . . . . 0.34999999999999998 112.618 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 54.9 t30 -66.85 123.49 20.31 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.225 -0.59 . . . . 0.44 109.695 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.84 8.57 69.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.912 -0.661 . . . . 0.28999999999999998 112.626 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 29.2 mmt -96.53 170.75 9.0 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 120.886 0.374 . . . . 1.1799999999999999 111.541 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 33.3 mt -105.22 126.79 52.48 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.571 -0.74 . . . . 0.44 109.377 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 11.5 mt -109.92 108.07 18.22 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.916 -0.772 . . . . 1.02 108.916 168.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 4.7 m-20 78.83 -33.75 0.16 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.166 0.916 . . . . 1.71 111.817 176.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 33.4 t70 168.77 -20.87 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.13 -0.941 . . . . 0.84999999999999998 111.754 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.486 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 97.6 mtt180 -100.9 138.67 37.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.714 -0.221 . . . . 0.95999999999999996 110.504 -174.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 161' ' ' MET . 3.5 ttmp? -83.96 120.6 26.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.453 HG11 HD23 ' A' ' 106' ' ' LEU . 17.1 m -102.64 148.98 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.579 0.704 . . . . 0.17000000000000001 111.615 -174.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 58.4 t80 -107.84 122.42 46.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.862 -1.063 . . . . 0.29999999999999999 109.101 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.615 HG22 HG12 ' A' ' 103' ' ' ILE . 47.1 t -115.14 125.42 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.205 -0.665 . . . . 0.13 109.205 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -146.83 -171.46 16.12 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.573 -0.822 . . . . 0.17999999999999999 111.984 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 . . . . . 0 C--N 1.323 -0.577 0 N-CA-C 109.741 -0.466 . . . . 1.9299999999999999 109.741 -178.429 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 121.118 0.485 . . . . 0.70999999999999996 112.22 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.23 23.99 77.11 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.809 -1.186 . . . . 0.20999999999999999 111.48 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.503 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.1 m120 -88.27 125.96 34.92 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.982 -0.747 . . . . 0.63 108.982 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.527 HG23 ' HB1' ' A' ' 151' ' ' ALA . 22.8 pt -135.4 162.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.096 -0.335 . . . . 0.14999999999999999 110.096 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.81 140.55 52.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.93 0.395 . . . . 0.20999999999999999 109.991 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 170' ' ' VAL . 5.8 mt -115.19 141.16 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.626 -0.715 . . . . 0.14999999999999999 110.033 -177.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 3.0 ttpm? -123.02 148.78 45.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.901 -0.136 . . . . 1.46 110.709 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.9 t30 72.43 48.36 0.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.664 0.786 . . . . 0.48999999999999999 111.856 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.544 HD22 HG21 ' A' ' 110' ' ' ILE . 32.3 mt -90.01 160.85 16.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.249 -0.432 . . . . 0.26000000000000001 110.765 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -93.9 155.57 17.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.70999999999999996 109.988 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -59.93 -28.01 67.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.428 -0.351 . . . . 2.2000000000000002 111.82 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -72.64 -8.47 55.46 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.85 0.315 . . . . 1.4099999999999999 111.85 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.613 HG22 HG21 ' A' ' 130' ' ' VAL . 30.9 mm -83.83 117.66 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.417 . . . . 0.26000000000000001 110.353 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -108.96 -175.62 2.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.397 -0.964 . . . . 1.5900000000000001 108.397 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -67.09 -30.37 70.38 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.947 -0.76 . . . . 0.59999999999999998 108.947 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -49.54 60.32 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.432 -1.258 . . . . 2.5800000000000001 109.457 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.71 -39.69 92.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.369 -1.287 . . . . 0.14999999999999999 110.628 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 130' ' ' VAL . 3.6 tt -67.44 -47.5 70.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.322 -0.854 . . . . 0.16 109.113 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.711 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 61.3 t80 -59.52 -46.43 88.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.919 -0.582 . . . . 0.29999999999999999 110.775 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -56.09 -39.14 71.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.282 -0.417 . . . . 0.40000000000000002 111.137 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.655 HG21 HD21 ' A' ' 163' ' ' LEU . 26.4 m -78.54 -54.25 6.35 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.436 0.532 . . . . 0.22 112.436 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.413 ' CD1' HD23 ' A' ' 115' ' ' LEU . 14.0 m-85 -73.0 -27.2 61.64 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.093 0.775 . . . . 0.11 113.093 -173.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.3 t -56.13 -28.84 59.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.818 0.303 . . . . 0.19 111.818 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.02 37.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.887 0.328 . . . . 0.14000000000000001 111.887 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -92.2 -12.86 31.61 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.538 0.199 . . . . 0.17999999999999999 111.538 -176.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.2 172.93 28.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.075 -0.583 . . . . 0.11 111.646 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -71.84 138.78 48.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.06 0.457 . . . . 0.25 110.408 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.424 HG21 ' HB3' ' A' ' 128' ' ' CYS . 72.7 mt -111.92 129.25 67.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.79 -0.641 . . . . 0.14000000000000001 109.862 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.709 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.89 -39.63 15.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.53 0.681 . . . . 0.54000000000000004 109.188 -178.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 50.8 m -151.58 105.06 3.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.286 -0.87 . . . . 0.76000000000000001 111.034 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.711 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 4.6 p -104.1 142.04 35.17 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.35 -0.611 . . . . 0.71999999999999997 109.35 174.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -143.59 130.94 20.92 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.432 -0.507 . . . . 1.0 112.038 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.703 HG22 HD12 ' A' ' 115' ' ' LEU . 57.8 t -114.26 110.66 32.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 106.808 -1.553 . . . . 0.28000000000000003 106.808 170.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t . . . . . 0 C--N 1.304 -1.371 0 CA-C-N 115.729 -0.669 . . . . 0.34000000000000002 109.324 -173.513 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.683 0 N-CA-C 113.572 0.189 . . . . 0.31 113.572 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -128.56 151.88 48.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 117.32 0.56 . . . . 0.48999999999999999 111.582 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.42 172.14 24.0 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.375 -0.83 . . . . 0.12 111.616 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -135.73 138.17 42.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.995 0.398 . . . . 0.25 110.923 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.525 ' HB ' HG12 ' A' ' 101' ' ' ILE . 47.1 t -110.33 133.89 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 120.985 0.421 . . . . 0.10000000000000001 110.686 172.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.5 OUTLIER -104.22 105.23 15.31 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.964 -0.754 . . . . 0.20999999999999999 108.964 167.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.524 ' CE2' HG11 ' A' ' 143' ' ' VAL . 14.4 m-85 -89.8 139.53 30.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.048 0.452 . . . . 0.17000000000000001 110.693 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.709 ' HA ' HD21 ' A' ' 126' ' ' LEU . 33.2 tt0 -52.3 -44.06 64.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.749 -1.114 . . . . 0.56999999999999995 110.214 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 63.4 p -111.78 150.47 30.26 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.666 -1.152 . . . . 0.40000000000000002 110.837 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -68.42 -35.55 77.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.968 -0.56 . . . . 0.46999999999999997 110.572 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.2 pt-20 -69.33 -34.34 74.5 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.237 -0.438 . . . . 0.73999999999999999 111.799 -176.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.89 79.45 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.115 0.483 . . . . 0.17999999999999999 110.59 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.527 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -62.64 -45.54 92.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.485 -0.779 . . . . 0.16 110.845 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.0 mt-10 -59.06 -37.4 76.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.95 -0.568 . . . . 1.4199999999999999 110.778 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.486 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.3 mtt180 -62.4 -45.59 92.43 Favored 'General case' 0 CA--C 1.523 -0.064 0 CA-C-O 120.986 0.422 . . . . 1.48 110.411 176.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.15 80.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.513 . . . . 0.10000000000000001 110.517 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 151' ' ' ALA . 89.4 mt -61.68 -54.47 34.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.066 -0.515 . . . . 0.14999999999999999 111.324 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.1 pt-20 -64.35 -43.16 95.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.329 0.585 . . . . 1.0800000000000001 111.98 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -78.98 -38.42 36.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.23 -0.895 . . . . 1.1599999999999999 112.773 -169.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.0 mmm -93.1 -24.21 18.35 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.47 0.545 . . . . 0.34999999999999998 112.47 -175.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -64.75 123.74 20.14 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.464 -0.494 . . . . 0.44 109.811 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.24 14.75 61.69 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.869 -0.681 . . . . 0.28999999999999998 112.909 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.597 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.6 mmt -106.83 162.65 13.61 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.523 -0.398 . . . . 1.1799999999999999 111.792 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.9 mt -98.78 108.76 21.53 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.863 -0.608 . . . . 0.44 109.7 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 118' ' ' THR . 17.3 mt -93.98 110.02 21.72 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.824 -0.751 . . . . 1.02 109.114 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 91.7 m-20 73.01 -67.62 0.26 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.323 -0.853 . . . . 1.71 110.919 -175.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -161.79 14.54 0.09 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.854 -0.612 . . . . 0.84999999999999998 111.491 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -131.34 133.2 45.09 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.813 -0.554 . . . . 0.95999999999999996 109.889 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 161' ' ' MET . 17.6 ttmt -78.64 119.47 21.95 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 18.9 m -101.57 141.98 17.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.348 0.594 . . . . 0.17000000000000001 111.183 -173.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -106.74 121.85 45.2 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.07 -0.968 . . . . 0.29999999999999999 109.406 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.508 HG22 HG12 ' A' ' 103' ' ' ILE . 37.7 t -116.07 125.98 73.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.549 -0.537 . . . . 0.13 109.549 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -140.05 -165.96 10.48 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.651 -0.785 . . . . 0.17999999999999999 112.02 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 . . . . . 0 C--N 1.326 -0.433 0 N-CA-C 109.834 -0.432 . . . . 1.9299999999999999 109.834 -177.432 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 121.537 0.684 . . . . 0.70999999999999996 112.008 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.36 25.51 65.7 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.057 -1.068 . . . . 0.20999999999999999 112.063 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.571 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.2 m120 -89.03 123.84 33.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.232 -0.655 . . . . 0.63 109.232 -172.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.565 HG12 ' HB ' ' A' ' 143' ' ' VAL . 17.3 pt -136.43 164.44 31.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.445 -0.343 . . . . 0.14999999999999999 110.301 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.55 147.81 49.81 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.925 -0.398 . . . . 0.20999999999999999 109.925 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.596 HG12 HG22 ' A' ' 170' ' ' VAL . 5.3 mt -122.18 137.37 55.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.786 -0.643 . . . . 0.14999999999999999 110.195 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -116.62 151.15 36.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.745 -0.207 . . . . 1.46 110.739 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 t30 73.97 38.4 0.58 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.938 0.774 . . . . 0.48999999999999999 111.543 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.496 HD23 HG11 ' A' ' 168' ' ' VAL . 23.2 mt -77.97 158.16 29.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.118 0.485 . . . . 0.26000000000000001 111.399 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 20.5 t70 -84.91 151.11 24.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.491 -0.777 . . . . 0.70999999999999996 110.561 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.1 pttm -58.52 -29.99 66.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.751 -0.658 . . . . 2.2000000000000002 112.681 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.5 m -82.84 -3.92 57.4 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.168 0.433 . . . . 1.4099999999999999 112.168 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.587 HG22 HG21 ' A' ' 130' ' ' VAL . 31.5 mm -73.97 127.44 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.135 0.493 . . . . 0.26000000000000001 110.905 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.7 -178.06 3.3 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.049 -0.723 . . . . 1.5900000000000001 109.049 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.95 -32.43 69.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.889 -0.782 . . . . 0.59999999999999998 108.889 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -47.59 72.15 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.802 -1.09 . . . . 2.5800000000000001 109.01 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.72 -44.16 97.45 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 114.029 -1.441 . . . . 0.14999999999999999 110.904 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.731 HD12 HG22 ' A' ' 130' ' ' VAL . 3.8 tt -65.07 -46.63 80.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.985 -0.746 . . . . 0.16 108.985 177.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.635 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 52.7 t80 -59.81 -49.63 76.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.859 -0.61 . . . . 0.29999999999999999 110.911 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -57.46 -38.69 74.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.394 . . . . 0.40000000000000002 110.774 -174.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.2 m -76.76 -53.65 7.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.881 -0.6 . . . . 0.22 111.507 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.88 -28.24 63.39 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.241 0.459 . . . . 0.11 112.241 -175.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 33.7 t -57.62 -29.09 64.25 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.305 0.242 . . . . 0.19 111.314 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.55 -22.21 43.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.798 0.332 . . . . 0.14000000000000001 111.475 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.422 ' CE2' ' HG2' ' A' ' 158' ' ' MET . 22.4 m-85 -90.3 -20.36 23.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.189 0.518 . . . . 0.17999999999999999 110.437 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 165.87 162.21 16.66 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.855 -0.898 . . . . 0.11 110.855 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.06 142.98 58.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.192 0.52 . . . . 0.25 110.03 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.46 ' HB ' ' CD2' ' A' ' 116' ' ' TYR . 76.5 mt -113.44 134.42 56.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.791 -0.641 . . . . 0.14000000000000001 110.014 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.525 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.78 -48.25 7.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.881 -0.785 . . . . 0.54000000000000004 108.881 -178.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.2 m -143.86 102.43 3.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.062 -0.972 . . . . 0.76000000000000001 110.749 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.5 p -102.12 150.91 22.78 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.729 -0.471 . . . . 0.71999999999999997 109.729 174.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -149.81 131.95 15.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.132 0.491 . . . . 1.0 111.304 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.731 HG22 HD12 ' A' ' 115' ' ' LEU . 59.6 t -114.66 110.19 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.868 -1.53 . . . . 0.28000000000000003 106.868 171.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 109.097 -0.705 . . . . 0.34000000000000002 109.097 -174.734 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.745 0 CA-C-O 120.278 -0.179 . . . . 0.31 113.365 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 25.7 p90 -130.04 148.13 51.86 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.485 0.643 . . . . 0.48999999999999999 111.868 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.55 174.5 23.41 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.154 -0.93 . . . . 0.12 111.379 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -138.86 143.68 38.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.864 0.332 . . . . 0.25 110.504 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.565 ' HB ' HG12 ' A' ' 101' ' ' ILE . 39.6 t -119.0 135.41 59.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.877 0.37 . . . . 0.10000000000000001 111.043 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.402 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 0.9 OUTLIER -104.49 106.33 16.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.844 -0.799 . . . . 0.20999999999999999 108.844 166.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.56 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 11.4 m-85 -89.77 135.37 33.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.21 0.529 . . . . 0.17000000000000001 111.41 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.525 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.8 tt0 -47.29 -44.29 23.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.348 -1.297 . . . . 0.56999999999999995 110.245 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.7 p -115.05 141.3 48.19 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.422 -1.263 . . . . 0.40000000000000002 111.001 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -60.4 -39.71 88.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.52 -0.764 . . . . 0.46999999999999997 111.048 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.1 -33.06 73.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.384 -0.371 . . . . 0.73999999999999999 111.728 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.34 -34.95 77.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.137 0.494 . . . . 0.17999999999999999 110.423 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.56 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -61.59 -47.86 83.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.466 -0.788 . . . . 0.16 110.527 177.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.616 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.9 mt-10 -59.13 -39.98 84.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.833 -0.621 . . . . 1.4199999999999999 110.889 177.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 87.1 mtt180 -58.93 -43.46 91.17 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.95 0.405 . . . . 1.48 110.708 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.72 92.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 0.10000000000000001 110.663 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 170' ' ' VAL . 87.5 mt -61.3 -51.92 67.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.978 -0.555 . . . . 0.14999999999999999 111.109 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.5 pt-20 -64.23 -43.58 94.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.085 0.469 . . . . 1.0800000000000001 111.897 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.489 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -81.81 -39.47 23.99 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 113.028 0.751 . . . . 1.1599999999999999 113.028 -169.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.604 ' HB2' HG21 ' A' ' 170' ' ' VAL . 93.9 mmm -90.56 -20.73 22.3 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.51 -0.476 . . . . 0.34999999999999998 112.217 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -64.9 123.99 20.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.102 -0.703 . . . . 0.44 109.102 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.95 25.98 43.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.563 -0.827 . . . . 0.28999999999999998 112.95 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.589 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 4.1 mmt -113.56 156.71 23.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.596 0.198 . . . . 1.1799999999999999 110.791 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 16.7 mt -95.76 110.76 22.86 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 109.552 -0.536 . . . . 0.44 109.552 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 21.8 mt -96.86 100.28 11.81 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.706 -0.798 . . . . 1.02 109.626 173.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 84.4 m-20 77.49 -25.64 0.2 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.021 -0.99 . . . . 1.71 113.184 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 33.3 t70 170.12 -23.43 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 O-C-N 123.623 0.577 . . . . 0.84999999999999998 111.918 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 91.2 mtt180 -111.19 135.49 51.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.441 -0.345 . . . . 0.95999999999999996 110.977 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.1 ttmt -81.81 117.78 22.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.23 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.496 HG11 HD23 ' A' ' 106' ' ' LEU . 15.3 m -100.15 147.29 7.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.862 0.839 . . . . 0.17000000000000001 111.765 -171.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 52.1 t80 -105.84 119.81 40.11 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.415 -1.266 . . . . 0.29999999999999999 108.915 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.604 HG21 ' HB2' ' A' ' 158' ' ' MET . 41.3 t -114.49 125.34 71.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 0.13 108.82 177.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.72 -170.43 14.51 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.846 -0.692 . . . . 0.17999999999999999 111.62 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 . . . . . 0 C--N 1.319 -0.753 0 N-CA-C 108.996 -0.742 . . . . 1.9299999999999999 108.996 -179.499 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 113.088 0.773 . . . . 0.70999999999999996 113.088 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.62 22.61 76.96 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.357 -0.838 . . . . 0.20999999999999999 111.935 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 143' ' ' VAL . 1.2 m120 -85.48 124.69 32.35 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.094 -0.706 . . . . 0.63 109.094 -175.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.583 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.7 pt -135.86 151.96 30.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.71 -0.478 . . . . 0.14999999999999999 109.71 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -116.61 137.09 52.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.905 -0.406 . . . . 0.20999999999999999 109.905 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.596 HG12 HG22 ' A' ' 170' ' ' VAL . 6.5 mt -116.0 134.66 58.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.503 -0.771 . . . . 0.14999999999999999 109.983 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -118.94 151.62 37.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.69 -0.232 . . . . 1.46 110.534 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.5 t30 76.91 34.7 0.41 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.045 0.841 . . . . 0.48999999999999999 111.282 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.536 HD22 HG21 ' A' ' 110' ' ' ILE . 22.7 mt -77.06 162.09 27.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.217 -0.447 . . . . 0.26000000000000001 110.925 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -92.57 152.13 19.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.499 . . . . 0.70999999999999996 110.122 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -57.11 -29.13 63.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.902 -0.59 . . . . 2.2000000000000002 112.16 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.0 m -72.43 -14.96 61.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.427 -0.351 . . . . 1.4099999999999999 111.741 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.536 HG21 HD22 ' A' ' 106' ' ' LEU . 37.6 mm -76.61 123.18 32.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.2 0.524 . . . . 0.26000000000000001 111.137 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 27.3 t70 -109.31 -177.37 3.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.376 -0.829 . . . . 1.5900000000000001 109.043 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -71.43 -33.22 69.21 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.79 -0.818 . . . . 0.59999999999999998 108.79 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -46.89 75.09 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.547 -1.206 . . . . 2.5800000000000001 108.949 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.28 -44.19 97.64 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.973 -1.467 . . . . 0.14999999999999999 110.83 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.684 HD12 HG22 ' A' ' 130' ' ' VAL . 3.6 tt -64.21 -46.84 82.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.443 -0.799 . . . . 0.16 109.056 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.745 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 41.6 t80 -59.14 -49.25 78.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 0.29999999999999999 110.573 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -57.0 -37.42 71.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.937 0.399 . . . . 0.40000000000000002 111.22 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.551 HG21 HD21 ' A' ' 163' ' ' LEU . 9.1 m -77.98 -53.58 7.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.138 -0.483 . . . . 0.22 111.832 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.426 ' CD1' HD23 ' A' ' 115' ' ' LEU . 9.9 m-85 -72.97 -27.5 61.85 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.754 0.649 . . . . 0.11 112.754 -174.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.0 t -56.89 -28.35 61.8 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.498 0.319 . . . . 0.19 111.633 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.95 -22.57 38.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.833 0.349 . . . . 0.14000000000000001 111.46 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.569 ' HZ ' ' HE2' ' A' ' 157' ' ' LYS . 34.2 m-85 -91.95 -11.72 35.39 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.83 0.348 . . . . 0.17999999999999999 111.086 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.95 169.1 20.47 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.796 -0.522 . . . . 0.11 111.796 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -69.17 138.35 54.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.942 0.401 . . . . 0.25 110.438 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 128' ' ' CYS . 76.0 mt -110.17 132.71 57.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.928 -0.578 . . . . 0.14000000000000001 109.988 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.615 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.27 -45.55 11.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.603 -0.888 . . . . 0.54000000000000004 108.603 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.1 m -144.73 109.27 4.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.103 -0.953 . . . . 0.76000000000000001 110.75 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.745 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.8 p -103.68 138.4 40.37 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.176 -0.676 . . . . 0.71999999999999997 109.176 172.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -136.23 126.9 27.19 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.938 0.399 . . . . 1.0 111.078 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.684 HG22 HD12 ' A' ' 115' ' ' LEU . 89.8 t -111.03 109.82 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 105.983 -1.858 . . . . 0.28000000000000003 105.983 168.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 9.0 t . . . . . 0 C--N 1.302 -1.483 0 N-CA-C 108.688 -0.856 . . . . 0.34000000000000002 108.688 -173.878 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 120.255 -0.192 . . . . 0.31 113.547 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -132.99 158.7 42.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.337 0.568 . . . . 0.48999999999999999 111.701 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.88 174.77 28.41 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.496 -0.774 . . . . 0.12 112.165 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -138.92 139.02 37.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.666 0.233 . . . . 0.25 110.541 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.583 ' HB ' HG12 ' A' ' 101' ' ' ILE . 47.7 t -111.64 136.52 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.829 0.347 . . . . 0.10000000000000001 110.651 173.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -106.1 106.05 16.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.119 -0.697 . . . . 0.20999999999999999 109.119 166.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.5 m-85 -89.02 137.41 32.34 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.125 0.488 . . . . 0.17000000000000001 110.856 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.615 ' HA ' HD21 ' A' ' 126' ' ' LEU . 43.3 tt0 -47.54 -43.95 25.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.348 -1.296 . . . . 0.56999999999999995 110.528 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.9 p -114.57 146.26 40.98 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.642 -1.163 . . . . 0.40000000000000002 111.191 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -62.37 -37.68 86.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.569 -0.741 . . . . 0.46999999999999997 111.191 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.93 -34.32 73.31 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.559 -0.292 . . . . 0.73999999999999999 111.774 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.21 76.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.125 0.488 . . . . 0.17999999999999999 110.297 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.597 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.53 -44.12 95.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.439 -0.8 . . . . 0.16 110.51 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -59.46 -44.04 93.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.921 -0.582 . . . . 1.4199999999999999 110.214 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -58.55 -39.58 80.63 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.904 0.383 . . . . 1.48 110.641 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.65 84.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 0.10000000000000001 110.368 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 151' ' ' ALA . 80.4 mt -61.68 -56.24 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.406 -0.361 . . . . 0.14999999999999999 111.32 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -43.79 77.83 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.23 0.538 . . . . 1.0800000000000001 111.278 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.569 ' HE2' ' HZ ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -83.14 -39.53 20.94 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.517 -0.765 . . . . 1.1599999999999999 112.541 -169.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.519 ' HB2' HG21 ' A' ' 170' ' ' VAL . 89.6 mmm -91.85 -24.44 19.35 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.527 -0.469 . . . . 0.34999999999999998 112.028 -172.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -66.78 123.63 20.67 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.424 -0.584 . . . . 0.44 109.424 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.6 62.04 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.765 -0.731 . . . . 0.28999999999999998 112.732 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.672 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 29.5 mmt -106.1 166.13 10.72 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 120.74 0.305 . . . . 1.1799999999999999 111.186 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 20.7 mt -101.25 122.13 43.11 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 109.368 -0.604 . . . . 0.44 109.368 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.551 HD21 HG21 ' A' ' 118' ' ' THR . 21.6 mt -107.04 102.15 11.52 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.874 -0.731 . . . . 1.02 109.212 170.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 57.5 m-20 78.61 -26.39 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.976 0.798 . . . . 1.71 112.584 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 20.2 t70 165.38 -23.65 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.289 0.636 . . . . 0.84999999999999998 111.332 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -101.68 134.15 45.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.269 -0.423 . . . . 0.95999999999999996 110.578 -172.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 161' ' ' MET . 16.7 ttmt -81.96 118.26 22.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.436 HG11 HD23 ' A' ' 106' ' ' LEU . 15.7 m -101.3 146.95 8.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.568 0.699 . . . . 0.17000000000000001 111.37 -172.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 72.6 t80 -106.57 120.78 42.84 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.781 -1.1 . . . . 0.29999999999999999 109.186 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.596 HG22 HG12 ' A' ' 103' ' ' ILE . 44.3 t -115.17 124.93 72.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.188 -0.671 . . . . 0.13 109.188 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -142.92 -170.89 13.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.497 -0.859 . . . . 0.17999999999999999 112.47 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 121.136 0.494 . . . . 1.9299999999999999 110.954 -175.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.1 t . . . . . 0 N--CA 1.472 0.626 0 CA-C-O 121.394 0.616 . . . . 0.70999999999999996 112.343 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 73.27 23.08 78.16 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.635 -0.793 . . . . 0.20999999999999999 112.255 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -85.02 123.96 31.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.377 -0.601 . . . . 0.63 109.377 -176.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.485 HG12 ' HB ' ' A' ' 143' ' ' VAL . 19.5 pt -135.67 163.47 35.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.704 -0.48 . . . . 0.14999999999999999 109.704 176.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.25 145.18 50.51 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.462 -0.495 . . . . 0.20999999999999999 109.858 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 170' ' ' VAL . 5.5 mt -118.19 131.64 70.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.642 -0.708 . . . . 0.14999999999999999 109.863 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -109.21 148.72 30.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.538 -0.301 . . . . 1.46 110.66 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.7 t30 70.46 39.93 1.15 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.919 0.762 . . . . 0.48999999999999999 112.148 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.631 HD22 HG21 ' A' ' 110' ' ' ILE . 21.7 mt -73.77 157.36 36.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.081 0.467 . . . . 0.26000000000000001 111.383 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.545 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 24.5 t70 -81.14 148.98 29.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.381 -0.827 . . . . 0.70999999999999996 111.05 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -52.78 -37.57 59.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.048 -0.978 . . . . 2.2000000000000002 112.419 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.2 m -81.8 -4.74 57.16 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.08 0.4 . . . . 1.4099999999999999 112.08 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.631 HG21 HD22 ' A' ' 106' ' ' LEU . 28.4 mm -74.47 120.44 23.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.242 0.544 . . . . 0.26000000000000001 110.766 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.492 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 8.1 t70 -109.04 -176.15 2.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.33 -0.85 . . . . 1.5900000000000001 108.882 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -69.4 -33.97 73.82 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.799 -0.815 . . . . 0.59999999999999998 108.799 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -45.98 74.34 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.539 -1.209 . . . . 2.5800000000000001 108.896 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.56 -43.8 98.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.687 -1.597 . . . . 0.14999999999999999 110.646 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.641 HD12 HG22 ' A' ' 130' ' ' VAL . 3.7 tt -65.46 -47.38 76.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.536 -0.756 . . . . 0.16 109.386 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.742 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.6 t80 -59.2 -46.6 88.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.549 . . . . 0.29999999999999999 110.963 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.93 -40.09 75.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.697 0.284 . . . . 0.40000000000000002 111.087 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 50.9 m -78.46 -53.62 7.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.37 0.508 . . . . 0.22 112.37 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.463 ' CD1' HD23 ' A' ' 115' ' ' LEU . 9.4 m-85 -71.9 -28.09 63.27 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.688 0.625 . . . . 0.11 112.688 -173.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.8 t -57.67 -28.96 64.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.539 0.209 . . . . 0.19 111.366 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.23 -22.26 39.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.751 0.31 . . . . 0.14000000000000001 111.645 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -89.84 -20.57 23.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.17999999999999999 111.122 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.4 168.97 30.35 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.584 -0.606 . . . . 0.11 111.584 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -68.77 132.59 47.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.25 110.092 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 128' ' ' CYS . 73.5 mt -104.96 126.8 59.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.106 -0.497 . . . . 0.14000000000000001 109.993 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.588 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -83.2 -35.25 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.9 -0.778 . . . . 0.54000000000000004 108.9 -178.162 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.0 m -159.06 119.63 3.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.129 -0.941 . . . . 0.76000000000000001 110.412 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.742 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.9 p -118.97 142.34 47.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.567 -0.531 . . . . 0.71999999999999997 109.567 176.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -139.94 132.28 28.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.889 0.376 . . . . 1.0 111.485 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.641 HG22 HD12 ' A' ' 115' ' ' LEU . 96.1 t -114.3 109.37 28.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 106.556 -1.646 . . . . 0.28000000000000003 106.556 169.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 C--N 1.305 -1.355 0 N-CA-C 109.159 -0.682 . . . . 0.34000000000000002 109.159 -173.825 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 113.747 0.259 . . . . 0.31 113.747 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 18.3 p90 -125.03 150.58 46.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 117.3 0.55 . . . . 0.48999999999999999 111.727 -173.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -140.07 170.94 24.12 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.361 -0.836 . . . . 0.12 111.49 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -135.83 141.05 44.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.927 0.363 . . . . 0.25 110.535 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.491 HG11 ' CE2' ' A' ' 145' ' ' PHE . 30.8 t -115.32 135.49 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 0.10000000000000001 110.714 173.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.427 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.4 OUTLIER -103.62 106.17 16.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.906 -0.776 . . . . 0.20999999999999999 108.906 166.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.491 ' CE2' HG11 ' A' ' 143' ' ' VAL . 12.6 m-85 -91.44 137.39 32.4 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.15 0.5 . . . . 0.17000000000000001 111.08 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.588 ' HA ' HD21 ' A' ' 126' ' ' LEU . 41.8 tt0 -45.73 -42.23 11.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.206 -1.361 . . . . 0.56999999999999995 111.273 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.7 p -121.05 155.76 33.68 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.182 -0.917 . . . . 0.40000000000000002 110.565 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -67.2 -32.01 72.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.852 -0.613 . . . . 0.46999999999999997 110.206 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 152' ' ' GLU . 10.3 pt-20 -70.67 -34.78 72.36 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.2 -0.455 . . . . 0.73999999999999999 111.964 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 145' ' ' PHE . . . -62.3 -34.85 77.4 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.047 0.451 . . . . 0.17999999999999999 110.22 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.477 ' O ' HG13 ' A' ' 155' ' ' ILE . . . -63.43 -41.08 98.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.648 -0.705 . . . . 0.16 110.171 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 13.0 mm-40 -58.56 -43.43 89.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.545 -0.752 . . . . 1.4199999999999999 111.303 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 44.8 mtt180 -64.14 -40.06 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 1.48 110.97 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.79 86.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.522 -0.308 . . . . 0.10000000000000001 110.46 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 151' ' ' ALA . 81.9 mt -59.54 -51.88 67.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.14999999999999999 111.251 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.1 pt-20 -63.75 -44.65 92.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.006 0.431 . . . . 1.0800000000000001 111.771 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.403 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.06 -39.29 23.66 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.173 0.805 . . . . 1.1599999999999999 113.173 -168.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.47 ' HB2' HG21 ' A' ' 170' ' ' VAL . 91.5 mmm -91.25 -20.0 22.39 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.224 0.453 . . . . 0.34999999999999998 112.224 -173.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.02 122.74 19.95 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.049 -0.66 . . . . 0.44 109.353 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.71 17.87 61.01 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.599 -0.81 . . . . 0.28999999999999998 112.458 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -103.63 164.91 11.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.233 -0.654 . . . . 1.1799999999999999 109.233 176.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.417 HD23 ' CA ' ' A' ' 167' ' ' LYS . 25.7 mt -103.04 132.18 49.5 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.859 -0.793 . . . . 0.44 108.859 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 19.7 mt -116.56 104.2 11.17 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 120.226 -0.59 . . . . 1.02 109.641 171.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 83.2 m-20 76.44 -27.39 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.129 -0.941 . . . . 1.71 113.063 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 20.5 t70 167.86 -24.5 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 O-C-N 123.938 0.774 . . . . 0.84999999999999998 111.712 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.545 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 94.3 mtt180 -107.2 135.92 47.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.787 0.327 . . . . 0.95999999999999996 110.852 -171.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 161' ' ' MET . 23.5 tttt -84.3 119.76 25.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.703 -0.68 . . . . 1.0 109.207 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.502 HG11 HD23 ' A' ' 106' ' ' LEU . 14.3 m -101.45 151.1 5.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.766 0.793 . . . . 0.17000000000000001 111.409 -172.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 35.8 t80 -109.93 120.82 43.66 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.665 -1.152 . . . . 0.29999999999999999 109.123 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.587 HG22 HG12 ' A' ' 103' ' ' ILE . 42.3 t -115.32 125.72 72.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.28 -0.637 . . . . 0.13 109.28 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.49 -176.76 22.19 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.62 -0.8 . . . . 0.17999999999999999 111.64 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 . . . . . 0 C--N 1.324 -0.541 0 N-CA-C 109.024 -0.732 . . . . 1.9299999999999999 109.024 176.443 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 121.525 0.679 . . . . 0.70999999999999996 111.987 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.78 24.18 77.01 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.74 -1.219 . . . . 0.20999999999999999 111.634 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.469 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.1 m-80 -85.12 124.02 31.3 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.29 -0.633 . . . . 0.63 109.29 -173.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.578 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.3 pt -135.66 159.98 39.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.015 -0.365 . . . . 0.14999999999999999 110.015 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.51 143.22 50.79 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.605 -0.517 . . . . 0.20999999999999999 109.605 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 170' ' ' VAL . 6.1 mt -118.56 133.81 64.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.854 -0.612 . . . . 0.14999999999999999 110.37 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -114.25 150.07 34.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.25 -0.432 . . . . 1.46 110.318 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 67.99 54.68 0.6 Allowed 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.844 0.715 . . . . 0.48999999999999999 111.63 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.534 HD22 HG21 ' A' ' 110' ' ' ILE . 12.1 mt -89.78 159.53 16.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.614 -0.721 . . . . 0.26000000000000001 111.264 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.572 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 14.9 t70 -77.75 151.09 34.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.70999999999999996 109.95 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -63.65 -31.88 73.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.617 -0.72 . . . . 2.2000000000000002 111.663 -175.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.4 p -76.41 -4.68 43.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.796 0.331 . . . . 1.4099999999999999 111.753 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.534 HG21 HD22 ' A' ' 106' ' ' LEU . 40.4 mm -77.26 121.55 29.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.216 0.532 . . . . 0.26000000000000001 110.734 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 26.9 t70 -108.15 -178.68 3.67 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.751 -0.833 . . . . 1.5900000000000001 108.751 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.412 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 2.8 m-20 -63.48 -38.95 93.09 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.639 -0.875 . . . . 0.59999999999999998 108.639 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.961 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.87 -49.28 78.11 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.006 -0.997 . . . . 2.5800000000000001 110.359 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.403 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.66 -43.66 98.44 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.296 -1.32 . . . . 0.14999999999999999 111.412 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 130' ' ' VAL . 4.3 tt -64.49 -47.5 78.7 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.198 -0.667 . . . . 0.16 109.198 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.717 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 68.7 t80 -59.84 -46.7 88.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.989 -0.55 . . . . 0.29999999999999999 110.608 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -57.03 -39.16 74.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.316 -0.402 . . . . 0.40000000000000002 110.989 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.658 HG21 HD21 ' A' ' 163' ' ' LEU . 20.7 m -77.04 -53.39 7.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.047 -0.524 . . . . 0.22 111.681 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -72.52 -29.0 63.21 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.434 0.531 . . . . 0.11 112.434 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.3 t -57.97 -28.05 63.99 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.6 0.238 . . . . 0.19 111.003 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.49 -22.73 34.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.461 -0.336 . . . . 0.14000000000000001 111.345 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -93.02 -13.92 28.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.456 -0.338 . . . . 0.17999999999999999 111.099 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.04 169.08 22.88 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.848 -0.692 . . . . 0.11 112.137 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -66.23 137.71 57.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.915 0.388 . . . . 0.25 110.54 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.493 ' HB ' ' CE1' ' A' ' 116' ' ' TYR . 76.3 mt -113.34 132.34 62.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.739 -0.664 . . . . 0.14000000000000001 109.711 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -85.89 -42.34 14.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.869 -0.789 . . . . 0.54000000000000004 108.869 -178.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.8 m -149.34 125.09 10.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.782 -1.099 . . . . 0.76000000000000001 110.279 -177.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.717 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 19.8 p -122.32 151.74 40.83 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.173 -0.677 . . . . 0.71999999999999997 109.173 174.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -143.14 129.72 20.19 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.627 -0.429 . . . . 1.0 111.727 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.553 HG22 HD12 ' A' ' 115' ' ' LEU . 70.8 t -114.87 109.67 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 106.796 -1.557 . . . . 0.28000000000000003 106.796 168.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 5.6 t . . . . . 0 C--N 1.305 -1.349 0 CA-C-N 115.775 -0.648 . . . . 0.34000000000000002 109.373 -174.072 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.335 0 N-CA-C 113.75 0.26 . . . . 0.31 113.75 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -133.01 156.62 47.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.243 0.521 . . . . 0.48999999999999999 110.913 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.56 177.22 26.94 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.893 -0.594 . . . . 0.12 112.012 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -140.82 143.75 34.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.867 0.333 . . . . 0.25 111.174 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.578 ' HB ' HG12 ' A' ' 101' ' ' ILE . 38.8 t -119.21 133.04 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.981 0.42 . . . . 0.10000000000000001 111.154 172.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.7 OUTLIER -103.47 105.82 16.18 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.775 -0.824 . . . . 0.20999999999999999 108.775 165.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.519 ' CE2' HG11 ' A' ' 143' ' ' VAL . 13.7 m-85 -88.19 138.5 31.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.94 0.4 . . . . 0.17000000000000001 111.008 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.625 ' HA ' HD21 ' A' ' 126' ' ' LEU . 26.4 tt0 -48.48 -47.33 38.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.903 -1.044 . . . . 0.56999999999999995 110.433 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 p -109.98 151.65 26.87 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.62 -1.173 . . . . 0.40000000000000002 110.672 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -67.89 -36.14 79.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.959 -0.564 . . . . 0.46999999999999997 110.719 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 14.0 pt-20 -70.04 -35.38 74.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.352 0.501 . . . . 0.73999999999999999 112.352 -176.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.45 -34.89 77.7 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.043 0.449 . . . . 0.17999999999999999 110.403 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 155' ' ' ILE . . . -63.6 -43.61 96.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.666 -0.697 . . . . 0.16 110.448 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 33.5 mt-10 -58.89 -37.75 77.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 1.4199999999999999 110.722 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 92.2 mtt180 -66.72 -44.31 81.94 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.805 0.336 . . . . 1.48 110.634 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.12 -38.92 90.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 0.10000000000000001 110.631 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 151' ' ' ALA . 84.4 mt -59.16 -53.99 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.14999999999999999 111.533 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.1 pt-20 -64.91 -44.63 88.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.332 0.587 . . . . 1.0800000000000001 111.967 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.453 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -77.62 -38.27 48.34 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.311 -0.859 . . . . 1.1599999999999999 112.665 -169.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.43 ' O ' ' HB2' ' A' ' 161' ' ' MET . 89.0 mmm -94.09 -17.75 22.5 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.496 -0.482 . . . . 0.34999999999999998 112.256 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.432 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 52.5 t30 -69.66 123.33 21.09 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.919 -0.712 . . . . 0.44 109.113 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.61 8.79 79.76 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.687 -0.768 . . . . 0.28999999999999998 112.061 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.7 OUTLIER -91.32 159.63 15.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.725 0.297 . . . . 1.1799999999999999 110.248 178.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 15.2 mt -104.49 108.23 19.55 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.644 -0.502 . . . . 0.44 109.644 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.658 HD21 HG21 ' A' ' 118' ' ' THR . 22.5 mt -93.42 105.75 17.78 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 119.75 -0.78 . . . . 1.02 109.395 173.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 73.06 -58.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.165 -0.925 . . . . 1.71 112.474 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -166.97 14.61 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.288 -0.414 . . . . 0.84999999999999998 111.894 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.572 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 92.7 mtt180 -135.54 134.66 39.65 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.713 -0.395 . . . . 0.95999999999999996 110.423 -175.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.3 tttt -82.18 121.57 26.77 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.236 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.04 143.36 14.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.467 0.651 . . . . 0.17000000000000001 111.3 -173.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.432 ' HA ' ' OD1' ' A' ' 159' ' ' ASN . 63.2 t80 -106.32 119.88 40.4 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.231 -0.895 . . . . 0.29999999999999999 109.062 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.552 HG22 HG12 ' A' ' 103' ' ' ILE . 43.9 t -115.16 126.57 72.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.234 -0.654 . . . . 0.13 109.234 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.63 -178.91 21.51 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.529 -0.843 . . . . 0.17999999999999999 112.199 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 . . . . . 0 C--N 1.324 -0.535 0 N-CA-C 110.226 -0.287 . . . . 1.9299999999999999 110.226 -178.169 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 121.804 0.811 . . . . 0.70999999999999996 112.587 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.1 23.0 78.63 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.84 -1.172 . . . . 0.20999999999999999 110.739 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.521 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.2 m120 -94.23 127.49 40.12 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.931 -0.766 . . . . 0.63 108.931 -174.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.597 HG23 ' HB1' ' A' ' 151' ' ' ALA . 27.4 pt -134.51 161.36 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.277 -0.268 . . . . 0.14999999999999999 110.277 177.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.96 143.24 50.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.938 -0.393 . . . . 0.20999999999999999 109.938 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.514 HG12 HG22 ' A' ' 170' ' ' VAL . 8.7 mt -116.6 146.73 20.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.756 -0.656 . . . . 0.14999999999999999 109.953 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 44.8 tttp -129.61 147.91 51.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.288 -0.415 . . . . 1.46 110.342 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.8 t30 64.81 47.7 2.64 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.549 0.74 . . . . 0.48999999999999999 111.954 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.664 HD22 HG21 ' A' ' 110' ' ' ILE . 23.0 mt -80.07 151.84 29.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.167 0.508 . . . . 0.26000000000000001 111.447 176.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.533 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 17.9 t70 -77.97 150.95 33.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.476 -0.784 . . . . 0.70999999999999996 111.313 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -51.7 -38.64 55.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.137 -0.938 . . . . 2.2000000000000002 112.946 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.3 m -85.09 -4.24 59.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.054 0.39 . . . . 1.4099999999999999 112.054 -173.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.664 HG21 HD22 ' A' ' 106' ' ' LEU . 33.5 mm -71.88 116.21 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.099 0.476 . . . . 0.26000000000000001 110.23 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -103.72 -179.36 3.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.637 -0.875 . . . . 1.5900000000000001 108.637 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -63.96 -37.25 86.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.736 -0.839 . . . . 0.59999999999999998 108.736 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 1.034 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -61.37 -49.66 76.02 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.168 -0.924 . . . . 2.5800000000000001 110.712 178.2 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.3 99.12 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.194 -1.366 . . . . 0.14999999999999999 111.068 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.762 HD12 HG22 ' A' ' 130' ' ' VAL . 3.8 tt -63.94 -47.87 78.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.419 -0.81 . . . . 0.16 109.105 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.657 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 51.5 t80 -58.69 -48.45 81.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.869 -0.605 . . . . 0.29999999999999999 110.914 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.3 -38.82 74.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.938 0.399 . . . . 0.40000000000000002 110.59 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.6 m -77.47 -54.17 6.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.148 -0.478 . . . . 0.22 111.875 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.446 ' CD1' HD23 ' A' ' 115' ' ' LEU . 7.2 m-85 -72.19 -27.87 62.84 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.248 0.462 . . . . 0.11 112.248 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 28.7 t -57.41 -28.03 62.91 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 111.629 0.233 . . . . 0.19 111.629 -177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.83 -22.88 39.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.016 0.436 . . . . 0.14000000000000001 111.345 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -90.19 -22.29 21.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.113 -0.494 . . . . 0.17999999999999999 110.777 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 169.36 169.02 32.16 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.89 -0.595 . . . . 0.11 111.784 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -70.65 139.55 51.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.018 0.437 . . . . 0.25 109.893 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.419 HG21 ' HB3' ' A' ' 128' ' ' CYS . 74.1 mt -112.88 131.93 63.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.907 -0.588 . . . . 0.14000000000000001 110.024 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -88.5 -41.06 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.922 -0.77 . . . . 0.54000000000000004 108.922 -177.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 72.1 m -147.7 119.6 8.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.163 -0.926 . . . . 0.76000000000000001 110.314 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 9.2 p -117.53 144.95 44.59 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.526 -0.546 . . . . 0.71999999999999997 109.526 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -142.19 129.3 20.89 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.503 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.762 HG22 HD12 ' A' ' 115' ' ' LEU . 61.2 t -115.55 110.7 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 106.848 -1.538 . . . . 0.28000000000000003 106.848 170.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.303 -1.416 0 N-CA-C 108.848 -0.797 . . . . 0.34000000000000002 108.848 -175.368 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 N-CA-C 113.324 0.09 . . . . 0.31 113.324 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -126.07 149.37 48.94 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 121.855 -0.791 . . . . 0.48999999999999999 111.874 -173.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.86 174.81 24.1 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.077 -0.965 . . . . 0.12 111.348 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -141.57 137.44 31.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.019 0.41 . . . . 0.25 110.615 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.583 ' HB ' HG12 ' A' ' 101' ' ' ILE . 43.2 t -112.88 133.68 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.10000000000000001 111.147 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.1 m170 -103.12 105.91 16.31 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.626 -0.715 . . . . 0.20999999999999999 109.143 166.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.581 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 12.5 m-85 -88.79 142.55 27.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.261 0.553 . . . . 0.17000000000000001 110.751 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.572 ' HA ' HD21 ' A' ' 126' ' ' LEU . 42.8 tt0 -51.67 -38.32 54.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.277 -1.329 . . . . 0.56999999999999995 110.542 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.6 p -125.32 150.38 47.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.307 -0.86 . . . . 0.40000000000000002 111.443 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -60.65 -37.76 82.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.603 -0.726 . . . . 0.46999999999999997 111.24 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.6 pt-20 -67.82 -35.38 78.5 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.56 -0.291 . . . . 0.73999999999999999 111.645 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.53 78.35 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.21 0.529 . . . . 0.17999999999999999 110.278 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.597 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -63.56 -46.57 85.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.339 -0.846 . . . . 0.16 110.565 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 42.6 mt-10 -58.96 -40.19 83.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 1.4199999999999999 110.526 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 88.8 mtt180 -58.96 -44.76 91.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.005 0.431 . . . . 1.48 110.719 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.4 94.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.968 -0.56 . . . . 0.10000000000000001 110.598 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 151' ' ' ALA . 88.6 mt -58.97 -53.56 46.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.889 -0.596 . . . . 0.14999999999999999 111.401 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 0.6 OUTLIER -63.64 -41.83 98.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.091 0.472 . . . . 1.0800000000000001 111.808 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.418 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -81.8 -39.98 23.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.681 -0.691 . . . . 1.1599999999999999 112.82 -169.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 91.3 mmm -91.24 -19.12 23.36 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.262 0.468 . . . . 0.34999999999999998 112.262 -173.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -66.54 122.78 18.35 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.396 -0.521 . . . . 0.44 109.826 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.48 26.81 37.87 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.91 -0.662 . . . . 0.28999999999999998 113.01 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.705 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 74.5 mmm -112.64 157.06 21.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.958 0.379 . . . . 1.1799999999999999 110.891 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 167' ' ' LYS . 19.6 mt -94.15 102.38 14.42 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.002 -0.74 . . . . 0.44 109.002 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 163' ' ' LEU . 16.7 mt -83.91 101.47 11.7 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 119.278 -0.969 . . . . 1.02 108.645 172.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 98.8 m-20 73.94 -70.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.856 -1.065 . . . . 1.71 111.467 -175.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -147.2 -0.57 0.68 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.425 -0.807 . . . . 0.84999999999999998 112.192 -173.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.533 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 91.6 mtt180 -132.1 128.76 38.84 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.955 -0.466 . . . . 0.95999999999999996 110.473 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.705 ' HA ' ' O ' ' A' ' 161' ' ' MET . 13.3 tttt -76.45 122.04 23.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.35 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 16.0 m -101.18 140.06 20.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.391 0.615 . . . . 0.17000000000000001 111.056 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -106.08 121.7 44.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.18 -0.918 . . . . 0.29999999999999999 108.871 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.514 HG22 HG12 ' A' ' 103' ' ' ILE . 39.6 t -115.88 130.15 71.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.976 -0.557 . . . . 0.13 109.565 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -142.87 -165.37 10.59 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.773 -0.727 . . . . 0.17999999999999999 111.949 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 . . . . . 0 C--N 1.323 -0.566 0 N-CA-C 109.61 -0.515 . . . . 1.9299999999999999 109.61 -178.055 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 121.221 0.534 . . . . 0.70999999999999996 111.923 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.18 23.05 78.36 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.481 -0.866 . . . . 0.20999999999999999 111.856 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 143' ' ' VAL . 1.8 m120 -89.32 126.2 35.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.335 -0.617 . . . . 0.63 109.335 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.512 HG12 ' HB ' ' A' ' 143' ' ' VAL . 22.0 pt -134.65 163.37 36.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.734 -0.666 . . . . 0.14999999999999999 109.547 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.07 146.45 50.36 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.564 -0.455 . . . . 0.20999999999999999 109.817 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.561 HG12 HG22 ' A' ' 170' ' ' VAL . 4.2 mt -118.22 138.37 49.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.688 -0.687 . . . . 0.14999999999999999 109.714 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -120.85 152.78 37.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.691 -0.231 . . . . 1.46 110.4 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.8 t30 70.57 41.07 0.98 Allowed 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.818 0.699 . . . . 0.48999999999999999 111.699 172.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.54 HD22 HG21 ' A' ' 110' ' ' ILE . 20.0 mt -79.4 164.83 23.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.217 0.532 . . . . 0.26000000000000001 111.907 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.461 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.8 t70 -89.01 155.55 19.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.406 -0.815 . . . . 0.70999999999999996 110.799 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.44 ' HG3' ' N ' ' A' ' 109' ' ' SER . 20.0 pttp -59.99 -36.68 77.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.228 -0.442 . . . . 2.2000000000000002 111.724 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.44 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 16.7 m -80.85 -3.21 50.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.243 -0.435 . . . . 1.4099999999999999 111.891 -173.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.554 HG22 HG21 ' A' ' 130' ' ' VAL . 34.5 mm -76.02 118.53 22.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.26000000000000001 110.254 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -108.66 -175.52 2.79 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.128 -0.693 . . . . 1.5900000000000001 109.128 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -69.39 -32.76 71.99 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.081 -0.711 . . . . 0.59999999999999998 109.081 -176.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.412 ' O ' ' HD2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -67.13 -48.47 67.97 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.54 -1.209 . . . . 2.5800000000000001 109.253 178.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.2 -41.42 96.78 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.198 -1.365 . . . . 0.14999999999999999 110.83 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.71 HD12 HG22 ' A' ' 130' ' ' VAL . 3.8 tt -66.98 -47.66 70.86 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.039 -0.726 . . . . 0.16 109.039 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.681 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.6 t80 -59.38 -46.45 88.62 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.933 -0.576 . . . . 0.29999999999999999 110.81 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.3 -41.08 75.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.09 0.471 . . . . 0.40000000000000002 110.978 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.469 HG21 HD21 ' A' ' 163' ' ' LEU . 18.0 m -77.07 -52.76 8.76 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.787 -0.642 . . . . 0.22 111.691 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.434 ' CD1' HD23 ' A' ' 115' ' ' LEU . 10.6 m-85 -72.69 -28.24 62.57 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.638 0.607 . . . . 0.11 112.638 -175.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.8 t -57.3 -28.8 63.35 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.563 0.221 . . . . 0.19 111.388 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.57 -24.13 45.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.896 0.379 . . . . 0.14000000000000001 111.226 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -89.17 -18.18 27.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.17999999999999999 111.408 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.44 173.55 32.27 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.033 -0.604 . . . . 0.11 112.024 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -69.46 135.37 50.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.914 0.387 . . . . 0.25 110.33 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 70.8 mt -110.67 124.29 67.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.217 -0.447 . . . . 0.14000000000000001 110.597 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -79.97 -36.37 36.21 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.777 -0.823 . . . . 0.54000000000000004 108.777 -176.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.4 m -154.97 141.49 18.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.86 -1.063 . . . . 0.76000000000000001 109.694 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.6 p -143.5 135.42 26.62 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.803 -0.443 . . . . 0.71999999999999997 109.803 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -140.76 133.25 28.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.112 0.482 . . . . 1.0 111.887 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.71 HG22 HD12 ' A' ' 115' ' ' LEU . 78.1 t -114.26 117.46 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 N-CA-C 106.717 -1.586 . . . . 0.28000000000000003 106.717 169.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 C--N 1.303 -1.433 0 N-CA-C 108.811 -0.811 . . . . 0.34000000000000002 108.811 -176.343 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 113.742 0.257 . . . . 0.31 113.742 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -122.6 152.39 40.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 117.421 0.611 . . . . 0.48999999999999999 112.208 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.67 175.25 24.47 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.01 -0.996 . . . . 0.12 111.438 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -140.52 142.24 35.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.088 0.444 . . . . 0.25 111.113 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.512 ' HB ' HG12 ' A' ' 101' ' ' ILE . 39.2 t -119.53 135.55 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-O 121.009 0.433 . . . . 0.10000000000000001 110.873 172.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -104.9 106.22 16.61 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.985 -0.746 . . . . 0.20999999999999999 108.985 166.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.54 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.7 m-85 -90.1 137.34 32.42 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.022 0.439 . . . . 0.17000000000000001 110.993 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.572 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.8 tt0 -45.81 -43.83 13.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.42 -1.264 . . . . 0.56999999999999995 111.021 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.3 p -116.8 153.39 32.54 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.266 -0.879 . . . . 0.40000000000000002 110.33 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -64.61 -36.95 85.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.939 -0.573 . . . . 0.46999999999999997 110.303 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 13.4 pt-20 -70.35 -34.37 72.56 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.035 -0.529 . . . . 0.73999999999999999 112.293 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.72 -35.76 77.14 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.981 0.42 . . . . 0.17999999999999999 110.52 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.54 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.82 -42.51 97.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.742 -0.663 . . . . 0.16 110.502 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.6 mt-10 -59.85 -40.55 88.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.884 -0.598 . . . . 1.4199999999999999 110.437 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 61.5 mtt180 -60.1 -42.09 93.93 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.455 0.472 . . . . 1.48 110.861 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.35 -39.41 85.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.10000000000000001 110.693 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 151' ' ' ALA . 88.2 mt -58.94 -53.61 45.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.119 -0.491 . . . . 0.14999999999999999 111.075 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.5 pt-20 -60.41 -45.36 93.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.926 0.394 . . . . 1.0800000000000001 111.796 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.461 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -80.93 -38.98 26.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.979 0.733 . . . . 1.1599999999999999 112.979 -169.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.469 ' O ' ' HB2' ' A' ' 161' ' ' MET . 95.1 mmm -95.23 -17.84 21.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.67 0.619 . . . . 0.34999999999999998 112.67 -171.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -70.12 122.09 18.77 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.683 -0.807 . . . . 0.44 109.187 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.79 23.55 55.52 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.602 -0.809 . . . . 0.28999999999999998 112.178 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.624 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.8 OUTLIER -102.92 158.73 16.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.532 0.206 . . . . 1.1799999999999999 110.536 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 21.7 mt -102.68 98.13 8.21 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.416 -0.356 . . . . 0.44 110.128 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.469 HD21 HG21 ' A' ' 118' ' ' THR . 18.6 mt -85.83 107.81 17.84 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 120.041 -0.664 . . . . 1.02 109.363 175.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 98.2 m-20 74.32 -61.86 0.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.164 -0.926 . . . . 1.71 111.599 -176.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -172.26 25.23 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.552 -0.749 . . . . 0.84999999999999998 110.658 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.2 mtt180 -137.82 129.55 28.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.396 -0.366 . . . . 0.95999999999999996 110.053 -178.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.9 tttt -79.89 118.88 22.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.82 -0.627 . . . . 1.0 109.377 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.482 HG11 HD23 ' A' ' 106' ' ' LEU . 19.3 m -102.33 150.78 6.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.294 0.569 . . . . 0.17000000000000001 111.668 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 64.7 t80 -106.59 120.57 42.29 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.277 -0.874 . . . . 0.29999999999999999 109.278 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.561 HG22 HG12 ' A' ' 103' ' ' ILE . 45.4 t -115.44 125.78 72.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.27 -0.641 . . . . 0.13 109.27 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.48 -174.29 20.06 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.708 -0.758 . . . . 0.17999999999999999 111.404 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 108.796 -0.816 . . . . 1.9299999999999999 108.796 178.463 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.8 t . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 121.633 0.73 . . . . 0.70999999999999996 112.44 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.02 23.81 77.11 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.963 -1.113 . . . . 0.20999999999999999 111.012 -179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.526 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.2 m120 -89.62 124.97 35.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.009 -0.737 . . . . 0.63 109.009 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.568 HG12 ' HB ' ' A' ' 143' ' ' VAL . 22.9 pt -135.62 163.41 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.545 -0.298 . . . . 0.14999999999999999 110.242 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.38 146.47 48.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.882 0.372 . . . . 0.20999999999999999 110.054 176.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.643 HG12 HG22 ' A' ' 170' ' ' VAL . 6.8 mt -124.48 144.92 32.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.765 -0.652 . . . . 0.14999999999999999 109.788 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -129.94 156.42 44.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.46 0.171 . . . . 1.46 111.073 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.7 t30 71.54 36.12 1.34 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.044 0.938 . . . . 0.48999999999999999 111.357 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.586 HD22 HG21 ' A' ' 110' ' ' ILE . 31.7 mt -76.59 143.36 40.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.187 -0.461 . . . . 0.26000000000000001 110.779 175.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.44 151.28 41.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.706 -0.679 . . . . 0.70999999999999996 110.923 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -52.84 -32.77 46.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.499 -0.773 . . . . 2.2000000000000002 112.321 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -80.45 -7.47 59.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.006 0.372 . . . . 1.4099999999999999 112.006 -175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.621 HG22 HG21 ' A' ' 130' ' ' VAL . 28.2 mm -76.07 127.38 37.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.078 0.466 . . . . 0.26000000000000001 110.928 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -115.64 -179.25 3.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.536 -0.756 . . . . 1.5900000000000001 109.026 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -65.71 -36.39 83.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.507 -0.553 . . . . 0.59999999999999998 109.507 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.983 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.98 -49.63 76.68 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.862 0.839 . . . . 2.5800000000000001 109.986 178.057 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.6 98.56 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.771 -1.559 . . . . 0.14999999999999999 111.315 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.743 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -64.76 -47.18 79.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.973 -0.751 . . . . 0.16 108.973 177.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.746 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 55.6 t80 -58.65 -49.1 78.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.29999999999999999 111.127 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.68 -37.51 73.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.863 0.363 . . . . 0.40000000000000002 110.922 -174.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.709 HG21 HD21 ' A' ' 163' ' ' LEU . 6.7 m -78.29 -53.9 6.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.521 . . . . 0.22 111.823 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 115' ' ' LEU . 21.2 m-85 -72.01 -28.29 63.29 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.31 0.485 . . . . 0.11 112.31 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.9 t -57.82 -27.53 63.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.529 0.204 . . . . 0.19 111.51 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.58 -21.83 29.41 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.762 0.315 . . . . 0.14000000000000001 111.736 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -93.12 -9.78 38.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.17999999999999999 110.932 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.29 161.46 10.85 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.743 -0.662 . . . . 0.11 111.665 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -61.24 132.23 52.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.24 0.543 . . . . 0.25 110.363 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.434 ' HB ' ' CD1' ' A' ' 116' ' ' TYR . 76.8 mt -100.84 134.9 39.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.62 -0.718 . . . . 0.14000000000000001 109.715 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 146' ' ' GLU . 19.9 mt -89.66 -39.14 13.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.847 0.832 . . . . 0.54000000000000004 108.867 -176.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.7 m -155.95 129.42 8.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.496 -1.229 . . . . 0.76000000000000001 109.502 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.746 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 8.5 p -123.84 149.71 45.43 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.192 -0.67 . . . . 0.71999999999999997 109.192 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -148.51 128.02 13.17 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.308 -0.557 . . . . 1.0 111.704 -177.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.743 HG22 HD12 ' A' ' 115' ' ' LEU . 59.7 t -111.31 109.59 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 106.195 -1.78 . . . . 0.28000000000000003 106.195 169.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.8 t . . . . . 0 C--N 1.299 -1.604 0 N-CA-C 108.714 -0.847 . . . . 0.34000000000000002 108.714 -174.903 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.792 0 CA-C-O 120.315 -0.158 . . . . 0.31 113.361 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -126.04 152.94 45.12 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.424 0.612 . . . . 0.48999999999999999 111.811 -173.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.65 174.64 26.43 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.352 -0.84 . . . . 0.12 111.619 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -139.97 136.88 34.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.947 0.374 . . . . 0.25 110.862 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.568 ' HB ' HG12 ' A' ' 101' ' ' ILE . 47.5 t -111.23 134.46 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.036 0.446 . . . . 0.10000000000000001 111.094 174.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -102.51 107.04 17.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.681 -0.69 . . . . 0.20999999999999999 109.159 165.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 21.2 m-85 -87.36 142.07 28.16 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.286 0.565 . . . . 0.17000000000000001 110.697 176.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.503 ' HA ' HD11 ' A' ' 126' ' ' LEU . 39.4 tt0 -51.7 -35.01 41.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.521 -1.218 . . . . 0.56999999999999995 111.001 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.1 p -130.04 150.06 51.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.582 -1.19 . . . . 0.40000000000000002 111.181 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -62.75 -38.43 90.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.665 -0.698 . . . . 0.46999999999999997 111.04 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -65.19 -33.75 76.75 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.113 -0.494 . . . . 0.73999999999999999 112.285 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.67 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 0.17999999999999999 110.298 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -64.62 -43.13 94.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.335 -0.848 . . . . 0.16 111.097 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 28.2 mt-10 -58.44 -40.69 83.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.851 -0.613 . . . . 1.4199999999999999 110.865 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 58.8 mtt85 -64.82 -42.33 95.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.74 0.305 . . . . 1.48 110.784 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.45 94.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.4 -0.364 . . . . 0.10000000000000001 110.605 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.7 mt -58.81 -54.47 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.14999999999999999 111.013 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.5 pt-20 -64.1 -45.52 88.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.188 0.518 . . . . 1.0800000000000001 111.841 -177.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.2 OUTLIER -77.36 -38.58 49.86 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.479 -0.782 . . . . 1.1599999999999999 112.617 -170.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.479 ' HB2' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -90.05 -25.46 20.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.17 0.433 . . . . 0.34999999999999998 112.17 -174.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 59.0 t30 -66.36 123.4 19.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.25 -0.648 . . . . 0.44 109.25 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.98 12.67 63.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.613 -0.803 . . . . 0.28999999999999998 112.638 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.8 mmt -101.6 158.05 16.37 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.634 -0.333 . . . . 1.1799999999999999 111.137 177.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 30.7 mt -98.34 107.61 20.12 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 109.207 -0.664 . . . . 0.44 109.207 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.709 HD21 HG21 ' A' ' 118' ' ' THR . 17.2 mt -90.77 107.64 19.31 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.853 -0.795 . . . . 1.02 108.853 171.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 82.5 m-20 72.78 -67.22 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.246 -0.888 . . . . 1.71 111.61 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -157.03 7.71 0.17 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.328 -0.851 . . . . 0.84999999999999998 111.742 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -130.56 134.35 46.94 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.592 -0.692 . . . . 0.95999999999999996 110.924 -175.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.6 tttt -79.01 118.97 21.5 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.421 HG11 HD23 ' A' ' 106' ' ' LEU . 5.7 m -100.19 146.81 8.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.596 0.712 . . . . 0.17000000000000001 111.046 -172.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 74.1 t80 -106.58 117.84 35.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.699 -1.137 . . . . 0.29999999999999999 109.369 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.643 HG22 HG12 ' A' ' 103' ' ' ILE . 39.4 t -115.61 131.03 69.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.425 -0.583 . . . . 0.13 109.425 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -151.85 -176.92 25.07 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.595 -0.812 . . . . 0.17999999999999999 112.195 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 . . . . . 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.389 . . . . 1.9299999999999999 110.284 -179.983 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.4 t . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 121.535 0.683 . . . . 0.70999999999999996 111.958 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 73.25 24.08 76.15 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.167 -1.016 . . . . 0.20999999999999999 111.551 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.542 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.2 m120 -88.13 125.23 34.49 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.005 -0.739 . . . . 0.63 109.005 -173.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.527 HG23 ' HB1' ' A' ' 151' ' ' ALA . 19.1 pt -135.67 164.08 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.301 -0.259 . . . . 0.14999999999999999 110.301 177.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -125.19 145.0 50.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.858 0.361 . . . . 0.20999999999999999 110.162 176.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.604 HG12 HG22 ' A' ' 170' ' ' VAL . 5.3 mt -123.06 142.89 37.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.855 -0.612 . . . . 0.14999999999999999 110.043 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -127.38 155.44 43.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.291 0.091 . . . . 1.46 111.125 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.9 t30 70.48 38.19 1.38 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.947 0.779 . . . . 0.48999999999999999 111.216 173.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.654 HD22 HG21 ' A' ' 110' ' ' ILE . 17.5 mt -79.63 163.44 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.535 -0.757 . . . . 0.26000000000000001 111.075 175.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -97.16 157.27 16.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.988 -0.551 . . . . 0.70999999999999996 109.976 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -62.79 -28.67 70.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.935 0.398 . . . . 2.2000000000000002 111.204 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.5 m -69.72 -6.52 32.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.267 -0.424 . . . . 1.4099999999999999 111.936 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.654 HG21 HD22 ' A' ' 106' ' ' LEU . 31.7 mm -89.41 114.2 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.175 0.512 . . . . 0.26000000000000001 110.46 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.53 -173.58 2.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.678 -0.86 . . . . 1.5900000000000001 108.678 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -70.46 -33.11 70.9 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.135 -1.061 . . . . 0.59999999999999998 108.135 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.654 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -66.8 -47.35 72.36 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 113.985 -1.461 . . . . 2.5800000000000001 109.661 178.054 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.11 97.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.972 -1.467 . . . . 0.14999999999999999 110.787 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.682 HD12 HG22 ' A' ' 130' ' ' VAL . 4.4 tt -67.07 -47.0 72.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.444 -0.798 . . . . 0.16 109.163 177.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.693 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 75.7 t80 -58.94 -46.61 87.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.078 -0.51 . . . . 0.29999999999999999 110.997 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -56.77 -40.05 75.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.977 0.417 . . . . 0.40000000000000002 110.886 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.442 HG21 HD21 ' A' ' 163' ' ' LEU . 9.6 m -77.67 -53.88 7.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.944 -0.571 . . . . 0.22 111.825 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.41 ' CD1' HD23 ' A' ' 115' ' ' LEU . 12.0 m-85 -72.42 -29.75 64.0 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.784 0.661 . . . . 0.11 112.784 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.6 t -58.64 -28.11 65.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.617 0.246 . . . . 0.19 111.174 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.86 -22.12 34.53 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.683 0.278 . . . . 0.14000000000000001 111.593 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.89 -11.9 35.04 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.899 0.38 . . . . 0.17999999999999999 110.984 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.57 160.88 10.96 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.749 -0.54 . . . . 0.11 111.749 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -62.45 139.24 58.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.25 110.185 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.436 HG21 ' HB3' ' A' ' 128' ' ' CYS . 67.1 mt -110.89 134.99 51.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.959 -0.564 . . . . 0.14000000000000001 109.857 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.577 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -87.49 -44.05 11.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.635 -0.876 . . . . 0.54000000000000004 108.635 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.6 m -145.33 127.48 15.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.85 -1.068 . . . . 0.76000000000000001 109.862 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.693 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 8.5 p -124.09 137.0 54.63 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.587 -0.523 . . . . 0.71999999999999997 109.587 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -136.39 129.59 31.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.909 0.385 . . . . 1.0 111.788 -173.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.682 HG22 HD12 ' A' ' 115' ' ' LEU . 60.9 t -115.1 110.81 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 107.171 -1.418 . . . . 0.28000000000000003 107.171 170.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 t . . . . . 0 C--N 1.305 -1.337 0 N-CA-C 109.015 -0.735 . . . . 0.34000000000000002 109.015 -175.503 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.684 0 N-CA-C 113.575 0.19 . . . . 0.31 113.575 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -127.21 151.24 48.96 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.491 0.645 . . . . 0.48999999999999999 111.817 -174.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.1 175.51 25.54 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.236 -0.893 . . . . 0.12 111.338 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 102' ' ' PHE . 55.2 m-85 -139.76 140.25 36.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.868 0.334 . . . . 0.25 110.688 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.473 ' HB ' HG12 ' A' ' 101' ' ' ILE . 49.5 t -114.69 136.11 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.043 0.449 . . . . 0.10000000000000001 111.076 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -104.26 106.02 16.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.706 -0.679 . . . . 0.20999999999999999 109.191 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.487 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 20.8 m-85 -90.65 136.29 33.16 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.163 0.506 . . . . 0.17000000000000001 111.102 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.577 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.2 tt0 -49.04 -40.69 32.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.514 -1.221 . . . . 0.56999999999999995 110.682 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.8 p -117.47 147.05 43.09 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.039 -0.982 . . . . 0.40000000000000002 110.731 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -63.11 -33.78 76.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.875 -0.602 . . . . 0.46999999999999997 111.042 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -68.75 -34.84 76.28 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.402 -0.363 . . . . 0.73999999999999999 111.456 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.81 -34.66 78.41 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.156 0.503 . . . . 0.17999999999999999 110.389 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.527 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -62.32 -48.46 79.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.483 -0.78 . . . . 0.16 110.639 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.632 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 41.0 mt-10 -58.79 -38.23 78.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.824 -0.625 . . . . 1.4199999999999999 110.841 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 51.4 mtt180 -62.1 -44.59 96.33 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.84 0.352 . . . . 1.48 111.011 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.19 86.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 0.10000000000000001 110.657 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 151' ' ' ALA . 82.4 mt -61.02 -53.65 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.14999999999999999 110.879 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.5 pt-20 -64.23 -41.73 96.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.957 0.408 . . . . 1.0800000000000001 111.98 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -81.36 -39.81 24.5 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.888 0.699 . . . . 1.1599999999999999 112.888 -171.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.533 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.3 mmm -93.02 -22.78 18.94 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.598 0.592 . . . . 0.34999999999999998 112.598 -172.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -66.96 123.33 19.91 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.028 -0.731 . . . . 0.44 109.028 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.2 13.21 66.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.585 -0.817 . . . . 0.28999999999999998 112.545 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.64 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.2 mmt -101.41 165.18 11.39 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.614 -0.345 . . . . 1.1799999999999999 111.224 177.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.33 130.46 46.44 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.949 -0.76 . . . . 0.44 108.949 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 22.0 mt -116.41 101.1 8.36 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.08 -0.648 . . . . 1.02 109.757 171.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 165' ' ' ASP . 55.9 m-20 78.5 -24.62 0.21 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.249 -0.887 . . . . 1.71 112.659 177.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 23.2 t70 166.17 -22.47 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 O-C-N 124.0 0.813 . . . . 0.84999999999999998 111.439 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 -110.71 132.02 54.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.497 -0.32 . . . . 0.95999999999999996 110.872 -170.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.64 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.6 ttmt -77.94 124.15 27.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.456 HG11 HD23 ' A' ' 106' ' ' LEU . 18.5 m -103.22 149.66 7.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.329 0.585 . . . . 0.17000000000000001 111.573 -174.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 43.3 t80 -107.21 120.91 43.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.3 -0.864 . . . . 0.29999999999999999 109.062 177.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.604 HG22 HG12 ' A' ' 103' ' ' ILE . 41.0 t -115.56 125.65 72.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.39 -0.596 . . . . 0.13 109.39 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.22 -173.76 16.8 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.568 -0.825 . . . . 0.17999999999999999 112.218 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 109.836 -0.431 . . . . 1.9299999999999999 109.836 179.897 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.473 0.721 0 N-CA-C 112.889 0.699 . . . . 0.70999999999999996 112.889 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 72.31 24.34 76.52 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.984 -1.103 . . . . 0.20999999999999999 111.768 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.499 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -86.51 125.21 33.59 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.535 -0.542 . . . . 0.63 109.535 -173.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.581 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.9 pt -135.57 160.43 39.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.228 -0.286 . . . . 0.14999999999999999 110.228 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -125.79 142.78 51.35 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.888 -0.412 . . . . 0.20999999999999999 109.888 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.648 HG12 HG22 ' A' ' 170' ' ' VAL . 7.2 mt -121.05 131.27 73.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 0.14999999999999999 110.251 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -116.06 151.32 35.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.681 -0.236 . . . . 1.46 110.561 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.2 t30 74.5 38.09 0.52 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.903 0.752 . . . . 0.48999999999999999 111.834 172.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.556 HD22 HG21 ' A' ' 110' ' ' ILE . 19.3 mt -76.78 158.47 30.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.059 0.457 . . . . 0.26000000000000001 111.065 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.504 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.0 t70 -84.26 151.69 24.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.553 -0.748 . . . . 0.70999999999999996 111.394 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -53.12 -36.19 60.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.13 -0.941 . . . . 2.2000000000000002 112.368 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -88.18 -2.57 58.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.242 -0.435 . . . . 1.4099999999999999 112.169 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.556 HG21 HD22 ' A' ' 106' ' ' LEU . 36.4 mm -73.59 124.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.2 0.524 . . . . 0.26000000000000001 110.823 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.518 ' OD2' ' HB3' ' A' ' 113' ' ' LYS . 0.2 OUTLIER -104.11 177.99 4.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.434 -0.803 . . . . 1.5900000000000001 110.865 -178.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -71.23 -33.67 70.08 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 107.56 -1.274 . . . . 0.59999999999999998 107.56 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.642 ' HB3' ' HZ3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -64.32 -48.87 73.95 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.833 -1.531 . . . . 2.5800000000000001 108.949 176.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -60.91 -44.87 96.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.367 -1.288 . . . . 0.14999999999999999 111.062 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.723 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -64.09 -47.1 81.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.302 -0.863 . . . . 0.16 109.056 177.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.674 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 69.8 t80 -59.61 -49.3 78.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.936 -0.575 . . . . 0.29999999999999999 111.135 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -58.3 -35.07 71.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.939 0.399 . . . . 0.40000000000000002 111.166 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 24.9 m -78.8 -54.45 6.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.319 -0.401 . . . . 0.22 112.022 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.438 ' CD1' HD23 ' A' ' 115' ' ' LEU . 8.6 m-85 -72.78 -29.72 63.52 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.665 0.617 . . . . 0.11 112.665 -173.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.2 t -58.76 -28.06 65.56 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.668 0.271 . . . . 0.19 111.454 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.56 -22.87 36.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.937 0.398 . . . . 0.14000000000000001 111.236 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -90.32 -19.04 24.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.17999999999999999 110.811 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.76 168.43 29.88 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 121.132 -0.556 . . . . 0.11 111.89 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -69.58 139.9 53.74 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.099 -0.334 . . . . 0.25 110.099 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 128' ' ' CYS . 73.5 mt -111.78 133.78 56.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.389 -0.369 . . . . 0.14000000000000001 110.526 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.641 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -91.94 -38.06 12.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.442 0.639 . . . . 0.54000000000000004 109.431 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 75.4 m -155.68 102.82 2.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.46 -0.791 . . . . 0.76000000000000001 110.942 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.674 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 9.3 p -106.12 142.64 35.48 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.848 -0.427 . . . . 0.71999999999999997 109.848 173.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -135.43 130.82 35.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.797 -173.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.723 HG22 HD12 ' A' ' 115' ' ' LEU . 63.3 t -114.91 110.08 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 106.838 -1.541 . . . . 0.28000000000000003 106.838 170.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.305 -1.334 0 N-CA-C 108.637 -0.875 . . . . 0.34000000000000002 108.637 -175.871 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.69 0 CA-C-O 120.359 -0.134 . . . . 0.31 113.265 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -129.14 148.32 51.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.535 0.668 . . . . 0.48999999999999999 111.875 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.28 170.99 25.25 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.05 -0.977 . . . . 0.12 111.433 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -137.77 137.57 38.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.757 0.278 . . . . 0.25 110.578 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.581 ' HB ' HG12 ' A' ' 101' ' ' ILE . 36.5 t -113.42 130.89 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 120.889 0.376 . . . . 0.10000000000000001 110.814 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.458 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 0.4 OUTLIER -100.61 105.95 17.4 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.019 -0.734 . . . . 0.20999999999999999 109.019 166.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.525 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 12.4 m-85 -89.36 137.32 32.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.266 0.555 . . . . 0.17000000000000001 111.209 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.641 ' HA ' HD21 ' A' ' 126' ' ' LEU . 41.5 tt0 -47.88 -48.75 31.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.235 -1.348 . . . . 0.56999999999999995 110.556 176.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 p -110.63 144.51 39.41 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.379 -1.282 . . . . 0.40000000000000002 111.218 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -61.77 -37.7 85.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.665 -0.698 . . . . 0.46999999999999997 110.996 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.0 pt-20 -69.91 -34.36 73.39 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.615 -0.266 . . . . 0.73999999999999999 111.682 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.55 77.61 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.154 0.502 . . . . 0.17999999999999999 110.403 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.526 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -62.97 -44.69 95.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.488 -0.778 . . . . 0.16 110.501 176.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 49.1 mt-10 -59.53 -40.55 87.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 1.4199999999999999 110.541 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.521 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 50.1 mtt180 -62.3 -39.93 94.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 1.48 110.823 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.02 -38.5 86.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.472 -0.331 . . . . 0.10000000000000001 110.423 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 151' ' ' ALA . 81.2 mt -58.68 -54.04 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 0.14999999999999999 111.167 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.0 OUTLIER -61.05 -44.25 97.67 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.149 0.499 . . . . 1.0800000000000001 112.028 -178.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.439 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.23 -38.7 24.12 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.48 -0.782 . . . . 1.1599999999999999 112.802 -169.002 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.47 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.9 mmm -91.23 -24.28 19.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.254 0.464 . . . . 0.34999999999999998 112.254 -173.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 59.9 t30 -67.72 123.02 19.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.215 -0.594 . . . . 0.44 109.507 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.0 8.83 64.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.732 -0.747 . . . . 0.28999999999999998 112.786 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.742 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.4 mmt -92.01 163.81 13.85 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.692 0.282 . . . . 1.1799999999999999 111.425 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 15.7 mt -105.55 107.21 18.07 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.536 -0.542 . . . . 0.44 109.536 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 163' ' ' LEU . 18.3 mt -94.61 108.55 20.52 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.793 -0.763 . . . . 1.02 109.245 172.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 94.4 m-20 72.11 -62.35 0.47 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.137 -0.938 . . . . 1.71 112.127 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -163.88 12.78 0.05 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.787 -0.642 . . . . 0.84999999999999998 111.438 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.504 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.1 mtt180 -134.41 129.85 35.96 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.966 -0.459 . . . . 0.95999999999999996 110.481 -174.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.742 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.2 ttmt -78.7 120.12 22.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.157 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.461 HG11 HD23 ' A' ' 106' ' ' LEU . 14.5 m -100.73 146.58 9.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.619 0.723 . . . . 0.17000000000000001 111.231 -172.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.583 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 75.2 t80 -106.9 118.38 36.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.729 -1.123 . . . . 0.29999999999999999 109.341 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.648 HG22 HG12 ' A' ' 103' ' ' ILE . 41.1 t -115.22 125.06 72.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.104 -0.702 . . . . 0.13 109.104 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.76 -174.46 17.96 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.512 -0.851 . . . . 0.17999999999999999 112.098 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.964 0.412 . . . . 1.9299999999999999 110.246 -179.595 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.5 t . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 121.51 0.671 . . . . 0.70999999999999996 111.857 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 73.27 24.15 75.98 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.181 -1.009 . . . . 0.20999999999999999 112.084 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.513 HD22 ' N ' ' A' ' 100' ' ' ASN . 0.9 OUTLIER -88.58 125.41 34.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.357 -0.608 . . . . 0.63 109.357 -174.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.522 HG23 ' HB1' ' A' ' 151' ' ' ALA . 21.4 pt -135.31 159.73 40.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.087 -0.338 . . . . 0.14999999999999999 110.087 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.39 138.18 54.62 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.899 -0.408 . . . . 0.20999999999999999 109.899 176.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.632 HG12 HG22 ' A' ' 170' ' ' VAL . 5.7 mt -116.71 131.49 69.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.548 -0.751 . . . . 0.14999999999999999 110.076 -177.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -113.66 152.56 30.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.493 -0.321 . . . . 1.46 110.588 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.8 t30 75.58 33.99 0.62 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.014 0.821 . . . . 0.48999999999999999 111.683 170.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.485 HD23 HG11 ' A' ' 168' ' ' VAL . 25.4 mt -75.64 156.82 34.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 0.26000000000000001 111.446 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.464 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 15.0 t70 -83.15 153.14 24.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.519 -0.764 . . . . 0.70999999999999996 111.36 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.421 ' HG3' ' N ' ' A' ' 109' ' ' SER . 55.1 pttt -54.09 -37.66 64.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.485 -0.78 . . . . 2.2000000000000002 112.501 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.421 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 13.7 m -80.86 -8.76 59.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.848 0.314 . . . . 1.4099999999999999 111.848 -172.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.502 ' O ' HG11 ' A' ' 130' ' ' VAL . 34.6 mm -71.16 120.17 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.013 0.435 . . . . 0.26000000000000001 110.376 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -109.27 -179.67 3.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.016 -0.735 . . . . 1.5900000000000001 109.016 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.58 -40.98 98.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.269 -0.641 . . . . 0.59999999999999998 109.269 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.884 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -59.97 -49.39 77.87 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.277 -0.874 . . . . 2.5800000000000001 110.567 178.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.9 98.19 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.265 -1.334 . . . . 0.14999999999999999 111.396 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.762 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -65.03 -47.15 78.42 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.952 -0.758 . . . . 0.16 108.952 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 64.4 t80 -57.54 -48.23 79.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.916 -0.584 . . . . 0.29999999999999999 111.009 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.25 -37.55 72.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.968 0.413 . . . . 0.40000000000000002 110.828 -175.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 m -77.88 -54.42 6.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.151 -0.477 . . . . 0.22 111.815 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.434 ' CD1' HD23 ' A' ' 115' ' ' LEU . 10.2 m-85 -73.02 -28.82 62.58 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.881 0.696 . . . . 0.11 112.881 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -57.57 -28.23 63.38 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.777 0.322 . . . . 0.19 110.875 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.45 -21.74 27.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.355 -0.384 . . . . 0.14000000000000001 111.618 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -92.98 -17.41 23.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.989 0.423 . . . . 0.17999999999999999 110.918 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.72 162.51 14.74 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.977 -0.556 . . . . 0.11 111.796 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -61.67 132.45 53.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.057 0.456 . . . . 0.25 110.538 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 128' ' ' CYS . 68.3 mt -106.35 133.68 50.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.808 -0.633 . . . . 0.14000000000000001 109.747 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.602 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.28 -40.31 13.72 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.01 -0.737 . . . . 0.54000000000000004 109.01 -177.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.3 m -147.68 129.66 15.37 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.973 -1.012 . . . . 0.76000000000000001 109.915 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 5.8 p -129.44 124.67 34.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.265 -0.643 . . . . 0.71999999999999997 109.265 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -123.95 127.93 48.67 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.906 0.384 . . . . 1.0 111.327 -173.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.762 HG22 HD12 ' A' ' 115' ' ' LEU . 54.8 t -114.48 109.55 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 106.856 -1.535 . . . . 0.28000000000000003 106.856 170.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 t . . . . . 0 C--N 1.302 -1.458 0 N-CA-C 108.611 -0.885 . . . . 0.34000000000000002 108.611 -175.142 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.75 0 CA-C-O 120.279 -0.179 . . . . 0.31 113.314 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 24.0 p90 -133.03 148.8 52.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.368 0.584 . . . . 0.48999999999999999 111.654 -176.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.86 168.56 25.93 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.24 -0.891 . . . . 0.12 111.377 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -136.47 136.49 39.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.059 0.43 . . . . 0.25 110.801 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.518 ' HB ' HG12 ' A' ' 101' ' ' ILE . 48.7 t -111.0 136.45 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.957 0.408 . . . . 0.10000000000000001 111.145 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.447 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 1.3 m170 -105.57 105.63 15.76 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.104 -0.702 . . . . 0.20999999999999999 109.104 166.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.472 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 17.5 m-85 -88.79 138.59 31.28 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.042 0.448 . . . . 0.17000000000000001 110.938 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.602 ' HA ' HD21 ' A' ' 126' ' ' LEU . 28.5 tt0 -45.87 -45.39 15.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.526 -1.215 . . . . 0.56999999999999995 110.923 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.3 p -119.8 150.78 39.86 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.938 -1.028 . . . . 0.40000000000000002 110.839 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -61.46 -33.41 73.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.49 -0.777 . . . . 0.46999999999999997 110.865 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.76 -35.65 75.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.73999999999999999 111.83 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.59 -34.23 76.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.093 0.473 . . . . 0.17999999999999999 110.498 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -64.2 -44.25 92.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.632 -0.713 . . . . 0.16 110.688 176.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 31.8 mt-10 -58.96 -38.61 79.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 1.4199999999999999 110.471 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.544 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 92.2 mtt180 -62.77 -43.51 98.6 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.03 0.443 . . . . 1.48 110.969 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.75 -37.29 85.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 0.10000000000000001 110.405 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 151' ' ' ALA . 90.6 mt -59.17 -52.74 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.14999999999999999 111.248 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.6 pt-20 -64.02 -46.24 85.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.09 0.472 . . . . 1.0800000000000001 111.809 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -80.86 -38.47 28.1 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.147 0.795 . . . . 1.1599999999999999 113.147 -168.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.419 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.0 mmm -93.29 -20.22 20.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.458 0.54 . . . . 0.34999999999999998 112.458 -173.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 53.8 t30 -68.58 123.75 21.71 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.221 -0.592 . . . . 0.44 109.652 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.52 64.48 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.777 -0.725 . . . . 0.28999999999999998 112.539 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.729 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.7 mmt -96.07 162.5 13.52 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.678 0.239 . . . . 1.1799999999999999 110.976 177.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.9 mt -103.35 105.04 15.22 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.345 -0.613 . . . . 0.44 109.345 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 18.0 mt -91.04 108.93 20.19 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.925 -0.71 . . . . 1.02 109.256 173.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 93.9 m-20 73.57 -60.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.302 -0.863 . . . . 1.71 111.827 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -172.61 22.9 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.549 -0.75 . . . . 0.84999999999999998 110.798 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.7 mtt180 -138.29 132.75 32.14 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.006 -0.434 . . . . 0.95999999999999996 109.96 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.729 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.2 tttt -84.19 115.02 22.21 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.485 HG11 HD23 ' A' ' 106' ' ' LEU . 15.6 m -100.12 147.83 7.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.599 0.714 . . . . 0.17000000000000001 111.485 -170.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 75.8 t80 -106.58 120.49 42.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.735 -1.121 . . . . 0.29999999999999999 109.365 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.632 HG22 HG12 ' A' ' 103' ' ' ILE . 42.3 t -115.48 125.58 72.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.154 -0.684 . . . . 0.13 109.154 177.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.53 -171.5 16.68 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.351 -0.928 . . . . 0.17999999999999999 112.235 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 . . . . . 0 C--N 1.325 -0.464 0 N-CA-C 109.426 -0.583 . . . . 1.9299999999999999 109.426 -179.793 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 120.93 0.395 . . . . 0.70999999999999996 111.908 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.08 24.08 69.93 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.218 -0.991 . . . . 0.20999999999999999 111.877 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 143' ' ' VAL . 2.2 m120 -87.45 125.8 34.51 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.969 -0.752 . . . . 0.63 108.969 -176.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.563 HG12 ' HB ' ' A' ' 143' ' ' VAL . 23.8 pt -135.02 163.55 36.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.477 -0.329 . . . . 0.14999999999999999 110.283 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.14 147.28 49.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.83 -0.433 . . . . 0.20999999999999999 109.83 175.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.561 HG12 HG22 ' A' ' 170' ' ' VAL . 4.4 mt -119.26 139.29 47.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.679 -0.691 . . . . 0.14999999999999999 109.811 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -117.16 153.22 33.2 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.952 0.158 . . . . 1.46 110.637 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.0 t30 71.39 39.73 0.9 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.863 0.727 . . . . 0.48999999999999999 112.16 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.434 HD23 HG11 ' A' ' 168' ' ' VAL . 33.5 mt -81.82 164.73 21.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.807 0.337 . . . . 0.26000000000000001 111.056 176.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -96.7 157.53 15.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.70999999999999996 109.813 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -61.51 -26.4 67.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.484 0.659 . . . . 2.2000000000000002 109.681 172.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 m -59.78 -23.12 63.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.632 -1.167 . . . . 1.4099999999999999 112.596 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.608 HG22 HG21 ' A' ' 130' ' ' VAL . 40.2 mm -86.43 131.32 34.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.407 0.622 . . . . 0.26000000000000001 111.502 -174.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -117.37 -175.39 2.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.235 -1.024 . . . . 1.5900000000000001 108.235 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -69.07 -29.68 67.85 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.608 -0.886 . . . . 0.59999999999999998 108.608 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -49.46 65.18 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.457 -1.247 . . . . 2.5800000000000001 109.404 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.78 85.47 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.7 -1.136 . . . . 0.14999999999999999 110.691 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.742 HD12 HG22 ' A' ' 130' ' ' VAL . 3.5 tt -70.72 -48.05 56.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.47 -0.786 . . . . 0.16 109.35 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.622 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 80.2 t80 -61.05 -45.12 96.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 0.29999999999999999 110.833 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.43 -41.83 77.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.014 0.435 . . . . 0.40000000000000002 110.884 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.418 HG21 HD21 ' A' ' 163' ' ' LEU . 24.0 m -77.66 -53.66 7.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 0.22 112.072 -177.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.455 ' CD1' HD23 ' A' ' 115' ' ' LEU . 17.7 m-85 -72.17 -29.46 64.04 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.46 0.541 . . . . 0.11 112.46 -173.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.6 t -58.67 -28.93 66.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.595 0.236 . . . . 0.19 111.201 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.38 -22.62 43.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 0.14000000000000001 111.554 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -93.64 -11.94 30.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 0.17999999999999999 110.875 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.95 164.06 15.14 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.929 -0.653 . . . . 0.11 111.846 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -67.05 137.5 56.48 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.932 0.396 . . . . 0.25 110.178 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.416 HG21 ' HB3' ' A' ' 128' ' ' CYS . 72.1 mt -110.21 129.57 64.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.119 -0.491 . . . . 0.14000000000000001 109.927 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.14 -35.37 20.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.054 -0.721 . . . . 0.54000000000000004 109.054 -177.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 65.8 m -154.31 128.72 9.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.17 -0.923 . . . . 0.76000000000000001 109.849 -177.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 2.6 p -134.14 144.85 48.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.802 0.334 . . . . 0.71999999999999997 110.247 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -143.78 133.15 23.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.59 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.742 HG22 HD12 ' A' ' 115' ' ' LEU . 59.6 t -113.23 111.11 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 106.383 -1.71 . . . . 0.28000000000000003 106.383 168.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 t . . . . . 0 C--N 1.301 -1.52 0 N-CA-C 108.804 -0.813 . . . . 0.34000000000000002 108.804 -174.567 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.832 0 CA-C-O 120.317 -0.157 . . . . 0.31 113.113 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 22.2 p90 -125.88 148.78 49.09 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.457 0.629 . . . . 0.48999999999999999 111.984 -174.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.36 173.81 23.2 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.002 -0.999 . . . . 0.12 111.358 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -136.11 141.85 44.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.032 0.416 . . . . 0.25 110.848 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.563 ' HB ' HG12 ' A' ' 101' ' ' ILE . 28.1 t -117.23 135.95 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.106 0.479 . . . . 0.10000000000000001 110.84 172.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.4 OUTLIER -107.2 106.17 16.5 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.031 -0.729 . . . . 0.20999999999999999 109.031 168.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.2 m-85 -90.49 139.06 31.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.596 0.713 . . . . 0.17000000000000001 111.936 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.576 ' HA ' HD21 ' A' ' 126' ' ' LEU . 46.5 tt0 -49.05 -40.79 32.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.912 -1.495 . . . . 0.56999999999999995 110.86 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.2 p -123.93 154.59 39.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.887 -1.051 . . . . 0.40000000000000002 110.513 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -66.14 -33.5 75.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.177 -0.465 . . . . 0.46999999999999997 110.902 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.07 -35.86 77.0 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.365 -0.379 . . . . 0.73999999999999999 111.518 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.19 -34.51 78.24 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.168 0.508 . . . . 0.17999999999999999 110.402 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.529 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.81 -48.01 80.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.523 -0.762 . . . . 0.16 110.606 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.634 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 29.3 mt-10 -58.64 -42.13 87.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.005 -0.543 . . . . 1.4199999999999999 110.696 177.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 72.5 mtt180 -58.65 -41.62 86.49 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.944 0.402 . . . . 1.48 110.949 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.22 -40.36 86.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.359 -0.382 . . . . 0.10000000000000001 110.612 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 151' ' ' ALA . 91.1 mt -60.33 -49.59 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.056 -0.52 . . . . 0.14999999999999999 111.176 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.9 pt-20 -64.07 -45.69 87.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.175 0.512 . . . . 1.0800000000000001 111.704 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.473 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -80.73 -38.58 28.5 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.329 0.863 . . . . 1.1599999999999999 113.329 -169.261 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.426 ' HB2' HG21 ' A' ' 170' ' ' VAL . 88.9 mmm -95.77 -17.12 21.44 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.709 0.633 . . . . 0.34999999999999998 112.709 -172.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.06 123.06 20.61 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.197 -0.601 . . . . 0.44 109.613 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.04 22.69 54.45 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.865 -0.684 . . . . 0.28999999999999998 112.419 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.564 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.5 OUTLIER -106.48 161.57 14.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.724 0.297 . . . . 1.1799999999999999 111.622 -179.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 75.4 mt -104.17 106.75 17.36 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.908 -0.775 . . . . 0.44 108.908 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.418 HD21 HG21 ' A' ' 118' ' ' THR . 2.6 mt -92.6 22.17 4.89 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.015 -0.674 . . . . 1.02 111.864 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.7 p30 169.92 -79.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.823 0.849 . . . . 1.71 109.153 -175.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -150.93 12.28 0.67 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.747 -1.115 . . . . 0.84999999999999998 109.536 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -124.04 135.04 53.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.589 -0.732 . . . . 0.95999999999999996 109.096 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 161' ' ' MET . 3.9 ttmp? -84.19 117.25 23.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.434 HG11 HD23 ' A' ' 106' ' ' LEU . 19.1 m -99.79 143.28 13.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.541 0.686 . . . . 0.17000000000000001 110.565 -172.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 39.7 t80 -106.53 122.18 45.78 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.882 -1.054 . . . . 0.29999999999999999 109.417 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.561 HG22 HG12 ' A' ' 103' ' ' ILE . 43.1 t -115.94 125.75 73.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.476 -0.564 . . . . 0.13 109.476 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.04 -167.23 12.1 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.319 -0.712 . . . . 0.17999999999999999 111.319 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 . . . . . 0 C--N 1.322 -0.614 0 N-CA-C 108.833 -0.803 . . . . 1.9299999999999999 108.833 179.79 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.3 t . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.45 0.643 . . . . 0.70999999999999996 112.531 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.32 24.87 74.37 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 119.873 -1.155 . . . . 0.20999999999999999 111.455 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.53 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.3 m120 -89.95 124.17 34.5 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.955 -0.757 . . . . 0.63 108.955 -173.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.482 HG23 ' HB1' ' A' ' 151' ' ' ALA . 17.1 pt -136.07 163.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.942 -0.392 . . . . 0.14999999999999999 109.942 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.94 143.22 51.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.1 0.476 . . . . 0.20999999999999999 109.775 176.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.662 HG12 HG22 ' A' ' 170' ' ' VAL . 6.1 mt -119.33 136.38 56.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.355 -0.839 . . . . 0.14999999999999999 109.876 -177.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -120.15 154.1 35.26 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 121.438 -0.105 . . . . 1.46 110.913 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.0 t30 73.73 32.79 1.09 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.878 0.871 . . . . 0.48999999999999999 111.528 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 110' ' ' ILE . 30.7 mt -73.99 154.31 39.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.408 . . . . 0.26000000000000001 111.255 177.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.46 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 25.6 t70 -83.17 152.3 25.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.675 . . . . 0.70999999999999996 110.681 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -56.15 -34.66 66.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.625 . . . . 2.2000000000000002 112.014 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.3 m -80.14 -2.83 46.33 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.416 0.524 . . . . 1.4099999999999999 112.416 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.645 HG21 HD22 ' A' ' 106' ' ' LEU . 31.6 mm -78.91 116.43 22.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.615 -0.434 . . . . 0.26000000000000001 110.057 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -105.85 -176.7 3.15 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.95 -0.759 . . . . 1.5900000000000001 108.95 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -68.81 -31.01 69.7 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.111 -0.7 . . . . 0.59999999999999998 109.111 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -48.33 66.15 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.634 -1.166 . . . . 2.5800000000000001 109.238 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.6 -41.6 97.66 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.269 -1.332 . . . . 0.14999999999999999 110.796 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.711 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -67.5 -47.37 70.21 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.243 -0.89 . . . . 0.16 108.994 177.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.724 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 62.3 t80 -58.34 -47.81 82.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.179 -0.464 . . . . 0.29999999999999999 111.155 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -56.74 -39.27 73.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.068 0.461 . . . . 0.40000000000000002 110.86 -174.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 m -78.48 -53.59 7.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.84 -0.618 . . . . 0.22 112.181 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 115' ' ' LEU . 8.3 m-85 -72.52 -28.29 62.77 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.802 0.667 . . . . 0.11 112.802 -174.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.5 t -57.05 -28.39 62.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.749 0.309 . . . . 0.19 111.428 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.35 -22.45 42.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.699 0.285 . . . . 0.14000000000000001 111.748 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.408 ' HZ ' ' HE2' ' A' ' 157' ' ' LYS . 23.9 m-85 -90.38 -18.23 25.84 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.968 0.413 . . . . 0.17999999999999999 111.102 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 165.31 166.93 25.11 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.901 -0.59 . . . . 0.11 111.632 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -67.7 129.75 40.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.927 0.394 . . . . 0.25 110.268 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.429 HG21 ' HB3' ' A' ' 128' ' ' CYS . 71.8 mt -100.48 131.97 47.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.134 -0.485 . . . . 0.14000000000000001 110.281 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.545 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.61 -44.73 11.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.497 -0.927 . . . . 0.54000000000000004 108.497 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.5 m -147.33 111.65 5.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.912 -1.04 . . . . 0.76000000000000001 110.544 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.4 p -107.22 145.12 33.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.254 -0.647 . . . . 0.71999999999999997 109.254 173.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -144.83 128.79 17.47 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.932 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.711 HG22 HD12 ' A' ' 115' ' ' LEU . 48.6 t -114.81 110.64 32.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 106.627 -1.62 . . . . 0.28000000000000003 106.627 168.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.303 -1.435 0 N-CA-C 108.985 -0.746 . . . . 0.34000000000000002 108.985 -174.926 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.644 0 CA-C-O 120.488 -0.062 . . . . 0.31 113.182 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 25.7 p90 -127.19 150.59 49.45 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.207 0.527 . . . . 0.48999999999999999 111.646 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.18 170.6 25.33 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.302 -0.863 . . . . 0.12 111.222 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -137.78 138.79 39.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.147 0.473 . . . . 0.25 110.841 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.501 HG11 ' CE2' ' A' ' 145' ' ' PHE . 42.6 t -113.74 135.45 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 120.962 0.41 . . . . 0.10000000000000001 110.8 173.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -105.2 106.23 16.62 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.086 -0.709 . . . . 0.20999999999999999 109.086 166.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.501 ' CE2' HG11 ' A' ' 143' ' ' VAL . 17.4 m-85 -90.24 139.98 30.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.265 0.555 . . . . 0.17000000000000001 111.079 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.545 ' HA ' HD21 ' A' ' 126' ' ' LEU . 42.3 tt0 -50.57 -37.56 40.37 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.524 -1.216 . . . . 0.56999999999999995 110.93 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.8 p -121.68 155.87 34.25 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.023 -0.989 . . . . 0.40000000000000002 110.515 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -68.48 -36.31 78.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.104 -0.498 . . . . 0.46999999999999997 110.447 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.35 -34.81 75.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.598 . . . . 0.73999999999999999 112.014 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.83 -36.77 79.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.153 0.502 . . . . 0.17999999999999999 110.454 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.482 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -65.04 -40.91 95.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.561 -0.745 . . . . 0.16 110.433 177.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 51.9 mt-10 -59.88 -37.35 79.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.636 -0.711 . . . . 1.4199999999999999 110.822 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 98.2 mtt180 -65.5 -43.99 88.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.352 -0.385 . . . . 1.48 110.876 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.43 83.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.222 -0.445 . . . . 0.10000000000000001 110.532 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 151' ' ' ALA . 92.8 mt -60.65 -53.49 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 0.14999999999999999 111.287 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.4 pt-20 -64.16 -43.4 95.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.182 0.515 . . . . 1.0800000000000001 111.902 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -81.26 -39.09 25.84 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.887 0.699 . . . . 1.1599999999999999 112.887 -169.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.511 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.7 mmm -94.86 -20.22 19.63 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.686 0.625 . . . . 0.34999999999999998 112.686 -172.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -68.05 123.39 20.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.392 -0.596 . . . . 0.44 109.392 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.53 16.89 63.16 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.656 -0.783 . . . . 0.28999999999999998 112.667 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.6 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 4.4 mmt -98.48 156.23 16.87 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.718 -0.283 . . . . 1.1799999999999999 111.072 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.48 HD22 ' O ' ' A' ' 165' ' ' ASP . 17.5 mt -98.77 103.75 15.73 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.626 -0.509 . . . . 0.44 109.626 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 22.4 mt -91.01 104.28 16.89 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 120.054 -0.658 . . . . 1.02 109.401 174.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 79.9 m-20 76.78 -27.75 0.18 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.129 -0.942 . . . . 1.71 112.519 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.48 ' O ' HD22 ' A' ' 162' ' ' LEU . 32.7 t70 163.94 -20.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.083 0.864 . . . . 0.84999999999999998 111.402 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.46 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.4 mtt180 -102.17 130.18 48.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.331 -0.395 . . . . 0.95999999999999996 110.846 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 161' ' ' MET . 19.5 tttt -78.7 115.03 18.13 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.395 -0.594 . . . . 1.0 109.395 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.529 HG11 HD23 ' A' ' 106' ' ' LEU . 12.9 m -100.56 149.57 6.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.614 0.721 . . . . 0.17000000000000001 111.366 -172.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 77.4 t80 -106.33 118.93 37.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.834 -1.076 . . . . 0.29999999999999999 109.612 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.662 HG22 HG12 ' A' ' 103' ' ' ILE . 39.4 t -115.74 126.36 73.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.435 -0.58 . . . . 0.13 109.435 176.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.24 -176.32 23.17 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.78 -0.724 . . . . 0.17999999999999999 111.524 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 109.457 -0.571 . . . . 1.9299999999999999 109.457 177.866 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 121.731 0.777 . . . . 0.70999999999999996 112.627 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.29 23.98 77.47 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.64 -1.267 . . . . 0.20999999999999999 111.507 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.408 ' N ' HD22 ' A' ' 100' ' ' ASN . 0.9 OUTLIER -84.28 126.44 33.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.887 -0.412 . . . . 0.63 109.887 -174.274 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.577 HG12 ' HB ' ' A' ' 143' ' ' VAL . 32.2 pt -134.55 155.8 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.708 -0.678 . . . . 0.14999999999999999 109.631 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.96 139.68 53.37 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.631 -0.507 . . . . 0.20999999999999999 109.631 178.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.677 HG12 HG22 ' A' ' 170' ' ' VAL . 8.6 mt -118.03 137.36 52.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.79 -0.641 . . . . 0.14999999999999999 110.197 -176.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -124.2 152.52 42.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.638 -0.256 . . . . 1.46 110.403 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 167' ' ' LYS . 5.2 t30 74.69 45.32 0.17 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.806 0.813 . . . . 0.48999999999999999 110.847 170.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.466 HD22 HG21 ' A' ' 110' ' ' ILE . 20.1 mt -88.38 166.83 13.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.963 -1.017 . . . . 0.26000000000000001 110.795 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -97.06 162.69 13.26 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.603 -0.517 . . . . 0.70999999999999996 109.603 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -66.27 -25.03 66.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.277 0.561 . . . . 2.2000000000000002 109.618 173.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.0 m -60.67 -16.19 36.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.122 -0.944 . . . . 1.4099999999999999 112.074 175.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.492 HG22 HG21 ' A' ' 130' ' ' VAL . 44.9 mm -93.07 128.38 44.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.332 0.587 . . . . 0.26000000000000001 111.166 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.419 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 8.7 t70 -118.65 -178.09 3.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.283 -1.006 . . . . 1.5900000000000001 108.283 175.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -61.81 -35.0 76.91 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.37 -0.604 . . . . 0.59999999999999998 109.37 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 1.006 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -61.76 -50.17 73.45 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.205 -0.907 . . . . 2.5800000000000001 110.583 177.457 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.419 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.15 -42.9 99.39 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.576 -1.193 . . . . 0.14999999999999999 110.968 -176.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.697 HD12 HG22 ' A' ' 130' ' ' VAL . 3.5 tt -65.51 -47.94 74.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.636 -0.711 . . . . 0.16 109.474 178.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.799 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.8 t80 -59.52 -44.71 93.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.442 . . . . 0.29999999999999999 110.71 176.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.73 -42.67 79.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.178 -0.464 . . . . 0.40000000000000002 111.154 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.5 m -78.05 -53.37 7.48 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.352 0.501 . . . . 0.22 112.352 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.483 ' CD1' HD23 ' A' ' 115' ' ' LEU . 7.4 m-85 -71.12 -28.12 64.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.548 0.573 . . . . 0.11 112.548 -172.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.3 t -57.89 -29.93 65.45 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.722 0.296 . . . . 0.19 111.351 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.42 -22.67 44.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 0.14000000000000001 111.361 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -91.07 -20.28 22.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.868 0.366 . . . . 0.17999999999999999 111.024 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.63 169.32 31.01 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.321 -0.711 . . . . 0.11 111.321 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -69.72 141.63 53.46 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.96 -0.385 . . . . 0.25 109.96 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.446 HG21 ' HB3' ' A' ' 128' ' ' CYS . 74.6 mt -112.43 135.94 50.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.241 -0.436 . . . . 0.14000000000000001 110.297 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.552 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -90.93 -41.73 10.98 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.635 -0.876 . . . . 0.54000000000000004 108.635 179.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' A' ' 144' ' ' HIS . 95.7 p -145.5 126.96 15.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.287 -0.87 . . . . 0.76000000000000001 109.966 176.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.6 p -122.97 116.04 22.91 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.149 -0.685 . . . . 0.71999999999999997 109.149 174.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -117.82 128.61 55.02 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.17 0.509 . . . . 1.0 111.438 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.697 HG22 HD12 ' A' ' 115' ' ' LEU . 99.3 t -114.67 109.34 28.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 106.45 -1.685 . . . . 0.28000000000000003 106.45 170.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.9 t . . . . . 0 C--N 1.305 -1.339 0 N-CA-C 108.553 -0.906 . . . . 0.34000000000000002 108.553 -175.142 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 113.941 0.336 . . . . 0.31 113.941 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -130.63 152.55 49.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.875 0.837 . . . . 0.48999999999999999 112.071 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.73 173.34 26.98 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.252 -0.885 . . . . 0.12 112.094 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -141.62 138.31 32.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.243 0.217 . . . . 0.25 110.818 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.577 ' HB ' HG12 ' A' ' 101' ' ' ILE . 33.2 t -115.56 130.73 69.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.849 0.356 . . . . 0.10000000000000001 111.277 175.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.456 ' HB2' ' OG ' ' A' ' 127' ' ' SER . 1.6 m170 -97.88 106.76 19.11 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.608 -0.886 . . . . 0.20999999999999999 108.608 165.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.519 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 7.8 m-85 -90.11 135.9 33.38 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.347 -0.541 . . . . 0.17000000000000001 111.196 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.552 ' HA ' HD21 ' A' ' 126' ' ' LEU . 36.2 tt0 -47.93 -40.26 21.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.531 -1.213 . . . . 0.56999999999999995 110.72 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.8 p -122.5 146.87 47.0 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.844 -1.071 . . . . 0.40000000000000002 110.765 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -64.18 -37.9 89.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.742 -0.663 . . . . 0.46999999999999997 111.149 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.35 -34.75 77.97 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.168 0.433 . . . . 0.73999999999999999 112.168 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.95 78.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.168 0.509 . . . . 0.17999999999999999 110.826 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.519 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.8 -44.75 95.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.532 -0.758 . . . . 0.16 111.046 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 47.7 mt-10 -59.4 -39.41 83.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.912 -0.585 . . . . 1.4199999999999999 111.012 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 157' ' ' LYS . 62.2 mtt85 -61.03 -42.06 97.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.799 0.333 . . . . 1.48 110.664 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.34 -38.19 90.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.271 -0.422 . . . . 0.10000000000000001 110.207 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.3 mt -61.55 -54.27 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.172 -0.467 . . . . 0.14999999999999999 111.244 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.3 pt-20 -64.18 -44.08 93.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.118 0.485 . . . . 1.0800000000000001 111.706 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -78.04 -38.99 43.33 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.919 0.711 . . . . 1.1599999999999999 112.919 -171.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.504 ' HB2' HG21 ' A' ' 170' ' ' VAL . 82.2 mmm -94.66 -27.51 15.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.907 0.706 . . . . 0.34999999999999998 112.907 -172.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -64.52 124.22 21.28 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.675 -0.41 . . . . 0.44 110.529 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.25 15.68 60.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.083 -0.579 . . . . 0.28999999999999998 113.296 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.695 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 79.5 mmm -109.45 162.62 14.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.897 0.349 . . . . 1.1799999999999999 111.806 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.8 mt -99.13 104.77 16.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.621 -0.881 . . . . 0.44 108.621 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.05 22.44 2.4 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.141 -0.624 . . . . 1.02 111.534 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.4 p30 171.35 -80.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.047 0.939 . . . . 1.71 108.54 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -150.32 17.6 0.84 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.45 -1.25 . . . . 0.84999999999999998 108.581 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -131.16 127.19 37.5 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.853 -1.067 . . . . 0.95999999999999996 109.768 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.3 tttt -76.41 121.93 23.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.654 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.429 HG11 HD23 ' A' ' 106' ' ' LEU . 17.8 m -101.29 142.17 16.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.282 0.563 . . . . 0.17000000000000001 110.955 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.628 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 76.5 t80 -106.25 118.08 35.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.27 -0.877 . . . . 0.29999999999999999 109.509 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 103' ' ' ILE . 39.0 t -115.24 125.16 72.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.283 -0.636 . . . . 0.13 109.283 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -141.64 -170.82 12.55 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.672 -0.775 . . . . 0.17999999999999999 112.13 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 . . . . . 0 C--N 1.326 -0.44 0 N-CA-C 110.246 -0.279 . . . . 1.9299999999999999 110.246 -177.002 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.2 t . . . . . 0 N--CA 1.47 0.55 0 CA-C-O 121.419 0.628 . . . . 0.70999999999999996 112.218 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 24.18 76.49 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.143 -1.027 . . . . 0.20999999999999999 111.39 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.54 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.3 m120 -88.36 124.64 34.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.858 -0.793 . . . . 0.63 108.858 -173.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.554 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.0 pt -136.26 163.7 33.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.628 -0.26 . . . . 0.14999999999999999 110.374 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.411 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -125.3 143.92 50.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.061 0.458 . . . . 0.20999999999999999 110.143 175.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.581 HG12 HG22 ' A' ' 170' ' ' VAL . 6.9 mt -119.39 138.85 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.466 -0.788 . . . . 0.14999999999999999 109.861 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -119.7 154.05 34.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.688 -0.233 . . . . 1.46 110.556 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 167' ' ' LYS . 35.0 t30 72.27 34.84 1.3 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.89 0.744 . . . . 0.48999999999999999 111.653 171.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.581 HD22 HG21 ' A' ' 110' ' ' ILE . 23.8 mt -74.73 160.19 31.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.122 0.486 . . . . 0.26000000000000001 111.0 177.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -91.3 156.33 17.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.54 -0.755 . . . . 0.70999999999999996 109.805 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -60.78 -28.82 69.03 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.248 0.342 . . . . 2.2000000000000002 111.26 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.5 p -66.78 -26.77 67.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 1.4099999999999999 111.859 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.581 HG21 HD22 ' A' ' 106' ' ' LEU . 47.8 mm -70.94 121.72 21.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.315 0.578 . . . . 0.26000000000000001 111.305 -172.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -111.79 -175.63 2.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.44 -0.948 . . . . 1.5900000000000001 108.44 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -69.71 -33.07 71.99 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 109.091 -0.707 . . . . 0.59999999999999998 109.091 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -48.24 72.39 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.861 -1.063 . . . . 2.5800000000000001 109.056 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.12 96.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.146 -1.388 . . . . 0.14999999999999999 110.878 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.743 HD12 HG22 ' A' ' 130' ' ' VAL . 3.1 tt -66.82 -47.38 72.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.843 -0.799 . . . . 0.16 108.843 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.692 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 52.2 t80 -59.36 -47.03 86.97 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.857 -0.611 . . . . 0.29999999999999999 110.733 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.12 -41.78 75.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 0.40000000000000002 110.83 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.466 HG21 HD21 ' A' ' 163' ' ' LEU . 7.4 m -77.53 -53.66 7.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.805 -0.634 . . . . 0.22 112.001 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.488 ' CD1' HD23 ' A' ' 115' ' ' LEU . 10.9 m-85 -73.11 -29.3 62.81 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.427 0.529 . . . . 0.11 112.427 -174.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 36.2 t -58.19 -27.76 64.16 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.678 0.275 . . . . 0.19 111.15 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.73 -21.41 27.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.42 -0.355 . . . . 0.14000000000000001 111.396 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -93.04 -20.75 20.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.17999999999999999 110.869 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 167.76 166.14 26.33 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.634 -0.586 . . . . 0.11 111.634 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -66.01 139.96 58.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.052 0.453 . . . . 0.25 110.514 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.442 HG21 ' HB3' ' A' ' 128' ' ' CYS . 79.6 mt -111.84 135.78 50.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.988 -0.551 . . . . 0.14000000000000001 109.969 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -89.01 -43.86 10.81 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.84 -0.8 . . . . 0.54000000000000004 108.84 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.5 m -147.74 113.8 5.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.076 -0.966 . . . . 0.76000000000000001 110.423 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.692 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 4.7 p -110.86 139.89 45.79 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.432 -0.581 . . . . 0.71999999999999997 109.432 174.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -138.63 128.23 24.78 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.014 0.435 . . . . 1.0 111.306 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.743 HG22 HD12 ' A' ' 115' ' ' LEU . 59.2 t -114.37 109.3 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 106.194 -1.78 . . . . 0.28000000000000003 106.194 169.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 t . . . . . 0 C--N 1.301 -1.523 0 N-CA-C 108.368 -0.975 . . . . 0.34000000000000002 108.368 -175.583 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.586 0 N-CA-C 113.878 0.311 . . . . 0.31 113.878 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -128.26 154.7 45.59 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.393 0.597 . . . . 0.48999999999999999 111.842 -173.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.29 171.06 25.85 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.276 -0.875 . . . . 0.12 111.53 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.411 ' CE1' ' HB2' ' A' ' 102' ' ' PHE . 66.1 m-85 -139.63 138.37 36.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.703 0.251 . . . . 0.25 110.535 -177.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.554 ' HB ' HG12 ' A' ' 101' ' ' ILE . 42.9 t -114.43 136.1 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.201 0.524 . . . . 0.10000000000000001 111.142 174.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.6 m170 -104.71 105.79 16.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.625 -0.716 . . . . 0.20999999999999999 109.07 165.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.561 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.3 m-85 -90.17 137.55 32.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.039 0.447 . . . . 0.17000000000000001 110.949 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.596 ' HA ' HD21 ' A' ' 126' ' ' LEU . 34.9 tt0 -48.24 -46.07 35.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.673 -1.148 . . . . 0.56999999999999995 110.587 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.8 p -114.0 148.39 37.04 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.911 -1.04 . . . . 0.40000000000000002 111.037 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -63.61 -36.12 82.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.612 -0.722 . . . . 0.46999999999999997 111.05 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -69.09 -35.32 76.34 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.324 -0.398 . . . . 0.73999999999999999 111.678 -176.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.13 79.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.049 0.452 . . . . 0.17999999999999999 110.622 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.561 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.63 -43.76 98.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.645 -0.707 . . . . 0.16 110.558 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.2 mt-10 -60.83 -37.28 81.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.496 -0.774 . . . . 1.4199999999999999 110.804 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.428 ' O ' ' HB2' ' A' ' 157' ' ' LYS . 91.4 mtt180 -63.17 -46.18 88.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.927 0.394 . . . . 1.48 110.623 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.08 -38.82 80.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 0.10000000000000001 110.532 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 170' ' ' VAL . 91.5 mt -60.13 -54.2 38.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.692 -0.686 . . . . 0.14999999999999999 111.477 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.2 pt-20 -65.5 -42.45 92.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.196 0.522 . . . . 1.0800000000000001 112.251 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -77.42 -39.21 47.7 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 113.038 0.755 . . . . 1.1599999999999999 113.038 -170.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.483 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.9 mmm -95.27 -16.44 22.45 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.519 0.563 . . . . 0.34999999999999998 112.519 -173.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 155' ' ' ILE . 49.2 t-20 -66.84 124.35 22.7 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.304 -0.558 . . . . 0.44 109.621 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.25 18.57 68.85 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.911 -0.661 . . . . 0.28999999999999998 112.228 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 8.6 tpp -105.05 156.51 17.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 1.1799999999999999 110.444 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 89.8 mt -100.66 102.52 13.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.872 -0.604 . . . . 0.44 109.566 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.466 HD21 HG21 ' A' ' 118' ' ' THR . 4.5 mt -81.75 11.66 4.65 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.745 0.646 . . . . 1.02 112.745 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.28 -64.2 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.806 0.812 . . . . 1.71 109.189 -174.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -168.62 23.97 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.811 -1.54 . . . . 0.84999999999999998 109.294 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -139.82 133.66 30.66 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.898 -0.778 . . . . 0.95999999999999996 108.898 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.4 mttm -77.77 122.42 25.37 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.326 0.391 . . . . 1.0 109.968 176.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.485 HG11 HD23 ' A' ' 106' ' ' LEU . 11.3 m -101.49 140.1 21.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.316 0.579 . . . . 0.17000000000000001 110.926 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 46.8 t80 -105.38 118.64 37.08 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.316 -0.856 . . . . 0.29999999999999999 109.178 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.581 HG22 HG12 ' A' ' 103' ' ' ILE . 34.0 t -115.35 127.79 72.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.412 -0.588 . . . . 0.13 109.412 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.99 -172.7 19.01 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.072 -0.585 . . . . 0.17999999999999999 111.68 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 35.8 mmt-85 . . . . . 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 1.9299999999999999 110.129 177.609 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.9 t . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 121.093 0.473 . . . . 0.70999999999999996 111.6 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.14 23.51 77.85 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 119.834 -1.174 . . . . 0.20999999999999999 111.433 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.491 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.1 m-80 -88.2 125.59 34.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.423 -0.584 . . . . 0.63 109.423 -174.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.552 HG23 ' HB1' ' A' ' 151' ' ' ALA . 21.6 pt -134.9 162.13 39.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.589 -0.522 . . . . 0.14999999999999999 109.589 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.06 140.61 52.74 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.862 -0.421 . . . . 0.20999999999999999 109.862 177.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.615 HG12 HG22 ' A' ' 170' ' ' VAL . 6.1 mt -117.16 141.86 33.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.588 -0.733 . . . . 0.14999999999999999 109.615 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -126.66 154.99 43.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.696 -0.229 . . . . 1.46 110.577 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.4 t30 73.56 32.63 1.16 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.969 0.793 . . . . 0.48999999999999999 111.389 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.485 HD23 HG11 ' A' ' 168' ' ' VAL . 30.1 mt -76.67 162.92 27.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.033 0.444 . . . . 0.26000000000000001 111.136 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -102.52 151.47 22.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.713 -0.676 . . . . 0.70999999999999996 109.467 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -22.4 63.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.636 -0.256 . . . . 2.2000000000000002 111.646 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.4 p -69.13 -11.05 60.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.648 -0.251 . . . . 1.4099999999999999 111.449 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.579 HG22 HG21 ' A' ' 130' ' ' VAL . 49.2 mm -92.18 122.83 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.26000000000000001 110.158 177.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -109.7 -177.25 3.22 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.518 -0.919 . . . . 1.5900000000000001 108.518 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.22 -34.56 78.37 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.192 -0.669 . . . . 0.59999999999999998 109.192 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.938 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -62.54 -50.49 71.14 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.19 -0.913 . . . . 2.5800000000000001 110.348 178.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.17 98.5 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.076 -1.42 . . . . 0.14999999999999999 111.253 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.473 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -66.75 -46.79 74.28 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.189 -0.914 . . . . 0.16 108.934 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.763 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 66.1 t80 -59.42 -46.48 88.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 0.29999999999999999 110.925 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -55.97 -40.92 73.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.008 0.433 . . . . 0.40000000000000002 111.059 -176.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.527 HG21 HD21 ' A' ' 163' ' ' LEU . 15.3 m -78.0 -53.71 7.11 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.754 -0.657 . . . . 0.22 112.127 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -72.55 -29.1 63.27 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.305 0.483 . . . . 0.11 112.305 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.3 t -58.13 -28.63 64.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.651 0.263 . . . . 0.19 111.091 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.64 37.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.725 0.298 . . . . 0.14000000000000001 111.293 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -91.82 -21.53 20.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.382 -0.372 . . . . 0.17999999999999999 111.002 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 169.24 166.1 27.72 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.86 -0.686 . . . . 0.11 112.183 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -62.53 133.93 55.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.012 0.434 . . . . 0.25 110.553 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.404 HG21 ' HB3' ' A' ' 128' ' ' CYS . 75.4 mt -109.04 128.8 64.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.899 -0.592 . . . . 0.14000000000000001 110.187 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.623 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -82.23 -38.9 23.83 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.702 -0.851 . . . . 0.54000000000000004 108.702 -178.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 m -153.32 129.95 10.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.094 -0.957 . . . . 0.76000000000000001 110.455 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.763 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.0 p -126.81 149.52 49.65 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.332 -0.618 . . . . 0.71999999999999997 109.332 176.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -150.73 131.65 14.21 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.437 -0.505 . . . . 1.0 112.175 -174.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.579 HG21 HG22 ' A' ' 110' ' ' ILE . 69.1 t -110.99 110.42 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 106.359 -1.719 . . . . 0.28000000000000003 106.359 167.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.2 t . . . . . 0 C--N 1.305 -1.36 0 N-CA-C 109.08 -0.711 . . . . 0.34000000000000002 109.08 -174.943 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 114.025 0.37 . . . . 0.31 114.025 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -125.49 156.58 38.75 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 117.501 0.65 . . . . 0.48999999999999999 111.912 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.79 172.41 28.95 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.353 -0.839 . . . . 0.12 111.598 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -137.92 140.84 40.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.015 0.407 . . . . 0.25 110.757 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.514 HG11 ' CE2' ' A' ' 145' ' ' PHE . 43.8 t -113.68 135.87 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.01 0.433 . . . . 0.10000000000000001 110.685 172.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.408 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 1.1 m170 -105.98 105.76 15.95 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.095 -0.706 . . . . 0.20999999999999999 109.095 167.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.514 ' CE2' HG11 ' A' ' 143' ' ' VAL . 15.8 m-85 -90.7 136.61 32.95 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.126 0.489 . . . . 0.17000000000000001 111.24 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.623 ' HA ' HD21 ' A' ' 126' ' ' LEU . 41.7 tt0 -49.31 -42.84 42.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.457 -1.247 . . . . 0.56999999999999995 110.726 178.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.8 p -115.28 144.85 43.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.64 -1.164 . . . . 0.40000000000000002 111.241 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -63.09 -36.97 85.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.498 -0.774 . . . . 0.46999999999999997 110.939 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 9.8 pt-20 -69.39 -35.11 75.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.389 -0.368 . . . . 0.73999999999999999 111.747 -177.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.64 -34.66 76.07 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.083 0.468 . . . . 0.17999999999999999 110.556 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.552 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -64.57 -43.04 95.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.6 -0.727 . . . . 0.16 110.883 177.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.583 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 53.5 mt-10 -59.53 -40.08 86.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.511 . . . . 1.4199999999999999 110.28 176.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.506 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 95.4 mtt180 -60.59 -40.75 92.89 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.186 -0.461 . . . . 1.48 110.943 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.62 -36.32 82.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 0.10000000000000001 110.568 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 151' ' ' ALA . 80.6 mt -62.53 -54.42 34.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.14999999999999999 110.995 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.3 pt-20 -60.78 -43.43 98.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.174 0.511 . . . . 1.0800000000000001 111.677 -179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -82.74 -39.05 22.42 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 113.062 0.764 . . . . 1.1599999999999999 113.062 -170.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 89.6 mmm -92.26 -24.51 18.97 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.78 0.659 . . . . 0.34999999999999998 112.78 -172.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 53.3 t30 -67.17 124.27 22.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.215 -0.594 . . . . 0.44 110.206 -178.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.04 11.12 63.65 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.833 -0.698 . . . . 0.28999999999999998 112.609 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.653 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 30.8 mmt -97.63 159.65 14.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.885 0.374 . . . . 1.1799999999999999 111.713 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.9 mt -102.49 101.14 11.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.952 -0.759 . . . . 0.44 108.952 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.527 HD21 HG21 ' A' ' 118' ' ' THR . 2.8 mt -78.16 13.52 1.45 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.042 0.756 . . . . 1.02 113.042 -175.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 167.48 -59.57 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.883 0.849 . . . . 1.71 109.368 -174.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -169.74 24.66 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.798 -1.546 . . . . 0.84999999999999998 109.433 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 166' ' ' ARG . 46.9 mtt180 -140.29 127.22 20.72 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.583 -0.735 . . . . 0.95999999999999996 109.381 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 161' ' ' MET . 13.6 tttt -76.77 116.47 17.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.485 HG11 HD23 ' A' ' 106' ' ' LEU . 13.2 m -100.33 144.79 12.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.383 0.611 . . . . 0.17000000000000001 110.846 -174.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 73.6 t80 -106.14 119.71 39.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.185 -0.916 . . . . 0.29999999999999999 109.517 -179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.615 HG22 HG12 ' A' ' 103' ' ' ILE . 42.0 t -114.93 125.64 72.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.988 -0.745 . . . . 0.13 108.988 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.18 -178.82 21.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.498 -0.858 . . . . 0.17999999999999999 112.413 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.8 mmt-85 . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 1.9299999999999999 111.384 179.325 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 121.914 0.864 . . . . 0.70999999999999996 112.547 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.25 23.85 77.31 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.941 -1.123 . . . . 0.20999999999999999 110.688 -175.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -94.06 126.82 39.5 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.539 -0.541 . . . . 0.63 109.539 -173.33 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 151' ' ' ALA . 20.8 pt -134.8 161.16 40.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.066 -0.346 . . . . 0.14999999999999999 110.066 175.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.72 142.66 51.24 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.836 -0.431 . . . . 0.20999999999999999 109.836 177.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.563 HG12 HG22 ' A' ' 170' ' ' VAL . 6.4 mt -119.52 135.69 59.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.707 -0.679 . . . . 0.14999999999999999 110.065 -177.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -117.48 153.26 33.44 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.468 -0.197 . . . . 1.46 110.468 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.0 t30 72.54 37.52 0.88 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.01 0.819 . . . . 0.48999999999999999 111.797 172.15 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.647 HD22 HG21 ' A' ' 110' ' ' ILE . 20.4 mt -76.89 153.83 34.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.359 -0.382 . . . . 0.26000000000000001 110.843 177.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.501 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 13.4 t70 -83.09 149.26 27.02 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.643 -0.502 . . . . 0.70999999999999996 109.643 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -56.94 -31.16 64.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.079 -0.51 . . . . 2.2000000000000002 111.659 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.4 p -71.42 -9.09 57.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 1.4099999999999999 112.015 -179.034 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.647 HG21 HD22 ' A' ' 106' ' ' LEU . 46.6 mm -82.48 113.4 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.071 0.462 . . . . 0.26000000000000001 110.622 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -102.75 -176.15 3.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.687 -0.857 . . . . 1.5900000000000001 108.687 176.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -61.97 -41.32 97.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.879 -0.786 . . . . 0.59999999999999998 108.879 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.93 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -58.97 -49.94 75.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.305 -0.861 . . . . 2.5800000000000001 110.583 178.093 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.15 -42.27 99.09 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.133 -1.394 . . . . 0.14999999999999999 111.266 -177.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.522 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -66.51 -46.63 75.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.33 -0.85 . . . . 0.16 108.994 177.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.629 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 67.9 t80 -58.63 -46.88 86.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.033 -0.531 . . . . 0.29999999999999999 110.917 175.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.32 -38.83 71.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.153 0.501 . . . . 0.40000000000000002 110.82 -175.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.654 HG21 HD21 ' A' ' 163' ' ' LEU . 9.3 m -77.93 -54.15 6.63 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.785 -0.643 . . . . 0.22 112.147 -178.341 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -73.07 -28.04 62.08 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.981 0.734 . . . . 0.11 112.981 -174.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.4 t -57.08 -29.4 63.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.764 0.316 . . . . 0.19 111.643 -176.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.42 -21.6 37.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.364 -0.38 . . . . 0.14000000000000001 111.744 178.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -92.67 -18.37 23.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.17999999999999999 111.393 -177.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 166.68 171.61 33.01 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.994 -0.622 . . . . 0.11 111.85 -178.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -72.57 135.93 45.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.797 0.332 . . . . 0.25 110.342 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.424 HG21 ' HB3' ' A' ' 128' ' ' CYS . 66.3 mt -111.24 134.88 52.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.401 -0.363 . . . . 0.14000000000000001 110.323 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -91.28 -49.18 6.5 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.801 -0.815 . . . . 0.54000000000000004 108.801 179.543 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 66.5 m -141.77 100.19 3.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.901 -1.045 . . . . 0.76000000000000001 110.915 -175.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 13.2 p -95.97 148.41 22.67 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.795 -0.817 . . . . 0.71999999999999997 108.795 172.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -146.68 129.14 15.92 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.645 -0.422 . . . . 1.0 111.546 -174.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.522 HG22 HD12 ' A' ' 115' ' ' LEU . 75.4 t -110.06 110.2 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 106.606 -1.627 . . . . 0.28000000000000003 106.606 169.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.6 t . . . . . 0 C--N 1.301 -1.506 0 CA-C-N 115.653 -0.703 . . . . 0.34000000000000002 109.565 -172.625 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 113.597 0.199 . . . . 0.31 113.597 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -132.4 157.01 45.63 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.24 0.52 . . . . 0.48999999999999999 111.186 -176.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.91 177.21 25.36 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.759 -0.655 . . . . 0.12 111.824 -177.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -136.35 143.12 43.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.494 -0.187 . . . . 0.25 110.494 -176.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.495 ' HB ' HG12 ' A' ' 101' ' ' ILE . 45.9 t -115.44 129.78 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.06 0.457 . . . . 0.10000000000000001 110.493 171.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.9 OUTLIER -100.73 105.32 16.65 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.079 -0.712 . . . . 0.20999999999999999 109.079 167.216 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.533 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.6 m-85 -88.13 140.92 29.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.264 0.554 . . . . 0.17000000000000001 110.693 178.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.596 ' HA ' HD21 ' A' ' 126' ' ' LEU . 24.6 tt0 -50.88 -41.13 58.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.324 -1.307 . . . . 0.56999999999999995 110.479 177.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.0 p -122.98 148.31 45.65 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.606 -1.179 . . . . 0.40000000000000002 111.229 -178.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -60.55 -36.55 78.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.441 -0.799 . . . . 0.46999999999999997 111.368 179.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 9.7 pt-20 -67.45 -35.97 80.27 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.0 0.37 . . . . 0.73999999999999999 112.0 -176.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.43 78.06 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.09 0.471 . . . . 0.17999999999999999 110.372 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.546 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -62.19 -44.63 96.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.516 -0.765 . . . . 0.16 110.86 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.963 ' HG2' HH12 ' A' ' 172' ' ' ARG . 28.1 mt-10 -59.5 -42.27 91.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 1.4199999999999999 110.707 178.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.531 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 46.8 mtt180 -59.47 -41.06 88.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.127 -0.488 . . . . 1.48 110.569 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.76 -37.15 84.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.088 -0.505 . . . . 0.10000000000000001 110.674 178.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.7 mt -60.01 -52.99 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.14999999999999999 110.988 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 0.7 OUTLIER -63.43 -45.47 90.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.01 0.433 . . . . 1.0800000000000001 111.877 -179.399 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.443 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -80.39 -39.19 28.86 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.884 0.698 . . . . 1.1599999999999999 112.884 -169.148 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.567 ' HB2' HG21 ' A' ' 170' ' ' VAL . 89.3 mmm -93.08 -15.85 25.62 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.277 0.473 . . . . 0.34999999999999998 112.277 -173.143 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -70.29 123.27 21.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.566 -0.901 . . . . 0.44 108.566 176.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.76 11.98 78.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.562 -0.828 . . . . 0.28999999999999998 111.967 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -93.09 150.7 20.34 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.827 -0.805 . . . . 1.1799999999999999 108.827 178.443 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.414 HD23 ' CA ' ' A' ' 167' ' ' LYS . 23.3 mt -97.11 124.57 41.17 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.92 -0.77 . . . . 0.44 108.92 177.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.654 HD21 HG21 ' A' ' 118' ' ' THR . 27.3 mt -110.05 99.35 8.46 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.796 -0.761 . . . . 1.02 109.838 173.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 70.5 m-20 78.29 -23.14 0.25 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.98 -1.009 . . . . 1.71 112.812 176.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 33.7 t70 167.77 -22.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.815 0.697 . . . . 0.84999999999999998 112.069 -177.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.1 mtt180 -109.81 136.78 48.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.797 0.332 . . . . 0.95999999999999996 110.875 -170.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.414 ' CA ' HD23 ' A' ' 162' ' ' LEU . 26.6 tttt -84.88 118.74 24.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.39 -178.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.455 HG11 HD23 ' A' ' 106' ' ' LEU . 13.3 m -101.27 148.43 7.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.7 0.762 . . . . 0.17000000000000001 111.791 -171.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 55.3 t80 -106.97 119.18 38.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.659 -1.155 . . . . 0.29999999999999999 109.318 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.567 HG21 ' HB2' ' A' ' 158' ' ' MET . 39.4 t -115.72 125.85 73.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.574 -0.528 . . . . 0.13 109.574 178.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.6 -175.15 20.14 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.715 -0.755 . . . . 0.17999999999999999 112.278 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.963 HH12 ' HG2' ' A' ' 152' ' ' GLU . 24.4 mmt180 . . . . . 0 C--N 1.324 -0.508 0 O-C-N 123.548 0.205 . . . . 1.9299999999999999 110.53 179.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 121.181 0.515 . . . . 0.70999999999999996 111.925 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.31 24.02 76.15 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.027 -1.082 . . . . 0.20999999999999999 111.535 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.537 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.3 m120 -88.63 125.3 34.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.933 -0.766 . . . . 0.63 108.933 -174.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.522 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.4 pt -135.74 163.53 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.533 -0.303 . . . . 0.14999999999999999 110.188 177.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.24 145.27 50.83 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.851 -0.425 . . . . 0.20999999999999999 109.851 175.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.521 HG12 HG22 ' A' ' 170' ' ' VAL . 6.2 mt -118.38 148.32 21.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.776 -0.647 . . . . 0.14999999999999999 110.019 -177.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -131.25 149.43 52.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.35 -0.386 . . . . 1.46 110.601 -172.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 64.1 t30 67.63 35.68 3.97 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.639 0.587 . . . . 0.48999999999999999 111.794 173.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.489 HD22 HG21 ' A' ' 110' ' ' ILE . 20.1 mt -72.33 152.91 41.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.083 0.468 . . . . 0.26000000000000001 111.133 176.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.4 t70 -77.19 150.4 35.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.466 -0.788 . . . . 0.70999999999999996 110.565 177.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -62.14 -33.92 75.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.053 -0.522 . . . . 2.2000000000000002 111.106 -177.019 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 t -76.05 -4.85 43.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.381 -0.372 . . . . 1.4099999999999999 111.057 -176.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.489 HG21 HD22 ' A' ' 106' ' ' LEU . 36.0 mm -78.82 127.19 39.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.898 0.38 . . . . 0.26000000000000001 110.433 178.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -111.6 -179.97 3.85 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.592 -0.521 . . . . 1.5900000000000001 109.592 -179.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.646 ' OD1' ' HA ' ' A' ' 129' ' ' LYS . 67.8 m-80 -65.4 -37.81 88.07 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.19 -0.67 . . . . 0.59999999999999998 109.19 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.98 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.76 -49.19 78.5 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.976 -1.011 . . . . 2.5800000000000001 110.017 177.618 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.29 97.41 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.772 -1.558 . . . . 0.14999999999999999 111.463 -177.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.671 HD12 HG22 ' A' ' 130' ' ' VAL . 4.2 tt -63.84 -47.3 81.3 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.993 -0.743 . . . . 0.16 108.993 177.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.712 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 63.8 t80 -60.2 -47.5 85.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.036 -0.529 . . . . 0.29999999999999999 110.846 176.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.57 -39.08 75.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.91 0.386 . . . . 0.40000000000000002 110.79 -175.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.5 m -77.21 -52.91 8.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 0.22 111.724 -178.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -71.93 -28.32 63.39 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.385 0.513 . . . . 0.11 112.385 -175.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.2 t -57.45 -28.95 63.8 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.457 0.169 . . . . 0.19 111.457 -177.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.82 -21.76 31.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.846 0.355 . . . . 0.14000000000000001 111.386 177.291 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -92.21 -10.76 37.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.17999999999999999 111.205 -178.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.59 163.75 12.7 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.128 -0.558 . . . . 0.11 111.725 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.95 137.82 58.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.185 0.517 . . . . 0.25 110.171 177.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 128' ' ' CYS . 82.2 mt -110.54 132.73 58.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.71 -0.677 . . . . 0.14000000000000001 109.877 -178.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.07 -39.13 14.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.87 -0.789 . . . . 0.54000000000000004 108.87 -177.429 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 144' ' ' HIS . 82.5 p -146.53 134.11 20.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.291 -0.868 . . . . 0.76000000000000001 109.681 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.3 p -133.81 130.28 37.74 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.285 -0.635 . . . . 0.71999999999999997 109.285 176.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.646 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 58.0 tptt -132.33 134.84 45.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.159 0.504 . . . . 1.0 111.891 -174.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.671 HG22 HD12 ' A' ' 115' ' ' LEU . 95.2 t -114.01 109.6 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 106.355 -1.72 . . . . 0.28000000000000003 106.355 170.028 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.308 -1.222 0 CA-C-N 115.917 -0.583 . . . . 0.34000000000000002 109.798 -172.019 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.287 0 N-CA-C 114.051 0.38 . . . . 0.31 114.051 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -122.26 155.26 36.27 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 117.523 0.661 . . . . 0.48999999999999999 111.315 -174.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -147.85 173.66 27.83 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.12 111.964 -178.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.37 136.73 36.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.826 0.313 . . . . 0.25 110.706 -177.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.522 ' HB ' HG12 ' A' ' 101' ' ' ILE . 38.5 t -114.56 134.98 55.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.02 0.438 . . . . 0.10000000000000001 111.002 173.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.437 ' HB2' ' OG ' ' A' ' 127' ' ' SER . 1.5 m170 -103.25 106.71 17.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.736 -0.665 . . . . 0.20999999999999999 109.212 167.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 14.4 m-85 -89.91 135.92 33.35 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.323 0.583 . . . . 0.17000000000000001 111.372 179.082 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.633 ' HA ' HD21 ' A' ' 126' ' ' LEU . 44.5 tt0 -46.36 -43.54 16.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.919 -1.492 . . . . 0.56999999999999995 111.017 177.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.4 p -116.4 147.37 41.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.937 -1.029 . . . . 0.40000000000000002 111.046 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -60.23 -39.81 87.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.887 -0.597 . . . . 0.46999999999999997 110.917 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.22 -33.44 73.33 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.319 -0.4 . . . . 0.73999999999999999 111.678 -177.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.59 74.22 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.149 0.499 . . . . 0.17999999999999999 110.318 177.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.475 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -67.34 -41.96 84.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.62 -0.718 . . . . 0.16 110.369 176.224 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.655 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 44.0 mt-10 -58.57 -40.26 82.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 1.4199999999999999 110.305 177.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 65.3 mtt180 -59.5 -50.14 75.08 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 120.882 0.372 . . . . 1.48 110.623 174.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.42 -38.85 81.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.10000000000000001 110.88 -178.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 151' ' ' ALA . 84.9 mt -60.98 -54.88 29.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.251 -0.431 . . . . 0.14999999999999999 110.864 178.108 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 3.2 pt-20 -64.22 -44.76 90.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.169 0.509 . . . . 1.0800000000000001 111.774 -178.737 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -76.37 -39.06 54.83 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.926 0.713 . . . . 1.1599999999999999 112.926 -170.739 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 91.4 mmm -94.26 -22.3 18.48 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.602 0.593 . . . . 0.34999999999999998 112.602 -173.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.49 123.65 20.21 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.221 -0.592 . . . . 0.44 109.823 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.496 ' O ' ' HE2' ' A' ' 167' ' ' LYS . . . 83.89 22.55 55.12 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.786 -0.721 . . . . 0.28999999999999998 112.513 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 2.7 mmt -109.26 160.31 16.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.76 0.314 . . . . 1.1799999999999999 111.159 177.061 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 29.7 mt -100.57 107.12 18.71 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.915 -0.584 . . . . 0.44 109.976 -176.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 163' ' ' LEU . 17.4 mt -90.99 109.67 20.91 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.686 -0.806 . . . . 1.02 109.163 172.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 82.8 m-20 73.08 -67.01 0.28 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.108 -0.951 . . . . 1.71 111.421 -175.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -163.66 18.61 0.07 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.873 -0.603 . . . . 0.84999999999999998 111.018 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 88.7 mtt180 -131.77 130.87 42.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.969 -0.457 . . . . 0.95999999999999996 109.971 -177.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 161' ' ' MET . 22.6 tttt -82.09 118.24 22.88 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 -177.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.478 HG11 HD23 ' A' ' 106' ' ' LEU . 16.9 m -100.8 145.87 10.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.547 0.689 . . . . 0.17000000000000001 111.161 -173.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -106.47 125.1 50.57 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.97 -1.014 . . . . 0.29999999999999999 109.388 176.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 103' ' ' ILE . 39.8 t -116.45 131.65 68.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.306 -0.627 . . . . 0.13 109.306 177.071 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.26 -173.26 19.71 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.606 -0.807 . . . . 0.17999999999999999 111.966 179.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 . . . . . 0 C--N 1.325 -0.457 0 CA-C-O 121.023 0.439 . . . . 1.9299999999999999 110.47 -178.07 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 121.086 0.47 . . . . 0.70999999999999996 111.195 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.0 23.46 77.83 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.124 -1.036 . . . . 0.20999999999999999 111.068 -178.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.51 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -90.39 124.89 35.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.544 -0.539 . . . . 0.63 109.544 -173.451 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.55 HG23 ' HB1' ' A' ' 151' ' ' ALA . 17.3 pt -135.98 163.71 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.299 -0.409 . . . . 0.14999999999999999 110.227 178.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.39 143.1 50.8 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.784 -0.45 . . . . 0.20999999999999999 109.784 175.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.572 HG12 HG22 ' A' ' 170' ' ' VAL . 6.2 mt -119.4 134.97 61.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.652 -0.703 . . . . 0.14999999999999999 110.016 -177.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -113.87 150.1 34.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.617 -0.265 . . . . 1.46 110.623 -179.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.3 t30 72.01 39.0 0.85 Allowed 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.974 0.796 . . . . 0.48999999999999999 111.77 171.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.534 HD22 HG21 ' A' ' 110' ' ' ILE . 21.8 mt -76.43 153.83 35.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.093 0.473 . . . . 0.26000000000000001 110.864 176.438 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.492 ' HB3' HG12 ' A' ' 110' ' ' ILE . 6.5 t70 -75.51 144.53 41.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.52 -0.764 . . . . 0.70999999999999996 110.163 175.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -61.48 -28.44 69.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 2.2000000000000002 111.398 -176.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.407 ' HB3' ' OD2' ' A' ' 107' ' ' ASP . 9.1 t -80.49 -7.84 59.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.276 -0.42 . . . . 1.4099999999999999 110.652 -179.189 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.534 HG21 HD22 ' A' ' 106' ' ' LEU . 30.8 mm -74.39 116.87 17.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.851 -0.426 . . . . 0.26000000000000001 109.851 176.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -103.1 -174.16 2.48 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.741 -0.837 . . . . 1.5900000000000001 108.741 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -67.86 -31.14 70.75 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.564 -0.902 . . . . 0.59999999999999998 108.564 -178.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -48.61 66.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.499 -1.228 . . . . 2.5800000000000001 109.236 178.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.82 -44.15 97.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.212 -1.358 . . . . 0.14999999999999999 110.703 -177.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.566 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -64.97 -46.79 80.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.068 -0.969 . . . . 0.16 109.138 177.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.775 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 65.6 t80 -58.86 -47.22 85.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.29999999999999999 111.084 175.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.75 -37.81 71.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.915 0.388 . . . . 0.40000000000000002 110.957 -176.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.516 HG21 HD21 ' A' ' 163' ' ' LEU . 7.0 m -78.55 -54.76 5.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.992 -0.549 . . . . 0.22 112.138 -178.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.415 ' CD1' HD23 ' A' ' 115' ' ' LEU . 11.9 m-85 -72.98 -27.92 62.08 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.248 0.832 . . . . 0.11 113.248 -173.394 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 t -57.0 -28.79 62.75 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 111.78 0.289 . . . . 0.19 111.78 -175.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.04 -22.12 36.5 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.856 0.36 . . . . 0.14000000000000001 111.755 178.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -89.43 -23.12 22.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.808 0.337 . . . . 0.17999999999999999 111.14 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 170.88 166.4 29.69 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.956 -0.565 . . . . 0.11 111.736 -178.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -67.69 129.07 38.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.25 110.11 179.083 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.413 HG21 ' HB3' ' A' ' 128' ' ' CYS . 78.8 mt -98.91 132.0 45.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.175 -0.466 . . . . 0.14000000000000001 109.995 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -84.68 -40.57 17.22 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.666 -0.864 . . . . 0.54000000000000004 108.666 -179.822 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 69.5 m -152.68 122.14 6.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.861 -1.063 . . . . 0.76000000000000001 110.27 -178.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.775 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.4 p -117.2 137.63 52.22 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.641 -0.503 . . . . 0.71999999999999997 109.641 176.045 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -138.2 132.97 32.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.193 0.52 . . . . 1.0 112.003 -174.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.566 HG22 HD12 ' A' ' 115' ' ' LEU . 86.1 t -114.33 109.87 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 106.582 -1.636 . . . . 0.28000000000000003 106.582 169.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.5 t . . . . . 0 C--N 1.305 -1.351 0 CA-C-N 115.931 -0.577 . . . . 0.34000000000000002 109.524 -173.479 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.446 0 CA-C-O 120.356 -0.136 . . . . 0.31 113.356 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -129.69 154.02 47.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 117.21 0.505 . . . . 0.48999999999999999 111.45 -177.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.29 175.18 25.0 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.688 -0.687 . . . . 0.12 111.895 -178.194 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -136.58 137.73 40.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.72 0.26 . . . . 0.25 110.65 -175.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' A' ' 145' ' ' PHE . 49.2 t -110.94 136.05 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.996 0.427 . . . . 0.10000000000000001 110.865 172.47 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 127' ' ' SER . 2.5 m170 -104.13 106.09 16.48 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.658 -0.701 . . . . 0.20999999999999999 109.303 167.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.51 ' CE2' HG11 ' A' ' 143' ' ' VAL . 14.8 m-85 -92.04 137.31 32.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.081 0.467 . . . . 0.17000000000000001 110.827 178.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.591 ' HA ' HD21 ' A' ' 126' ' ' LEU . 39.0 tt0 -47.83 -41.42 23.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.522 -1.217 . . . . 0.56999999999999995 111.131 179.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.8 p -119.32 151.14 38.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.325 -0.852 . . . . 0.40000000000000002 110.825 179.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -62.31 -35.96 80.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.46999999999999997 110.72 179.039 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.36 -34.67 74.93 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.33 -0.396 . . . . 0.73999999999999999 111.948 -178.161 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.08 -34.74 78.24 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.005 0.431 . . . . 0.17999999999999999 110.678 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.55 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -63.68 -41.38 98.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 0.16 110.359 176.321 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.486 ' CD ' HH21 ' A' ' 172' ' ' ARG . 7.2 mm-40 -59.27 -40.41 85.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.689 -0.687 . . . . 1.4199999999999999 110.923 177.147 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.588 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 96.8 mtt180 -60.86 -43.2 98.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.566 -0.743 . . . . 1.48 111.059 177.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.75 83.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.222 -0.445 . . . . 0.10000000000000001 110.521 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.468 HG12 HG12 ' A' ' 170' ' ' VAL . 66.7 mt -62.51 -52.41 60.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.227 -0.442 . . . . 0.14999999999999999 111.106 178.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 0.1 OUTLIER -62.57 -44.31 96.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.192 0.52 . . . . 1.0800000000000001 111.941 179.931 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -82.68 -38.7 23.05 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.243 0.831 . . . . 1.1599999999999999 113.243 -168.722 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.467 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.2 mmm -93.93 -16.28 24.14 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.439 0.533 . . . . 0.34999999999999998 112.439 -173.053 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 155' ' ' ILE . 47.4 t-20 -67.03 122.93 18.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.302 -0.629 . . . . 0.44 109.302 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.09 70.34 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.911 -0.661 . . . . 0.28999999999999998 112.865 178.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.655 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 30.3 mmt -96.21 163.03 13.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.997 0.399 . . . . 1.1799999999999999 111.494 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 20.8 mt -104.61 111.83 24.68 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.868 -0.605 . . . . 0.44 109.879 -177.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 118' ' ' THR . 19.0 mt -100.15 100.87 11.77 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 120.073 -0.651 . . . . 1.02 109.758 174.334 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 87.6 m-20 78.58 -23.59 0.24 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 114.883 -1.053 . . . . 1.71 112.615 178.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 21.0 t70 166.15 -23.07 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.174 0.921 . . . . 0.84999999999999998 111.724 -177.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.0 mtt180 -106.65 132.38 52.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.82 0.343 . . . . 0.95999999999999996 111.112 -169.244 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 161' ' ' MET . 8.3 ttmm -77.11 118.59 19.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.468 -0.787 . . . . 1.0 109.385 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.468 HG11 HD23 ' A' ' 106' ' ' LEU . 14.7 m -100.83 146.23 9.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.562 0.696 . . . . 0.17000000000000001 111.149 -174.602 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 40.4 t80 -110.62 121.96 46.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.908 -1.042 . . . . 0.29999999999999999 109.267 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.572 HG22 HG12 ' A' ' 103' ' ' ILE . 41.4 t -115.7 127.07 73.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.981 -0.378 . . . . 0.13 109.981 -178.322 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.08 176.86 27.66 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.876 -0.678 . . . . 0.17999999999999999 112.361 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.486 HH21 ' CD ' ' A' ' 152' ' ' GLU . 14.6 mmt85 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.029 0.442 . . . . 1.9299999999999999 111.148 -179.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.8 t . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 121.126 0.489 . . . . 0.70999999999999996 111.924 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.03 24.51 63.96 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.912 -1.137 . . . . 0.20999999999999999 112.883 174.336 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -89.92 126.08 35.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.532 -0.544 . . . . 0.63 109.532 -175.024 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.483 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.2 pt -134.24 163.73 36.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.237 -0.438 . . . . 0.14999999999999999 109.909 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.14 147.49 49.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.99 -0.374 . . . . 0.20999999999999999 109.99 177.51 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.536 HG12 HG22 ' A' ' 170' ' ' VAL . 5.2 mt -122.4 148.16 26.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.83 -0.623 . . . . 0.14999999999999999 110.144 -176.286 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -128.04 157.29 41.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.524 -0.307 . . . . 1.46 110.962 -175.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.0 t30 67.44 31.61 6.24 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.738 0.649 . . . . 0.48999999999999999 111.698 172.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.654 HD22 HG21 ' A' ' 110' ' ' ILE . 42.6 mt -75.62 148.61 38.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 0.26000000000000001 111.354 178.208 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -80.18 153.74 28.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.792 -0.64 . . . . 0.70999999999999996 110.364 178.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.7 pttt -55.16 -34.27 63.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.842 -0.617 . . . . 2.2000000000000002 111.983 178.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.4 t -76.06 -4.51 41.81 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.464 -0.335 . . . . 1.4099999999999999 111.718 -177.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.654 HG21 HD22 ' A' ' 106' ' ' LEU . 45.7 mm -81.55 113.83 21.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 122.069 -0.394 . . . . 0.26000000000000001 110.067 175.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -106.84 -177.76 3.45 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.212 -0.662 . . . . 1.5900000000000001 109.212 178.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -60.54 -37.85 82.57 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.746 -0.464 . . . . 0.59999999999999998 109.746 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.887 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -62.29 -50.55 71.21 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.477 -0.783 . . . . 2.5800000000000001 110.673 178.381 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.54 95.72 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.174 -1.375 . . . . 0.14999999999999999 111.079 -176.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.708 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -67.05 -47.22 71.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.471 -0.786 . . . . 0.16 109.174 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 72.7 t80 -58.96 -47.13 86.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.528 . . . . 0.29999999999999999 110.848 176.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.36 -37.93 73.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.158 0.504 . . . . 0.40000000000000002 111.017 -176.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.655 HG21 HD21 ' A' ' 163' ' ' LEU . 13.4 m -78.24 -54.36 6.31 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.057 -0.519 . . . . 0.22 112.065 -178.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.409 ' CD1' HD23 ' A' ' 115' ' ' LEU . 19.6 m-85 -73.65 -29.79 62.54 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.007 0.743 . . . . 0.11 113.007 -174.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.2 t -58.59 -27.2 64.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.685 0.278 . . . . 0.19 111.332 -176.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.99 -22.3 25.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.603 0.24 . . . . 0.14000000000000001 111.344 177.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -92.45 -17.62 24.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.531 -0.304 . . . . 0.17999999999999999 111.352 -178.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.71 174.55 37.46 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.999 -0.62 . . . . 0.11 111.875 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -76.69 139.71 40.61 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.836 -0.431 . . . . 0.25 109.836 -179.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.44 HG21 ' HB3' ' A' ' 128' ' ' CYS . 71.0 mt -112.13 135.3 51.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.366 -0.379 . . . . 0.14000000000000001 110.223 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -90.69 -42.85 10.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.774 -0.824 . . . . 0.54000000000000004 108.774 179.748 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 67.5 m -146.1 111.31 5.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.249 -0.887 . . . . 0.76000000000000001 110.659 -178.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.6 p -108.52 137.84 45.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.255 -0.646 . . . . 0.71999999999999997 109.255 172.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -136.58 131.24 33.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.957 0.408 . . . . 1.0 111.418 -174.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.708 HG22 HD12 ' A' ' 115' ' ' LEU . 91.0 t -114.78 113.74 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 106.738 -1.579 . . . . 0.28000000000000003 106.738 170.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.9 t . . . . . 0 C--N 1.304 -1.386 0 N-CA-C 108.718 -0.845 . . . . 0.34000000000000002 108.718 -176.473 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 114.076 0.391 . . . . 0.31 114.076 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -126.34 152.52 46.12 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.373 0.587 . . . . 0.48999999999999999 111.753 -174.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.43 174.14 25.56 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.538 -0.755 . . . . 0.12 111.694 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -139.5 139.3 36.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.877 0.339 . . . . 0.25 110.728 -177.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.483 ' HB ' HG12 ' A' ' 101' ' ' ILE . 42.6 t -113.85 133.81 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.05 0.452 . . . . 0.10000000000000001 110.854 172.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.6 OUTLIER -105.37 106.09 16.43 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.708 -0.678 . . . . 0.20999999999999999 109.186 167.986 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.541 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 14.6 m-85 -89.68 140.04 29.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.336 0.589 . . . . 0.17000000000000001 111.264 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.633 ' HA ' HD21 ' A' ' 126' ' ' LEU . 36.5 tt0 -53.43 -43.18 67.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.54 -1.209 . . . . 0.56999999999999995 110.087 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.5 p -114.28 144.52 43.1 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.405 -1.27 . . . . 0.40000000000000002 111.337 -178.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -62.4 -38.02 88.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.376 -0.829 . . . . 0.46999999999999997 111.064 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.27 -35.95 76.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.451 -0.341 . . . . 0.73999999999999999 111.83 -176.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.83 -34.69 78.5 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.344 0.592 . . . . 0.17999999999999999 110.33 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.541 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.21 -40.88 97.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 0.16 111.194 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.61 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 1.9 mm-40 -68.37 -36.32 79.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.018 -0.537 . . . . 1.4199999999999999 110.278 -179.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 90.4 mtt180 -60.21 -42.89 96.11 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-N 116.099 -0.5 . . . . 1.48 110.362 175.096 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.34 87.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.96 -0.563 . . . . 0.10000000000000001 110.651 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 151' ' ' ALA . 76.1 mt -63.02 -53.99 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.542 -0.299 . . . . 0.14999999999999999 110.921 178.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.61 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.9 pt-20 -61.55 -43.09 99.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.066 0.46 . . . . 1.0800000000000001 111.764 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -81.6 -39.04 25.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.172 0.804 . . . . 1.1599999999999999 113.172 -171.415 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 90.9 mmm -93.22 -18.98 21.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.616 0.599 . . . . 0.34999999999999998 112.616 -172.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.5 122.56 19.91 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.615 -0.834 . . . . 0.44 109.096 176.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.35 77.09 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.715 -0.755 . . . . 0.28999999999999998 112.009 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.8 tpt -93.16 151.4 19.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.157 -0.682 . . . . 1.1799999999999999 109.157 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.1 mt -96.45 107.46 19.86 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.437 -0.579 . . . . 0.44 109.437 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 118' ' ' THR . 11.5 mt -92.38 108.1 19.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.489 -0.884 . . . . 1.02 109.369 172.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 5.4 m-20 77.41 -33.43 0.19 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.397 -0.82 . . . . 1.71 111.986 176.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 163' ' ' LEU . 27.1 t70 168.54 -19.78 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.115 -0.948 . . . . 0.84999999999999998 111.889 -174.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -107.45 136.72 46.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.644 0.259 . . . . 0.95999999999999996 110.478 -172.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -80.83 116.38 20.79 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 -178.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.42 HG11 HD23 ' A' ' 106' ' ' LEU . 16.0 m -100.45 146.68 8.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.677 0.751 . . . . 0.17000000000000001 111.124 -173.186 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 55.6 t80 -105.98 119.19 38.55 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.718 -1.128 . . . . 0.29999999999999999 109.083 179.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.536 HG22 HG12 ' A' ' 103' ' ' ILE . 43.4 t -116.1 129.7 72.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.077 0.465 . . . . 0.13 109.849 179.101 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.6 177.72 25.69 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 111.04 -0.824 . . . . 0.17999999999999999 111.04 176.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 N-CA-C 110.156 -0.313 . . . . 1.9299999999999999 110.156 179.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.6 t . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 112.763 0.653 . . . . 0.70999999999999996 112.763 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.58 25.26 74.59 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.655 -1.26 . . . . 0.20999999999999999 111.433 176.248 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.497 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -88.4 124.17 33.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.594 -0.521 . . . . 0.63 109.594 -172.65 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.598 HG12 ' HB ' ' A' ' 143' ' ' VAL . 34.8 pt -135.05 151.75 31.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.765 -0.457 . . . . 0.14999999999999999 109.765 176.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.81 141.23 49.69 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.566 -0.531 . . . . 0.20999999999999999 109.566 178.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.567 HG12 HG22 ' A' ' 170' ' ' VAL . 5.2 mt -119.34 129.54 75.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.653 -0.703 . . . . 0.14999999999999999 110.064 -176.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -112.45 151.62 29.67 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.682 -0.235 . . . . 1.46 110.616 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.9 t30 73.69 36.7 0.73 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.97 0.794 . . . . 0.48999999999999999 111.629 172.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 110' ' ' ILE . 18.3 mt -76.15 154.36 35.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 0.26000000000000001 111.261 177.089 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.452 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 13.5 t70 -78.33 149.98 33.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.465 -0.789 . . . . 0.70999999999999996 109.514 174.003 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -68.63 -26.65 65.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.924 0.392 . . . . 2.2000000000000002 110.881 -175.045 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 m -72.65 -7.87 52.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 1.4099999999999999 111.292 178.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 106' ' ' LEU . 31.9 mm -79.12 113.75 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.106 0.479 . . . . 0.26000000000000001 109.95 178.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 11.2 t70 -99.3 -176.25 3.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.679 -0.692 . . . . 1.5900000000000001 109.223 -178.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -66.96 -34.45 77.79 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.08 -1.081 . . . . 0.59999999999999998 108.08 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -47.83 66.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.137 -1.392 . . . . 2.5800000000000001 109.269 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -60.84 -44.05 97.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.047 -1.433 . . . . 0.14999999999999999 110.963 -178.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.609 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -65.82 -46.74 77.47 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.361 -0.836 . . . . 0.16 109.238 177.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.747 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 49.1 t80 -59.93 -46.95 87.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.29999999999999999 110.831 176.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.46 -41.45 76.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.96 0.409 . . . . 0.40000000000000002 110.985 -175.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.409 HG21 HD21 ' A' ' 163' ' ' LEU . 19.2 m -77.18 -52.66 8.87 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.86 -0.609 . . . . 0.22 111.902 -176.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -72.91 -28.26 62.36 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.46 0.541 . . . . 0.11 112.46 -174.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.8 t -57.81 -28.43 64.03 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.649 0.262 . . . . 0.19 111.444 -177.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.41 -21.18 23.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.835 0.35 . . . . 0.14000000000000001 111.499 177.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -94.95 -14.15 24.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.17999999999999999 111.066 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.65 166.55 22.68 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 116.037 -0.529 . . . . 0.11 111.898 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -69.49 138.7 53.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.896 -0.409 . . . . 0.25 109.896 178.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.417 HG21 ' HB3' ' A' ' 128' ' ' CYS . 67.7 mt -111.11 134.09 54.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.98 -0.554 . . . . 0.14000000000000001 109.751 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.18 -50.65 6.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.435 -0.95 . . . . 0.54000000000000004 108.435 179.93 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.3 m -138.01 99.14 3.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.801 -1.091 . . . . 0.76000000000000001 110.72 -176.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.747 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 0.8 OUTLIER -97.98 139.95 33.05 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.165 -0.679 . . . . 0.71999999999999997 109.165 172.512 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -139.2 129.3 25.22 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.634 -172.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.609 HG22 HD12 ' A' ' 115' ' ' LEU . 95.8 t -114.14 109.27 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 106.573 -1.64 . . . . 0.28000000000000003 106.573 168.148 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 C--N 1.305 -1.349 0 CA-C-N 115.693 -0.685 . . . . 0.34000000000000002 109.783 -172.121 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 CA-C-O 120.49 -0.061 . . . . 0.31 113.243 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -133.99 155.32 50.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.85 0.357 . . . . 0.48999999999999999 111.001 -177.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.6 175.28 24.4 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.81 -0.632 . . . . 0.12 111.938 -178.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -137.06 139.33 41.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.547 0.173 . . . . 0.25 110.838 -177.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.598 ' HB ' HG12 ' A' ' 101' ' ' ILE . 41.9 t -112.09 132.93 59.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.881 0.372 . . . . 0.10000000000000001 110.578 171.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' HIS . . . . . 0.413 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 0.8 OUTLIER -104.16 106.05 16.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.082 -0.71 . . . . 0.20999999999999999 109.082 167.405 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.488 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 20.0 m-85 -87.7 138.62 31.31 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.331 0.586 . . . . 0.17000000000000001 111.155 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.576 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.9 tt0 -49.01 -39.47 27.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.038 -1.437 . . . . 0.56999999999999995 110.715 178.205 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.5 p -125.61 152.62 44.9 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.833 -1.076 . . . . 0.40000000000000002 110.663 -179.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -66.94 -31.07 71.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.915 -0.584 . . . . 0.46999999999999997 110.977 -177.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.65 -35.15 74.92 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.039 0.385 . . . . 0.73999999999999999 112.039 -178.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.8 -34.61 78.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.11 0.481 . . . . 0.17999999999999999 110.711 -178.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.488 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.97 -43.85 94.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.506 -0.77 . . . . 0.16 111.252 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 33.5 mt-10 -58.68 -41.9 87.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 1.4199999999999999 110.638 179.242 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.457 HH11 ' HD2' ' A' ' 153' ' ' ARG . 65.2 mtt85 -61.27 -44.52 97.1 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.259 -0.428 . . . . 1.48 111.285 177.354 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.74 -37.4 84.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.374 -0.376 . . . . 0.10000000000000001 110.713 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 151' ' ' ALA . 87.3 mt -62.41 -54.48 33.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.381 -0.372 . . . . 0.14999999999999999 111.081 178.154 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.9 pt-20 -62.72 -40.24 96.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.983 0.42 . . . . 1.0800000000000001 111.814 -177.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -82.35 -38.66 23.9 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.872 0.693 . . . . 1.1599999999999999 112.872 -172.746 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' MET . . . . . 0.409 ' HB2' HG21 ' A' ' 170' ' ' VAL . 90.5 mmm -93.2 -26.8 17.22 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.549 0.574 . . . . 0.34999999999999998 112.549 -173.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -64.85 123.4 19.3 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.131 -0.628 . . . . 0.44 109.383 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.79 19.51 56.07 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.635 -0.793 . . . . 0.28999999999999998 112.557 -179.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.4 mmt -105.15 156.35 18.17 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.788 -0.243 . . . . 1.1799999999999999 110.861 176.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 162' ' ' LEU . 14.4 mt -98.27 97.45 8.84 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.455 -0.572 . . . . 0.44 109.455 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 18.1 mt -81.82 105.07 12.66 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 119.469 -0.893 . . . . 1.02 109.068 174.382 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 86.4 m-20 74.1 -66.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.974 -1.012 . . . . 1.71 111.909 -177.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -156.47 6.84 0.19 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.854 -0.612 . . . . 0.84999999999999998 111.686 -177.184 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.2 mtt180 -134.39 128.34 33.41 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 121.769 -0.582 . . . . 0.95999999999999996 110.255 -172.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 161' ' ' MET . 17.0 tttt -76.66 119.77 20.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.483 -178.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.452 HG11 HD23 ' A' ' 106' ' ' LEU . 15.9 m -100.73 144.51 12.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.491 0.662 . . . . 0.17000000000000001 111.365 -172.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 72.9 t80 -106.82 119.76 40.21 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.687 -1.142 . . . . 0.29999999999999999 109.325 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.567 HG22 HG12 ' A' ' 103' ' ' ILE . 40.6 t -115.63 128.82 72.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.501 -0.555 . . . . 0.13 109.501 178.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.28 -175.02 19.79 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.64 -0.79 . . . . 0.17999999999999999 112.356 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 . . . . . 0 C--N 1.325 -0.476 0 CA-C-O 120.895 0.378 . . . . 1.9299999999999999 110.729 -177.744 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.766 0 N-CA-C 111.855 -0.498 . . . . 14.85 111.855 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -119.76 -65.29 1.17 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.969 0.414 . . . . 13.5 110.117 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -170.08 117.43 0.51 Allowed Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.832 -0.622 . . . . 11.25 110.351 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.55 -4.16 13.91 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.591 2.194 . . . . 11.140000000000001 112.219 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.666 ' HB2' ' HE1' ' A' ' 144' ' ' HIS . 1.1 m -84.84 13.34 5.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.983 -0.553 . . . . 9.3000000000000007 111.155 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 93.7 mt -80.4 56.12 2.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.523 0.678 . . . . 7.8899999999999997 110.441 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -137.43 -150.51 0.36 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.045 -0.979 . . . . 7.7800000000000002 108.366 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.739 ' HB3' ' HB1' ' A' ' 181' ' ' ALA . 43.7 tttm -99.28 1.06 44.26 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.83 -0.804 . . . . 2.3700000000000001 108.83 171.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 p -105.85 19.74 20.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.384 -0.826 . . . . 1.79 111.811 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.12 6.16 83.8 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.52 -0.848 . . . . 0.44 111.799 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 73.2 t 60.35 121.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.118 0.967 . . . . 0.70999999999999996 112.664 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.429 ' HA2' ' CB ' ' A' ' 151' ' ' ALA . . . 72.24 25.62 74.07 Favored Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 119.732 -1.223 . . . . 0.20999999999999999 112.406 172.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.541 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.2 m120 -85.58 123.85 31.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.806 -0.813 . . . . 0.63 108.806 -174.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.515 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.1 pt -135.72 159.93 39.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 110.319 -0.252 . . . . 0.14999999999999999 110.319 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -124.05 141.35 52.12 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.815 -0.439 . . . . 0.20999999999999999 109.815 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.649 HG12 HG22 ' A' ' 170' ' ' VAL . 7.2 mt -117.95 137.61 51.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.58 -0.737 . . . . 0.14999999999999999 110.07 -178.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 ttpp -120.72 151.57 39.37 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.679 -0.237 . . . . 1.46 110.522 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.1 t30 69.77 54.37 0.37 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.86 0.725 . . . . 0.48999999999999999 111.307 170.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.67 HD22 HG21 ' A' ' 110' ' ' ILE . 14.6 mt -91.61 162.88 14.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.426 -0.807 . . . . 0.26000000000000001 111.169 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.465 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 14.0 t70 -87.38 155.74 19.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.034 -0.53 . . . . 0.70999999999999996 109.936 177.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.948 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 62.8 pttt -62.24 -31.39 71.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.388 -0.369 . . . . 2.2000000000000002 111.417 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 36.8 p -72.32 -4.59 30.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.186 -0.461 . . . . 1.4099999999999999 111.936 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.698 HG22 HG21 ' A' ' 130' ' ' VAL . 45.1 mm -84.57 118.4 31.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.482 . . . . 0.26000000000000001 110.776 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.462 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 15.6 t70 -108.73 -175.27 2.72 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.297 -1.001 . . . . 1.5900000000000001 108.297 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -67.66 -32.52 73.25 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.478 -0.934 . . . . 0.59999999999999998 108.478 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -48.72 71.14 Favored 'General case' 0 N--CA 1.428 -1.546 0 CA-C-N 114.624 -1.171 . . . . 2.5800000000000001 109.263 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.462 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -62.43 -43.03 99.79 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.274 -1.33 . . . . 0.14999999999999999 110.84 -177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.73 HD12 HG22 ' A' ' 130' ' ' VAL . 3.5 tt -65.73 -47.79 74.12 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.172 -0.677 . . . . 0.16 109.172 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.651 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 55.3 t80 -59.26 -46.3 88.87 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.743 -0.662 . . . . 0.29999999999999999 110.486 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -56.84 -39.85 74.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.505 -0.316 . . . . 0.40000000000000002 111.232 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.448 HG21 HD21 ' A' ' 163' ' ' LEU . 91.3 m -77.73 -53.78 7.13 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.264 0.468 . . . . 0.22 112.264 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.46 ' CD1' HD23 ' A' ' 115' ' ' LEU . 6.5 m-85 -71.76 -28.09 63.42 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.54 0.57 . . . . 0.11 112.54 -173.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.5 t -57.71 -28.86 64.22 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.571 0.224 . . . . 0.19 111.296 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.33 -22.86 45.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.678 0.275 . . . . 0.14000000000000001 111.385 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.401 ' HZ ' ' HE3' ' A' ' 157' ' ' LYS . 26.7 m-85 -89.76 -26.22 20.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.038 0.447 . . . . 0.17999999999999999 110.546 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 172.89 169.77 35.82 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.125 -0.79 . . . . 0.11 111.125 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -71.04 143.59 50.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.65 -0.5 . . . . 0.25 109.65 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.436 HG21 ' HB3' ' A' ' 128' ' ' CYS . 76.2 mt -114.76 134.93 56.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 116.014 -0.539 . . . . 0.14000000000000001 110.015 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.666 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -93.02 -36.45 12.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.343 0.592 . . . . 0.54000000000000004 109.508 -179.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.1 m -156.18 97.61 1.8 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.733 -0.667 . . . . 0.76000000000000001 111.365 -176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.651 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.7 p -103.84 153.54 20.63 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.355 -0.609 . . . . 0.71999999999999997 109.355 172.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -150.61 132.44 15.05 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.818 0.342 . . . . 1.0 111.255 -175.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.73 HG22 HD12 ' A' ' 115' ' ' LEU . 57.5 t -114.28 110.31 31.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 107.183 -1.414 . . . . 0.28000000000000003 107.183 171.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.7 t -78.67 114.5 19.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 108.432 -0.951 . . . . 0.34000000000000002 108.432 -175.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.887 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 3.6 p -105.79 135.03 47.94 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.759 0.652 . . . . 1.5800000000000001 112.759 -164.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.422 ' CG ' ' H ' ' A' ' 135' ' ' ASN . 0.2 OUTLIER -87.33 174.45 8.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 108.919 -0.771 . . . . 2.0800000000000001 108.919 172.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -55.11 -31.86 61.57 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.013 0.375 . . . . 2.4500000000000002 112.013 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.422 ' H ' ' CG ' ' A' ' 133' ' ' ASP . 60.0 m-80 -86.23 -12.3 50.05 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.621 0.248 . . . . 1.6499999999999999 110.974 -175.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.948 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 151.22 -50.19 0.53 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.07 -1.062 . . . . 1.1200000000000001 113.834 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.887 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 38.2 t -160.96 145.99 14.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.476 0.638 . . . . 1.6100000000000001 111.51 -176.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -78.18 -12.96 60.03 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.3 0.571 . . . . 1.51 110.297 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 101.66 22.83 9.87 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.203 -0.999 . . . . 0.31 113.877 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -161.18 153.93 20.77 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 117.742 0.771 . . . . 0.48999999999999999 111.285 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.29 174.06 28.09 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.457 -0.792 . . . . 0.12 111.625 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.428 ' CD1' ' HE2' ' A' ' 173' ' ' PHE . 44.5 m-85 -139.93 142.65 36.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.928 0.364 . . . . 0.25 110.555 -177.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.515 ' HB ' HG12 ' A' ' 101' ' ' ILE . 24.6 t -118.34 133.96 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.105 0.479 . . . . 0.10000000000000001 111.362 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.666 ' HE1' ' HB2' ' A' ' 92' ' ' SER . 0.1 OUTLIER -106.45 106.58 17.16 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.851 -0.796 . . . . 0.20999999999999999 108.851 167.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 8.7 m-85 -89.28 139.76 30.17 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.284 0.564 . . . . 0.17000000000000001 111.915 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.666 ' HA ' HD21 ' A' ' 126' ' ' LEU . 43.8 tt0 -52.48 -48.74 65.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.112 -1.404 . . . . 0.56999999999999995 110.07 175.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.2 p -111.77 144.45 41.03 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 114.137 -1.392 . . . . 0.40000000000000002 111.062 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -61.92 -40.32 95.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.299 -0.864 . . . . 0.46999999999999997 111.026 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.449 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.8 pt-20 -67.68 -35.18 78.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.73999999999999999 111.408 -175.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.84 78.43 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.241 0.543 . . . . 0.17999999999999999 110.489 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.475 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.97 -44.72 91.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.388 -0.824 . . . . 0.16 110.86 178.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.553 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 37.7 mt-10 -62.06 -37.33 84.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.646 -0.707 . . . . 1.4199999999999999 110.356 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 157' ' ' LYS . 88.8 mtt180 -62.54 -47.05 85.57 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.332 -0.394 . . . . 1.48 110.592 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.78 81.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.997 -0.547 . . . . 0.10000000000000001 111.012 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.0 mt -61.21 -53.77 44.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.239 -0.437 . . . . 0.14999999999999999 111.131 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 4.2 pt-20 -64.69 -45.01 88.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.186 0.517 . . . . 1.0800000000000001 111.919 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -75.52 -38.92 59.07 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.483 -0.78 . . . . 1.1599999999999999 112.893 -170.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.459 ' HB2' HG21 ' A' ' 170' ' ' VAL . 83.8 mmm -93.51 -26.23 17.25 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.917 0.71 . . . . 0.34999999999999998 112.917 -173.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.401 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 52.7 t30 -64.79 123.74 20.15 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.549 -0.46 . . . . 0.44 110.15 -177.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.42 11.65 62.27 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.816 -0.706 . . . . 0.28999999999999998 113.184 178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.676 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 75.2 mmm -105.39 164.25 12.0 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.568 -0.372 . . . . 1.1799999999999999 111.508 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.442 HD23 ' N ' ' A' ' 167' ' ' LYS . 19.8 mt -96.33 123.21 39.89 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 108.928 -0.768 . . . . 0.44 108.928 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.53 HD12 HG11 ' A' ' 168' ' ' VAL . 24.9 mt -106.43 100.21 9.75 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.934 -0.706 . . . . 1.02 109.659 172.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 94.5 m-20 77.72 -28.82 0.16 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 114.871 -1.059 . . . . 1.71 112.725 178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 35.7 t70 174.44 -23.85 0.0 OUTLIER 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.772 -0.649 . . . . 0.84999999999999998 112.221 -174.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.465 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.7 mtt180 -115.96 134.93 54.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.935 0.397 . . . . 0.95999999999999996 111.602 -173.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.676 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.5 ttmt -76.92 123.83 26.86 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.418 -0.81 . . . . 1.0 109.171 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.53 HG11 HD12 ' A' ' 163' ' ' LEU . 23.2 m -103.05 146.6 10.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.434 0.635 . . . . 0.17000000000000001 111.528 -174.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 73.5 t80 -107.51 119.26 38.94 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.016 -0.993 . . . . 0.29999999999999999 109.116 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.649 HG22 HG12 ' A' ' 103' ' ' ILE . 43.0 t -114.82 128.04 72.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.467 -0.568 . . . . 0.13 109.467 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.61 -177.44 22.86 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.365 -0.922 . . . . 0.17999999999999999 112.714 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.496 ' HA ' ' HE ' ' A' ' 172' ' ' ARG . 0.0 OUTLIER -73.01 133.45 44.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.889 0.376 . . . . 1.9299999999999999 110.795 -177.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.428 ' HE2' ' CD1' ' A' ' 142' ' ' PHE . 17.6 t80 -78.21 91.03 4.33 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.685 -0.689 . . . . 1.4399999999999999 110.077 -175.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -92.54 96.52 10.26 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.798 -0.815 . . . . 4.6600000000000001 108.798 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.405 ' HB3' ' HE1' ' A' ' 173' ' ' PHE . 0.8 OUTLIER -61.8 -42.03 98.5 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.536 -0.756 . . . . 3.6000000000000001 111.827 -174.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -170.83 -82.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.673 0.273 . . . . 7.5999999999999996 110.964 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -169.65 72.76 0.08 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.411 -0.589 . . . . 8.6099999999999994 109.411 -174.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -110.06 148.81 31.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.166 -0.47 . . . . 8.5500000000000007 110.865 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.549 ' HA ' ' NE ' ' A' ' 179' ' ' ARG . 3.2 mmp_? -76.26 -39.46 54.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.969 -0.56 . . . . 12.18 109.749 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -88.51 101.48 13.98 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.284 -0.871 . . . . 12.699999999999999 109.399 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.739 ' HB1' ' HB3' ' A' ' 95' ' ' LYS . . . -164.43 141.79 6.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.909 -0.587 . . . . 13.65 110.459 -177.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 . . . . . 0 C--O 1.242 0.7 0 CA-C-O 118.122 -0.942 . . . . 15.050000000000001 109.797 176.76 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.704 0 N-CA-C 111.933 -0.467 . . . . 14.85 111.933 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.63 -42.56 82.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.795 0.331 . . . . 13.5 110.999 -178.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.565 ' HB3' ' HE2' ' A' ' 95' ' ' LYS . 2.9 m-20 -123.32 81.46 52.67 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 116.131 -0.486 . . . . 11.25 110.335 177.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -93.83 94.28 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.33 2.687 . . . . 11.140000000000001 111.416 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.3 p 46.78 50.33 13.46 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.63 0.729 . . . . 9.3000000000000007 109.925 -172.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.723 ' HG ' ' HG3' ' A' ' 94' ' ' ARG . 60.8 tp -125.13 121.67 34.9 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.898 -1.046 . . . . 7.8899999999999997 111.081 -172.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.723 ' HG3' ' HG ' ' A' ' 93' ' ' LEU . 46.6 mtm180 67.68 21.74 9.21 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.055 0.542 . . . . 7.7800000000000002 112.093 173.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.565 ' HE2' ' HB3' ' A' ' 90' ' ' ASP . 35.3 mttm -136.39 171.91 13.79 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.777 -0.369 . . . . 2.3700000000000001 110.966 -176.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.2 t -120.92 -32.31 4.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.102 0.477 . . . . 1.79 109.875 -178.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.485 ' HA3' ' OD1' ' A' ' 100' ' ' ASN . . . -66.59 -47.2 70.47 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 115.7 -0.682 . . . . 0.44 112.837 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER 63.88 134.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.353 1.061 . . . . 0.70999999999999996 111.781 -174.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.89 22.71 78.9 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.265 -0.969 . . . . 0.20999999999999999 111.217 -174.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.485 ' OD1' ' HA3' ' A' ' 97' ' ' GLY . 2.7 m120 -96.18 128.38 43.04 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.14 -0.689 . . . . 0.63 109.14 -176.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.486 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.8 pt -133.31 162.5 39.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.162 -0.472 . . . . 0.14999999999999999 109.864 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.24 144.63 50.37 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.006 0.431 . . . . 0.20999999999999999 109.908 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.627 HG12 HG22 ' A' ' 170' ' ' VAL . 5.7 mt -119.92 135.49 60.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.588 -0.733 . . . . 0.14999999999999999 110.071 -177.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt -116.66 152.37 34.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.732 -0.213 . . . . 1.46 110.652 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 t30 71.58 40.65 0.78 Allowed 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.942 0.777 . . . . 0.48999999999999999 111.79 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.622 HD22 HG21 ' A' ' 110' ' ' ILE . 20.6 mt -78.24 158.55 28.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.389 0.614 . . . . 0.26000000000000001 111.755 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.477 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 25.1 t70 -81.93 150.76 27.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.359 -0.837 . . . . 0.70999999999999996 110.916 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -55.72 -36.88 67.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.599 -0.728 . . . . 2.2000000000000002 112.131 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.6 m -84.02 -3.87 58.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.89 0.33 . . . . 1.4099999999999999 111.89 -174.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.671 HG22 HG21 ' A' ' 130' ' ' VAL . 27.9 mm -71.87 117.14 14.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.091 0.472 . . . . 0.26000000000000001 110.183 176.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 15.6 t70 -105.64 -171.74 1.96 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.798 -0.815 . . . . 1.5900000000000001 108.798 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.413 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 87.3 m-20 -72.17 -32.61 67.01 Favored 'General case' 0 CA--C 1.508 -0.651 0 N-CA-C 108.319 -0.993 . . . . 0.59999999999999998 108.319 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.63 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -68.68 -45.05 72.71 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.039 -1.437 . . . . 2.5800000000000001 109.661 179.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.76 -44.25 97.26 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.662 -1.608 . . . . 0.14999999999999999 110.574 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.626 HD12 HG22 ' A' ' 130' ' ' VAL . 4.1 tt -67.4 -47.19 71.0 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.165 -0.925 . . . . 0.16 109.378 176.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.802 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 83.5 t80 -58.98 -45.31 90.88 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.893 -0.594 . . . . 0.29999999999999999 111.165 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.85 -40.89 76.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.852 0.358 . . . . 0.40000000000000002 110.877 -175.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 58.8 m -77.41 -53.71 7.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.238 -0.437 . . . . 0.22 112.136 -179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.429 ' CD1' HD23 ' A' ' 115' ' ' LEU . 14.1 m-85 -71.59 -28.43 63.81 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.657 0.614 . . . . 0.11 112.657 -173.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.1 t -57.75 -28.42 63.91 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 120.609 0.243 . . . . 0.19 111.078 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.78 -22.68 37.74 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 111.804 0.298 . . . . 0.14000000000000001 111.804 177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -91.88 -15.54 27.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.997 0.427 . . . . 0.17999999999999999 111.038 -178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.19 166.79 22.6 Favored Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.531 -0.628 . . . . 0.11 111.531 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -67.57 139.44 56.91 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.033 0.444 . . . . 0.25 110.201 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.457 HG21 ' HB3' ' A' ' 128' ' ' CYS . 65.9 mt -113.37 133.91 57.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.725 -0.671 . . . . 0.14000000000000001 109.723 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.615 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -90.37 -43.7 10.15 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.884 -0.784 . . . . 0.54000000000000004 108.884 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 55.7 m -145.65 99.75 3.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.231 -0.895 . . . . 0.76000000000000001 110.962 -177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.802 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.6 p -97.53 145.9 25.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.17 -0.678 . . . . 0.71999999999999997 109.17 171.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.6 tptt -148.79 134.27 18.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.063 0.459 . . . . 1.0 111.8 -177.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.671 HG21 HG22 ' A' ' 110' ' ' ILE . 99.1 t -114.02 115.07 48.56 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.873 0 N-CA-C 106.587 -1.634 . . . . 0.28000000000000003 106.587 170.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.2 t -82.72 115.09 24.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 108.709 -0.848 . . . . 0.34000000000000002 108.709 -176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.757 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 58.5 m -104.22 141.09 36.88 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.523 -0.762 . . . . 1.5800000000000001 111.495 -169.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -85.6 160.9 19.5 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.669 -1.234 . . . . 2.0800000000000001 107.669 174.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -64.2 -19.01 65.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 118.681 0.673 . . . . 2.4500000000000002 110.208 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -92.17 2.32 56.67 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.94 -0.573 . . . . 1.6499999999999999 110.686 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 132' ' ' CYS . . . 143.08 -80.19 0.24 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.766 -0.73 . . . . 1.1200000000000001 113.711 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.757 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 32.5 t -141.94 153.4 44.32 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 117.973 0.886 . . . . 1.6100000000000001 109.62 -176.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -88.0 -11.19 48.09 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.153 0.502 . . . . 1.51 110.266 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.22 -24.41 22.84 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.455 -0.878 . . . . 0.31 113.35 176.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -123.68 152.84 41.6 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.457 0.646 . . . . 0.48999999999999999 111.976 -172.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.89 174.36 23.63 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 114.954 -1.021 . . . . 0.12 111.309 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -138.72 140.99 38.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.01 0.405 . . . . 0.25 110.72 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.486 ' HB ' HG12 ' A' ' 101' ' ' ILE . 43.0 t -115.45 129.17 72.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-O 120.946 0.403 . . . . 0.10000000000000001 110.492 172.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.1 m170 -100.47 105.19 16.62 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.267 -0.642 . . . . 0.20999999999999999 109.267 167.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.555 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 18.8 m-85 -87.25 142.97 27.5 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.078 0.466 . . . . 0.17000000000000001 110.392 178.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.615 ' HA ' HD21 ' A' ' 126' ' ' LEU . 35.5 tt0 -52.89 -34.45 54.87 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.426 -1.261 . . . . 0.56999999999999995 110.706 178.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 66.6 p -129.94 152.38 49.47 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.348 -0.842 . . . . 0.40000000000000002 111.277 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 -62.18 -36.02 80.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.694 -0.684 . . . . 0.46999999999999997 111.204 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -69.26 -35.66 76.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.008 0.373 . . . . 0.73999999999999999 112.008 -175.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.88 -34.67 78.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 0.17999999999999999 110.553 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.555 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -65.3 -41.72 93.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.722 -0.672 . . . . 0.16 110.944 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 32.4 mt-10 -59.33 -40.19 85.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 1.4199999999999999 110.775 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 70.8 mtt180 -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 1.48 111.192 179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.94 -36.68 84.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.438 -0.346 . . . . 0.10000000000000001 110.451 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.1 mt -62.26 -53.25 49.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.242 -0.435 . . . . 0.14999999999999999 111.168 178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.492 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 0.9 OUTLIER -64.27 -41.86 96.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.07 0.462 . . . . 1.0800000000000001 111.899 -179.144 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.479 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.23 -38.69 24.14 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 113.084 0.772 . . . . 1.1599999999999999 113.084 -171.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.462 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.8 mmm -93.81 -20.52 20.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 112.843 0.683 . . . . 0.34999999999999998 112.843 -172.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 58.2 t30 -68.5 123.83 21.89 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 119.965 -0.694 . . . . 0.44 109.495 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.53 17.01 57.78 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.742 -0.742 . . . . 0.28999999999999998 112.721 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.729 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.4 mmt -100.91 163.4 12.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.675 0.274 . . . . 1.1799999999999999 111.54 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 mt -104.3 105.21 15.27 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.983 -0.553 . . . . 0.44 109.826 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 163' ' ' LEU . 18.8 mt -93.04 105.97 17.99 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 119.974 -0.691 . . . . 1.02 109.881 175.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 93.3 m-20 75.09 -51.23 0.67 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.124 -0.944 . . . . 1.71 111.843 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -178.63 22.09 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.88 -0.6 . . . . 0.84999999999999998 111.729 177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.477 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.4 mtt180 -138.76 135.48 34.72 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.681 -0.637 . . . . 0.95999999999999996 109.957 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.729 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.2 ttmt -83.08 117.68 23.02 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 -177.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.479 HG11 HD23 ' A' ' 106' ' ' LEU . 11.5 m -100.52 148.39 6.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 121.588 0.709 . . . . 0.17000000000000001 111.448 -171.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 69.2 t80 -106.46 120.61 42.35 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.647 -1.16 . . . . 0.29999999999999999 109.292 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.627 HG22 HG12 ' A' ' 103' ' ' ILE . 43.2 t -115.65 126.24 73.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.448 -0.575 . . . . 0.13 109.448 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.06 -175.9 21.89 Favored Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.745 -0.741 . . . . 0.17999999999999999 111.548 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.6 mmt180 -62.24 141.74 58.07 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.3 -0.63 . . . . 1.9299999999999999 109.3 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -57.88 104.71 0.21 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.591 -0.522 . . . . 1.4399999999999999 109.591 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -68.13 118.98 11.99 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.263 0.554 . . . . 4.6600000000000001 110.956 -176.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.8 m -84.37 91.31 7.76 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.448 -0.796 . . . . 3.6000000000000001 109.366 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 71.2 mtp180 -75.19 149.37 38.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.011 -0.54 . . . . 7.5999999999999996 111.453 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.418 ' HG2' ' O ' ' A' ' 177' ' ' LYS . 74.8 tttt -157.86 20.73 0.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.03 -0.729 . . . . 8.6099999999999994 109.03 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -60.01 113.36 2.28 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.259 -0.882 . . . . 8.5500000000000007 110.864 -177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.412 ' HB2' ' H ' ' A' ' 180' ' ' GLU . 18.7 mmm180 -102.38 -92.11 0.33 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.039 0.447 . . . . 12.18 109.98 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.412 ' H ' ' HB2' ' A' ' 179' ' ' ARG . 43.1 tt0 -156.38 116.23 3.58 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.582 -0.895 . . . . 12.699999999999999 108.582 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 60.51 21.83 11.55 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.313 0.578 . . . . 13.65 110.524 -172.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--O 1.251 1.132 0 CA-C-N 115.407 -0.815 . . . . 15.050000000000001 108.994 -178.315 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 112.016 -0.434 . . . . 14.85 112.016 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.449 ' O ' ' HD3' ' A' ' 91' ' ' PRO . . . -152.13 -178.35 6.73 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.295 -0.261 . . . . 13.5 110.295 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -97.19 102.57 12.7 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 109.264 -0.643 . . . . 11.25 109.264 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 89' ' ' ALA . 34.8 Cg_exo -58.19 -58.92 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 123.191 2.594 . . . . 11.140000000000001 113.29 -172.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.4 m -83.13 12.34 5.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.207 0.447 . . . . 9.3000000000000007 112.207 -174.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 47.2 tp -107.71 -39.77 5.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.662 0.268 . . . . 7.8899999999999997 110.52 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.665 ' O ' ' HD2' ' A' ' 95' ' ' LYS . 95.1 mtt180 -69.4 -42.44 75.11 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.37 -0.377 . . . . 7.7800000000000002 110.345 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.729 ' HE2' ' HB3' ' A' ' 172' ' ' ARG . 0.5 OUTLIER -151.22 174.51 13.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.061 -0.348 . . . . 2.3700000000000001 110.061 173.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 98' ' ' VAL . 18.0 m -99.92 158.83 15.53 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.183 -1.043 . . . . 1.79 108.183 174.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 76.9 -26.17 1.75 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.38 -0.914 . . . . 0.44 111.738 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.465 ' H ' ' C ' ' A' ' 96' ' ' SER . 78.9 t 63.87 126.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.328 1.051 . . . . 0.70999999999999996 112.25 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.437 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 72.8 24.05 76.78 Favored Glycine 0 N--CA 1.436 -1.325 0 C-N-CA 119.974 -1.107 . . . . 0.20999999999999999 111.605 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.491 HD22 ' N ' ' A' ' 100' ' ' ASN . 0.9 OUTLIER -88.74 125.96 35.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.273 -0.64 . . . . 0.63 109.273 -174.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.596 HG23 ' HB1' ' A' ' 151' ' ' ALA . 21.6 pt -135.46 161.43 39.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.989 -0.374 . . . . 0.14999999999999999 109.989 175.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.23 137.87 54.11 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.88 -0.415 . . . . 0.20999999999999999 109.88 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.56 HG12 HG22 ' A' ' 170' ' ' VAL . 5.1 mt -115.21 135.05 56.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.612 -0.722 . . . . 0.14999999999999999 110.013 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.9 ttpp -117.12 152.95 33.65 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.292 -0.262 . . . . 1.46 110.292 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 53.3 t30 74.89 35.1 0.65 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 123.818 0.699 . . . . 0.48999999999999999 111.474 171.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.433 HD22 HG21 ' A' ' 110' ' ' ILE . 30.7 mt -79.79 159.54 26.49 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.12 0.486 . . . . 0.26000000000000001 111.185 177.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -92.66 150.71 20.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.596 -0.729 . . . . 0.70999999999999996 110.414 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.566 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 65.2 pttt -52.1 -31.98 33.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.758 -0.656 . . . . 2.2000000000000002 112.213 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.5 m -71.78 -17.32 62.18 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.096 0.406 . . . . 1.4099999999999999 112.096 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.575 HG22 HG21 ' A' ' 130' ' ' VAL . 28.5 mm -71.43 123.52 25.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.251 0.548 . . . . 0.26000000000000001 110.835 -177.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.473 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 26.5 t70 -107.87 -177.98 3.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.279 -0.873 . . . . 1.5900000000000001 109.056 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -69.61 -35.09 74.96 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.344 -0.984 . . . . 0.59999999999999998 108.344 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.51 -45.66 71.68 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.628 -1.169 . . . . 2.5800000000000001 109.052 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.473 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -60.75 -40.24 91.73 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.006 -1.452 . . . . 0.14999999999999999 110.669 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.589 HD12 HG22 ' A' ' 130' ' ' VAL . 3.8 tt -68.87 -47.02 66.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.199 -0.91 . . . . 0.16 109.231 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.727 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 65.6 t80 -60.64 -45.1 95.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.114 -0.494 . . . . 0.29999999999999999 111.132 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -56.8 -40.61 76.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.03 0.443 . . . . 0.40000000000000002 110.543 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.575 HG21 HD21 ' A' ' 163' ' ' LEU . 20.4 m -77.52 -53.81 7.16 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.747 -0.661 . . . . 0.22 111.822 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.411 ' CD1' HD23 ' A' ' 115' ' ' LEU . 11.1 m-85 -72.48 -28.16 62.73 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.743 0.646 . . . . 0.11 112.743 -174.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.6 t -57.57 -29.05 64.12 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.58 0.229 . . . . 0.19 111.207 -177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.35 39.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.928 0.394 . . . . 0.14000000000000001 111.716 177.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -92.83 -14.83 27.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.414 -0.357 . . . . 0.17999999999999999 111.019 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 162.5 169.83 26.43 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.624 -0.59 . . . . 0.11 111.624 -179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -73.15 138.65 45.86 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.108 0.48 . . . . 0.25 110.247 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.406 HG21 ' HB3' ' A' ' 128' ' ' CYS . 69.2 mt -111.03 132.09 60.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.718 -0.673 . . . . 0.14000000000000001 110.038 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.602 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -84.57 -43.27 14.64 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.569 -0.9 . . . . 0.54000000000000004 108.569 179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.3 m -146.5 131.78 18.49 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.819 -1.082 . . . . 0.76000000000000001 110.255 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.727 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.5 p -128.69 134.67 48.56 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.117 -0.698 . . . . 0.71999999999999997 109.117 175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.3 tptt -133.76 133.33 41.6 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.586 -0.446 . . . . 1.0 111.776 -173.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.589 HG22 HD12 ' A' ' 115' ' ' LEU . 83.9 t -114.56 110.44 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.688 0 N-CA-C 107.012 -1.477 . . . . 0.28000000000000003 107.012 170.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.1 t -79.6 116.35 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.971 -0.752 . . . . 0.34000000000000002 108.971 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.791 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 61.7 m -106.85 135.94 47.55 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.723 -0.671 . . . . 1.5800000000000001 112.567 -164.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.41 ' H ' ' CA ' ' A' ' 137' ' ' SER . 26.8 t70 -86.35 164.69 16.91 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.063 -0.971 . . . . 2.0800000000000001 108.733 172.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -61.66 -22.54 65.38 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.039 0.447 . . . . 2.4500000000000002 110.544 174.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -88.09 -2.68 58.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.898 -0.592 . . . . 1.6499999999999999 110.491 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.566 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 140.34 -68.95 0.47 Allowed Glycine 0 C--O 1.227 -0.303 0 C-N-CA 120.728 -0.749 . . . . 1.1200000000000001 113.249 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.791 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 38.4 t -144.51 153.3 41.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.436 0.618 . . . . 1.6100000000000001 110.493 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 35.2 mtpt -84.32 -10.13 57.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.159 0.504 . . . . 1.51 109.683 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 105.5 -10.35 45.99 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.286 -0.959 . . . . 0.31 113.527 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 29.9 p90 -132.79 150.75 52.12 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.359 0.6 . . . . 0.48999999999999999 111.854 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.22 167.14 26.18 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.036 -0.984 . . . . 0.12 111.341 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -133.99 136.97 44.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.937 0.368 . . . . 0.25 110.738 -176.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.54 ' HB ' HG12 ' A' ' 101' ' ' ILE . 42.7 t -110.79 136.16 47.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.842 0.353 . . . . 0.10000000000000001 110.644 174.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.454 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 1.2 m170 -105.95 105.37 15.38 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.774 -0.824 . . . . 0.20999999999999999 108.774 166.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.576 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 17.8 m-85 -88.71 140.8 29.08 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.099 0.476 . . . . 0.17000000000000001 110.732 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.602 ' HA ' HD21 ' A' ' 126' ' ' LEU . 34.7 tt0 -51.7 -41.33 61.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.749 -1.114 . . . . 0.56999999999999995 110.361 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 78.2 p -115.24 150.52 36.04 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.701 -1.136 . . . . 0.40000000000000002 110.157 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -65.65 -36.12 82.76 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.132 -0.485 . . . . 0.46999999999999997 110.593 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 12.5 pt-20 -69.04 -35.0 76.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.115 -0.493 . . . . 0.73999999999999999 111.828 -176.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.29 79.92 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.067 0.46 . . . . 0.17999999999999999 110.639 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.596 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -64.02 -46.31 85.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.705 -0.68 . . . . 0.16 110.507 177.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.532 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 42.7 mt-10 -61.74 -34.55 76.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.328 -0.851 . . . . 1.4199999999999999 110.91 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 95.9 mtt180 -61.82 -47.63 84.21 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.106 0.479 . . . . 1.48 110.543 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.8 -35.8 77.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.86 -0.609 . . . . 0.10000000000000001 110.587 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 151' ' ' ALA . 86.5 mt -60.61 -54.41 35.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.1 -0.5 . . . . 0.14999999999999999 111.225 177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 0.8 OUTLIER -64.04 -42.44 97.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.214 0.53 . . . . 1.0800000000000001 111.768 -177.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.25 -37.97 31.88 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.486 -0.779 . . . . 1.1599999999999999 112.819 -170.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.468 ' HB2' HG21 ' A' ' 170' ' ' VAL . 91.9 mmm -96.41 -16.93 20.95 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.818 0.673 . . . . 0.34999999999999998 112.818 -173.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -70.0 124.04 23.05 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.09 -0.644 . . . . 0.44 109.882 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.19 15.56 74.13 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 116.166 -0.47 . . . . 0.28999999999999998 112.088 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.484 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 11.7 tpp -99.91 157.6 16.41 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.065 -0.346 . . . . 1.1799999999999999 110.065 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.0 mt -96.94 110.92 23.34 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 109.349 -0.612 . . . . 0.44 109.349 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.575 HD21 HG21 ' A' ' 118' ' ' THR . 20.8 mt -98.02 105.18 17.29 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 119.981 -0.687 . . . . 1.02 109.539 173.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 61.3 m-20 77.11 -29.62 0.17 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.22 -0.9 . . . . 1.71 112.681 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.436 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 21.1 t70 168.19 -22.18 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 O-C-N 123.701 0.625 . . . . 0.84999999999999998 111.864 -170.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 80.5 mtt-85 -113.3 137.78 50.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.867 0.365 . . . . 0.95999999999999996 111.118 -170.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 161' ' ' MET . 8.0 tttm -81.5 112.96 19.22 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.669 -0.696 . . . . 1.0 109.307 -177.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.412 HG11 HD23 ' A' ' 106' ' ' LEU . 16.0 m -100.15 148.48 6.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-O 121.599 0.714 . . . . 0.17000000000000001 111.245 -172.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 68.3 t80 -106.68 119.49 39.45 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 114.726 -1.124 . . . . 0.29999999999999999 109.384 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.56 HG22 HG12 ' A' ' 103' ' ' ILE . 40.1 t -114.57 125.46 71.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 108.983 -0.747 . . . . 0.13 108.983 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -144.41 -171.68 14.52 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.577 -0.821 . . . . 0.17999999999999999 112.095 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.729 ' HB3' ' HE2' ' A' ' 95' ' ' LYS . 20.0 mmt180 -70.47 122.4 19.6 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.879 -0.415 . . . . 1.9299999999999999 109.879 -178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.578 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 56.1 t80 -59.85 127.9 34.25 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.809 -0.441 . . . . 1.4399999999999999 109.809 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -74.49 89.15 2.15 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.229 0.538 . . . . 4.6600000000000001 110.734 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 43.2 m -98.12 29.38 3.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.188 -0.915 . . . . 3.6000000000000001 109.895 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -76.83 81.49 3.42 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.86 -0.609 . . . . 7.5999999999999996 110.739 -176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.78 ' HE2' ' HA ' ' A' ' 177' ' ' LYS . 0.6 OUTLIER -90.27 2.95 54.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.878 -0.601 . . . . 8.6099999999999994 109.461 176.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -164.64 160.17 19.75 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.558 -0.746 . . . . 8.5500000000000007 109.772 -174.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -58.66 -35.42 72.54 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.947 0.351 . . . . 12.18 111.947 -177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -85.56 12.97 7.55 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.995 0.426 . . . . 12.699999999999999 111.397 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -111.61 61.19 0.62 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.624 -0.51 . . . . 13.65 109.624 173.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.56 -0.733 . . . . 15.050000000000001 110.813 -175.463 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 111.66 -0.576 . . . . 14.85 111.66 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.62 165.92 16.63 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.795 0.331 . . . . 13.5 110.888 -176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -117.57 102.04 52.08 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.957 0.408 . . . . 11.25 110.03 178.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -58.09 -30.04 89.05 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.878 2.386 . . . . 11.140000000000001 112.553 -177.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.65 ' HA ' ' HD3' ' A' ' 95' ' ' LYS . 24.6 m -61.35 -23.53 65.81 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.267 0.469 . . . . 9.3000000000000007 112.267 -177.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 87.5 mt -65.49 -18.83 65.62 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.026 0.441 . . . . 7.8899999999999997 110.943 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 94' ' ' ARG . 9.5 mpt_? -88.54 -5.27 58.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.215 0.531 . . . . 7.7800000000000002 110.193 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.65 ' HD3' ' HA ' ' A' ' 92' ' ' SER . 2.3 mptp? -112.27 70.6 0.72 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.75 -0.834 . . . . 2.3700000000000001 108.75 175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.8 t -62.05 -12.3 18.31 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.09 0.404 . . . . 1.79 112.09 -175.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.592 ' C ' HD21 ' A' ' 100' ' ' ASN . . . -69.94 -20.74 76.41 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.819 -0.705 . . . . 0.44 111.845 175.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.4 t 64.32 122.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.032 0.933 . . . . 0.70999999999999996 112.505 -176.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.69 24.18 73.13 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.384 -0.912 . . . . 0.20999999999999999 112.117 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.592 HD21 ' C ' ' A' ' 97' ' ' GLY . 1.6 m120 -86.88 124.26 32.9 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.445 -0.576 . . . . 0.63 109.445 -174.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.493 HG12 ' HB ' ' A' ' 143' ' ' VAL . 20.2 pt -135.67 161.88 37.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.995 -0.548 . . . . 0.14999999999999999 109.803 177.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.42 144.11 50.67 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.864 -0.421 . . . . 0.20999999999999999 109.864 176.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.615 HG12 HG22 ' A' ' 170' ' ' VAL . 4.5 mt -118.82 130.99 72.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.613 -0.721 . . . . 0.14999999999999999 110.166 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -109.65 152.25 25.81 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.587 -0.278 . . . . 1.46 110.702 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.6 t30 72.14 33.65 1.55 Allowed 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.926 0.766 . . . . 0.48999999999999999 111.861 169.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.453 HD23 HG11 ' A' ' 168' ' ' VAL . 17.3 mt -72.64 155.39 40.06 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.063 0.459 . . . . 0.26000000000000001 111.446 178.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.486 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 23.3 t70 -75.25 146.91 40.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.732 -0.667 . . . . 0.70999999999999996 109.832 176.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -60.47 -31.72 70.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.108 -0.496 . . . . 2.2000000000000002 111.796 -176.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t -79.04 -4.29 49.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.575 -0.284 . . . . 1.4099999999999999 111.499 -176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.467 HG12 ' HB3' ' A' ' 107' ' ' ASP . 32.0 mm -73.03 127.14 34.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.419 . . . . 0.26000000000000001 110.393 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.503 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 10.5 t70 -110.89 -177.15 3.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.748 -0.66 . . . . 1.5900000000000001 109.28 -178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.6 ' OD1' ' HA ' ' A' ' 129' ' ' LYS . 69.1 m-80 -72.06 -32.08 66.73 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.565 -0.902 . . . . 0.59999999999999998 108.565 -178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -47.95 74.35 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.675 -1.148 . . . . 2.5800000000000001 108.797 176.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.503 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.63 -43.57 98.6 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.039 -1.437 . . . . 0.14999999999999999 111.103 -177.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.523 HD12 HG22 ' A' ' 130' ' ' VAL . 3.2 tt -66.54 -46.58 75.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.478 -0.783 . . . . 0.16 109.27 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.432 ' CE1' ' HB ' ' A' ' 125' ' ' ILE . 62.3 t80 -60.52 -46.35 90.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.29999999999999999 110.658 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -56.55 -39.49 73.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.858 0.361 . . . . 0.40000000000000002 111.044 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 m -78.1 -54.02 6.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.001 -0.545 . . . . 0.22 112.087 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.401 ' CD1' HD23 ' A' ' 115' ' ' LEU . 9.2 m-85 -72.15 -28.39 63.21 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.683 0.623 . . . . 0.11 112.683 -173.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.8 t -57.67 -28.46 63.78 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.826 0.346 . . . . 0.19 110.809 -178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.4 36.01 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.227 -0.442 . . . . 0.14000000000000001 111.637 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -89.74 -31.99 17.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.984 0.421 . . . . 0.17999999999999999 110.723 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.49 165.41 34.08 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.392 -0.683 . . . . 0.11 111.392 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -62.19 140.84 58.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.971 0.415 . . . . 0.25 109.972 178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.753 HD13 ' SG ' ' A' ' 128' ' ' CYS . 94.8 mt -114.34 133.96 58.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.937 -0.574 . . . . 0.14000000000000001 110.637 -176.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.539 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -91.05 -37.12 13.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.076 -0.712 . . . . 0.54000000000000004 109.076 -179.276 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 70.5 m -159.54 111.11 2.05 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.529 -0.759 . . . . 0.76000000000000001 111.227 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.794 ' SG ' HG13 ' A' ' 143' ' ' VAL . 54.2 m -109.12 144.9 36.57 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.527 -0.546 . . . . 0.71999999999999997 109.527 169.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.6 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 53.1 tptt -135.62 131.96 36.47 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.416 -175.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 115' ' ' LEU . 88.5 t -114.19 110.13 31.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 106.539 -1.652 . . . . 0.28000000000000003 106.539 168.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.448 HG12 ' HG3' ' A' ' 138' ' ' LYS . 15.9 t -79.3 135.9 24.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.55 -0.75 . . . . 0.34000000000000002 109.976 -171.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.412 ' C ' ' HG2' ' A' ' 138' ' ' LYS . 6.6 p -95.43 134.14 38.59 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.626 0.726 . . . . 1.5800000000000001 111.629 -169.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.553 ' HB2' ' HA ' ' A' ' 138' ' ' LYS . 17.0 t70 -87.92 165.92 14.9 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.716 -1.129 . . . . 2.0800000000000001 108.842 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -59.0 -26.36 64.44 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.261 0.553 . . . . 2.4500000000000002 109.702 171.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -93.27 4.5 53.88 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.614 -0.721 . . . . 1.6499999999999999 110.902 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 126.39 -61.9 0.62 Allowed Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.363 -0.922 . . . . 1.1200000000000001 113.938 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.481 ' C ' ' HB2' ' A' ' 133' ' ' ASP . 68.3 m -137.89 129.65 28.38 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 117.352 0.576 . . . . 1.6100000000000001 111.349 -173.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.553 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 18.0 mmmt -66.67 -35.51 80.31 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.086 0.47 . . . . 1.51 112.045 -172.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.2 -13.22 10.4 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.466 -0.874 . . . . 0.31 113.114 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.522 ' OH ' ' HE2' ' A' ' 138' ' ' LYS . 25.6 p90 -132.34 153.44 50.74 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.835 0.35 . . . . 0.48999999999999999 110.907 -176.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.7 173.35 24.02 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.87 -0.605 . . . . 0.12 111.898 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -135.59 143.99 45.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.731 0.265 . . . . 0.25 110.722 -176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.794 HG13 ' SG ' ' A' ' 128' ' ' CYS . 40.1 t -118.58 136.45 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.10000000000000001 111.142 173.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.1 m170 -106.46 106.38 16.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.19 -0.67 . . . . 0.20999999999999999 109.19 166.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.575 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.5 m-85 -89.4 137.61 32.17 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.329 0.585 . . . . 0.17000000000000001 111.354 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.539 ' HA ' HD21 ' A' ' 126' ' ' LEU . 43.7 tt0 -47.86 -40.25 20.9 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.19 -1.368 . . . . 0.56999999999999995 110.951 178.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 41.1 p -120.3 153.0 37.01 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.276 -0.875 . . . . 0.40000000000000002 110.914 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -67.35 -34.95 78.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.91 -0.586 . . . . 0.46999999999999997 110.453 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 12.1 pt-20 -70.04 -34.74 73.64 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.261 -0.427 . . . . 0.73999999999999999 111.737 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.05 -34.84 77.0 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.998 0.427 . . . . 0.17999999999999999 110.649 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.575 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.82 -46.5 84.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.681 -0.691 . . . . 0.16 110.717 177.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 40.3 mt-10 -59.18 -37.7 78.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.781 -0.645 . . . . 1.4199999999999999 111.003 176.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 86.6 mtt180 -59.58 -44.89 93.2 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.983 0.42 . . . . 1.48 110.54 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -36.79 85.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.984 -0.553 . . . . 0.10000000000000001 110.452 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 151' ' ' ALA . 78.1 mt -62.76 -54.17 37.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.209 -0.45 . . . . 0.14999999999999999 111.063 178.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.3 pt-20 -60.59 -44.04 96.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.13 0.49 . . . . 1.0800000000000001 111.613 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.427 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -82.04 -39.42 23.52 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.211 0.819 . . . . 1.1599999999999999 113.211 -170.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 95.4 mmm -92.61 -23.33 19.05 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.618 0.599 . . . . 0.34999999999999998 112.618 -173.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 54.9 t30 -66.85 123.49 20.31 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.225 -0.59 . . . . 0.44 109.695 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.84 8.57 69.42 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.912 -0.661 . . . . 0.28999999999999998 112.626 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 29.2 mmt -96.53 170.75 9.0 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 120.886 0.374 . . . . 1.1799999999999999 111.541 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 33.3 mt -105.22 126.79 52.48 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.571 -0.74 . . . . 0.44 109.377 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 11.5 mt -109.92 108.07 18.22 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.916 -0.772 . . . . 1.02 108.916 168.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 4.7 m-20 78.83 -33.75 0.16 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 124.166 0.916 . . . . 1.71 111.817 176.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 33.4 t70 168.77 -20.87 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.13 -0.941 . . . . 0.84999999999999998 111.754 -177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.486 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 97.6 mtt180 -100.9 138.67 37.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.714 -0.221 . . . . 0.95999999999999996 110.504 -174.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 161' ' ' MET . 3.5 ttmp? -83.96 120.6 26.3 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.453 HG11 HD23 ' A' ' 106' ' ' LEU . 17.1 m -102.64 148.98 7.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-O 121.579 0.704 . . . . 0.17000000000000001 111.615 -174.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 58.4 t80 -107.84 122.42 46.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.862 -1.063 . . . . 0.29999999999999999 109.101 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.615 HG22 HG12 ' A' ' 103' ' ' ILE . 47.1 t -115.14 125.42 72.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.205 -0.665 . . . . 0.13 109.205 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -146.83 -171.46 16.12 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.573 -0.822 . . . . 0.17999999999999999 111.984 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -68.64 136.14 52.51 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.741 -0.466 . . . . 1.9299999999999999 109.741 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.591 ' HE1' ' HB3' ' A' ' 176' ' ' ARG . 4.2 t80 -60.06 103.52 0.23 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.407 -0.36 . . . . 1.4399999999999999 110.624 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -124.95 10.46 8.23 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.16 -0.473 . . . . 4.6600000000000001 110.212 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.2 m -115.67 89.29 3.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.076 -0.511 . . . . 3.6000000000000001 111.597 -174.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.591 ' HB3' ' HE1' ' A' ' 173' ' ' PHE . 5.8 ptp180 -133.58 154.69 50.67 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.07 -0.513 . . . . 7.5999999999999996 110.272 177.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -120.81 -39.01 2.77 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.898 -0.779 . . . . 8.6099999999999994 108.898 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -137.5 158.42 44.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.835 -1.075 . . . . 8.5500000000000007 108.102 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -103.14 65.29 0.86 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.255 -0.578 . . . . 12.18 112.013 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.58 158.48 23.62 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.665 -0.865 . . . . 12.699999999999999 108.665 169.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 63.64 24.88 14.11 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.078 0.466 . . . . 13.65 111.101 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.611 -0.709 . . . . 15.050000000000001 109.175 178.657 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 112.089 -0.404 . . . . 14.85 112.089 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.03 24.73 5.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.561 0.696 . . . . 13.5 110.011 178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.607 ' HB2' ' HG ' ' A' ' 93' ' ' LEU . 12.8 p-10 -102.15 129.1 26.99 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.369 -0.832 . . . . 11.25 111.149 -176.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 8.0 Cg_exo -73.55 -66.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.36 2.04 . . . . 11.140000000000001 110.372 170.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 56.2 m -156.68 90.23 1.15 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.53 -0.759 . . . . 9.3000000000000007 109.34 172.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.607 ' HG ' ' HB2' ' A' ' 90' ' ' ASP . 84.4 mt -77.53 128.61 34.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.491 -0.322 . . . . 7.8899999999999997 110.155 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.69 ' HD2' ' HG3' ' A' ' 177' ' ' LYS . 90.0 mtt-85 -107.57 28.73 7.87 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.41 0.624 . . . . 7.7800000000000002 110.258 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.411 ' HE2' HD22 ' A' ' 93' ' ' LEU . 1.8 mptp? -78.98 80.38 5.32 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.402 -0.962 . . . . 2.3700000000000001 108.402 170.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.8 m -61.11 -18.09 56.14 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.943 0.72 . . . . 1.79 112.943 -171.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.99 -26.24 74.84 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.364 -0.922 . . . . 0.44 111.79 175.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t 65.87 125.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.673 0.789 . . . . 0.70999999999999996 112.22 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.23 23.99 77.11 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 119.809 -1.186 . . . . 0.20999999999999999 111.48 176.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.503 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.1 m120 -88.27 125.96 34.92 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.982 -0.747 . . . . 0.63 108.982 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.527 HG23 ' HB1' ' A' ' 151' ' ' ALA . 22.8 pt -135.4 162.32 37.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 110.096 -0.335 . . . . 0.14999999999999999 110.096 176.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -126.81 140.55 52.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.93 0.395 . . . . 0.20999999999999999 109.991 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 170' ' ' VAL . 5.8 mt -115.19 141.16 33.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.626 -0.715 . . . . 0.14999999999999999 110.033 -177.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 3.0 ttpm? -123.02 148.78 45.16 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.901 -0.136 . . . . 1.46 110.709 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.9 t30 72.43 48.36 0.23 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.664 0.786 . . . . 0.48999999999999999 111.856 175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.544 HD22 HG21 ' A' ' 110' ' ' ILE . 32.3 mt -90.01 160.85 16.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.249 -0.432 . . . . 0.26000000000000001 110.765 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -93.9 155.57 17.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.984 -0.553 . . . . 0.70999999999999996 109.988 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.58 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 43.2 pttt -59.93 -28.01 67.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.428 -0.351 . . . . 2.2000000000000002 111.82 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.2 p -72.64 -8.47 55.46 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.85 0.315 . . . . 1.4099999999999999 111.85 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.613 HG22 HG21 ' A' ' 130' ' ' VAL . 30.9 mm -83.83 117.66 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.417 . . . . 0.26000000000000001 110.353 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -108.96 -175.62 2.82 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.397 -0.964 . . . . 1.5900000000000001 108.397 178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -67.09 -30.37 70.38 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 108.947 -0.76 . . . . 0.59999999999999998 108.947 -177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -49.54 60.32 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.432 -1.258 . . . . 2.5800000000000001 109.457 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.71 -39.69 92.4 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.369 -1.287 . . . . 0.14999999999999999 110.628 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 130' ' ' VAL . 3.6 tt -67.44 -47.5 70.01 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.322 -0.854 . . . . 0.16 109.113 177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.711 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 61.3 t80 -59.52 -46.43 88.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.919 -0.582 . . . . 0.29999999999999999 110.775 176.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -56.09 -39.14 71.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.282 -0.417 . . . . 0.40000000000000002 111.137 -175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.655 HG21 HD21 ' A' ' 163' ' ' LEU . 26.4 m -78.54 -54.25 6.35 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.436 0.532 . . . . 0.22 112.436 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.413 ' CD1' HD23 ' A' ' 115' ' ' LEU . 14.0 m-85 -73.0 -27.2 61.64 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.093 0.775 . . . . 0.11 113.093 -173.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 32.3 t -56.13 -28.84 59.46 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.818 0.303 . . . . 0.19 111.818 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.17 -22.02 37.35 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.887 0.328 . . . . 0.14000000000000001 111.887 178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -92.2 -12.86 31.61 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.538 0.199 . . . . 0.17999999999999999 111.538 -176.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.2 172.93 28.09 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.075 -0.583 . . . . 0.11 111.646 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -71.84 138.78 48.54 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.06 0.457 . . . . 0.25 110.408 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.424 HG21 ' HB3' ' A' ' 128' ' ' CYS . 72.7 mt -111.92 129.25 67.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.79 -0.641 . . . . 0.14000000000000001 109.862 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.709 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.89 -39.63 15.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.53 0.681 . . . . 0.54000000000000004 109.188 -178.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.496 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 50.8 m -151.58 105.06 3.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.286 -0.87 . . . . 0.76000000000000001 111.034 -175.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.711 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 4.6 p -104.1 142.04 35.17 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.35 -0.611 . . . . 0.71999999999999997 109.35 174.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -143.59 130.94 20.92 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.432 -0.507 . . . . 1.0 112.038 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.703 HG22 HD12 ' A' ' 115' ' ' LEU . 57.8 t -114.26 110.66 32.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 106.808 -1.553 . . . . 0.28000000000000003 106.808 170.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 10.9 t -76.4 120.61 26.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.729 -0.669 . . . . 0.34000000000000002 109.324 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 16.6 p -97.17 134.47 40.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.79 0.805 . . . . 1.5800000000000001 112.926 -165.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -87.28 167.26 14.24 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.618 -1.174 . . . . 2.0800000000000001 108.134 174.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -58.45 -25.67 62.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.039 0.447 . . . . 2.4500000000000002 110.088 172.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -92.13 -1.86 56.92 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.716 -0.675 . . . . 1.6499999999999999 111.112 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.58 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 137.59 -67.09 0.53 Allowed Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.304 -0.951 . . . . 1.1200000000000001 113.651 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.664 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 47.3 t -142.45 148.53 37.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.496 0.648 . . . . 1.6100000000000001 110.767 -177.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -83.02 -5.95 59.3 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.355 0.597 . . . . 1.51 110.435 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.42 -21.12 29.13 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.394 -0.907 . . . . 0.31 113.572 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -128.56 151.88 48.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 117.32 0.56 . . . . 0.48999999999999999 111.582 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.42 172.14 24.0 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.375 -0.83 . . . . 0.12 111.616 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.488 ' CD1' ' HE2' ' A' ' 173' ' ' PHE . 34.5 m-85 -135.73 138.17 42.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.995 0.398 . . . . 0.25 110.923 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.525 ' HB ' HG12 ' A' ' 101' ' ' ILE . 47.1 t -110.33 133.89 54.3 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-O 120.985 0.421 . . . . 0.10000000000000001 110.686 172.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.5 OUTLIER -104.22 105.23 15.31 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 108.964 -0.754 . . . . 0.20999999999999999 108.964 167.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.524 ' CE2' HG11 ' A' ' 143' ' ' VAL . 14.4 m-85 -89.8 139.53 30.49 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.048 0.452 . . . . 0.17000000000000001 110.693 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.709 ' HA ' HD21 ' A' ' 126' ' ' LEU . 33.2 tt0 -52.3 -44.06 64.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 114.749 -1.114 . . . . 0.56999999999999995 110.214 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 63.4 p -111.78 150.47 30.26 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 114.666 -1.152 . . . . 0.40000000000000002 110.837 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -68.42 -35.55 77.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.968 -0.56 . . . . 0.46999999999999997 110.572 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.2 pt-20 -69.33 -34.34 74.5 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.237 -0.438 . . . . 0.73999999999999999 111.799 -176.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.16 -34.89 79.45 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.115 0.483 . . . . 0.17999999999999999 110.59 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.527 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -62.64 -45.54 92.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.485 -0.779 . . . . 0.16 110.845 178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.0 mt-10 -59.06 -37.4 76.96 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.95 -0.568 . . . . 1.4199999999999999 110.778 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.486 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 48.3 mtt180 -62.4 -45.59 92.43 Favored 'General case' 0 CA--C 1.523 -0.064 0 CA-C-O 120.986 0.422 . . . . 1.48 110.411 176.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.15 80.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.513 . . . . 0.10000000000000001 110.517 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 151' ' ' ALA . 89.4 mt -61.68 -54.47 34.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.066 -0.515 . . . . 0.14999999999999999 111.324 178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.1 pt-20 -64.35 -43.16 95.45 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.329 0.585 . . . . 1.0800000000000001 111.98 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -78.98 -38.42 36.9 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.23 -0.895 . . . . 1.1599999999999999 112.773 -169.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 84.0 mmm -93.1 -24.21 18.35 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.47 0.545 . . . . 0.34999999999999998 112.47 -175.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -64.75 123.74 20.14 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.464 -0.494 . . . . 0.44 109.811 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.24 14.75 61.69 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.869 -0.681 . . . . 0.28999999999999998 112.909 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.597 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.6 mmt -106.83 162.65 13.61 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.523 -0.398 . . . . 1.1799999999999999 111.792 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.9 mt -98.78 108.76 21.53 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.863 -0.608 . . . . 0.44 109.7 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 118' ' ' THR . 17.3 mt -93.98 110.02 21.72 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.824 -0.751 . . . . 1.02 109.114 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 91.7 m-20 73.01 -67.62 0.26 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.323 -0.853 . . . . 1.71 110.919 -175.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -161.79 14.54 0.09 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.854 -0.612 . . . . 0.84999999999999998 111.491 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -131.34 133.2 45.09 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.813 -0.554 . . . . 0.95999999999999996 109.889 -176.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 161' ' ' MET . 17.6 ttmt -78.64 119.47 21.95 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.41 -0.589 . . . . 1.0 109.41 -179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 18.9 m -101.57 141.98 17.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 121.348 0.594 . . . . 0.17000000000000001 111.183 -173.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -106.74 121.85 45.2 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.07 -0.968 . . . . 0.29999999999999999 109.406 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.508 HG22 HG12 ' A' ' 103' ' ' ILE . 37.7 t -116.07 125.98 73.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 109.549 -0.537 . . . . 0.13 109.549 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -140.05 -165.96 10.48 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.651 -0.785 . . . . 0.17999999999999999 112.02 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -77.26 137.81 39.03 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.834 -0.432 . . . . 1.9299999999999999 109.834 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.488 ' HE2' ' CD1' ' A' ' 142' ' ' PHE . 40.3 t80 -75.85 132.04 40.1 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.425 -0.583 . . . . 1.4399999999999999 109.425 -178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.452 ' HB3' ' NZ ' ' A' ' 174' ' ' LYS . 7.2 mtpm? -53.78 -52.12 61.24 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.373 0.421 . . . . 4.6600000000000001 111.815 -175.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.1 t 72.25 166.95 0.31 Allowed 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.876 0.735 . . . . 3.6000000000000001 110.051 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 177' ' ' LYS . 34.4 mmt180 -81.72 -41.06 21.82 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.087 -0.338 . . . . 7.5999999999999996 110.087 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.69 ' HG3' ' HD2' ' A' ' 94' ' ' ARG . 29.5 tttm 74.17 -37.96 0.38 Allowed 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.516 0.51 . . . . 8.6099999999999994 112.181 175.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -75.15 29.85 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.013 0.435 . . . . 8.5500000000000007 111.471 178.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 177' ' ' LYS . 22.3 ttt180 -89.57 -11.19 43.46 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.713 0.768 . . . . 12.18 108.954 173.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.412 ' HG3' HH11 ' A' ' 94' ' ' ARG . 7.2 pt-20 -164.36 106.63 0.89 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.821 -1.081 . . . . 12.699999999999999 109.47 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -81.86 120.04 24.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.975 -0.557 . . . . 13.65 111.857 -172.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.528 ' HB3' ' NH2' ' A' ' 94' ' ' ARG . 10.3 tp10 . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.305 -0.855 . . . . 15.050000000000001 109.457 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.828 0 N-CA-C 112.087 -0.405 . . . . 14.85 112.087 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.78 61.54 5.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.382 0.611 . . . . 13.5 109.895 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -159.02 146.19 13.02 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.224 -0.898 . . . . 11.25 109.332 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -62.2 -62.93 0.1 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.165 1.91 . . . . 11.140000000000001 111.888 172.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.65 ' HB3' ' O ' ' A' ' 175' ' ' SER . 68.4 m -146.1 47.04 1.24 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.995 0.369 . . . . 9.3000000000000007 111.995 -178.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 60.7 mt -101.57 21.22 14.68 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.133 -0.355 . . . . 7.8899999999999997 110.98 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.413 ' HB3' ' CE1' ' A' ' 173' ' ' PHE . 10.8 mpt_? -65.29 -11.94 46.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.762 0.315 . . . . 7.7800000000000002 111.089 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.519 ' HB2' ' OG ' ' A' ' 175' ' ' SER . 89.2 tttt -89.71 -13.32 37.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.24 -0.436 . . . . 2.3700000000000001 110.541 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.6 t -84.72 21.31 1.56 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.289 0.566 . . . . 1.79 110.948 -174.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -84.42 2.63 87.72 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.797 -0.716 . . . . 0.44 111.442 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 42.8 t 64.62 119.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 C-N-CA 123.802 0.841 . . . . 0.70999999999999996 112.008 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.36 25.51 65.7 Favored Glycine 0 N--CA 1.438 -1.228 0 C-N-CA 120.057 -1.068 . . . . 0.20999999999999999 112.063 175.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.571 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.2 m120 -89.03 123.84 33.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.232 -0.655 . . . . 0.63 109.232 -172.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.565 HG12 ' HB ' ' A' ' 143' ' ' VAL . 17.3 pt -136.43 164.44 31.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.445 -0.343 . . . . 0.14999999999999999 110.301 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.55 147.81 49.81 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.925 -0.398 . . . . 0.20999999999999999 109.925 174.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.596 HG12 HG22 ' A' ' 170' ' ' VAL . 5.3 mt -122.18 137.37 55.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.786 -0.643 . . . . 0.14999999999999999 110.195 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.7 ttpp -116.62 151.15 36.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.745 -0.207 . . . . 1.46 110.739 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.3 t30 73.97 38.4 0.58 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.938 0.774 . . . . 0.48999999999999999 111.543 171.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.496 HD23 HG11 ' A' ' 168' ' ' VAL . 23.2 mt -77.97 158.16 29.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.118 0.485 . . . . 0.26000000000000001 111.399 177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.447 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 20.5 t70 -84.91 151.11 24.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.491 -0.777 . . . . 0.70999999999999996 110.561 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.715 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 14.1 pttm -58.52 -29.99 66.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.751 -0.658 . . . . 2.2000000000000002 112.681 -177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.5 m -82.84 -3.92 57.4 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.168 0.433 . . . . 1.4099999999999999 112.168 -176.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.587 HG22 HG21 ' A' ' 130' ' ' VAL . 31.5 mm -73.97 127.44 35.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.135 0.493 . . . . 0.26000000000000001 110.905 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -112.7 -178.06 3.3 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.049 -0.723 . . . . 1.5900000000000001 109.049 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -70.95 -32.43 69.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.889 -0.782 . . . . 0.59999999999999998 108.889 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.62 -47.59 72.15 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 114.802 -1.09 . . . . 2.5800000000000001 109.01 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.72 -44.16 97.45 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 114.029 -1.441 . . . . 0.14999999999999999 110.904 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.731 HD12 HG22 ' A' ' 130' ' ' VAL . 3.8 tt -65.07 -46.63 80.38 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.985 -0.746 . . . . 0.16 108.985 177.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.635 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 52.7 t80 -59.81 -49.63 76.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.859 -0.61 . . . . 0.29999999999999999 110.911 177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -57.46 -38.69 74.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.926 0.394 . . . . 0.40000000000000002 110.774 -174.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.2 m -76.76 -53.65 7.66 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.881 -0.6 . . . . 0.22 111.507 -178.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -71.88 -28.24 63.39 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.241 0.459 . . . . 0.11 112.241 -175.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 33.7 t -57.62 -29.09 64.25 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.305 0.242 . . . . 0.19 111.314 -177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.55 -22.21 43.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.798 0.332 . . . . 0.14000000000000001 111.475 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.422 ' CE2' ' HG2' ' A' ' 158' ' ' MET . 22.4 m-85 -90.3 -20.36 23.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.189 0.518 . . . . 0.17999999999999999 110.437 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 165.87 162.21 16.66 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.855 -0.898 . . . . 0.11 110.855 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -65.06 142.98 58.22 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.192 0.52 . . . . 0.25 110.03 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.46 ' HB ' ' CD2' ' A' ' 116' ' ' TYR . 76.5 mt -113.44 134.42 56.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.791 -0.641 . . . . 0.14000000000000001 110.014 -178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.525 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.78 -48.25 7.63 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.881 -0.785 . . . . 0.54000000000000004 108.881 -178.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.2 m -143.86 102.43 3.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.062 -0.972 . . . . 0.76000000000000001 110.749 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.5 p -102.12 150.91 22.78 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.729 -0.471 . . . . 0.71999999999999997 109.729 174.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -149.81 131.95 15.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.132 0.491 . . . . 1.0 111.304 -178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.731 HG22 HD12 ' A' ' 115' ' ' LEU . 59.6 t -114.66 110.19 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 106.868 -1.53 . . . . 0.28000000000000003 106.868 171.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 11.4 t -77.43 116.53 20.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 109.097 -0.705 . . . . 0.34000000000000002 109.097 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.78 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 25.4 p -100.86 136.39 40.79 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 113.015 0.746 . . . . 1.5800000000000001 113.015 -163.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -86.63 165.42 16.16 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.843 -1.169 . . . . 2.0800000000000001 107.843 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 25.0 pm0 -64.47 -21.87 66.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 118.555 0.616 . . . . 2.4500000000000002 110.242 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -90.49 -0.3 57.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.978 -0.555 . . . . 1.6499999999999999 110.71 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.715 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 142.66 -73.41 0.36 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.739 -0.743 . . . . 1.1200000000000001 113.062 177.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.78 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 32.2 t -142.08 150.97 41.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.421 0.611 . . . . 1.6100000000000001 109.965 -177.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -81.9 -10.4 59.3 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.121 0.486 . . . . 1.51 110.041 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.81 -14.19 34.74 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.397 -0.906 . . . . 0.31 113.365 175.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 25.7 p90 -130.04 148.13 51.86 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.485 0.643 . . . . 0.48999999999999999 111.868 -174.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.55 174.5 23.41 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.154 -0.93 . . . . 0.12 111.379 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -138.86 143.68 38.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.864 0.332 . . . . 0.25 110.504 -177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.565 ' HB ' HG12 ' A' ' 101' ' ' ILE . 39.6 t -119.0 135.41 59.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.877 0.37 . . . . 0.10000000000000001 111.043 175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.402 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 0.9 OUTLIER -104.49 106.33 16.79 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.844 -0.799 . . . . 0.20999999999999999 108.844 166.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.56 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 11.4 m-85 -89.77 135.37 33.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.21 0.529 . . . . 0.17000000000000001 111.41 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.525 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.8 tt0 -47.29 -44.29 23.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.348 -1.297 . . . . 0.56999999999999995 110.245 176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.7 p -115.05 141.3 48.19 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.422 -1.263 . . . . 0.40000000000000002 111.001 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -60.4 -39.71 88.32 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.52 -0.764 . . . . 0.46999999999999997 111.048 -179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.1 -33.06 73.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.384 -0.371 . . . . 0.73999999999999999 111.728 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.34 -34.95 77.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.137 0.494 . . . . 0.17999999999999999 110.423 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.56 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -61.59 -47.86 83.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.466 -0.788 . . . . 0.16 110.527 177.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.616 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.9 mt-10 -59.13 -39.98 84.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.833 -0.621 . . . . 1.4199999999999999 110.889 177.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 87.1 mtt180 -58.93 -43.46 91.17 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-O 120.95 0.405 . . . . 1.48 110.708 175.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.77 -38.72 92.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.325 -0.398 . . . . 0.10000000000000001 110.663 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 170' ' ' VAL . 87.5 mt -61.3 -51.92 67.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.978 -0.555 . . . . 0.14999999999999999 111.109 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.5 pt-20 -64.23 -43.58 94.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.085 0.469 . . . . 1.0800000000000001 111.897 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.489 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -81.81 -39.47 23.99 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 113.028 0.751 . . . . 1.1599999999999999 113.028 -169.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.604 ' HB2' HG21 ' A' ' 170' ' ' VAL . 93.9 mmm -90.56 -20.73 22.3 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.51 -0.476 . . . . 0.34999999999999998 112.217 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -64.9 123.99 20.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.102 -0.703 . . . . 0.44 109.102 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.95 25.98 43.03 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.563 -0.827 . . . . 0.28999999999999998 112.95 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.589 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 4.1 mmt -113.56 156.71 23.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.596 0.198 . . . . 1.1799999999999999 110.791 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 16.7 mt -95.76 110.76 22.86 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 109.552 -0.536 . . . . 0.44 109.552 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 21.8 mt -96.86 100.28 11.81 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.706 -0.798 . . . . 1.02 109.626 173.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 84.4 m-20 77.49 -25.64 0.2 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.021 -0.99 . . . . 1.71 113.184 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 33.3 t70 170.12 -23.43 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.735 0 O-C-N 123.623 0.577 . . . . 0.84999999999999998 111.918 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.447 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 91.2 mtt180 -111.19 135.49 51.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.441 -0.345 . . . . 0.95999999999999996 110.977 -171.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.1 ttmt -81.81 117.78 22.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.696 -0.684 . . . . 1.0 109.23 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.496 HG11 HD23 ' A' ' 106' ' ' LEU . 15.3 m -100.15 147.29 7.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.862 0.839 . . . . 0.17000000000000001 111.765 -171.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 52.1 t80 -105.84 119.81 40.11 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 114.415 -1.266 . . . . 0.29999999999999999 108.915 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.604 HG21 ' HB2' ' A' ' 158' ' ' MET . 41.3 t -114.49 125.34 71.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 108.82 -0.807 . . . . 0.13 108.82 177.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.72 -170.43 14.51 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.846 -0.692 . . . . 0.17999999999999999 111.62 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -70.08 145.08 51.91 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.996 -0.742 . . . . 1.9299999999999999 108.996 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 94' ' ' ARG . 46.9 t80 -53.94 141.17 28.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.21 0.528 . . . . 1.4399999999999999 111.115 -175.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -76.85 12.82 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.767 1.025 . . . . 4.6600000000000001 113.767 -166.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.65 ' O ' ' HB3' ' A' ' 92' ' ' SER . 72.0 p -79.92 3.21 20.59 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 121.852 -0.53 . . . . 3.6000000000000001 110.84 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -78.22 -1.53 33.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.044 0.45 . . . . 7.5999999999999996 110.306 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -86.11 79.58 9.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.281 0.562 . . . . 8.6099999999999994 110.837 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -139.11 -36.8 0.52 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.095 -1.076 . . . . 8.5500000000000007 108.095 171.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -124.77 104.84 8.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.512 -1.222 . . . . 12.18 108.212 171.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -115.1 91.13 3.51 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.24 0.543 . . . . 12.699999999999999 111.041 -174.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -118.47 33.19 5.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.419 -0.81 . . . . 13.65 109.466 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--O 1.25 1.104 0 CA-C-N 115.465 -0.789 . . . . 15.050000000000001 109.965 -176.229 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 2.001 0 N-CA-C 112.447 -0.261 . . . . 14.85 112.447 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -128.93 32.33 4.78 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.256 -1.016 . . . . 13.5 108.256 175.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -153.74 144.47 15.98 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 114.35 -1.295 . . . . 11.25 109.741 -170.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -61.39 -56.76 0.74 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.067 1.845 . . . . 11.140000000000001 110.439 171.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 33.2 t -167.21 91.02 0.38 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.505 -0.77 . . . . 9.3000000000000007 109.953 174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 65.1 mt -57.49 140.07 51.61 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 109.519 -0.548 . . . . 7.8899999999999997 109.519 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 94' ' ' ARG . 13.5 mtp180 -68.8 -29.77 68.21 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 111.989 0.366 . . . . 7.7800000000000002 111.989 -172.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.565 ' HG2' ' HA ' ' A' ' 174' ' ' LYS . 53.2 mttp 62.93 88.77 0.09 Allowed 'General case' 0 N--CA 1.482 1.147 0 O-C-N 123.425 0.453 . . . . 2.3700000000000001 111.014 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 13.3 p -64.56 -14.12 56.11 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 121.881 -0.512 . . . . 1.79 112.004 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.602 ' C ' HD21 ' A' ' 100' ' ' ASN . . . -74.99 -30.02 59.88 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.89 -0.671 . . . . 0.44 111.459 174.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.1 t 62.61 124.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.149 0.98 . . . . 0.70999999999999996 113.088 -176.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 74.62 22.61 76.96 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.357 -0.838 . . . . 0.20999999999999999 111.935 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.602 HD21 ' C ' ' A' ' 97' ' ' GLY . 1.2 m120 -85.48 124.69 32.35 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.094 -0.706 . . . . 0.63 109.094 -175.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.583 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.7 pt -135.86 151.96 30.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 109.71 -0.478 . . . . 0.14999999999999999 109.71 175.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.786 ' HB3' ' HB2' ' A' ' 173' ' ' PHE . 0.0 OUTLIER -116.61 137.09 52.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.905 -0.406 . . . . 0.20999999999999999 109.905 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.596 HG12 HG22 ' A' ' 170' ' ' VAL . 6.5 mt -116.0 134.66 58.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.503 -0.771 . . . . 0.14999999999999999 109.983 -177.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -118.94 151.62 37.82 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.69 -0.232 . . . . 1.46 110.534 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 47.5 t30 76.91 34.7 0.41 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.045 0.841 . . . . 0.48999999999999999 111.282 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.536 HD22 HG21 ' A' ' 110' ' ' ILE . 22.7 mt -77.06 162.09 27.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.217 -0.447 . . . . 0.26000000000000001 110.925 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -92.57 152.13 19.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.101 -0.499 . . . . 0.70999999999999996 110.122 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.459 ' HA ' ' HB2' ' A' ' 137' ' ' SER . 55.5 pttt -57.11 -29.13 63.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.902 -0.59 . . . . 2.2000000000000002 112.16 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.0 m -72.43 -14.96 61.82 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.427 -0.351 . . . . 1.4099999999999999 111.741 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.536 HG21 HD22 ' A' ' 106' ' ' LEU . 37.6 mm -76.61 123.18 32.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.2 0.524 . . . . 0.26000000000000001 111.137 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 27.3 t70 -109.31 -177.37 3.27 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.376 -0.829 . . . . 1.5900000000000001 109.043 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -71.43 -33.22 69.21 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.79 -0.818 . . . . 0.59999999999999998 108.79 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -46.89 75.09 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 114.547 -1.206 . . . . 2.5800000000000001 108.949 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.28 -44.19 97.64 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.973 -1.467 . . . . 0.14999999999999999 110.83 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.684 HD12 HG22 ' A' ' 130' ' ' VAL . 3.6 tt -64.21 -46.84 82.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.443 -0.799 . . . . 0.16 109.056 177.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.745 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 41.6 t80 -59.14 -49.25 78.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 0.29999999999999999 110.573 176.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -57.0 -37.42 71.64 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.937 0.399 . . . . 0.40000000000000002 111.22 -175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.551 HG21 HD21 ' A' ' 163' ' ' LEU . 9.1 m -77.98 -53.58 7.27 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.138 -0.483 . . . . 0.22 111.832 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.426 ' CD1' HD23 ' A' ' 115' ' ' LEU . 9.9 m-85 -72.97 -27.5 61.85 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.754 0.649 . . . . 0.11 112.754 -174.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 24.0 t -56.89 -28.35 61.8 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 122.498 0.319 . . . . 0.19 111.633 -175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.95 -22.57 38.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.833 0.349 . . . . 0.14000000000000001 111.46 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.569 ' HZ ' ' HE2' ' A' ' 157' ' ' LYS . 34.2 m-85 -91.95 -11.72 35.39 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 120.83 0.348 . . . . 0.17999999999999999 111.086 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.95 169.1 20.47 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 111.796 -0.522 . . . . 0.11 111.796 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -69.17 138.35 54.05 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.942 0.401 . . . . 0.25 110.438 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.43 HG21 ' HB3' ' A' ' 128' ' ' CYS . 76.0 mt -110.17 132.71 57.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.928 -0.578 . . . . 0.14000000000000001 109.988 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.615 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.27 -45.55 11.16 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.603 -0.888 . . . . 0.54000000000000004 108.603 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.1 m -144.73 109.27 4.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.103 -0.953 . . . . 0.76000000000000001 110.75 -178.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.745 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.8 p -103.68 138.4 40.37 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.176 -0.676 . . . . 0.71999999999999997 109.176 172.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -136.23 126.9 27.19 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.938 0.399 . . . . 1.0 111.078 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.684 HG22 HD12 ' A' ' 115' ' ' LEU . 89.8 t -111.03 109.82 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 N-CA-C 105.983 -1.858 . . . . 0.28000000000000003 105.983 168.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.59 HG12 ' HG3' ' A' ' 138' ' ' LYS . 9.0 t -75.16 115.11 16.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 108.688 -0.856 . . . . 0.34000000000000002 108.688 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 4.1 p -98.59 135.93 39.41 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.595 -0.729 . . . . 1.5800000000000001 111.396 -169.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -85.89 163.34 18.13 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.432 -0.951 . . . . 2.0800000000000001 108.432 176.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -57.52 -26.05 60.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.016 0.436 . . . . 2.4500000000000002 110.458 173.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -92.17 -2.61 56.45 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.107 -0.497 . . . . 1.6499999999999999 110.899 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 143.46 -75.68 0.31 Allowed Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.54 -0.838 . . . . 1.1200000000000001 113.695 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.653 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 11.1 t -138.78 147.48 42.64 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 117.946 0.873 . . . . 1.6100000000000001 110.942 -175.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.59 ' HG3' HG12 ' A' ' 131' ' ' VAL . 4.8 mmpt? -84.25 -13.74 51.81 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.145 0.498 . . . . 1.51 110.487 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 105.35 -14.73 47.24 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.395 -0.907 . . . . 0.31 113.547 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -132.99 158.7 42.03 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.337 0.568 . . . . 0.48999999999999999 111.701 -175.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.88 174.77 28.41 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.496 -0.774 . . . . 0.12 112.165 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -138.92 139.02 37.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.666 0.233 . . . . 0.25 110.541 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.583 ' HB ' HG12 ' A' ' 101' ' ' ILE . 47.7 t -111.64 136.52 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 CA-C-O 120.829 0.347 . . . . 0.10000000000000001 110.651 173.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -106.1 106.05 16.38 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.119 -0.697 . . . . 0.20999999999999999 109.119 166.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.5 m-85 -89.02 137.41 32.34 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.125 0.488 . . . . 0.17000000000000001 110.856 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.615 ' HA ' HD21 ' A' ' 126' ' ' LEU . 43.3 tt0 -47.54 -43.95 25.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.348 -1.296 . . . . 0.56999999999999995 110.528 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.9 p -114.57 146.26 40.98 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.642 -1.163 . . . . 0.40000000000000002 111.191 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -62.37 -37.68 86.65 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.569 -0.741 . . . . 0.46999999999999997 111.191 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.93 -34.32 73.31 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.559 -0.292 . . . . 0.73999999999999999 111.774 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.33 -35.21 76.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.125 0.488 . . . . 0.17999999999999999 110.297 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.597 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.53 -44.12 95.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.439 -0.8 . . . . 0.16 110.51 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -59.46 -44.04 93.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.921 -0.582 . . . . 1.4199999999999999 110.214 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -58.55 -39.58 80.63 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.904 0.383 . . . . 1.48 110.641 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.6 -36.65 84.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.935 -0.575 . . . . 0.10000000000000001 110.368 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 151' ' ' ALA . 80.4 mt -61.68 -56.24 19.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.406 -0.361 . . . . 0.14999999999999999 111.32 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.95 -43.79 77.83 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.23 0.538 . . . . 1.0800000000000001 111.278 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.569 ' HE2' ' HZ ' ' A' ' 122' ' ' PHE . 0.4 OUTLIER -83.14 -39.53 20.94 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.517 -0.765 . . . . 1.1599999999999999 112.541 -169.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.519 ' HB2' HG21 ' A' ' 170' ' ' VAL . 89.6 mmm -91.85 -24.44 19.35 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.527 -0.469 . . . . 0.34999999999999998 112.028 -172.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -66.78 123.63 20.67 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.424 -0.584 . . . . 0.44 109.424 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.41 17.6 62.04 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.765 -0.731 . . . . 0.28999999999999998 112.732 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.672 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 29.5 mmt -106.1 166.13 10.72 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-O 120.74 0.305 . . . . 1.1799999999999999 111.186 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 20.7 mt -101.25 122.13 43.11 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 109.368 -0.604 . . . . 0.44 109.368 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.551 HD21 HG21 ' A' ' 118' ' ' THR . 21.6 mt -107.04 102.15 11.52 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.874 -0.731 . . . . 1.02 109.212 170.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 57.5 m-20 78.61 -26.39 0.18 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.976 0.798 . . . . 1.71 112.584 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 20.2 t70 165.38 -23.65 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.289 0.636 . . . . 0.84999999999999998 111.332 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -101.68 134.15 45.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.269 -0.423 . . . . 0.95999999999999996 110.578 -172.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.672 ' HA ' ' O ' ' A' ' 161' ' ' MET . 16.7 ttmt -81.96 118.26 22.83 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.316 -0.624 . . . . 1.0 109.316 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.436 HG11 HD23 ' A' ' 106' ' ' LEU . 15.7 m -101.3 146.95 8.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.568 0.699 . . . . 0.17000000000000001 111.37 -172.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 72.6 t80 -106.57 120.78 42.84 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.781 -1.1 . . . . 0.29999999999999999 109.186 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.596 HG22 HG12 ' A' ' 103' ' ' ILE . 44.3 t -115.17 124.93 72.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.188 -0.671 . . . . 0.13 109.188 178.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -142.92 -170.89 13.11 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.497 -0.859 . . . . 0.17999999999999999 112.47 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -77.38 120.84 22.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.136 0.494 . . . . 1.9299999999999999 110.954 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.786 ' HB2' ' HB3' ' A' ' 102' ' ' PHE . 15.6 t80 -121.27 145.45 47.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.732 -0.667 . . . . 1.4399999999999999 109.27 178.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.565 ' HA ' ' HG2' ' A' ' 95' ' ' LYS . 44.6 pttt -92.27 -167.1 1.69 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.556 0.217 . . . . 4.6600000000000001 110.855 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.422 ' HB2' ' H ' ' A' ' 97' ' ' GLY . 26.1 t -83.21 -36.5 24.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.84 0.352 . . . . 3.6000000000000001 110.708 -175.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -110.09 116.49 31.65 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.36 -0.382 . . . . 7.5999999999999996 109.981 178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -62.66 144.95 55.73 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 109.685 -0.487 . . . . 8.6099999999999994 109.685 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -161.21 112.28 1.76 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.46 -0.57 . . . . 8.5500000000000007 109.46 -174.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -52.79 109.8 0.45 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.773 0.797 . . . . 12.18 112.026 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -129.3 122.23 29.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.127 -0.942 . . . . 12.699999999999999 108.764 175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 64.85 29.05 12.71 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.561 0.538 . . . . 13.65 110.868 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.543 -0.741 . . . . 15.050000000000001 109.06 179.817 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 N-CA-C 111.688 -0.565 . . . . 14.85 111.688 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.55 -47.7 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.966 0.413 . . . . 13.5 110.502 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -161.66 111.14 1.2 Allowed Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.922 -0.581 . . . . 11.25 109.822 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -69.93 -27.27 25.85 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 122.079 1.853 . . . . 11.140000000000001 113.042 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.6 m -81.76 -43.1 18.85 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.733 0.642 . . . . 9.3000000000000007 112.733 -178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 96' ' ' SER . 46.7 tp -97.44 -14.9 20.9 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.833 -0.542 . . . . 7.8899999999999997 110.771 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.42 -92.05 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.616 -0.72 . . . . 7.7800000000000002 110.431 -176.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -138.57 109.39 6.69 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.328 -0.619 . . . . 2.3700000000000001 109.328 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.581 ' HB3' HD21 ' A' ' 93' ' ' LEU . 3.2 p -71.92 -22.2 61.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 118.708 0.685 . . . . 1.79 110.851 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.539 ' C ' HD21 ' A' ' 100' ' ' ASN . . . -64.14 -41.46 98.4 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.743 -0.662 . . . . 0.44 112.286 176.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.1 t 66.35 127.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.469 0.708 . . . . 0.70999999999999996 112.343 -177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 73.27 23.08 78.16 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.635 -0.793 . . . . 0.20999999999999999 112.255 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.539 HD21 ' C ' ' A' ' 97' ' ' GLY . 1.2 m120 -85.02 123.96 31.17 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.377 -0.601 . . . . 0.63 109.377 -176.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.485 HG12 ' HB ' ' A' ' 143' ' ' VAL . 19.5 pt -135.67 163.47 35.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.704 -0.48 . . . . 0.14999999999999999 109.704 176.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.25 145.18 50.51 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.462 -0.495 . . . . 0.20999999999999999 109.858 175.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.587 HG12 HG22 ' A' ' 170' ' ' VAL . 5.5 mt -118.19 131.64 70.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.642 -0.708 . . . . 0.14999999999999999 109.863 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.3 ttpp -109.21 148.72 30.49 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.538 -0.301 . . . . 1.46 110.66 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.7 t30 70.46 39.93 1.15 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.919 0.762 . . . . 0.48999999999999999 112.148 171.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.631 HD22 HG21 ' A' ' 110' ' ' ILE . 21.7 mt -73.77 157.36 36.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.081 0.467 . . . . 0.26000000000000001 111.383 177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.545 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 24.5 t70 -81.14 148.98 29.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.381 -0.827 . . . . 0.70999999999999996 111.05 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -52.78 -37.57 59.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.048 -0.978 . . . . 2.2000000000000002 112.419 -179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.2 m -81.8 -4.74 57.16 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 112.08 0.4 . . . . 1.4099999999999999 112.08 -175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.631 HG21 HD22 ' A' ' 106' ' ' LEU . 28.4 mm -74.47 120.44 23.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.242 0.544 . . . . 0.26000000000000001 110.766 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.492 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 8.1 t70 -109.04 -176.15 2.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.33 -0.85 . . . . 1.5900000000000001 108.882 -178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -69.4 -33.97 73.82 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 108.799 -0.815 . . . . 0.59999999999999998 108.799 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.47 -45.98 74.34 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.539 -1.209 . . . . 2.5800000000000001 108.896 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.492 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.56 -43.8 98.2 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.687 -1.597 . . . . 0.14999999999999999 110.646 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.641 HD12 HG22 ' A' ' 130' ' ' VAL . 3.7 tt -65.46 -47.38 76.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.536 -0.756 . . . . 0.16 109.386 177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.742 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.6 t80 -59.2 -46.6 88.01 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.991 -0.549 . . . . 0.29999999999999999 110.963 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -56.93 -40.09 75.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.697 0.284 . . . . 0.40000000000000002 111.087 -175.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 50.9 m -78.46 -53.62 7.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.37 0.508 . . . . 0.22 112.37 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.463 ' CD1' HD23 ' A' ' 115' ' ' LEU . 9.4 m-85 -71.9 -28.09 63.27 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.688 0.625 . . . . 0.11 112.688 -173.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.8 t -57.67 -28.96 64.23 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.539 0.209 . . . . 0.19 111.366 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.23 -22.26 39.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.751 0.31 . . . . 0.14000000000000001 111.645 177.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -89.84 -20.57 23.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.843 0.354 . . . . 0.17999999999999999 111.122 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.4 168.97 30.35 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 111.584 -0.606 . . . . 0.11 111.584 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -68.77 132.59 47.05 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.25 110.092 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 128' ' ' CYS . 73.5 mt -104.96 126.8 59.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.106 -0.497 . . . . 0.14000000000000001 109.993 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.588 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -83.2 -35.25 25.6 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.9 -0.778 . . . . 0.54000000000000004 108.9 -178.162 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.0 m -159.06 119.63 3.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.129 -0.941 . . . . 0.76000000000000001 110.412 -177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.742 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.9 p -118.97 142.34 47.87 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.567 -0.531 . . . . 0.71999999999999997 109.567 176.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -139.94 132.28 28.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.889 0.376 . . . . 1.0 111.485 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.641 HG22 HD12 ' A' ' 115' ' ' LEU . 96.1 t -114.3 109.37 28.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 106.556 -1.646 . . . . 0.28000000000000003 106.556 169.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 17.4 t -76.36 117.3 20.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 109.159 -0.682 . . . . 0.34000000000000002 109.159 -173.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.678 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 58.7 m -101.0 137.75 38.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.539 -0.755 . . . . 1.5800000000000001 112.271 -166.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.4 ' H ' ' CA ' ' A' ' 137' ' ' SER . 24.3 t70 -85.44 162.12 19.12 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.825 -1.176 . . . . 2.0800000000000001 107.825 174.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.7 pm0 -64.17 -19.67 65.47 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 118.284 0.493 . . . . 2.4500000000000002 110.275 177.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -92.21 -4.3 54.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.992 -0.549 . . . . 1.6499999999999999 110.856 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 146.96 -72.89 0.31 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.402 -0.904 . . . . 1.1200000000000001 113.935 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.678 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 43.3 t -143.75 147.04 33.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.724 0.762 . . . . 1.6100000000000001 110.558 -174.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 13.2 mtpp -87.19 -7.56 57.82 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-O 121.111 0.482 . . . . 1.51 110.257 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 104.68 -20.85 38.12 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.412 -0.899 . . . . 0.31 113.747 174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 18.3 p90 -125.03 150.58 46.61 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 117.3 0.55 . . . . 0.48999999999999999 111.727 -173.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -140.07 170.94 24.12 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.361 -0.836 . . . . 0.12 111.49 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -135.83 141.05 44.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.927 0.363 . . . . 0.25 110.535 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.491 HG11 ' CE2' ' A' ' 145' ' ' PHE . 30.8 t -115.32 135.49 55.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.881 0.372 . . . . 0.10000000000000001 110.714 173.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.427 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.4 OUTLIER -103.62 106.17 16.61 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.906 -0.776 . . . . 0.20999999999999999 108.906 166.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.491 ' CE2' HG11 ' A' ' 143' ' ' VAL . 12.6 m-85 -91.44 137.39 32.4 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.15 0.5 . . . . 0.17000000000000001 111.08 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.588 ' HA ' HD21 ' A' ' 126' ' ' LEU . 41.8 tt0 -45.73 -42.23 11.62 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.206 -1.361 . . . . 0.56999999999999995 111.273 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 76.7 p -121.05 155.76 33.68 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.182 -0.917 . . . . 0.40000000000000002 110.565 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -67.2 -32.01 72.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.852 -0.613 . . . . 0.46999999999999997 110.206 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 152' ' ' GLU . 10.3 pt-20 -70.67 -34.78 72.36 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.2 -0.455 . . . . 0.73999999999999999 111.964 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.448 ' HB3' ' HB3' ' A' ' 145' ' ' PHE . . . -62.3 -34.85 77.4 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.047 0.451 . . . . 0.17999999999999999 110.22 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.477 ' O ' HG13 ' A' ' 155' ' ' ILE . . . -63.43 -41.08 98.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.648 -0.705 . . . . 0.16 110.171 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 13.0 mm-40 -58.56 -43.43 89.38 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.545 -0.752 . . . . 1.4199999999999999 111.303 177.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 44.8 mtt180 -64.14 -40.06 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 1.48 110.97 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.79 86.36 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.522 -0.308 . . . . 0.10000000000000001 110.46 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 151' ' ' ALA . 81.9 mt -59.54 -51.88 67.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.251 -0.431 . . . . 0.14999999999999999 111.251 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.523 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.1 pt-20 -63.75 -44.65 92.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.006 0.431 . . . . 1.0800000000000001 111.771 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.403 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.06 -39.29 23.66 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 113.173 0.805 . . . . 1.1599999999999999 113.173 -168.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.47 ' HB2' HG21 ' A' ' 170' ' ' VAL . 91.5 mmm -91.25 -20.0 22.39 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.224 0.453 . . . . 0.34999999999999998 112.224 -173.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.02 122.74 19.95 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.049 -0.66 . . . . 0.44 109.353 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.71 17.87 61.01 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.599 -0.81 . . . . 0.28999999999999998 112.458 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -103.63 164.91 11.37 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.233 -0.654 . . . . 1.1799999999999999 109.233 176.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.417 HD23 ' CA ' ' A' ' 167' ' ' LYS . 25.7 mt -103.04 132.18 49.5 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.859 -0.793 . . . . 0.44 108.859 178.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 19.7 mt -116.56 104.2 11.17 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 120.226 -0.59 . . . . 1.02 109.641 171.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 83.2 m-20 76.44 -27.39 0.18 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.129 -0.941 . . . . 1.71 113.063 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 20.5 t70 167.86 -24.5 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 O-C-N 123.938 0.774 . . . . 0.84999999999999998 111.712 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.545 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 94.3 mtt180 -107.2 135.92 47.9 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.787 0.327 . . . . 0.95999999999999996 110.852 -171.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 161' ' ' MET . 23.5 tttt -84.3 119.76 25.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.703 -0.68 . . . . 1.0 109.207 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.502 HG11 HD23 ' A' ' 106' ' ' LEU . 14.3 m -101.45 151.1 5.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.766 0.793 . . . . 0.17000000000000001 111.409 -172.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 35.8 t80 -109.93 120.82 43.66 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.665 -1.152 . . . . 0.29999999999999999 109.123 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.587 HG22 HG12 ' A' ' 103' ' ' ILE . 42.3 t -115.32 125.72 72.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 109.28 -0.637 . . . . 0.13 109.28 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.49 -176.76 22.19 Favored Glycine 0 N--CA 1.438 -1.181 0 C-N-CA 120.62 -0.8 . . . . 0.17999999999999999 111.64 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 28.3 mmt85 -58.21 142.22 48.21 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.024 -0.732 . . . . 1.9299999999999999 109.024 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.449 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 39.8 t80 -59.65 -20.29 55.09 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.556 -0.293 . . . . 1.4399999999999999 111.5 -176.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 173' ' ' PHE . 61.3 tttp 76.96 -52.82 0.57 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.495 0.718 . . . . 4.6600000000000001 110.906 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.2 t -106.66 -163.26 0.9 Allowed 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.372 -0.603 . . . . 3.6000000000000001 109.372 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.514 ' O ' ' HG3' ' A' ' 176' ' ' ARG . 18.2 ptt85 -139.72 91.14 2.45 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.116 -0.698 . . . . 7.5999999999999996 109.116 170.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -92.71 36.14 1.02 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.158 0.504 . . . . 8.6099999999999994 110.036 -173.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.43 ' OE1' ' HB2' ' A' ' 176' ' ' ARG . 0.9 OUTLIER -56.3 126.59 26.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.536 -0.756 . . . . 8.5500000000000007 111.339 179.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.501 ' HA ' ' HE ' ' A' ' 179' ' ' ARG . 0.3 OUTLIER -104.93 116.95 32.83 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.782 -0.645 . . . . 12.18 109.705 178.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -128.88 70.33 1.4 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.749 0.785 . . . . 12.699999999999999 109.83 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.85 21.96 2.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.41 -0.814 . . . . 13.65 111.23 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--O 1.247 0.952 0 CA-C-N 115.597 -0.729 . . . . 15.050000000000001 109.694 178.506 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 111.738 -0.545 . . . . 14.85 111.738 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.89 163.8 16.95 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.325 -0.25 . . . . 13.5 110.325 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -129.4 103.84 17.91 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.562 0.22 . . . . 11.25 110.578 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.72 -26.39 60.7 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 121.971 1.781 . . . . 11.140000000000001 110.976 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.3 m -91.88 26.24 2.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.351 -0.841 . . . . 9.3000000000000007 110.655 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.551 HD23 ' O ' ' A' ' 93' ' ' LEU . 6.2 tt -69.72 -26.99 64.6 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.499 -0.926 . . . . 7.8899999999999997 108.499 176.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.602 ' H ' ' HD2' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -126.44 -178.59 4.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.375 -0.83 . . . . 7.7800000000000002 109.015 175.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -145.7 70.67 1.25 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 120.885 -0.326 . . . . 2.3700000000000001 111.307 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.4 p -74.17 174.89 8.1 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 109.475 -0.565 . . . . 1.79 109.475 171.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.49 -48.47 3.66 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.224 -0.988 . . . . 0.44 110.829 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.7 t 65.3 127.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 123.95 0.9 . . . . 0.70999999999999996 111.987 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.78 24.18 77.01 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 119.74 -1.219 . . . . 0.20999999999999999 111.634 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.469 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.1 m-80 -85.12 124.02 31.3 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.29 -0.633 . . . . 0.63 109.29 -173.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.578 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.3 pt -135.66 159.98 39.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 110.015 -0.365 . . . . 0.14999999999999999 110.015 176.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.51 143.22 50.79 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.605 -0.517 . . . . 0.20999999999999999 109.605 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.552 HG12 HG22 ' A' ' 170' ' ' VAL . 6.1 mt -118.56 133.81 64.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.854 -0.612 . . . . 0.14999999999999999 110.37 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -114.25 150.07 34.92 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.25 -0.432 . . . . 1.46 110.318 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 67.99 54.68 0.6 Allowed 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.844 0.715 . . . . 0.48999999999999999 111.63 169.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.534 HD22 HG21 ' A' ' 110' ' ' ILE . 12.1 mt -89.78 159.53 16.99 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.614 -0.721 . . . . 0.26000000000000001 111.264 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.572 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 14.9 t70 -77.75 151.09 34.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.70999999999999996 109.95 176.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.467 ' HA ' ' OG ' ' A' ' 137' ' ' SER . 24.5 pttm -63.65 -31.88 73.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.617 -0.72 . . . . 2.2000000000000002 111.663 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.4 p -76.41 -4.68 43.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.796 0.331 . . . . 1.4099999999999999 111.753 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.534 HG21 HD22 ' A' ' 106' ' ' LEU . 40.4 mm -77.26 121.55 29.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.216 0.532 . . . . 0.26000000000000001 110.734 -179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' A' ' 112' ' ' ASN . 26.9 t70 -108.15 -178.68 3.67 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.751 -0.833 . . . . 1.5900000000000001 108.751 177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.412 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 2.8 m-20 -63.48 -38.95 93.09 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.639 -0.875 . . . . 0.59999999999999998 108.639 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.961 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.87 -49.28 78.11 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.006 -0.997 . . . . 2.5800000000000001 110.359 178.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.403 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.66 -43.66 98.44 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.296 -1.32 . . . . 0.14999999999999999 111.412 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 130' ' ' VAL . 4.3 tt -64.49 -47.5 78.7 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.198 -0.667 . . . . 0.16 109.198 177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.717 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 68.7 t80 -59.84 -46.7 88.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.989 -0.55 . . . . 0.29999999999999999 110.608 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -57.03 -39.16 74.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.316 -0.402 . . . . 0.40000000000000002 110.989 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.658 HG21 HD21 ' A' ' 163' ' ' LEU . 20.7 m -77.04 -53.39 7.86 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.047 -0.524 . . . . 0.22 111.681 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -72.52 -29.0 63.21 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 112.434 0.531 . . . . 0.11 112.434 -175.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.3 t -57.97 -28.05 63.99 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.6 0.238 . . . . 0.19 111.003 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.49 -22.73 34.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.461 -0.336 . . . . 0.14000000000000001 111.345 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -93.02 -13.92 28.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.456 -0.338 . . . . 0.17999999999999999 111.099 -179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.04 169.08 22.88 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.848 -0.692 . . . . 0.11 112.137 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -66.23 137.71 57.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.915 0.388 . . . . 0.25 110.54 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.493 ' HB ' ' CE1' ' A' ' 116' ' ' TYR . 76.3 mt -113.34 132.34 62.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.739 -0.664 . . . . 0.14000000000000001 109.711 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -85.89 -42.34 14.17 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.869 -0.789 . . . . 0.54000000000000004 108.869 -178.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.8 m -149.34 125.09 10.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.782 -1.099 . . . . 0.76000000000000001 110.279 -177.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.717 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 19.8 p -122.32 151.74 40.83 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.173 -0.677 . . . . 0.71999999999999997 109.173 174.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -143.14 129.72 20.19 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.627 -0.429 . . . . 1.0 111.727 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.553 HG22 HD12 ' A' ' 115' ' ' LEU . 70.8 t -114.87 109.67 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.649 0 N-CA-C 106.796 -1.557 . . . . 0.28000000000000003 106.796 168.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 138' ' ' LYS . 5.6 t -77.23 127.08 38.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.775 -0.648 . . . . 0.34000000000000002 109.373 -174.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 18.6 m -96.77 135.97 37.98 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.826 -0.624 . . . . 1.5800000000000001 111.238 -168.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.706 ' HA ' ' HD2' ' A' ' 138' ' ' LYS . 25.5 t70 -85.27 166.32 16.6 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.491 -0.929 . . . . 2.0800000000000001 108.491 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -62.44 -26.16 68.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.4 -0.593 . . . . 2.4500000000000002 109.4 173.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 -93.2 4.26 54.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.685 -0.688 . . . . 1.6499999999999999 110.742 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 133.08 -66.11 0.58 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.055 -1.069 . . . . 1.1200000000000001 114.245 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.467 ' OG ' ' HA ' ' A' ' 108' ' ' LYS . 11.0 p -138.35 131.41 29.94 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 117.42 0.61 . . . . 1.6100000000000001 111.869 -170.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.706 ' HD2' ' HA ' ' A' ' 133' ' ' ASP . 13.3 mmmt -70.54 -36.83 73.92 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 121.479 0.657 . . . . 1.51 111.028 -176.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 120.96 -11.26 10.06 Favored Glycine 0 C--N 1.314 -0.679 0 CA-C-N 115.184 -0.917 . . . . 0.31 113.75 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -133.01 156.62 47.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 117.243 0.521 . . . . 0.48999999999999999 110.913 -176.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.56 177.22 26.94 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.893 -0.594 . . . . 0.12 112.012 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -140.82 143.75 34.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.867 0.333 . . . . 0.25 111.174 -176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.578 ' HB ' HG12 ' A' ' 101' ' ' ILE . 38.8 t -119.21 133.04 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.981 0.42 . . . . 0.10000000000000001 111.154 172.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.7 OUTLIER -103.47 105.82 16.18 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.775 -0.824 . . . . 0.20999999999999999 108.775 165.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.519 ' CE2' HG11 ' A' ' 143' ' ' VAL . 13.7 m-85 -88.19 138.5 31.38 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.94 0.4 . . . . 0.17000000000000001 111.008 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.625 ' HA ' HD21 ' A' ' 126' ' ' LEU . 26.4 tt0 -48.48 -47.33 38.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.903 -1.044 . . . . 0.56999999999999995 110.433 177.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 80.9 p -109.98 151.65 26.87 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.62 -1.173 . . . . 0.40000000000000002 110.672 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -67.89 -36.14 79.72 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.959 -0.564 . . . . 0.46999999999999997 110.719 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 14.0 pt-20 -70.04 -35.38 74.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.352 0.501 . . . . 0.73999999999999999 112.352 -176.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.45 -34.89 77.7 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.043 0.449 . . . . 0.17999999999999999 110.403 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.513 ' O ' HG13 ' A' ' 155' ' ' ILE . . . -63.6 -43.61 96.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.666 -0.697 . . . . 0.16 110.448 177.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 33.5 mt-10 -58.89 -37.75 77.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.974 -0.557 . . . . 1.4199999999999999 110.722 178.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 92.2 mtt180 -66.72 -44.31 81.94 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.805 0.336 . . . . 1.48 110.634 177.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.12 -38.92 90.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 0.10000000000000001 110.631 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 151' ' ' ALA . 84.4 mt -59.16 -53.99 40.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.14999999999999999 111.533 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.1 pt-20 -64.91 -44.63 88.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.332 0.587 . . . . 1.0800000000000001 111.967 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.453 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -77.62 -38.27 48.34 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.311 -0.859 . . . . 1.1599999999999999 112.665 -169.054 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.43 ' O ' ' HB2' ' A' ' 161' ' ' MET . 89.0 mmm -94.09 -17.75 22.5 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.496 -0.482 . . . . 0.34999999999999998 112.256 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.432 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 52.5 t30 -69.66 123.33 21.09 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 119.919 -0.712 . . . . 0.44 109.113 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.61 8.79 79.76 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.687 -0.768 . . . . 0.28999999999999998 112.061 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.7 OUTLIER -91.32 159.63 15.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.725 0.297 . . . . 1.1799999999999999 110.248 178.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 15.2 mt -104.49 108.23 19.55 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.644 -0.502 . . . . 0.44 109.644 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.658 HD21 HG21 ' A' ' 118' ' ' THR . 22.5 mt -93.42 105.75 17.78 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 119.75 -0.78 . . . . 1.02 109.395 173.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 73.06 -58.32 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.165 -0.925 . . . . 1.71 112.474 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -166.97 14.61 0.03 OUTLIER 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.288 -0.414 . . . . 0.84999999999999998 111.894 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.572 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 92.7 mtt180 -135.54 134.66 39.65 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.713 -0.395 . . . . 0.95999999999999996 110.423 -175.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.3 tttt -82.18 121.57 26.77 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.707 -0.679 . . . . 1.0 109.236 -177.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.6 m -102.04 143.36 14.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.467 0.651 . . . . 0.17000000000000001 111.3 -173.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.432 ' HA ' ' OD1' ' A' ' 159' ' ' ASN . 63.2 t80 -106.32 119.88 40.4 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.231 -0.895 . . . . 0.29999999999999999 109.062 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.552 HG22 HG12 ' A' ' 103' ' ' ILE . 43.9 t -115.16 126.57 72.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.234 -0.654 . . . . 0.13 109.234 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.63 -178.91 21.51 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 120.529 -0.843 . . . . 0.17999999999999999 112.199 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.5 mmt180 -67.39 126.78 30.36 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.226 -0.287 . . . . 1.9299999999999999 110.226 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.889 ' HD1' ' H ' ' A' ' 175' ' ' SER . 4.6 t80 -66.15 138.5 57.75 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.423 -0.954 . . . . 1.4399999999999999 108.423 174.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -69.86 -11.36 60.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.679 0.622 . . . . 4.6600000000000001 112.679 -173.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.889 ' H ' ' HD1' ' A' ' 173' ' ' PHE . 67.0 m 60.76 88.65 0.08 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.617 0.722 . . . . 3.6000000000000001 111.225 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -145.75 -66.03 0.31 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.393 -0.821 . . . . 7.5999999999999996 110.132 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.6 ' HE3' ' HG2' ' A' ' 182' ' ' GLU . 2.6 tmmm? -94.61 129.91 41.28 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.732 -0.47 . . . . 8.6099999999999994 109.732 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.505 ' N ' ' HD2' ' A' ' 177' ' ' LYS . 9.1 pt-20 -165.95 104.72 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.152 -0.684 . . . . 8.5500000000000007 109.152 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -119.85 -75.2 0.59 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.946 0.403 . . . . 12.18 111.706 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -145.71 105.37 3.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.033 -0.531 . . . . 12.699999999999999 109.963 -171.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 56.48 23.63 7.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.318 0.58 . . . . 13.65 110.601 -175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.6 ' HG2' ' HE3' ' A' ' 177' ' ' LYS . 33.7 tt0 . . . . . 0 C--O 1.247 0.928 0 CA-C-N 115.348 -0.842 . . . . 15.050000000000001 108.793 -176.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 111.454 -0.659 . . . . 14.85 111.454 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.62 -42.22 18.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.748 0.309 . . . . 13.5 110.787 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.446 ' HB2' ' HG ' ' A' ' 93' ' ' LEU . 2.0 p-10 -148.41 138.32 12.69 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.253 -0.431 . . . . 11.25 110.302 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -84.03 45.05 1.67 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.661 2.241 . . . . 11.140000000000001 111.482 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 21.8 m 69.66 76.28 0.22 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.24 -0.891 . . . . 9.3000000000000007 110.362 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.446 ' HG ' ' HB2' ' A' ' 90' ' ' ASP . 79.3 mt -94.48 -42.41 8.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.37 -0.832 . . . . 7.8899999999999997 110.575 178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.5 mtp180 53.73 -166.24 0.08 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.962 -0.563 . . . . 7.7800000000000002 111.7 -176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -116.55 20.2 14.22 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.539 0.685 . . . . 2.3700000000000001 109.613 -176.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.3 m -68.49 -11.23 59.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.336 -0.847 . . . . 1.79 111.62 -177.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -68.09 -31.71 75.45 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 121.053 -0.594 . . . . 0.44 112.213 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 59.22 135.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.325 1.05 . . . . 0.70999999999999996 112.587 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.1 23.0 78.63 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 119.84 -1.172 . . . . 0.20999999999999999 110.739 -175.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.521 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.2 m120 -94.23 127.49 40.12 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.931 -0.766 . . . . 0.63 108.931 -174.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.597 HG23 ' HB1' ' A' ' 151' ' ' ALA . 27.4 pt -134.51 161.36 40.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 110.277 -0.268 . . . . 0.14999999999999999 110.277 177.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.96 143.24 50.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.938 -0.393 . . . . 0.20999999999999999 109.938 176.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.514 HG12 HG22 ' A' ' 170' ' ' VAL . 8.7 mt -116.6 146.73 20.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.756 -0.656 . . . . 0.14999999999999999 109.953 -178.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 168' ' ' VAL . 44.8 tttp -129.61 147.91 51.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.288 -0.415 . . . . 1.46 110.342 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 56.8 t30 64.81 47.7 2.64 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 123.549 0.74 . . . . 0.48999999999999999 111.954 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.664 HD22 HG21 ' A' ' 110' ' ' ILE . 23.0 mt -80.07 151.84 29.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.167 0.508 . . . . 0.26000000000000001 111.447 176.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.533 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 17.9 t70 -77.97 150.95 33.88 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.476 -0.784 . . . . 0.70999999999999996 111.313 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.56 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 22.3 pttp -51.7 -38.64 55.99 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.137 -0.938 . . . . 2.2000000000000002 112.946 -177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.3 m -85.09 -4.24 59.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.054 0.39 . . . . 1.4099999999999999 112.054 -173.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.664 HG21 HD22 ' A' ' 106' ' ' LEU . 33.5 mm -71.88 116.21 13.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.099 0.476 . . . . 0.26000000000000001 110.23 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -103.72 -179.36 3.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.637 -0.875 . . . . 1.5900000000000001 108.637 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -63.96 -37.25 86.72 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.736 -0.839 . . . . 0.59999999999999998 108.736 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 1.034 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -61.37 -49.66 76.02 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.168 -0.924 . . . . 2.5800000000000001 110.712 178.2 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.3 99.12 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 114.194 -1.366 . . . . 0.14999999999999999 111.068 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.762 HD12 HG22 ' A' ' 130' ' ' VAL . 3.8 tt -63.94 -47.87 78.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.419 -0.81 . . . . 0.16 109.105 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.657 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 51.5 t80 -58.69 -48.45 81.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.869 -0.605 . . . . 0.29999999999999999 110.914 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.3 -38.82 74.59 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.938 0.399 . . . . 0.40000000000000002 110.59 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.6 m -77.47 -54.17 6.75 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.148 -0.478 . . . . 0.22 111.875 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.446 ' CD1' HD23 ' A' ' 115' ' ' LEU . 7.2 m-85 -72.19 -27.87 62.84 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 112.248 0.462 . . . . 0.11 112.248 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 28.7 t -57.41 -28.03 62.91 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 111.629 0.233 . . . . 0.19 111.629 -177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.83 -22.88 39.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.016 0.436 . . . . 0.14000000000000001 111.345 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -90.19 -22.29 21.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.113 -0.494 . . . . 0.17999999999999999 110.777 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 169.36 169.02 32.16 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.89 -0.595 . . . . 0.11 111.784 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -70.65 139.55 51.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.018 0.437 . . . . 0.25 109.893 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.419 HG21 ' HB3' ' A' ' 128' ' ' CYS . 74.1 mt -112.88 131.93 63.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.907 -0.588 . . . . 0.14000000000000001 110.024 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -88.5 -41.06 12.98 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.922 -0.77 . . . . 0.54000000000000004 108.922 -177.8 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 72.1 m -147.7 119.6 8.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.163 -0.926 . . . . 0.76000000000000001 110.314 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 9.2 p -117.53 144.95 44.59 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.526 -0.546 . . . . 0.71999999999999997 109.526 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -142.19 129.3 20.89 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.67 -0.412 . . . . 1.0 111.503 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.762 HG22 HD12 ' A' ' 115' ' ' LEU . 61.2 t -115.55 110.7 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 106.848 -1.538 . . . . 0.28000000000000003 106.848 170.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t -80.25 115.39 22.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.848 -0.797 . . . . 0.34000000000000002 108.848 -175.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.748 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 7.7 p -99.29 135.74 40.26 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.211 0.819 . . . . 1.5800000000000001 113.211 -164.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -86.89 163.88 16.91 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.771 -1.104 . . . . 2.0800000000000001 108.923 174.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.09 -29.59 60.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.735 0.302 . . . . 2.4500000000000002 111.065 174.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -88.94 -5.89 57.66 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.934 0.397 . . . . 1.6499999999999999 110.944 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.56 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 149.03 -74.01 0.28 Allowed Glycine 0 C--O 1.225 -0.442 0 C-N-CA 120.484 -0.865 . . . . 1.1200000000000001 112.95 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.748 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 42.5 t -138.75 145.92 40.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.621 0.71 . . . . 1.6100000000000001 110.335 -176.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -77.49 -11.74 59.88 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.383 0.611 . . . . 1.51 109.808 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 111.47 -19.24 24.4 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.177 -0.92 . . . . 0.31 113.324 175.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -126.07 149.37 48.94 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 121.855 -0.791 . . . . 0.48999999999999999 111.874 -173.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.86 174.81 24.1 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.077 -0.965 . . . . 0.12 111.348 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -141.57 137.44 31.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 117.019 0.41 . . . . 0.25 110.615 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.583 ' HB ' HG12 ' A' ' 101' ' ' ILE . 43.2 t -112.88 133.68 57.93 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.081 0.467 . . . . 0.10000000000000001 111.147 173.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.1 m170 -103.12 105.91 16.31 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.626 -0.715 . . . . 0.20999999999999999 109.143 166.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.581 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 12.5 m-85 -88.79 142.55 27.57 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.261 0.553 . . . . 0.17000000000000001 110.751 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.572 ' HA ' HD21 ' A' ' 126' ' ' LEU . 42.8 tt0 -51.67 -38.32 54.4 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.277 -1.329 . . . . 0.56999999999999995 110.542 178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.6 p -125.32 150.38 47.19 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.307 -0.86 . . . . 0.40000000000000002 111.443 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -60.65 -37.76 82.6 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.603 -0.726 . . . . 0.46999999999999997 111.24 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.6 pt-20 -67.82 -35.38 78.5 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.56 -0.291 . . . . 0.73999999999999999 111.645 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -65.85 -34.53 78.35 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.21 0.529 . . . . 0.17999999999999999 110.278 -178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.597 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -63.56 -46.57 85.3 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.339 -0.846 . . . . 0.16 110.565 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 42.6 mt-10 -58.96 -40.19 83.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 1.4199999999999999 110.526 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.53 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 88.8 mtt180 -58.96 -44.76 91.54 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.005 0.431 . . . . 1.48 110.719 177.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.01 -39.4 94.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.968 -0.56 . . . . 0.10000000000000001 110.598 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 151' ' ' ALA . 88.6 mt -58.97 -53.56 46.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.889 -0.596 . . . . 0.14999999999999999 111.401 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 0.6 OUTLIER -63.64 -41.83 98.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.091 0.472 . . . . 1.0800000000000001 111.808 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.418 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -81.8 -39.98 23.24 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.681 -0.691 . . . . 1.1599999999999999 112.82 -169.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 91.3 mmm -91.24 -19.12 23.36 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.262 0.468 . . . . 0.34999999999999998 112.262 -173.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -66.54 122.78 18.35 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.396 -0.521 . . . . 0.44 109.826 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.48 26.81 37.87 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.91 -0.662 . . . . 0.28999999999999998 113.01 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.705 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 74.5 mmm -112.64 157.06 21.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.958 0.379 . . . . 1.1799999999999999 110.891 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.469 HD23 ' N ' ' A' ' 167' ' ' LYS . 19.6 mt -94.15 102.38 14.42 Favored 'General case' 0 CA--C 1.499 -1.006 0 N-CA-C 109.002 -0.74 . . . . 0.44 109.002 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 163' ' ' LEU . 16.7 mt -83.91 101.47 11.7 Favored 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 119.278 -0.969 . . . . 1.02 108.645 172.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 98.8 m-20 73.94 -70.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.856 -1.065 . . . . 1.71 111.467 -175.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -147.2 -0.57 0.68 Allowed 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.425 -0.807 . . . . 0.84999999999999998 112.192 -173.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.533 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 91.6 mtt180 -132.1 128.76 38.84 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.955 -0.466 . . . . 0.95999999999999996 110.473 -174.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.705 ' HA ' ' O ' ' A' ' 161' ' ' MET . 13.3 tttt -76.45 122.04 23.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.849 -0.614 . . . . 1.0 109.35 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 104' ' ' LYS . 16.0 m -101.18 140.06 20.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 121.391 0.615 . . . . 0.17000000000000001 111.056 -173.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -106.08 121.7 44.68 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.18 -0.918 . . . . 0.29999999999999999 108.871 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.514 HG22 HG12 ' A' ' 103' ' ' ILE . 39.6 t -115.88 130.15 71.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.976 -0.557 . . . . 0.13 109.565 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -142.87 -165.37 10.59 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.773 -0.727 . . . . 0.17999999999999999 111.949 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.71 ' HB2' ' HE3' ' A' ' 174' ' ' LYS . 16.4 mmt180 -75.57 134.49 40.7 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.61 -0.515 . . . . 1.9299999999999999 109.61 -178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -63.73 -61.81 2.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 1.4399999999999999 111.193 -174.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.71 ' HE3' ' HB2' ' A' ' 172' ' ' ARG . 81.9 mttt 70.24 -58.78 0.53 Allowed 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.802 0.689 . . . . 4.6600000000000001 111.022 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 21.3 p 168.72 -67.83 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.617 -1.253 . . . . 3.6000000000000001 107.617 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -160.8 15.9 0.12 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 113.77 -1.559 . . . . 7.5999999999999996 108.011 172.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 182' ' ' GLU . 58.5 tttm -82.0 52.37 1.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.391 -1.277 . . . . 8.6099999999999994 111.438 -169.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.742 ' HG3' ' HB3' ' A' ' 182' ' ' GLU . 29.0 tt0 -159.73 13.43 0.14 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.751 0.786 . . . . 8.5500000000000007 109.006 171.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -79.0 94.08 5.22 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.161 -0.927 . . . . 12.18 109.129 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 71.63 -44.53 0.59 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.825 0.703 . . . . 12.699999999999999 111.263 -174.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -123.35 128.41 49.86 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.67 -0.492 . . . . 13.65 109.67 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.742 ' HB3' ' HG3' ' A' ' 178' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 119.151 -0.452 . . . . 15.050000000000001 110.901 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.694 ' N ' ' HG ' ' A' ' 127' ' ' SER . . . . . . . . 0 N--CA 1.483 1.792 0 N-CA-C 112.426 -0.27 . . . . 14.85 112.426 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.96 -19.21 60.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.101 0.477 . . . . 13.5 110.767 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.549 ' HB2' ' HG ' ' A' ' 93' ' ' LEU . 7.5 p-10 -93.85 142.97 25.76 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.508 -0.769 . . . . 11.25 109.848 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.43 -55.71 1.67 Allowed 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.22 1.947 . . . . 11.140000000000001 110.829 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.3 p -170.9 86.72 0.1 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.589 -0.732 . . . . 9.3000000000000007 110.712 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.549 ' HG ' ' HB2' ' A' ' 90' ' ' ASP . 91.0 mt -75.63 128.67 35.73 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.377 -0.601 . . . . 7.8899999999999997 109.377 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -58.53 -49.49 77.2 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 111.591 0.219 . . . . 7.7800000000000002 111.591 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -151.23 -0.47 0.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.132 0.492 . . . . 2.3700000000000001 110.606 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.1 m -80.74 0.28 35.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.54 . . . . 1.79 110.514 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.417 ' C ' HD21 ' A' ' 100' ' ' ASN . . . -65.27 -26.9 71.86 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.611 -0.722 . . . . 0.44 112.153 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.2 t 69.07 124.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.466 0.706 . . . . 0.70999999999999996 111.923 -176.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.18 23.05 78.36 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.481 -0.866 . . . . 0.20999999999999999 111.856 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 143' ' ' VAL . 1.8 m120 -89.32 126.2 35.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.335 -0.617 . . . . 0.63 109.335 -175.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.512 HG12 ' HB ' ' A' ' 143' ' ' VAL . 22.0 pt -134.65 163.37 36.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.734 -0.666 . . . . 0.14999999999999999 109.547 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.07 146.45 50.36 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.564 -0.455 . . . . 0.20999999999999999 109.817 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.561 HG12 HG22 ' A' ' 170' ' ' VAL . 4.2 mt -118.22 138.37 49.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.688 -0.687 . . . . 0.14999999999999999 109.714 -177.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -120.85 152.78 37.99 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.691 -0.231 . . . . 1.46 110.4 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.8 t30 70.57 41.07 0.98 Allowed 'General case' 0 CA--C 1.536 0.438 0 O-C-N 123.818 0.699 . . . . 0.48999999999999999 111.699 172.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.54 HD22 HG21 ' A' ' 110' ' ' ILE . 20.0 mt -79.4 164.83 23.7 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.217 0.532 . . . . 0.26000000000000001 111.907 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.461 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.8 t70 -89.01 155.55 19.41 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.406 -0.815 . . . . 0.70999999999999996 110.799 177.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.711 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 20.0 pttp -59.99 -36.68 77.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.228 -0.442 . . . . 2.2000000000000002 111.724 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.44 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 16.7 m -80.85 -3.21 50.41 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.243 -0.435 . . . . 1.4099999999999999 111.891 -173.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.554 HG22 HG21 ' A' ' 130' ' ' VAL . 34.5 mm -76.02 118.53 22.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.809 0.338 . . . . 0.26000000000000001 110.254 177.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -108.66 -175.52 2.79 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.128 -0.693 . . . . 1.5900000000000001 109.128 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -69.39 -32.76 71.99 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.081 -0.711 . . . . 0.59999999999999998 109.081 -176.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.412 ' O ' ' HD2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -67.13 -48.47 67.97 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 114.54 -1.209 . . . . 2.5800000000000001 109.253 178.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.2 -41.42 96.78 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.198 -1.365 . . . . 0.14999999999999999 110.83 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.71 HD12 HG22 ' A' ' 130' ' ' VAL . 3.8 tt -66.98 -47.66 70.86 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.039 -0.726 . . . . 0.16 109.039 177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.681 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.6 t80 -59.38 -46.45 88.62 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.933 -0.576 . . . . 0.29999999999999999 110.81 176.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.3 -41.08 75.38 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.09 0.471 . . . . 0.40000000000000002 110.978 -176.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.469 HG21 HD21 ' A' ' 163' ' ' LEU . 18.0 m -77.07 -52.76 8.76 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.787 -0.642 . . . . 0.22 111.691 -177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.434 ' CD1' HD23 ' A' ' 115' ' ' LEU . 10.6 m-85 -72.69 -28.24 62.57 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.638 0.607 . . . . 0.11 112.638 -175.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.8 t -57.3 -28.8 63.35 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.563 0.221 . . . . 0.19 111.388 -177.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.57 -24.13 45.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.896 0.379 . . . . 0.14000000000000001 111.226 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -89.17 -18.18 27.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 0.17999999999999999 111.408 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.44 173.55 32.27 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.033 -0.604 . . . . 0.11 112.024 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -69.46 135.37 50.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.914 0.387 . . . . 0.25 110.33 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 70.8 mt -110.67 124.29 67.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.217 -0.447 . . . . 0.14000000000000001 110.597 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.572 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -79.97 -36.37 36.21 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 108.777 -0.823 . . . . 0.54000000000000004 108.777 -176.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.694 ' HG ' ' N ' ' A' ' 88' ' ' GLY . 73.4 m -154.97 141.49 18.8 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.86 -1.063 . . . . 0.76000000000000001 109.694 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.681 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.6 p -143.5 135.42 26.62 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.803 -0.443 . . . . 0.71999999999999997 109.803 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -140.76 133.25 28.5 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.112 0.482 . . . . 1.0 111.887 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.71 HG22 HD12 ' A' ' 115' ' ' LEU . 78.1 t -114.26 117.46 55.62 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 N-CA-C 106.717 -1.586 . . . . 0.28000000000000003 106.717 169.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.1 t -86.48 115.82 28.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.811 -0.811 . . . . 0.34000000000000002 108.811 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.764 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 60.2 m -109.85 139.54 44.81 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.024 0.75 . . . . 1.5800000000000001 113.024 -164.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.405 ' H ' ' CA ' ' A' ' 137' ' ' SER . 19.8 t70 -85.31 160.2 19.87 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 114.938 -1.028 . . . . 2.0800000000000001 108.439 171.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -58.51 -22.8 56.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.913 0.387 . . . . 2.4500000000000002 110.774 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -92.41 4.14 54.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.072 -0.513 . . . . 1.6499999999999999 110.673 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.711 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 140.25 -75.52 0.35 Allowed Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.763 -0.732 . . . . 1.1200000000000001 113.443 177.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.764 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 30.7 t -144.07 156.33 44.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.753 0.777 . . . . 1.6100000000000001 110.312 -176.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -89.21 -11.39 43.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.383 0.611 . . . . 1.51 109.494 176.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 110.81 -21.54 22.94 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.37 -0.832 . . . . 0.31 113.742 174.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -122.6 152.39 40.49 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 117.421 0.611 . . . . 0.48999999999999999 112.208 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.67 175.25 24.47 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.01 -0.996 . . . . 0.12 111.438 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -140.52 142.24 35.24 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.088 0.444 . . . . 0.25 111.113 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.512 ' HB ' HG12 ' A' ' 101' ' ' ILE . 39.2 t -119.53 135.55 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-O 121.009 0.433 . . . . 0.10000000000000001 110.873 172.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -104.9 106.22 16.61 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 108.985 -0.746 . . . . 0.20999999999999999 108.985 166.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.54 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.7 m-85 -90.1 137.34 32.42 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.022 0.439 . . . . 0.17000000000000001 110.993 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.572 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.8 tt0 -45.81 -43.83 13.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.42 -1.264 . . . . 0.56999999999999995 111.021 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 73.3 p -116.8 153.39 32.54 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.266 -0.879 . . . . 0.40000000000000002 110.33 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -64.61 -36.95 85.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.939 -0.573 . . . . 0.46999999999999997 110.303 178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 13.4 pt-20 -70.35 -34.37 72.56 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.035 -0.529 . . . . 0.73999999999999999 112.293 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.72 -35.76 77.14 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.981 0.42 . . . . 0.17999999999999999 110.52 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.54 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.82 -42.51 97.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.742 -0.663 . . . . 0.16 110.502 176.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.631 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.6 mt-10 -59.85 -40.55 88.96 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.884 -0.598 . . . . 1.4199999999999999 110.437 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 61.5 mtt180 -60.1 -42.09 93.93 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.455 0.472 . . . . 1.48 110.861 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.35 -39.41 85.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.028 -0.533 . . . . 0.10000000000000001 110.693 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 151' ' ' ALA . 88.2 mt -58.94 -53.61 45.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.119 -0.491 . . . . 0.14999999999999999 111.075 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.631 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.5 pt-20 -60.41 -45.36 93.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.926 0.394 . . . . 1.0800000000000001 111.796 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.461 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -80.93 -38.98 26.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 112.979 0.733 . . . . 1.1599999999999999 112.979 -169.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.469 ' O ' ' HB2' ' A' ' 161' ' ' MET . 95.1 mmm -95.23 -17.84 21.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.67 0.619 . . . . 0.34999999999999998 112.67 -171.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -70.12 122.09 18.77 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 119.683 -0.807 . . . . 0.44 109.187 178.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 82.79 23.55 55.52 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.602 -0.809 . . . . 0.28999999999999998 112.178 -176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.624 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.8 OUTLIER -102.92 158.73 16.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.532 0.206 . . . . 1.1799999999999999 110.536 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 21.7 mt -102.68 98.13 8.21 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-N 116.416 -0.356 . . . . 0.44 110.128 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.469 HD21 HG21 ' A' ' 118' ' ' THR . 18.6 mt -85.83 107.81 17.84 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 120.041 -0.664 . . . . 1.02 109.363 175.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 98.2 m-20 74.32 -61.86 0.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.164 -0.926 . . . . 1.71 111.599 -176.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -172.26 25.23 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.552 -0.749 . . . . 0.84999999999999998 110.658 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.461 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.2 mtt180 -137.82 129.55 28.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.396 -0.366 . . . . 0.95999999999999996 110.053 -178.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.9 tttt -79.89 118.88 22.05 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.82 -0.627 . . . . 1.0 109.377 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.482 HG11 HD23 ' A' ' 106' ' ' LEU . 19.3 m -102.33 150.78 6.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.294 0.569 . . . . 0.17000000000000001 111.668 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 64.7 t80 -106.59 120.57 42.29 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.277 -0.874 . . . . 0.29999999999999999 109.278 177.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.561 HG22 HG12 ' A' ' 103' ' ' ILE . 45.4 t -115.44 125.78 72.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.27 -0.641 . . . . 0.13 109.27 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.48 -174.29 20.06 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 120.708 -0.758 . . . . 0.17999999999999999 111.404 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -60.75 138.61 58.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.796 -0.816 . . . . 1.9299999999999999 108.796 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -50.35 111.74 0.58 Allowed 'General case' 0 C--O 1.233 0.199 0 N-CA-C 109.597 -0.52 . . . . 1.4399999999999999 109.597 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -79.08 81.77 5.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.762 -0.654 . . . . 4.6600000000000001 110.795 -172.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 12.4 p -130.6 84.56 2.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.441 -0.8 . . . . 3.6000000000000001 110.13 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -129.02 140.19 51.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.098 -0.501 . . . . 7.5999999999999996 110.969 -176.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -136.14 163.63 29.9 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.563 -0.903 . . . . 8.6099999999999994 108.563 175.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -85.7 41.22 0.89 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.009 0.433 . . . . 8.5500000000000007 109.834 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 34.4 ttp85 -67.8 113.51 5.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.97 -0.559 . . . . 12.18 110.037 -178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -97.69 -22.46 16.43 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.734 -0.666 . . . . 12.699999999999999 110.148 -175.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -89.19 133.0 34.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.722 -0.672 . . . . 13.65 110.608 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.505 -0.76 . . . . 15.050000000000001 109.506 -179.731 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.667 0 N-CA-C 111.598 -0.601 . . . . 14.85 111.598 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.36 62.49 5.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.342 0.591 . . . . 13.5 110.243 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -145.54 138.08 13.68 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.679 -0.691 . . . . 11.25 110.066 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -74.53 61.72 5.3 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.581 2.187 . . . . 11.140000000000001 111.425 172.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.2 p 49.36 70.47 0.48 Allowed 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.545 -0.752 . . . . 9.3000000000000007 110.884 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 83.7 mt -104.77 134.95 47.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.902 -0.59 . . . . 7.8899999999999997 110.452 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 66.29 -79.91 0.03 OUTLIER 'General case' 0 C--N 1.344 0.347 0 C-N-CA 123.069 0.548 . . . . 7.7800000000000002 109.594 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.472 ' HG2' ' HB2' ' A' ' 100' ' ' ASN . 1.3 mtmm 177.67 33.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 123.788 0.835 . . . . 2.3700000000000001 109.308 171.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.2 t -63.39 -15.66 58.2 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.368 -0.833 . . . . 1.79 111.29 -175.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -60.14 -24.42 60.9 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.957 -0.639 . . . . 0.44 112.021 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 34.8 t 63.76 128.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.729 0.812 . . . . 0.70999999999999996 112.44 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.02 23.81 77.11 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.963 -1.113 . . . . 0.20999999999999999 111.012 -179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.526 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.2 m120 -89.62 124.97 35.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.009 -0.737 . . . . 0.63 109.009 -173.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.568 HG12 ' HB ' ' A' ' 143' ' ' VAL . 22.9 pt -135.62 163.41 35.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.545 -0.298 . . . . 0.14999999999999999 110.242 178.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.38 146.47 48.85 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.882 0.372 . . . . 0.20999999999999999 110.054 176.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.643 HG12 HG22 ' A' ' 170' ' ' VAL . 6.8 mt -124.48 144.92 32.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.765 -0.652 . . . . 0.14999999999999999 109.788 -178.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -129.94 156.42 44.46 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.46 0.171 . . . . 1.46 111.073 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.7 t30 71.54 36.12 1.34 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.044 0.938 . . . . 0.48999999999999999 111.357 177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.586 HD22 HG21 ' A' ' 110' ' ' ILE . 31.7 mt -76.59 143.36 40.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.187 -0.461 . . . . 0.26000000000000001 110.779 175.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.44 151.28 41.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.706 -0.679 . . . . 0.70999999999999996 110.923 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -52.84 -32.77 46.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.499 -0.773 . . . . 2.2000000000000002 112.321 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.2 m -80.45 -7.47 59.16 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.006 0.372 . . . . 1.4099999999999999 112.006 -175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.621 HG22 HG21 ' A' ' 130' ' ' VAL . 28.2 mm -76.07 127.38 37.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-O 121.078 0.466 . . . . 0.26000000000000001 110.928 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -115.64 -179.25 3.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.536 -0.756 . . . . 1.5900000000000001 109.026 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -65.71 -36.39 83.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.507 -0.553 . . . . 0.59999999999999998 109.507 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.983 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.98 -49.63 76.68 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.862 0.839 . . . . 2.5800000000000001 109.986 178.057 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.6 98.56 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 113.771 -1.559 . . . . 0.14999999999999999 111.315 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.743 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -64.76 -47.18 79.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.973 -0.751 . . . . 0.16 108.973 177.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.746 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 55.6 t80 -58.65 -49.1 78.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.29999999999999999 111.127 176.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -57.68 -37.51 73.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.863 0.363 . . . . 0.40000000000000002 110.922 -174.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.709 HG21 HD21 ' A' ' 163' ' ' LEU . 6.7 m -78.29 -53.9 6.8 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.055 -0.521 . . . . 0.22 111.823 -178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 115' ' ' LEU . 21.2 m-85 -72.01 -28.29 63.29 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.31 0.485 . . . . 0.11 112.31 -174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 19.9 t -57.82 -27.53 63.25 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.529 0.204 . . . . 0.19 111.51 -177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.58 -21.83 29.41 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.762 0.315 . . . . 0.14000000000000001 111.736 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -93.12 -9.78 38.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.988 0.423 . . . . 0.17999999999999999 110.932 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 157.29 161.46 10.85 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.743 -0.662 . . . . 0.11 111.665 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -61.24 132.23 52.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.24 0.543 . . . . 0.25 110.363 178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.434 ' HB ' ' CD1' ' A' ' 116' ' ' TYR . 76.8 mt -100.84 134.9 39.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 115.62 -0.718 . . . . 0.14000000000000001 109.715 178.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.503 HD11 ' HA ' ' A' ' 146' ' ' GLU . 19.9 mt -89.66 -39.14 13.4 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.847 0.832 . . . . 0.54000000000000004 108.867 -176.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 73.7 m -155.95 129.42 8.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.496 -1.229 . . . . 0.76000000000000001 109.502 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.746 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 8.5 p -123.84 149.71 45.43 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.192 -0.67 . . . . 0.71999999999999997 109.192 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.2 tptt -148.51 128.02 13.17 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.308 -0.557 . . . . 1.0 111.704 -177.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.743 HG22 HD12 ' A' ' 115' ' ' LEU . 59.7 t -111.31 109.59 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 106.195 -1.78 . . . . 0.28000000000000003 106.195 169.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.519 HG12 ' HG3' ' A' ' 138' ' ' LYS . 14.8 t -74.44 116.52 17.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 108.714 -0.847 . . . . 0.34000000000000002 108.714 -174.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 62.9 m -96.59 135.95 37.79 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.702 -0.681 . . . . 1.5800000000000001 111.666 -166.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -86.28 161.4 18.78 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 108.144 -1.058 . . . . 2.0800000000000001 108.144 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -56.58 -28.79 61.06 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.084 0.468 . . . . 2.4500000000000002 110.028 173.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -92.24 1.06 57.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.821 -0.627 . . . . 1.6499999999999999 110.899 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 139.08 -73.08 0.42 Allowed Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.371 -0.919 . . . . 1.1200000000000001 114.003 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 34.5 t -137.58 140.14 40.81 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 117.934 0.867 . . . . 1.6100000000000001 111.379 -174.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.519 ' HG3' HG12 ' A' ' 131' ' ' VAL . 3.9 mmpt? -79.01 -9.92 59.68 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.275 0.56 . . . . 1.51 110.089 178.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 103.26 -22.05 37.64 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.393 -0.822 . . . . 0.31 113.361 175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -126.04 152.94 45.12 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 117.424 0.612 . . . . 0.48999999999999999 111.811 -173.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.65 174.64 26.43 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.352 -0.84 . . . . 0.12 111.619 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -139.97 136.88 34.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.947 0.374 . . . . 0.25 110.862 -176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.568 ' HB ' HG12 ' A' ' 101' ' ' ILE . 47.5 t -111.23 134.46 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 121.036 0.446 . . . . 0.10000000000000001 111.094 174.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 3.1 m170 -102.51 107.04 17.87 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.681 -0.69 . . . . 0.20999999999999999 109.159 165.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 21.2 m-85 -87.36 142.07 28.16 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.286 0.565 . . . . 0.17000000000000001 110.697 176.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.503 ' HA ' HD11 ' A' ' 126' ' ' LEU . 39.4 tt0 -51.7 -35.01 41.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.521 -1.218 . . . . 0.56999999999999995 111.001 177.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 34.1 p -130.04 150.06 51.48 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.582 -1.19 . . . . 0.40000000000000002 111.181 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -62.75 -38.43 90.53 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.665 -0.698 . . . . 0.46999999999999997 111.04 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -65.19 -33.75 76.75 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.113 -0.494 . . . . 0.73999999999999999 112.285 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.67 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 0.17999999999999999 110.298 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -64.62 -43.13 94.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.335 -0.848 . . . . 0.16 111.097 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 28.2 mt-10 -58.44 -40.69 83.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.851 -0.613 . . . . 1.4199999999999999 110.865 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 58.8 mtt85 -64.82 -42.33 95.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.74 0.305 . . . . 1.48 110.784 177.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.45 94.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.4 -0.364 . . . . 0.10000000000000001 110.605 178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.7 mt -58.81 -54.47 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.334 -0.393 . . . . 0.14999999999999999 111.013 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.5 pt-20 -64.1 -45.52 88.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.188 0.518 . . . . 1.0800000000000001 111.841 -177.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.2 OUTLIER -77.36 -38.58 49.86 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.479 -0.782 . . . . 1.1599999999999999 112.617 -170.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.479 ' HB2' HG21 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -90.05 -25.46 20.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.17 0.433 . . . . 0.34999999999999998 112.17 -174.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 59.0 t30 -66.36 123.4 19.88 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.25 -0.648 . . . . 0.44 109.25 178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.98 12.67 63.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.613 -0.803 . . . . 0.28999999999999998 112.638 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.8 mmt -101.6 158.05 16.37 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 122.634 -0.333 . . . . 1.1799999999999999 111.137 177.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 30.7 mt -98.34 107.61 20.12 Favored 'General case' 0 CA--C 1.501 -0.929 0 N-CA-C 109.207 -0.664 . . . . 0.44 109.207 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.709 HD21 HG21 ' A' ' 118' ' ' THR . 17.2 mt -90.77 107.64 19.31 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.853 -0.795 . . . . 1.02 108.853 171.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 82.5 m-20 72.78 -67.22 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.246 -0.888 . . . . 1.71 111.61 -175.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -157.03 7.71 0.17 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.328 -0.851 . . . . 0.84999999999999998 111.742 -175.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -130.56 134.35 46.94 Favored 'General case' 0 CA--C 1.511 -0.523 0 O-C-N 121.592 -0.692 . . . . 0.95999999999999996 110.924 -175.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.6 tttt -79.01 118.97 21.5 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 177.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.421 HG11 HD23 ' A' ' 106' ' ' LEU . 5.7 m -100.19 146.81 8.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.596 0.712 . . . . 0.17000000000000001 111.046 -172.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 74.1 t80 -106.58 117.84 35.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.699 -1.137 . . . . 0.29999999999999999 109.369 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.643 HG22 HG12 ' A' ' 103' ' ' ILE . 39.4 t -115.61 131.03 69.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.425 -0.583 . . . . 0.13 109.425 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -151.85 -176.92 25.07 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.595 -0.812 . . . . 0.17999999999999999 112.195 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -64.37 142.63 58.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.916 0.389 . . . . 1.9299999999999999 110.284 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.453 ' HB3' ' HD3' ' A' ' 95' ' ' LYS . 73.5 t80 -70.44 138.79 51.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.72 -0.673 . . . . 1.4399999999999999 110.314 -174.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.491 ' HD3' ' HG2' ' A' ' 177' ' ' LYS . 64.5 mttp -75.0 -71.62 0.34 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.671 0.272 . . . . 4.6600000000000001 111.354 -177.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 174' ' ' LYS . 40.9 t 69.19 -64.63 0.33 Allowed 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 115.373 -0.83 . . . . 3.6000000000000001 110.247 -170.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -104.97 106.81 17.46 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 116.169 -0.468 . . . . 7.5999999999999996 109.743 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.491 ' HG2' ' HD3' ' A' ' 174' ' ' LYS . 34.3 mtmm -81.41 -18.32 45.85 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.608 -0.886 . . . . 8.6099999999999994 108.608 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -136.94 134.28 36.58 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.457 -1.247 . . . . 8.5500000000000007 107.733 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.415 HH21 ' HA ' ' A' ' 182' ' ' GLU . 12.1 tpt180 -52.63 133.45 36.29 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.832 0.349 . . . . 12.18 111.609 -177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -139.38 156.11 47.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.674 -0.694 . . . . 12.699999999999999 110.43 178.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 65.49 89.04 0.1 Allowed 'General case' 0 N--CA 1.466 0.37 0 O-C-N 124.001 0.813 . . . . 13.65 113.081 170.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.415 ' HA ' HH21 ' A' ' 179' ' ' ARG . 7.8 mp0 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.508 -0.758 . . . . 15.050000000000001 109.101 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.618 0 N-CA-C 112.002 -0.439 . . . . 14.85 112.002 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.45 162.56 17.21 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.889 -0.412 . . . . 13.5 109.889 178.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.687 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 15.4 t70 -164.29 140.84 5.16 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.7 -0.481 . . . . 11.25 109.7 -177.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.14 -29.06 54.22 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.478 2.119 . . . . 11.140000000000001 112.54 176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.1 m -114.0 50.31 0.94 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.461 -0.336 . . . . 9.3000000000000007 110.813 -178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.851 HD22 ' HB3' ' A' ' 176' ' ' ARG . 71.6 mt -60.52 151.17 29.21 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 110.086 -0.339 . . . . 7.8899999999999997 110.086 175.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.534 ' HG2' ' H ' ' A' ' 95' ' ' LYS . 20.1 ttp180 66.44 -176.85 0.19 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.82 -0.807 . . . . 7.7800000000000002 108.82 -173.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.534 ' H ' ' HG2' ' A' ' 94' ' ' ARG . 20.7 pttm -137.84 45.85 2.12 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 121.581 -0.699 . . . . 2.3700000000000001 110.705 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 35.9 t -75.79 5.94 5.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.262 -0.881 . . . . 1.79 110.394 179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -71.08 -12.18 71.38 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 116.003 -0.544 . . . . 0.44 112.049 176.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 40.4 t 65.49 125.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.61 0.764 . . . . 0.70999999999999996 111.958 -177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.464 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 73.25 24.08 76.15 Favored Glycine 0 N--CA 1.44 -1.059 0 C-N-CA 120.167 -1.016 . . . . 0.20999999999999999 111.551 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.542 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.2 m120 -88.13 125.23 34.49 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.005 -0.739 . . . . 0.63 109.005 -173.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.527 HG23 ' HB1' ' A' ' 151' ' ' ALA . 19.1 pt -135.67 164.08 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 110.301 -0.259 . . . . 0.14999999999999999 110.301 177.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.408 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -125.19 145.0 50.17 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.858 0.361 . . . . 0.20999999999999999 110.162 176.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.604 HG12 HG22 ' A' ' 170' ' ' VAL . 5.3 mt -123.06 142.89 37.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.855 -0.612 . . . . 0.14999999999999999 110.043 -177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.2 ttpp -127.38 155.44 43.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.291 0.091 . . . . 1.46 111.125 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.9 t30 70.48 38.19 1.38 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.947 0.779 . . . . 0.48999999999999999 111.216 173.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.654 HD22 HG21 ' A' ' 110' ' ' ILE . 17.5 mt -79.63 163.44 24.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.535 -0.757 . . . . 0.26000000000000001 111.075 175.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -97.16 157.27 16.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.988 -0.551 . . . . 0.70999999999999996 109.976 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' A' ' 137' ' ' SER . 51.7 pttt -62.79 -28.67 70.15 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.935 0.398 . . . . 2.2000000000000002 111.204 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.5 m -69.72 -6.52 32.39 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.267 -0.424 . . . . 1.4099999999999999 111.936 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.654 HG21 HD22 ' A' ' 106' ' ' LEU . 31.7 mm -89.41 114.2 27.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.175 0.512 . . . . 0.26000000000000001 110.46 178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.53 -173.58 2.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.678 -0.86 . . . . 1.5900000000000001 108.678 178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -70.46 -33.11 70.9 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.135 -1.061 . . . . 0.59999999999999998 108.135 -176.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.654 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -66.8 -47.35 72.36 Favored 'General case' 0 N--CA 1.434 -1.261 0 CA-C-N 113.985 -1.461 . . . . 2.5800000000000001 109.661 178.054 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.89 -44.11 97.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.972 -1.467 . . . . 0.14999999999999999 110.787 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.682 HD12 HG22 ' A' ' 130' ' ' VAL . 4.4 tt -67.07 -47.0 72.6 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.444 -0.798 . . . . 0.16 109.163 177.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.693 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 75.7 t80 -58.94 -46.61 87.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.078 -0.51 . . . . 0.29999999999999999 110.997 176.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -56.77 -40.05 75.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.977 0.417 . . . . 0.40000000000000002 110.886 -176.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.442 HG21 HD21 ' A' ' 163' ' ' LEU . 9.6 m -77.67 -53.88 7.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.944 -0.571 . . . . 0.22 111.825 -178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.41 ' CD1' HD23 ' A' ' 115' ' ' LEU . 12.0 m-85 -72.42 -29.75 64.0 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.784 0.661 . . . . 0.11 112.784 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 22.6 t -58.64 -28.11 65.36 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.617 0.246 . . . . 0.19 111.174 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.86 -22.12 34.53 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 120.683 0.278 . . . . 0.14000000000000001 111.593 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.89 -11.9 35.04 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.899 0.38 . . . . 0.17999999999999999 110.984 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.57 160.88 10.96 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.749 -0.54 . . . . 0.11 111.749 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -62.45 139.24 58.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.25 110.185 178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.436 HG21 ' HB3' ' A' ' 128' ' ' CYS . 67.1 mt -110.89 134.99 51.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.959 -0.564 . . . . 0.14000000000000001 109.857 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.577 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -87.49 -44.05 11.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.635 -0.876 . . . . 0.54000000000000004 108.635 -179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 64.6 m -145.33 127.48 15.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.85 -1.068 . . . . 0.76000000000000001 109.862 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.693 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 8.5 p -124.09 137.0 54.63 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.587 -0.523 . . . . 0.71999999999999997 109.587 176.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -136.39 129.59 31.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.909 0.385 . . . . 1.0 111.788 -173.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.682 HG22 HD12 ' A' ' 115' ' ' LEU . 60.9 t -115.1 110.81 33.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 107.171 -1.418 . . . . 0.28000000000000003 107.171 170.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 t -79.74 115.67 22.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.015 -0.735 . . . . 0.34000000000000002 109.015 -175.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.756 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 26.0 p -100.74 140.76 34.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.481 -0.781 . . . . 1.5800000000000001 112.398 -166.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.435 ' H ' ' CA ' ' A' ' 137' ' ' SER . 29.0 t70 -86.15 160.27 19.28 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.811 -1.181 . . . . 2.0800000000000001 107.811 169.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -57.73 -22.81 48.65 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.045 0.45 . . . . 2.4500000000000002 110.934 176.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -90.03 -7.84 52.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.135 -0.484 . . . . 1.6499999999999999 110.882 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.494 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 151.83 -71.38 0.29 Allowed Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.488 -0.863 . . . . 1.1200000000000001 113.213 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.756 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 34.3 t -145.32 153.77 41.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.536 0.668 . . . . 1.6100000000000001 110.564 -177.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 37.0 mtpt -87.63 -9.02 55.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.217 0.532 . . . . 1.51 110.297 178.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 105.25 -18.73 41.63 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.169 -1.015 . . . . 0.31 113.575 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -127.21 151.24 48.96 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 117.491 0.645 . . . . 0.48999999999999999 111.817 -174.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.1 175.51 25.54 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.236 -0.893 . . . . 0.12 111.338 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 102' ' ' PHE . 55.2 m-85 -139.76 140.25 36.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.868 0.334 . . . . 0.25 110.688 -176.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.473 ' HB ' HG12 ' A' ' 101' ' ' ILE . 49.5 t -114.69 136.11 52.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 121.043 0.449 . . . . 0.10000000000000001 111.076 174.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -104.26 106.02 16.38 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.706 -0.679 . . . . 0.20999999999999999 109.191 167.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.487 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 20.8 m-85 -90.65 136.29 33.16 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.163 0.506 . . . . 0.17000000000000001 111.102 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.577 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.2 tt0 -49.04 -40.69 32.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.514 -1.221 . . . . 0.56999999999999995 110.682 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 38.8 p -117.47 147.05 43.09 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.039 -0.982 . . . . 0.40000000000000002 110.731 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -63.11 -33.78 76.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.875 -0.602 . . . . 0.46999999999999997 111.042 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -68.75 -34.84 76.28 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.402 -0.363 . . . . 0.73999999999999999 111.456 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.81 -34.66 78.41 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.156 0.503 . . . . 0.17999999999999999 110.389 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.527 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -62.32 -48.46 79.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.483 -0.78 . . . . 0.16 110.639 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.632 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 41.0 mt-10 -58.79 -38.23 78.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.824 -0.625 . . . . 1.4199999999999999 110.841 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 51.4 mtt180 -62.1 -44.59 96.33 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.84 0.352 . . . . 1.48 111.011 176.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.03 -37.19 86.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 0.10000000000000001 110.657 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 151' ' ' ALA . 82.4 mt -61.02 -53.65 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 0.14999999999999999 110.879 177.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.5 pt-20 -64.23 -41.73 96.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.957 0.408 . . . . 1.0800000000000001 111.98 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -81.36 -39.81 24.5 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 112.888 0.699 . . . . 1.1599999999999999 112.888 -171.544 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.533 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.3 mmm -93.02 -22.78 18.94 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.598 0.592 . . . . 0.34999999999999998 112.598 -172.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -66.96 123.33 19.91 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.028 -0.731 . . . . 0.44 109.028 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.2 13.21 66.43 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.585 -0.817 . . . . 0.28999999999999998 112.545 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.64 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.2 mmt -101.41 165.18 11.39 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.614 -0.345 . . . . 1.1799999999999999 111.224 177.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.33 130.46 46.44 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 108.949 -0.76 . . . . 0.44 108.949 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 22.0 mt -116.41 101.1 8.36 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.08 -0.648 . . . . 1.02 109.757 171.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 165' ' ' ASP . 55.9 m-20 78.5 -24.62 0.21 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.249 -0.887 . . . . 1.71 112.659 177.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 23.2 t70 166.17 -22.47 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.656 0 O-C-N 124.0 0.813 . . . . 0.84999999999999998 111.439 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 51.6 mtt180 -110.71 132.02 54.55 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.497 -0.32 . . . . 0.95999999999999996 110.872 -170.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.64 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.6 ttmt -77.94 124.15 27.66 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.456 HG11 HD23 ' A' ' 106' ' ' LEU . 18.5 m -103.22 149.66 7.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.329 0.585 . . . . 0.17000000000000001 111.573 -174.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 43.3 t80 -107.21 120.91 43.4 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.3 -0.864 . . . . 0.29999999999999999 109.062 177.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.604 HG22 HG12 ' A' ' 103' ' ' ILE . 41.0 t -115.56 125.65 72.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.39 -0.596 . . . . 0.13 109.39 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.22 -173.76 16.8 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.568 -0.825 . . . . 0.17999999999999999 112.218 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -65.4 145.13 56.55 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.836 -0.431 . . . . 1.9299999999999999 109.836 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.523 ' HD2' ' HB3' ' A' ' 95' ' ' LYS . 72.6 t80 -68.59 133.88 49.16 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.953 -0.567 . . . . 1.4399999999999999 110.907 -172.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.432 ' HB3' ' NZ ' ' A' ' 174' ' ' LYS . 0.4 OUTLIER -141.14 79.47 1.69 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.947 -0.57 . . . . 4.6600000000000001 111.266 -178.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.9 p -66.26 -57.52 7.37 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.811 -0.631 . . . . 3.6000000000000001 109.642 175.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.851 ' HB3' HD22 ' A' ' 93' ' ' LEU . 6.6 ptm180 -88.58 147.83 24.39 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.702 -0.851 . . . . 7.5999999999999996 108.702 173.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -125.66 7.92 7.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.217 0.532 . . . . 8.6099999999999994 110.561 -179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -101.76 143.88 31.14 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.757 -0.656 . . . . 8.5500000000000007 109.823 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? -94.06 -28.43 15.73 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.214 -0.661 . . . . 12.18 109.214 175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 70.66 121.24 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.283 -0.871 . . . . 12.699999999999999 111.278 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.3 92.68 8.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.036 0.446 . . . . 13.65 110.429 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 . . . . . 0 C--O 1.247 0.973 0 CA-C-O 118.644 -0.693 . . . . 15.050000000000001 110.226 -177.734 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.776 0 N-CA-C 112.18 -0.368 . . . . 14.85 112.18 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.13 -30.81 17.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.009 0.433 . . . . 13.5 110.391 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -83.05 122.91 77.95 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.866 -0.606 . . . . 11.25 109.495 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.32 -72.16 0.03 OUTLIER 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.591 2.194 . . . . 11.140000000000001 112.255 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.2 m -156.84 94.46 1.44 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.389 -0.369 . . . . 9.3000000000000007 110.7 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 99.4 mt -99.26 120.98 40.43 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.128 -0.323 . . . . 7.8899999999999997 110.128 177.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 -102.51 -41.91 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.378 0.609 . . . . 7.7800000000000002 109.962 -178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -96.4 93.67 6.97 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.281 -0.872 . . . . 2.3700000000000001 109.855 -177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.2 m -62.74 -14.03 39.78 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 112.182 0.438 . . . . 1.79 112.182 -177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -72.06 -29.33 66.95 Favored Glycine 0 CA--C 1.522 0.486 0 C-N-CA 120.872 -0.68 . . . . 0.44 111.943 174.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 61.4 t 61.13 127.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 123.868 0.867 . . . . 0.70999999999999996 112.889 -176.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 72.31 24.34 76.52 Favored Glycine 0 N--CA 1.442 -0.92 0 C-N-CA 119.984 -1.103 . . . . 0.20999999999999999 111.768 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.499 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -86.51 125.21 33.59 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.535 -0.542 . . . . 0.63 109.535 -173.258 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.581 HG12 ' HB ' ' A' ' 143' ' ' VAL . 26.9 pt -135.57 160.43 39.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 110.228 -0.286 . . . . 0.14999999999999999 110.228 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -125.79 142.78 51.35 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.888 -0.412 . . . . 0.20999999999999999 109.888 177.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.648 HG12 HG22 ' A' ' 170' ' ' VAL . 7.2 mt -121.05 131.27 73.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.639 -0.71 . . . . 0.14999999999999999 110.251 -176.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -116.06 151.32 35.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.681 -0.236 . . . . 1.46 110.561 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.2 t30 74.5 38.09 0.52 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.903 0.752 . . . . 0.48999999999999999 111.834 172.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.556 HD22 HG21 ' A' ' 110' ' ' ILE . 19.3 mt -76.78 158.47 30.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.059 0.457 . . . . 0.26000000000000001 111.065 176.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.504 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.0 t70 -84.26 151.69 24.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.553 -0.748 . . . . 0.70999999999999996 111.394 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -53.12 -36.19 60.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.13 -0.941 . . . . 2.2000000000000002 112.368 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.8 m -88.18 -2.57 58.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.242 -0.435 . . . . 1.4099999999999999 112.169 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.556 HG21 HD22 ' A' ' 106' ' ' LEU . 36.4 mm -73.59 124.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.2 0.524 . . . . 0.26000000000000001 110.823 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.518 ' OD2' ' HB3' ' A' ' 113' ' ' LYS . 0.2 OUTLIER -104.11 177.99 4.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.434 -0.803 . . . . 1.5900000000000001 110.865 -178.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -71.23 -33.67 70.08 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 107.56 -1.274 . . . . 0.59999999999999998 107.56 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.642 ' HB3' ' HZ3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -64.32 -48.87 73.95 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-N 113.833 -1.531 . . . . 2.5800000000000001 108.949 176.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -60.91 -44.87 96.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.367 -1.288 . . . . 0.14999999999999999 111.062 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.723 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -64.09 -47.1 81.4 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.302 -0.863 . . . . 0.16 109.056 177.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.674 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 69.8 t80 -59.61 -49.3 78.28 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.936 -0.575 . . . . 0.29999999999999999 111.135 176.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -58.3 -35.07 71.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.939 0.399 . . . . 0.40000000000000002 111.166 -175.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 24.9 m -78.8 -54.45 6.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.319 -0.401 . . . . 0.22 112.022 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.438 ' CD1' HD23 ' A' ' 115' ' ' LEU . 8.6 m-85 -72.78 -29.72 63.52 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.665 0.617 . . . . 0.11 112.665 -173.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 21.2 t -58.76 -28.06 65.56 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.668 0.271 . . . . 0.19 111.454 -177.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.56 -22.87 36.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.937 0.398 . . . . 0.14000000000000001 111.236 176.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -90.32 -19.04 24.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 0.17999999999999999 110.811 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.76 168.43 29.88 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 121.132 -0.556 . . . . 0.11 111.89 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -69.58 139.9 53.74 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.099 -0.334 . . . . 0.25 110.099 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.433 HG21 ' HB3' ' A' ' 128' ' ' CYS . 73.5 mt -111.78 133.78 56.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.389 -0.369 . . . . 0.14000000000000001 110.526 -178.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.641 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -91.94 -38.06 12.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.442 0.639 . . . . 0.54000000000000004 109.431 -179.707 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 75.4 m -155.68 102.82 2.24 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.46 -0.791 . . . . 0.76000000000000001 110.942 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.674 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 9.3 p -106.12 142.64 35.48 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.848 -0.427 . . . . 0.71999999999999997 109.848 173.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -135.43 130.82 35.38 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.797 -173.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.723 HG22 HD12 ' A' ' 115' ' ' LEU . 63.3 t -114.91 110.08 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 106.838 -1.541 . . . . 0.28000000000000003 106.838 170.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.3 t -79.08 115.29 21.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 108.637 -0.875 . . . . 0.34000000000000002 108.637 -175.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.799 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 8.8 p -103.54 135.83 44.4 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.733 0.642 . . . . 1.5800000000000001 112.733 -167.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.406 ' H ' ' CA ' ' A' ' 137' ' ' SER . 20.5 t70 -86.6 169.78 12.44 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 114.974 -1.012 . . . . 2.0800000000000001 108.878 175.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.31 -29.49 68.89 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.069 0.461 . . . . 2.4500000000000002 109.971 173.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -85.14 -1.35 56.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.953 -0.567 . . . . 1.6499999999999999 111.317 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 139.46 -69.64 0.47 Allowed Glycine 0 C--O 1.226 -0.387 0 C-N-CA 120.407 -0.902 . . . . 1.1200000000000001 112.986 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.799 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 33.3 t -141.13 149.83 42.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.388 0.594 . . . . 1.6100000000000001 109.877 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -80.9 -13.78 58.6 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.287 0.565 . . . . 1.51 109.721 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 109.53 -14.75 32.58 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.446 -0.883 . . . . 0.31 113.265 175.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -129.14 148.32 51.07 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.535 0.668 . . . . 0.48999999999999999 111.875 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.28 170.99 25.25 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.05 -0.977 . . . . 0.12 111.433 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -137.77 137.57 38.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.757 0.278 . . . . 0.25 110.578 -176.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.581 ' HB ' HG12 ' A' ' 101' ' ' ILE . 36.5 t -113.42 130.89 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-O 120.889 0.376 . . . . 0.10000000000000001 110.814 174.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.458 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 0.4 OUTLIER -100.61 105.95 17.4 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.019 -0.734 . . . . 0.20999999999999999 109.019 166.397 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.525 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 12.4 m-85 -89.36 137.32 32.42 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.266 0.555 . . . . 0.17000000000000001 111.209 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.641 ' HA ' HD21 ' A' ' 126' ' ' LEU . 41.5 tt0 -47.88 -48.75 31.23 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.235 -1.348 . . . . 0.56999999999999995 110.556 176.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 6.4 p -110.63 144.51 39.41 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 114.379 -1.282 . . . . 0.40000000000000002 111.218 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -61.77 -37.7 85.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.665 -0.698 . . . . 0.46999999999999997 110.996 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 8.0 pt-20 -69.91 -34.36 73.39 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.615 -0.266 . . . . 0.73999999999999999 111.682 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.28 -35.55 77.61 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.154 0.502 . . . . 0.17999999999999999 110.403 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.526 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -62.97 -44.69 95.36 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.488 -0.778 . . . . 0.16 110.501 176.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.462 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 49.1 mt-10 -59.53 -40.55 87.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.848 -0.615 . . . . 1.4199999999999999 110.541 177.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.521 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 50.1 mtt180 -62.3 -39.93 94.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.262 -0.426 . . . . 1.48 110.823 177.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.02 -38.5 86.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.472 -0.331 . . . . 0.10000000000000001 110.423 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 151' ' ' ALA . 81.2 mt -58.68 -54.04 38.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.284 -0.416 . . . . 0.14999999999999999 111.167 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.521 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.0 OUTLIER -61.05 -44.25 97.67 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.149 0.499 . . . . 1.0800000000000001 112.028 -178.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.439 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -82.23 -38.7 24.12 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.48 -0.782 . . . . 1.1599999999999999 112.802 -169.002 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.47 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.9 mmm -91.23 -24.28 19.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 112.254 0.464 . . . . 0.34999999999999998 112.254 -173.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 59.9 t30 -67.72 123.02 19.36 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.215 -0.594 . . . . 0.44 109.507 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 91.0 8.83 64.47 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.732 -0.747 . . . . 0.28999999999999998 112.786 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.742 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.4 mmt -92.01 163.81 13.85 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 120.692 0.282 . . . . 1.1799999999999999 111.425 178.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 15.7 mt -105.55 107.21 18.07 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 109.536 -0.542 . . . . 0.44 109.536 178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 163' ' ' LEU . 18.3 mt -94.61 108.55 20.52 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 119.793 -0.763 . . . . 1.02 109.245 172.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 94.4 m-20 72.11 -62.35 0.47 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.137 -0.938 . . . . 1.71 112.127 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -163.88 12.78 0.05 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.787 -0.642 . . . . 0.84999999999999998 111.438 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.504 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.1 mtt180 -134.41 129.85 35.96 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 121.966 -0.459 . . . . 0.95999999999999996 110.481 -174.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.742 ' HA ' ' O ' ' A' ' 161' ' ' MET . 18.2 ttmt -78.7 120.12 22.91 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.588 -0.733 . . . . 1.0 109.157 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.461 HG11 HD23 ' A' ' 106' ' ' LEU . 14.5 m -100.73 146.58 9.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.619 0.723 . . . . 0.17000000000000001 111.231 -172.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.583 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 75.2 t80 -106.9 118.38 36.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.729 -1.123 . . . . 0.29999999999999999 109.341 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.648 HG22 HG12 ' A' ' 103' ' ' ILE . 41.1 t -115.22 125.06 72.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.104 -0.702 . . . . 0.13 109.104 177.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.76 -174.46 17.96 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.512 -0.851 . . . . 0.17999999999999999 112.098 -178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 -67.86 120.02 13.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.964 0.412 . . . . 1.9299999999999999 110.246 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -58.2 127.78 33.83 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.445 -0.798 . . . . 1.4399999999999999 111.015 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -66.56 95.61 0.34 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.025 -0.732 . . . . 4.6600000000000001 109.025 176.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 12.8 m -94.73 -22.64 17.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.553 -0.749 . . . . 3.6000000000000001 110.376 -173.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 176' ' ' ARG . 40.1 ttt180 65.05 -91.67 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.963 0.789 . . . . 7.5999999999999996 109.735 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm 174.43 -38.25 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.62 -0.881 . . . . 8.6099999999999994 108.62 175.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.752 ' HG3' ' H ' ' A' ' 180' ' ' GLU . 12.2 tp10 -82.21 135.56 35.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.087 -0.961 . . . . 8.5500000000000007 109.734 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -99.51 8.7 44.29 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.319 -0.623 . . . . 12.18 109.319 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.752 ' H ' ' HG3' ' A' ' 178' ' ' GLU . 7.0 mm-40 74.93 -41.37 0.46 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.005 -0.998 . . . . 12.699999999999999 111.976 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -108.43 95.22 5.52 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 120.838 0.352 . . . . 13.65 110.449 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.46 -0.781 . . . . 15.050000000000001 109.818 -179.545 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.693 0 N-CA-C 112.007 -0.437 . . . . 14.85 112.007 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.66 156.56 28.96 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.845 -0.209 . . . . 13.5 110.467 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.474 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 29.1 t70 -83.15 128.47 64.85 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.776 0.322 . . . . 11.25 110.557 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 21.1 Cg_exo -66.05 -10.47 27.22 Favored 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.233 2.622 . . . . 11.140000000000001 113.138 -178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.645 ' HB3' ' HA ' ' A' ' 176' ' ' ARG . 25.3 m -108.01 67.48 0.68 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.337 0.589 . . . . 9.3000000000000007 111.139 -177.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 83.3 mt -141.14 109.17 5.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.501 -0.772 . . . . 7.8899999999999997 108.979 176.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 54.96 -153.57 0.31 Allowed 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.343 -0.614 . . . . 7.7800000000000002 109.343 -171.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.771 ' HE2' ' HB3' ' A' ' 172' ' ' ARG . 12.5 mptt -92.86 167.91 11.52 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.608 -0.437 . . . . 2.3700000000000001 110.241 173.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 98' ' ' VAL . 7.0 p -154.82 -179.22 7.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.674 -0.862 . . . . 1.79 108.674 -177.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 75.71 -26.22 1.39 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.979 -0.629 . . . . 0.44 111.898 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.477 ' H ' ' C ' ' A' ' 96' ' ' SER . 71.5 t 66.13 124.11 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 C-N-CA 124.165 0.986 . . . . 0.70999999999999996 111.857 -176.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 151' ' ' ALA . . . 73.27 24.15 75.98 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.181 -1.009 . . . . 0.20999999999999999 112.084 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.513 HD22 ' N ' ' A' ' 100' ' ' ASN . 0.9 OUTLIER -88.58 125.41 34.79 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.357 -0.608 . . . . 0.63 109.357 -174.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.522 HG23 ' HB1' ' A' ' 151' ' ' ALA . 21.4 pt -135.31 159.73 40.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.087 -0.338 . . . . 0.14999999999999999 110.087 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.39 138.18 54.62 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.899 -0.408 . . . . 0.20999999999999999 109.899 176.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.632 HG12 HG22 ' A' ' 170' ' ' VAL . 5.7 mt -116.71 131.49 69.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.548 -0.751 . . . . 0.14999999999999999 110.076 -177.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -113.66 152.56 30.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.493 -0.321 . . . . 1.46 110.588 -179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 46.8 t30 75.58 33.99 0.62 Allowed 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.014 0.821 . . . . 0.48999999999999999 111.683 170.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.485 HD23 HG11 ' A' ' 168' ' ' VAL . 25.4 mt -75.64 156.82 34.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 0.26000000000000001 111.446 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.464 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 15.0 t70 -83.15 153.14 24.95 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.519 -0.764 . . . . 0.70999999999999996 111.36 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.422 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 55.1 pttt -54.09 -37.66 64.48 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.485 -0.78 . . . . 2.2000000000000002 112.501 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.421 ' N ' ' HG3' ' A' ' 108' ' ' LYS . 13.7 m -80.86 -8.76 59.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.848 0.314 . . . . 1.4099999999999999 111.848 -172.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.502 ' O ' HG11 ' A' ' 130' ' ' VAL . 34.6 mm -71.16 120.17 18.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.013 0.435 . . . . 0.26000000000000001 110.376 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -109.27 -179.67 3.9 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.016 -0.735 . . . . 1.5900000000000001 109.016 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.58 -40.98 98.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.269 -0.641 . . . . 0.59999999999999998 109.269 -178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.884 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -59.97 -49.39 77.87 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.277 -0.874 . . . . 2.5800000000000001 110.567 178.416 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.9 98.19 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 114.265 -1.334 . . . . 0.14999999999999999 111.396 -177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.762 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -65.03 -47.15 78.42 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.952 -0.758 . . . . 0.16 108.952 177.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 64.4 t80 -57.54 -48.23 79.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.916 -0.584 . . . . 0.29999999999999999 111.009 176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.25 -37.55 72.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.968 0.413 . . . . 0.40000000000000002 110.828 -175.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.9 m -77.88 -54.42 6.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.151 -0.477 . . . . 0.22 111.815 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.434 ' CD1' HD23 ' A' ' 115' ' ' LEU . 10.2 m-85 -73.02 -28.82 62.58 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.881 0.696 . . . . 0.11 112.881 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 23.1 t -57.57 -28.23 63.38 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.777 0.322 . . . . 0.19 110.875 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.45 -21.74 27.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.355 -0.384 . . . . 0.14000000000000001 111.618 177.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -92.98 -17.41 23.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.989 0.423 . . . . 0.17999999999999999 110.918 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.72 162.51 14.74 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.977 -0.556 . . . . 0.11 111.796 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -61.67 132.45 53.29 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.057 0.456 . . . . 0.25 110.538 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.474 HG21 ' HB3' ' A' ' 128' ' ' CYS . 68.3 mt -106.35 133.68 50.13 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.808 -0.633 . . . . 0.14000000000000001 109.747 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.602 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.28 -40.31 13.72 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.01 -0.737 . . . . 0.54000000000000004 109.01 -177.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 75.3 m -147.68 129.66 15.37 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.973 -1.012 . . . . 0.76000000000000001 109.915 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 5.8 p -129.44 124.67 34.68 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.265 -0.643 . . . . 0.71999999999999997 109.265 178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 60.7 tptt -123.95 127.93 48.67 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 120.906 0.384 . . . . 1.0 111.327 -173.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.762 HG22 HD12 ' A' ' 115' ' ' LEU . 54.8 t -114.48 109.55 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 106.856 -1.535 . . . . 0.28000000000000003 106.856 170.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.47 HG12 ' HG3' ' A' ' 138' ' ' LYS . 6.4 t -75.77 115.91 17.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 108.611 -0.885 . . . . 0.34000000000000002 108.611 -175.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 3.2 p -97.15 134.56 40.32 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.732 -0.667 . . . . 1.5800000000000001 112.443 -165.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -87.56 163.95 16.36 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.225 -1.028 . . . . 2.0800000000000001 108.225 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -56.25 -27.42 55.03 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.806 0.336 . . . . 2.4500000000000002 110.538 174.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -92.34 -1.24 57.18 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.261 -0.427 . . . . 1.6499999999999999 111.134 -179.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.422 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 142.35 -69.11 0.44 Allowed Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.516 -0.85 . . . . 1.1200000000000001 113.656 178.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.674 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 34.3 t -142.2 145.87 34.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 117.292 0.546 . . . . 1.6100000000000001 110.538 -177.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.47 ' HG3' HG12 ' A' ' 131' ' ' VAL . 4.2 mmpt? -76.07 -15.65 60.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.325 0.583 . . . . 1.51 110.279 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 112.28 -12.4 26.23 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.186 -0.916 . . . . 0.31 113.314 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 24.0 p90 -133.03 148.8 52.23 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.368 0.584 . . . . 0.48999999999999999 111.654 -176.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -142.86 168.56 25.93 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.24 -0.891 . . . . 0.12 111.377 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -136.47 136.49 39.5 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 117.059 0.43 . . . . 0.25 110.801 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.518 ' HB ' HG12 ' A' ' 101' ' ' ILE . 48.7 t -111.0 136.45 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-O 120.957 0.408 . . . . 0.10000000000000001 111.145 176.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.447 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 1.3 m170 -105.57 105.63 15.76 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.104 -0.702 . . . . 0.20999999999999999 109.104 166.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.472 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 17.5 m-85 -88.79 138.59 31.28 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.042 0.448 . . . . 0.17000000000000001 110.938 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.602 ' HA ' HD21 ' A' ' 126' ' ' LEU . 28.5 tt0 -45.87 -45.39 15.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.526 -1.215 . . . . 0.56999999999999995 110.923 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 23.3 p -119.8 150.78 39.86 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.938 -1.028 . . . . 0.40000000000000002 110.839 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -61.46 -33.41 73.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.49 -0.777 . . . . 0.46999999999999997 110.865 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.76 -35.65 75.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.73999999999999999 111.83 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.59 -34.23 76.57 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.093 0.473 . . . . 0.17999999999999999 110.498 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.522 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -64.2 -44.25 92.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.632 -0.713 . . . . 0.16 110.688 176.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 31.8 mt-10 -58.96 -38.61 79.47 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.951 -0.568 . . . . 1.4199999999999999 110.471 178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.544 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 92.2 mtt180 -62.77 -43.51 98.6 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.03 0.443 . . . . 1.48 110.969 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.75 -37.29 85.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.293 -0.412 . . . . 0.10000000000000001 110.405 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 151' ' ' ALA . 90.6 mt -59.17 -52.74 57.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.14999999999999999 111.248 177.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 1.6 pt-20 -64.02 -46.24 85.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.09 0.472 . . . . 1.0800000000000001 111.809 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -80.86 -38.47 28.1 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.147 0.795 . . . . 1.1599999999999999 113.147 -168.462 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.419 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.0 mmm -93.29 -20.22 20.62 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.458 0.54 . . . . 0.34999999999999998 112.458 -173.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 53.8 t30 -68.58 123.75 21.71 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.221 -0.592 . . . . 0.44 109.652 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.52 64.48 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.777 -0.725 . . . . 0.28999999999999998 112.539 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.729 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 32.7 mmt -96.07 162.5 13.52 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.678 0.239 . . . . 1.1799999999999999 110.976 177.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 28.9 mt -103.35 105.04 15.22 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 109.345 -0.613 . . . . 0.44 109.345 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 18.0 mt -91.04 108.93 20.19 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.925 -0.71 . . . . 1.02 109.256 173.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 93.9 m-20 73.57 -60.34 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.302 -0.863 . . . . 1.71 111.827 -176.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -172.61 22.9 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.549 -0.75 . . . . 0.84999999999999998 110.798 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.7 mtt180 -138.29 132.75 32.14 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 122.006 -0.434 . . . . 0.95999999999999996 109.96 -178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.729 ' HA ' ' O ' ' A' ' 161' ' ' MET . 20.2 tttt -84.19 115.02 22.21 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.441 -0.577 . . . . 1.0 109.441 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.485 HG11 HD23 ' A' ' 106' ' ' LEU . 15.6 m -100.12 147.83 7.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.599 0.714 . . . . 0.17000000000000001 111.485 -170.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 75.8 t80 -106.58 120.49 42.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.735 -1.121 . . . . 0.29999999999999999 109.365 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.632 HG22 HG12 ' A' ' 103' ' ' ILE . 42.3 t -115.48 125.58 72.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.154 -0.684 . . . . 0.13 109.154 177.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.53 -171.5 16.68 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.351 -0.928 . . . . 0.17999999999999999 112.235 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.771 ' HB3' ' HE2' ' A' ' 95' ' ' LYS . 25.9 mmt180 -69.3 131.19 44.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.426 -0.583 . . . . 1.9299999999999999 109.426 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.562 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 49.4 t80 -63.97 128.62 36.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.052 -0.522 . . . . 1.4399999999999999 110.296 -176.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -82.53 85.44 6.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.116 0.484 . . . . 4.6600000000000001 110.086 -177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 95' ' ' LYS . 0.5 OUTLIER -84.89 -16.81 39.92 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.885 -0.598 . . . . 3.6000000000000001 111.85 -177.27 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.645 ' HA ' ' HB3' ' A' ' 92' ' ' SER . 19.2 ttp180 -109.72 -90.1 0.47 Allowed 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.543 -0.463 . . . . 7.5999999999999996 110.635 179.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -142.38 -170.56 3.21 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.194 -0.298 . . . . 8.6099999999999994 110.194 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -125.09 127.05 46.29 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.574 -0.899 . . . . 8.5500000000000007 108.574 173.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 180' ' ' GLU . 40.9 ttm180 -90.86 -74.59 0.49 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.852 -0.339 . . . . 12.18 111.231 -174.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 179' ' ' ARG . 36.9 tt0 163.13 -37.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.609 -0.886 . . . . 12.699999999999999 108.609 -173.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -142.33 101.3 3.88 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.513 -1.221 . . . . 13.65 109.185 -179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-N 115.631 -0.713 . . . . 15.050000000000001 110.136 -175.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.976 0 N-CA-C 112.278 -0.329 . . . . 14.85 112.278 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 176' ' ' ARG . . . -137.1 31.04 2.69 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.015 -0.735 . . . . 13.5 109.015 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.748 ' HB2' ' HB3' ' A' ' 93' ' ' LEU . 2.7 m-20 -102.73 110.31 62.95 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.847 -1.07 . . . . 11.25 110.611 -172.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.56 ' HA ' ' HB2' ' A' ' 175' ' ' SER . 50.7 Cg_exo -56.4 -50.8 10.84 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.085 2.523 . . . . 11.140000000000001 112.76 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.2 m -82.13 11.23 5.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.451 -0.34 . . . . 9.3000000000000007 111.822 -176.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.748 ' HB3' ' HB2' ' A' ' 90' ' ' ASP . 3.2 tm? -117.64 -50.31 2.52 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.032 -0.358 . . . . 7.8899999999999997 110.032 178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 2.6 mmp_? -65.86 -51.12 61.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 7.7800000000000002 111.605 -178.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.94 11.02 24.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.784 0.326 . . . . 2.3700000000000001 111.268 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.8 t -79.05 -6.26 55.99 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.276 0.56 . . . . 1.79 110.31 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' A' ' 98' ' ' VAL . . . -67.8 -22.72 73.89 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.782 -0.644 . . . . 0.44 111.923 176.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 97' ' ' GLY . 41.2 t 72.06 117.69 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 123.711 0.804 . . . . 0.70999999999999996 111.908 -176.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 76.08 24.08 69.93 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.218 -0.991 . . . . 0.20999999999999999 111.877 176.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 173' ' ' PHE . 2.2 m120 -87.45 125.8 34.51 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.969 -0.752 . . . . 0.63 108.969 -176.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.563 HG12 ' HB ' ' A' ' 143' ' ' VAL . 23.8 pt -135.02 163.55 36.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.477 -0.329 . . . . 0.14999999999999999 110.283 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.14 147.28 49.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.83 -0.433 . . . . 0.20999999999999999 109.83 175.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.561 HG12 HG22 ' A' ' 170' ' ' VAL . 4.4 mt -119.26 139.29 47.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.679 -0.691 . . . . 0.14999999999999999 109.811 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 ttpp -117.16 153.22 33.2 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 122.952 0.158 . . . . 1.46 110.637 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.0 t30 71.39 39.73 0.9 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.863 0.727 . . . . 0.48999999999999999 112.16 171.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.434 HD23 HG11 ' A' ' 168' ' ' VAL . 33.5 mt -81.82 164.73 21.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.807 0.337 . . . . 0.26000000000000001 111.056 176.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -96.7 157.53 15.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.475 . . . . 0.70999999999999996 109.813 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.843 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 22.2 pttp -61.51 -26.4 67.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.484 0.659 . . . . 2.2000000000000002 109.681 172.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 m -59.78 -23.12 63.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.632 -1.167 . . . . 1.4099999999999999 112.596 174.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.608 HG22 HG21 ' A' ' 130' ' ' VAL . 40.2 mm -86.43 131.32 34.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.407 0.622 . . . . 0.26000000000000001 111.502 -174.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -117.37 -175.39 2.79 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.235 -1.024 . . . . 1.5900000000000001 108.235 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -69.07 -29.68 67.85 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 108.608 -0.886 . . . . 0.59999999999999998 108.608 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.03 -49.46 65.18 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.457 -1.247 . . . . 2.5800000000000001 109.404 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.73 -37.78 85.47 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.7 -1.136 . . . . 0.14999999999999999 110.691 -177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.742 HD12 HG22 ' A' ' 130' ' ' VAL . 3.5 tt -70.72 -48.05 56.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.47 -0.786 . . . . 0.16 109.35 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.622 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 80.2 t80 -61.05 -45.12 96.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.237 -0.438 . . . . 0.29999999999999999 110.833 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -56.43 -41.83 77.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.014 0.435 . . . . 0.40000000000000002 110.884 -176.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.418 HG21 HD21 ' A' ' 163' ' ' LEU . 24.0 m -77.66 -53.66 7.29 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.742 -0.663 . . . . 0.22 112.072 -177.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.455 ' CD1' HD23 ' A' ' 115' ' ' LEU . 17.7 m-85 -72.17 -29.46 64.04 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.46 0.541 . . . . 0.11 112.46 -173.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.6 t -58.67 -28.93 66.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.595 0.236 . . . . 0.19 111.201 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.38 -22.62 43.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.796 0.331 . . . . 0.14000000000000001 111.554 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -93.64 -11.94 30.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 0.17999999999999999 110.875 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 160.95 164.06 15.14 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.929 -0.653 . . . . 0.11 111.846 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -67.05 137.5 56.48 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.932 0.396 . . . . 0.25 110.178 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.416 HG21 ' HB3' ' A' ' 128' ' ' CYS . 72.1 mt -110.21 129.57 64.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 116.119 -0.491 . . . . 0.14000000000000001 109.927 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.14 -35.37 20.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.054 -0.721 . . . . 0.54000000000000004 109.054 -177.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 65.8 m -154.31 128.72 9.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.17 -0.923 . . . . 0.76000000000000001 109.849 -177.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 2.6 p -134.14 144.85 48.79 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.802 0.334 . . . . 0.71999999999999997 110.247 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 19.4 tptp -143.78 133.15 23.29 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.299 -0.41 . . . . 1.0 111.59 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.742 HG22 HD12 ' A' ' 115' ' ' LEU . 59.6 t -113.23 111.11 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 N-CA-C 106.383 -1.71 . . . . 0.28000000000000003 106.383 168.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.4 t -79.99 115.86 23.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.804 -0.813 . . . . 0.34000000000000002 108.804 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 5.6 p -99.5 135.88 40.26 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.759 0.652 . . . . 1.5800000000000001 112.759 -166.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.41 ' H ' ' CA ' ' A' ' 137' ' ' SER . 31.5 t70 -86.1 163.29 17.97 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.962 -1.017 . . . . 2.0800000000000001 108.818 174.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -54.83 -31.33 59.16 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.791 0.329 . . . . 2.4500000000000002 110.7 174.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -86.28 -6.62 58.92 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.196 -0.456 . . . . 1.6499999999999999 110.979 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.843 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 148.4 -71.1 0.32 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.743 -0.741 . . . . 1.1200000000000001 113.271 178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.746 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 27.6 t -142.81 146.27 34.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.336 0.568 . . . . 1.6100000000000001 110.409 -176.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 37.5 mtpt -78.65 -8.1 58.32 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.342 0.591 . . . . 1.51 110.137 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 102.94 -19.93 45.15 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.466 -0.873 . . . . 0.31 113.113 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.439 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 22.2 p90 -125.88 148.78 49.09 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 117.457 0.629 . . . . 0.48999999999999999 111.984 -174.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.36 173.81 23.2 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.002 -0.999 . . . . 0.12 111.358 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -136.11 141.85 44.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 117.032 0.416 . . . . 0.25 110.848 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.563 ' HB ' HG12 ' A' ' 101' ' ' ILE . 28.1 t -117.23 135.95 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 121.106 0.479 . . . . 0.10000000000000001 110.84 172.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.4 OUTLIER -107.2 106.17 16.5 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.031 -0.729 . . . . 0.20999999999999999 109.031 168.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.529 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.2 m-85 -90.49 139.06 31.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.596 0.713 . . . . 0.17000000000000001 111.936 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.576 ' HA ' HD21 ' A' ' 126' ' ' LEU . 46.5 tt0 -49.05 -40.79 32.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 113.912 -1.495 . . . . 0.56999999999999995 110.86 178.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 82.2 p -123.93 154.59 39.53 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.887 -1.051 . . . . 0.40000000000000002 110.513 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -66.14 -33.5 75.91 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.177 -0.465 . . . . 0.46999999999999997 110.902 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.07 -35.86 77.0 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.365 -0.379 . . . . 0.73999999999999999 111.518 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.19 -34.51 78.24 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.168 0.508 . . . . 0.17999999999999999 110.402 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.529 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.81 -48.01 80.97 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.523 -0.762 . . . . 0.16 110.606 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.634 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 29.3 mt-10 -58.64 -42.13 87.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.005 -0.543 . . . . 1.4199999999999999 110.696 177.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 72.5 mtt180 -58.65 -41.62 86.49 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 120.944 0.402 . . . . 1.48 110.949 177.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.22 -40.36 86.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.359 -0.382 . . . . 0.10000000000000001 110.612 177.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 151' ' ' ALA . 91.1 mt -60.33 -49.59 83.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.056 -0.52 . . . . 0.14999999999999999 111.176 179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.9 pt-20 -64.07 -45.69 87.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.175 0.512 . . . . 1.0800000000000001 111.704 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.473 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -80.73 -38.58 28.5 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 113.329 0.863 . . . . 1.1599999999999999 113.329 -169.261 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.426 ' HB2' HG21 ' A' ' 170' ' ' VAL . 88.9 mmm -95.77 -17.12 21.44 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.709 0.633 . . . . 0.34999999999999998 112.709 -172.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.06 123.06 20.61 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.197 -0.601 . . . . 0.44 109.613 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.04 22.69 54.45 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.865 -0.684 . . . . 0.28999999999999998 112.419 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.564 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 0.5 OUTLIER -106.48 161.57 14.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.724 0.297 . . . . 1.1799999999999999 111.622 -179.091 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 75.4 mt -104.17 106.75 17.36 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 108.908 -0.775 . . . . 0.44 108.908 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.418 HD21 HG21 ' A' ' 118' ' ' THR . 2.6 mt -92.6 22.17 4.89 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.015 -0.674 . . . . 1.02 111.864 -178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.7 p30 169.92 -79.71 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 123.823 0.849 . . . . 1.71 109.153 -175.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -150.93 12.28 0.67 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.747 -1.115 . . . . 0.84999999999999998 109.536 171.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -124.04 135.04 53.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.589 -0.732 . . . . 0.95999999999999996 109.096 -176.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 161' ' ' MET . 3.9 ttmp? -84.19 117.25 23.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.173 -0.677 . . . . 1.0 109.173 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.434 HG11 HD23 ' A' ' 106' ' ' LEU . 19.1 m -99.79 143.28 13.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.541 0.686 . . . . 0.17000000000000001 110.565 -172.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 39.7 t80 -106.53 122.18 45.78 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.882 -1.054 . . . . 0.29999999999999999 109.417 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.561 HG22 HG12 ' A' ' 103' ' ' ILE . 43.1 t -115.94 125.75 73.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.476 -0.564 . . . . 0.13 109.476 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.04 -167.23 12.1 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.319 -0.712 . . . . 0.17999999999999999 111.319 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 13.6 mmt180 -68.97 136.43 52.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.833 -0.803 . . . . 1.9299999999999999 108.833 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 174' ' ' LYS . 68.0 t80 -38.18 -87.48 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 O-C-N 124.507 1.129 . . . . 1.4399999999999999 113.434 -169.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 173' ' ' PHE . 63.8 tttm 162.49 105.19 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.895 -0.78 . . . . 4.6600000000000001 108.895 -178.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 91' ' ' PRO . 0.1 OUTLIER -94.35 -64.6 1.06 Allowed 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.68 0.276 . . . . 3.6000000000000001 111.174 -176.654 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 39.8 ttm180 -113.18 -55.24 2.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.414 0.626 . . . . 7.5999999999999996 110.132 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -179.15 -32.39 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.673 -1.149 . . . . 8.6099999999999994 108.322 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 61.22 82.15 0.17 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 114.507 -1.224 . . . . 8.5500000000000007 110.717 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -73.49 111.24 8.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.183 -0.917 . . . . 12.18 109.464 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -127.3 -4.34 6.12 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.425 -0.352 . . . . 12.699999999999999 111.35 -175.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -81.51 93.21 6.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.927 0.394 . . . . 13.65 110.485 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.538 -0.744 . . . . 15.050000000000001 109.641 -178.968 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.558 0 N-CA-C 112.056 -0.418 . . . . 14.85 112.056 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.36 -176.04 2.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.418 -0.586 . . . . 13.5 109.418 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -106.38 128.53 26.09 Favored Pre-proline 0 C--N 1.321 -0.668 0 C-N-CA 120.743 -0.383 . . . . 11.25 110.323 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -58.26 -35.2 98.95 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.861 2.374 . . . . 11.140000000000001 111.735 178.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 23.1 m -119.83 78.33 1.32 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.172 -0.677 . . . . 9.3000000000000007 109.172 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 23.5 tp -73.08 -32.64 65.13 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.151 -0.685 . . . . 7.8899999999999997 109.151 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -84.77 157.67 20.94 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.31 -1.367 . . . . 7.7800000000000002 107.31 164.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -93.08 153.24 18.8 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.722 -0.791 . . . . 2.3700000000000001 111.114 -166.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 p -79.49 -27.9 41.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.873 0.368 . . . . 1.79 110.97 -172.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -69.86 -29.89 70.66 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.597 -0.811 . . . . 0.44 111.183 175.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 55.3 t 61.47 127.14 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.847 0.859 . . . . 0.70999999999999996 112.531 -177.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.32 24.87 74.37 Favored Glycine 0 N--CA 1.44 -1.06 0 C-N-CA 119.873 -1.155 . . . . 0.20999999999999999 111.455 178.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.53 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.3 m120 -89.95 124.17 34.5 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.955 -0.757 . . . . 0.63 108.955 -173.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.482 HG23 ' HB1' ' A' ' 151' ' ' ALA . 17.1 pt -136.07 163.55 34.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.942 -0.392 . . . . 0.14999999999999999 109.942 177.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.94 143.22 51.17 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.1 0.476 . . . . 0.20999999999999999 109.775 176.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.662 HG12 HG22 ' A' ' 170' ' ' VAL . 6.1 mt -119.33 136.38 56.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.355 -0.839 . . . . 0.14999999999999999 109.876 -177.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -120.15 154.1 35.26 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 121.438 -0.105 . . . . 1.46 110.913 -178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 51.0 t30 73.73 32.79 1.09 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.878 0.871 . . . . 0.48999999999999999 111.528 174.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.645 HD22 HG21 ' A' ' 110' ' ' ILE . 30.7 mt -73.99 154.31 39.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.956 0.408 . . . . 0.26000000000000001 111.255 177.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.46 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 25.6 t70 -83.17 152.3 25.31 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.716 -0.675 . . . . 0.70999999999999996 110.681 179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.667 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 63.6 pttt -56.15 -34.66 66.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.625 . . . . 2.2000000000000002 112.014 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 54.3 m -80.14 -2.83 46.33 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.416 0.524 . . . . 1.4099999999999999 112.416 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.645 HG21 HD22 ' A' ' 106' ' ' LEU . 31.6 mm -78.91 116.43 22.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.615 -0.434 . . . . 0.26000000000000001 110.057 175.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -105.85 -176.7 3.15 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.95 -0.759 . . . . 1.5900000000000001 108.95 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -68.81 -31.01 69.7 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 109.111 -0.7 . . . . 0.59999999999999998 109.111 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.96 -48.33 66.15 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.634 -1.166 . . . . 2.5800000000000001 109.238 178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.6 -41.6 97.66 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.269 -1.332 . . . . 0.14999999999999999 110.796 -177.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.711 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -67.5 -47.37 70.21 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.243 -0.89 . . . . 0.16 108.994 177.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.724 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 62.3 t80 -58.34 -47.81 82.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.179 -0.464 . . . . 0.29999999999999999 111.155 176.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -56.74 -39.27 73.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.068 0.461 . . . . 0.40000000000000002 110.86 -174.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.7 m -78.48 -53.59 7.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.84 -0.618 . . . . 0.22 112.181 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.443 ' CD1' HD23 ' A' ' 115' ' ' LEU . 8.3 m-85 -72.52 -28.29 62.77 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.802 0.667 . . . . 0.11 112.802 -174.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 28.5 t -57.05 -28.39 62.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.749 0.309 . . . . 0.19 111.428 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.35 -22.45 42.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.699 0.285 . . . . 0.14000000000000001 111.748 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.408 ' HZ ' ' HE2' ' A' ' 157' ' ' LYS . 23.9 m-85 -90.38 -18.23 25.84 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.968 0.413 . . . . 0.17999999999999999 111.102 -177.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 165.31 166.93 25.11 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.901 -0.59 . . . . 0.11 111.632 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -67.7 129.75 40.89 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.927 0.394 . . . . 0.25 110.268 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.429 HG21 ' HB3' ' A' ' 128' ' ' CYS . 71.8 mt -100.48 131.97 47.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 116.134 -0.485 . . . . 0.14000000000000001 110.281 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.545 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -86.61 -44.73 11.65 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.497 -0.927 . . . . 0.54000000000000004 108.497 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 58.5 m -147.33 111.65 5.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.912 -1.04 . . . . 0.76000000000000001 110.544 -177.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.4 p -107.22 145.12 33.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.254 -0.647 . . . . 0.71999999999999997 109.254 173.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -144.83 128.79 17.47 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.407 -0.517 . . . . 1.0 111.932 -176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.711 HG22 HD12 ' A' ' 115' ' ' LEU . 48.6 t -114.81 110.64 32.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 106.627 -1.62 . . . . 0.28000000000000003 106.627 168.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.67 121.08 32.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 108.985 -0.746 . . . . 0.34000000000000002 108.985 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 58.9 m -96.24 134.79 38.9 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.694 0.759 . . . . 1.5800000000000001 112.642 -165.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -87.35 163.62 16.7 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.702 -1.135 . . . . 2.0800000000000001 107.995 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -58.39 -25.9 62.6 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.024 0.44 . . . . 2.4500000000000002 110.607 173.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -91.61 -0.63 57.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.082 -0.508 . . . . 1.6499999999999999 110.341 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.667 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 138.98 -71.37 0.45 Allowed Glycine 0 C--O 1.226 -0.401 0 C-N-CA 120.653 -0.784 . . . . 1.1200000000000001 113.367 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.6 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 37.1 t -139.44 144.47 38.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.432 0.616 . . . . 1.6100000000000001 110.081 -177.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt -76.87 -9.01 58.39 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.367 0.603 . . . . 1.51 110.237 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.32 -17.56 34.09 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.422 -0.808 . . . . 0.31 113.182 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 103' ' ' ILE . 25.7 p90 -127.19 150.59 49.45 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.207 0.527 . . . . 0.48999999999999999 111.646 -174.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -143.18 170.6 25.33 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.302 -0.863 . . . . 0.12 111.222 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -137.78 138.79 39.59 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 117.147 0.473 . . . . 0.25 110.841 -176.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.501 HG11 ' CE2' ' A' ' 145' ' ' PHE . 42.6 t -113.74 135.45 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-O 120.962 0.41 . . . . 0.10000000000000001 110.8 173.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -105.2 106.23 16.62 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.086 -0.709 . . . . 0.20999999999999999 109.086 166.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.501 ' CE2' HG11 ' A' ' 143' ' ' VAL . 17.4 m-85 -90.24 139.98 30.13 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.265 0.555 . . . . 0.17000000000000001 111.079 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.545 ' HA ' HD21 ' A' ' 126' ' ' LEU . 42.3 tt0 -50.57 -37.56 40.37 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.524 -1.216 . . . . 0.56999999999999995 110.93 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.8 p -121.68 155.87 34.25 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.023 -0.989 . . . . 0.40000000000000002 110.515 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.0 tp60 -68.48 -36.31 78.77 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.104 -0.498 . . . . 0.46999999999999997 110.447 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.35 -34.81 75.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.883 -0.598 . . . . 0.73999999999999999 112.014 -177.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.83 -36.77 79.94 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.153 0.502 . . . . 0.17999999999999999 110.454 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.482 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -65.04 -40.91 95.46 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.561 -0.745 . . . . 0.16 110.433 177.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 51.9 mt-10 -59.88 -37.35 79.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.636 -0.711 . . . . 1.4199999999999999 110.822 178.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.472 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 98.2 mtt180 -65.5 -43.99 88.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.352 -0.385 . . . . 1.48 110.876 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.55 -37.43 83.78 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.222 -0.445 . . . . 0.10000000000000001 110.532 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 151' ' ' ALA . 92.8 mt -60.65 -53.49 48.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.22 -0.445 . . . . 0.14999999999999999 111.287 177.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.4 pt-20 -64.16 -43.4 95.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.182 0.515 . . . . 1.0800000000000001 111.902 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -81.26 -39.09 25.84 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 112.887 0.699 . . . . 1.1599999999999999 112.887 -169.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.511 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.7 mmm -94.86 -20.22 19.63 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.686 0.625 . . . . 0.34999999999999998 112.686 -172.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -68.05 123.39 20.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.392 -0.596 . . . . 0.44 109.392 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.53 16.89 63.16 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.656 -0.783 . . . . 0.28999999999999998 112.667 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.6 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 4.4 mmt -98.48 156.23 16.87 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 122.718 -0.283 . . . . 1.1799999999999999 111.072 177.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.48 HD22 ' O ' ' A' ' 165' ' ' ASP . 17.5 mt -98.77 103.75 15.73 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.626 -0.509 . . . . 0.44 109.626 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 22.4 mt -91.01 104.28 16.89 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 120.054 -0.658 . . . . 1.02 109.401 174.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 79.9 m-20 76.78 -27.75 0.18 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.129 -0.942 . . . . 1.71 112.519 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.48 ' O ' HD22 ' A' ' 162' ' ' LEU . 32.7 t70 163.94 -20.45 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.819 0 O-C-N 124.083 0.864 . . . . 0.84999999999999998 111.402 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.46 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.4 mtt180 -102.17 130.18 48.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.331 -0.395 . . . . 0.95999999999999996 110.846 -172.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 161' ' ' MET . 19.5 tttt -78.7 115.03 18.13 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.395 -0.594 . . . . 1.0 109.395 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.529 HG11 HD23 ' A' ' 106' ' ' LEU . 12.9 m -100.56 149.57 6.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.614 0.721 . . . . 0.17000000000000001 111.366 -172.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.594 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 77.4 t80 -106.33 118.93 37.92 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.834 -1.076 . . . . 0.29999999999999999 109.612 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.662 HG22 HG12 ' A' ' 103' ' ' ILE . 39.4 t -115.74 126.36 73.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.435 -0.58 . . . . 0.13 109.435 176.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.24 -176.32 23.17 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.78 -0.724 . . . . 0.17999999999999999 111.524 178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -59.33 137.96 57.8 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.457 -0.571 . . . . 1.9299999999999999 109.457 177.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -61.29 94.6 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.973 -0.38 . . . . 1.4399999999999999 109.973 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.29 139.55 58.14 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.064 -0.517 . . . . 4.6600000000000001 110.596 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.1 m -78.28 52.7 1.15 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.601 0.715 . . . . 3.6000000000000001 110.288 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 19.0 mmt180 -121.6 12.29 10.7 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.465 -0.789 . . . . 7.5999999999999996 109.597 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -115.78 81.59 1.62 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.79 -0.641 . . . . 8.6099999999999994 109.73 176.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -118.71 -5.54 10.67 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.814 -0.81 . . . . 8.5500000000000007 108.814 174.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 38.3 ttp85 -81.59 100.36 9.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.957 -1.02 . . . . 12.18 109.339 172.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -101.91 -5.9 24.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.675 -0.693 . . . . 12.699999999999999 110.254 -175.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.42 33.77 0.16 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.618 -0.719 . . . . 13.65 112.196 -176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 . . . . . 0 C--O 1.246 0.872 0 CA-C-O 117.96 -1.019 . . . . 15.050000000000001 108.995 174.13 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 111.941 -0.463 . . . . 14.85 111.941 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.44 -19.36 23.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.641 0.258 . . . . 13.5 111.252 -177.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.601 ' HB2' ' HE ' ' A' ' 176' ' ' ARG . 34.5 m-20 -93.87 114.92 64.36 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.504 -0.316 . . . . 11.25 110.478 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.4 -67.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.653 2.236 . . . . 11.140000000000001 111.963 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 44.2 m -145.32 109.53 4.89 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.441 -0.345 . . . . 9.3000000000000007 111.085 -177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 84.2 mt -120.77 -41.54 2.56 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.886 0.374 . . . . 7.8899999999999997 110.813 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 58.1 mtm180 -147.6 -178.35 6.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.016 -0.538 . . . . 7.7800000000000002 109.857 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.518 ' HG3' ' HA ' ' A' ' 174' ' ' LYS . 4.9 ttmp? -107.27 75.81 1.05 Allowed 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.447 -0.575 . . . . 2.3700000000000001 109.447 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.509 ' HA ' ' HG2' ' A' ' 182' ' ' GLU . 2.8 p -73.86 162.51 29.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 121.909 -0.494 . . . . 1.79 110.482 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 103.12 -39.71 2.69 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.37 -1.092 . . . . 0.44 110.37 -172.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 38.3 t 61.0 128.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 123.932 0.893 . . . . 0.70999999999999996 112.627 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 71.29 23.98 77.47 Favored Glycine 0 N--CA 1.437 -1.287 0 C-N-CA 119.64 -1.267 . . . . 0.20999999999999999 111.507 175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 173' ' ' PHE . 0.9 OUTLIER -84.28 126.44 33.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.887 -0.412 . . . . 0.63 109.887 -174.274 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.577 HG12 ' HB ' ' A' ' 143' ' ' VAL . 32.2 pt -134.55 155.8 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.708 -0.678 . . . . 0.14999999999999999 109.631 176.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -121.96 139.68 53.37 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.631 -0.507 . . . . 0.20999999999999999 109.631 178.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.677 HG12 HG22 ' A' ' 170' ' ' VAL . 8.6 mt -118.03 137.36 52.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.79 -0.641 . . . . 0.14999999999999999 110.197 -176.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -124.2 152.52 42.81 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.638 -0.256 . . . . 1.46 110.403 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 167' ' ' LYS . 5.2 t30 74.69 45.32 0.17 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.806 0.813 . . . . 0.48999999999999999 110.847 170.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.466 HD22 HG21 ' A' ' 110' ' ' ILE . 20.1 mt -88.38 166.83 13.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.963 -1.017 . . . . 0.26000000000000001 110.795 176.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -97.06 162.69 13.26 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.603 -0.517 . . . . 0.70999999999999996 109.603 178.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.729 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 17.3 pttm -66.27 -25.03 66.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.277 0.561 . . . . 2.2000000000000002 109.618 173.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 37.0 m -60.67 -16.19 36.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.122 -0.944 . . . . 1.4099999999999999 112.074 175.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.492 HG22 HG21 ' A' ' 130' ' ' VAL . 44.9 mm -93.07 128.38 44.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.332 0.587 . . . . 0.26000000000000001 111.166 -177.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.419 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 8.7 t70 -118.65 -178.09 3.46 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.283 -1.006 . . . . 1.5900000000000001 108.283 175.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -61.81 -35.0 76.91 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.37 -0.604 . . . . 0.59999999999999998 109.37 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 1.006 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -61.76 -50.17 73.45 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.205 -0.907 . . . . 2.5800000000000001 110.583 177.457 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.419 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -61.15 -42.9 99.39 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.576 -1.193 . . . . 0.14999999999999999 110.968 -176.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.697 HD12 HG22 ' A' ' 130' ' ' VAL . 3.5 tt -65.51 -47.94 74.25 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.636 -0.711 . . . . 0.16 109.474 178.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.799 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 71.8 t80 -59.52 -44.71 93.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.442 . . . . 0.29999999999999999 110.71 176.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.73 -42.67 79.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.178 -0.464 . . . . 0.40000000000000002 111.154 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.5 m -78.05 -53.37 7.48 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.352 0.501 . . . . 0.22 112.352 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.483 ' CD1' HD23 ' A' ' 115' ' ' LEU . 7.4 m-85 -71.12 -28.12 64.07 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.548 0.573 . . . . 0.11 112.548 -172.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 45.3 t -57.89 -29.93 65.45 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.722 0.296 . . . . 0.19 111.351 -177.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.42 -22.67 44.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.763 0.316 . . . . 0.14000000000000001 111.361 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -91.07 -20.28 22.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.868 0.366 . . . . 0.17999999999999999 111.024 -177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.63 169.32 31.01 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.321 -0.711 . . . . 0.11 111.321 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -69.72 141.63 53.46 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.96 -0.385 . . . . 0.25 109.96 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.446 HG21 ' HB3' ' A' ' 128' ' ' CYS . 74.6 mt -112.43 135.94 50.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 116.241 -0.436 . . . . 0.14000000000000001 110.297 -178.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.552 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -90.93 -41.73 10.98 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.635 -0.876 . . . . 0.54000000000000004 108.635 179.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.456 ' OG ' ' HB2' ' A' ' 144' ' ' HIS . 95.7 p -145.5 126.96 15.01 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.287 -0.87 . . . . 0.76000000000000001 109.966 176.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.799 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 1.6 p -122.97 116.04 22.91 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.149 -0.685 . . . . 0.71999999999999997 109.149 174.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -117.82 128.61 55.02 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.17 0.509 . . . . 1.0 111.438 -173.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.697 HG22 HD12 ' A' ' 115' ' ' LEU . 99.3 t -114.67 109.34 28.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 106.45 -1.685 . . . . 0.28000000000000003 106.45 170.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.9 t -76.14 115.6 17.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 108.553 -0.906 . . . . 0.34000000000000002 108.553 -175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.79 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 19.7 p -106.91 137.74 44.4 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.53 -0.759 . . . . 1.5800000000000001 112.685 -164.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -85.25 161.35 19.59 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 108.147 -1.056 . . . . 2.0800000000000001 108.147 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -58.83 -22.29 58.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.832 0.348 . . . . 2.4500000000000002 110.861 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -90.83 -5.91 54.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.013 0.435 . . . . 1.6499999999999999 110.649 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.729 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 149.66 -72.44 0.29 Allowed Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.471 -0.871 . . . . 1.1200000000000001 113.297 178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.79 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 37.7 t -147.09 154.73 41.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.461 0.631 . . . . 1.6100000000000001 110.736 -176.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 138' ' ' LYS . 36.6 mtpt -88.42 -10.36 49.48 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.073 0.463 . . . . 1.51 110.611 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 107.09 -13.61 40.69 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.359 -0.924 . . . . 0.31 113.941 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -130.63 152.55 49.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.875 0.837 . . . . 0.48999999999999999 112.071 -175.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.73 173.34 26.98 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.252 -0.885 . . . . 0.12 112.094 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -141.62 138.31 32.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 122.243 0.217 . . . . 0.25 110.818 -176.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.577 ' HB ' HG12 ' A' ' 101' ' ' ILE . 33.2 t -115.56 130.73 69.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.849 0.356 . . . . 0.10000000000000001 111.277 175.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.456 ' HB2' ' OG ' ' A' ' 127' ' ' SER . 1.6 m170 -97.88 106.76 19.11 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.608 -0.886 . . . . 0.20999999999999999 108.608 165.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.519 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 7.8 m-85 -90.11 135.9 33.38 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.347 -0.541 . . . . 0.17000000000000001 111.196 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.552 ' HA ' HD21 ' A' ' 126' ' ' LEU . 36.2 tt0 -47.93 -40.26 21.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.531 -1.213 . . . . 0.56999999999999995 110.72 178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 24.8 p -122.5 146.87 47.0 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.844 -1.071 . . . . 0.40000000000000002 110.765 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -64.18 -37.9 89.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.742 -0.663 . . . . 0.46999999999999997 111.149 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -67.35 -34.75 77.97 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.168 0.433 . . . . 0.73999999999999999 112.168 -178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.95 78.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.168 0.509 . . . . 0.17999999999999999 110.826 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.519 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.8 -44.75 95.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.532 -0.758 . . . . 0.16 111.046 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 47.7 mt-10 -59.4 -39.41 83.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.912 -0.585 . . . . 1.4199999999999999 111.012 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 157' ' ' LYS . 62.2 mtt85 -61.03 -42.06 97.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.799 0.333 . . . . 1.48 110.664 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.34 -38.19 90.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.271 -0.422 . . . . 0.10000000000000001 110.207 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.3 mt -61.55 -54.27 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.172 -0.467 . . . . 0.14999999999999999 111.244 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.3 pt-20 -64.18 -44.08 93.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.118 0.485 . . . . 1.0800000000000001 111.706 -178.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -78.04 -38.99 43.33 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.919 0.711 . . . . 1.1599999999999999 112.919 -171.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.504 ' HB2' HG21 ' A' ' 170' ' ' VAL . 82.2 mmm -94.66 -27.51 15.83 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.907 0.706 . . . . 0.34999999999999998 112.907 -172.227 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -64.52 124.22 21.28 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.675 -0.41 . . . . 0.44 110.529 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 88.25 15.68 60.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.083 -0.579 . . . . 0.28999999999999998 113.296 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.695 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 79.5 mmm -109.45 162.62 14.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.897 0.349 . . . . 1.1799999999999999 111.806 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 96.8 mt -99.13 104.77 16.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.621 -0.881 . . . . 0.44 108.621 177.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.05 22.44 2.4 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.141 -0.624 . . . . 1.02 111.534 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.4 p30 171.35 -80.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 124.047 0.939 . . . . 1.71 108.54 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -150.32 17.6 0.84 Allowed 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.45 -1.25 . . . . 0.84999999999999998 108.581 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 91.4 mtt180 -131.16 127.19 37.5 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.853 -1.067 . . . . 0.95999999999999996 109.768 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.3 tttt -76.41 121.93 23.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.807 -0.633 . . . . 1.0 109.654 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.429 HG11 HD23 ' A' ' 106' ' ' LEU . 17.8 m -101.29 142.17 16.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.282 0.563 . . . . 0.17000000000000001 110.955 -174.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.628 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 76.5 t80 -106.25 118.08 35.7 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.27 -0.877 . . . . 0.29999999999999999 109.509 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 103' ' ' ILE . 39.0 t -115.24 125.16 72.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.283 -0.636 . . . . 0.13 109.283 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -141.64 -170.82 12.55 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.672 -0.775 . . . . 0.17999999999999999 112.13 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -73.88 130.97 40.98 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.246 -0.279 . . . . 1.9299999999999999 110.246 -177.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.477 ' HB3' ' HB3' ' A' ' 100' ' ' ASN . 1.5 t80 -110.48 112.41 24.3 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.456 -0.572 . . . . 1.4399999999999999 109.456 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.518 ' HA ' ' HG3' ' A' ' 95' ' ' LYS . 83.2 tttt -97.48 96.1 8.1 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.775 -0.454 . . . . 4.6600000000000001 109.775 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 11.7 t -100.02 134.27 43.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.037 -0.529 . . . . 3.6000000000000001 110.843 -175.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.601 ' HE ' ' HB2' ' A' ' 90' ' ' ASP . 30.8 tpt180 -137.89 4.41 2.53 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.287 0.565 . . . . 7.5999999999999996 110.14 176.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.578 ' HG3' ' HG2' ' A' ' 178' ' ' GLU . 13.3 ptmm? -59.65 -23.44 63.05 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.306 -0.406 . . . . 8.6099999999999994 111.048 178.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.578 ' HG2' ' HG3' ' A' ' 177' ' ' LYS . 11.0 pt-20 -173.23 139.44 0.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.021 -0.536 . . . . 8.5500000000000007 109.641 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.563 ' HG3' ' HB2' ' A' ' 182' ' ' GLU . 13.1 ttp180 -85.39 91.87 8.32 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.156 0.503 . . . . 12.18 110.275 -178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -90.88 -9.31 46.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.724 -0.671 . . . . 12.699999999999999 110.291 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.405 ' O ' ' HG2' ' A' ' 182' ' ' GLU . . . -170.32 102.25 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.885 -0.598 . . . . 13.65 110.732 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.563 ' HB2' ' HG3' ' A' ' 179' ' ' ARG . 4.0 mm-40 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 124.023 0.929 . . . . 15.050000000000001 108.818 173.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.744 0 N-CA-C 112.227 -0.349 . . . . 14.85 112.227 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -111.29 -165.99 1.04 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.793 -0.447 . . . . 13.5 109.793 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -76.43 129.87 78.67 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.984 0.421 . . . . 11.25 110.689 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -83.73 -18.53 5.53 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.541 2.161 . . . . 11.140000000000001 111.168 172.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 93' ' ' LEU . 12.3 p 170.3 -63.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.671 -1.15 . . . . 9.3000000000000007 109.695 -174.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 92' ' ' SER . 56.7 mt 73.89 160.1 0.23 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.144 -0.935 . . . . 7.8899999999999997 111.035 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -129.12 -30.15 2.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.666 -0.697 . . . . 7.7800000000000002 110.5 -176.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.422 ' HB3' ' HB2' ' A' ' 100' ' ' ASN . 2.1 mptp? -122.51 45.87 2.27 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.555 -0.906 . . . . 2.3700000000000001 108.555 175.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.1 p -59.93 -19.17 50.38 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.211 -0.904 . . . . 1.79 112.744 -173.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -66.26 -15.04 62.74 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.905 -0.664 . . . . 0.44 112.311 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 45.2 t 66.15 126.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.861 0.864 . . . . 0.70999999999999996 112.218 -177.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.91 24.18 76.49 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.143 -1.027 . . . . 0.20999999999999999 111.39 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.54 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.3 m120 -88.36 124.64 34.12 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.858 -0.793 . . . . 0.63 108.858 -173.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.554 HG12 ' HB ' ' A' ' 143' ' ' VAL . 21.0 pt -136.26 163.7 33.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.628 -0.26 . . . . 0.14999999999999999 110.374 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.411 ' HB2' ' CE1' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -125.3 143.92 50.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.061 0.458 . . . . 0.20999999999999999 110.143 175.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.581 HG12 HG22 ' A' ' 170' ' ' VAL . 6.9 mt -119.39 138.85 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.466 -0.788 . . . . 0.14999999999999999 109.861 -178.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 18.4 ttpp -119.7 154.05 34.68 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.688 -0.233 . . . . 1.46 110.556 -179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 167' ' ' LYS . 35.0 t30 72.27 34.84 1.3 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.89 0.744 . . . . 0.48999999999999999 111.653 171.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.581 HD22 HG21 ' A' ' 110' ' ' ILE . 23.8 mt -74.73 160.19 31.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.122 0.486 . . . . 0.26000000000000001 111.0 177.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -91.3 156.33 17.87 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.54 -0.755 . . . . 0.70999999999999996 109.805 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.678 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 15.6 pttp -60.78 -28.82 69.03 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 123.248 0.342 . . . . 2.2000000000000002 111.26 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.5 p -66.78 -26.77 67.12 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.97 -0.559 . . . . 1.4099999999999999 111.859 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.581 HG21 HD22 ' A' ' 106' ' ' LEU . 47.8 mm -70.94 121.72 21.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.315 0.578 . . . . 0.26000000000000001 111.305 -172.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -111.79 -175.63 2.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.44 -0.948 . . . . 1.5900000000000001 108.44 178.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -69.71 -33.07 71.99 Favored 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 109.091 -0.707 . . . . 0.59999999999999998 109.091 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -48.24 72.39 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.861 -1.063 . . . . 2.5800000000000001 109.056 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.12 96.84 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.146 -1.388 . . . . 0.14999999999999999 110.878 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.743 HD12 HG22 ' A' ' 130' ' ' VAL . 3.1 tt -66.82 -47.38 72.21 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.843 -0.799 . . . . 0.16 108.843 177.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.692 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 52.2 t80 -59.36 -47.03 86.97 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-N 115.857 -0.611 . . . . 0.29999999999999999 110.733 176.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -56.12 -41.78 75.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 0.40000000000000002 110.83 -176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.466 HG21 HD21 ' A' ' 163' ' ' LEU . 7.4 m -77.53 -53.66 7.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.805 -0.634 . . . . 0.22 112.001 -176.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.488 ' CD1' HD23 ' A' ' 115' ' ' LEU . 10.9 m-85 -73.11 -29.3 62.81 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.427 0.529 . . . . 0.11 112.427 -174.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' GLY . 36.2 t -58.19 -27.76 64.16 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.678 0.275 . . . . 0.19 111.15 -178.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.73 -21.41 27.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.42 -0.355 . . . . 0.14000000000000001 111.396 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -93.04 -20.75 20.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.39 -0.368 . . . . 0.17999999999999999 110.869 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 120' ' ' SER . . . 167.76 166.14 26.33 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.634 -0.586 . . . . 0.11 111.634 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -66.01 139.96 58.25 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.052 0.453 . . . . 0.25 110.514 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.442 HG21 ' HB3' ' A' ' 128' ' ' CYS . 79.6 mt -111.84 135.78 50.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.988 -0.551 . . . . 0.14000000000000001 109.969 -179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -89.01 -43.86 10.81 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.84 -0.8 . . . . 0.54000000000000004 108.84 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 58.5 m -147.74 113.8 5.83 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.076 -0.966 . . . . 0.76000000000000001 110.423 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.692 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 4.7 p -110.86 139.89 45.79 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.432 -0.581 . . . . 0.71999999999999997 109.432 174.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -138.63 128.23 24.78 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.014 0.435 . . . . 1.0 111.306 -176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.743 HG22 HD12 ' A' ' 115' ' ' LEU . 59.2 t -114.37 109.3 27.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 106.194 -1.78 . . . . 0.28000000000000003 106.194 169.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.46 HG12 ' HG3' ' A' ' 138' ' ' LYS . 15.5 t -74.63 114.6 14.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.368 -0.975 . . . . 0.34000000000000002 108.368 -175.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.691 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 8.6 p -101.56 137.64 39.61 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.404 -0.816 . . . . 1.5800000000000001 112.438 -165.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.56 164.4 16.9 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.004 -1.11 . . . . 2.0800000000000001 108.004 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -63.67 -23.81 67.53 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.079 0.466 . . . . 2.4500000000000002 110.058 175.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 61.6 m-80 -91.96 3.62 54.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.152 -0.476 . . . . 1.6499999999999999 110.376 178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.678 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 139.77 -74.73 0.37 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.481 -0.866 . . . . 1.1200000000000001 113.792 177.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.691 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 34.8 t -142.01 151.19 42.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.735 0.767 . . . . 1.6100000000000001 110.924 -174.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.46 ' HG3' HG12 ' A' ' 131' ' ' VAL . 3.1 mmpt? -87.39 -4.96 59.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.31 0.576 . . . . 1.51 110.081 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 108.02 -20.55 30.92 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.403 -0.817 . . . . 0.31 113.878 173.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -128.26 154.7 45.59 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 117.393 0.597 . . . . 0.48999999999999999 111.842 -173.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.29 171.06 25.85 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.276 -0.875 . . . . 0.12 111.53 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.411 ' CE1' ' HB2' ' A' ' 102' ' ' PHE . 66.1 m-85 -139.63 138.37 36.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.703 0.251 . . . . 0.25 110.535 -177.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.554 ' HB ' HG12 ' A' ' 101' ' ' ILE . 42.9 t -114.43 136.1 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.201 0.524 . . . . 0.10000000000000001 111.142 174.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 127' ' ' SER . 1.6 m170 -104.71 105.79 16.01 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.625 -0.716 . . . . 0.20999999999999999 109.07 165.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.561 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.3 m-85 -90.17 137.55 32.25 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.039 0.447 . . . . 0.17000000000000001 110.949 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.596 ' HA ' HD21 ' A' ' 126' ' ' LEU . 34.9 tt0 -48.24 -46.07 35.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.673 -1.148 . . . . 0.56999999999999995 110.587 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 22.8 p -114.0 148.39 37.04 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.911 -1.04 . . . . 0.40000000000000002 111.037 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -63.61 -36.12 82.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.612 -0.722 . . . . 0.46999999999999997 111.05 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -69.09 -35.32 76.34 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.324 -0.398 . . . . 0.73999999999999999 111.678 -176.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.13 79.65 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.049 0.452 . . . . 0.17999999999999999 110.622 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.561 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.63 -43.76 98.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.645 -0.707 . . . . 0.16 110.558 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 34.2 mt-10 -60.83 -37.28 81.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.496 -0.774 . . . . 1.4199999999999999 110.804 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.428 ' O ' ' HB2' ' A' ' 157' ' ' LYS . 91.4 mtt180 -63.17 -46.18 88.33 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.927 0.394 . . . . 1.48 110.623 176.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.08 -38.82 80.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.962 -0.563 . . . . 0.10000000000000001 110.532 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 170' ' ' VAL . 91.5 mt -60.13 -54.2 38.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.692 -0.686 . . . . 0.14999999999999999 111.477 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.2 pt-20 -65.5 -42.45 92.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.196 0.522 . . . . 1.0800000000000001 112.251 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -77.42 -39.21 47.7 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 113.038 0.755 . . . . 1.1599999999999999 113.038 -170.589 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.483 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.9 mmm -95.27 -16.44 22.45 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.519 0.563 . . . . 0.34999999999999998 112.519 -173.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 155' ' ' ILE . 49.2 t-20 -66.84 124.35 22.7 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.304 -0.558 . . . . 0.44 109.621 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 81.25 18.57 68.85 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.911 -0.661 . . . . 0.28999999999999998 112.228 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.446 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 8.6 tpp -105.05 156.51 17.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.849 0.357 . . . . 1.1799999999999999 110.444 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 89.8 mt -100.66 102.52 13.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.872 -0.604 . . . . 0.44 109.566 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.466 HD21 HG21 ' A' ' 118' ' ' THR . 4.5 mt -81.75 11.66 4.65 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.745 0.646 . . . . 1.02 112.745 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.28 -64.2 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.806 0.812 . . . . 1.71 109.189 -174.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -168.62 23.97 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.811 -1.54 . . . . 0.84999999999999998 109.294 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -139.82 133.66 30.66 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.898 -0.778 . . . . 0.95999999999999996 108.898 -178.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 161' ' ' MET . 12.4 mttm -77.77 122.42 25.37 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 123.326 0.391 . . . . 1.0 109.968 176.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.485 HG11 HD23 ' A' ' 106' ' ' LEU . 11.3 m -101.49 140.1 21.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.316 0.579 . . . . 0.17000000000000001 110.926 -178.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 46.8 t80 -105.38 118.64 37.08 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.316 -0.856 . . . . 0.29999999999999999 109.178 -177.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.581 HG22 HG12 ' A' ' 103' ' ' ILE . 34.0 t -115.35 127.79 72.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.412 -0.588 . . . . 0.13 109.412 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.99 -172.7 19.01 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 121.072 -0.585 . . . . 0.17999999999999999 111.68 179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 35.8 mmt-85 -60.28 141.76 55.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.869 0.366 . . . . 1.9299999999999999 110.129 177.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.414 ' HB2' ' C ' ' A' ' 100' ' ' ASN . 80.2 t80 -63.78 102.97 0.51 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.7 -0.682 . . . . 1.4399999999999999 111.591 -175.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -79.72 150.13 30.96 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.762 -0.829 . . . . 4.6600000000000001 108.762 173.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.8 m -65.89 89.9 0.12 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.264 0.554 . . . . 3.6000000000000001 111.09 -177.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.483 ' HA ' ' NH1' ' A' ' 176' ' ' ARG . 8.0 mmm180 -128.01 48.17 2.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.74 -0.663 . . . . 7.5999999999999996 109.338 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 92.1 mttt 64.27 -166.83 0.22 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.659 -0.701 . . . . 8.6099999999999994 110.136 -173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 59.74 27.67 16.99 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.066 0.46 . . . . 8.5500000000000007 111.915 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -77.09 -23.47 51.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.051 -0.522 . . . . 12.18 110.169 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -89.9 6.7 40.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.851 -0.613 . . . . 12.699999999999999 111.047 -177.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.408 ' HB2' ' CE1' ' A' ' 144' ' ' HIS . . . 61.96 27.74 16.84 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.988 -0.551 . . . . 13.65 112.159 176.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.653 -0.689 . . . . 15.050000000000001 109.966 179.251 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.803 0 N-CA-C 111.638 -0.585 . . . . 14.85 111.638 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.68 -18.48 62.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.604 0.716 . . . . 13.5 109.705 174.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 8.7 p-10 -82.29 123.39 79.27 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 114.816 -1.084 . . . . 11.25 110.476 177.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 24.3 Cg_exo -64.56 -74.15 0.02 OUTLIER 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.731 2.287 . . . . 11.140000000000001 112.269 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.4 p -144.9 116.69 8.21 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.819 -0.437 . . . . 9.3000000000000007 109.819 177.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.632 ' HB3' ' HA ' ' A' ' 96' ' ' SER . 75.7 mt -99.44 97.23 8.28 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 122.043 -0.411 . . . . 7.8899999999999997 111.124 -174.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.558 ' HB2' ' OE1' ' A' ' 180' ' ' GLU . 14.3 mtm180 -72.41 -46.71 53.96 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.726 -1.583 . . . . 7.7800000000000002 106.726 167.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.986 ' HB2' ' HG2' ' A' ' 180' ' ' GLU . 47.5 tttp -86.9 80.52 8.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.234 -1.348 . . . . 2.3700000000000001 108.638 168.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.632 ' HA ' ' HB3' ' A' ' 93' ' ' LEU . 11.6 p -71.66 -177.84 2.03 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.108 0.48 . . . . 1.79 112.15 -174.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.438 ' O ' ' HB ' ' A' ' 98' ' ' VAL . . . 85.93 -53.21 4.64 Favored Glycine 0 N--CA 1.444 -0.818 0 N-CA-C 111.218 -0.753 . . . . 0.44 111.218 -174.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 97' ' ' GLY . 42.9 t 72.05 127.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.609 0.764 . . . . 0.70999999999999996 111.6 -174.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.14 23.51 77.85 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 119.834 -1.174 . . . . 0.20999999999999999 111.433 178.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.491 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.1 m-80 -88.2 125.59 34.71 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.423 -0.584 . . . . 0.63 109.423 -174.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.552 HG23 ' HB1' ' A' ' 151' ' ' ALA . 21.6 pt -134.9 162.13 39.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.589 -0.522 . . . . 0.14999999999999999 109.589 175.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.06 140.61 52.74 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.862 -0.421 . . . . 0.20999999999999999 109.862 177.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.615 HG12 HG22 ' A' ' 170' ' ' VAL . 6.1 mt -117.16 141.86 33.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.588 -0.733 . . . . 0.14999999999999999 109.615 -177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -126.66 154.99 43.3 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.696 -0.229 . . . . 1.46 110.577 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 48.4 t30 73.56 32.63 1.16 Allowed 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.969 0.793 . . . . 0.48999999999999999 111.389 172.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.485 HD23 HG11 ' A' ' 168' ' ' VAL . 30.1 mt -76.67 162.92 27.33 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.033 0.444 . . . . 0.26000000000000001 111.136 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -102.52 151.47 22.28 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.713 -0.676 . . . . 0.70999999999999996 109.467 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -22.4 63.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.636 -0.256 . . . . 2.2000000000000002 111.646 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.4 p -69.13 -11.05 60.45 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.648 -0.251 . . . . 1.4099999999999999 111.449 174.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.579 HG22 HG21 ' A' ' 130' ' ' VAL . 49.2 mm -92.18 122.83 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.26000000000000001 110.158 177.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -109.7 -177.25 3.22 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.518 -0.919 . . . . 1.5900000000000001 108.518 177.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.22 -34.56 78.37 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.192 -0.669 . . . . 0.59999999999999998 109.192 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.938 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -62.54 -50.49 71.14 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.19 -0.913 . . . . 2.5800000000000001 110.348 178.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.42 -41.17 98.5 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.076 -1.42 . . . . 0.14999999999999999 111.253 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.473 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -66.75 -46.79 74.28 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.189 -0.914 . . . . 0.16 108.934 178.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.763 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 66.1 t80 -59.42 -46.48 88.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.77 -0.65 . . . . 0.29999999999999999 110.925 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -55.97 -40.92 73.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.008 0.433 . . . . 0.40000000000000002 111.059 -176.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.527 HG21 HD21 ' A' ' 163' ' ' LEU . 15.3 m -78.0 -53.71 7.11 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.754 -0.657 . . . . 0.22 112.127 -177.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -72.55 -29.1 63.27 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 112.305 0.483 . . . . 0.11 112.305 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 44.3 t -58.13 -28.63 64.84 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.651 0.263 . . . . 0.19 111.091 -178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.81 -22.64 37.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.725 0.298 . . . . 0.14000000000000001 111.293 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -91.82 -21.53 20.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.382 -0.372 . . . . 0.17999999999999999 111.002 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 169.24 166.1 27.72 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.86 -0.686 . . . . 0.11 112.183 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -62.53 133.93 55.65 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.012 0.434 . . . . 0.25 110.553 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.404 HG21 ' HB3' ' A' ' 128' ' ' CYS . 75.4 mt -109.04 128.8 64.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.899 -0.592 . . . . 0.14000000000000001 110.187 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.623 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -82.23 -38.9 23.83 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.702 -0.851 . . . . 0.54000000000000004 108.702 -178.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 38.7 m -153.32 129.95 10.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.094 -0.957 . . . . 0.76000000000000001 110.455 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.763 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 6.0 p -126.81 149.52 49.65 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.332 -0.618 . . . . 0.71999999999999997 109.332 176.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -150.73 131.65 14.21 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.437 -0.505 . . . . 1.0 112.175 -174.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.579 HG21 HG22 ' A' ' 110' ' ' ILE . 69.1 t -110.99 110.42 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 106.359 -1.719 . . . . 0.28000000000000003 106.359 167.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.2 t -80.96 115.67 23.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 N-CA-C 109.08 -0.711 . . . . 0.34000000000000002 109.08 -174.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.786 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 71.9 m -105.98 146.56 29.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.355 -0.839 . . . . 1.5800000000000001 111.689 -170.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.463 ' H ' ' CA ' ' A' ' 137' ' ' SER . 34.4 t70 -85.01 158.63 20.42 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.166 -1.05 . . . . 2.0800000000000001 108.166 173.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -55.23 -29.65 58.42 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.789 0.328 . . . . 2.4500000000000002 110.352 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 -91.58 4.15 53.31 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.449 -0.341 . . . . 1.6499999999999999 111.315 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 132' ' ' CYS . . . 149.78 -72.87 0.29 Allowed Glycine 0 CA--C 1.522 0.514 0 C-N-CA 119.735 -1.222 . . . . 1.1200000000000001 114.939 176.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.786 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 23.6 p -155.19 146.65 23.01 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 117.735 0.768 . . . . 1.6100000000000001 110.594 -169.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -93.06 -14.8 26.87 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.015 0.436 . . . . 1.51 111.147 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 106.49 -19.71 36.1 Favored Glycine 0 C--N 1.314 -0.674 0 C-N-CA 120.095 -1.05 . . . . 0.31 114.025 174.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -125.49 156.58 38.75 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 117.501 0.65 . . . . 0.48999999999999999 111.912 -173.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -148.79 172.41 28.95 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.353 -0.839 . . . . 0.12 111.598 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -137.92 140.84 40.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.015 0.407 . . . . 0.25 110.757 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.514 HG11 ' CE2' ' A' ' 145' ' ' PHE . 43.8 t -113.68 135.87 51.92 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.01 0.433 . . . . 0.10000000000000001 110.685 172.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.408 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 1.1 m170 -105.98 105.76 15.95 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.095 -0.706 . . . . 0.20999999999999999 109.095 167.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.514 ' CE2' HG11 ' A' ' 143' ' ' VAL . 15.8 m-85 -90.7 136.61 32.95 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.126 0.489 . . . . 0.17000000000000001 111.24 179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.623 ' HA ' HD21 ' A' ' 126' ' ' LEU . 41.7 tt0 -49.31 -42.84 42.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.457 -1.247 . . . . 0.56999999999999995 110.726 178.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.8 p -115.28 144.85 43.11 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.64 -1.164 . . . . 0.40000000000000002 111.241 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -63.09 -36.97 85.38 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.498 -0.774 . . . . 0.46999999999999997 110.939 -178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 9.8 pt-20 -69.39 -35.11 75.47 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.389 -0.368 . . . . 0.73999999999999999 111.747 -177.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.64 -34.66 76.07 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.083 0.468 . . . . 0.17999999999999999 110.556 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.552 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -64.57 -43.04 95.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.6 -0.727 . . . . 0.16 110.883 177.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.583 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 53.5 mt-10 -59.53 -40.08 86.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.075 -0.511 . . . . 1.4199999999999999 110.28 176.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.506 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 95.4 mtt180 -60.59 -40.75 92.89 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.186 -0.461 . . . . 1.48 110.943 177.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.62 -36.32 82.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 0.10000000000000001 110.568 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 151' ' ' ALA . 80.6 mt -62.53 -54.42 34.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.14999999999999999 110.995 178.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.3 pt-20 -60.78 -43.43 98.08 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.174 0.511 . . . . 1.0800000000000001 111.677 -179.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -82.74 -39.05 22.42 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 113.062 0.764 . . . . 1.1599999999999999 113.062 -170.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 89.6 mmm -92.26 -24.51 18.97 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 112.78 0.659 . . . . 0.34999999999999998 112.78 -172.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 169' ' ' PHE . 53.3 t30 -67.17 124.27 22.61 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.215 -0.594 . . . . 0.44 110.206 -178.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 90.04 11.12 63.65 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.833 -0.698 . . . . 0.28999999999999998 112.609 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.653 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 30.8 mmt -97.63 159.65 14.8 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.885 0.374 . . . . 1.1799999999999999 111.713 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 97.9 mt -102.49 101.14 11.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.952 -0.759 . . . . 0.44 108.952 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.527 HD21 HG21 ' A' ' 118' ' ' THR . 2.8 mt -78.16 13.52 1.45 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.042 0.756 . . . . 1.02 113.042 -175.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 167.48 -59.57 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.883 0.849 . . . . 1.71 109.368 -174.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -169.74 24.66 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 113.798 -1.546 . . . . 0.84999999999999998 109.433 175.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 166' ' ' ARG . 46.9 mtt180 -140.29 127.22 20.72 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.583 -0.735 . . . . 0.95999999999999996 109.381 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 161' ' ' MET . 13.6 tttt -76.77 116.47 17.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.18 -0.674 . . . . 1.0 109.18 177.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.485 HG11 HD23 ' A' ' 106' ' ' LEU . 13.2 m -100.33 144.79 12.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.383 0.611 . . . . 0.17000000000000001 110.846 -174.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 73.6 t80 -106.14 119.71 39.94 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.185 -0.916 . . . . 0.29999999999999999 109.517 -179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.615 HG22 HG12 ' A' ' 103' ' ' ILE . 42.0 t -114.93 125.64 72.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.988 -0.745 . . . . 0.13 108.988 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -145.18 -178.82 21.05 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.498 -0.858 . . . . 0.17999999999999999 112.413 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 55.8 mmt-85 -60.54 126.87 29.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.885 0.374 . . . . 1.9299999999999999 111.384 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -77.06 122.9 25.59 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.327 -1.36 . . . . 1.4399999999999999 107.327 170.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.529 ' HD3' ' HG3' ' A' ' 178' ' ' GLU . 51.5 mttp -68.34 -70.41 0.27 Allowed 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.792 -0.363 . . . . 4.6600000000000001 110.743 -173.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.525 ' HB3' ' O ' ' A' ' 177' ' ' LYS . 22.6 t 175.67 -158.1 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.321 -0.992 . . . . 3.6000000000000001 108.321 -176.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.527 ' HD3' ' H ' ' A' ' 176' ' ' ARG . 0.1 OUTLIER -70.96 -25.36 62.69 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.649 -0.871 . . . . 7.5999999999999996 108.649 172.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.588 ' HD3' ' N ' ' A' ' 178' ' ' GLU . 1.7 tmtp? -143.61 155.41 44.26 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.315 -1.365 . . . . 8.6099999999999994 107.315 175.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.588 ' N ' ' HD3' ' A' ' 177' ' ' LYS . 38.8 tt0 -65.86 91.39 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.268 0.556 . . . . 8.5500000000000007 110.697 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -131.99 3.53 4.07 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.601 -0.727 . . . . 12.18 110.83 178.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.986 ' HG2' ' HB2' ' A' ' 95' ' ' LYS . 9.1 tp10 -133.44 21.28 3.98 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.551 0.691 . . . . 12.699999999999999 110.337 -173.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -111.06 71.79 0.76 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.855 -0.611 . . . . 13.65 110.032 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.641 -0.695 . . . . 15.050000000000001 109.859 -178.21 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.487 0 N-CA-C 111.768 -0.533 . . . . 14.85 111.768 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -141.32 -59.3 0.49 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.981 0.419 . . . . 13.5 110.261 179.623 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -148.45 113.95 3.8 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.747 -0.66 . . . . 11.25 110.383 -179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.64 -23.97 63.11 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.799 2.333 . . . . 11.140000000000001 111.883 177.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.1 m -125.73 101.69 6.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.059 -0.519 . . . . 9.3000000000000007 110.373 178.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 52.9 mt -114.52 -43.43 3.17 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.049 0.452 . . . . 7.8899999999999997 110.38 177.12 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -113.12 -172.34 2.04 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.78 -0.645 . . . . 7.7800000000000002 109.648 -177.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -100.6 6.4 44.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.422 0.629 . . . . 2.3700000000000001 110.106 -176.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.0 m -71.47 2.53 4.87 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.69 -0.686 . . . . 1.79 111.653 -177.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -78.54 -23.63 64.58 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.178 -0.534 . . . . 0.44 111.909 174.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 59.14 136.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.624 1.169 . . . . 0.70999999999999996 112.547 -174.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.25 23.85 77.31 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 119.941 -1.123 . . . . 0.20999999999999999 110.688 -175.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -94.06 126.82 39.5 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.539 -0.541 . . . . 0.63 109.539 -173.33 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.546 HG23 ' HB1' ' A' ' 151' ' ' ALA . 20.8 pt -134.8 161.16 40.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 110.066 -0.346 . . . . 0.14999999999999999 110.066 175.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.72 142.66 51.24 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.836 -0.431 . . . . 0.20999999999999999 109.836 177.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.563 HG12 HG22 ' A' ' 170' ' ' VAL . 6.4 mt -119.52 135.69 59.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.707 -0.679 . . . . 0.14999999999999999 110.065 -177.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -117.48 153.26 33.44 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.468 -0.197 . . . . 1.46 110.468 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 39.0 t30 72.54 37.52 0.88 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 124.01 0.819 . . . . 0.48999999999999999 111.797 172.15 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.647 HD22 HG21 ' A' ' 110' ' ' ILE . 20.4 mt -76.89 153.83 34.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.359 -0.382 . . . . 0.26000000000000001 110.843 177.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.501 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 13.4 t70 -83.09 149.26 27.02 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.643 -0.502 . . . . 0.70999999999999996 109.643 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -56.94 -31.16 64.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.079 -0.51 . . . . 2.2000000000000002 111.659 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.4 p -71.42 -9.09 57.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 1.4099999999999999 112.015 -179.034 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.647 HG21 HD22 ' A' ' 106' ' ' LEU . 46.6 mm -82.48 113.4 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.071 0.462 . . . . 0.26000000000000001 110.622 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -102.75 -176.15 3.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.687 -0.857 . . . . 1.5900000000000001 108.687 176.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -61.97 -41.32 97.88 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.879 -0.786 . . . . 0.59999999999999998 108.879 179.651 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.93 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -58.97 -49.94 75.98 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.305 -0.861 . . . . 2.5800000000000001 110.583 178.093 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.15 -42.27 99.09 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.133 -1.394 . . . . 0.14999999999999999 111.266 -177.489 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.522 HD12 HG22 ' A' ' 130' ' ' VAL . 4.0 tt -66.51 -46.63 75.58 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.33 -0.85 . . . . 0.16 108.994 177.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.629 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 67.9 t80 -58.63 -46.88 86.13 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.033 -0.531 . . . . 0.29999999999999999 110.917 175.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -56.32 -38.83 71.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.153 0.501 . . . . 0.40000000000000002 110.82 -175.725 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.654 HG21 HD21 ' A' ' 163' ' ' LEU . 9.3 m -77.93 -54.15 6.63 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.785 -0.643 . . . . 0.22 112.147 -178.341 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -73.07 -28.04 62.08 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.981 0.734 . . . . 0.11 112.981 -174.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.4 t -57.08 -29.4 63.45 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.764 0.316 . . . . 0.19 111.643 -176.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.42 -21.6 37.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.364 -0.38 . . . . 0.14000000000000001 111.744 178.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -92.67 -18.37 23.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.371 -0.377 . . . . 0.17999999999999999 111.393 -177.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 166.68 171.61 33.01 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.994 -0.622 . . . . 0.11 111.85 -178.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -72.57 135.93 45.68 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.797 0.332 . . . . 0.25 110.342 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.424 HG21 ' HB3' ' A' ' 128' ' ' CYS . 66.3 mt -111.24 134.88 52.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.401 -0.363 . . . . 0.14000000000000001 110.323 -179.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -91.28 -49.18 6.5 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 108.801 -0.815 . . . . 0.54000000000000004 108.801 179.543 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 66.5 m -141.77 100.19 3.7 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.901 -1.045 . . . . 0.76000000000000001 110.915 -175.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 13.2 p -95.97 148.41 22.67 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.795 -0.817 . . . . 0.71999999999999997 108.795 172.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -146.68 129.14 15.92 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 120.645 -0.422 . . . . 1.0 111.546 -174.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.522 HG22 HD12 ' A' ' 115' ' ' LEU . 75.4 t -110.06 110.2 31.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 106.606 -1.627 . . . . 0.28000000000000003 106.606 169.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.6 t -76.64 120.28 26.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-N 115.653 -0.703 . . . . 0.34000000000000002 109.565 -172.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . . . . . . . . . 3.8 p -96.0 137.06 35.6 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.1 -0.954 . . . . 1.5800000000000001 111.278 -168.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.417 ' HB2' ' HA ' ' A' ' 138' ' ' LYS . 23.4 t70 -86.01 161.98 18.71 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.773 -0.825 . . . . 2.0800000000000001 108.773 178.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -56.37 -28.95 60.72 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.059 0.457 . . . . 2.4500000000000002 110.108 171.373 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 58.5 m-80 -88.6 0.52 56.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.01 -0.541 . . . . 1.6499999999999999 110.502 178.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 132.43 -66.34 0.58 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.646 -0.787 . . . . 1.1200000000000001 113.97 -179.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 15.5 p -138.86 130.28 27.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.423 0.612 . . . . 1.6100000000000001 110.858 -172.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 34.1 mtpt -74.43 -36.66 63.42 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-O 121.155 0.502 . . . . 1.51 111.038 -175.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 123.14 -14.91 8.29 Favored Glycine 0 C--N 1.309 -0.953 0 C-N-CA 120.15 -1.024 . . . . 0.31 113.597 -179.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -132.4 157.01 45.63 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 117.24 0.52 . . . . 0.48999999999999999 111.186 -176.254 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -146.91 177.21 25.36 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.759 -0.655 . . . . 0.12 111.824 -177.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -136.35 143.12 43.91 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.494 -0.187 . . . . 0.25 110.494 -176.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.495 ' HB ' HG12 ' A' ' 101' ' ' ILE . 45.9 t -115.44 129.78 71.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-O 121.06 0.457 . . . . 0.10000000000000001 110.493 171.055 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.9 OUTLIER -100.73 105.32 16.65 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.079 -0.712 . . . . 0.20999999999999999 109.079 167.216 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.533 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 13.6 m-85 -88.13 140.92 29.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.264 0.554 . . . . 0.17000000000000001 110.693 178.674 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.596 ' HA ' HD21 ' A' ' 126' ' ' LEU . 24.6 tt0 -50.88 -41.13 58.01 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.324 -1.307 . . . . 0.56999999999999995 110.479 177.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 30.0 p -122.98 148.31 45.65 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.606 -1.179 . . . . 0.40000000000000002 111.229 -178.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -60.55 -36.55 78.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.441 -0.799 . . . . 0.46999999999999997 111.368 179.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 153' ' ' ARG . 9.7 pt-20 -67.45 -35.97 80.27 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.0 0.37 . . . . 0.73999999999999999 112.0 -176.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.03 -34.43 78.06 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.09 0.471 . . . . 0.17999999999999999 110.372 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.546 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -62.19 -44.63 96.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.516 -0.765 . . . . 0.16 110.86 177.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.963 ' HG2' HH12 ' A' ' 172' ' ' ARG . 28.1 mt-10 -59.5 -42.27 91.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 1.4199999999999999 110.707 178.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.531 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 46.8 mtt180 -59.47 -41.06 88.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.127 -0.488 . . . . 1.48 110.569 178.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.76 -37.15 84.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.088 -0.505 . . . . 0.10000000000000001 110.674 178.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 151' ' ' ALA . 85.7 mt -60.01 -52.99 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.14999999999999999 110.988 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.531 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 0.7 OUTLIER -63.43 -45.47 90.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.01 0.433 . . . . 1.0800000000000001 111.877 -179.399 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.443 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.0 OUTLIER -80.39 -39.19 28.86 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.884 0.698 . . . . 1.1599999999999999 112.884 -169.148 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.567 ' HB2' HG21 ' A' ' 170' ' ' VAL . 89.3 mmm -93.08 -15.85 25.62 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.277 0.473 . . . . 0.34999999999999998 112.277 -173.143 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 46.0 t-20 -70.29 123.27 21.29 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.566 -0.901 . . . . 0.44 108.566 176.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 83.76 11.98 78.42 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.562 -0.828 . . . . 0.28999999999999998 111.967 -177.332 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -93.09 150.7 20.34 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.827 -0.805 . . . . 1.1799999999999999 108.827 178.443 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.414 HD23 ' CA ' ' A' ' 167' ' ' LYS . 23.3 mt -97.11 124.57 41.17 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.92 -0.77 . . . . 0.44 108.92 177.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.654 HD21 HG21 ' A' ' 118' ' ' THR . 27.3 mt -110.05 99.35 8.46 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.796 -0.761 . . . . 1.02 109.838 173.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 70.5 m-20 78.29 -23.14 0.25 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.98 -1.009 . . . . 1.71 112.812 176.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 33.7 t70 167.77 -22.06 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.815 0.697 . . . . 0.84999999999999998 112.069 -177.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 98.1 mtt180 -109.81 136.78 48.59 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.797 0.332 . . . . 0.95999999999999996 110.875 -170.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.414 ' CA ' HD23 ' A' ' 162' ' ' LEU . 26.6 tttt -84.88 118.74 24.69 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.39 -178.751 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.455 HG11 HD23 ' A' ' 106' ' ' LEU . 13.3 m -101.27 148.43 7.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.7 0.762 . . . . 0.17000000000000001 111.791 -171.636 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 55.3 t80 -106.97 119.18 38.67 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.659 -1.155 . . . . 0.29999999999999999 109.318 179.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.567 HG21 ' HB2' ' A' ' 158' ' ' MET . 39.4 t -115.72 125.85 73.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.574 -0.528 . . . . 0.13 109.574 178.208 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.6 -175.15 20.14 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.715 -0.755 . . . . 0.17999999999999999 112.278 -179.161 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.963 HH12 ' HG2' ' A' ' 152' ' ' GLU . 24.4 mmt180 -61.71 139.45 58.31 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 123.548 0.205 . . . . 1.9299999999999999 110.53 179.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -85.08 113.44 21.48 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.709 -0.848 . . . . 1.4399999999999999 108.709 174.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.63 139.86 38.69 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.215 0.531 . . . . 4.6600000000000001 111.258 -178.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 13.5 t -78.12 169.88 17.54 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.308 -1.367 . . . . 3.6000000000000001 107.308 168.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 67.9 mtp180 -60.58 -32.99 72.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.248 0.547 . . . . 7.5999999999999996 109.787 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -108.89 89.17 2.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.733 -0.667 . . . . 8.6099999999999994 110.027 168.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -79.54 87.07 5.14 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.951 -0.759 . . . . 8.5500000000000007 108.951 175.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -134.99 136.92 42.55 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.586 -0.733 . . . . 12.18 110.217 -176.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -136.32 103.88 5.44 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.668 -0.493 . . . . 12.699999999999999 109.668 175.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -77.82 84.34 4.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.055 0.455 . . . . 13.65 110.894 -177.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.66 -0.686 . . . . 15.050000000000001 109.211 -179.839 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.748 0 N-CA-C 112.15 -0.38 . . . . 14.85 112.15 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.4 -4.82 59.13 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.274 0.559 . . . . 13.5 110.422 178.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.664 ' HB2' ' HG ' ' A' ' 93' ' ' LEU . 11.6 p-10 -83.35 123.63 76.74 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.492 -0.776 . . . . 11.25 110.356 178.394 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 90' ' ' ASP . 14.5 Cg_exo -68.75 -71.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.474 2.116 . . . . 11.140000000000001 111.144 177.308 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.1 m -144.65 90.27 2.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.155 -0.475 . . . . 9.3000000000000007 110.103 175.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.664 ' HG ' ' HB2' ' A' ' 90' ' ' ASP . 82.9 mt -78.46 145.84 34.79 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.37 -0.604 . . . . 7.8899999999999997 109.37 176.018 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.551 ' O ' ' HB2' ' A' ' 95' ' ' LYS . 73.3 mtt180 -78.49 -34.53 47.4 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.976 0.172 . . . . 7.7800000000000002 110.624 -177.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.551 ' HB2' ' O ' ' A' ' 94' ' ' ARG . 79.8 tttt 166.21 -9.18 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.265 0.978 . . . . 2.3700000000000001 109.272 177.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.5 p -73.17 14.95 0.25 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.218 -0.901 . . . . 1.79 112.735 -176.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.423 ' O ' ' HB ' ' A' ' 98' ' ' VAL . . . -70.93 -27.62 71.93 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 120.8 -0.714 . . . . 0.44 111.58 176.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 97' ' ' GLY . 42.4 t 71.55 123.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.416 0.687 . . . . 0.70999999999999996 111.925 -175.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.31 24.02 76.15 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.027 -1.082 . . . . 0.20999999999999999 111.535 178.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.537 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.3 m120 -88.63 125.3 34.76 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.933 -0.766 . . . . 0.63 108.933 -174.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.522 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.4 pt -135.74 163.53 34.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.533 -0.303 . . . . 0.14999999999999999 110.188 177.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.24 145.27 50.83 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.851 -0.425 . . . . 0.20999999999999999 109.851 175.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.521 HG12 HG22 ' A' ' 170' ' ' VAL . 6.2 mt -118.38 148.32 21.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.776 -0.647 . . . . 0.14999999999999999 110.019 -177.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.5 tttm -131.25 149.43 52.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.35 -0.386 . . . . 1.46 110.601 -172.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 64.1 t30 67.63 35.68 3.97 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 123.639 0.587 . . . . 0.48999999999999999 111.794 173.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.489 HD22 HG21 ' A' ' 110' ' ' ILE . 20.1 mt -72.33 152.91 41.79 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.083 0.468 . . . . 0.26000000000000001 111.133 176.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 21.4 t70 -77.19 150.4 35.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.466 -0.788 . . . . 0.70999999999999996 110.565 177.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.478 ' NZ ' ' HA3' ' A' ' 136' ' ' GLY . 3.4 tptt -62.14 -33.92 75.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.053 -0.522 . . . . 2.2000000000000002 111.106 -177.019 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.1 t -76.05 -4.85 43.6 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.381 -0.372 . . . . 1.4099999999999999 111.057 -176.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.489 HG21 HD22 ' A' ' 106' ' ' LEU . 36.0 mm -78.82 127.19 39.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.898 0.38 . . . . 0.26000000000000001 110.433 178.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -111.6 -179.97 3.85 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.592 -0.521 . . . . 1.5900000000000001 109.592 -179.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.646 ' OD1' ' HA ' ' A' ' 129' ' ' LYS . 67.8 m-80 -65.4 -37.81 88.07 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 109.19 -0.67 . . . . 0.59999999999999998 109.19 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.98 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -60.76 -49.19 78.5 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 114.976 -1.011 . . . . 2.5800000000000001 110.017 177.618 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.29 97.41 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 113.772 -1.558 . . . . 0.14999999999999999 111.463 -177.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.671 HD12 HG22 ' A' ' 130' ' ' VAL . 4.2 tt -63.84 -47.3 81.3 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.993 -0.743 . . . . 0.16 108.993 177.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.712 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 63.8 t80 -60.2 -47.5 85.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.036 -0.529 . . . . 0.29999999999999999 110.846 176.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.57 -39.08 75.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.91 0.386 . . . . 0.40000000000000002 110.79 -175.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.5 m -77.21 -52.91 8.42 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 0.22 111.724 -178.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -71.93 -28.32 63.39 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.385 0.513 . . . . 0.11 112.385 -175.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.2 t -57.45 -28.95 63.8 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.457 0.169 . . . . 0.19 111.457 -177.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.82 -21.76 31.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.846 0.355 . . . . 0.14000000000000001 111.386 177.291 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -92.21 -10.76 37.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.315 -0.402 . . . . 0.17999999999999999 111.205 -178.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 156.59 163.75 12.7 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.128 -0.558 . . . . 0.11 111.725 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -63.95 137.82 58.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.185 0.517 . . . . 0.25 110.171 177.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 128' ' ' CYS . 82.2 mt -110.54 132.73 58.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.71 -0.677 . . . . 0.14000000000000001 109.877 -178.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.07 -39.13 14.86 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.87 -0.789 . . . . 0.54000000000000004 108.87 -177.429 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 144' ' ' HIS . 82.5 p -146.53 134.11 20.96 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.291 -0.868 . . . . 0.76000000000000001 109.681 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.712 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.3 p -133.81 130.28 37.74 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.285 -0.635 . . . . 0.71999999999999997 109.285 176.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.646 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 58.0 tptt -132.33 134.84 45.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.159 0.504 . . . . 1.0 111.891 -174.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.671 HG22 HD12 ' A' ' 115' ' ' LEU . 95.2 t -114.01 109.6 29.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 106.355 -1.72 . . . . 0.28000000000000003 106.355 170.028 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.99 121.04 27.1 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-N 115.917 -0.583 . . . . 0.34000000000000002 109.798 -172.019 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.813 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 58.6 m -97.51 135.29 39.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.186 -0.915 . . . . 1.5800000000000001 112.204 -165.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.459 ' H ' ' CA ' ' A' ' 137' ' ' SER . 0.2 OUTLIER -87.33 175.01 8.21 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.074 -0.713 . . . . 2.0800000000000001 109.074 174.384 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -53.28 -33.17 52.06 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.756 0.28 . . . . 2.4500000000000002 111.756 177.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . 0.403 ' H ' ' CG ' ' A' ' 133' ' ' ASP . 91.2 m-20 -92.12 -7.76 47.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 1.6499999999999999 111.438 -178.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.478 ' HA3' ' NZ ' ' A' ' 108' ' ' LYS . . . 148.01 -44.61 0.77 Allowed Glycine 0 C--O 1.225 -0.45 0 C-N-CA 119.461 -1.352 . . . . 1.1200000000000001 115.135 175.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.813 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 45.8 m -155.15 133.46 11.75 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.04 0.92 . . . . 1.6100000000000001 111.895 -172.213 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 33.5 mtpt -79.66 -36.47 37.7 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.041 0.448 . . . . 1.51 111.602 -176.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 131.57 -19.85 4.72 Favored Glycine 0 C--N 1.311 -0.806 0 C-N-CA 120.135 -1.031 . . . . 0.31 114.051 -178.789 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -122.26 155.26 36.27 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 117.523 0.661 . . . . 0.48999999999999999 111.315 -174.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -147.85 173.66 27.83 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.797 -0.638 . . . . 0.12 111.964 -178.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.37 136.73 36.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.826 0.313 . . . . 0.25 110.706 -177.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.522 ' HB ' HG12 ' A' ' 101' ' ' ILE . 38.5 t -114.56 134.98 55.84 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-O 121.02 0.438 . . . . 0.10000000000000001 111.002 173.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.437 ' HB2' ' OG ' ' A' ' 127' ' ' SER . 1.5 m170 -103.25 106.71 17.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.736 -0.665 . . . . 0.20999999999999999 109.212 167.218 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.475 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 14.4 m-85 -89.91 135.92 33.35 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.323 0.583 . . . . 0.17000000000000001 111.372 179.082 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.633 ' HA ' HD21 ' A' ' 126' ' ' LEU . 44.5 tt0 -46.36 -43.54 16.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 113.919 -1.492 . . . . 0.56999999999999995 111.017 177.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 13.4 p -116.4 147.37 41.72 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.937 -1.029 . . . . 0.40000000000000002 111.046 177.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 23.6 tp60 -60.23 -39.81 87.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.887 -0.597 . . . . 0.46999999999999997 110.917 179.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -69.22 -33.44 73.33 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.319 -0.4 . . . . 0.73999999999999999 111.678 -177.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.59 74.22 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 121.149 0.499 . . . . 0.17999999999999999 110.318 177.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.475 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -67.34 -41.96 84.34 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.62 -0.718 . . . . 0.16 110.369 176.224 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.655 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 44.0 mt-10 -58.57 -40.26 82.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.762 -0.654 . . . . 1.4199999999999999 110.305 177.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 65.3 mtt180 -59.5 -50.14 75.08 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 120.882 0.372 . . . . 1.48 110.623 174.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.42 -38.85 81.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.10000000000000001 110.88 -178.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 151' ' ' ALA . 84.9 mt -60.98 -54.88 29.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.251 -0.431 . . . . 0.14999999999999999 110.864 178.108 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 3.2 pt-20 -64.22 -44.76 90.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.169 0.509 . . . . 1.0800000000000001 111.774 -178.737 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -76.37 -39.06 54.83 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 112.926 0.713 . . . . 1.1599999999999999 112.926 -170.739 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 91.4 mmm -94.26 -22.3 18.48 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.602 0.593 . . . . 0.34999999999999998 112.602 -173.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -65.49 123.65 20.21 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.221 -0.592 . . . . 0.44 109.823 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.496 ' O ' ' HE2' ' A' ' 167' ' ' LYS . . . 83.89 22.55 55.12 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.786 -0.721 . . . . 0.28999999999999998 112.513 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.583 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 2.7 mmt -109.26 160.31 16.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.76 0.314 . . . . 1.1799999999999999 111.159 177.061 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 29.7 mt -100.57 107.12 18.71 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.915 -0.584 . . . . 0.44 109.976 -176.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 163' ' ' LEU . 17.4 mt -90.99 109.67 20.91 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.686 -0.806 . . . . 1.02 109.163 172.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 82.8 m-20 73.08 -67.01 0.28 Allowed 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.108 -0.951 . . . . 1.71 111.421 -175.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -163.66 18.61 0.07 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.873 -0.603 . . . . 0.84999999999999998 111.018 178.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 88.7 mtt180 -131.77 130.87 42.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.969 -0.457 . . . . 0.95999999999999996 109.971 -177.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.583 ' HA ' ' O ' ' A' ' 161' ' ' MET . 22.6 tttt -82.09 118.24 22.88 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 -177.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.478 HG11 HD23 ' A' ' 106' ' ' LEU . 16.9 m -100.8 145.87 10.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.547 0.689 . . . . 0.17000000000000001 111.161 -173.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -106.47 125.1 50.57 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.97 -1.014 . . . . 0.29999999999999999 109.388 176.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 103' ' ' ILE . 39.8 t -116.45 131.65 68.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 N-CA-C 109.306 -0.627 . . . . 0.13 109.306 177.071 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.26 -173.26 19.71 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.606 -0.807 . . . . 0.17999999999999999 111.966 179.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -66.93 145.43 55.45 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.023 0.439 . . . . 1.9299999999999999 110.47 -178.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -80.84 114.76 19.95 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.927 -0.579 . . . . 1.4399999999999999 110.325 -176.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -120.78 88.76 3.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.356 -0.384 . . . . 4.6600000000000001 110.564 178.278 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 11.2 p -80.54 -29.99 37.14 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.485 -0.932 . . . . 3.6000000000000001 108.485 170.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 177' ' ' LYS . 5.2 tpm_? -135.37 -87.07 0.36 Allowed 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.315 -1.311 . . . . 7.5999999999999996 108.442 173.856 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 176' ' ' ARG . 9.9 ttmt 169.04 1.77 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.952 0.782 . . . . 8.6099999999999994 109.364 177.516 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -118.24 137.12 53.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.516 -0.765 . . . . 8.5500000000000007 111.427 -166.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 179' ' ' ARG . 38.7 ttm180 -75.14 -58.98 2.95 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.464 -0.569 . . . . 12.18 109.464 169.419 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -155.46 -33.58 0.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.372 -0.831 . . . . 12.699999999999999 108.896 176.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -126.73 122.33 34.57 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.032 -0.986 . . . . 13.65 109.897 173.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.414 -0.803 . . . . 15.050000000000001 108.948 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.635 0 N-CA-C 111.996 -0.442 . . . . 14.85 111.996 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -79.93 59.12 3.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.091 0.472 . . . . 13.5 110.273 178.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -165.06 111.11 0.82 Allowed Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.694 -0.684 . . . . 11.25 110.883 -175.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -76.16 -28.36 7.4 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.025 2.484 . . . . 11.140000000000001 112.071 175.009 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.4 m -151.47 133.68 15.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.187 -0.461 . . . . 9.3000000000000007 110.461 178.044 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.4 mt -110.34 -179.39 3.76 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.153 -0.314 . . . . 7.8899999999999997 110.153 178.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -98.24 -68.62 0.79 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.756 -0.831 . . . . 7.7800000000000002 108.756 177.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.622 ' HE3' ' O ' ' A' ' 173' ' ' PHE . 57.3 mttp -146.75 177.9 8.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.304 -0.862 . . . . 2.3700000000000001 109.081 173.845 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.3 p -154.33 -178.92 7.46 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.222 -0.659 . . . . 1.79 109.222 179.04 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 98' ' ' VAL . . . 77.65 -49.88 3.15 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.774 -0.726 . . . . 0.44 111.707 -176.413 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 97' ' ' GLY . 42.0 t 75.16 130.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 123.792 0.837 . . . . 0.70999999999999996 111.195 -175.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 73.0 23.46 77.83 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.124 -1.036 . . . . 0.20999999999999999 111.068 -178.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.51 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -90.39 124.89 35.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.544 -0.539 . . . . 0.63 109.544 -173.451 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.55 HG23 ' HB1' ' A' ' 151' ' ' ALA . 17.3 pt -135.98 163.71 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.299 -0.409 . . . . 0.14999999999999999 110.227 178.46 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.39 143.1 50.8 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.784 -0.45 . . . . 0.20999999999999999 109.784 175.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.572 HG12 HG22 ' A' ' 170' ' ' VAL . 6.2 mt -119.4 134.97 61.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.652 -0.703 . . . . 0.14999999999999999 110.016 -177.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpt -113.87 150.1 34.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.617 -0.265 . . . . 1.46 110.623 -179.284 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.3 t30 72.01 39.0 0.85 Allowed 'General case' 0 N--CA 1.467 0.404 0 O-C-N 123.974 0.796 . . . . 0.48999999999999999 111.77 171.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.534 HD22 HG21 ' A' ' 110' ' ' ILE . 21.8 mt -76.43 153.83 35.32 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.093 0.473 . . . . 0.26000000000000001 110.864 176.438 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.492 ' HB3' HG12 ' A' ' 110' ' ' ILE . 6.5 t70 -75.51 144.53 41.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.52 -0.764 . . . . 0.70999999999999996 110.163 175.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -61.48 -28.44 69.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.881 -0.6 . . . . 2.2000000000000002 111.398 -176.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.407 ' HB3' ' OD2' ' A' ' 107' ' ' ASP . 9.1 t -80.49 -7.84 59.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.276 -0.42 . . . . 1.4099999999999999 110.652 -179.189 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.534 HG21 HD22 ' A' ' 106' ' ' LEU . 30.8 mm -74.39 116.87 17.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.851 -0.426 . . . . 0.26000000000000001 109.851 176.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -103.1 -174.16 2.48 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.741 -0.837 . . . . 1.5900000000000001 108.741 178.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -67.86 -31.14 70.75 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 108.564 -0.902 . . . . 0.59999999999999998 108.564 -178.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -48.61 66.31 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.499 -1.228 . . . . 2.5800000000000001 109.236 178.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.82 -44.15 97.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.212 -1.358 . . . . 0.14999999999999999 110.703 -177.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.566 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -64.97 -46.79 80.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.068 -0.969 . . . . 0.16 109.138 177.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.775 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 65.6 t80 -58.86 -47.22 85.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.29999999999999999 111.084 175.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -56.75 -37.81 71.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.915 0.388 . . . . 0.40000000000000002 110.957 -176.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.516 HG21 HD21 ' A' ' 163' ' ' LEU . 7.0 m -78.55 -54.76 5.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.992 -0.549 . . . . 0.22 112.138 -178.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.415 ' CD1' HD23 ' A' ' 115' ' ' LEU . 11.9 m-85 -72.98 -27.92 62.08 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.248 0.832 . . . . 0.11 113.248 -173.394 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 39.0 t -57.0 -28.79 62.75 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 111.78 0.289 . . . . 0.19 111.78 -175.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.04 -22.12 36.5 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.856 0.36 . . . . 0.14000000000000001 111.755 178.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -89.43 -23.12 22.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.808 0.337 . . . . 0.17999999999999999 111.14 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 170.88 166.4 29.69 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.956 -0.565 . . . . 0.11 111.736 -178.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -67.69 129.07 38.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.851 0.358 . . . . 0.25 110.11 179.083 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.413 HG21 ' HB3' ' A' ' 128' ' ' CYS . 78.8 mt -98.91 132.0 45.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 116.175 -0.466 . . . . 0.14000000000000001 109.995 179.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -84.68 -40.57 17.22 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.666 -0.864 . . . . 0.54000000000000004 108.666 -179.822 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.403 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 69.5 m -152.68 122.14 6.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.861 -1.063 . . . . 0.76000000000000001 110.27 -178.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.775 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 3.4 p -117.2 137.63 52.22 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.641 -0.503 . . . . 0.71999999999999997 109.641 176.045 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -138.2 132.97 32.66 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.193 0.52 . . . . 1.0 112.003 -174.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.566 HG22 HD12 ' A' ' 115' ' ' LEU . 86.1 t -114.33 109.87 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 106.582 -1.636 . . . . 0.28000000000000003 106.582 169.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.525 HG12 ' HG3' ' A' ' 138' ' ' LYS . 16.5 t -75.48 116.4 18.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.931 -0.577 . . . . 0.34000000000000002 109.524 -173.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.76 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 4.7 p -99.82 135.74 40.79 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.419 -0.809 . . . . 1.5800000000000001 111.761 -170.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -82.37 160.92 22.7 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 108.333 -0.988 . . . . 2.0800000000000001 108.333 173.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -53.84 -28.14 33.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.858 0.361 . . . . 2.4500000000000002 110.935 175.125 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -90.81 -6.01 54.86 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.434 -0.348 . . . . 1.6499999999999999 111.048 -178.261 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 151.8 -67.99 0.32 Allowed Glycine 0 CA--C 1.523 0.584 0 C-N-CA 119.961 -1.114 . . . . 1.1200000000000001 114.325 178.782 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.76 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 69.1 m -152.49 145.47 24.49 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.114 -0.639 . . . . 1.6100000000000001 110.827 -174.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.525 ' HG3' HG12 ' A' ' 131' ' ' VAL . 3.3 mmpt? -81.63 -28.94 33.41 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.128 0.489 . . . . 1.51 111.32 -178.162 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 115.14 -14.31 18.93 Favored Glycine 0 C--N 1.311 -0.841 0 C-N-CA 120.587 -0.816 . . . . 0.31 113.356 178.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -129.69 154.02 47.57 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 117.21 0.505 . . . . 0.48999999999999999 111.45 -177.512 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.29 175.18 25.0 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.688 -0.687 . . . . 0.12 111.895 -178.194 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -136.58 137.73 40.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.72 0.26 . . . . 0.25 110.65 -175.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' A' ' 145' ' ' PHE . 49.2 t -110.94 136.05 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.319 0 CA-C-O 120.996 0.427 . . . . 0.10000000000000001 110.865 172.47 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 127' ' ' SER . 2.5 m170 -104.13 106.09 16.48 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.658 -0.701 . . . . 0.20999999999999999 109.303 167.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.51 ' CE2' HG11 ' A' ' 143' ' ' VAL . 14.8 m-85 -92.04 137.31 32.47 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.081 0.467 . . . . 0.17000000000000001 110.827 178.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.591 ' HA ' HD21 ' A' ' 126' ' ' LEU . 39.0 tt0 -47.83 -41.42 23.84 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.522 -1.217 . . . . 0.56999999999999995 111.131 179.572 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.8 p -119.32 151.14 38.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.325 -0.852 . . . . 0.40000000000000002 110.825 179.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -62.31 -35.96 80.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.46999999999999997 110.72 179.039 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.36 -34.67 74.93 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.33 -0.396 . . . . 0.73999999999999999 111.948 -178.161 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.08 -34.74 78.24 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.005 0.431 . . . . 0.17999999999999999 110.678 179.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.55 ' HB1' HG23 ' A' ' 101' ' ' ILE . . . -63.68 -41.38 98.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.698 -0.683 . . . . 0.16 110.359 176.321 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.486 ' CD ' HH21 ' A' ' 172' ' ' ARG . 7.2 mm-40 -59.27 -40.41 85.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.689 -0.687 . . . . 1.4199999999999999 110.923 177.147 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.588 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 96.8 mtt180 -60.86 -43.2 98.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.566 -0.743 . . . . 1.48 111.059 177.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.39 -36.75 83.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.222 -0.445 . . . . 0.10000000000000001 110.521 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.468 HG12 HG12 ' A' ' 170' ' ' VAL . 66.7 mt -62.51 -52.41 60.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.227 -0.442 . . . . 0.14999999999999999 111.106 178.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' A' ' 153' ' ' ARG . 0.1 OUTLIER -62.57 -44.31 96.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.192 0.52 . . . . 1.0800000000000001 111.941 179.931 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.2 OUTLIER -82.68 -38.7 23.05 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 113.243 0.831 . . . . 1.1599999999999999 113.243 -168.722 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.467 ' HB2' HG21 ' A' ' 170' ' ' VAL . 92.2 mmm -93.93 -16.28 24.14 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.439 0.533 . . . . 0.34999999999999998 112.439 -173.053 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 155' ' ' ILE . 47.4 t-20 -67.03 122.93 18.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.302 -0.629 . . . . 0.44 109.302 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 85.82 13.09 70.34 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.911 -0.661 . . . . 0.28999999999999998 112.865 178.529 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.655 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 30.3 mmt -96.21 163.03 13.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.997 0.399 . . . . 1.1799999999999999 111.494 179.017 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 20.8 mt -104.61 111.83 24.68 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-N 115.868 -0.605 . . . . 0.44 109.879 -177.645 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 118' ' ' THR . 19.0 mt -100.15 100.87 11.77 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 120.073 -0.651 . . . . 1.02 109.758 174.334 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 87.6 m-20 78.58 -23.59 0.24 Allowed 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 114.883 -1.053 . . . . 1.71 112.615 178.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 164' ' ' ASN . 21.0 t70 166.15 -23.07 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.174 0.921 . . . . 0.84999999999999998 111.724 -177.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 96.0 mtt180 -106.65 132.38 52.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.82 0.343 . . . . 0.95999999999999996 111.112 -169.244 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 161' ' ' MET . 8.3 ttmm -77.11 118.59 19.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.468 -0.787 . . . . 1.0 109.385 179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.468 HG11 HD23 ' A' ' 106' ' ' LEU . 14.7 m -100.83 146.23 9.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.562 0.696 . . . . 0.17000000000000001 111.149 -174.602 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.434 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 40.4 t80 -110.62 121.96 46.61 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.908 -1.042 . . . . 0.29999999999999999 109.267 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.572 HG22 HG12 ' A' ' 103' ' ' ILE . 41.4 t -115.7 127.07 73.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.981 -0.378 . . . . 0.13 109.981 -178.322 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -149.08 176.86 27.66 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.876 -0.678 . . . . 0.17999999999999999 112.361 -179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.486 HH21 ' CD ' ' A' ' 152' ' ' GLU . 14.6 mmt85 -61.31 129.48 41.45 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.029 0.442 . . . . 1.9299999999999999 111.148 -179.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.622 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 62.1 t80 -60.34 134.83 57.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.423 -0.808 . . . . 1.4399999999999999 111.154 -179.018 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -90.73 132.27 35.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.92 0.39 . . . . 4.6600000000000001 110.485 179.878 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 11.5 p -98.64 11.47 38.38 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.025 0.44 . . . . 3.6000000000000001 111.063 -178.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -97.17 174.49 6.71 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.183 -0.462 . . . . 7.5999999999999996 110.345 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 38.4 tptt 71.5 -58.61 0.57 Allowed 'General case' 0 N--CA 1.475 0.822 0 O-C-N 123.817 0.698 . . . . 8.6099999999999994 111.573 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -114.9 101.4 9.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.09 0.471 . . . . 8.5500000000000007 109.873 -179.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -116.35 104.42 11.46 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.824 -0.625 . . . . 12.18 110.884 -177.049 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -119.88 99.19 6.48 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.165 -0.68 . . . . 12.699999999999999 109.165 172.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -155.49 98.82 1.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.058 -0.519 . . . . 13.65 110.942 -177.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.37 -0.824 . . . . 15.050000000000001 109.453 175.979 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.802 0 N-CA-C 111.972 -0.451 . . . . 14.85 111.972 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -102.66 -33.05 9.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 13.5 110.506 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -72.19 122.26 86.9 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.981 -0.554 . . . . 11.25 110.885 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -77.75 -165.61 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.582 2.188 . . . . 11.140000000000001 110.957 173.533 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 42.9 m -68.87 87.83 0.37 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.007 0.432 . . . . 9.3000000000000007 110.747 177.134 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 94.6 mt -119.48 -21.51 7.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 7.8899999999999997 110.503 179.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 66.5 179.68 0.21 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.599 -0.728 . . . . 7.7800000000000002 111.138 -174.525 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -146.25 116.62 7.49 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.156 -0.683 . . . . 2.3700000000000001 109.156 -178.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.0 p -66.57 -18.62 65.47 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.054 0.843 . . . . 1.79 112.248 -173.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.554 ' HA3' ' OD1' ' A' ' 100' ' ' ASN . . . -63.67 -34.57 90.3 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.813 -0.708 . . . . 0.44 111.798 175.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.8 t 66.36 116.06 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.208 0.603 . . . . 0.70999999999999996 111.924 -174.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.03 24.51 63.96 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 119.912 -1.137 . . . . 0.20999999999999999 112.883 174.336 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.554 ' OD1' ' HA3' ' A' ' 97' ' ' GLY . 1.7 m120 -89.92 126.08 35.59 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.532 -0.544 . . . . 0.63 109.532 -175.024 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.483 HG12 ' HB ' ' A' ' 143' ' ' VAL . 24.2 pt -134.24 163.73 36.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.237 -0.438 . . . . 0.14999999999999999 109.909 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -126.14 147.49 49.61 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.99 -0.374 . . . . 0.20999999999999999 109.99 177.51 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.536 HG12 HG22 ' A' ' 170' ' ' VAL . 5.2 mt -122.4 148.16 26.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.83 -0.623 . . . . 0.14999999999999999 110.144 -176.286 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 22.0 tttt -128.04 157.29 41.07 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.524 -0.307 . . . . 1.46 110.962 -175.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 60.0 t30 67.44 31.61 6.24 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.738 0.649 . . . . 0.48999999999999999 111.698 172.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.654 HD22 HG21 ' A' ' 110' ' ' ILE . 42.6 mt -75.62 148.61 38.62 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 0.26000000000000001 111.354 178.208 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -80.18 153.74 28.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.792 -0.64 . . . . 0.70999999999999996 110.364 178.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.702 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . 65.7 pttt -55.16 -34.27 63.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.842 -0.617 . . . . 2.2000000000000002 111.983 178.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.4 t -76.06 -4.51 41.81 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.464 -0.335 . . . . 1.4099999999999999 111.718 -177.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.654 HG21 HD22 ' A' ' 106' ' ' LEU . 45.7 mm -81.55 113.83 21.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 122.069 -0.394 . . . . 0.26000000000000001 110.067 175.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -106.84 -177.76 3.45 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.212 -0.662 . . . . 1.5900000000000001 109.212 178.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -60.54 -37.85 82.57 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.746 -0.464 . . . . 0.59999999999999998 109.746 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.887 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -62.29 -50.55 71.21 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 115.477 -0.783 . . . . 2.5800000000000001 110.673 178.381 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.86 -40.54 95.72 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.174 -1.375 . . . . 0.14999999999999999 111.079 -176.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.708 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -67.05 -47.22 71.98 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.471 -0.786 . . . . 0.16 109.174 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.756 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 72.7 t80 -58.96 -47.13 86.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.528 . . . . 0.29999999999999999 110.848 176.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.36 -37.93 73.37 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.158 0.504 . . . . 0.40000000000000002 111.017 -176.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.655 HG21 HD21 ' A' ' 163' ' ' LEU . 13.4 m -78.24 -54.36 6.31 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.057 -0.519 . . . . 0.22 112.065 -178.505 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.409 ' CD1' HD23 ' A' ' 115' ' ' LEU . 19.6 m-85 -73.65 -29.79 62.54 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 113.007 0.743 . . . . 0.11 113.007 -174.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 15.2 t -58.59 -27.2 64.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.685 0.278 . . . . 0.19 111.332 -176.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.99 -22.3 25.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.603 0.24 . . . . 0.14000000000000001 111.344 177.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -92.45 -17.62 24.31 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.531 -0.304 . . . . 0.17999999999999999 111.352 -178.626 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 168.71 174.55 37.46 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.999 -0.62 . . . . 0.11 111.875 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -76.69 139.71 40.61 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.836 -0.431 . . . . 0.25 109.836 -179.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.44 HG21 ' HB3' ' A' ' 128' ' ' CYS . 71.0 mt -112.13 135.3 51.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.366 -0.379 . . . . 0.14000000000000001 110.223 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.633 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -90.69 -42.85 10.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.774 -0.824 . . . . 0.54000000000000004 108.774 179.748 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 144' ' ' HIS . 67.5 m -146.1 111.31 5.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.249 -0.887 . . . . 0.76000000000000001 110.659 -178.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.756 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 7.6 p -108.52 137.84 45.81 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.255 -0.646 . . . . 0.71999999999999997 109.255 172.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -136.58 131.24 33.52 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.957 0.408 . . . . 1.0 111.418 -174.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.708 HG22 HD12 ' A' ' 115' ' ' LEU . 91.0 t -114.78 113.74 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.823 0 N-CA-C 106.738 -1.579 . . . . 0.28000000000000003 106.738 170.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 8.9 t -82.61 114.61 23.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.718 -0.845 . . . . 0.34000000000000002 108.718 -176.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.905 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 64.3 m -109.13 141.62 41.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.457 -0.792 . . . . 1.5800000000000001 112.759 -165.503 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.41 171.74 10.34 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.104 -1.073 . . . . 2.0800000000000001 108.104 170.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -61.2 -25.21 66.88 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.008 0.373 . . . . 2.4500000000000002 112.008 -177.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -92.71 -12.28 31.84 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 120.827 -0.349 . . . . 1.6499999999999999 111.242 -177.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.702 ' HA3' ' HB2' ' A' ' 108' ' ' LYS . . . 165.64 -68.0 0.2 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 119.923 -1.132 . . . . 1.1200000000000001 114.241 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.905 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 33.3 t -156.62 153.8 29.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.721 0.761 . . . . 1.6100000000000001 111.261 -174.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -88.08 -8.6 55.26 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.079 0.466 . . . . 1.51 110.21 178.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 107.42 -16.64 37.74 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.45 -0.881 . . . . 0.31 114.076 174.029 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -126.34 152.52 46.12 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.373 0.587 . . . . 0.48999999999999999 111.753 -174.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -145.43 174.14 25.56 Favored Glycine 0 N--CA 1.449 -0.489 0 CA-C-N 115.538 -0.755 . . . . 0.12 111.694 -178.887 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -139.5 139.3 36.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.877 0.339 . . . . 0.25 110.728 -177.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.483 ' HB ' HG12 ' A' ' 101' ' ' ILE . 42.6 t -113.85 133.81 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-O 121.05 0.452 . . . . 0.10000000000000001 110.854 172.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 127' ' ' SER . 0.6 OUTLIER -105.37 106.09 16.43 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.708 -0.678 . . . . 0.20999999999999999 109.186 167.986 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.541 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 14.6 m-85 -89.68 140.04 29.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.336 0.589 . . . . 0.17000000000000001 111.264 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.633 ' HA ' HD21 ' A' ' 126' ' ' LEU . 36.5 tt0 -53.43 -43.18 67.81 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.54 -1.209 . . . . 0.56999999999999995 110.087 177.228 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 17.5 p -114.28 144.52 43.1 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.405 -1.27 . . . . 0.40000000000000002 111.337 -178.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -62.4 -38.02 88.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.376 -0.829 . . . . 0.46999999999999997 111.064 179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.27 -35.95 76.6 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.451 -0.341 . . . . 0.73999999999999999 111.83 -176.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.83 -34.69 78.5 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.344 0.592 . . . . 0.17999999999999999 110.33 -179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.541 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -62.21 -40.88 97.58 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.25 -0.886 . . . . 0.16 111.194 178.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.61 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 1.9 mm-40 -68.37 -36.32 79.02 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.018 -0.537 . . . . 1.4199999999999999 110.278 -179.082 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.471 ' O ' ' HG3' ' A' ' 156' ' ' GLU . 90.4 mtt180 -60.21 -42.89 96.11 Favored 'General case' 0 CA--C 1.523 -0.095 0 CA-C-N 116.099 -0.5 . . . . 1.48 110.362 175.096 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.47 -37.34 87.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.96 -0.563 . . . . 0.10000000000000001 110.651 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 151' ' ' ALA . 76.1 mt -63.02 -53.99 39.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.542 -0.299 . . . . 0.14999999999999999 110.921 178.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.61 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 1.9 pt-20 -61.55 -43.09 99.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.066 0.46 . . . . 1.0800000000000001 111.764 -179.112 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 153' ' ' ARG . 0.0 OUTLIER -81.6 -39.04 25.1 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 113.172 0.804 . . . . 1.1599999999999999 113.172 -171.415 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . . . . . . . . . 90.9 mmm -93.22 -18.98 21.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.616 0.599 . . . . 0.34999999999999998 112.616 -172.802 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -70.5 122.56 19.91 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.615 -0.834 . . . . 0.44 109.096 176.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.35 77.09 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.715 -0.755 . . . . 0.28999999999999998 112.009 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . . . . . . . . . 2.8 tpt -93.16 151.4 19.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.157 -0.682 . . . . 1.1799999999999999 109.157 179.253 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 18.1 mt -96.45 107.46 19.86 Favored 'General case' 0 CA--C 1.502 -0.897 0 N-CA-C 109.437 -0.579 . . . . 0.44 109.437 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 118' ' ' THR . 11.5 mt -92.38 108.1 19.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.489 -0.884 . . . . 1.02 109.369 172.416 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 5.4 m-20 77.41 -33.43 0.19 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.397 -0.82 . . . . 1.71 111.986 176.246 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.423 ' H ' ' C ' ' A' ' 163' ' ' LEU . 27.1 t70 168.54 -19.78 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.115 -0.948 . . . . 0.84999999999999998 111.889 -174.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -107.45 136.72 46.76 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.644 0.259 . . . . 0.95999999999999996 110.478 -172.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -80.83 116.38 20.79 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.359 -0.608 . . . . 1.0 109.359 -178.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.42 HG11 HD23 ' A' ' 106' ' ' LEU . 16.0 m -100.45 146.68 8.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-O 121.677 0.751 . . . . 0.17000000000000001 111.124 -173.186 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.422 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 55.6 t80 -105.98 119.19 38.55 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.718 -1.128 . . . . 0.29999999999999999 109.083 179.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.536 HG22 HG12 ' A' ' 103' ' ' ILE . 43.4 t -116.1 129.7 72.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.077 0.465 . . . . 0.13 109.849 179.101 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.6 177.72 25.69 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 111.04 -0.824 . . . . 0.17999999999999999 111.04 176.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.95 141.99 56.82 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.156 -0.313 . . . . 1.9299999999999999 110.156 179.4 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -56.56 100.63 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.361 0.413 . . . . 1.4399999999999999 110.213 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 64.4 pttt -83.11 148.63 27.38 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.125 0.488 . . . . 4.6600000000000001 111.957 -172.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 176' ' ' ARG . 6.4 m -88.33 -169.85 2.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.311 -0.996 . . . . 3.6000000000000001 108.311 170.19 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 175' ' ' SER . 35.6 ttm180 76.37 -8.2 1.69 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.133 0.492 . . . . 7.5999999999999996 111.161 172.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -62.05 -20.63 64.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.479 0.657 . . . . 8.6099999999999994 109.483 172.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -120.55 146.64 46.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.125 -0.943 . . . . 8.5500000000000007 109.33 172.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -104.39 -9.49 18.42 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.447 -0.575 . . . . 12.18 109.447 174.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 68.94 17.84 8.58 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.053 -0.976 . . . . 12.699999999999999 109.253 -173.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -165.94 111.0 0.84 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.245 -0.889 . . . . 13.65 109.793 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.749 -0.643 . . . . 15.050000000000001 110.093 -178.032 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.513 0 N-CA-C 112.069 -0.412 . . . . 14.85 112.069 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -135.91 174.87 10.14 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.025 -0.361 . . . . 13.5 110.025 178.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -107.06 98.55 22.37 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.688 -0.486 . . . . 11.25 109.688 178.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -84.97 156.66 11.47 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.275 1.983 . . . . 11.140000000000001 111.94 -179.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.7 m 69.71 -36.87 0.36 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.061 0.545 . . . . 9.3000000000000007 112.208 -179.888 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 96' ' ' SER . 36.2 tp -85.77 132.46 34.12 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.029 -0.73 . . . . 7.8899999999999997 109.029 178.473 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.465 HH11 ' HD2' ' A' ' 94' ' ' ARG . 39.2 ttm180 -102.72 -56.33 2.26 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.637 -0.425 . . . . 7.7800000000000002 111.005 -171.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -125.49 83.79 2.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.314 -0.403 . . . . 2.3700000000000001 110.359 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.497 ' HB3' HD21 ' A' ' 93' ' ' LEU . 10.2 p -63.03 -27.19 69.24 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 111.762 0.282 . . . . 1.79 111.762 -178.328 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -62.02 -35.17 91.03 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.926 -0.654 . . . . 0.44 112.761 179.3 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 54.6 t 61.51 126.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 123.366 0.666 . . . . 0.70999999999999996 112.763 -176.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.58 25.26 74.59 Favored Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 119.655 -1.26 . . . . 0.20999999999999999 111.433 176.248 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.497 HD22 ' N ' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -88.4 124.17 33.68 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.594 -0.521 . . . . 0.63 109.594 -172.65 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.598 HG12 ' HB ' ' A' ' 143' ' ' VAL . 34.8 pt -135.05 151.75 31.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.765 -0.457 . . . . 0.14999999999999999 109.765 176.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.613 ' HB3' ' HB2' ' A' ' 173' ' ' PHE . 0.1 OUTLIER -119.81 141.23 49.69 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.566 -0.531 . . . . 0.20999999999999999 109.566 178.633 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.567 HG12 HG22 ' A' ' 170' ' ' VAL . 5.2 mt -119.34 129.54 75.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.653 -0.703 . . . . 0.14999999999999999 110.064 -176.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 8.5 ttpp -112.45 151.62 29.67 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.682 -0.235 . . . . 1.46 110.616 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.9 t30 73.69 36.7 0.73 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.97 0.794 . . . . 0.48999999999999999 111.629 172.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 110' ' ' ILE . 18.3 mt -76.15 154.36 35.48 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.101 0.477 . . . . 0.26000000000000001 111.261 177.089 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.452 ' HA ' ' HD2' ' A' ' 166' ' ' ARG . 13.5 t70 -78.33 149.98 33.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.465 -0.789 . . . . 0.70999999999999996 109.514 174.003 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -68.63 -26.65 65.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.924 0.392 . . . . 2.2000000000000002 110.881 -175.045 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 m -72.65 -7.87 52.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.045 -0.525 . . . . 1.4099999999999999 111.292 178.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 106' ' ' LEU . 31.9 mm -79.12 113.75 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 121.106 0.479 . . . . 0.26000000000000001 109.95 178.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 114' ' ' ALA . 11.2 t70 -99.3 -176.25 3.25 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.679 -0.692 . . . . 1.5900000000000001 109.223 -178.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -66.96 -34.45 77.79 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 108.08 -1.081 . . . . 0.59999999999999998 108.08 -179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -47.83 66.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 114.137 -1.392 . . . . 2.5800000000000001 109.269 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HB3' ' H ' ' A' ' 111' ' ' ASP . . . -60.84 -44.05 97.47 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.047 -1.433 . . . . 0.14999999999999999 110.963 -178.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.609 HD12 HG22 ' A' ' 130' ' ' VAL . 3.9 tt -65.82 -46.74 77.47 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.361 -0.836 . . . . 0.16 109.238 177.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.747 ' HB2' ' SG ' ' A' ' 128' ' ' CYS . 49.1 t80 -59.93 -46.95 87.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.29999999999999999 110.831 176.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -56.46 -41.45 76.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.96 0.409 . . . . 0.40000000000000002 110.985 -175.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.409 HG21 HD21 ' A' ' 163' ' ' LEU . 19.2 m -77.18 -52.66 8.87 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.86 -0.609 . . . . 0.22 111.902 -176.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -72.91 -28.26 62.36 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.46 0.541 . . . . 0.11 112.46 -174.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.8 t -57.81 -28.43 64.03 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.649 0.262 . . . . 0.19 111.444 -177.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.41 -21.18 23.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.835 0.35 . . . . 0.14000000000000001 111.499 177.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -94.95 -14.15 24.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.81 0.338 . . . . 0.17999999999999999 111.066 -179.374 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 163.65 166.55 22.68 Favored Glycine 0 N--CA 1.448 -0.51 0 CA-C-N 116.037 -0.529 . . . . 0.11 111.898 179.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -69.49 138.7 53.61 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.896 -0.409 . . . . 0.25 109.896 178.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.417 HG21 ' HB3' ' A' ' 128' ' ' CYS . 67.7 mt -111.11 134.09 54.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.98 -0.554 . . . . 0.14000000000000001 109.751 -179.065 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.576 HD21 ' HA ' ' A' ' 146' ' ' GLU . 0.2 OUTLIER -88.18 -50.65 6.24 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.435 -0.95 . . . . 0.54000000000000004 108.435 179.93 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.3 m -138.01 99.14 3.81 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 114.801 -1.091 . . . . 0.76000000000000001 110.72 -176.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.747 ' SG ' ' HB2' ' A' ' 116' ' ' TYR . 0.8 OUTLIER -97.98 139.95 33.05 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.165 -0.679 . . . . 0.71999999999999997 109.165 172.512 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -139.2 129.3 25.22 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.507 -0.477 . . . . 1.0 111.634 -172.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.609 HG22 HD12 ' A' ' 115' ' ' LEU . 95.8 t -114.14 109.27 27.88 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 106.573 -1.64 . . . . 0.28000000000000003 106.573 168.148 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 t -79.1 131.41 34.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 115.693 -0.685 . . . . 0.34000000000000002 109.783 -172.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 137' ' ' SER . 1.5 p -95.24 133.87 38.63 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.773 0.796 . . . . 1.5800000000000001 111.394 -170.096 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.662 ' HB2' ' HA ' ' A' ' 138' ' ' LYS . 16.7 t70 -87.61 164.85 15.84 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 114.443 -1.253 . . . . 2.0800000000000001 108.579 -178.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -60.3 -25.4 65.72 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.378 0.609 . . . . 2.4500000000000002 109.494 171.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ASN . . . . . . . . . . . . . 56.2 m-80 -92.51 4.32 53.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.291 -0.868 . . . . 1.6499999999999999 110.736 178.281 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 127.82 -71.35 0.49 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.579 -0.82 . . . . 1.1200000000000001 113.765 -179.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 132' ' ' CYS . 30.5 m -134.85 132.34 38.49 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 117.582 0.691 . . . . 1.6100000000000001 109.801 -176.109 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.662 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 29.7 mtpt -70.82 -20.29 62.58 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.462 0.542 . . . . 1.51 112.462 -169.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 109.08 -13.15 34.17 Favored Glycine 0 C--N 1.313 -0.732 0 C-N-CA 120.397 -0.906 . . . . 0.31 113.243 177.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -133.99 155.32 50.18 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.85 0.357 . . . . 0.48999999999999999 111.001 -177.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -144.6 175.28 24.4 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.81 -0.632 . . . . 0.12 111.938 -178.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -137.06 139.33 41.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.547 0.173 . . . . 0.25 110.838 -177.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.598 ' HB ' HG12 ' A' ' 101' ' ' ILE . 41.9 t -112.09 132.93 59.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.881 0.372 . . . . 0.10000000000000001 110.578 171.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . 0.413 ' CD2' ' ND2' ' A' ' 100' ' ' ASN . 0.8 OUTLIER -104.16 106.05 16.41 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.082 -0.71 . . . . 0.20999999999999999 109.082 167.405 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.488 ' CD2' ' HA ' ' A' ' 151' ' ' ALA . 20.0 m-85 -87.7 138.62 31.31 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.331 0.586 . . . . 0.17000000000000001 111.155 179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.576 ' HA ' HD21 ' A' ' 126' ' ' LEU . 38.9 tt0 -49.01 -39.47 27.02 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.038 -1.437 . . . . 0.56999999999999995 110.715 178.205 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.5 p -125.61 152.62 44.9 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.833 -1.076 . . . . 0.40000000000000002 110.663 -179.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 -66.94 -31.07 71.4 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.915 -0.584 . . . . 0.46999999999999997 110.977 -177.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.65 -35.15 74.92 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.039 0.385 . . . . 0.73999999999999999 112.039 -178.126 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -64.8 -34.61 78.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.11 0.481 . . . . 0.17999999999999999 110.711 -178.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.488 ' HA ' ' CD2' ' A' ' 145' ' ' PHE . . . -63.97 -43.85 94.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.506 -0.77 . . . . 0.16 111.252 -179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.587 ' O ' ' HG2' ' A' ' 156' ' ' GLU . 33.5 mt-10 -58.68 -41.9 87.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 1.4199999999999999 110.638 179.242 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.457 HH11 ' HD2' ' A' ' 153' ' ' ARG . 65.2 mtt85 -61.27 -44.52 97.1 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.259 -0.428 . . . . 1.48 111.285 177.354 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.74 -37.4 84.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.374 -0.376 . . . . 0.10000000000000001 110.713 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 151' ' ' ALA . 87.3 mt -62.41 -54.48 33.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.381 -0.372 . . . . 0.14999999999999999 111.081 178.154 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.587 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 2.9 pt-20 -62.72 -40.24 96.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.983 0.42 . . . . 1.0800000000000001 111.814 -177.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' A' ' 157' ' ' LYS . 0.1 OUTLIER -82.35 -38.66 23.9 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.872 0.693 . . . . 1.1599999999999999 112.872 -172.746 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' MET . . . . . 0.409 ' HB2' HG21 ' A' ' 170' ' ' VAL . 90.5 mmm -93.2 -26.8 17.22 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.549 0.574 . . . . 0.34999999999999998 112.549 -173.266 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -64.85 123.4 19.3 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.131 -0.628 . . . . 0.44 109.383 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.79 19.51 56.07 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.635 -0.793 . . . . 0.28999999999999998 112.557 -179.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.61 ' O ' ' HA ' ' A' ' 167' ' ' LYS . 3.4 mmt -105.15 156.35 18.17 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 122.788 -0.243 . . . . 1.1799999999999999 110.861 176.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 162' ' ' LEU . 14.4 mt -98.27 97.45 8.84 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.455 -0.572 . . . . 0.44 109.455 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 164' ' ' ASN . 18.1 mt -81.82 105.07 12.66 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 119.469 -0.893 . . . . 1.02 109.068 174.382 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 163' ' ' LEU . 86.4 m-20 74.1 -66.67 0.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 114.974 -1.012 . . . . 1.71 111.909 -177.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -156.47 6.84 0.19 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 115.854 -0.612 . . . . 0.84999999999999998 111.686 -177.184 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 107' ' ' ASP . 95.2 mtt180 -134.39 128.34 33.41 Favored 'General case' 0 C--N 1.32 -0.676 0 O-C-N 121.769 -0.582 . . . . 0.95999999999999996 110.255 -172.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 161' ' ' MET . 17.0 tttt -76.66 119.77 20.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.836 -0.62 . . . . 1.0 109.483 -178.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.452 HG11 HD23 ' A' ' 106' ' ' LEU . 15.9 m -100.73 144.51 12.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.491 0.662 . . . . 0.17000000000000001 111.365 -172.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 72.9 t80 -106.82 119.76 40.21 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.687 -1.142 . . . . 0.29999999999999999 109.325 -179.899 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.567 HG22 HG12 ' A' ' 103' ' ' ILE . 40.6 t -115.63 128.82 72.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.501 -0.555 . . . . 0.13 109.501 178.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -147.28 -175.02 19.79 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.64 -0.79 . . . . 0.17999999999999999 112.356 -179.452 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -70.33 119.5 14.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.895 0.378 . . . . 1.9299999999999999 110.729 -177.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' PHE . . . . . 0.613 ' HB2' ' HB3' ' A' ' 102' ' ' PHE . 4.3 t80 -105.12 116.82 32.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.753 -0.658 . . . . 1.4399999999999999 109.732 -179.375 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.55 147.61 25.73 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.854 -0.612 . . . . 4.6600000000000001 111.102 -178.372 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.7 p -71.12 -39.89 71.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.661 -0.699 . . . . 3.6000000000000001 111.534 -177.072 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 60.8 -101.44 0.11 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 122.629 0.372 . . . . 7.5999999999999996 110.71 -178.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -119.72 5.81 10.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.632 0.73 . . . . 8.6099999999999994 109.52 176.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -98.65 68.08 1.78 Allowed 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.273 -0.876 . . . . 8.5500000000000007 110.006 -177.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 73.5 ttt180 -105.03 42.48 1.21 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.255 -1.017 . . . . 12.18 108.255 175.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -89.16 -34.52 16.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.926 -1.034 . . . . 12.699999999999999 110.994 -174.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -72.07 109.24 5.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.165 -0.471 . . . . 13.65 109.921 -179.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.205 -0.902 . . . . 15.050000000000001 109.803 -175.661 . . . . . . . . 0 0 . 1 stop_ save_